{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Requirement already satisfied: biopython in c:\\users\\kaitb\\anaconda3\\lib\\site-packages (1.78)\n",
      "Requirement already satisfied: numpy in c:\\users\\kaitb\\anaconda3\\lib\\site-packages (from biopython) (1.19.2)\n"
     ]
    }
   ],
   "source": [
    "#installing Biopython to assist with accessing API to obtain data from PubMed\n",
    "!pip install biopython"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "#setting up filenames\n",
    "absts_filename = \"cardiac_absts.txt\"\n",
    "absts_annotations_filename = \"cardiac_absts_pubtator_annotations.xml\"\n",
    "reports_filename = \"cardiac_fulltexts.xml\"\n",
    "reports_annotations_filename = \"cardiac_fulltexts_pubtator_annotations.xml\"\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'Count': '233', 'RetMax': '200', 'RetStart': '0', 'IdList': ['32938215', '32806897', '32704130', '32487995', '32427855', '32385381', '32178279', '32117548', '31988066', '31918764', '31862877', '31844116', '31825151', '31819116', '31806903', '31783201', '31734660', '31585756', '31562990', '31494943', '31476444', '31434864', '31286493', '31242583', '31204432', '31186442', '31104495', '31092728', '31056672', '30928653', '30922315', '30907085', '30887811', '30874584', '30870787', '30838756', '30836973', '30806752', '30805593', '30782942', '30742448', '30739867', '30658193', '30571344', '30562113', '30496173', '30478197', '30451909', '30368668', '30347343', '30332462', '30261322', '30255987', '30248148', '30224653', '30212933', '30201848', '30192561', '30002058', '29956481', '29915101', '29854824', '29853569', '29784904', '29717219', '29682908', '29676857', '29665821', '29649363', '29540862', '29505607', '29484645', '29369166', '29320704', '29258991', '29258006', '29251807', '29235871', '29215023', '29158831', '29151592', '28922609', '28800743', '28794502', '28784649', '28720870', '28679606', '28624389', '28501389', '28437237', '28427148', '28341603', '28329269', '28273075', '28256566', '28223106', '28209220', '28196416', '27908912', '27616206', '27711126', '27624754', '27450324', '27429122', '27412778', '27363418', '27308822', '27230659', '27220540', '27122311', '27095521', '27084846', '26898369', '26834087', '26792056', '26750556', '26688386', '26653129', '26620461', '26603189', '26564600', '26561523', '26535788', '26483418', '26476107', '26437904', '26285659', '26160894', '26078484', '26063667', '26037829', '26028931', '25995210', '25945665', '25944670', '25905469', '25857276', '25786980', '25684225', '25666440', '25548805', '25424990', '25397948', '25382018', '25341944', '25318410', '25226522', '25217443', '25117565', '25099258', '25083839', '25072840', '25065337', '24859250', '24780726', '24738046', '24689886', '24548642', '24182678', '24140280', '24055733', '23974919', '23916682', '23836408', '23804534', '23797974', '23704777', '23701180', '23660474', '23593175', '23519648', '23431486', '23384050', '23195030', '23160667', '23002038', '22959663', '22789915', '22781565', '22665935', '22543060', '22435364', '22384053', '22276806', '22221959', '21767674', '21751358', '21736391', '21712045', '21681990', '21593211', '21545686', '21468545', '21211997', '21166718', '21043527', '21041689', '20936781', '20936720', '20853909'], 'TranslationSet': [{'From': 'cardiac', 'To': '\"heart\"[MeSH Terms] OR \"heart\"[All Fields] OR \"cardiac\"[All Fields]'}, {'From': 'proteome', 'To': '\"proteome\"[MeSH Terms] OR \"proteome\"[All Fields]'}, {'From': 'Adults[MeSH Terms]', 'To': '\"adult\"[MeSH Terms]'}], 'TranslationStack': [{'Term': '\"heart\"[MeSH Terms]', 'Field': 'MeSH Terms', 'Count': '509786', 'Explode': 'Y'}, {'Term': '\"heart\"[All Fields]', 'Field': 'All Fields', 'Count': '1466370', 'Explode': 'N'}, 'OR', {'Term': '\"cardiac\"[All Fields]', 'Field': 'All Fields', 'Count': '827195', 'Explode': 'N'}, 'OR', 'GROUP', {'Term': '\"proteome\"[MeSH Terms]', 'Field': 'MeSH Terms', 'Count': '32242', 'Explode': 'Y'}, {'Term': '\"proteome\"[All Fields]', 'Field': 'All Fields', 'Count': '59532', 'Explode': 'N'}, 'OR', 'GROUP', 'AND', {'Term': '\"adult\"[MeSH Terms]', 'Field': 'MeSH Terms', 'Count': '7332326', 'Explode': 'Y'}, 'AND', 'GROUP'], 'QueryTranslation': '(\"heart\"[MeSH Terms] OR \"heart\"[All Fields] OR \"cardiac\"[All Fields]) AND (\"proteome\"[MeSH Terms] OR \"proteome\"[All Fields]) AND \"adult\"[MeSH Terms]'}\n",
      "['32938215', '32806897', '32704130', '32487995', '32427855', '32385381', '32178279', '32117548', '31988066', '31918764', '31862877', '31844116', '31825151', '31819116', '31806903', '31783201', '31734660', '31585756', '31562990', '31494943', '31476444', '31434864', '31286493', '31242583', '31204432', '31186442', '31104495', '31092728', '31056672', '30928653', '30922315', '30907085', '30887811', '30874584', '30870787', '30838756', '30836973', '30806752', '30805593', '30782942', '30742448', '30739867', '30658193', '30571344', '30562113', '30496173', '30478197', '30451909', '30368668', '30347343', '30332462', '30261322', '30255987', '30248148', '30224653', '30212933', '30201848', '30192561', '30002058', '29956481', '29915101', '29854824', '29853569', '29784904', '29717219', '29682908', '29676857', '29665821', '29649363', '29540862', '29505607', '29484645', '29369166', '29320704', '29258991', '29258006', '29251807', '29235871', '29215023', '29158831', '29151592', '28922609', '28800743', '28794502', '28784649', '28720870', '28679606', '28624389', '28501389', '28437237', '28427148', '28341603', '28329269', '28273075', '28256566', '28223106', '28209220', '28196416', '27908912', '27616206', '27711126', '27624754', '27450324', '27429122', '27412778', '27363418', '27308822', '27230659', '27220540', '27122311', '27095521', '27084846', '26898369', '26834087', '26792056', '26750556', '26688386', '26653129', '26620461', '26603189', '26564600', '26561523', '26535788', '26483418', '26476107', '26437904', '26285659', '26160894', '26078484', '26063667', '26037829', '26028931', '25995210', '25945665', '25944670', '25905469', '25857276', '25786980', '25684225', '25666440', '25548805', '25424990', '25397948', '25382018', '25341944', '25318410', '25226522', '25217443', '25117565', '25099258', '25083839', '25072840', '25065337', '24859250', '24780726', '24738046', '24689886', '24548642', '24182678', '24140280', '24055733', '23974919', '23916682', '23836408', '23804534', '23797974', '23704777', '23701180', '23660474', '23593175', '23519648', '23431486', '23384050', '23195030', '23160667', '23002038', '22959663', '22789915', '22781565', '22665935', '22543060', '22435364', '22384053', '22276806', '22221959', '21767674', '21751358', '21736391', '21712045', '21681990', '21593211', '21545686', '21468545', '21211997', '21166718', '21043527', '21041689', '20936781', '20936720', '20853909']\n"
     ]
    }
   ],
   "source": [
    "#downloading set of PubMed records through the API\n",
    "from Bio import Entrez\n",
    "Entrez.email = \"kbali01@g.ucla.edu\"  # Write your email address in between the quotes\n",
    "search_term = \"((cardiac) AND (proteome)AND Adults[MeSH Terms])\"\n",
    "handle = Entrez.esearch(db=\"pubmed\", term=search_term, retmax=200) #We don't know how many results there will be, but we can set retmax to up to 10,000 to get that many results.\n",
    "record = Entrez.read(handle)\n",
    "handle.close()\n",
    "\n",
    "#prints the list of PubMed IDs\n",
    "print(record)\n",
    "idlist = record['IdList']\n",
    "print(idlist)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'PMID': '32938215', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20201214', 'LR': '20201214', 'IS': '1524-4636 (Electronic) 1079-5642 (Linking)', 'VI': '40', 'IP': '11', 'DP': '2020 Nov', 'TI': 'Free Thiol beta2-GPI (beta-2-Glycoprotein-I) Provides a Link Between Inflammation and Oxidative Stress in Atherosclerotic Coronary Artery Disease.', 'PG': '2794-2804', 'LID': '10.1161/ATVBAHA.120.315156 [doi]', 'AB': 'OBJECTIVE: Atherosclerotic coronary artery disease is well recognised as an inflammatory disorder that is also influenced by oxidative stress. beta2-GPI (beta-2-glycoprotein-I) is a circulating plasma protein that undergoes post-translational modification and exists in free thiol as well as oxidized forms. The aim of this study was to assess the association between these 2 post-translational redox forms of beta2-GPI and atherosclerotic coronary artery disease. Approach and Results: Stable patients presenting for elective coronary angiography or CT coronary angiography were prospectively recruited. A separate group of patients after reperfused ST-segment-elevation myocardial infarction formed an acute coronary syndrome subgroup. All patients had collection of fasting serum and plasma for quantification of total and free thiol beta2-GPI. Coronary artery disease extent was quantified by the Syntax and Gensini scores. A total of 552 patients with stable disease and 44 with acute coronary syndrome were recruited. While total beta2-GPI was not associated with stable coronary artery disease, a higher free thiol beta2-GPI was associated with its presence and extent. This finding remained significant after correcting for confounding variables, and free thiol beta2-GPI was a better predictor of stable coronary artery disease than hs-CRP (high-sensitivity C-reactive protein). Paradoxically, there were lower levels of free thiol beta2-GPI after ST-segment-elevation myocardial infarction. CONCLUSIONS: Free thiol beta2-GPI is a predictor of coronary artery disease presence and extent in stable patients. Free thiol beta2-GPI was a better predictor than high-sensitivity C-reactive protein.', 'FAU': ['Weaver, James C', 'Ullah, Inaam', 'Qi, Miao', 'Giannakopoulos, Bill', 'Rye, Kerry Anne', 'Kockx, Maaike', 'Kritharides, Leonard', 'Krilis, Steven A'], 'AU': ['Weaver JC', 'Ullah I', 'Qi M', 'Giannakopoulos B', 'Rye KA', 'Kockx M', 'Kritharides L', 'Krilis SA'], 'AD': ['University of NSW, Sydney, Australia (J.C.W., I.U., M.Q., B.G., K.A.R., S.A.K.).', 'Department of Cardiology, Royal Prince Alfred Hospital, Camperdown, Sydney, Australia (J.C.W.).', 'University of NSW, Sydney, Australia (J.C.W., I.U., M.Q., B.G., K.A.R., S.A.K.).', 'Department of Cardiology, St George Hospital, Kogarah, Sydney, Australia (I.U.).', 'University of NSW, Sydney, Australia (J.C.W., I.U., M.Q., B.G., K.A.R., S.A.K.).', 'Department of Infectious Disease, Immunology and Sexual Health, St George Hospital, Kogarah, Sydney, Australia (M.Q., B.G., S.A.K.).', 'University of NSW, Sydney, Australia (J.C.W., I.U., M.Q., B.G., K.A.R., S.A.K.).', 'Department of Infectious Disease, Immunology and Sexual Health, St George Hospital, Kogarah, Sydney, Australia (M.Q., B.G., S.A.K.).', 'Department of Rheumatology, St George Hospital, Kogarah, Sydney, Australia (B.G.).', 'University of NSW, Sydney, Australia (J.C.W., I.U., M.Q., B.G., K.A.R., S.A.K.).', 'ANZAC Research Institute, University of Sydney, Concord, Australia (M.K., L.K.).', 'ANZAC Research Institute, University of Sydney, Concord, Australia (M.K., L.K.).', 'Department of Cardiology, Concord Hospital, Sydney, Australia (L.K.).', 'University of NSW, Sydney, Australia (J.C.W., I.U., M.Q., B.G., K.A.R., S.A.K.).', 'Department of Infectious Disease, Immunology and Sexual Health, St George Hospital, Kogarah, Sydney, Australia (M.Q., B.G., S.A.K.).'], 'LA': ['eng'], 'PT': ['Comparative Study', 'Journal Article'], 'DEP': '20200917', 'PL': 'United States', 'TA': 'Arterioscler Thromb Vasc Biol', 'JT': 'Arteriosclerosis, thrombosis, and vascular biology', 'JID': '9505803', 'RN': ['0 (Biomarkers)', '0 (Inflammation Mediators)', '0 (Lipids)', '0 (beta 2-Glycoprotein I)', '9007-41-4 (C-Reactive Protein)'], 'SB': 'IM', 'MH': ['Acute Coronary Syndrome/blood/diagnostic imaging', 'Aged', 'Biomarkers/blood', 'C-Reactive Protein/analysis', 'Coronary Angiography', 'Coronary Artery Disease/*blood/diagnostic imaging', 'Female', 'Heart Disease Risk Factors', 'Humans', 'Inflammation/*blood/diagnosis', 'Inflammation Mediators/blood', 'Lipids/blood', 'Male', 'Middle Aged', 'Oxidation-Reduction', '*Oxidative Stress', 'Predictive Value of Tests', 'Prospective Studies', 'ST Elevation Myocardial Infarction/blood/diagnostic imaging', 'beta 2-Glycoprotein I/*blood'], 'OTO': ['NOTNLM'], 'OT': ['*coronary angiography', '*coronary artery disease', '*cysteine', '*metabolome', '*proteome'], 'EDAT': '2020/09/18 06:00', 'MHDA': '2020/12/15 06:00', 'CRDT': ['2020/09/17 05:29'], 'PHST': ['2020/09/18 06:00 [pubmed]', '2020/12/15 06:00 [medline]', '2020/09/17 05:29 [entrez]'], 'AID': ['10.1161/ATVBAHA.120.315156 [doi]'], 'PST': 'ppublish', 'SO': 'Arterioscler Thromb Vasc Biol. 2020 Nov;40(11):2794-2804. doi: 10.1161/ATVBAHA.120.315156. Epub 2020 Sep 17.'}\n",
      "{'PMID': '32806897', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20201130', 'LR': '20201218', 'IS': '1535-3907 (Electronic) 1535-3893 (Linking)', 'VI': '19', 'IP': '11', 'DP': '2020 Nov 6', 'TI': 'Integrative Modeling of Quantitative Plasma Lipoprotein, Metabolic, and Amino Acid Data Reveals a Multiorgan Pathological Signature of SARS-CoV-2 Infection.', 'PG': '4442-4454', 'LID': '10.1021/acs.jproteome.0c00519 [doi]', 'AB': \"The metabolic effects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection on human blood plasma were characterized using multiplatform metabolic phenotyping with nuclear magnetic resonance (NMR) spectroscopy and liquid chromatography-mass spectrometry (LC-MS). Quantitative measurements of lipoprotein subfractions, alpha-1-acid glycoprotein, glucose, and biogenic amines were made on samples from symptomatic coronavirus disease 19 (COVID-19) patients who had tested positive for the SARS-CoV-2 virus (n = 17) and from age- and gender-matched controls (n = 25). Data were analyzed using an orthogonal-projections to latent structures (OPLS) method and used to construct an exceptionally strong (AUROC = 1) hybrid NMR-MS model that enabled detailed metabolic discrimination between the groups and their biochemical relationships. Key discriminant metabolites included markers of inflammation including elevated alpha-1-acid glycoprotein and an increased kynurenine/tryptophan ratio. There was also an abnormal lipoprotein, glucose, and amino acid signature consistent with diabetes and coronary artery disease (low total and HDL Apolipoprotein A1, low HDL triglycerides, high LDL and VLDL triglycerides), plus multiple highly significant amino acid markers of liver dysfunction (including the elevated glutamine/glutamate and Fischer's ratios) that present themselves as part of a distinct SARS-CoV-2 infection pattern. A multivariate training-test set model was validated using independent samples from additional SARS-CoV-2 positive patients and controls. The predictive model showed a sensitivity of 100% for SARS-CoV-2 positivity. The breadth of the disturbed pathways indicates a systemic signature of SARS-CoV-2 positivity that includes elements of liver dysfunction, dyslipidemia, diabetes, and coronary heart disease risk that are consistent with recent reports that COVID-19 is a systemic disease affecting multiple organs and systems. Metabolights study reference: MTBLS2014.\", 'FAU': ['Kimhofer, Torben', 'Lodge, Samantha', 'Whiley, Luke', 'Gray, Nicola', 'Loo, Ruey Leng', 'Lawler, Nathan G', 'Nitschke, Philipp', 'Bong, Sze-How', 'Morrison, David L', 'Begum, Sofina', 'Richards, Toby', 'Yeap, Bu B', 'Smith, Chris', 'Smith, Kenneth G C', 'Holmes, Elaine', 'Nicholson, Jeremy K'], 'AU': ['Kimhofer T', 'Lodge S', 'Whiley L', 'Gray N', 'Loo RL', 'Lawler NG', 'Nitschke P', 'Bong SH', 'Morrison DL', 'Begum S', 'Richards T', 'Yeap BB', 'Smith C', 'Smith KGC', 'Holmes E', 'Nicholson JK'], 'AUID': ['ORCID: 0000-0001-7158-9930', 'ORCID: 0000-0002-9088-4799', 'ORCID: 0000-0002-0094-5245', 'ORCID: 0000-0001-5307-5709', 'ORCID: 0000-0001-9649-425X', 'ORCID: 0000-0002-0556-8389'], 'AD': ['Australian National Phenome Centre, Computational and Systems Medicine, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, Western Australia 6150, Australia.', 'Australian National Phenome Centre, Computational and Systems Medicine, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, Western Australia 6150, Australia.', 'Australian National Phenome Centre, Computational and Systems Medicine, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, Western Australia 6150, Australia.', 'Perron Institute for Neurological and Translational Science, Nedlands, Western Australia 6009, Australia.', 'Australian National Phenome Centre, Computational and Systems Medicine, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, Western Australia 6150, Australia.', 'Australian National Phenome Centre, Computational and Systems Medicine, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, Western Australia 6150, Australia.', 'Australian National Phenome Centre, Computational and Systems Medicine, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, Western Australia 6150, Australia.', 'Australian National Phenome Centre, Computational and Systems Medicine, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, Western Australia 6150, Australia.', 'Australian National Phenome Centre, Computational and Systems Medicine, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, Western Australia 6150, Australia.', 'Australian National Phenome Centre, Computational and Systems Medicine, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, Western Australia 6150, Australia.', 'Section for Nutrition Research, Imperial College London, Sir Alexander Fleming Building, South Kensington, London SW7 2AZ, U.K.', 'Medical School, Faculty of Health and Medical Sciences, University of Western Australia, and Department of Endocrinology and Diabetes, Fiona Stanley Hospital, Harry Perkins Building, Murdoch, Perth, Western Australia 6150, Australia.', 'Medical School, Faculty of Health and Medical Sciences, University of Western Australia, and Department of Endocrinology and Diabetes, Fiona Stanley Hospital, Harry Perkins Building, Murdoch, Perth, Western Australia 6150, Australia.', \"The Cambridge Institute of Therapeutic Immunology and Infectious Disease, Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge CB2 0QQ, U.K.\", \"The Cambridge Institute of Therapeutic Immunology and Infectious Disease, Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge CB2 0QQ, U.K.\", 'Australian National Phenome Centre, Computational and Systems Medicine, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, Western Australia 6150, Australia.', 'Section for Nutrition Research, Imperial College London, Sir Alexander Fleming Building, South Kensington, London SW7 2AZ, U.K.', 'Australian National Phenome Centre, Computational and Systems Medicine, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, Western Australia 6150, Australia.', 'Medical School, Faculty of Health and Medical Sciences, University of Western Australia, and Department of Endocrinology and Diabetes, Fiona Stanley Hospital, Harry Perkins Building, Murdoch, Perth, Western Australia 6150, Australia.', 'Institute of Global Health Innovation, Imperial College London, Level 1, Faculty Building South Kensington Campus, London SW7 2AZ, U.K.'], 'LA': ['eng'], 'PT': ['Journal Article'], 'DEP': '20200914', 'PL': 'United States', 'TA': 'J Proteome Res', 'JT': 'Journal of proteome research', 'JID': '101128775', 'RN': ['0 (Amino Acids)', '0 (Biomarkers)', '0 (Blood Glucose)', '0 (Lipoproteins)'], 'SB': 'IM', 'MH': ['Aged', 'Amino Acids/*blood', 'Betacoronavirus', 'Biomarkers', 'Blood Glucose/analysis', 'COVID-19', '*Coronavirus Infections/blood/complications/epidemiology/metabolism', 'Female', 'Humans', 'Lipoproteins/*blood', 'Magnetic Resonance Spectroscopy', 'Male', 'Mass Spectrometry', 'Metabolome', 'Middle Aged', '*Models, Biological', '*Multiple Organ Failure/blood/etiology/metabolism', '*Pandemics', '*Pneumonia, Viral/blood/complications/epidemiology/metabolism', 'SARS-CoV-2'], 'PMC': 'PMC7489050', 'OTO': ['NOTNLM'], 'OT': ['*COVID-19', '*NMR spectroscopy', '*SARS-CoV-2', '*amino acids', '*biomarkers', '*lipoproteins', '*mass spectrometry', '*metabolic phenotyping', '*mosaic disease', '*multiorgan damage', '*systems model'], 'EDAT': '2020/08/19 06:00', 'MHDA': '2020/12/01 06:00', 'CRDT': ['2020/08/19 06:00'], 'PHST': ['2020/08/19 06:00 [pubmed]', '2020/12/01 06:00 [medline]', '2020/08/19 06:00 [entrez]'], 'AID': ['10.1021/acs.jproteome.0c00519 [doi]'], 'PST': 'ppublish', 'SO': 'J Proteome Res. 2020 Nov 6;19(11):4442-4454. doi: 10.1021/acs.jproteome.0c00519. Epub 2020 Sep 14.'}\n",
      "{'PMID': '32704130', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20201221', 'LR': '20201221', 'IS': '2045-2322 (Electronic) 2045-2322 (Linking)', 'VI': '10', 'IP': '1', 'DP': '2020 Jul 23', 'TI': 'Plasma extracellular vesicle proteins are associated with stress-induced myocardial ischemia in women presenting with chest pain.', 'PG': '12257', 'LID': '10.1038/s41598-020-69297-0 [doi]', 'AB': 'Diagnosing stable ischemic heart disease (IHD) is challenging, especially in females. Currently, no blood test is available. Plasma extracellular vesicles (EV) are emerging as potential biomarker source. We therefore aimed to identify stress induced ischemia due to stable IHD with plasma extracellular vesicle protein levels in chest pain patients. We analyzed 450 patients suspected for stable IHD who were referred for (82)Rb PET/CT in the outpatient clinic. Blood samples were collected before PET/CT and plasma EVs were isolated in 3 plasma subfractions named: TEX, HDL, LDL. In total 6 proteins were quantified in each of these subfractions using immuno-bead assays. CD14 and CystatinC protein levels were independent significant predictors of stress-induced ischemia in the LDL and the HDL subfraction and SerpinC1 and SerpinG1 protein levels in the HDL fraction. Subgroup-analysis on sex revealed that these associations were completely attributed to the associations in women. None of the significant EV proteins remained significant in men. Plasma EV proteins levels are associated with the presence of stable IHD in females presenting with chest pain. This finding, if confirmed in larger cohort studies could be a crucial step in improving diagnostic assessment of women with suspected IHD.', 'FAU': ['Dekker, Mirthe', 'Waissi, Farahnaz', 'van Bennekom, Joelle', 'Silvis, Max J M', 'Timmerman, Nathalie', 'Bank, Ingrid E M', 'Walter, Joan E', 'Mueller, Christian', 'Schoneveld, A H', 'Schiffelers, Raymond M', 'Pasterkamp, Gerard', 'Grobbee, Diederick E', 'de Winter, Robbert J', 'Mosterd, A', 'de Kleijn, Dominique P V', 'Timmers, Leo'], 'AU': ['Dekker M', 'Waissi F', 'van Bennekom J', 'Silvis MJM', 'Timmerman N', 'Bank IEM', 'Walter JE', 'Mueller C', 'Schoneveld AH', 'Schiffelers RM', 'Pasterkamp G', 'Grobbee DE', 'de Winter RJ', 'Mosterd A', 'de Kleijn DPV', 'Timmers L'], 'AD': ['Department of Vascular Surgery, University Medical Centre, Utrecht, the Netherlands. m.dekker-17@umcturecht.nl.', 'Department of Cardiology, Academic Medical Centre, Amsterdam, the Netherlands. m.dekker-17@umcturecht.nl.', 'Department of Cardiology, UMC Utrecht, Heidelberglaan 100, 3508GA, Utrecht, the Netherlands. m.dekker-17@umcturecht.nl.', 'Department of Vascular Surgery, University Medical Centre, Utrecht, the Netherlands.', 'Department of Cardiology, Academic Medical Centre, Amsterdam, the Netherlands.', 'Department of Vascular Surgery, University Medical Centre, Utrecht, the Netherlands.', 'Department of Cardiology, University Medical Centre, Utrecht, the Netherlands.', 'Department of Vascular Surgery, University Medical Centre, Utrecht, the Netherlands.', 'Department of Cardiology, St. Antonius Hospital, Nieuwegein, the Netherlands.', 'Department of Cardiology and Cardiovascular Research Institute Basel (CRIB), University Hospital Basel, University of Basel, Basel, Switzerland.', 'Department of Cardiology and Cardiovascular Research Institute Basel (CRIB), University Hospital Basel, University of Basel, Basel, Switzerland.', 'Department of Clinical Chemistry and Haematology, University Medical Centre, Utrecht, the Netherlands.', 'Department of Clinical Chemistry and Haematology, University Medical Centre, Utrecht, the Netherlands.', 'Department of Clinical Chemistry and Haematology, University Medical Centre, Utrecht, the Netherlands.', 'Julius Center for Health Sciences and Primary Care, University Medical Centre, Utrecht, the Netherlands.', 'Department of Cardiology, Academic Medical Centre, Amsterdam, the Netherlands.', 'Department of Cardiology, Meander Medical Centre, Amersfoort, the Netherlands.', 'Department of Vascular Surgery, University Medical Centre, Utrecht, the Netherlands.', 'Netherlands Heart Institute, Utrecht, the Netherlands.', 'Department of Cardiology, St. Antonius Hospital, Nieuwegein, the Netherlands.'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20200723', 'PL': 'England', 'TA': 'Sci Rep', 'JT': 'Scientific reports', 'JID': '101563288', 'RN': ['0 (Biomarkers)', '0 (Proteins)', '0 (Proteome)'], 'SB': 'IM', 'MH': ['Aged', 'Biomarkers', 'Chest Pain/*etiology/*metabolism', 'Computed Tomography Angiography', 'Extracellular Vesicles/*metabolism', 'Female', 'Humans', 'Male', 'Middle Aged', 'Myocardial Ischemia/diagnosis/*etiology/*metabolism', 'Positron Emission Tomography Computed Tomography', 'Proteins/*metabolism', 'Proteome', 'Proteomics/methods', 'Risk Factors', 'Sex Factors', '*Stress, Physiological'], 'PMC': 'PMC7378184', 'EDAT': '2020/07/25 06:00', 'MHDA': '2020/12/22 06:00', 'CRDT': ['2020/07/25 06:00'], 'PHST': ['2020/03/30 00:00 [received]', '2020/06/12 00:00 [accepted]', '2020/07/25 06:00 [entrez]', '2020/07/25 06:00 [pubmed]', '2020/12/22 06:00 [medline]'], 'AID': ['10.1038/s41598-020-69297-0 [doi]', '10.1038/s41598-020-69297-0 [pii]'], 'PST': 'epublish', 'SO': 'Sci Rep. 2020 Jul 23;10(1):12257. doi: 10.1038/s41598-020-69297-0.'}\n",
      "{'PMID': '32487995', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20200818', 'LR': '20200818', 'IS': '2041-1723 (Electronic) 2041-1723 (Linking)', 'VI': '11', 'IP': '1', 'DP': '2020 Jun 2', 'TI': 'Core functional nodes and sex-specific pathways in human ischaemic and dilated cardiomyopathy.', 'PG': '2843', 'LID': '10.1038/s41467-020-16584-z [doi]', 'AB': 'Poor access to human left ventricular myocardium is a significant limitation in the study of heart failure (HF). Here, we utilise a carefully procured large human heart biobank of cryopreserved left ventricular myocardium to obtain direct molecular insights into ischaemic cardiomyopathy (ICM) and dilated cardiomyopathy (DCM), the most common causes of HF worldwide. We perform unbiased, deep proteomic and metabolomic analyses of 51 left ventricular (LV) samples from 44 cryopreserved human ICM and DCM hearts, compared to age-, gender-, and BMI-matched, histopathologically normal, donor controls. We report a dramatic reduction in serum amyloid A1 protein in ICM hearts, perturbed thyroid hormone signalling pathways and significant reductions in oxidoreductase co-factor riboflavin-5-monophosphate and glycolytic intermediate fructose-6-phosphate in both; unveil gender-specific changes in HF, including nitric oxide-related arginine metabolism, mitochondrial substrates, and X chromosome-linked protein and metabolite changes; and provide an interactive online application as a publicly-available resource.', 'FAU': ['Li, Mengbo', 'Parker, Benjamin L', 'Pearson, Evangeline', 'Hunter, Benjamin', 'Cao, Jacob', 'Koay, Yen Chin', 'Guneratne, Oneka', 'James, David E', 'Yang, Jean', 'Lal, Sean', \"O'Sullivan, John F\"], 'AU': ['Li M', 'Parker BL', 'Pearson E', 'Hunter B', 'Cao J', 'Koay YC', 'Guneratne O', 'James DE', 'Yang J', 'Lal S', \"O'Sullivan JF\"], 'AUID': ['ORCID: 0000-0002-9666-5810', 'ORCID: 0000-0002-5271-2603', 'ORCID: 0000-0002-5841-560X', 'ORCID: 0000-0001-8016-5128'], 'AD': ['School of Mathematics and Statistics, Faculty of Science, The University of Sydney, Sydney, NSW, Australia.', 'Precision Cardiovascular Laboratory, The University of Sydney, Sydney, NSW, Australia.', 'Charles Perkins Centre, School of Life and Environmental Sciences, The University of Sydney, Sydney, NSW, Australia.', 'Charles Perkins Centre, School of Life and Environmental Sciences, The University of Sydney, Sydney, NSW, Australia.', 'Department of Physiology, School of Biomedical Sciences, The University of Melbourne, Melbourne, VIC, Australia.', 'Precision Cardiovascular Laboratory, The University of Sydney, Sydney, NSW, Australia.', 'Charles Perkins Centre, School of Life and Environmental Sciences, The University of Sydney, Sydney, NSW, Australia.', 'Precision Cardiovascular Laboratory, The University of Sydney, Sydney, NSW, Australia.', 'Discipline of Anatomy and Histology, School of Medical Sciences, The University of Sydney, Sydney, NSW, Australia.', 'Precision Cardiovascular Laboratory, The University of Sydney, Sydney, NSW, Australia.', 'Discipline of Anatomy and Histology, School of Medical Sciences, The University of Sydney, Sydney, NSW, Australia.', 'Precision Cardiovascular Laboratory, The University of Sydney, Sydney, NSW, Australia.', 'Charles Perkins Centre, School of Life and Environmental Sciences, The University of Sydney, Sydney, NSW, Australia.', 'Heart Research Institute, The University of Sydney, Sydney, NSW, Australia.', 'Precision Cardiovascular Laboratory, The University of Sydney, Sydney, NSW, Australia.', 'Discipline of Anatomy and Histology, School of Medical Sciences, The University of Sydney, Sydney, NSW, Australia.', 'Charles Perkins Centre, School of Life and Environmental Sciences, The University of Sydney, Sydney, NSW, Australia.', 'School of Life and Environmental Sciences, Faculty of Science, The University of Sydney, Sydney, NSW, Australia.', 'Central Clinical School, Sydney Medical School, Faculty of Medicine, The University of Sydney, Sydney, NSW, Australia.', 'School of Mathematics and Statistics, Faculty of Science, The University of Sydney, Sydney, NSW, Australia.', 'Charles Perkins Centre, School of Life and Environmental Sciences, The University of Sydney, Sydney, NSW, Australia.', 'Precision Cardiovascular Laboratory, The University of Sydney, Sydney, NSW, Australia. sean.lal@sydney.edu.au.', 'Discipline of Anatomy and Histology, School of Medical Sciences, The University of Sydney, Sydney, NSW, Australia. sean.lal@sydney.edu.au.', 'Central Clinical School, Sydney Medical School, Faculty of Medicine, The University of Sydney, Sydney, NSW, Australia. sean.lal@sydney.edu.au.', 'Department of Cardiology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. sean.lal@sydney.edu.au.', 'Precision Cardiovascular Laboratory, The University of Sydney, Sydney, NSW, Australia. john.osullivan@hri.org.au.', 'Charles Perkins Centre, School of Life and Environmental Sciences, The University of Sydney, Sydney, NSW, Australia. john.osullivan@hri.org.au.', 'Heart Research Institute, The University of Sydney, Sydney, NSW, Australia. john.osullivan@hri.org.au.', 'Central Clinical School, Sydney Medical School, Faculty of Medicine, The University of Sydney, Sydney, NSW, Australia. john.osullivan@hri.org.au.', 'Department of Cardiology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. john.osullivan@hri.org.au.'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20200602', 'PL': 'England', 'TA': 'Nat Commun', 'JT': 'Nature communications', 'JID': '101528555', 'RN': ['0 (Proteome)'], 'SB': 'IM', 'MH': ['Cardiomyopathy, Dilated/*metabolism/pathology', 'Female', 'Heart Ventricles/metabolism/pathology', 'Humans', 'Male', 'Metabolome', 'Metabolomics', 'Middle Aged', 'Myocardial Ischemia/*metabolism/pathology', 'Myocardium/metabolism/pathology', 'Principal Component Analysis', 'Protein Interaction Maps', 'Proteome/metabolism', 'Proteomics', '*Sex Characteristics', '*Signal Transduction', 'Tissue Donors'], 'PMC': 'PMC7266817', 'EDAT': '2020/06/04 06:00', 'MHDA': '2020/08/19 06:00', 'CRDT': ['2020/06/04 06:00'], 'PHST': ['2019/08/22 00:00 [received]', '2020/05/06 00:00 [accepted]', '2020/06/04 06:00 [entrez]', '2020/06/04 06:00 [pubmed]', '2020/08/19 06:00 [medline]'], 'AID': ['10.1038/s41467-020-16584-z [doi]', '10.1038/s41467-020-16584-z [pii]'], 'PST': 'epublish', 'SO': 'Nat Commun. 2020 Jun 2;11(1):2843. doi: 10.1038/s41467-020-16584-z.'}\n",
      "{'PMID': '32427855', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20201204', 'LR': '20201214', 'IS': '2045-2322 (Electronic) 2045-2322 (Linking)', 'VI': '10', 'IP': '1', 'DP': '2020 May 19', 'TI': 'Associations of urinary polymeric immunoglobulin receptor peptides in the context of cardio-renal syndrome.', 'PG': '8291', 'LID': '10.1038/s41598-020-65154-2 [doi]', 'AB': 'The polymeric immunoglobulin receptor (pIgR) transports immunoglobulins from the basolateral to the apical surface of epithelial cells. PIgR was recently shown to be associated with kidney dysfunction. The immune defense is initiated at the apical surface of epithelial cells where the N-terminal domain of pIgR, termed secretory component (SC), is proteolytically cleaved and released either unbound (free SC) or bound to immunoglobulins. The aim of our study was to evaluate the association of pIgR peptides with the cardio-renal syndrome in a large cohort and to obtain information on how the SC is released. We investigated urinary peptides of 2964 individuals available in the Human Urine Proteome Database generated using capillary electrophoresis coupled to mass spectrometry. The mean amplitude of 23 different pIgR peptides correlated negatively with the estimated glomerular filtration rate (eGFR, rho = -0.309, p < 0.0001). Furthermore, pIgR peptides were significantly increased in cardiovascular disease (coronary artery disease and heart failure) after adjustment for eGFR. We further predicted potential proteases involved in urinary peptide generation using the Proteasix algorithm. Peptide cleavage site analysis suggested that several, and not one, proteases are involved in the generation of the SC. In this large cohort, we could demonstrate that pIgR is associated with the cardio-renal syndrome and provided a more detailed insight on how pIgR can be potentially cleaved to release the SC.', 'FAU': ['He, Tianlin', 'Siwy, Justyna', 'Metzger, Jochen', 'Mullen, William', 'Mischak, Harald', 'Schanstra, Joost P', 'Zurbig, Petra', 'Jankowski, Vera'], 'AU': ['He T', 'Siwy J', 'Metzger J', 'Mullen W', 'Mischak H', 'Schanstra JP', 'Zurbig P', 'Jankowski V'], 'AD': ['Mosaiques Diagnostics GmbH, Hannover, Germany.', 'Institute for Molecular Cardiovascular Research (IMCAR), University Hospital RWTH Aachen, Aachen, Germany.', 'Mosaiques Diagnostics GmbH, Hannover, Germany.', 'Mosaiques Diagnostics GmbH, Hannover, Germany.', 'Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.', 'Mosaiques Diagnostics GmbH, Hannover, Germany.', 'Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.', 'INSERM U1048, Institute of Cardiovascular and Metabolic Diseases, Toulouse, France. joost-peter.schanstra@inserm.fr.', 'Universite Toulouse III Paul-Sabatier, Toulouse, France. joost-peter.schanstra@inserm.fr.', 'Mosaiques Diagnostics GmbH, Hannover, Germany. zuerbig@mosaiques-diagnostics.com.', 'Institute for Molecular Cardiovascular Research (IMCAR), University Hospital RWTH Aachen, Aachen, Germany.'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20200519', 'PL': 'England', 'TA': 'Sci Rep', 'JT': 'Scientific reports', 'JID': '101563288', 'RN': ['0 (Immunoglobulins)', '0 (Peptides)', '0 (Receptors, Polymeric Immunoglobulin)', '0 (Secretory Component)'], 'SB': 'IM', 'MH': ['Adult', 'Aged', 'Cardio-Renal Syndrome/*metabolism/physiopathology/urine', 'Female', 'Glomerular Filtration Rate', 'Humans', 'Immunoglobulins/metabolism', 'Male', 'Middle Aged', 'Peptides/*urine', 'Proteomics', 'Receptors, Polymeric Immunoglobulin/*chemistry', 'Secretory Component/urine'], 'PMC': 'PMC7237418', 'EDAT': '2020/05/20 06:00', 'MHDA': '2020/12/15 06:00', 'CRDT': ['2020/05/20 06:00'], 'PHST': ['2019/12/17 00:00 [received]', '2020/04/24 00:00 [accepted]', '2020/05/20 06:00 [entrez]', '2020/05/20 06:00 [pubmed]', '2020/12/15 06:00 [medline]'], 'AID': ['10.1038/s41598-020-65154-2 [doi]', '10.1038/s41598-020-65154-2 [pii]'], 'PST': 'epublish', 'SO': 'Sci Rep. 2020 May 19;10(1):8291. doi: 10.1038/s41598-020-65154-2.'}\n",
      "{'PMID': '32385381', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20201201', 'LR': '20201201', 'IS': '2045-2322 (Electronic) 2045-2322 (Linking)', 'VI': '10', 'IP': '1', 'DP': '2020 May 8', 'TI': 'Label-free plasma proteomics identifies haptoglobin-related protein as candidate marker of idiopathic pulmonary fibrosis and dysregulation of complement and oxidative pathways.', 'PG': '7787', 'LID': '10.1038/s41598-020-64759-x [doi]', 'AB': 'Idiopathic pulmonary fibrosis (IPF) is a lung parenchymal disease of unknown cause usually occurring in older adults. It is a chronic and progressive condition with poor prognosis and diagnosis is largely clinical. Currently, there exist few biomarkers that can predict patient outcome or response to therapies. Together with lack of markers, the need for novel markers for the detection and monitoring of IPF, is paramount. We have performed label-free plasma proteomics of thirty six individuals, 17 of which had confirmed IPF. Proteomics data was analyzed by volcano plot, hierarchical clustering, Partial-least square discriminant analysis (PLS-DA) and Ingenuity pathway analysis. Univariate and multivariate statistical analysis overlap identified haptoglobin-related protein as a possible marker of IPF when compared to control samples (Area under the curve 0.851, ROC-analysis). LXR/RXR activation and complement activation pathways were enriched in t-test significant proteins and oxidative regulators, complement proteins and protease inhibitors were enriched in PLS-DA significant proteins. Our pilot study points towards aberrations in complement activation and oxidative damage in IPF patients and provides haptoglobin-related protein as a new candidate biomarker of IPF.', 'FAU': ['Saraswat, Mayank', 'Joenvaara, Sakari', 'Tohmola, Tiialotta', 'Sutinen, Eva', 'Vartiainen, Ville', 'Koli, Katri', 'Myllarniemi, Marjukka', 'Renkonen, Risto'], 'AU': ['Saraswat M', 'Joenvaara S', 'Tohmola T', 'Sutinen E', 'Vartiainen V', 'Koli K', 'Myllarniemi M', 'Renkonen R'], 'AD': ['Transplantation Laboratory, Faculty of Medicine, University of Helsinki, Helsinki, Finland. sarawat.mk@gmail.com.', 'HUSLAB, Helsinki University Hospital, Helsinki, Finland. sarawat.mk@gmail.com.', 'Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, 55905, USA. sarawat.mk@gmail.com.', 'Center for Molecular Medicine, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, 560029, India. sarawat.mk@gmail.com.', 'Manipal Academy of Higher Education (MAHE), Manipal, 576104, Karnataka, India. sarawat.mk@gmail.com.', 'Transplantation Laboratory, Faculty of Medicine, University of Helsinki, Helsinki, Finland.', 'HUSLAB, Helsinki University Hospital, Helsinki, Finland.', 'Transplantation Laboratory, Faculty of Medicine, University of Helsinki, Helsinki, Finland.', 'HUSLAB, Helsinki University Hospital, Helsinki, Finland.', 'Department of Pulmonary Medicine, Heart and Lung Center, Helsinki University Hospital, Helsinki, Finland.', 'Individualized Drug Therapy Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.', 'Department of Pulmonary Medicine, Heart and Lung Center, Helsinki University Hospital, Helsinki, Finland.', 'Individualized Drug Therapy Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.', 'Individualized Drug Therapy Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.', 'Department of Pulmonary Medicine, Heart and Lung Center, Helsinki University Hospital, Helsinki, Finland.', 'Individualized Drug Therapy Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.', 'Transplantation Laboratory, Faculty of Medicine, University of Helsinki, Helsinki, Finland.', 'HUSLAB, Helsinki University Hospital, Helsinki, Finland.'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20200508', 'PL': 'England', 'TA': 'Sci Rep', 'JT': 'Scientific reports', 'JID': '101563288', 'RN': ['0 (Biomarkers)', '0 (Blood Proteins)', '0 (Haptoglobins)', '0 (Proteome)', '9007-36-7 (Complement System Proteins)'], 'SB': 'IM', 'MH': ['Aged', 'Biomarkers', '*Blood Proteins', 'Case-Control Studies', 'Complement System Proteins/*immunology/metabolism', 'Computational Biology/methods', 'Female', 'Haptoglobins/*metabolism', 'Humans', 'Idiopathic Pulmonary Fibrosis/*immunology/*metabolism/pathology', 'Male', '*Oxidative Stress', 'Proteome', '*Proteomics/methods', 'ROC Curve', '*Signal Transduction'], 'PMC': 'PMC7211010', 'EDAT': '2020/05/10 06:00', 'MHDA': '2020/12/02 06:00', 'CRDT': ['2020/05/10 06:00'], 'PHST': ['2019/03/29 00:00 [received]', '2020/04/19 00:00 [accepted]', '2020/05/10 06:00 [entrez]', '2020/05/10 06:00 [pubmed]', '2020/12/02 06:00 [medline]'], 'AID': ['10.1038/s41598-020-64759-x [doi]', '10.1038/s41598-020-64759-x [pii]'], 'PST': 'epublish', 'SO': 'Sci Rep. 2020 May 8;10(1):7787. doi: 10.1038/s41598-020-64759-x.'}\n",
      "{'PMID': '32178279', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20201204', 'LR': '20201214', 'IS': '2072-6643 (Electronic) 2072-6643 (Linking)', 'VI': '12', 'IP': '3', 'DP': '2020 Mar 12', 'TI': 'Comparison of Omega-3 Eicosapentaenoic Acid Versus Docosahexaenoic Acid-Rich Fish Oil Supplementation on Plasma Lipids and Lipoproteins in Normolipidemic Adults.', 'LID': 'E749 [pii] 10.3390/nu12030749 [doi]', 'AB': 'BACKGROUND: Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) have both shared and different cardiovascular effects, and commonly used fish oil supplements have considerably varied EPA/DHA ratios. AIMS: We compared the effects of fish oil supplements with different EPA/DHA ratios on lipoprotein metabolism. METHODS: In a double-blind, randomized cross-over study, normolipidemic adults (n = 30) consumed 12 g/day of EPA-rich (EPA/DHA: 2.3) or DHA-rich (EPA/DHA: 0.3) fish oil for 8-weeks, separated by an 8-week washout period. RESULTS: Both fish oil supplements similarly lowered plasma TG levels and TG-related NMR parameters versus baseline (p < 0.05). There were no changes in plasma cholesterol-related parameters due to either fish oil, although on-treatment levels for LDL particle number were slightly higher for DHA-rich oil compared with EPA-rich oil (p < 0.05). Both fish oil supplements similarly altered HDL subclass profile and proteome, and down regulated HDL proteins related to inflammation, with EPA-rich oil to a greater extent. Furthermore, EPA-rich oil increased apoM abundance versus DHA-rich oil (p < 0.05). CONCLUSIONS: Overall, fish oil supplements with varied EPA/DHA ratios had similar effects on total lipids/lipoproteins, but differences were observed in lipoprotein subfraction composition and distribution, which could impact on the use of EPA versus DHA for improving cardiovascular health.', 'FAU': ['Yang, Zhi-Hong', 'Amar, Marcelo', 'Sampson, Maureen', 'Courville, Amber B', 'Sorokin, Alexander V', 'Gordon, Scott M', 'Aponte, Angel M', 'Stagliano, Michael', 'Playford, Martin P', 'Fu, Yi-Ping', 'Yang, Shanna', 'Mehta, Nehal N', 'Remaley, Alan T'], 'AU': ['Yang ZH', 'Amar M', 'Sampson M', 'Courville AB', 'Sorokin AV', 'Gordon SM', 'Aponte AM', 'Stagliano M', 'Playford MP', 'Fu YP', 'Yang S', 'Mehta NN', 'Remaley AT'], 'AUID': ['ORCID: 0000-0002-1885-3162', 'ORCID: 0000-0002-1419-3937', 'ORCID: 0000-0002-2291-4888'], 'AD': ['Lipoprotein Metabolism Section, Translational Vascular Medicine Branch, National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD 20892-1666, USA.', 'Lipoprotein Metabolism Section, Translational Vascular Medicine Branch, National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD 20892-1666, USA.', 'Clinical Center, Department of Laboratory Medicine, NIH, Bethesda, MD 20814, USA.', 'Clinical Center, Nutrition Department, NIH, Bethesda, MD 20814, USA.', 'Lipoprotein Metabolism Section, Translational Vascular Medicine Branch, National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD 20892-1666, USA.', 'Lipoprotein Metabolism Section, Translational Vascular Medicine Branch, National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD 20892-1666, USA.', 'Saha Cardiovascular Research Center and Department of Physiology, University of Kentucky College of Medicine, Lexington, KY 40506, USA.', 'Proteomics Core, Cardiovascular Branch, NHLBI, NIH, Bethesda, MD 20814, USA.', 'Lipoprotein Metabolism Section, Translational Vascular Medicine Branch, National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD 20892-1666, USA.', 'Section of Inflammation and Cardiometabolic Diseases, Cardiovascular Branch, NHLBI, NIH, Bethesda, MD 20814, USA.', 'Office of Biostatistics Research, NHLBI, NIH, Bethesda, MD 20814, USA.', 'Clinical Center, Nutrition Department, NIH, Bethesda, MD 20814, USA.', 'Section of Inflammation and Cardiometabolic Diseases, Cardiovascular Branch, NHLBI, NIH, Bethesda, MD 20814, USA.', 'Lipoprotein Metabolism Section, Translational Vascular Medicine Branch, National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD 20892-1666, USA.'], 'LA': ['eng'], 'GR': ['Intramural Research Program of the National Heart, Lung and Blood Institute', '(NHLBI) (HL006095)/NH/NIH HHS/United States'], 'PT': ['Comparative Study', 'Journal Article', 'Randomized Controlled Trial'], 'DEP': '20200312', 'PL': 'Switzerland', 'TA': 'Nutrients', 'JT': 'Nutrients', 'JID': '101521595', 'RN': ['0 (Lipoproteins, HDL)', '0 (Lipoproteins, LDL)', '0 (Triglycerides)', '25167-62-8 (Docosahexaenoic Acids)', 'AAN7QOV9EA (Eicosapentaenoic Acid)'], 'SB': 'IM', 'MH': ['Adult', 'Cross-Over Studies', 'Docosahexaenoic Acids/*administration & dosage', 'Double-Blind Method', 'Eicosapentaenoic Acid/*administration & dosage', 'Female', 'Humans', 'Lipoproteins, HDL/*blood', 'Lipoproteins, LDL/*blood', 'Male', 'Triglycerides/*blood'], 'PMC': 'PMC7146314', 'OTO': ['NOTNLM'], 'OT': ['HDL cholesterol', 'LDL cholesterol', 'docosahexaenoic acid (DHA)', 'eicosapentaenoic acid (EPA)', 'lipoprotein metabolism', 'omega-3 fatty acids', 'triglyceride'], 'EDAT': '2020/03/18 06:00', 'MHDA': '2020/12/15 06:00', 'CRDT': ['2020/03/18 06:00'], 'PHST': ['2020/02/13 00:00 [received]', '2020/03/05 00:00 [revised]', '2020/03/08 00:00 [accepted]', '2020/03/18 06:00 [entrez]', '2020/03/18 06:00 [pubmed]', '2020/12/15 06:00 [medline]'], 'AID': ['nu12030749 [pii]', '10.3390/nu12030749 [doi]'], 'PST': 'epublish', 'SO': 'Nutrients. 2020 Mar 12;12(3). pii: nu12030749. doi: 10.3390/nu12030749.'}\n",
      "{'PMID': '32117548', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20200717', 'LR': '20200717', 'IS': '2005-4408 (Electronic) 2005-291X (Linking)', 'VI': '12', 'IP': '1', 'DP': '2020 Mar', 'TI': 'Proteomic Classification and Identification of Proteins Related to Tissue Healing of Platelet-Rich Plasma.', 'PG': '120-129', 'LID': '10.4055/cios.2020.12.1.120 [doi]', 'AB': 'Background: Platelet-rich plasma (PRP) is a plasma component of autologous blood containing a high concentration of platelets. PRP is used to promote healing of damaged tissues. However, there are not many studies on the composition and expression patterns of active proteins in PRP. The purpose of this study was to identify unknown factors that contribute to tissue healing by proteomic analysis of proteins in PRP. Methods: Three men in their 30s with no basal disease participated in this study. All identified proteins were classified for tissue healing-related functions on the basis of the gene ontology analysis of adhesion molecule with Ig-like domain 2 (AmiGO2). PRP was prepared by using the ACP kit and GPS III kit. Results: We identified a total of 125 proteins related to wound healing, along with three proteins for angiogenesis involved in wound healing, two proteins for fibroblast migration, four proteins for collagen biosynthesis process, two proteins for glycosaminoglycan biosynthesis process, and 13 proteins for glycosaminoglycan binding. So, in addition to the growth factors that have been already known to be involved in tissue healing, 25 new proteins were identified. Conclusions: We identified the unknown proteins associated with tissue healing in PRP. Our findings may serve as a foundation for the establishment of basic medical evidence for PRP applications.', 'CI': ['Copyright (c) 2020 by The Korean Orthopaedic Association.'], 'FAU': ['Lee, Ho Won', 'Choi, Kyung-Ho', 'Kim, Jung-Youn', 'Kim, Kyung-Ok', 'Haotian, Bai', 'Yuxuan, Liu', 'Noh, Kyu-Cheol'], 'AU': ['Lee HW', 'Choi KH', 'Kim JY', 'Kim KO', 'Haotian B', 'Yuxuan L', 'Noh KC'], 'AD': ['Department of Orthopaedic Surgery, Hallym University Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea.', 'Department of Orthopaedic Surgery, Hallym University Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea.', 'Department of Orthopaedic Surgery, Hallym University Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea.', 'Gachon Medical Research Institute, Gil Medical Center, Gachon University, Incheon, Korea.', 'Department of Orthopaedic Surgery, Hallym University Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea.', 'Department of Orthopaedic Surgery, The Second Hospital of Jilin University, Changchun, China.', 'Department of Orthopaedic Surgery, The Second Hospital of Jilin University, Changchun, China.', 'Department of Radiology, Hallym University Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea.', 'Department of Orthopaedic Surgery, Hallym University Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea.'], 'LA': ['eng'], 'PT': ['Journal Article'], 'DEP': '20200213', 'PL': 'Korea (South)', 'TA': 'Clin Orthop Surg', 'JT': 'Clinics in orthopedic surgery', 'JID': '101505087', 'SB': 'IM', 'MH': ['Adult', 'Chromatography, Liquid', 'Healthy Volunteers', 'Humans', 'Male', 'Mass Spectrometry', 'Platelet-Rich Plasma/*chemistry', '*Proteomics', 'Wound Healing/*genetics'], 'PMC': 'PMC7031431', 'OTO': ['NOTNLM'], 'OT': ['Gene ontology', 'Platelet-rich plasma', 'Proteome', 'Wound healing'], 'COIS': ['CONFLICT OF INTEREST: No potential conflict of interest relevant to this article', 'was reported.'], 'EDAT': '2020/03/03 06:00', 'MHDA': '2020/07/18 06:00', 'CRDT': ['2020/03/03 06:00'], 'PHST': ['2019/01/30 00:00 [received]', '2019/08/02 00:00 [accepted]', '2020/03/03 06:00 [entrez]', '2020/03/03 06:00 [pubmed]', '2020/07/18 06:00 [medline]'], 'AID': ['10.4055/cios.2020.12.1.120 [doi]'], 'PST': 'ppublish', 'SO': 'Clin Orthop Surg. 2020 Mar;12(1):120-129. doi: 10.4055/cios.2020.12.1.120. Epub 2020 Feb 13.'}\n",
      "{'PMID': '31988066', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20201209', 'LR': '20201214', 'IS': '1935-5548 (Electronic) 0149-5992 (Linking)', 'VI': '43', 'IP': '4', 'DP': '2020 Apr', 'TI': 'Coronary Artery Disease and Type 2 Diabetes: A Proteomic Study.', 'PG': '843-851', 'LID': '10.2337/dc19-1902 [doi]', 'AB': 'OBJECTIVE: Coronary artery disease (CAD) is a major challenge in patients with type 2 diabetes (T2D). Coronary computed tomography angiography (CCTA) provides a detailed anatomic map of the coronary circulation. Proteomics are increasingly used to improve diagnostic and therapeutic algorithms. We hypothesized that the protein panel is differentially associated with T2D and CAD. RESEARCH DESIGN AND METHODS: In CAPIRE (Coronary Atherosclerosis in Outlier Subjects: Protective and Novel Individual Risk Factors Evaluation-a cohort of 528 individuals with no previous cardiovascular event undergoing CCTA), participants were grouped into CAD(-) (clean coronaries) and CAD(+) (diffuse lumen narrowing or plaques). Plasma proteins were screened by aptamer analysis. Two-way partial least squares was used to simultaneously rank proteins by diabetes status and CAD. RESULTS: Though CAD(+) was more prevalent among participants with T2D (HbA1c 6.7 +/- 1.1%) than those without diabetes (56 vs. 30%, P < 0.0001), CCTA-based atherosclerosis burden did not differ. Of the 20 top-ranking proteins, 15 were associated with both T2D and CAD, and 3 (osteomodulin, cartilage intermediate-layer protein 15, and HTRA1) were selectively associated with T2D only and 2 (epidermal growth factor receptor and contactin-1) with CAD only. Elevated renin and GDF15, and lower adiponectin, were independently associated with both T2D and CAD. In multivariate analysis adjusting for the Framingham risk panel, patients with T2D were \"protected\" from CAD if female (P = 0.007), younger (P = 0.021), and with lower renin levels (P = 0.02). CONCLUSIONS: We concluded that 1) CAD severity and quality do not differ between participants with T2D and without diabetes; 2) renin, GDF15, and adiponectin are shared markers by T2D and CAD; 3) several proteins are specifically associated with T2D or CAD; and 4) in T2D, lower renin levels may protect against CAD.', 'CI': ['(c) 2020 by the American Diabetes Association.'], 'FAU': ['Ferrannini, Giulia', 'Manca, Maria Laura', 'Magnoni, Marco', 'Andreotti, Felicita', 'Andreini, Daniele', 'Latini, Roberto', 'Maseri, Attilio', 'Maggioni, Aldo P', 'Ostroff, Rachel M', 'Williams, Stephen A', 'Ferrannini, Ele'], 'AU': ['Ferrannini G', 'Manca ML', 'Magnoni M', 'Andreotti F', 'Andreini D', 'Latini R', 'Maseri A', 'Maggioni AP', 'Ostroff RM', 'Williams SA', 'Ferrannini E'], 'AUID': ['ORCID: 0000-0002-0318-7435', 'ORCID: 0000-0002-1384-1584'], 'AD': ['Department of Medical Sciences, Postgraduate School of Internal Medicine, University of Turin, Turin, Italy.', 'Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.', 'Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.', 'IRCCS Ospedale San Raffaele and Universita Vita-Salute San Raffaele, Milan, Italy.', 'Institute of Cardiology, FPG IRCCS, Catholic University Medical School, Rome, Italy.', 'Centro Cardiologico Monzino, IRCCS, Milan, Italy.', 'Cardiovascular Section, Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.', 'Mario Negri Institute of Pharmacological Research-IRCCS, Milan, Italy.', 'Heart Care Foundation, Florence, Italy.', 'ANMCO Research Center, Heart Care Foundation, Florence, Italy.', 'Clinical Research and Development, SomaLogic Inc., Boulder, CO.', 'Clinical Research and Development, SomaLogic Inc., Boulder, CO.', 'CNR Institute of Clinical Physiology, Pisa, Italy ferranni@ifc.cnr.it.'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20200127', 'PL': 'United States', 'TA': 'Diabetes Care', 'JT': 'Diabetes care', 'JID': '7805975', 'RN': ['0 (Proteome)'], 'SB': 'IM', 'MH': ['Aged', 'Cohort Studies', 'Computed Tomography Angiography', 'Coronary Angiography/methods', 'Coronary Artery Disease/diagnosis/epidemiology/*metabolism', 'Diabetes Mellitus, Type 2/complications/diagnosis/epidemiology/*metabolism', 'Diabetic Angiopathies/diagnosis/epidemiology/metabolism', 'Female', 'Humans', 'Male', 'Middle Aged', 'Prevalence', 'Proteome/*analysis/metabolism', '*Proteomics/methods', 'Risk Factors', 'Tomography, X-Ray Computed/methods'], 'EDAT': '2020/01/29 06:00', 'MHDA': '2020/12/15 06:00', 'CRDT': ['2020/01/29 06:00'], 'PHST': ['2019/09/24 00:00 [received]', '2019/12/31 00:00 [accepted]', '2020/01/29 06:00 [pubmed]', '2020/12/15 06:00 [medline]', '2020/01/29 06:00 [entrez]'], 'AID': ['dc19-1902 [pii]', '10.2337/dc19-1902 [doi]'], 'PST': 'ppublish', 'SO': 'Diabetes Care. 2020 Apr;43(4):843-851. doi: 10.2337/dc19-1902. Epub 2020 Jan 27.'}\n",
      "{'PMID': '31918764', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20200930', 'LR': '20200930', 'IS': '1466-609X (Electronic) 1364-8535 (Linking)', 'VI': '24', 'IP': '1', 'DP': '2020 Jan 9', 'TI': 'A novel urinary biomarker predicts 1-year mortality after discharge from intensive care.', 'PG': '10', 'LID': '10.1186/s13054-019-2686-0 [doi]', 'AB': 'RATIONALE: The urinary proteome reflects molecular drivers of disease. OBJECTIVES: To construct a urinary proteomic biomarker predicting 1-year post-ICU mortality. METHODS: In 1243 patients, the urinary proteome was measured on ICU admission, using capillary electrophoresis coupled with mass spectrometry along with clinical variables, circulating biomarkers (BNP, hsTnT, active ADM, and NGAL), and urinary albumin. Methods included support vector modeling to construct the classifier, Cox regression, the integrated discrimination (IDI), and net reclassification (NRI) improvement, and area under the curve (AUC) to assess predictive accuracy, and Proteasix and protein-proteome interactome analyses. MEASUREMENTS AND MAIN RESULTS: In the discovery (deaths/survivors, 70/299) and test (175/699) datasets, the new classifier ACM128, mainly consisting of collagen fragments, yielding AUCs of 0.755 (95% CI, 0.708-0.798) and 0.688 (0.656-0.719), respectively. While accounting for study site and clinical risk factors, hazard ratios in 1243 patients were 2.41 (2.00-2.91) for ACM128 (+ 1 SD), 1.24 (1.16-1.32) for the Charlson Comorbidity Index (+ 1 point), and >/= 1.19 (P </= 0.022) for other biomarkers (+ 1 SD). ACM128 improved (P </= 0.0001) IDI (>/= + 0.50), NRI (>/= + 53.7), and AUC (>/= + 0.037) over and beyond clinical risk indicators and other biomarkers. Interactome mapping, using parental proteins derived from sequenced peptides included in ACM128 and in silico predicted proteases, including/excluding urinary collagen fragments (63/35 peptides), revealed as top molecular pathways protein digestion and absorption, lysosomal activity, and apoptosis. CONCLUSIONS: The urinary proteomic classifier ACM128 predicts the 1-year post-ICU mortality over and beyond clinical risk factors and other biomarkers and revealed molecular pathways potentially contributing to a fatal outcome.', 'FAU': ['Nkuipou-Kenfack, Esther', 'Latosinska, Agnieszka', 'Yang, Wen-Yi', 'Fournier, Marie-Celine', 'Blet, Alice', 'Mujaj, Blerim', 'Thijs, Lutgarde', 'Feliot, Elodie', 'Gayat, Etienne', 'Mischak, Harald', 'Staessen, Jan A', 'Mebazaa, Alexandre', 'Zhang, Zhen-Yu'], 'AU': ['Nkuipou-Kenfack E', 'Latosinska A', 'Yang WY', 'Fournier MC', 'Blet A', 'Mujaj B', 'Thijs L', 'Feliot E', 'Gayat E', 'Mischak H', 'Staessen JA', 'Mebazaa A', 'Zhang ZY'], 'AD': ['Mosaiques Diagnostics GmbH, Hannover, Germany.', 'Mosaiques Diagnostics GmbH, Hannover, Germany.', 'Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Campus Sint Rafael, Kapucijnenvoer 35, Box 7001, 3000, Leuven, Belgium.', 'Department of Cardiology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.', 'Department of Anesthesiology and Intensive Care, Saint Louis-Lariboisiere - Fernand Widal University Hospital, Assistance Publique Hopitaux de Paris, Paris, France.', 'Department of Anesthesiology and Intensive Care, Saint Louis-Lariboisiere - Fernand Widal University Hospital, Assistance Publique Hopitaux de Paris, Paris, France.', 'Universite de Paris, Paris, France.', 'Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Campus Sint Rafael, Kapucijnenvoer 35, Box 7001, 3000, Leuven, Belgium.', 'Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Campus Sint Rafael, Kapucijnenvoer 35, Box 7001, 3000, Leuven, Belgium.', 'Department of Anesthesiology and Intensive Care, Saint Louis-Lariboisiere - Fernand Widal University Hospital, Assistance Publique Hopitaux de Paris, Paris, France.', 'Department of Anesthesiology and Intensive Care, Saint Louis-Lariboisiere - Fernand Widal University Hospital, Assistance Publique Hopitaux de Paris, Paris, France.', 'Universite de Paris, Paris, France.', 'INSERM UMR-S 942 - MASCOT, Paris, France.', 'Mosaiques Diagnostics GmbH, Hannover, Germany.', 'Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Campus Sint Rafael, Kapucijnenvoer 35, Box 7001, 3000, Leuven, Belgium.', 'Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, the Netherlands.', 'Department of Anesthesiology and Intensive Care, Saint Louis-Lariboisiere - Fernand Widal University Hospital, Assistance Publique Hopitaux de Paris, Paris, France.', 'Universite de Paris, Paris, France.', 'INSERM UMR-S 942 - MASCOT, Paris, France.', 'Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Campus Sint Rafael, Kapucijnenvoer 35, Box 7001, 3000, Leuven, Belgium. zhenyu.zhang@kuleuven.be.'], 'AUID': ['ORCID: 0000-0002-3785-7417'], 'CN': ['French and European Outcome Registry in Intensive Care Unit Investigators'], 'LA': ['eng'], 'GR': ['713601/FP7 Ideas: European Research Council/International', 'JTC2017-046-PROACT/European Research Area Net for Cardiovascular', 'Diseases/International', 'G.0881.13/Fonds Wetenschappelijk Onderzoek/International'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20200109', 'PL': 'England', 'TA': 'Crit Care', 'JT': 'Critical care (London, England)', 'JID': '9801902', 'RN': ['0 (Biomarkers)'], 'SB': 'IM', 'MH': ['Aged', 'Analysis of Variance', 'Area Under Curve', 'Biomarkers/*analysis/*urine', 'Female', 'Humans', 'Intensive Care Units/organization & administration/statistics & numerical data', 'Male', 'Middle Aged', '*Mortality', 'Patient Discharge/*statistics & numerical data', 'Prognosis', 'Proportional Hazards Models', 'ROC Curve'], 'PMC': 'PMC6953276', 'OTO': ['NOTNLM'], 'OT': ['*Biomarker', '*Heart failure', '*Intensive care medicine', '*Mortality', '*Urinary proteomics'], 'IR': ['Deye N', 'Fauvaux C', 'Mebazaa A', 'Damoisel C', 'Payen D', 'Azoulay E', 'Moreau AS', 'Jacob L', 'Marie O', 'Wolf M', 'Sonneville R', 'Bronchard R', 'Rennuit I', 'Paugam C', 'Mira JP', 'Cariou A', 'Tesnieres A', 'Dufour N', 'Anguel N', 'Guerin L', 'Duranteau J', 'Ract C', 'Leone M', 'Pastene B', 'Sharshar T', 'Fayssoyl A', 'Baudel JL', 'Guidet B', 'Lu Q', 'Gu WJ', 'Brechot N', 'Combes A', 'Jaber S', 'Pradel A', 'Coisel Y', 'Conseil M', 'Vieillard-Baron A', 'Bodson L', 'Lefrant JY', 'Elotmani L', 'Ayral A', 'Lloret S', 'Pily-Flouri S', 'Pretalli JB', 'Laterre PF', 'Montiel V', 'Dujardin MF', 'Berghe C'], 'FIR': ['Deye, N', 'Fauvaux, C', 'Mebazaa, A', 'Damoisel, C', 'Payen, D', 'Azoulay, E', 'Moreau, A S', 'Jacob, L', 'Marie, O', 'Wolf, M', 'Sonneville, R', 'Bronchard, R', 'Rennuit, I', 'Paugam, C', 'Mira, J P', 'Cariou, A', 'Tesnieres, A', 'Dufour, N', 'Anguel, N', 'Guerin, L', 'Duranteau, J', 'Ract, C', 'Leone, M', 'Pastene, B', 'Sharshar, T', 'Fayssoyl, A', 'Baudel, J L', 'Guidet, B', 'Lu, Q', 'Gu, W Jie', 'Brechot, N', 'Combes, A', 'Jaber, S', 'Pradel, A', 'Coisel, Y', 'Conseil, M', 'Vieillard-Baron, A', 'Bodson, L', 'Lefrant, J Y', 'Elotmani, L', 'Ayral, A', 'Lloret, S', 'Pily-Flouri, S', 'Pretalli, J B', 'Laterre, P F', 'Montiel, V', 'Dujardin, M F', 'Berghe, C'], 'EDAT': '2020/01/11 06:00', 'MHDA': '2020/10/02 06:00', 'CRDT': ['2020/01/11 06:00'], 'PHST': ['2019/07/28 00:00 [received]', '2019/11/26 00:00 [accepted]', '2020/01/11 06:00 [entrez]', '2020/01/11 06:00 [pubmed]', '2020/10/02 06:00 [medline]'], 'AID': ['10.1186/s13054-019-2686-0 [doi]', '10.1186/s13054-019-2686-0 [pii]'], 'PST': 'epublish', 'SO': 'Crit Care. 2020 Jan 9;24(1):10. doi: 10.1186/s13054-019-2686-0.'}\n",
      "{'PMID': '31862877', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20200406', 'LR': '20201219', 'IS': '2041-1723 (Electronic) 2041-1723 (Linking)', 'VI': '10', 'IP': '1', 'DP': '2019 Dec 20', 'TI': 'Profiling of the plasma proteome across different stages of human heart failure.', 'PG': '5830', 'LID': '10.1038/s41467-019-13306-y [doi]', 'AB': 'Heart failure (HF) is a major public health problem characterized by inability of the heart to maintain sufficient output of blood. The systematic characterization of circulating proteins across different stages of HF may provide pathophysiological insights and identify therapeutic targets. Here we report application of aptamer-based proteomics to identify proteins associated with prospective HF incidence in a population-based cohort, implicating modulation of immunological, complement, coagulation, natriuretic and matrix remodeling pathways up to two decades prior to overt disease onset. We observe further divergence of these proteins from the general population in advanced HF, and regression after heart transplantation. By leveraging coronary sinus samples and transcriptomic tools, we describe likely cardiac and specific cellular origins for several of the proteins, including Nt-proBNP, thrombospondin-2, interleukin-18 receptor, gelsolin, and activated C5. Our findings provide a broad perspective on both cardiac and systemic factors associated with HF development.', 'FAU': ['Egerstedt, Anna', 'Berntsson, John', 'Smith, Maya Landenhed', 'Gidlof, Olof', 'Nilsson, Roland', 'Benson, Mark', 'Wells, Quinn S', 'Celik, Selvi', 'Lejonberg, Carl', 'Farrell, Laurie', 'Sinha, Sumita', 'Shen, Dongxiao', 'Lundgren, Jakob', 'Radegran, Goran', 'Ngo, Debby', 'Engstrom, Gunnar', 'Yang, Qiong', 'Wang, Thomas J', 'Gerszten, Robert E', 'Smith, J Gustav'], 'AU': ['Egerstedt A', 'Berntsson J', 'Smith ML', 'Gidlof O', 'Nilsson R', 'Benson M', 'Wells QS', 'Celik S', 'Lejonberg C', 'Farrell L', 'Sinha S', 'Shen D', 'Lundgren J', 'Radegran G', 'Ngo D', 'Engstrom G', 'Yang Q', 'Wang TJ', 'Gerszten RE', 'Smith JG'], 'AD': ['Department of Cardiology, Clinical Sciences, Lund University, Lund, Sweden.', 'Department of Cardiology, Clinical Sciences, Lund University, Lund, Sweden.', 'Cardiovascular Epidemiology, Clinical Sciences, Lund University, Malmo, Sweden.', 'Department of Cardiothoracic Surgery, Clinical Sciences, Lund University and Skane University Hospital, Lund, Sweden.', 'Department of Cardiology, Clinical Sciences, Lund University, Lund, Sweden.', 'Department of Medicine, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.', 'Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.', 'Division of Cardiovascular Medicine, Vanderbilt University, Nashville, TN, USA.', 'Department of Cardiology, Clinical Sciences, Lund University, Lund, Sweden.', 'Department of Cardiology, Clinical Sciences, Lund University, Lund, Sweden.', 'Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.', 'Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.', 'Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.', 'Department of Cardiology, Clinical Sciences, Lund University, Lund, Sweden.', 'Department of Heart Failure and Valvular Disease, Skane University Hospital, Lund, Sweden.', 'Department of Cardiology, Clinical Sciences, Lund University, Lund, Sweden.', 'Department of Heart Failure and Valvular Disease, Skane University Hospital, Lund, Sweden.', 'Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.', 'Cardiovascular Epidemiology, Clinical Sciences, Lund University, Malmo, Sweden.', 'Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA.', 'Division of Cardiovascular Medicine, Vanderbilt University, Nashville, TN, USA.', 'Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.', 'Program in Medical and Population Genetics, Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA, USA.', 'Department of Cardiology, Clinical Sciences, Lund University, Lund, Sweden. gustav.smith@med.lu.se.', 'Department of Heart Failure and Valvular Disease, Skane University Hospital, Lund, Sweden. gustav.smith@med.lu.se.', 'Program in Medical and Population Genetics, Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA, USA. gustav.smith@med.lu.se.', 'Wallenberg Center for Molecular Medicine and Lund University Diabetes Center, Lund University, Lund, Sweden. gustav.smith@med.lu.se.'], 'AUID': ['ORCID: http://orcid.org/0000-0002-3464-5427', 'ORCID: http://orcid.org/0000-0002-7402-3139', 'ORCID: http://orcid.org/0000-0002-6020-7498', 'ORCID: http://orcid.org/0000-0001-7032-3444', 'ORCID: http://orcid.org/0000-0002-3658-1375'], 'LA': ['eng'], 'GR': ['K08 HL145095/HL/NHLBI NIH HHS/United States', 'P30 DK040561/DK/NIDDK NIH HHS/United States', 'S10 OD017985/OD/NIH HHS/United States'], 'PT': ['Journal Article', 'Research Support, N.I.H., Extramural', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20191220', 'PL': 'England', 'TA': 'Nat Commun', 'JT': 'Nature communications', 'JID': '101528555', 'RN': ['0 (Aptamers, Peptide)', '0 (Biomarkers)', '0 (Proteome)'], 'SB': 'IM', 'MH': ['Adult', 'Aged', 'Aptamers, Peptide/metabolism', 'Biomarkers/blood/metabolism', 'Coronary Sinus/metabolism/pathology', 'Female', 'Gene Expression Profiling', 'Heart Failure/*blood/epidemiology/pathology/surgery', '*Heart Transplantation', 'Humans', 'Incidence', 'Male', 'Middle Aged', 'Prospective Studies', 'Proteome/*analysis/metabolism', 'Proteomics/methods', 'Risk Factors'], 'PMC': 'PMC6925199', 'EDAT': '2019/12/22 06:00', 'MHDA': '2020/04/09 06:00', 'CRDT': ['2019/12/22 06:00'], 'PHST': ['2018/10/01 00:00 [received]', '2019/10/31 00:00 [accepted]', '2019/12/22 06:00 [entrez]', '2019/12/22 06:00 [pubmed]', '2020/04/09 06:00 [medline]'], 'AID': ['10.1038/s41467-019-13306-y [doi]', '10.1038/s41467-019-13306-y [pii]'], 'PST': 'epublish', 'SO': 'Nat Commun. 2019 Dec 20;10(1):5830. doi: 10.1038/s41467-019-13306-y.'}\n",
      "{'PMID': '31844116', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20201104', 'LR': '20201215', 'IS': '2045-2322 (Electronic) 2045-2322 (Linking)', 'VI': '9', 'IP': '1', 'DP': '2019 Dec 16', 'TI': 'Circulating proteomic signature of early death in heart failure patients with reduced ejection fraction.', 'PG': '19202', 'LID': '10.1038/s41598-019-55727-1 [doi]', 'AB': 'Heart failure (HF) remains a main cause of mortality worldwide. Risk stratification of patients with systolic chronic HF is critical to identify those who may benefit from advanced HF therapies. The aim of this study is to identify plasmatic proteins that could predict the early death (within 3 years) of HF patients with reduced ejection fraction hospitalized in CHRU de Lille. The subproteome targeted by an aptamer-based technology, the Slow Off-rate Modified Aptamer (SOMA) scan assay of 1310 proteins, was profiled in blood samples from 168 HF patients, and 203 proteins were significantly modulated between patients who died of cardiovascular death and patients who were alive after 3 years of HF evaluation (Wilcoxon test, FDR 5%). A molecular network was built using these 203 proteins, and the resulting network contained 2281 molecules assigned to 34 clusters annotated to biological pathways by Gene Ontology. This network model highlighted extracellular matrix organization as the main mechanism involved in early death in HF patients. In parallel, an adaptive Least Absolute Shrinkage and Selection Operator (LASSO) was performed on these 203 proteins, and six proteins were selected as candidates to predict early death in HF patients: complement C3, cathepsin S and F107B were decreased and MAPK5, MMP1 and MMP7 increased in patients who died of cardiovascular causes compared with patients living 3 years after HF evaluation. This proteomic signature of 6 circulating plasma proteins allows the identification of systolic HF patients with a risk of early death.', 'FAU': ['Cuvelliez, Marie', 'Vandewalle, Vincent', 'Brunin, Maxime', 'Beseme, Olivia', 'Hulot, Audrey', 'de Groote, Pascal', 'Amouyel, Philippe', 'Bauters, Christophe', 'Marot, Guillemette', 'Pinet, Florence'], 'AU': ['Cuvelliez M', 'Vandewalle V', 'Brunin M', 'Beseme O', 'Hulot A', 'de Groote P', 'Amouyel P', 'Bauters C', 'Marot G', 'Pinet F'], 'AD': ['Univ. Lille, CHU Lille, Inserm, Institut Pasteur de Lille, U1167 - RID-AGE - Facteurs de risque et determinants moleculaires des maladies liees au vieillissement, F-59000, Lille, France.', 'FHU REMOD-HF, Lille, France.', 'Univ. Lille, CHU Lille, Inria Lille Nord-Europe, EA2694 - MODAL - MOdels for Data Analysis and Learning, F-59000, Lille, France.', 'Univ. Lille, << Institut Francais de Bioinformatique >>, << Billille- plateforme de bioinformatique et bioanalyse de Lille >>, F-59000, Lille, France.', 'Univ. Lille, << Institut Francais de Bioinformatique >>, << Billille- plateforme de bioinformatique et bioanalyse de Lille >>, F-59000, Lille, France.', 'Univ. Lille, CHU Lille, Inserm, Institut Pasteur de Lille, U1167 - RID-AGE - Facteurs de risque et determinants moleculaires des maladies liees au vieillissement, F-59000, Lille, France.', 'FHU REMOD-HF, Lille, France.', 'Univ. Lille, << Institut Francais de Bioinformatique >>, << Billille- plateforme de bioinformatique et bioanalyse de Lille >>, F-59000, Lille, France.', 'Univ. Lille, CHU Lille, Inserm, Institut Pasteur de Lille, U1167 - RID-AGE - Facteurs de risque et determinants moleculaires des maladies liees au vieillissement, F-59000, Lille, France.', 'FHU REMOD-HF, Lille, France.', 'Univ. Lille, CHU Lille, Inserm, Institut Pasteur de Lille, U1167 - RID-AGE - Facteurs de risque et determinants moleculaires des maladies liees au vieillissement, F-59000, Lille, France.', 'Univ. Lille, CHU Lille, Inserm, Institut Pasteur de Lille, U1167 - RID-AGE - Facteurs de risque et determinants moleculaires des maladies liees au vieillissement, F-59000, Lille, France.', 'FHU REMOD-HF, Lille, France.', 'Univ. Lille, CHU Lille, Inria Lille Nord-Europe, EA2694 - MODAL - MOdels for Data Analysis and Learning, F-59000, Lille, France.', 'Univ. Lille, << Institut Francais de Bioinformatique >>, << Billille- plateforme de bioinformatique et bioanalyse de Lille >>, F-59000, Lille, France.', 'Univ. Lille, CHU Lille, Inserm, Institut Pasteur de Lille, U1167 - RID-AGE - Facteurs de risque et determinants moleculaires des maladies liees au vieillissement, F-59000, Lille, France. florence.pinet@pasteur-lille.fr.', 'FHU REMOD-HF, Lille, France. florence.pinet@pasteur-lille.fr.'], 'AUID': ['ORCID: http://orcid.org/0000-0002-9647-6470', 'ORCID: http://orcid.org/0000-0002-5471-1487'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20191216', 'PL': 'England', 'TA': 'Sci Rep', 'JT': 'Scientific reports', 'JID': '101563288', 'RN': ['0 (Proteome)'], 'SB': 'IM', 'MH': ['Cardiovascular System/metabolism', 'Cause of Death', 'Extracellular Matrix/metabolism', 'Female', 'Heart Failure/*blood/metabolism/*mortality', 'Humans', 'Male', 'Middle Aged', 'Proteome/*metabolism', 'Proteomics/methods', 'Risk Factors'], 'PMC': 'PMC6914779', 'EDAT': '2019/12/18 06:00', 'MHDA': '2020/11/05 06:00', 'CRDT': ['2019/12/18 06:00'], 'PHST': ['2019/06/13 00:00 [received]', '2019/12/03 00:00 [accepted]', '2019/12/18 06:00 [entrez]', '2019/12/18 06:00 [pubmed]', '2020/11/05 06:00 [medline]'], 'AID': ['10.1038/s41598-019-55727-1 [doi]', '10.1038/s41598-019-55727-1 [pii]'], 'PST': 'epublish', 'SO': 'Sci Rep. 2019 Dec 16;9(1):19202. doi: 10.1038/s41598-019-55727-1.'}\n",
      "{'PMID': '31825151', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20201221', 'LR': '20201221', 'IS': '1615-9861 (Electronic) 1615-9853 (Linking)', 'VI': '20', 'IP': '1', 'DP': '2020 Jan', 'TI': 'Proteomic Insights into Endometrial Receptivity and Embryo-Endometrial Epithelium Interaction for Implantation Reveal Critical Determinants of Fertility.', 'PG': 'e1900250', 'LID': '10.1002/pmic.201900250 [doi]', 'AB': 'In vitro fertilization has overcome infertility issues for many couples. However, achieving implantation of a viable embryo into the maternal endometrium remains a limiting step in optimizing pregnancy success. The molecular mechanisms which characterize the transient state of endometrial receptivity, critical in enabling embryo-endometrial interactions, and proteins which underpin adhesion at the implantation interface, are limited in humans despite these temporally regulated processes fundamental to life. Hence, failure of implantation remains the \"final frontier\" in infertility. A human coculture model is utilized utilizing spheroids of a trophectoderm (trophoblast stem) cell line, derived from pre-implantation human embryos, and primary human endometrial epithelial cells, to functionally identify \"fertile\" versus \"infertile\" endometrial epithelium based on adhesion between these cell types. Quantitative proteomics identified proteins associated with human endometrial epithelial receptivity (\"epithelial receptome\") and trophectoderm adhesion (\"adhesome\"). As validation, key \"epithelial receptome\" proteins (MAGT-1/CDA/LGMN/KYNU/PC4) localized to the epithelium of receptive phase (mid-secretory) endometrium obtained from fertile, normally cycling women but is largely absent from non-receptive (proliferative) phase tissues. Factors involved in embryo-epithelium interaction in successive temporal stages of endometrial receptivity and implantation are demonstrated and potential targets for improving fertility are provided, enhancing potential to become pregnant either naturally or in a clinical setting.', 'CI': ['(c) 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.'], 'FAU': ['Evans, Jemma', 'Hutchison, Jennifer', 'Salamonsen, Lois A', 'Greening, David W'], 'AU': ['Evans J', 'Hutchison J', 'Salamonsen LA', 'Greening DW'], 'AUID': ['ORCID: 0000-0002-3300-8127', 'ORCID: 0000-0002-8083-9740', 'ORCID: 0000-0001-7516-485X'], 'AD': ['Hudson Institute of Medical Research, Monash University, Clayton, Victoria, 3168, Australia.', 'Department of Molecular and Translational Science, Monash University, Clayton, Victoria, 3168, Australia.', 'Hudson Institute of Medical Research, Monash University, Clayton, Victoria, 3168, Australia.', 'Department of Molecular and Translational Science, Monash University, Clayton, Victoria, 3168, Australia.', 'Hudson Institute of Medical Research, Monash University, Clayton, Victoria, 3168, Australia.', 'Department of Molecular and Translational Science, Monash University, Clayton, Victoria, 3168, Australia.', 'Baker Heart and Diabetes Institute, Molecular Proteomics, Melbourne, Victoria, 3004, Australia.', 'Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Bundoora, Victoria, 3086, Australia.'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'PL': 'Germany', 'TA': 'Proteomics', 'JT': 'Proteomics', 'JID': '101092707', 'RN': ['0 (Proteome)'], 'SB': 'IM', 'MH': ['Adult', 'Cell Line', 'Coculture Techniques', '*Embryo Implantation', 'Embryo, Mammalian/cytology/*metabolism', 'Embryonic Development', 'Endometrium/cytology/*metabolism', 'Epithelial Cells/cytology/metabolism', 'Epithelium/metabolism', 'Female', 'Fertility', 'Humans', 'Pregnancy', 'Proteome/*metabolism', 'Proteomics/*methods', 'Trophoblasts/cytology/*metabolism'], 'OTO': ['NOTNLM'], 'OT': ['*adhesion', '*cell-cell interactions', '*endometrium', '*implantation', '*receptivity', '*trophectoderm'], 'EDAT': '2019/12/12 06:00', 'MHDA': '2020/12/22 06:00', 'CRDT': ['2019/12/12 06:00'], 'PHST': ['2019/07/24 00:00 [received]', '2019/11/25 00:00 [revised]', '2019/12/12 06:00 [pubmed]', '2020/12/22 06:00 [medline]', '2019/12/12 06:00 [entrez]'], 'AID': ['10.1002/pmic.201900250 [doi]'], 'PST': 'ppublish', 'SO': 'Proteomics. 2020 Jan;20(1):e1900250. doi: 10.1002/pmic.201900250.'}\n",
      "{'PMID': '31819116', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20201215', 'LR': '20201215', 'IS': '2045-2322 (Electronic) 2045-2322 (Linking)', 'VI': '9', 'IP': '1', 'DP': '2019 Dec 9', 'TI': 'Integrative proteomics and phosphoproteomics in pulmonary arterial hypertension.', 'PG': '18623', 'LID': '10.1038/s41598-019-55053-6 [doi]', 'AB': 'Pulmonary arterial endothelial cells (PAEC) are mechanistically linked to origins of pulmonary arterial hypertension (PAH). Here, global proteomics and phosphoproteomics of PAEC from PAH (n = 4) and healthy lungs (n = 5) were performed using LC-MS/MS to confirm known pathways and identify new areas of investigation in PAH. Among PAH and control cells, 170 proteins and 240 phosphopeptides were differentially expressed; of these, 45 proteins and 18 phosphopeptides were located in the mitochondria. Pathologic pathways were identified with integrative bioinformatics and human protein-protein interactome network analyses, then confirmed with targeted proteomics in PAH PAEC and non-targeted metabolomics and targeted high-performance liquid chromatography of metabolites in plasma from PAH patients (n = 30) and healthy controls (n = 12). Dysregulated pathways in PAH include accelerated one carbon metabolism, abnormal tricarboxylic acid (TCA) cycle flux and glutamate metabolism, dysfunctional arginine and nitric oxide pathways, and increased oxidative stress. Functional studies in cells confirmed abnormalities in glucose metabolism, mitochondrial oxygen consumption, and production of reactive oxygen species in PAH. Altogether, the findings indicate that PAH is typified by changes in metabolic pathways that are primarily found in mitochondria.', 'FAU': ['Xu, Weiling', 'Comhair, Suzy A A', 'Chen, Ruoying', 'Hu, Bo', 'Hou, Yuan', 'Zhou, Yadi', 'Mavrakis, Lori A', 'Janocha, Allison J', 'Li, Ling', 'Zhang, Dongmei', 'Willard, Belinda B', 'Asosingh, Kewal', 'Cheng, Feixiong', 'Erzurum, Serpil C'], 'AU': ['Xu W', 'Comhair SAA', 'Chen R', 'Hu B', 'Hou Y', 'Zhou Y', 'Mavrakis LA', 'Janocha AJ', 'Li L', 'Zhang D', 'Willard BB', 'Asosingh K', 'Cheng F', 'Erzurum SC'], 'AUID': ['ORCID: http://orcid.org/0000-0003-1572-4311'], 'AD': ['Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, United States of America. xuw@ccf.org.', 'Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, United States of America.', 'Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, United States of America.', 'Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, United States of America.', 'Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, United States of America.', 'Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, United States of America.', 'Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, United States of America.', 'Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, United States of America.', 'Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, United States of America.', 'Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, United States of America.', 'Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, United States of America.', 'Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, United States of America.', 'Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, United States of America.', 'Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, United States of America. erzurus@ccf.org.', 'Respiratory Institute, Cleveland Clinic, Cleveland, Ohio, United States of America. erzurus@ccf.org.'], 'LA': ['eng'], 'GR': ['S10 RR031537/RR/NCRR NIH HHS/United States', 'HL060917/U.S. Department of Health &amp; Human Services | NIH | National Heart,', 'Lung, and Blood Institute (NHLBI)/International', 'S10 OD023436/OD/NIH HHS/United States', 'R01 HL060917/HL/NHLBI NIH HHS/United States', 'R01 HL069170/HL/NHLBI NIH HHS/United States'], 'PT': ['Journal Article', 'Research Support, N.I.H., Extramural', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20191209', 'PL': 'England', 'TA': 'Sci Rep', 'JT': 'Scientific reports', 'JID': '101563288', 'RN': ['0 (Peptides)', '0 (Phosphoproteins)', '0 (Proteome)', '0 (Reactive Oxygen Species)', '31C4KY9ESH (Nitric Oxide)', '94ZLA3W45F (Arginine)', 'IY9XDZ35W2 (Glucose)'], 'SB': 'IM', 'MH': ['Adult', 'Arginine/metabolism', 'Citric Acid Cycle', 'Computational Biology', 'Endothelial Cells/metabolism', 'Female', 'Glucose/metabolism', 'Humans', 'Lung/metabolism', 'Lung Transplantation', 'Male', 'Metabolomics', 'Middle Aged', 'Mitochondria/metabolism', 'Nitric Oxide/metabolism', 'Oxidative Stress', 'Peptides/*metabolism', 'Phosphoproteins/*metabolism', 'Protein Interaction Mapping', 'Proteome', 'Proteomics/*methods', 'Pulmonary Arterial Hypertension/*metabolism', 'Reactive Oxygen Species/metabolism'], 'PMC': 'PMC6901481', 'EDAT': '2019/12/11 06:00', 'MHDA': '2020/12/16 06:00', 'CRDT': ['2019/12/11 06:00'], 'PHST': ['2019/09/05 00:00 [received]', '2019/11/21 00:00 [accepted]', '2019/12/11 06:00 [entrez]', '2019/12/11 06:00 [pubmed]', '2020/12/16 06:00 [medline]'], 'AID': ['10.1038/s41598-019-55053-6 [doi]', '10.1038/s41598-019-55053-6 [pii]'], 'PST': 'epublish', 'SO': 'Sci Rep. 2019 Dec 9;9(1):18623. doi: 10.1038/s41598-019-55053-6.'}\n",
      "{'PMID': '31806903', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20200127', 'LR': '20201204', 'IS': '1546-170X (Electronic) 1078-8956 (Linking)', 'VI': '25', 'IP': '12', 'DP': '2019 Dec', 'TI': 'Undulating changes in human plasma proteome profiles across the lifespan.', 'PG': '1843-1850', 'LID': '10.1038/s41591-019-0673-2 [doi]', 'AB': 'Aging is a predominant risk factor for several chronic diseases that limit healthspan(1). Mechanisms of aging are thus increasingly recognized as potential therapeutic targets. Blood from young mice reverses aspects of aging and disease across multiple tissues(2-10), which supports a hypothesis that age-related molecular changes in blood could provide new insights into age-related disease biology. We measured 2,925 plasma proteins from 4,263 young adults to nonagenarians (18-95 years old) and developed a new bioinformatics approach that uncovered marked non-linear alterations in the human plasma proteome with age. Waves of changes in the proteome in the fourth, seventh and eighth decades of life reflected distinct biological pathways and revealed differential associations with the genome and proteome of age-related diseases and phenotypic traits. This new approach to the study of aging led to the identification of unexpected signatures and pathways that might offer potential targets for age-related diseases.', 'FAU': ['Lehallier, Benoit', 'Gate, David', 'Schaum, Nicholas', 'Nanasi, Tibor', 'Lee, Song Eun', 'Yousef, Hanadie', 'Moran Losada, Patricia', 'Berdnik, Daniela', 'Keller, Andreas', 'Verghese, Joe', 'Sathyan, Sanish', 'Franceschi, Claudio', 'Milman, Sofiya', 'Barzilai, Nir', 'Wyss-Coray, Tony'], 'AU': ['Lehallier B', 'Gate D', 'Schaum N', 'Nanasi T', 'Lee SE', 'Yousef H', 'Moran Losada P', 'Berdnik D', 'Keller A', 'Verghese J', 'Sathyan S', 'Franceschi C', 'Milman S', 'Barzilai N', 'Wyss-Coray T'], 'AUID': ['ORCID: http://orcid.org/0000-0001-7452-3785', 'ORCID: http://orcid.org/0000-0002-5361-0895', 'ORCID: http://orcid.org/0000-0001-5893-0831'], 'AD': ['Department of Neurology and Neurological Sciences, Stanford University, Stanford, CA, USA. lehallib@stanford.edu.', 'Wu Tsai Neurosciences Institute, Stanford University, Stanford, CA, USA. lehallib@stanford.edu.', 'Paul F. Glenn Center for the Biology of Aging, Stanford University, Stanford, CA, USA. lehallib@stanford.edu.', 'Department of Neurology and Neurological Sciences, Stanford University, Stanford, CA, USA.', 'Wu Tsai Neurosciences Institute, Stanford University, Stanford, CA, USA.', 'Paul F. Glenn Center for the Biology of Aging, Stanford University, Stanford, CA, USA.', 'Department of Veterans Affairs, VA Palo Alto Health Care System, Palo Alto, CA, USA.', 'Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA, USA.', 'Department of Neurology and Neurological Sciences, Stanford University, Stanford, CA, USA.', 'Wu Tsai Neurosciences Institute, Stanford University, Stanford, CA, USA.', 'Paul F. Glenn Center for the Biology of Aging, Stanford University, Stanford, CA, USA.', 'Institute of Cognitive Neuroscience and Psychology, Hungarian Academy of Sciences Research Centre for Natural Sciences, Budapest, Hungary.', 'Department of Neurology and Neurological Sciences, Stanford University, Stanford, CA, USA.', 'Wu Tsai Neurosciences Institute, Stanford University, Stanford, CA, USA.', 'Paul F. Glenn Center for the Biology of Aging, Stanford University, Stanford, CA, USA.', 'Department of Veterans Affairs, VA Palo Alto Health Care System, Palo Alto, CA, USA.', 'Department of Neurology and Neurological Sciences, Stanford University, Stanford, CA, USA.', 'Wu Tsai Neurosciences Institute, Stanford University, Stanford, CA, USA.', 'Paul F. Glenn Center for the Biology of Aging, Stanford University, Stanford, CA, USA.', 'Department of Veterans Affairs, VA Palo Alto Health Care System, Palo Alto, CA, USA.', 'Department of Neurology and Neurological Sciences, Stanford University, Stanford, CA, USA.', 'Wu Tsai Neurosciences Institute, Stanford University, Stanford, CA, USA.', 'Paul F. Glenn Center for the Biology of Aging, Stanford University, Stanford, CA, USA.', 'Department of Neurology and Neurological Sciences, Stanford University, Stanford, CA, USA.', 'Wu Tsai Neurosciences Institute, Stanford University, Stanford, CA, USA.', 'Paul F. Glenn Center for the Biology of Aging, Stanford University, Stanford, CA, USA.', 'Department of Veterans Affairs, VA Palo Alto Health Care System, Palo Alto, CA, USA.', 'Clinical Bioinformatics, Saarland University, Saarbrucken, Germany.', 'Institute for Aging Research, Department of Medicine, Albert Einstein College of Medicine, Bronx, NY, USA.', 'Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA.', 'Institute for Aging Research, Department of Medicine, Albert Einstein College of Medicine, Bronx, NY, USA.', 'Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA.', 'Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.', 'Department of Applied Mathematics, National Research Lobachevsky State University of Nizhny Novgorod, Nizhny Novgorod, Russia.', 'Institute for Aging Research, Department of Medicine, Albert Einstein College of Medicine, Bronx, NY, USA.', 'Department of Genetics, Albert Einstein College of Medicine, Bronx, NY, USA.', 'Institute for Aging Research, Department of Medicine, Albert Einstein College of Medicine, Bronx, NY, USA.', 'Department of Genetics, Albert Einstein College of Medicine, Bronx, NY, USA.', 'Department of Neurology and Neurological Sciences, Stanford University, Stanford, CA, USA. twc@stanford.edu.', 'Wu Tsai Neurosciences Institute, Stanford University, Stanford, CA, USA. twc@stanford.edu.', 'Paul F. Glenn Center for the Biology of Aging, Stanford University, Stanford, CA, USA. twc@stanford.edu.', 'Department of Veterans Affairs, VA Palo Alto Health Care System, Palo Alto, CA, USA. twc@stanford.edu.'], 'LA': ['eng'], 'GR': ['RG/18/13/33946/BHF_/British Heart Foundation/United Kingdom', 'RG/13/13/30194/BHF_/British Heart Foundation/United Kingdom', 'R01 AG061155/AG/NIA NIH HHS/United States', 'R01 AG044829/AG/NIA NIH HHS/United States', 'DP1 AG053015/AG/NIA NIH HHS/United States', 'P30 AG038072/AG/NIA NIH HHS/United States', 'F32 AG055255/AG/NIA NIH HHS/United States', 'R01 AG045034/AG/NIA NIH HHS/United States', 'R01 AG057909/AG/NIA NIH HHS/United States', 'P50 AG047366/AG/NIA NIH HHS/United States', 'K23 AG051148/AG/NIA NIH HHS/United States'], 'PT': ['Journal Article', 'Research Support, N.I.H., Extramural', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20191205', 'PL': 'United States', 'TA': 'Nat Med', 'JT': 'Nature medicine', 'JID': '9502015', 'RN': ['0 (Blood Proteins)', '0 (Proteome)'], 'SB': 'IM', 'MH': ['Adolescent', 'Adult', 'Aged', 'Aged, 80 and over', 'Aging/*blood/genetics', 'Animals', 'Blood Proteins/*genetics', 'Chronic Disease', 'Female', 'Humans', 'Longevity/*genetics', 'Male', 'Mice', 'Middle Aged', 'Proteome/*genetics', 'Risk Factors', 'Young Adult'], 'PMC': 'PMC7062043', 'MID': ['NIHMS1541641'], 'EDAT': '2019/12/07 06:00', 'MHDA': '2020/01/28 06:00', 'CRDT': ['2019/12/07 06:00'], 'PHST': ['2019/01/18 00:00 [received]', '2019/10/30 00:00 [accepted]', '2019/12/07 06:00 [entrez]', '2019/12/07 06:00 [pubmed]', '2020/01/28 06:00 [medline]'], 'AID': ['10.1038/s41591-019-0673-2 [doi]', '10.1038/s41591-019-0673-2 [pii]'], 'PST': 'ppublish', 'SO': 'Nat Med. 2019 Dec;25(12):1843-1850. doi: 10.1038/s41591-019-0673-2. Epub 2019 Dec 5.'}\n",
      "{'PMID': '31783201', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20201231', 'LR': '20201231', 'IS': '1879-1484 (Electronic) 0021-9150 (Linking)', 'VI': '292', 'DP': '2020 Jan', 'TI': 'Epicardial adipose tissue volume and annexin A2/fetuin-A signalling are linked to coronary calcification in advanced coronary artery disease: Computed tomography and proteomic biomarkers from the EPICHEART study.', 'PG': '75-83', 'LID': 'S0021-9150(19)31572-2 [pii] 10.1016/j.atherosclerosis.2019.11.015 [doi]', 'AB': 'BACKGROUND & AIMS: The role of epicardial adipose tissue (EAT) in the pathophysiology of late stage-coronary artery disease (CAD) has not been investigated. We explored the association of EAT volume and its proteome with advanced coronary atherosclerosis. METHODS: The EPICHEART Study prospectively enrolled 574 severe aortic stenosis patients referred to cardiac surgery. Before surgery, EAT volume was quantified by computed tomography (CT). During surgery, epicardial, mediastinal (MAT) and subcutaneous (SAT) adipose tissue samples were collected to explore fat phenotype by analyzing the proteomic profile using SWATH-mass spectrometry; pericardial fluid and peripheral venous blood were also collected. CAD presence was defined as coronary artery stenosis >/=50% in invasive angiography and by CT-derived Agatston coronary calcium score (CCS). RESULTS: EAT volume adjusted for body fat was associated with higher CCS, but not with the presence of coronary stenosis. In comparison with mediastinal and subcutaneous fat depots, EAT exhibited a pro-calcifying proteomic profile in patients with CAD characterized by upregulation of annexin-A2 and downregulation of fetuin-A; annexin-A2 protein levels in EAT samples were also positively correlated with CCS. We confirmed that the annexin-A2 gene was overexpressed in EAT samples of CAD patients and positively correlated with CCS. Fetuin-A gene was not detected in EAT samples, but systemic fetuin-A was higher in CAD than in non-CAD patients, suggesting that fetuin-A was locally downregulated. CONCLUSIONS: In an elderly cohort of stable patients, CCS was associated with EAT volume and annexin-A2/fetuin-A signaling, suggesting that EAT might orchestrate pro-calcifying conditions in the late phases of CAD.', 'CI': ['Copyright (c) 2019 Elsevier B.V. All rights reserved.'], 'FAU': ['Mancio, Jennifer', 'Barros, Antonio S', 'Conceicao, Gloria', 'Pessoa-Amorim, Guilherme', 'Santa, Catia', 'Bartosch, Carla', 'Ferreira, Wilson', 'Carvalho, Monica', 'Ferreira, Nuno', 'Vouga, Luis', 'Miranda, Isabel M', 'Vitorino, Rui', 'Manadas, Bruno', 'Falcao-Pires, Ines', 'Ribeiro, Vasco Gama', 'Leite-Moreira, Adelino', 'Bettencourt, Nuno'], 'AU': ['Mancio J', 'Barros AS', 'Conceicao G', 'Pessoa-Amorim G', 'Santa C', 'Bartosch C', 'Ferreira W', 'Carvalho M', 'Ferreira N', 'Vouga L', 'Miranda IM', 'Vitorino R', 'Manadas B', 'Falcao-Pires I', 'Ribeiro VG', 'Leite-Moreira A', 'Bettencourt N'], 'AD': ['Department of Surgery and Physiology, Cardiovascular Research Unit (UnIC), Faculty of Medicine, University of Porto, Portugal; Department of Cardiology, Centro Hospitalar de Vila Nova de Gaia, Portugal. Electronic address: up200104593@med.up.pt.', 'Department of Surgery and Physiology, Cardiovascular Research Unit (UnIC), Faculty of Medicine, University of Porto, Portugal.', 'Department of Surgery and Physiology, Cardiovascular Research Unit (UnIC), Faculty of Medicine, University of Porto, Portugal.', 'Department of Surgery and Physiology, Cardiovascular Research Unit (UnIC), Faculty of Medicine, University of Porto, Portugal.', 'CNC - Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal; III: Institute for Interdisciplinary Research, University of Coimbra (IIIUC), Portugal.', 'Department of Pathology, Portuguese Oncology Institute of Porto, Porto, Portugal.', 'Department of Cardiology, Centro Hospitalar de Vila Nova de Gaia, Portugal.', 'Department of Cardiology, Centro Hospitalar de Vila Nova de Gaia, Portugal.', 'Department of Cardiology, Centro Hospitalar de Vila Nova de Gaia, Portugal.', 'Department of Cardiothoracic Surgery, Centro Hospitalar de Vila Nova de Gaia, Portugal.', 'Department of Surgery and Physiology, Cardiovascular Research Unit (UnIC), Faculty of Medicine, University of Porto, Portugal.', 'Department of Surgery and Physiology, Cardiovascular Research Unit (UnIC), Faculty of Medicine, University of Porto, Portugal.', 'CNC - Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal.', 'Department of Surgery and Physiology, Cardiovascular Research Unit (UnIC), Faculty of Medicine, University of Porto, Portugal.', 'Department of Cardiology, Centro Hospitalar de Vila Nova de Gaia, Portugal.', 'Department of Surgery and Physiology, Cardiovascular Research Unit (UnIC), Faculty of Medicine, University of Porto, Portugal; Department of Cardiothoracic Surgery, Centro Hospitalar de Sao Joao, Portugal.', 'Department of Surgery and Physiology, Cardiovascular Research Unit (UnIC), Faculty of Medicine, University of Porto, Portugal.'], 'LA': ['eng'], 'PT': ['Journal Article'], 'DEP': '20191115', 'PL': 'Ireland', 'TA': 'Atherosclerosis', 'JT': 'Atherosclerosis', 'JID': '0242543', 'RN': ['0 (Annexin A2)', '0 (Biomarkers)', '0 (alpha-2-HS-Glycoprotein)'], 'SB': 'IM', 'MH': ['Adipose Tissue/*anatomy & histology/chemistry/*diagnostic imaging', 'Aged', 'Aged, 80 and over', 'Annexin A2/*analysis/*physiology', 'Biomarkers/analysis', 'Coronary Artery Disease/blood/*diagnostic imaging/etiology', 'Female', 'Humans', 'Male', 'Organ Size', 'Pericardium/*anatomy & histology/chemistry/*diagnostic imaging', 'Prospective Studies', 'Proteomics', 'Severity of Illness Index', '*Signal Transduction', '*Tomography, X-Ray Computed', 'Vascular Calcification/blood/*diagnostic imaging/etiology', 'alpha-2-HS-Glycoprotein/*analysis/*physiology'], 'OTO': ['NOTNLM'], 'OT': ['*Cardiac computed tomography', '*Coronary atherosclerosis', '*Coronary calcification', '*EPICHEART study', '*Epicardial adipose tissue', '*Epicardial fat', '*Mass spectrometry', '*Proteomics'], 'EDAT': '2019/11/30 06:00', 'MHDA': '2021/01/01 06:00', 'CRDT': ['2019/11/30 06:00'], 'PHST': ['2019/06/16 00:00 [received]', '2019/10/27 00:00 [revised]', '2019/11/13 00:00 [accepted]', '2019/11/30 06:00 [pubmed]', '2021/01/01 06:00 [medline]', '2019/11/30 06:00 [entrez]'], 'AID': ['S0021-9150(19)31572-2 [pii]', '10.1016/j.atherosclerosis.2019.11.015 [doi]'], 'PST': 'ppublish', 'SO': 'Atherosclerosis. 2020 Jan;292:75-83. doi: 10.1016/j.atherosclerosis.2019.11.015. Epub 2019 Nov 15.'}\n",
      "{'PMID': '31734660', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20200930', 'LR': '20200930', 'IS': '1421-9751 (Electronic) 0008-6312 (Linking)', 'VI': '145', 'IP': '1', 'DP': '2020', 'TI': 'Proteomic Analyses of Endarterectomized Tissues from Patients with Chronic Thromboembolic Pulmonary Hypertension.', 'PG': '48-52', 'LID': '10.1159/000502831 [doi]', 'AB': 'BACKGROUND: The pathogenesis of chronic thromboembolic pulmonary hypertension (CTEPH) is largely unknown. Proteomics offers an approach to overview the molecular activities and signal transduction pathways involved in specific disease processes. OBJECTIVES: In this study, the expression of proteins in endarterectomized tissues from patients with CTEPH was investigated in a novel strategy to explore the pathophysiology of this disease. METHODS: We used the iTRAQ (isobaric tag for relative and absolute quantitation) approach combined with a Thermo Scientific Q Exactive MS analysis to compare the protein profiles in endarterectomized tissues from CTEPH patients and that of the control samples (mixture of cultured human pulmonary artery endothelial cells, human pulmonary artery smooth muscle cells, and human pulmonary fibroblasts). GO and KEGG analyses were performed to understand the functional classification and molecular activities of all the tissue-specific proteins, and the involved signal transduction pathways. RESULTS: Six hundred and seventy-nine tissue-specific proteins were detected. Bioinformatic analysis showed that the major biological processes involving these proteins were: response to wounding, defense response, acute inflammatory response, immune response, complement activation, and blood coagulation. The main pathways involved were: complement and coagulation cascade, systemic lupus erythematosus, extracellular matrix-receptor interaction, cell adhesion molecules, FcepsilonRI signaling, and leukocyte transendothelial migration. CONCLUSIONS: The present study revealed that immune and defense response might play an important role in CTEPH.', 'CI': ['(c) 2019 S. Karger AG, Basel.'], 'FAU': ['Xi, Qunying', 'Liu, Zhihong', 'Song, Yunhu', 'Gan, Huili', 'Huang, Zhiwei', 'Luo, Qin', 'Zhao, Zhihui'], 'AU': ['Xi Q', 'Liu Z', 'Song Y', 'Gan H', 'Huang Z', 'Luo Q', 'Zhao Z'], 'AD': ['Department of Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences, Shenzhen, China.', 'Center for Pulmonary Vascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, fuwaipumc@163.com.', 'Center of Adult Cardiac Surgery, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.', 'Department of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing, China.', 'Center for Pulmonary Vascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.', 'Center for Pulmonary Vascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.', 'Center for Pulmonary Vascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.'], 'LA': ['eng'], 'PT': ['News', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20191115', 'PL': 'Switzerland', 'TA': 'Cardiology', 'JT': 'Cardiology', 'JID': '1266406', 'RN': ['0 (Proteome)'], 'SB': 'IM', 'MH': ['Adult', 'Cell Proliferation', 'Cells, Cultured', 'Chronic Disease', '*Endarterectomy', 'Endothelial Cells/metabolism', 'Female', 'Humans', 'Hypertension, Pulmonary/*metabolism/pathology/surgery', 'Male', 'Middle Aged', 'Muscle, Smooth, Vascular/cytology/metabolism', '*Proteome', 'Pulmonary Artery/*surgery', 'Signal Transduction', 'Thromboembolism/*metabolism/pathology/surgery', 'Young Adult'], 'OTO': ['NOTNLM'], 'OT': ['*Chronic thromboembolic pulmonary hypertension', '*Proteomic analysis', '*Pulmonary endarterectomy'], 'EDAT': '2019/11/18 06:00', 'MHDA': '2020/10/02 06:00', 'CRDT': ['2019/11/18 06:00'], 'PHST': ['2018/10/15 00:00 [received]', '2019/08/19 00:00 [accepted]', '2019/11/18 06:00 [pubmed]', '2020/10/02 06:00 [medline]', '2019/11/18 06:00 [entrez]'], 'AID': ['000502831 [pii]', '10.1159/000502831 [doi]'], 'PST': 'ppublish', 'SO': 'Cardiology. 2020;145(1):48-52. doi: 10.1159/000502831. Epub 2019 Nov 15.'}\n",
      "{'PMID': '31585756', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20201111', 'LR': '20201111', 'IS': '1097-685X (Electronic) 0022-5223 (Linking)', 'VI': '159', 'IP': '2', 'DP': '2020 Feb', 'TI': 'Maladaptive remodeling of pulmonary artery root autografts after Ross procedure: A proteomic study.', 'PG': '621-632.e3', 'LID': 'S0022-5223(19)31634-4 [pii] 10.1016/j.jtcvs.2019.07.083 [doi]', 'AB': 'OBJECTIVE: Pulmonary autograft root dilatation is the major long-term complication after Ross procedure and the leading cause for reoperation. However, the mechanisms underlying dilatation remain to be elucidated. This study analyzed the proteomic changes seen in the dilated pulmonary autograft compared with normal pulmonary artery and aorta tissues. METHODS: Pulmonary autograft surgical samples were taken from 9 consecutive patients (mean age 37 +/- 14; 15-51 years) with mean diameters of 5.2 +/- 0.5 cm (4.6-5.8 cm) reoperated 8 to 16 years after Ross procedure. Control pulmonary artery and aorta samples were from 7 age- and sex-matched cardiac donors. Tunicae mediae from all samples were processed for proteomic analysis via 2-dimensional electrophoresis, matrix-assisted-laser-desorption-ionization-time of flight/mass spectrometry, and bioinformatics. The thus-identified putatively relevant proteins were validated via Western immunoblotting. RESULTS: Pulmonary autograft proteome features differed markedly from control pulmonary arteries, since proteins related to focal adhesions (eg, paxillin), cytoskeleton (eg, vimentin), and metalloprotease-regulating proteoglycans (eg, testican-2) were significantly up-regulated, whereas significant decreases occurred in microfibril-associated glycoprotein1, which controls elastic fiber buildup. Profound changes also occurred in cell-signaling proteins, ie, increases in soluble Jagged-1 fragment and ectodysplasin-2 receptor, and decreases in Notch-1 intracellular domain fragment. Moreover, pulmonary autograft expression levels of Paxillin, Vimentin, Jagged-1 fragment, and Notch1 intracellular domain fragment also differed from those of control aorta. CONCLUSIONS: This study provides the first description of the specific proteomic features of dilated pulmonary autograft tunica media, which separate them sharply not only from those of control pulmonary artery and aorta but also of aortic aneurysms. These findings suggest that dilated pulmonary autografts undergo a unique maladaptive remodeling process deserving further investigation.', 'CI': ['Copyright (c) 2019 The American Association for Thoracic Surgery. Published by', 'Elsevier Inc. All rights reserved.'], 'FAU': ['Chiarini, Anna', 'Dal Pra, Ilaria', 'Faggian, Giuseppe', 'Armato, Ubaldo', 'Luciani, Giovanni Battista'], 'AU': ['Chiarini A', 'Dal Pra I', 'Faggian G', 'Armato U', 'Luciani GB'], 'AD': ['Human Histology & Embryology Unit, Medical School, University of Verona, Verona, Italy.', 'Human Histology & Embryology Unit, Medical School, University of Verona, Verona, Italy.', 'Division of Cardiac Surgery, Department of Surgery, Dentistry, Pediatrics and Gynecology, Medical School, University of Verona, Verona, Italy.', 'Human Histology & Embryology Unit, Medical School, University of Verona, Verona, Italy.', 'Division of Cardiac Surgery, Department of Surgery, Dentistry, Pediatrics and Gynecology, Medical School, University of Verona, Verona, Italy. Electronic address: giovanni.luciani@univr.it.'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20190825', 'PL': 'United States', 'TA': 'J Thorac Cardiovasc Surg', 'JT': 'The Journal of thoracic and cardiovascular surgery', 'JID': '0376343', 'RN': ['0 (Proteome)'], 'SB': 'AIM IM', 'CIN': ['J Thorac Cardiovasc Surg. 2020 Feb;159(2):633-634. PMID: 31604643', 'J Thorac Cardiovasc Surg. 2020 Feb;159(2):635-636. PMID: 31635868'], 'MH': ['Adolescent', 'Adult', '*Autografts/chemistry/metabolism/pathology/transplantation', 'Cardiac Surgical Procedures/*adverse effects', 'Female', 'Focal Adhesions/metabolism', 'Humans', 'Male', 'Middle Aged', 'Proteome/*analysis/chemistry/metabolism', 'Proteomics', '*Pulmonary Artery/chemistry/metabolism/pathology/transplantation', 'Signal Transduction', 'Transplantation, Autologous/*adverse effects', 'Tunica Media/pathology', 'Vascular Remodeling', 'Young Adult'], 'OTO': ['NOTNLM'], 'OT': ['*Ross procedure', '*aneurysm', '*ascending aorta', '*maladaptive remodeling', '*proteomics', '*pulmonary artery', '*root autografts'], 'EDAT': '2019/10/06 06:00', 'MHDA': '2020/11/12 06:00', 'CRDT': ['2019/10/06 06:00'], 'PHST': ['2019/01/30 00:00 [received]', '2019/06/26 00:00 [revised]', '2019/07/02 00:00 [accepted]', '2019/10/06 06:00 [pubmed]', '2020/11/12 06:00 [medline]', '2019/10/06 06:00 [entrez]'], 'AID': ['S0022-5223(19)31634-4 [pii]', '10.1016/j.jtcvs.2019.07.083 [doi]'], 'PST': 'ppublish', 'SO': 'J Thorac Cardiovasc Surg. 2020 Feb;159(2):621-632.e3. doi: 10.1016/j.jtcvs.2019.07.083. Epub 2019 Aug 25.'}\n",
      "{'PMID': '31562990', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20200220', 'LR': '20200220', 'IS': '1095-8673 (Electronic) 0022-4804 (Linking)', 'VI': '246', 'DP': '2020 Feb', 'TI': 'Proteomic Analysis of Infants Undergoing Cardiopulmonary Bypass Using Contemporary Ontological Tools.', 'PG': '83-92', 'LID': 'S0022-4804(19)30625-0 [pii] 10.1016/j.jss.2019.08.019 [doi]', 'AB': 'BACKGROUND: Cardiopulmonary bypass (CPB) is essential for the repair of many congenital cardiac defects in infants but is associated with significant derangements in hemostasis and systemic inflammation. As a result, hemorrhagic complications and thrombosis are major challenges in the management of children requiring CPB or extracorporeal membrane oxygenation. Conventional clinical laboratory tests capture individual hemostatic derangements (low platelets, elevated fibrinogen) but fail to describe the complex, overlapping interactions among the various components of coagulation, including cellular interactions, contact activation, fibrinolysis, and inflammation. Given recent advances in analytic tools for identifying protein-protein interactions in the plasma proteome, we hypothesized that an unbiased proteomic analysis would help identify networks of interacting proteins for further investigation in pediatric CPB. MATERIALS AND METHODS: Infants up to 1 y of age were enrolled. Plasma samples were collected at 0, 1, 4, and 24 h after CPB. Mass spectrometry was used to identify proteins undergoing changes in concentration after CPB, and STRING and ToppGene tools were used to identify biological networks. Two-dimensional difference gel electrophoresis identified changes in protein concentrations. Inflammatory markers were assessed by enzyme-linked immunosorbent assay at the same time points. RESULTS: Ten infants with cardiac anomalies requiring surgery and CPB were enrolled; no major complications were recorded (median age, 127.5 d; interquartile range, 181.25 d). Using two-dimensional difference gel electrophoresis, >1400 individual protein spots were observed, and 89 proteins demonstrated change in concentration >30% with P < 0.02 when comparing 1, 4, or 24 h to baseline. Among protein spots with significant changes in concentration after CPB, 29 were identified with mass spectrometry (33%). In our interrogation of functional associations among these differentially expressed proteins, our results were dominated by the acute phase response, coagulation, and cell signaling functional categories. Among cytokines analyzed by enzyme-linked immunosorbent assay, IL-2, IL-8, and IL-10 were elevated at 4 h but normalized by 24 h, whereas IL-6 was persistently elevated. CONCLUSIONS: Infants manifest a robust response to CPB that includes overlapping, complex pathways. Further investigation of interactions among immune, coagulation, and cell signaling systems may lead to novel therapeutics or biomarkers useful in the management of infants requiring CPB.', 'CI': ['Copyright (c) 2019 Elsevier Inc. All rights reserved.'], 'FAU': ['Reed, Christopher Robert', 'McCoy, Christopher Cameron', 'Nag, Uttara', 'Nixon, Andrew B', 'Otto, James', 'Lawson, Jeffrey Harold', 'Lodge, Andrew J', 'Turek, Joseph W', 'Tracy, Elisabeth Tomlinson'], 'AU': ['Reed CR', 'McCoy CC', 'Nag U', 'Nixon AB', 'Otto J', 'Lawson JH', 'Lodge AJ', 'Turek JW', 'Tracy ET'], 'AD': ['Department of Surgery, Duke University Medical Center, Durham, North Carolina. Electronic address: christopher.reed2@duke.edu.', 'Acute Care Surgery, and Surgical Critical Care, University of Texas Houston, Houston, Texas.', 'Department of Surgery, Duke University Medical Center, Durham, North Carolina.', 'Department of Medicine, Duke University Medical Center, Durham, North Carolina.', 'Department of Surgery, Duke University Medical Center, Durham, North Carolina.', 'Humacyte, Research Triangle Park, North Carolina.', 'Section of Pediatric Cardiac Surgery, Department of Surgery, Duke University Medical Center, Durham, North Carolina.', 'Section of Pediatric Cardiac Surgery, Department of Surgery, Duke University Medical Center, Durham, North Carolina.', 'Department of Surgery, Duke University Medical Center, Durham, North Carolina.'], 'LA': ['eng'], 'PT': ['Journal Article', 'Observational Study', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20190925', 'PL': 'United States', 'TA': 'J Surg Res', 'JT': 'The Journal of surgical research', 'JID': '0376340', 'RN': ['0 (Biomarkers)'], 'SB': 'IM', 'MH': ['Aged, 80 and over', 'Biomarkers/blood', 'Cardiopulmonary Bypass/*adverse effects', 'Female', 'Heart Defects, Congenital/*surgery', 'Humans', 'Infant', 'Infant, Newborn', 'Male', 'Postoperative Hemorrhage/blood/*diagnosis/etiology', 'Proteomics/*methods', 'Thrombosis/blood/*diagnosis/etiology'], 'OTO': ['NOTNLM'], 'OT': ['*Cardiopulmonary bypass', '*Congenital cardiac surgery', '*Inflammation', '*Pediatrics', '*Proteomics'], 'EDAT': '2019/09/29 06:00', 'MHDA': '2020/02/23 06:00', 'CRDT': ['2019/09/29 06:00'], 'PHST': ['2019/03/18 00:00 [received]', '2019/07/08 00:00 [revised]', '2019/08/29 00:00 [accepted]', '2019/09/29 06:00 [pubmed]', '2020/02/23 06:00 [medline]', '2019/09/29 06:00 [entrez]'], 'AID': ['S0022-4804(19)30625-0 [pii]', '10.1016/j.jss.2019.08.019 [doi]'], 'PST': 'ppublish', 'SO': 'J Surg Res. 2020 Feb;246:83-92. doi: 10.1016/j.jss.2019.08.019. Epub 2019 Sep 25.'}\n",
      "{'PMID': '31494943', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20201120', 'LR': '20201120', 'IS': '1525-1594 (Electronic) 0160-564X (Linking)', 'VI': '44', 'IP': '3', 'DP': '2020 Mar', 'TI': 'Impact of left ventricular assist device therapy on the cardiac proteome and metabolome composition in ischemic cardiomyopathy.', 'PG': '257-267', 'LID': '10.1111/aor.13566 [doi]', 'AB': 'The changes in the myocardial proteome and metabolome associated with left ventricular assist device (LVAD) therapy in patients with ischemic cardiomyopathy (ICM) are poorly characterized. We investigated the impact of mechanical unloading following LVAD therapy on the myocardial proteome and metabolome. Matched samples of 5 patients\\' myocardial tissue, harvested at the time of LVAD implant (\"pre-LVAD\") or heart transplant (\"post-LVAD\"), were studied by quantitative proteomics and metabolomics as well as being probed for T-tubule structure and connexin-43 distribution. Moreover, pre-LVAD proteome profiles of ICM context were bioinformatically compared to pre-LVAD proteome profiles of dilated cardiac myopathy (DCM). More than 2120 proteins were reliably identified and quantified in paired patient samples. LVAD therapy led to proteomic remodeling, including reduced levels of alpha-1-antichymotrypsin together with an overall decrease of immune response proteins and an increase of proteins involved in membrane biology. Metabolomics highlighted increased glucose and glucose-6-phosphate levels in the left ventricle upon LVAD therapy. Wheat germ agglutinin staining demonstrated improved T-tubule structure. Connexin-43 displayed a trend for more pronounced intercalated disc localization. In comparing pre-LVAD proteome profiles of ICM context with pre-LVAD proteome profiles of dilated cardiac myopathy (DCM), we noticed an overrepresentation in ICM of proteins associated with humoral immune response. Our findings underline an impact of LVAD therapy on left ventricular biology in ICM. The proteomic, metabolomic, and structural alterations described here are typically associated with cardiac recovery. On the molecular level, our findings indicate the possibility of cardiac remodeling under LVAD therapy in ICM.', 'CI': ['(c) 2019 The Authors. Artificial Organs published by International Center for', 'Artificial Organ and Transplantation (ICAOT) and Wiley Periodicals, Inc.'], 'FAU': ['Shahinian, Jasmin Hasmik', 'Rog-Zielinska, Eva A', 'Schlimpert, Manuel', 'Mayer, Bettina', 'Tholen, Stefan', 'Kammerer, Bernd', 'Biniossek, Martin L', 'Beyersdorf, Friedhelm', 'Schilling, Oliver', 'Siepe, Matthias'], 'AU': ['Shahinian JH', 'Rog-Zielinska EA', 'Schlimpert M', 'Mayer B', 'Tholen S', 'Kammerer B', 'Biniossek ML', 'Beyersdorf F', 'Schilling O', 'Siepe M'], 'AUID': ['ORCID: https://orcid.org/0000-0002-8825-5977'], 'AD': ['Department of Cardiovascular Surgery, University Heart Center Freiburg * Bad Krozingen, Freiburg, Germany.', 'Faculty of Medicine, University of Freiburg, Freiburg, Germany.', 'Faculty of Medicine, University of Freiburg, Freiburg, Germany.', 'Institute for Experimental Cardiovascular Medicine, University Heart Center Freiburg * Bad Krozingen, Freiburg, Germany.', 'Center for Biological Systems Analysis, University of Freiburg, Freiburg, Germany.', 'Spemann Graduate School of Biology and Medicine, University of Freiburg, Freiburg, Germany.', 'Faculty of Biology, Albert-Ludwigs-University of Freiburg, Freiburg, Germany.', 'Faculty of Medicine, University of Freiburg, Freiburg, Germany.', 'Institute for Molecular Medicine and Cell Research, University of Freiburg, Freiburg, Germany.', 'Faculty of Medicine, University of Freiburg, Freiburg, Germany.', 'Institute for Molecular Medicine and Cell Research, University of Freiburg, Freiburg, Germany.', 'Spemann Graduate School of Biology and Medicine, University of Freiburg, Freiburg, Germany.', 'Center for Biological Systems Analysis ZBSA, Albert-Ludwigs-University, Freiburg, Germany.', 'BIOSS Center for Biological Signaling Studies, University of Freiburg, Freiburg, Germany.', 'Faculty of Medicine, University of Freiburg, Freiburg, Germany.', 'Institute for Molecular Medicine and Cell Research, University of Freiburg, Freiburg, Germany.', 'Department of Cardiovascular Surgery, University Heart Center Freiburg * Bad Krozingen, Freiburg, Germany.', 'Faculty of Medicine, University of Freiburg, Freiburg, Germany.', 'Faculty of Medicine, University of Freiburg, Freiburg, Germany.', 'BIOSS Center for Biological Signaling Studies, University of Freiburg, Freiburg, Germany.', 'Institute of Surgical Pathology, Medical Center, University of Freiburg, Freiburg, Germany.', 'German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany.', 'Department of Cardiovascular Surgery, University Heart Center Freiburg * Bad Krozingen, Freiburg, Germany.', 'Faculty of Medicine, University of Freiburg, Freiburg, Germany.'], 'LA': ['eng'], 'GR': ['GR 1748/6-1/Deutsche Forschungsgemeinschaft', 'SCHI 871/8-1/Deutsche Forschungsgemeinschaft', 'SCHI 871/9-1/Deutsche Forschungsgemeinschaft', 'SCHI 871/11-1/Deutsche Forschungsgemeinschaft', 'SCHI 871/12-1/Deutsche Forschungsgemeinschaft', 'INST 39/900-1/Deutsche Forschungsgemeinschaft', 'SFB850-Project Z1 (INST 39/766-3)/Deutsche Forschungsgemeinschaft', 'RO-5694/1-1/Deutsche Forschungsgemeinschaft', 'I-1444-201.2/2017/The German-Israel Foundation', 'I-1444-201.2/2017/German-Israel Foundation'], 'PT': ['Journal Article'], 'DEP': '20191010', 'PL': 'United States', 'TA': 'Artif Organs', 'JT': 'Artificial organs', 'JID': '7802778', 'RN': ['0 (Connexin 43)', '0 (Proteome)', 'IY9XDZ35W2 (Glucose)'], 'SB': 'IM', 'MH': ['Aged', 'Cardiomyopathy, Dilated/metabolism/pathology', 'Connexin 43/analysis/metabolism', 'Female', 'Glucose/analysis/metabolism', 'Heart Ventricles/*metabolism/pathology', '*Heart-Assist Devices', 'Humans', 'Male', '*Metabolome', 'Middle Aged', 'Myocardial Ischemia/metabolism/pathology/*therapy', 'Myocardium/metabolism/pathology', 'Proteome/analysis/*metabolism'], 'OTO': ['NOTNLM'], 'OT': ['left ventricular assist device', 'mechanical unloading', 'reverse remodeling'], 'EDAT': '2019/09/09 06:00', 'MHDA': '2020/11/21 06:00', 'CRDT': ['2019/09/09 06:00'], 'PHST': ['2019/03/03 00:00 [received]', '2019/07/26 00:00 [revised]', '2019/08/28 00:00 [accepted]', '2019/09/09 06:00 [pubmed]', '2020/11/21 06:00 [medline]', '2019/09/09 06:00 [entrez]'], 'AID': ['10.1111/aor.13566 [doi]'], 'PST': 'ppublish', 'SO': 'Artif Organs. 2020 Mar;44(3):257-267. doi: 10.1111/aor.13566. Epub 2019 Oct 10.'}\n",
      "{'PMID': '31476444', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20200918', 'LR': '20200918', 'IS': '1876-7737 (Electronic) 1874-3919 (Linking)', 'VI': '209', 'DP': '2019 Oct 30', 'TI': 'Global plasma protein profiling reveals DCM characteristic protein signatures.', 'PG': '103508', 'LID': 'S1874-3919(19)30280-5 [pii] 10.1016/j.jprot.2019.103508 [doi]', 'AB': 'To identify potential biomarkers supporting better phenotyping and to improve understanding of the pathophysiology of dilated cardiomyopathy (DCM), this study comparatively analyzed plasma protein profiles of DCM patients and individuals with low normal and normal left ventricular ejection fraction (LVEF) by mass spectrometry. After plasma depletion using a MARS Hu-6 column, global proteome profiling was performed using a LTQ-Orbitrap Velos mass spectrometer. To compare and confirm results, two different discovery sets of samples were investigated. Differentially abundant proteins are involved in lipid metabolism, coagulation, and acute phase response. Serum paraoxonase 1 (PON1), cystatin C, lysozyme C, apolipoprotein A-II, and apolipoprotein M were validated by targeted protein analysis in a third independent patient cohort. Additionally, PON1 levels were also determined by an ELISA. These data highlight PON1 as a potential marker for differentiating DCM patients not only from patients with normal LVEF, but also from heart failure patients with preserved ejection fraction. The results highlight lipid metabolism and inflammation as the major pathways being altered in DCM patients in comparison to patients presenting with suspicious myocarditis to the hospital. SIGNIFICANCE: Several studies focused on the identification of heart failure (HF) associated protein signatures in blood plasma, but only few that are largely based on only small sample series considered specific HF pathologies. Therefore, we performed a comparative global blood plasma protein profiling of a larger sample of individuals with reduced left ventricular ejection fraction (LVEF) classified as dilated cardiomyopathy patients and individuals with normal LVEF but presenting with suspicious myocarditis. DCM patients displayed altered levels of proteins involved in lipid metabolism, coagulation, and acute phase response. The most reliable candidates, such as serum paraoxonase 1 (PON1), cystatin C, lysozyme C, apolipoprotein A-II, and apolipoprotein M were validated by targeted protein analysis in an independent patient cohort. PON1 levels were also determined by an ELISA. These data highlight PON1 as a potential marker for differentiating DCM patients not only from patients with normal LVEF, but also from heart failure patients with preserved ejection fraction.', 'CI': ['Copyright (c) 2019 Elsevier B.V. All rights reserved.'], 'FAU': ['Feig, Martin Andreas', 'Pop, Cristina', 'Bhardwaj, Gourav', 'Sappa, Praveen Kumar', 'Dorr, Marcus', 'Ameling, Sabine', 'Weitmann, Kerstin', 'Nauck, Matthias', 'Lehnert, Kristin', 'Beug, Daniel', 'Kuhl, Uwe', 'Schultheiss, Heinz-Peter', 'Volker, Uwe', 'Felix, Stephan Burkhard', 'Hammer, Elke'], 'AU': ['Feig MA', 'Pop C', 'Bhardwaj G', 'Sappa PK', 'Dorr M', 'Ameling S', 'Weitmann K', 'Nauck M', 'Lehnert K', 'Beug D', 'Kuhl U', 'Schultheiss HP', 'Volker U', 'Felix SB', 'Hammer E'], 'AD': ['Department of Functional Genomics, Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Germany. Electronic address: feigm@uni-greifswald.de.', 'Department of Functional Genomics, Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Germany; Department of Pharmacology, Physiology and Pathophysiology, Faculty of Pharmacy, \"Iuliu Hatieganu\" University of Medicine and Pharmacy, Cluj-Napoca, Romania. Electronic address: pop.cristina@umfcluj.ro.', 'Department of Functional Genomics, Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Germany.', 'Department of Functional Genomics, Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Germany.', 'Department of Internal Medicine B, University Medicine Greifswald, Germany; German Center for Cardiovascular Research, Partner Site Greifswald, Germany. Electronic address: mdoerr@uni-greifswald.de.', 'Department of Functional Genomics, Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Germany; German Center for Cardiovascular Research, Partner Site Greifswald, Germany. Electronic address: amelings@uni-greifswald.de.', 'Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany. Electronic address: kerstin.weitmann@uni-greifswald.de.', 'German Center for Cardiovascular Research, Partner Site Greifswald, Germany; Insitute for Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, Greifswald, Germany. Electronic address: matthias.nauck@uni-greifswald.de.', 'Department of Internal Medicine B, University Medicine Greifswald, Germany; German Center for Cardiovascular Research, Partner Site Greifswald, Germany. Electronic address: lehnertk@unigreifswald.de.', 'Department of Internal Medicine B, University Medicine Greifswald, Germany; German Center for Cardiovascular Research, Partner Site Greifswald, Germany. Electronic address: daniel.beug@uni-greifswald.de.', 'Department of Cardiology, Campus Virchow, Charite-University Hospital Berlin, Berlin, Germany; Institute of Cardiac Diagnostics and Therapy (IKDT), Berlin, Germany. Electronic address: uwe.kuehl@charite.de.', 'Institute of Cardiac Diagnostics and Therapy (IKDT), Berlin, Germany. Electronic address: heinz-peter.schultheiss@charite.de.', 'Department of Functional Genomics, Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Germany; German Center for Cardiovascular Research, Partner Site Greifswald, Germany. Electronic address: voelker@uni-greifswald.de.', 'Department of Internal Medicine B, University Medicine Greifswald, Germany; German Center for Cardiovascular Research, Partner Site Greifswald, Germany. Electronic address: felix@uni-greifswald.de.', 'Department of Functional Genomics, Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Germany; German Center for Cardiovascular Research, Partner Site Greifswald, Germany. Electronic address: hammer@uni-greifswald.de.'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20190830', 'PL': 'Netherlands', 'TA': 'J Proteomics', 'JT': 'Journal of proteomics', 'JID': '101475056', 'RN': ['0 (Acute-Phase Proteins)', '0 (Biomarkers)', 'EC 3.1.8.1 (Aryldialkylphosphatase)', 'EC 3.1.8.1 (PON1 protein, human)'], 'SB': 'IM', 'MH': ['Acute-Phase Proteins', 'Aryldialkylphosphatase/analysis/blood', 'Biomarkers/blood', 'Blood Coagulation', 'Cardiomyopathy, Dilated/blood/*metabolism', 'Female', '*Gene Expression Profiling', 'Humans', 'Inflammation', 'Lipid Metabolism', 'Male', 'Mass Spectrometry', 'Middle Aged', 'Plasma/*chemistry', 'Proteomics/methods', 'Stroke Volume'], 'OTO': ['NOTNLM'], 'OT': ['*DCM', '*ELISA', '*LC-MS/MS', '*Lipid metabolism', '*Plasma proteome profiling', '*Serum paraoxonase 1'], 'EDAT': '2019/09/03 06:00', 'MHDA': '2020/09/20 06:00', 'CRDT': ['2019/09/03 06:00'], 'PHST': ['2019/06/14 00:00 [received]', '2019/08/07 00:00 [revised]', '2019/08/26 00:00 [accepted]', '2019/09/03 06:00 [pubmed]', '2020/09/20 06:00 [medline]', '2019/09/03 06:00 [entrez]'], 'AID': ['S1874-3919(19)30280-5 [pii]', '10.1016/j.jprot.2019.103508 [doi]'], 'PST': 'ppublish', 'SO': 'J Proteomics. 2019 Oct 30;209:103508. doi: 10.1016/j.jprot.2019.103508. Epub 2019 Aug 30.'}\n",
      "{'PMID': '31434864', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20200318', 'LR': '20200318', 'IS': '1897-4279 (Electronic) 0022-9032 (Linking)', 'VI': '77', 'IP': '10', 'DP': '2019 Oct 25', 'TI': 'An altered left ventricle protein profile in human ischemic cardiomyopathy revealed in comparative quantitative proteomics.', 'PG': '951-959', 'LID': '10.33963/KP.14936 [doi]', 'AB': 'BACKGROUND: Ischemic cardiomyopathy (ICM) resulting from coronary artery disease is a major cause of heart failure. The identification and quantification of differentially expressed proteins in patients with ICM may potentially lead to more effective diagnostic workup and treatment. AIMS: Liquid chromatography coupled to tandem mass spectrometry analysis was applied to identify differentially expressed proteins in individuals with ICM. METHODS: To identify proteins involved in the molecular mechanisms of ICM, we quantitatively analyzed the left ventricular proteome profiles of patients with ICM who had undergone heart transplantation. Liquid chromatography coupled to tandem mass spectrometry, which presents better comprehensiveness and accuracy of quantification than 2dimensional electrophoresis, in combination with bioinformatics was applied to analyze cardiac samples and identify proteins that were differentially expressed in the left ventricles of 6 patients with ICM compared with 7 normal heart donors. RESULTS: A total of 1723 proteins was successfully quantified in 2 repeated experiments. Out of those, 104 proteins were upregulated and 63 proteins were downregulated in the left ventricles of individuals with ICM. For all these altered proteins, gene ontology (GO) analysis, the Kyoto Encyclopedia of Genes and Genomes pathway mapping, and protein interaction analysis were performed, which showed that most of the proteins were related to the extracellular matrix, metabolism, immune response, muscle contraction, cytoskeleton organization, transcription / translation, and signal transduction. Most importantly, in response to an ischemic stimulus, the C1 inhibitor SERPING1 helped to compensate for increases in complement activation through complement inhibition. CONCLUSIONS: Collectively, these differentially expressed proteins represent potential novel diagnostic and therapeutic targets for the treatment of patients with ICM.', 'FAU': ['Yi, Xin', 'Jiang, Ding-Sheng', 'Feng, Gaoke', 'Jiang, Xue-Jun', 'Zeng, Hao-Long'], 'AU': ['Yi X', 'Jiang DS', 'Feng G', 'Jiang XJ', 'Zeng HL'], 'AD': [\"Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, People's Republic of China\", \"Cardiovascular Research Institute, Wuhan University, Wuhan, People's Republic of China\", \"Hubei KeyLaboratory of Cardiology, Wuhan, People's Republic of China\", \"Division of Cardiothoracic and Vascular Surgery,Tongji Hospital,Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China\", \"KeyLaboratory of Organ Transplantation, Ministry of Education, Wuhan, People's Republic of China\", \"KeyLaboratory of Organ Transplantation,Tongji Hospital,Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China\", \"Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, People's Republic of China\", \"Cardiovascular Research Institute, Wuhan University, Wuhan, People's Republic of China\", \"Hubei KeyLaboratory of Cardiology, Wuhan, People's Republic of China\", \"Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, People's Republic of China\", \"Cardiovascular Research Institute, Wuhan University, Wuhan, People's Republic of China\", \"Hubei KeyLaboratory of Cardiology, Wuhan, People's Republic of China\", \"Department ofLaboratory Medicine,Tongji Hospital,Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China. Electronic address: zenghaolongtjh@163.com\"], 'LA': ['eng'], 'PT': ['Journal Article'], 'DEP': '20190822', 'PL': 'Poland', 'TA': 'Kardiol Pol', 'JT': 'Kardiologia polska', 'JID': '0376352', 'RN': ['0 (Proteome)'], 'SB': 'IM', 'MH': ['Cardiomyopathies/*genetics/metabolism', 'Gene Expression Regulation', 'Heart Ventricles/*metabolism', 'Humans', 'Male', 'Middle Aged', 'Myocardial Ischemia/*genetics/metabolism', '*Proteome'], 'EDAT': '2019/08/23 06:00', 'MHDA': '2020/03/19 06:00', 'CRDT': ['2019/08/23 06:00'], 'PHST': ['2019/08/23 06:00 [pubmed]', '2020/03/19 06:00 [medline]', '2019/08/23 06:00 [entrez]'], 'AID': ['10.33963/KP.14936 [doi]'], 'PST': 'ppublish', 'SO': 'Kardiol Pol. 2019 Oct 25;77(10):951-959. doi: 10.33963/KP.14936. Epub 2019 Aug 22.'}\n",
      "{'PMID': '31286493', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20200206', 'LR': '20200206', 'IS': '1097-0215 (Electronic) 0020-7136 (Linking)', 'VI': '146', 'IP': '1', 'DP': '2020 Jan 1', 'TI': 'Proteome-based classification of Nonmuscle Invasive Bladder Cancer.', 'PG': '281-294', 'LID': '10.1002/ijc.32556 [doi]', 'AB': 'DNA/RNA-based classification of bladder cancer (BC) supports the existence of multiple molecular subtypes, while investigations at the protein level are scarce. Here, we aimed to investigate if Nonmuscle Invasive Bladder Cancer (NMIBC) can be stratified to biologically meaningful groups based on the proteome. Tissue specimens from 117 patients at primary diagnosis (98 with NMIBC and 19 with MIBC), were processed for high-resolution proteomics analysis by liquid chromatography-tandem mass spectrometry (LC-MS/MS). The proteomics output was subjected to unsupervised consensus clustering, principal component analysis (PCA) and investigation of subtype-specific features, pathways, and gene sets. NMIBC patients were optimally stratified to three NMIBC proteomic subtypes (NPS), differing in size, clinicopathologic and molecular backgrounds: NPS1 (mostly high stage/grade/risk samples) was the smallest in size (17/98) and overexpressed proteins reflective of an immune/inflammatory phenotype, involved in cell proliferation, unfolded protein response and DNA damage response, whereas NPS2 (mixed stage/grade/risk composition) presented with an infiltrated/mesenchymal profile. NPS3 was rich in luminal/differentiation markers, in line with its pathological composition (mostly low stage/grade/risk samples). PCA revealed a close proximity of NPS1 and conversely, remoteness of NPS3 to the proteome of MIBC. Proteins distinguishing these two extreme subtypes were also found to consistently differ at the mRNA levels between high and low-risk subtypes of the UROMOL and LUND cohorts. Collectively, our study identifies three proteomic NMIBC subtypes and following a cross-omics validation in two independent cohorts, shortlists molecular features meriting further investigation for their biomarker or potentially therapeutic value.', 'CI': ['(c) 2019 UICC.'], 'FAU': ['Stroggilos, Rafael', 'Mokou, Marika', 'Latosinska, Agnieszka', 'Makridakis, Manousos', 'Lygirou, Vasiliki', 'Mavrogeorgis, Emmanouil', 'Drekolias, Dimitrios', 'Frantzi, Maria', 'Mullen, William', 'Fragkoulis, Charalampos', 'Stasinopoulos, Konstantinos', 'Papadopoulos, Georgios', 'Stathouros, Georgios', 'Lazaris, Andreas C', 'Makrythanasis, Periklis', 'Ntoumas, Konstantinos', 'Mischak, Harald', 'Zoidakis, Jerome', 'Vlahou, Antonia'], 'AU': ['Stroggilos R', 'Mokou M', 'Latosinska A', 'Makridakis M', 'Lygirou V', 'Mavrogeorgis E', 'Drekolias D', 'Frantzi M', 'Mullen W', 'Fragkoulis C', 'Stasinopoulos K', 'Papadopoulos G', 'Stathouros G', 'Lazaris AC', 'Makrythanasis P', 'Ntoumas K', 'Mischak H', 'Zoidakis J', 'Vlahou A'], 'AUID': ['ORCID: 0000-0003-4068-9167'], 'AD': ['Biotechnology Division, Biomedical Research Foundation of the Academy of Athens, Athens, Greece.', 'Biotechnology Division, Biomedical Research Foundation of the Academy of Athens, Athens, Greece.', 'Mosaiques Diagnostics GmbH, Hannover, Germany.', 'Biotechnology Division, Biomedical Research Foundation of the Academy of Athens, Athens, Greece.', 'Biotechnology Division, Biomedical Research Foundation of the Academy of Athens, Athens, Greece.', 'Department of Biotechnology, Agricultural University of Athens, Athens, Greece.', 'Department of Pathology, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.', 'Mosaiques Diagnostics GmbH, Hannover, Germany.', 'British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom.', \"Department of Urology, General Hospital of Athens 'Georgios Gennimatas', Athens, Greece.\", \"Department of Urology, General Hospital of Athens 'Georgios Gennimatas', Athens, Greece.\", \"Department of Urology, General Hospital of Athens 'Georgios Gennimatas', Athens, Greece.\", \"Department of Urology, General Hospital of Athens 'Georgios Gennimatas', Athens, Greece.\", 'Department of Pathology, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.', 'Biotechnology Division, Biomedical Research Foundation of the Academy of Athens, Athens, Greece.', 'Department of Genetic Medicine and Development, University of Geneva, Geneva, Switzerland.', \"Department of Urology, General Hospital of Athens 'Georgios Gennimatas', Athens, Greece.\", 'Mosaiques Diagnostics GmbH, Hannover, Germany.', 'British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom.', 'Biotechnology Division, Biomedical Research Foundation of the Academy of Athens, Athens, Greece.', 'Biotechnology Division, Biomedical Research Foundation of the Academy of Athens, Athens, Greece.'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20190726', 'PL': 'United States', 'TA': 'Int J Cancer', 'JT': 'International journal of cancer', 'JID': '0042124', 'RN': ['0 (Biomarkers, Tumor)', '0 (Proteome)', '0 (RNA, Messenger)'], 'SB': 'IM', 'MH': ['Aged', 'Biomarkers, Tumor/metabolism', 'Chromatography, Liquid/methods', 'Disease Progression', 'Female', 'Humans', 'Inflammation/metabolism/pathology', 'Kaplan-Meier Estimate', 'Male', 'Phenotype', 'Prognosis', 'Proteome/*metabolism', 'Proteomics/methods', 'RNA, Messenger/metabolism', 'Tandem Mass Spectrometry/methods', 'Urinary Bladder Neoplasms/*metabolism/pathology'], 'OTO': ['NOTNLM'], 'OT': ['*NMIBC', '*bladder cancer', '*classification', '*proteomics', '*subtype'], 'EDAT': '2019/07/10 06:00', 'MHDA': '2020/02/07 06:00', 'CRDT': ['2019/07/10 06:00'], 'PHST': ['2019/02/15 00:00 [received]', '2019/06/17 00:00 [accepted]', '2019/07/10 06:00 [pubmed]', '2020/02/07 06:00 [medline]', '2019/07/10 06:00 [entrez]'], 'AID': ['10.1002/ijc.32556 [doi]'], 'PST': 'ppublish', 'SO': 'Int J Cancer. 2020 Jan 1;146(1):281-294. doi: 10.1002/ijc.32556. Epub 2019 Jul 26.'}\n",
      "{'PMID': '31242583', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20191206', 'LR': '20200225', 'IS': '1422-0067 (Electronic) 1422-0067 (Linking)', 'VI': '20', 'IP': '12', 'DP': '2019 Jun 25', 'TI': 'Serum Proteome Alterations in Human Cystathionine beta-Synthase Deficiency and Ischemic Stroke Subtypes.', 'LID': 'E3096 [pii] 10.3390/ijms20123096 [doi]', 'AB': 'Ischemic stroke induces brain injury via thrombotic or embolic mechanisms involving large or small vessels. Cystathionine beta-synthase deficiency (CBS), an inborn error of metabolism, is associated with vascular thromboembolism, the major cause of morbidity and mortality in affected patients. Because thromboembolism involves the brain vasculature in these patients, we hypothesize that CBS deficiency and ischemic stroke have similar molecular phenotypes. We used label-free mass spectrometry for quantification of changes in serum proteomes in CBS-deficient patients (n = 10) and gender/age-matched unaffected controls (n = 14), as well as in patients with cardioembolic (n = 17), large-vessel (n = 26), or lacunar (n = 25) ischemic stroke subtype. In CBS-deficient patients, 40 differentially expressed serum proteins were identified, of which 18 were associated with elevated homocysteine (Hcy) and 22 were Hcy-independent. We also identified Hcy-independent differentially expressed serum proteins in ischemic stroke patients, some of which were unique to a specific subtype: 10 of 32 for cardioembolic vs. large-vessel, six of 33 for cardioembolic vs. lacunar, and six of 23 for large-vessel vs. lacunar. There were significant overlaps between proteins affected by CBS deficiency and ischemic stroke, particularly the cardioembolic subtype, similar to protein overlaps between ischemic stroke subtypes. Top molecular pathways affected by CBS deficiency and ischemic stroke subtypes included acute phase response signaling and coagulation system. Similar molecular networks centering on NFkappaB were affected by CBS deficiency and stroke subtypes. These findings suggest common mechanisms involved in the pathologies of CBS deficiency and ischemic stroke subtypes.', 'FAU': ['Sikora, Marta', 'Lewandowska, Izabela', 'Kupc, Malgorzata', 'Kubalska, Jolanta', 'Graban, Alla', 'Marczak, Lukasz', 'Kazmierski, Radoslaw', 'Jakubowski, Hieronim'], 'AU': ['Sikora M', 'Lewandowska I', 'Kupc M', 'Kubalska J', 'Graban A', 'Marczak L', 'Kazmierski R', 'Jakubowski H'], 'AD': ['European Centre for Bioinformatics and Genomics, Institute of Bioorganic Chemistry, Polish Academy of Sciences, 60-965 Poznan, Poland. martas@ibch.poznan.pl.', 'European Centre for Bioinformatics and Genomics, Institute of Bioorganic Chemistry, Polish Academy of Sciences, 60-965 Poznan, Poland. izek1988@gmail.com.', 'Department of Biochemistry and Biotechnology, University of Life Sciences, 60-632 Poznan, Poland. gosia.kupc@gmail.com.', 'Department of Genetics, Institute of Psychiatry and Neurology, 02-957 Warsaw, Poland. kubalska@ipin.edu.pl.', 'First Department of Neurology, Institute of Psychiatry and Neurology, 02-957 Warsaw, Poland. graban@ipin.edu.pl.', 'European Centre for Bioinformatics and Genomics, Institute of Bioorganic Chemistry, Polish Academy of Sciences, 60-965 Poznan, Poland. lukasmar@ibch.poznan.pl.', 'Department of Neurology and Cerebrovascular Disorders, Poznan University of Medical Sciences, L. Bierkowski Hospital, 60-631 Poznan, Poland. rkazmierski@ump.edu.pl.', 'Department of Biochemistry and Biotechnology, University of Life Sciences, 60-632 Poznan, Poland. jakubows@rutgers.edu.', 'Department of Microbiology, Biochemistry and Molecular Genetics, Rutgers-New Jersey Medical School, International Center for Public Health, Newark, NJ 07-103, USA. jakubows@rutgers.edu.'], 'AUID': ['ORCID: 0000-0002-9760-4884', 'ORCID: 0000-0001-5845-4409'], 'LA': ['eng'], 'GR': ['2013/11/B/NZ1/00091/Narodowe Centrum Nauki', '2014/15/N/NZ5/01647/Narodowe Centrum Nauki', '2015/17/D/NZ5/03444/Narodowe Centrum Nauki', '2016/23/B/NZ5/00573/Narodowe Centrum Nauki', '2018/29/B/NZ4/0071/Narodowe Centrum Nauki', '17GRNT32910002/American Heart Association'], 'PT': ['Journal Article'], 'DEP': '20190625', 'PL': 'Switzerland', 'TA': 'Int J Mol Sci', 'JT': 'International journal of molecular sciences', 'JID': '101092791', 'RN': ['0 (Biomarkers)', '0 (Proteome)', 'EC 4.2.1.22 (Cystathionine beta-Synthase)'], 'SB': 'IM', 'MH': ['Adult', 'Biomarkers/*blood', 'Brain Ischemia/*complications', 'Computational Biology/methods', 'Cystathionine beta-Synthase/*deficiency', 'Female', 'Humans', 'Male', 'Middle Aged', '*Proteome', '*Proteomics/methods', 'Signal Transduction', 'Stroke/*blood/*etiology'], 'PMC': 'PMC6627068', 'OTO': ['NOTNLM'], 'OT': ['cystathionine beta-synthase deficiency', 'ischemic stroke subtypes', 'label-free mass spectrometry', 'proteomics', 'proteostasis', 'serum protein markers'], 'EDAT': '2019/06/28 06:00', 'MHDA': '2019/12/18 06:00', 'CRDT': ['2019/06/28 06:00'], 'PHST': ['2019/05/21 00:00 [received]', '2019/06/20 00:00 [revised]', '2019/06/23 00:00 [accepted]', '2019/06/28 06:00 [entrez]', '2019/06/28 06:00 [pubmed]', '2019/12/18 06:00 [medline]'], 'AID': ['ijms20123096 [pii]', '10.3390/ijms20123096 [doi]'], 'PST': 'epublish', 'SO': 'Int J Mol Sci. 2019 Jun 25;20(12). pii: ijms20123096. doi: 10.3390/ijms20123096.'}\n",
      "{'PMID': '31204432', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20201021', 'LR': '20201021', 'IS': '1522-9645 (Electronic) 0195-668X (Linking)', 'VI': '40', 'IP': '32', 'DP': '2019 Aug 21', 'TI': 'Protein-based cardiogenic shock patient classifier.', 'PG': '2684-2694', 'LID': '10.1093/eurheartj/ehz294 [doi]', 'AB': 'AIMS: Cardiogenic shock (CS) is associated with high short-term mortality and a precise CS risk stratification could guide interventions to improve patient outcome. Here, we developed a circulating protein-based score to predict short-term mortality risk among patients with CS. METHODS AND RESULTS: Mass spectrometry analysis of 2654 proteins was used for screening in the Barcelona discovery cohort (n = 48). Targeted quantitative proteomics analyses (n = 51 proteins) were used in the independent CardShock cohort (n = 97) to derive and cross-validate the protein classifier. The combination of four circulating proteins (Cardiogenic Shock 4 proteins-CS4P), discriminated patients with low and high 90-day risk of mortality. CS4P comprises the abundances of liver-type fatty acid-binding protein, beta-2-microglobulin, fructose-bisphosphate aldolase B, and SerpinG1. Within the CardShock cohort used for internal validation, the C-statistic was 0.78 for the CardShock risk score, 0.83 for the CS4P model, and 0.84 (P = 0.033 vs. CardShock risk score) for the combination of CardShock risk score with the CS4P model. The CardShock risk score with the CS4P model showed a marked benefit in patient reclassification, with a net reclassification improvement (NRI) of 0.49 (P = 0.020) compared with CardShock risk score. Similar reclassification metrics were observed in the IABP-SHOCK II risk score combined with CS4P (NRI =0.57; P = 0.032). The CS4P patient classification power was confirmed by enzyme-linked immunosorbent assay (ELISA). CONCLUSION: A new protein-based CS patient classifier, the CS4P, was developed for short-term mortality risk stratification. CS4P improved predictive metrics in combination with contemporary risk scores, which may guide clinicians in selecting patients for advanced therapies.', 'CI': ['Published on behalf of the European Society of Cardiology. All rights reserved.', '(c) The Author(s) 2019. For permissions, please email:', 'journals.permissions@oup.com.'], 'FAU': ['Rueda, Ferran', 'Borras, Eva', 'Garcia-Garcia, Cosme', 'Iborra-Egea, Oriol', 'Revuelta-Lopez, Elena', 'Harjola, Veli-Pekka', 'Cediel, German', 'Lassus, Johan', 'Tarvasmaki, Tuukka', 'Mebazaa, Alexandre', 'Sabido, Eduard', 'Bayes-Genis, Antoni'], 'AU': ['Rueda F', 'Borras E', 'Garcia-Garcia C', 'Iborra-Egea O', 'Revuelta-Lopez E', 'Harjola VP', 'Cediel G', 'Lassus J', 'Tarvasmaki T', 'Mebazaa A', 'Sabido E', 'Bayes-Genis A'], 'AD': ['Heart Institute, Hospital Universitari Germans Trias i Pujol, c/ Canyet SN, 08916 Badalona, Spain.', 'Department of Medicine, CIBERCV, Autonomous University of Barcelona, Barcelona, Spain.', 'Proteomics Unit, Centre de Regulacio Genomica (CRG), Barcelona Institute of Science and Technology (BIST), Dr Aiguader 88, Barcelona, Spain.', 'Universitat Pompeu Fabra (UPF), Dr Aiguader 88, Barcelona, Spain.', 'Heart Institute, Hospital Universitari Germans Trias i Pujol, c/ Canyet SN, 08916 Badalona, Spain.', 'Department of Medicine, CIBERCV, Autonomous University of Barcelona, Barcelona, Spain.', 'Heart Institute, Hospital Universitari Germans Trias i Pujol, c/ Canyet SN, 08916 Badalona, Spain.', 'Department of Medicine, CIBERCV, Autonomous University of Barcelona, Barcelona, Spain.', 'Heart Institute, Hospital Universitari Germans Trias i Pujol, c/ Canyet SN, 08916 Badalona, Spain.', 'Department of Medicine, CIBERCV, Autonomous University of Barcelona, Barcelona, Spain.', 'Emergency Medicine, Department of Emergency Medicine and Services, University of Helsinki, Helsinki University Hospital, Finland.', 'Heart Institute, Hospital Universitari Germans Trias i Pujol, c/ Canyet SN, 08916 Badalona, Spain.', 'Department of Medicine, CIBERCV, Autonomous University of Barcelona, Barcelona, Spain.', 'Cardiology, University of Helsinki, Heart and Lung Center, Helsinki University Hospital, Finland.', 'Cardiology, University of Helsinki, Heart and Lung Center, Helsinki University Hospital, Finland.', 'U942 Inserm, University Paris Diderot, APHP Hopitaux Universitaires Saint-Louis-Lariboisiere, INI-CRCT, Paris, France.', 'Proteomics Unit, Centre de Regulacio Genomica (CRG), Barcelona Institute of Science and Technology (BIST), Dr Aiguader 88, Barcelona, Spain.', 'Universitat Pompeu Fabra (UPF), Dr Aiguader 88, Barcelona, Spain.', 'Heart Institute, Hospital Universitari Germans Trias i Pujol, c/ Canyet SN, 08916 Badalona, Spain.', 'Department of Medicine, CIBERCV, Autonomous University of Barcelona, Barcelona, Spain.'], 'LA': ['eng'], 'PT': ['Journal Article'], 'PL': 'England', 'TA': 'Eur Heart J', 'JT': 'European heart journal', 'JID': '8006263', 'RN': ['0 (Blood Proteins)', '0 (Proteome)'], 'SB': 'IM', 'CIN': ['Eur Heart J. 2019 Aug 21;40(32):2695-2699. PMID: 31347663'], 'MH': ['Aged', 'Aged, 80 and over', 'Blood Proteins/*analysis', 'Female', 'Humans', 'Male', 'Middle Aged', 'Prospective Studies', 'Proteome/*analysis', 'Proteomics', 'Risk Assessment', '*Shock, Cardiogenic/blood/classification/epidemiology/mortality'], 'OTO': ['NOTNLM'], 'OT': ['*90 days', '*Cardiogenic shock', '*Mortality', '*Proteome'], 'EDAT': '2019/06/18 06:00', 'MHDA': '2020/10/22 06:00', 'CRDT': ['2019/06/18 06:00'], 'PHST': ['2018/11/11 00:00 [received]', '2019/01/04 00:00 [revised]', '2019/04/19 00:00 [accepted]', '2019/06/18 06:00 [pubmed]', '2020/10/22 06:00 [medline]', '2019/06/18 06:00 [entrez]'], 'AID': ['5519422 [pii]', '10.1093/eurheartj/ehz294 [doi]'], 'PST': 'ppublish', 'SO': 'Eur Heart J. 2019 Aug 21;40(32):2684-2694. doi: 10.1093/eurheartj/ehz294.'}\n",
      "{'PMID': '31186442', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20201015', 'LR': '20201015', 'IS': '2045-2322 (Electronic) 2045-2322 (Linking)', 'VI': '9', 'IP': '1', 'DP': '2019 Jun 11', 'TI': 'Indoleamine 2,3-dioxygenase and ischemic heart disease: a Mendelian Randomization study.', 'PG': '8491', 'LID': '10.1038/s41598-019-44819-7 [doi]', 'AB': 'Tryptophan is an essential amino acid. Indoleamine 2,3-dioxygenase (IDO), the rate-limiting enzyme in the tryptophan-kynurenine pathway, is positively associated with cardiac events, and may be relevant to cancer. We used Mendelian Randomization to obtain unconfounded estimates of the association of IDO1 with ischemic heart disease (IHD), ischemic stroke and their risk factors, all-cancer, cancer of the prostate, lung and bronchus, and breast. We obtained genetic instruments independently and strongly (p-value < 5 x 10(-8)) predicting plasma IDO1 from a proteome genome-wide association study (GWAS), and applied them to consortia GWAS of the outcomes, including the UK Biobank SOFT CAD GWAS (cases < = 76 014, non-cases < = 264 785) for IHD. Estimates were obtained using inverse variance weighting; with MR-Egger, weighted median and MR-PRESSO as sensitivity analyses. IDO1 was inversely associated with IHD (odds ratio (OR) 0.96 per standard deviation, 95% confidence interval (CI) 0.93 to 1.00, p-value = 0.04), diabetes (OR 0.91, 95% CI 0.85 to 0.97) and prostate cancer (OR 0.96, 95% CI 0.93 to 0.99) with a directionally consistent estimate for stroke (OR 0.98, 95% CI 0.95 to 1.02) but not with blood pressure, or the other cancers considered. IDO1 might be a potential therapeutic target for IHD, diabetes and prostate cancer.', 'FAU': ['Li, Mengyu', 'Kwok, Man Ki', 'Fong, Shirley Siu Ming', 'Schooling, Catherine Mary'], 'AU': ['Li M', 'Kwok MK', 'Fong SSM', 'Schooling CM'], 'AD': ['School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.', 'School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.', 'School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.', 'School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China. cms1@hku.hk.', 'City University of New York, Graduate School of Public Health and Health Policy, New York, NY, USA. cms1@hku.hk.'], 'AUID': ['ORCID: http://orcid.org/0000-0003-3777-4766', 'ORCID: http://orcid.org/0000-0001-6410-7606', 'ORCID: http://orcid.org/0000-0001-9933-5887'], 'LA': ['eng'], 'GR': ['U19 CA148065/CA/NCI NIH HHS/United States', 'CIHR/Canada', 'C1287/A10118/CRUK_/Cancer Research UK/United Kingdom', 'C1287/A16563/CRUK_/Cancer Research UK/United Kingdom', 'C1287/A10710/CRUK_/Cancer Research UK/United Kingdom'], 'PT': ['Journal Article', 'Research Support, N.I.H., Extramural', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20190611', 'PL': 'England', 'TA': 'Sci Rep', 'JT': 'Scientific reports', 'JID': '101563288', 'RN': ['0 (Indoleamine-Pyrrole 2,3,-Dioxygenase)', 'EC 2.6.1.- (Transaminases)', 'EC 2.6.1.7 (kynurenine-oxoglutarate transaminase)'], 'SB': 'IM', 'MH': ['Adult', 'Blood Pressure/genetics', 'Diabetes Mellitus, Type 2/genetics', 'Diastole/genetics', 'Female', 'Genetic Association Studies', 'Genetic Predisposition to Disease', 'Genome-Wide Association Study', 'Humans', 'Indoleamine-Pyrrole 2,3,-Dioxygenase/*genetics', 'Male', '*Mendelian Randomization Analysis', 'Myocardial Ischemia/*enzymology/*genetics', 'Neoplasms/genetics', 'Polymorphism, Single Nucleotide/genetics', 'Stroke', 'Systole/genetics', 'Transaminases/genetics'], 'PMC': 'PMC6560130', 'EDAT': '2019/06/13 06:00', 'MHDA': '2020/10/21 06:00', 'CRDT': ['2019/06/13 06:00'], 'PHST': ['2019/02/10 00:00 [received]', '2019/05/16 00:00 [accepted]', '2019/06/13 06:00 [entrez]', '2019/06/13 06:00 [pubmed]', '2020/10/21 06:00 [medline]'], 'AID': ['10.1038/s41598-019-44819-7 [doi]', '10.1038/s41598-019-44819-7 [pii]'], 'PST': 'epublish', 'SO': 'Sci Rep. 2019 Jun 11;9(1):8491. doi: 10.1038/s41598-019-44819-7.'}\n",
      "{'PMID': '31104495', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20200309', 'LR': '20200309', 'IS': '1941-3297 (Electronic) 1941-3289 (Linking)', 'VI': '12', 'IP': '5', 'DP': '2019 May', 'TI': 'Proteomic Bioprofiles and Mechanistic Pathways of Progression to Heart Failure.', 'PG': 'e005897', 'LID': '10.1161/CIRCHEARTFAILURE.118.005897 [doi]', 'AB': 'Background Identifying the mechanistic pathways potentially associated with incident heart failure (HF) may provide a basis for novel preventive strategies. Methods and Results To identify proteomic biomarkers and the potential underlying mechanistic pathways that may be associated with incident HF defined as the first hospitalization for HF, a nested-matched case-control design was used with cases (incident HF) and controls (without HF) selected from 3 cohorts (>20 000 individuals). Controls were matched on cohort, follow-up time, age, and sex. Two independent sample sets (a discovery set with 286 cases and 591 controls and a replication set with 276 cases and 280 controls) were used to discover and replicate the findings. Two hundred fifty-two circulating proteins in the plasma were studied. Adjusting for the matching variables age, sex, and follow-up time (and correcting for multiplicity of tests), 89 proteins were found to be associated with incident HF in the discovery phase, of which 38 were also associated with incident HF in the replication phase. These 38 proteins pointed to 4 main network clusters underlying incident HF: (1) inflammation and apoptosis, indicated by the expression of the TNF (tumor necrosis factor)-family members; (2) extracellular matrix remodeling, angiogenesis and growth, indicated by the expression of proteins associated with collagen metabolism, endothelial function, and vascular homeostasis; (3) blood pressure regulation, indicated by the expression of natriuretic peptides and proteins related to the renin-angiotensin-aldosterone system; and (4) metabolism, associated with cholesterol and atherosclerosis. Conclusions Clusters of biomarkers associated with mechanistic pathways leading to HF were identified linking inflammation, apoptosis, vascular function, matrix remodeling, blood pressure control, and metabolism. These findings provide important insight on the pathophysiological mechanisms leading to HF. Clinical Trial Registration: URL: https://www.clinicaltrials.gov . Unique identifier: NCT02556450.', 'FAU': ['Ferreira, Joao Pedro', 'Verdonschot, Job', 'Collier, Timothy', 'Wang, Ping', 'Pizard, Anne', 'Bar, Christian', 'Bjorkman, Jens', 'Boccanelli, Alessandro', 'Butler, Javed', 'Clark, Andrew', 'Cleland, John G', 'Delles, Christian', 'Diez, Javier', 'Girerd, Nicolas', 'Gonzalez, Arantxa', 'Hazebroek, Mark', 'Huby, Anne-Cecile', 'Jukema, Wouter', 'Latini, Roberto', 'Leenders, Joost', 'Levy, Daniel', 'Mebazaa, Alexandre', 'Mischak, Harald', 'Pinet, Florence', 'Rossignol, Patrick', 'Sattar, Naveed', 'Sever, Peter', 'Staessen, Jan A', 'Thum, Thomas', 'Vodovar, Nicolas', 'Zhang, Zhen-Yu', 'Heymans, Stephane', 'Zannad, Faiez'], 'AU': ['Ferreira JP', 'Verdonschot J', 'Collier T', 'Wang P', 'Pizard A', 'Bar C', 'Bjorkman J', 'Boccanelli A', 'Butler J', 'Clark A', 'Cleland JG', 'Delles C', 'Diez J', 'Girerd N', 'Gonzalez A', 'Hazebroek M', 'Huby AC', 'Jukema W', 'Latini R', 'Leenders J', 'Levy D', 'Mebazaa A', 'Mischak H', 'Pinet F', 'Rossignol P', 'Sattar N', 'Sever P', 'Staessen JA', 'Thum T', 'Vodovar N', 'Zhang ZY', 'Heymans S', 'Zannad F'], 'AD': [\"Universite de Lorraine, Inserm, Centre d'Investigations Cliniques-Plurithematique 14-33, and Inserm U1116, CHRU, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France (J.P.F., A.P., N.G., A.-C.H., P.R., F.Z.).\", 'Department of Physiology and Cardiothoracic Surgery, Cardiovascular Research and Development Unit, Faculty of Medicine, University of Porto, Portugal (J.P.F.).', 'Department of Cardiology, Maastricht University Medical Centre, Center for Heart Failure Research, Cardiovascular Research Institute Maastricht (CARIM), University Hospital Maastricht, the Netherlands (J.V., M.H., S.H.).', 'Department of Clinical Genetics, Maastricht University Medical Center, the Netherlands (J.V., P.W.).', 'London School of Hygiene and Tropical Medicine, United Kingdom (T.C.).', 'Department of Clinical Genetics, Maastricht University Medical Center, the Netherlands (J.V., P.W.).', \"Universite de Lorraine, Inserm, Centre d'Investigations Cliniques-Plurithematique 14-33, and Inserm U1116, CHRU, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France (J.P.F., A.P., N.G., A.-C.H., P.R., F.Z.).\", \"Inserm 1024, Institut de Biologie de l'Ecole Normale Superieure (IBENS), PSL University of Paris, France (A.P.).\", 'Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Germany (C.B., T.T.).', 'Casa di Cura Quisisana, Rome, Italy (A.B.).', 'TATAA Biocenter AB, Gothenburg, Sweden (J.B.).', 'Department of Medicine, University of Mississippi School of Medicine, Jackson (J.B.).', 'Excellence Cluster REBIRTH, Hannover Medical School, Germany (J.B.).', 'Hull York Medical School, Castle Hill Hospital, Cottingham, United Kingdom (A.C.).', 'Robertson Centre for Biostatistics and Clinical Trials, Institute of Health and Wellbeing, Glasgow, United Kingdom (J.G.C.).', 'National Heart and Lung Institute, Royal Brompton and Harefield Hospitals, Imperial College, University of Glasgow, London, United Kingdom (J.G.C.).', 'Institute of Cardiovascular and Medical Sciences, University of Glasgow, Scotland, United Kingdom (C.D.).', 'Program of Cardiovascular Diseases, Centre for Applied Medical Research, University of Navarra, Pamplona, Spain (J.D., A.G.).', 'CIBERCV, Carlos III Institute of Health, Madrid, Spain (J.D., A.G.).', 'Instituto de Investigacion Sanitaria de Navarra (IdiSNA), Spain (J.D., A.G.).', 'Departments of Nephrology, and Cardiology and Cardiac Surgery, University of Navarra Clinic, Pamplona, Spain (J.D.).', \"Universite de Lorraine, Inserm, Centre d'Investigations Cliniques-Plurithematique 14-33, and Inserm U1116, CHRU, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France (J.P.F., A.P., N.G., A.-C.H., P.R., F.Z.).\", 'Program of Cardiovascular Diseases, Centre for Applied Medical Research, University of Navarra, Pamplona, Spain (J.D., A.G.).', 'CIBERCV, Carlos III Institute of Health, Madrid, Spain (J.D., A.G.).', 'Instituto de Investigacion Sanitaria de Navarra (IdiSNA), Spain (J.D., A.G.).', 'Department of Cardiology, Maastricht University Medical Centre, Center for Heart Failure Research, Cardiovascular Research Institute Maastricht (CARIM), University Hospital Maastricht, the Netherlands (J.V., M.H., S.H.).', \"Universite de Lorraine, Inserm, Centre d'Investigations Cliniques-Plurithematique 14-33, and Inserm U1116, CHRU, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France (J.P.F., A.P., N.G., A.-C.H., P.R., F.Z.).\", 'Department of Cardiology, Leiden University Medical Center, the Netherlands (W.J.).', 'IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy (R.L.).', 'ACS Biomarker BV, Amsterdam, the Netherlands (J.L.).', \"National Heart, Lung, and Blood Institute's and Boston University's Framingham Heart Study, MA (D.L.).\", 'Population Sciences Branch, Division of Intramural Research, National Heart, Lung, and Blood Institute, Bethesda, MD (D.L.). UMRS 942, University Paris Diderot.', 'APHP, University Hospitals Saint Louis Lariboisiere, France (A.M., N.V.).', 'Mosaiquesdiagnostics, Hannover, Germany (H.M.).', 'Inserm U1167, Institut Pasteur de Lille, Universite de Lille, FHU-REMOD-VHF, France (F.P.).', \"Universite de Lorraine, Inserm, Centre d'Investigations Cliniques-Plurithematique 14-33, and Inserm U1116, CHRU, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France (J.P.F., A.P., N.G., A.-C.H., P.R., F.Z.).\", 'Institute of Cardiovascular and Medical Sciences, University of Glasgow, United Kingdom (N.S.).', 'International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London, England (P.S.).', 'Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium (J.A.S., Z.-Y.Z.).', 'Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, the Netherlands (J.A.S.).', 'Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Germany (C.B., T.T.).', 'National Heart and Lung Institute, Imperial College London, United Kingdom (T.T.).', 'APHP, University Hospitals Saint Louis Lariboisiere, France (A.M., N.V.).', 'Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium (J.A.S., Z.-Y.Z.).', 'Department of Cardiology, Maastricht University Medical Centre, Center for Heart Failure Research, Cardiovascular Research Institute Maastricht (CARIM), University Hospital Maastricht, the Netherlands (J.V., M.H., S.H.).', 'Department of Cardiovascular Research, University of Leuven, Belgium (S.H.). Netherlands Heart Institute (ICIN), Utrecht, the Netherlands (S.H.).', \"Universite de Lorraine, Inserm, Centre d'Investigations Cliniques-Plurithematique 14-33, and Inserm U1116, CHRU, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France (J.P.F., A.P., N.G., A.-C.H., P.R., F.Z.).\"], 'LA': ['eng'], 'SI': ['ClinicalTrials.gov/NCT02556450'], 'PT': ['Journal Article', 'Multicenter Study', \"Research Support, Non-U.S. Gov't\"], 'PL': 'United States', 'TA': 'Circ Heart Fail', 'JT': 'Circulation. Heart failure', 'JID': '101479941', 'RN': ['0 (Biomarkers)', '0 (Proteome)'], 'SB': 'IM', 'MH': ['Aged', 'Biomarkers/*blood', 'Case-Control Studies', 'Disease Progression', 'Female', 'Heart Failure/*blood/*physiopathology', 'Humans', 'Male', 'Proteome/*analysis', 'Proteomics'], 'OTO': ['NOTNLM'], 'OT': ['*apoptosis', '*atherosclerosis', '*blood pressure', '*heart failure', '*proteomics'], 'EDAT': '2019/05/21 06:00', 'MHDA': '2020/03/10 06:00', 'CRDT': ['2019/05/21 06:00'], 'PHST': ['2019/05/21 06:00 [entrez]', '2019/05/21 06:00 [pubmed]', '2020/03/10 06:00 [medline]'], 'AID': ['10.1161/CIRCHEARTFAILURE.118.005897 [doi]'], 'PST': 'ppublish', 'SO': 'Circ Heart Fail. 2019 May;12(5):e005897. doi: 10.1161/CIRCHEARTFAILURE.118.005897.'}\n",
      "{'PMID': '31092728', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20200817', 'LR': '20200817', 'IS': '2379-3708 (Electronic) 2379-3708 (Linking)', 'VI': '4', 'IP': '10', 'DP': '2019 May 16', 'TI': 'Systems biology identifies cytosolic PLA2 as a target in vascular calcification treatment.', 'LID': '10.1172/jci.insight.125638 [doi] 125638 [pii]', 'AB': 'Although cardiovascular disease (CVD) is the leading cause of morbimortality worldwide, promising new drug candidates are lacking. We compared the arterial high-resolution proteome of patients with advanced versus early-stage CVD to predict, from a library of small bioactive molecules, drug candidates able to reverse this disease signature. Of the approximately 4000 identified proteins, 100 proteins were upregulated and 52 were downregulated in advanced-stage CVD. Arachidonyl trifluoromethyl ketone (AACOCF3), a cytosolic phospholipase A2 (cPLA2) inhibitor was predicted as the top drug able to reverse the advanced-stage CVD signature. Vascular cPLA2 expression was increased in patients with advanced-stage CVD. Treatment with AACOCF3 significantly reduced vascular calcification in a cholecalciferol-overload mouse model and inhibited osteoinductive signaling in vivo and in vitro in human aortic smooth muscle cells. In conclusion, using a systems biology approach, we have identified a potentially new compound that prevented typical vascular calcification in CVD in vivo. Apart from the clear effect of this approach in CVD, such strategy should also be able to generate novel drug candidates in other complex diseases.', 'FAU': ['Schanstra, Joost P', 'Luong, Trang Td', 'Makridakis, Manousos', 'Van Linthout, Sophie', 'Lygirou, Vasiliki', 'Latosinska, Agnieszka', 'Alesutan, Ioana', 'Boehme, Beate', 'Schelski, Nadeshda', 'Von Lewinski, Dirk', 'Mullen, William', 'Nicklin, Stuart', 'Delles, Christian', 'Feuillet, Guylene', 'Denis, Colette', 'Lang, Florian', 'Pieske, Burkert', 'Bascands, Jean-Loup', 'Mischak, Harald', 'Saulnier-Blache, Jean-Sebastien', 'Voelkl, Jakob', 'Vlahou, Antonia', 'Klein, Julie'], 'AU': ['Schanstra JP', 'Luong TT', 'Makridakis M', 'Van Linthout S', 'Lygirou V', 'Latosinska A', 'Alesutan I', 'Boehme B', 'Schelski N', 'Von Lewinski D', 'Mullen W', 'Nicklin S', 'Delles C', 'Feuillet G', 'Denis C', 'Lang F', 'Pieske B', 'Bascands JL', 'Mischak H', 'Saulnier-Blache JS', 'Voelkl J', 'Vlahou A', 'Klein J'], 'AD': ['Institute of Cardiovascular and Metabolic Disease, INSERM, Toulouse, France.', 'Universite Toulouse III Paul-Sabatier, Toulouse, France.', 'Department of Internal Medicine and Cardiology, Charite - Universitatsmedizin Berlin, Campus Virchow-Klinikum, Berlin, Germany.', 'Biotechnology Laboratory, Centre of Basic Research, Biomedical Research Foundation of the Academy of Athens, Athens, Greece.', 'Department of Internal Medicine and Cardiology, Charite - Universitatsmedizin Berlin, Campus Virchow-Klinikum, Berlin, Germany.', 'Charite - Universitatsmedizin Berlin, Berlin Institute of Health Center for Regenerative Therapies (BCRT), Berlin, Germany.', 'German Center for Cardiovascular Research (DZHK), partner site Berlin, Berlin, Germany.', 'Biotechnology Laboratory, Centre of Basic Research, Biomedical Research Foundation of the Academy of Athens, Athens, Greece.', 'Mosaiques Diagnostics GmbH, Hannover, Germany.', 'Department of Internal Medicine and Cardiology, Charite - Universitatsmedizin Berlin, Campus Virchow-Klinikum, Berlin, Germany.', 'German Center for Cardiovascular Research (DZHK), partner site Berlin, Berlin, Germany.', 'Berlin Institute of Health, Berlin, Germany.', 'Institute for Physiology and Pathophysiology, Johannes Kepler University Linz, Linz, Austria.', 'Department of Internal Medicine and Cardiology, Charite - Universitatsmedizin Berlin, Campus Virchow-Klinikum, Berlin, Germany.', 'Department of Internal Medicine and Cardiology, Charite - Universitatsmedizin Berlin, Campus Virchow-Klinikum, Berlin, Germany.', 'Department of Cardiology, Medical University of Graz, Graz, Austria.', 'Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom.', 'Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom.', 'Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom.', 'Institute of Cardiovascular and Metabolic Disease, INSERM, Toulouse, France.', 'Universite Toulouse III Paul-Sabatier, Toulouse, France.', 'Institute of Cardiovascular and Metabolic Disease, INSERM, Toulouse, France.', 'Universite Toulouse III Paul-Sabatier, Toulouse, France.', 'Department of Physiology I, University of Tubingen, Tubingen, Germany.', 'Department of Internal Medicine and Cardiology, Charite - Universitatsmedizin Berlin, Campus Virchow-Klinikum, Berlin, Germany.', 'German Center for Cardiovascular Research (DZHK), partner site Berlin, Berlin, Germany.', 'INSERM, U1188, Universite de La Reunion, Sainte-Clotilde, La Reunion, France.', 'Mosaiques Diagnostics GmbH, Hannover, Germany.', 'Institute of Cardiovascular and Metabolic Disease, INSERM, Toulouse, France.', 'Universite Toulouse III Paul-Sabatier, Toulouse, France.', 'Department of Internal Medicine and Cardiology, Charite - Universitatsmedizin Berlin, Campus Virchow-Klinikum, Berlin, Germany.', 'German Center for Cardiovascular Research (DZHK), partner site Berlin, Berlin, Germany.', 'Institute for Physiology and Pathophysiology, Johannes Kepler University Linz, Linz, Austria.', 'Biotechnology Laboratory, Centre of Basic Research, Biomedical Research Foundation of the Academy of Athens, Athens, Greece.', 'Institute of Cardiovascular and Metabolic Disease, INSERM, Toulouse, France.', 'Universite Toulouse III Paul-Sabatier, Toulouse, France.'], 'LA': ['eng'], 'GR': ['RE/13/5/30177/BHF_/British Heart Foundation/United Kingdom'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20190516', 'PL': 'United States', 'TA': 'JCI Insight', 'JT': 'JCI insight', 'JID': '101676073', 'RN': ['0 (Antigens, Human Platelet)', '0 (Apolipoproteins E)', '0 (Arachidonic Acids)', '0 (human platelet antigen 1b)', '00XIW1CR0F (arachidonyltrifluoromethane)'], 'SB': 'IM', 'MH': ['Adult', 'Animals', 'Antigens, Human Platelet/*metabolism', 'Apolipoproteins E/genetics', 'Arachidonic Acids', 'Atherosclerosis', 'Cardiovascular Diseases', 'Cytosol/*metabolism', 'Disease Models, Animal', 'Female', 'Humans', 'Male', 'Mice', 'Mice, Inbred C57BL', 'Mice, Knockout', 'Middle Aged', 'Myocytes, Smooth Muscle/metabolism', '*Systems Biology', 'Up-Regulation', 'Vascular Calcification/*metabolism/*therapy'], 'PMC': 'PMC6542631', 'OTO': ['NOTNLM'], 'OT': ['*Atherosclerosis', '*Cardiovascular disease', '*Vascular Biology'], 'EDAT': '2019/05/17 06:00', 'MHDA': '2020/08/18 06:00', 'CRDT': ['2019/05/17 06:00'], 'PHST': ['2018/11/09 00:00 [received]', '2019/04/17 00:00 [accepted]', '2019/05/17 06:00 [entrez]', '2019/05/17 06:00 [pubmed]', '2020/08/18 06:00 [medline]'], 'AID': ['125638 [pii]', '10.1172/jci.insight.125638 [doi]'], 'PST': 'epublish', 'SO': 'JCI Insight. 2019 May 16;4(10). pii: 125638. doi: 10.1172/jci.insight.125638. eCollection 2019 May 16.'}\n",
      "{'PMID': '31056672', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20191202', 'LR': '20191202', 'IS': '1745-7270 (Electronic) 1672-9145 (Linking)', 'VI': '51', 'IP': '6', 'DP': '2019 Jun 20', 'TI': 'Comparative proteomics analysis of myocardium in left ventricular non-compaction cardiomyopathy.', 'PG': '653-655', 'LID': '10.1093/abbs/gmz039 [doi]', 'FAU': ['Du, Haiwei', 'Liu, Shenghua', 'Li, Chunyan', 'Wei, Yingjie'], 'AU': ['Du H', 'Liu S', 'Li C', 'Wei Y'], 'AD': ['State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.', 'State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.', 'State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.', 'State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.'], 'LA': ['eng'], 'PT': ['Comparative Study', 'Journal Article'], 'PL': 'China', 'TA': 'Acta Biochim Biophys Sin (Shanghai)', 'JT': 'Acta biochimica et biophysica Sinica', 'JID': '101206716', 'RN': ['0 (Proteome)', 'Noncompaction of Left Ventricular Myocardium with Congenital Heart Defects'], 'SB': 'IM', 'MH': ['Adolescent', 'Adult', 'Blotting, Western', 'Cardiomyopathies/*metabolism', 'Female', 'Heart Defects, Congenital/*metabolism', 'Humans', 'Male', 'Myocardium/*metabolism', 'Proteome/*metabolism', 'Proteomics/*methods', 'Young Adult'], 'EDAT': '2019/05/06 06:00', 'MHDA': '2019/12/04 06:00', 'CRDT': ['2019/05/07 06:00'], 'PHST': ['2019/02/25 00:00 [received]', '2019/05/06 06:00 [pubmed]', '2019/12/04 06:00 [medline]', '2019/05/07 06:00 [entrez]'], 'AID': ['5481913 [pii]', '10.1093/abbs/gmz039 [doi]'], 'PST': 'ppublish', 'SO': 'Acta Biochim Biophys Sin (Shanghai). 2019 Jun 20;51(6):653-655. doi: 10.1093/abbs/gmz039.'}\n",
      "{'PMID': '30928653', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20200518', 'LR': '20200518', 'IS': '1097-6825 (Electronic) 0091-6749 (Linking)', 'VI': '144', 'IP': '1', 'DP': '2019 Jul', 'TI': 'Stratification of asthma phenotypes by airway proteomic signatures.', 'PG': '70-82', 'LID': 'S0091-6749(19)30415-4 [pii] 10.1016/j.jaci.2019.03.013 [doi]', 'AB': 'BACKGROUND: Stratification by eosinophil and neutrophil counts increases our understanding of asthma and helps target therapy, but there is room for improvement in our accuracy in prediction of treatment responses and a need for better understanding of the underlying mechanisms. OBJECTIVE: We sought to identify molecular subphenotypes of asthma defined by proteomic signatures for improved stratification. METHODS: Unbiased label-free quantitative mass spectrometry and topological data analysis were used to analyze the proteomes of sputum supernatants from 246 participants (206 asthmatic patients) as a novel means of asthma stratification. Microarray analysis of sputum cells provided transcriptomics data additionally to inform on underlying mechanisms. RESULTS: Analysis of the sputum proteome resulted in 10 clusters (ie, proteotypes) based on similarity in proteomic features, representing discrete molecular subphenotypes of asthma. Overlaying granulocyte counts onto the 10 clusters as metadata further defined 3 of these as highly eosinophilic, 3 as highly neutrophilic, and 2 as highly atopic with relatively low granulocytic inflammation. For each of these 3 phenotypes, logistic regression analysis identified candidate protein biomarkers, and matched transcriptomic data pointed to differentially activated underlying mechanisms. CONCLUSION: This study provides further stratification of asthma currently classified based on quantification of granulocytic inflammation and provided additional insight into their underlying mechanisms, which could become targets for novel therapies.', 'CI': ['Copyright (c) 2019. Published by Elsevier Inc.'], 'FAU': ['Schofield, James P R', 'Burg, Dominic', 'Nicholas, Ben', 'Strazzeri, Fabio', 'Brandsma, Joost', 'Staykova, Doroteya', 'Folisi, Caterina', 'Bansal, Aruna T', 'Xian, Yang', 'Guo, Yike', 'Rowe, Anthony', 'Corfield, Julie', 'Wilson, Susan', 'Ward, Jonathan', 'Lutter, Rene', 'Shaw, Dominick E', 'Bakke, Per S', 'Caruso, Massimo', 'Dahlen, Sven-Erik', 'Fowler, Stephen J', 'Horvath, Ildiko', 'Howarth, Peter', 'Krug, Norbert', 'Montuschi, Paolo', 'Sanak, Marek', 'Sandstrom, Thomas', 'Sun, Kai', 'Pandis, Ioannis', 'Riley, John', 'Auffray, Charles', 'De Meulder, Bertrand', 'Lefaudeux, Diane', 'Sousa, Ana R', 'Adcock, Ian M', 'Chung, Kian Fan', 'Sterk, Peter J', 'Skipp, Paul J', 'Djukanovic, Ratko'], 'AU': ['Schofield JPR', 'Burg D', 'Nicholas B', 'Strazzeri F', 'Brandsma J', 'Staykova D', 'Folisi C', 'Bansal AT', 'Xian Y', 'Guo Y', 'Rowe A', 'Corfield J', 'Wilson S', 'Ward J', 'Lutter R', 'Shaw DE', 'Bakke PS', 'Caruso M', 'Dahlen SE', 'Fowler SJ', 'Horvath I', 'Howarth P', 'Krug N', 'Montuschi P', 'Sanak M', 'Sandstrom T', 'Sun K', 'Pandis I', 'Riley J', 'Auffray C', 'De Meulder B', 'Lefaudeux D', 'Sousa AR', 'Adcock IM', 'Chung KF', 'Sterk PJ', 'Skipp PJ', 'Djukanovic R'], 'AD': ['Centre for Proteomic Research, Biological Sciences, University of Southampton, Southampton, United Kingdom; NIHR Southampton Biomedical Research Centre, Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.', 'Centre for Proteomic Research, Biological Sciences, University of Southampton, Southampton, United Kingdom; NIHR Southampton Biomedical Research Centre, Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.', 'NIHR Southampton Biomedical Research Centre, Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.', 'Centre for Proteomic Research, Biological Sciences, University of Southampton, Southampton, United Kingdom; Mathematical Sciences, University of Southampton, Southampton, United Kingdom.', 'NIHR Southampton Biomedical Research Centre, Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.', 'Centre for Proteomic Research, Biological Sciences, University of Southampton, Southampton, United Kingdom.', 'Centre for Proteomic Research, Biological Sciences, University of Southampton, Southampton, United Kingdom.', 'Acclarogen, Cambridge, United Kingdom.', 'Data Science Institute, Imperial College, London, United Kingdom.', 'Data Science Institute, Imperial College, London, United Kingdom.', 'Janssen Research & Development, High Wycombe, United Kingdom.', 'Areteva, Nottingham, United Kingdom.', 'NIHR Southampton Biomedical Research Centre, Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.', 'NIHR Southampton Biomedical Research Centre, Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.', 'AMC, Department of Experimental Immunology, University of Amsterdam, Amsterdam, The Netherlands; Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.', 'Respiratory Research Unit, University of Nottingham, Nottingham, United Kingdom.', 'Institute of Medicine, University of Bergen, Bergen, Norway.', 'Department of Clinical and Experimental Medicine Hospital University, University of Catania, Catania, Italy.', 'Centre for Allergy Research, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.', 'Respiratory and Allergy Research Group, University of Manchester, Manchester, United Kingdom.', 'Department of Pulmonology, Semmelweis University, Budapest, Hungary.', 'NIHR Southampton Biomedical Research Centre, Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.', 'Fraunhofer Institute for Toxicology and Experimental Medicine Hannover, Hannover, Germany.', 'Faculty of Medicine, Catholic University of the Sacred Heart, Rome, Italy.', 'Laboratory of Molecular Biology and Clinical Genetics, Medical College, Jagiellonian University, Krakow, Poland.', 'Department of Medicine, Department of Public Health and Clinical Medicine Respiratory Medicine Unit, Umea University, Umea, Sweden.', 'Data Science Institute, Imperial College, London, United Kingdom.', 'Data Science Institute, Imperial College, London, United Kingdom.', 'Respiratory Therapeutic Unit, GlaxoSmithKline, Stockley Park, United Kingdom.', 'European Institute for Systems Biology and Medicine, CNRS-ENS-UCBL-INSERM, Universite de Lyon, Lyon, France.', 'European Institute for Systems Biology and Medicine, CNRS-ENS-UCBL-INSERM, Universite de Lyon, Lyon, France.', 'European Institute for Systems Biology and Medicine, CNRS-ENS-UCBL-INSERM, Universite de Lyon, Lyon, France.', 'Respiratory Therapeutic Unit, GlaxoSmithKline, Stockley Park, United Kingdom.', 'Cell and Molecular Biology Group, Airways Disease Section, National Heart and Lung Institute, Imperial College London, London, United Kingdom.', 'Cell and Molecular Biology Group, Airways Disease Section, National Heart and Lung Institute, Imperial College London, London, United Kingdom.', 'Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.', 'Centre for Proteomic Research, Biological Sciences, University of Southampton, Southampton, United Kingdom.', 'NIHR Southampton Biomedical Research Centre, Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom. Electronic address: R.Djukanovic@soton.ac.uk.'], 'CN': ['U-BIOPRED Study Group'], 'LA': ['eng'], 'PT': ['Journal Article', 'Multicenter Study', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20190328', 'PL': 'United States', 'TA': 'J Allergy Clin Immunol', 'JT': 'The Journal of allergy and clinical immunology', 'JID': '1275002', 'RN': ['0 (Biomarkers)', '0 (Proteome)'], 'SB': 'AIM IM', 'MH': ['Adult', 'Aged', 'Asthma/immunology/*metabolism/physiopathology', 'Biomarkers/metabolism', 'Eosinophilia/immunology/metabolism/physiopathology', 'Eosinophils/immunology', 'Female', 'Forced Expiratory Volume', 'Humans', 'Male', 'Middle Aged', 'Neutrophils/immunology', 'Phenotype', '*Proteome', 'Proteomics', 'Sputum/*metabolism', 'Young Adult'], 'OTO': ['NOTNLM'], 'OT': ['*Asthma', '*biomarkers', '*eosinophils', '*neutrophils', '*proteomics'], 'IR': ['Ahmed H', 'Allen D', 'Badorrek P', 'Ballereau S', 'Baribaud F', 'Bedding A', 'Behndig AF', 'Berglind A', 'Berton A', 'Bigler J', 'Boedigheimer MJ', 'Bonnelykke K', 'Brinkman P', 'Bush A', 'Campagna D', 'Casaulta C', 'Chaiboonchoe A', 'Davison T', 'De Meulder B', 'Delin I', 'Dennison P', 'Dodson P', 'El Hadjam L', 'Erzen D', 'Faulenbach C', 'Fichtner K', 'Fitch N', 'Formaggio E', 'Gahlemann M', 'Galffy G', 'Garissi D', 'Garret T', 'Gent J', 'Guillmant-Farry E', 'Henriksson E', 'Hoda U', 'Hohlfeld JM', 'Hu X', 'James A', 'Johnson K', 'Jullian N', 'Kerry G', 'Kluglich M', 'Knowles R', 'Konradsen JR', 'Kretsos K', 'Krueger L', 'Lantz AS', 'Larminie C', 'Latzin P', 'Lefaudeux D', 'Lemonnier N', 'Lowe LA', 'Lutter R', 'Manta A', 'Mazein A', 'McEvoy L', 'Menzies-Gow A', 'Mores N', 'Murray CS', 'Nething K', 'Nihlen U', 'Niven R', 'Nordlund B', 'Nsubuga S', 'Pellet J', 'Pison C', 'Pratico G', 'Valls MP', 'Riemann K', 'Rocha JP', 'Rossios C', 'Santini G', 'Saqi M', 'Scott S', 'Sehgal N', 'Selby A', 'Soderman P', 'Sogbesan A', 'Spycher F', 'Stephan S', 'Stokholm J', 'Sunther M', 'Szentkereszty M', 'Tamasi L', 'Tariq K', 'Valente S', 'van Aalderen WM', 'van Drunen CM', 'Van Eyll J', 'Vyas A', 'Yu W', 'Zetterquist W', 'Zolkipli Z', 'Zwinderman AH'], 'FIR': ['Ahmed, H', 'Allen, D', 'Badorrek, P', 'Ballereau, S', 'Baribaud, F', 'Bedding, A', 'Behndig, A F', 'Berglind, A', 'Berton, A', 'Bigler, J', 'Boedigheimer, M J', 'Bonnelykke, K', 'Brinkman, P', 'Bush, A', 'Campagna, D', 'Casaulta, C', 'Chaiboonchoe, A', 'Davison, T', 'De Meulder, B', 'Delin, I', 'Dennison, P', 'Dodson, P', 'El Hadjam, L', 'Erzen, D', 'Faulenbach, C', 'Fichtner, K', 'Fitch, N', 'Formaggio, E', 'Gahlemann, M', 'Galffy, G', 'Garissi, D', 'Garret, T', 'Gent, J', 'Guillmant-Farry, E', 'Henriksson, E', 'Hoda, U', 'Hohlfeld, J M', 'Hu, X', 'James, A', 'Johnson, K', 'Jullian, N', 'Kerry, G', 'Kluglich, M', 'Knowles, R', 'Konradsen, J R', 'Kretsos, K', 'Krueger, L', 'Lantz, A-S', 'Larminie, C', 'Latzin, P', 'Lefaudeux, D', 'Lemonnier, N', 'Lowe, L A', 'Lutter, R', 'Manta, A', 'Mazein, A', 'McEvoy, L', 'Menzies-Gow, A', 'Mores, N', 'Murray, C S', 'Nething, K', 'Nihlen, U', 'Niven, R', 'Nordlund, B', 'Nsubuga, S', 'Pellet, J', 'Pison, C', 'Pratico, G', 'Valls, M Puig', 'Riemann, K', 'Rocha, J P', 'Rossios, C', 'Santini, G', 'Saqi, M', 'Scott, S', 'Sehgal, N', 'Selby, A', 'Soderman, P', 'Sogbesan, A', 'Spycher, F', 'Stephan, S', 'Stokholm, J', 'Sunther, M', 'Szentkereszty, M', 'Tamasi, L', 'Tariq, K', 'Valente, S', 'van Aalderen, W M', 'van Drunen, C M', 'Van Eyll, J', 'Vyas, A', 'Yu, W', 'Zetterquist, W', 'Zolkipli, Z', 'Zwinderman, A H'], 'EDAT': '2019/04/01 06:00', 'MHDA': '2020/05/19 06:00', 'CRDT': ['2019/04/01 06:00'], 'PHST': ['2018/11/12 00:00 [received]', '2019/02/14 00:00 [revised]', '2019/03/08 00:00 [accepted]', '2019/04/01 06:00 [pubmed]', '2020/05/19 06:00 [medline]', '2019/04/01 06:00 [entrez]'], 'AID': ['S0091-6749(19)30415-4 [pii]', '10.1016/j.jaci.2019.03.013 [doi]'], 'PST': 'ppublish', 'SO': 'J Allergy Clin Immunol. 2019 Jul;144(1):70-82. doi: 10.1016/j.jaci.2019.03.013. Epub 2019 Mar 28.'}\n",
      "{'PMID': '30922315', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20190611', 'LR': '20200309', 'IS': '1475-2840 (Electronic) 1475-2840 (Linking)', 'VI': '18', 'IP': '1', 'DP': '2019 Mar 28', 'TI': 'Proteomic alterations of HDL in youth with type 1 diabetes and their associations with glycemic control: a case-control study.', 'PG': '43', 'LID': '10.1186/s12933-019-0846-9 [doi]', 'AB': 'BACKGROUND: Patients with type 1 diabetes (T1DM) typically have normal or even elevated plasma high density lipoprotein (HDL) cholesterol concentrations; however, HDL protein composition can be altered without a change in cholesterol content. Alteration of the HDL proteome can result in dysfunctional HDL particles with reduced ability to protect against cardiovascular disease (CVD). The objective of this study was to compare the HDL proteomes of youth with T1DM and healthy controls (HC) and to evaluate the influence of glycemic control on HDL protein composition. METHODS: This was a cross-sectional case-control study. Blood samples were obtained from patients with T1DM and HC. HDL was isolated from plasma by size-exclusion chromatography and further purified using a lipid binding resin. The HDL proteome was analyzed by mass spectrometry using label-free SWATH peptide quantification. RESULTS: Samples from 26 patients with T1DM and 13 HC were analyzed and 78 HDL-bound proteins were measured. Youth with T1DM had significantly increased amounts of complement factor H related protein 2 (FHR2; adjusted P < 0.05), compared to HC. When patients were analyzed based on glucose control, several trends emerged. Some proteins were altered in T1DM and not influenced by glycemic control (e.g. FHR2) while others were partially or completely corrected with optimal glucose control (e.g. alpha-1-beta glycoprotein, A1BG). In a subgroup of poorly controlled T1DM patients, inter alpha trypsin inhibitor 4 (ITIH4) was dramatically elevated (P < 0.0001) and this was partially reversed in patients with optimal glucose control. Some proteins including complement component C3 (CO3) and albumin (ALB) were significantly different only in T1DM patients with optimal glucose control, suggesting a possible effect of exogenous insulin. CONCLUSIONS: Youth with T1DM have proteomic alterations of their HDL compared to HC, despite similar concentration of HDL cholesterol. The influence of these compositional changes on HDL function are not yet known. Future efforts should focus on investigating the role of these HDL associated proteins in regard to HDL function and their role in CVD risk in patients with T1DM. Trial registration NCT02275091.', 'FAU': ['Gourgari, Evgenia', 'Ma, Junfeng', 'Playford, Martin P', 'Mehta, Nehal N', 'Goldman, Radoslav', 'Remaley, Alan T', 'Gordon, Scott M'], 'AU': ['Gourgari E', 'Ma J', 'Playford MP', 'Mehta NN', 'Goldman R', 'Remaley AT', 'Gordon SM'], 'AUID': ['ORCID: 0000-0002-5788-7955'], 'AD': ['Division of Pediatric Endocrinology, Department of Pediatrics, Georgetown University, Washington, DC, 20016, USA. eg685@georgetown.edu.', 'Proteomics and Metabolomics Shared Resource, Georgetown University Medical Center, Washington, DC, USA.', 'Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.', 'Section of Inflammation and Cardiometabolic Diseases, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.', 'Section of Inflammation and Cardiometabolic Diseases, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.', 'Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.', 'Lipoprotein Metabolism Section, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA.', 'Saha Cardiovascular Research Center, University of Kentucky, Lexington, KY, USA.', 'Department of Physiology, University of Kentucky, Lexington, KY, USA.'], 'LA': ['eng'], 'SI': ['ClinicalTrials.gov/NCT02275091'], 'GR': ['P30 CA051008/CA/NCI NIH HHS/United States', 'R01 CA135069/CA/NCI NIH HHS/United States', 'S10 OD023557/OD/NIH HHS/United States', 'UL1 TR001409/TR/NCATS NIH HHS/United States'], 'PT': ['Journal Article', 'Research Support, N.I.H., Extramural', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20190328', 'PL': 'England', 'TA': 'Cardiovasc Diabetol', 'JT': 'Cardiovascular diabetology', 'JID': '101147637', 'RN': ['0 (Biomarkers)', '0 (Blood Glucose)', '0 (Cholesterol, HDL)', '0 (Hypoglycemic Agents)', '0 (Lipoproteins, HDL)'], 'SB': 'IM', 'MH': ['Adolescent', 'Age Factors', 'Animals', 'Biomarkers/blood', 'Blood Glucose/*drug effects/metabolism', 'Case-Control Studies', 'Cell Line', 'Child', 'Cholesterol, HDL/blood', 'Chromatography, Liquid', 'Diabetes Mellitus, Type 1/*blood/diagnosis/*drug therapy', 'Female', 'Humans', 'Hypoglycemic Agents/*therapeutic use', 'Lipoproteins, HDL/*blood', 'Macrophages/metabolism', 'Male', 'Mice', 'Proteomics/*methods', 'Tandem Mass Spectrometry', 'Treatment Outcome', 'Young Adult'], 'PMC': 'PMC6437869', 'OTO': ['NOTNLM'], 'OT': ['*A1BG', '*Cardiovascular', '*HDL', '*ITIH4', '*Proteomics', '*Type 1 diabetes'], 'EDAT': '2019/03/30 06:00', 'MHDA': '2019/06/14 06:00', 'CRDT': ['2019/03/30 06:00'], 'PHST': ['2019/01/16 00:00 [received]', '2019/03/18 00:00 [accepted]', '2019/03/30 06:00 [entrez]', '2019/03/30 06:00 [pubmed]', '2019/06/14 06:00 [medline]'], 'AID': ['10.1186/s12933-019-0846-9 [doi]', '10.1186/s12933-019-0846-9 [pii]'], 'PST': 'epublish', 'SO': 'Cardiovasc Diabetol. 2019 Mar 28;18(1):43. doi: 10.1186/s12933-019-0846-9.'}\n",
      "{'PMID': '30907085', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20200601', 'LR': '20200601', 'IS': '1535-3907 (Electronic) 1535-3893 (Linking)', 'VI': '18', 'IP': '5', 'DP': '2019 May 3', 'TI': 'A Large-Scale, Multi-Center Urine Biomarkers Identification of Coronary Heart Disease in TCM Syndrome Differentiation.', 'PG': '1994-2003', 'LID': '10.1021/acs.jproteome.8b00799 [doi]', 'AB': 'Coronary heart disease (CHD) threatens human health. The discovery and assessment of potential biometabolic markers for different syndrome types of CHD may contribute to decipher pathophysiological mechanisms and identify new targets for diagnosis and treatment. On the basis of UPLC-Q-TOF/MS metabolomics technology, urine samples of 1072 participants from nine centers, including normal control, phlegm and blood stasis (PBS) syndrome and Qi and Yin deficiency (QYD) syndrome, and other syndromes of CHD, were conducted to find biomarkers. Among them, the discovery set ( n = 125) and the test set ( n = 337) were used to identify and validate biomarkers, and the validation set ( n = 610) was used for the application and evaluation of the support vector machine (SVM) prediction model. We discovered 15 CHD-PBS syndrome biomarkers and 12 CHD-QYD syndrome biomarkers, and the receiver-operator characteristic (ROC) area-under-the-curve (AUC) values of them were 0.963 and 0.990. The established SVM model has a good diagnostic ability and can well distinguish the two syndromes of CHD with a high predicted accuracy >98.0%. The discovery of biomarkers and metabolic pathways in different syndrome types of CHD provides a basis for the diagnosis and evaluation of CHD, thereby improving the accurate diagnosis and precise treatment level of Chinese medicine.', 'FAU': ['Zhou, Haonan', 'Li, Lin', 'Zhao, Huan', 'Wang, Yuming', 'Du, Jun', 'Zhang, Pengjie', 'Li, Chunjie', 'Wang, Xianliang', 'Liu, Yuechen', 'Xu, Qiang', 'Zhang, Tianpu', 'Song, Yanqi', 'Yu, Chunquan', 'Li, Yubo'], 'AU': ['Zhou H', 'Li L', 'Zhao H', 'Wang Y', 'Du J', 'Zhang P', 'Li C', 'Wang X', 'Liu Y', 'Xu Q', 'Zhang T', 'Song Y', 'Yu C', 'Li Y'], 'AD': ['Tianjin University of Traditional Chinese Medicine , Tianjin 300193 , China.', 'Tianjin University of Traditional Chinese Medicine , Tianjin 300193 , China.', 'Tianjin University of Traditional Chinese Medicine , Tianjin 300193 , China.', 'Tianjin University of Traditional Chinese Medicine , Tianjin 300193 , China.', 'Tianjin University of Traditional Chinese Medicine , Tianjin 300193 , China.', 'Tianjin University of Traditional Chinese Medicine , Tianjin 300193 , China.', 'Tianjin Chest Hospital , Tianjin 300193 , China.', 'First Teaching Hospital of Tianjin University of TCM , Tianjin 300193 , China.', 'Tianjin University of Traditional Chinese Medicine , Tianjin 300193 , China.', 'Second Affiliated Hospital of Tianjin University of TCM , Tianjin 300150 , China.', 'Tianjin University of Traditional Chinese Medicine , Tianjin 300193 , China.', 'Tianjin University of Traditional Chinese Medicine , Tianjin 300193 , China.', 'Tianjin University of Traditional Chinese Medicine , Tianjin 300193 , China.', 'Tianjin University of Traditional Chinese Medicine , Tianjin 300193 , China.'], 'AUID': ['ORCID: 0000-0003-0455-0969'], 'LA': ['eng'], 'PT': ['Journal Article', 'Multicenter Study', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20190409', 'PL': 'United States', 'TA': 'J Proteome Res', 'JT': 'Journal of proteome research', 'JID': '101128775', 'RN': ['0 (Biomarkers)'], 'SB': 'IM', 'MH': ['Adult', 'Aged', 'Aged, 80 and over', 'Area Under Curve', 'Biomarkers/urine', 'Case-Control Studies', 'Chromatography, High Pressure Liquid', 'Coronary Disease/*diagnosis/physiopathology/urine', 'Diagnosis, Differential', 'Female', 'Humans', 'Male', 'Medicine, Chinese Traditional/*methods', '*Metabolome', 'Middle Aged', 'ROC Curve', 'Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization', 'Support Vector Machine', 'Syndrome'], 'OTO': ['NOTNLM'], 'OT': ['*Qi and Yin deficiency', '*UPLC-Q-TOF/MS', '*biomarkers', '*coronary heart disease', '*metabolomics', '*phlegm and blood stasis', '*support vector machine'], 'EDAT': '2019/03/26 06:00', 'MHDA': '2020/06/02 06:00', 'CRDT': ['2019/03/26 06:00'], 'PHST': ['2019/03/26 06:00 [pubmed]', '2020/06/02 06:00 [medline]', '2019/03/26 06:00 [entrez]'], 'AID': ['10.1021/acs.jproteome.8b00799 [doi]'], 'PST': 'ppublish', 'SO': 'J Proteome Res. 2019 May 3;18(5):1994-2003. doi: 10.1021/acs.jproteome.8b00799. Epub 2019 Apr 9.'}\n",
      "{'PMID': '30887811', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20200527', 'LR': '20200715', 'IS': '1535-3907 (Electronic) 1535-3893 (Linking)', 'VI': '18', 'IP': '6', 'DP': '2019 Jun 7', 'TI': 'An Unbiased Lipid Phenotyping Approach To Study the Genetic Determinants of Lipids and Their Association with Coronary Heart Disease Risk Factors.', 'PG': '2397-2410', 'LID': '10.1021/acs.jproteome.8b00786 [doi]', 'AB': 'Direct infusion high-resolution mass spectrometry (DIHRMS) is a novel, high-throughput approach to rapidly and accurately profile hundreds of lipids in human serum without prior chromatography, facilitating in-depth lipid phenotyping for large epidemiological studies to reveal the detailed associations of individual lipids with coronary heart disease (CHD) risk factors. Intact lipid profiling by DIHRMS was performed on 5662 serum samples from healthy participants in the Pakistan Risk of Myocardial Infarction Study (PROMIS). We developed a novel semi-targeted peak-picking algorithm to detect mass-to-charge ratios in positive and negative ionization modes. We analyzed lipid partial correlations, assessed the association of lipid principal components with established CHD risk factors and genetic variants, and examined differences between lipids for a common genetic polymorphism. The DIHRMS method provided information on 360 lipids (including fatty acyls, glycerolipids, glycerophospholipids, sphingolipids, and sterol lipids), with a median coefficient of variation of 11.6% (range: 5.4-51.9). The lipids were highly correlated and exhibited a range of associations with clinical chemistry biomarkers and lifestyle factors. This platform can provide many novel insights into the effects of physiology and lifestyle on lipid metabolism, genetic determinants of lipids, and the relationship between individual lipids and CHD risk factors.', 'FAU': ['Harshfield, Eric L', 'Koulman, Albert', 'Ziemek, Daniel', 'Marney, Luke', 'Fauman, Eric B', 'Paul, Dirk S', 'Stacey, David', 'Rasheed, Asif', 'Lee, Jung-Jin', 'Shah, Nabi', 'Jabeen, Sehrish', 'Imran, Atif', 'Abbas, Shahid', 'Hina, Zoubia', 'Qamar, Nadeem', 'Mallick, Nadeem Hayyat', 'Yaqoob, Zia', 'Saghir, Tahir', 'Rizvi, Syed Nadeem Hasan', 'Memon, Anis', 'Rasheed, Syed Zahed', 'Memon, Fazal-Ur-Rehman', 'Qureshi, Irshad Hussain', 'Ishaq, Muhammad', 'Frossard, Philippe', 'Danesh, John', 'Saleheen, Danish', 'Butterworth, Adam S', 'Wood, Angela M', 'Griffin, Julian L'], 'AU': ['Harshfield EL', 'Koulman A', 'Ziemek D', 'Marney L', 'Fauman EB', 'Paul DS', 'Stacey D', 'Rasheed A', 'Lee JJ', 'Shah N', 'Jabeen S', 'Imran A', 'Abbas S', 'Hina Z', 'Qamar N', 'Mallick NH', 'Yaqoob Z', 'Saghir T', 'Rizvi SNH', 'Memon A', 'Rasheed SZ', 'Memon FU', 'Qureshi IH', 'Ishaq M', 'Frossard P', 'Danesh J', 'Saleheen D', 'Butterworth AS', 'Wood AM', 'Griffin JL'], 'AUID': ['ORCID: 0000-0001-8767-0928', 'ORCID: 0000-0003-1336-7744'], 'AD': ['MRC/BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care , University of Cambridge , Cambridge CB1 8RN , U.K.', 'Stroke Research Group, Department of Clinical Neurosciences , University of Cambridge , Cambridge CB2 0QQ , U.K.', 'Core Metabolomics and Lipidomics Laboratory , National Institute for Health Research Cambridge Biomedical Research Centre , Cambridge CB2 0QQ , U.K.', 'Inflammation and Immunology, Pfizer Worldwide Research & Development , 10785 Berlin , Germany.', 'College of Science and Engineering , Seattle University , Seattle , Washington 98122 , United States.', 'Genomic Sciences and Technologies, Pfizer Worldwide Research & Development , Cambridge , Massachusetts 02139 , United States.', 'MRC/BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care , University of Cambridge , Cambridge CB1 8RN , U.K.', 'MRC/BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care , University of Cambridge , Cambridge CB1 8RN , U.K.', 'Center for Non-Communicable Diseases , Karachi 75300 , Pakistan.', 'Department of Medicine , Mayo Hospital , Lahore 54000 , Pakistan.', 'Center for Non-Communicable Diseases , Karachi 75300 , Pakistan.', 'Department of Pharmacy , COMSATS Institute of Information Technology , Abbottabad 22060 , Pakistan.', 'Center for Non-Communicable Diseases , Karachi 75300 , Pakistan.', 'Center for Non-Communicable Diseases , Karachi 75300 , Pakistan.', 'Department of Cardiology , Faisalabad Institute of Cardiology , Faisalabad 38000 , Pakistan.', 'Department of Cardiology , Faisalabad Institute of Cardiology , Faisalabad 38000 , Pakistan.', 'National Institute of Cardiovascular Disorders , Karachi 75510 , Pakistan.', 'Punjab Institute of Cardiology , Lahore 42000 , Pakistan.', 'Karachi Institute of Heart Diseases , Karachi 75950 , Pakistan.', 'National Institute of Cardiovascular Disorders , Karachi 75510 , Pakistan.', 'National Institute of Cardiovascular Disorders , Karachi 75510 , Pakistan.', 'National Institute of Cardiovascular Disorders , Karachi 75510 , Pakistan.', 'Karachi Institute of Heart Diseases , Karachi 75950 , Pakistan.', 'Red Crescent Institute of Cardiology , Hyderabad 71500 , Pakistan.', 'Department of Medicine , Mayo Hospital , Lahore 54000 , Pakistan.', 'Karachi Institute of Heart Diseases , Karachi 75950 , Pakistan.', 'Center for Non-Communicable Diseases , Karachi 75300 , Pakistan.', 'MRC/BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care , University of Cambridge , Cambridge CB1 8RN , U.K.', 'Center for Non-Communicable Diseases , Karachi 75300 , Pakistan.', 'Department of Biostatistics and Epidemiology , University of Pennsylvania , Philadelphia , Pennsylvania 19104 , United States.', 'MRC/BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care , University of Cambridge , Cambridge CB1 8RN , U.K.', 'MRC/BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care , University of Cambridge , Cambridge CB1 8RN , U.K.', 'Department of Biochemistry and Cambridge Systems Biology Centre , University of Cambridge , Cambridge CB2 1GA , U.K.'], 'LA': ['eng'], 'GR': ['G0800270/MRC_/Medical Research Council/United Kingdom', 'RG/18/13/33946/BHF_/British Heart Foundation/United Kingdom', 'MC_EX_G0800783/MRC_/Medical Research Council/United Kingdom', 'MC_UU_00014/5/MRC_/Medical Research Council/United Kingdom', 'MC_UU_12012/5/MRC_/Medical Research Council/United Kingdom', 'SP/09/002/ERC_/European Research Council/International', '105602/Z/14/Z/WT_/Wellcome Trust/United Kingdom', 'WT_/Wellcome Trust/United Kingdom', 'MC_UP_A090_1006/MRC_/Medical Research Council/United Kingdom', 'MC_PC_13030/MRC_/Medical Research Council/United Kingdom'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20190426', 'PL': 'United States', 'TA': 'J Proteome Res', 'JT': 'Journal of proteome research', 'JID': '101128775', 'RN': ['0 (Biomarkers)', '0 (Glycerophospholipids)', '0 (Lipids)', '0 (Sphingolipids)', '0 (Sterols)'], 'SB': 'IM', 'MH': ['Biomarkers/*blood', 'Coronary Disease/blood/*genetics/pathology', 'Female', 'Genetic Variation', 'Glycerophospholipids/blood', 'Humans', 'Lipid Metabolism/genetics', 'Lipids/blood/*genetics', 'Male', 'Middle Aged', 'Risk Factors', 'Sphingolipids/blood/genetics', 'Sterols/blood'], 'PMC': 'PMC6558644', 'OTO': ['NOTNLM'], 'OT': ['*coronary heart disease', '*genetics', '*lipidomics', '*mass spectrometry', '*protocol'], 'EDAT': '2019/03/20 06:00', 'MHDA': '2020/05/28 06:00', 'CRDT': ['2019/03/20 06:00'], 'PHST': ['2019/03/20 06:00 [pubmed]', '2020/05/28 06:00 [medline]', '2019/03/20 06:00 [entrez]'], 'AID': ['10.1021/acs.jproteome.8b00786 [doi]'], 'PST': 'ppublish', 'SO': 'J Proteome Res. 2019 Jun 7;18(6):2397-2410. doi: 10.1021/acs.jproteome.8b00786. Epub 2019 Apr 26.'}\n",
      "{'PMID': '30874584', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20201001', 'LR': '20201001', 'IS': '2045-2322 (Electronic) 2045-2322 (Linking)', 'VI': '9', 'IP': '1', 'DP': '2019 Mar 15', 'TI': 'Definition of a cell surface signature for human cardiac progenitor cells after comprehensive comparative transcriptomic and proteomic characterization.', 'PG': '4647', 'LID': '10.1038/s41598-019-39571-x [doi]', 'AB': 'Adult cardiac progenitor/stem cells (CPC/CSC) are multipotent resident populations involved in cardiac homeostasis and heart repair. Assisted by complementary RNAseq analysis, we defined the fraction of the CPC proteome associable with specific functions by comparison with human bone marrow mesenchymal stem cells (MSC), the reference population for cell therapy, and human dermal fibroblasts (HDF), as a distant reference. Label-free proteomic analysis identified 526 proteins expressed differentially in CPC. iTRAQ analysis confirmed differential expression of a substantial proportion of those proteins in CPC relative to MSC, and systems biology analysis defined a clear overrepresentation of several categories related to enhanced angiogenic potential. The CPC plasma membrane compartment comprised 1,595 proteins, including a minimal signature of 167 proteins preferentially or exclusively expressed by CPC. CDH5 (VE-cadherin), OX2G (OX-2 membrane glycoprotein; CD200), GPR4 (G protein-coupled receptor 4), CACNG7 (calcium voltage-gated channel auxiliary subunit gamma 7) and F11R (F11 receptor; junctional adhesion molecule A; JAM-A; CD321) were selected for validation. Their differential expression was confirmed both in expanded CPC batches and in early stages of isolation, particularly when compared against cardiac fibroblasts. Among them, GPR4 demonstrated the highest discrimination capacity between all cell lineages analyzed.', 'FAU': ['Toran, Jose Luis', 'Lopez, Juan Antonio', 'Gomes-Alves, Patricia', 'Aguilar, Susana', 'Torroja, Carlos', 'Trevisan-Herraz, Marco', 'Moscoso, Isabel', 'Sebastiao, Maria Joao', 'Serra, Margarida', 'Brito, Catarina', 'Cruz, Francisco Miguel', 'Sepulveda, Juan Carlos', 'Abad, Jose Luis', 'Galan-Arriola, Carlos', 'Ibanez, Borja', 'Martinez, Fernando', 'Fernandez, Maria Eugenia', 'Fernandez-Aviles, Francisco', 'Palacios, Itziar', 'R-Borlado, Luis', 'Vazquez, Jesus', 'Alves, Paula M', 'Bernad, Antonio'], 'AU': ['Toran JL', 'Lopez JA', 'Gomes-Alves P', 'Aguilar S', 'Torroja C', 'Trevisan-Herraz M', 'Moscoso I', 'Sebastiao MJ', 'Serra M', 'Brito C', 'Cruz FM', 'Sepulveda JC', 'Abad JL', 'Galan-Arriola C', 'Ibanez B', 'Martinez F', 'Fernandez ME', 'Fernandez-Aviles F', 'Palacios I', 'R-Borlado L', 'Vazquez J', 'Alves PM', 'Bernad A'], 'AD': ['Department of Immunology and Oncology, Centro Nacional de Biotecnologia (CNB-CSIC), Campus Universidad Autonoma de Madrid, 28049, Madrid, Spain.', 'Cardiovascular Development and Repair Department, Spanish National Cardiovascular Research Center (CNIC), Melchor Fernandez Almagro 3, 28029, Madrid, Spain.', 'Laboratory of Cardiovascular Proteomics, Spanish National Cardiovascular Research Center (CNIC), Melchor Fernandez Almagro 3, 28029, Madrid, Spain.', 'iBET, Instituto de Biologia Experimental e Tecnologica, Apartado 12, 2781-901, Oeiras, Portugal.', 'Instituto de Tecnologia Quimica e Biologica, Universidade Nova de Lisboa, Av. da Republica, 2780-157, Oeiras, Portugal.', 'Department of Immunology and Oncology, Centro Nacional de Biotecnologia (CNB-CSIC), Campus Universidad Autonoma de Madrid, 28049, Madrid, Spain.', 'Cardiovascular Development and Repair Department, Spanish National Cardiovascular Research Center (CNIC), Melchor Fernandez Almagro 3, 28029, Madrid, Spain.', 'Bioinformatics Unit, Spanish National Cardiovascular Research Center (CNIC), Melchor Fernandez Almagro 3, 28029, Madrid, Spain.', 'Laboratory of Cardiovascular Proteomics, Spanish National Cardiovascular Research Center (CNIC), Melchor Fernandez Almagro 3, 28029, Madrid, Spain.', 'Cardiovascular Development and Repair Department, Spanish National Cardiovascular Research Center (CNIC), Melchor Fernandez Almagro 3, 28029, Madrid, Spain.', 'CIMUS, Avda Barcelona s/n, Santiago de Compostela, 15782A, Coruna, Spain.', 'iBET, Instituto de Biologia Experimental e Tecnologica, Apartado 12, 2781-901, Oeiras, Portugal.', 'Instituto de Tecnologia Quimica e Biologica, Universidade Nova de Lisboa, Av. da Republica, 2780-157, Oeiras, Portugal.', 'iBET, Instituto de Biologia Experimental e Tecnologica, Apartado 12, 2781-901, Oeiras, Portugal.', 'Instituto de Tecnologia Quimica e Biologica, Universidade Nova de Lisboa, Av. da Republica, 2780-157, Oeiras, Portugal.', 'iBET, Instituto de Biologia Experimental e Tecnologica, Apartado 12, 2781-901, Oeiras, Portugal.', 'Instituto de Tecnologia Quimica e Biologica, Universidade Nova de Lisboa, Av. da Republica, 2780-157, Oeiras, Portugal.', 'Cardiovascular Development and Repair Department, Spanish National Cardiovascular Research Center (CNIC), Melchor Fernandez Almagro 3, 28029, Madrid, Spain.', 'Department of Immunology and Oncology, Centro Nacional de Biotecnologia (CNB-CSIC), Campus Universidad Autonoma de Madrid, 28049, Madrid, Spain.', 'Cardiovascular Development and Repair Department, Spanish National Cardiovascular Research Center (CNIC), Melchor Fernandez Almagro 3, 28029, Madrid, Spain.', 'Coretherapix S.L. U. Santiago Grisolia 2, 28769, Tres Cantos, Madrid, Spain.', 'Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain.', 'Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain.', 'Bioinformatics Unit, Spanish National Cardiovascular Research Center (CNIC), Melchor Fernandez Almagro 3, 28029, Madrid, Spain.', 'Department of Cardiology, Hospital General Universitario Gregorio Maranon, Instituto de Investigacion Sanitaria Gregorio Maranon, C/ Dr Esquerdo, 46, 28007, Madrid, Spain.', 'Department of Cardiology, Hospital General Universitario Gregorio Maranon, Instituto de Investigacion Sanitaria Gregorio Maranon, C/ Dr Esquerdo, 46, 28007, Madrid, Spain.', 'Coretherapix S.L. U. Santiago Grisolia 2, 28769, Tres Cantos, Madrid, Spain.', 'Coretherapix S.L. U. Santiago Grisolia 2, 28769, Tres Cantos, Madrid, Spain.', 'Laboratory of Cardiovascular Proteomics, Spanish National Cardiovascular Research Center (CNIC), Melchor Fernandez Almagro 3, 28029, Madrid, Spain.', 'iBET, Instituto de Biologia Experimental e Tecnologica, Apartado 12, 2781-901, Oeiras, Portugal.', 'Instituto de Tecnologia Quimica e Biologica, Universidade Nova de Lisboa, Av. da Republica, 2780-157, Oeiras, Portugal.', 'Department of Immunology and Oncology, Centro Nacional de Biotecnologia (CNB-CSIC), Campus Universidad Autonoma de Madrid, 28049, Madrid, Spain. abernad@cnb.csic.es.', 'Cardiovascular Development and Repair Department, Spanish National Cardiovascular Research Center (CNIC), Melchor Fernandez Almagro 3, 28029, Madrid, Spain. abernad@cnb.csic.es.'], 'AUID': ['ORCID: 0000-0002-7129-0602', 'ORCID: 0000-0002-6078-4666', 'ORCID: 0000-0003-1904-5164', 'ORCID: 0000-0003-1461-5092'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20190315', 'PL': 'England', 'TA': 'Sci Rep', 'JT': 'Scientific reports', 'JID': '101563288', 'RN': ['0 (Antigens, CD)', '0 (Biomarkers)', '0 (CACNG7 protein, human)', '0 (Cadherins)', '0 (Calcium Channels)', '0 (Cell Adhesion Molecules)', '0 (F11R protein, human)', '0 (GPR4 protein, human)', '0 (Proteome)', '0 (Receptors, Cell Surface)', '0 (Receptors, G-Protein-Coupled)', '0 (cadherin 5)', 'UQ4V77A8VA (antigens, CD200)'], 'SB': 'IM', 'MH': ['Adult', 'Antigens, CD', 'Biomarkers', 'Cadherins', 'Calcium Channels', 'Cell Adhesion Molecules', 'Cell Differentiation/*physiology', 'Gene Expression Profiling/methods', 'Heart/*growth & development', 'Humans', 'Mesenchymal Stem Cells/metabolism', 'Multipotent Stem Cells/metabolism', 'Myocytes, Cardiac/*metabolism', 'Proteome/genetics', 'Proteomics/methods', 'Receptors, Cell Surface', 'Receptors, G-Protein-Coupled', 'Transcriptome/genetics'], 'PMC': 'PMC6420620', 'EDAT': '2019/03/16 06:00', 'MHDA': '2020/10/02 06:00', 'CRDT': ['2019/03/16 06:00'], 'PHST': ['2018/04/26 00:00 [received]', '2019/01/22 00:00 [accepted]', '2019/03/16 06:00 [entrez]', '2019/03/16 06:00 [pubmed]', '2020/10/02 06:00 [medline]'], 'AID': ['10.1038/s41598-019-39571-x [doi]', '10.1038/s41598-019-39571-x [pii]'], 'PST': 'epublish', 'SO': 'Sci Rep. 2019 Mar 15;9(1):4647. doi: 10.1038/s41598-019-39571-x.'}\n",
      "{'PMID': '30870787', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20191125', 'LR': '20200309', 'IS': '2213-2317 (Electronic) 2213-2317 (Linking)', 'VI': '22', 'DP': '2019 Apr', 'TI': 'Protein disulfide isomerase plasma levels in healthy humans reveal proteomic signatures involved in contrasting endothelial phenotypes.', 'PG': '101142', 'LID': 'S2213-2317(19)30021-7 [pii] 10.1016/j.redox.2019.101142 [doi]', 'AB': 'Redox-related plasma proteins are candidate reporters of protein signatures associated with endothelial structure/function. Thiol-proteins from protein disulfide isomerase (PDI) family are unexplored in this context. Here, we investigate the occurrence and physiological significance of a circulating pool of PDI in healthy humans. We validated an assay for detecting PDI in plasma of healthy individuals. Our results indicate high inter-individual (median=330pg/mL) but low intra-individual variability over time and repeated measurements. Remarkably, plasma PDI levels could discriminate between distinct plasma proteome signatures, with PDI-rich (>median) plasma differentially expressing proteins related to cell differentiation, protein processing, housekeeping functions and others, while PDI-poor plasma differentially displayed proteins associated with coagulation, inflammatory responses and immunoactivation. Platelet function was similar among individuals with PDI-rich vs. PDI-poor plasma. Remarkably, such protein signatures closely correlated with endothelial function and phenotype, since cultured endothelial cells incubated with PDI-poor or PDI-rich plasma recapitulated gene expression and secretome patterns in line with their corresponding plasma signatures. Furthermore, such signatures translated into functional responses, with PDI-poor plasma promoting impairment of endothelial adhesion to fibronectin and a disturbed pattern of wound-associated migration and recovery area. Patients with cardiovascular events had lower PDI levels vs. healthy individuals. This is the first study describing PDI levels as reporters of specific plasma proteome signatures directly promoting contrasting endothelial phenotypes and functional responses.', 'CI': ['Copyright (c) 2019 The Authors. Published by Elsevier B.V. All rights reserved.'], 'FAU': ['Oliveira, Percillia Victoria Santos de', 'Garcia-Rosa, Sheila', 'Sachetto, Ana Teresa Azevedo', 'Moretti, Ana Iochabel Soares', 'Debbas, Victor', 'De Bessa, Tiphany Coralie', 'Silva, Nathalia Tenguan', 'Pereira, Alexandre da Costa', 'Martins-de-Souza, Daniel', 'Santoro, Marcelo Larami', 'Laurindo, Francisco Rafael Martins'], 'AU': ['Oliveira PVS', 'Garcia-Rosa S', 'Sachetto ATA', 'Moretti AIS', 'Debbas V', 'De Bessa TC', 'Silva NT', 'Pereira ADC', 'Martins-de-Souza D', 'Santoro ML', 'Laurindo FRM'], 'AD': ['Laboratorio de Biologia Vascular, LIM-64 (Biologia Cardiovascular Translacional), Instituto do Coracao (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil.', 'Laboratory of Neuroproteomics, Department of Biochemistry and Tissue Biology, Institute of Biology, University of Campinas, Campinas, Brazil; Instituto Nacional de Biomarcadores em Neuropsiquiatria (INBION), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Sao Paulo, Brazil.', 'Laboratorio de Fisiopatologia, Instituto Butantan, Sao Paulo, 05503-900, Brazil.', 'Laboratorio de Biologia Vascular, LIM-64 (Biologia Cardiovascular Translacional), Instituto do Coracao (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil.', 'Laboratorio de Biologia Vascular, LIM-64 (Biologia Cardiovascular Translacional), Instituto do Coracao (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil.', 'Laboratorio de Biologia Vascular, LIM-64 (Biologia Cardiovascular Translacional), Instituto do Coracao (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil.', 'Laboratorio de Biologia Vascular, LIM-64 (Biologia Cardiovascular Translacional), Instituto do Coracao (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil.', 'Laboratory of Genetics and Molecular Cardiology, Heart Institute (InCor), University of Sao Paulo Medical School Hospital, Sao Paulo, Brazil.', 'Laboratory of Neuroproteomics, Department of Biochemistry and Tissue Biology, Institute of Biology, University of Campinas, Campinas, Brazil; Instituto Nacional de Biomarcadores em Neuropsiquiatria (INBION), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Sao Paulo, Brazil.', 'Laboratorio de Fisiopatologia, Instituto Butantan, Sao Paulo, 05503-900, Brazil.', 'Laboratorio de Biologia Vascular, LIM-64 (Biologia Cardiovascular Translacional), Instituto do Coracao (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil. Electronic address: francisco.laurindo@incor.usp.br.'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20190219', 'PL': 'Netherlands', 'TA': 'Redox Biol', 'JT': 'Redox biology', 'JID': '101605639', 'RN': ['0 (Biomarkers)', '0 (Proteome)', 'EC 5.3.4.1 (Protein Disulfide-Isomerases)'], 'SB': 'IM', 'MH': ['Adult', 'Biomarkers', 'Cell Survival', 'Cells, Cultured', 'Endothelial Cells/*metabolism', 'Enzyme-Linked Immunosorbent Assay', 'Female', 'Gene Expression', 'Healthy Volunteers', 'Humans', 'Male', 'Oxidation-Reduction', '*Phenotype', 'Platelet Aggregation', 'Protein Disulfide-Isomerases/*blood', '*Proteome', '*Proteomics/methods', 'Reproducibility of Results'], 'PMC': 'PMC6430080', 'OTO': ['NOTNLM'], 'OT': ['*Endothelial cells', '*Plasma protein signatures', '*Plasma proteome', '*Protein disulfide isomerase', '*Thiol proteins'], 'EDAT': '2019/03/15 06:00', 'MHDA': '2019/11/26 06:00', 'CRDT': ['2019/03/15 06:00'], 'PHST': ['2019/01/04 00:00 [received]', '2019/01/22 00:00 [revised]', '2019/02/12 00:00 [accepted]', '2019/03/15 06:00 [pubmed]', '2019/11/26 06:00 [medline]', '2019/03/15 06:00 [entrez]'], 'AID': ['S2213-2317(19)30021-7 [pii]', '10.1016/j.redox.2019.101142 [doi]'], 'PST': 'ppublish', 'SO': 'Redox Biol. 2019 Apr;22:101142. doi: 10.1016/j.redox.2019.101142. Epub 2019 Feb 19.'}\n",
      "{'PMID': '30838756', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20200716', 'LR': '20200716', 'IS': '1582-4934 (Electronic) 1582-1838 (Linking)', 'VI': '23', 'IP': '5', 'DP': '2019 May', 'TI': 'Increased level of fibrinogen chains in the proteome of blood platelets in secondary progressive multiple sclerosis patients.', 'PG': '3476-3482', 'LID': '10.1111/jcmm.14244 [doi]', 'AB': \"Epidemiological studies indicate a high risk of stroke, heart failure and myocardial infarction in patients with multiple sclerosis, especially in its secondary progressive (SPMS) phase. Some ischaemic events are directly associated with abnormal platelet functions and their prothrombotic activity. Recent reports, including this study, confirm the increased activation of circulating platelets in SPMS, and also show increased platelet reactivity, among other responses, as well as strong aggregation. In this current study, we conducted a comparative analysis of the platelet proteome in SPMS patients and in healthy controls, to demonstrate the quantitative and qualitative differences likely to affect functional changes observed in SPMS. During densitometry evaluation of 2-D fluorescence difference gel electrophoresis, we observed differences between the electrophoretic patterns of SPMS platelets and the control samples. To determine a detailed characterisation of the proteome changes in the SPMS patients' blood platelets, in the next stage, we performed mass spectrometry of selected spots and indicated the increased presence of four proteins (fibrinogen, alpha-2 macroglobulin, septin-14 and tubulin beta-1 chain). The most important of these is the increased amount of prothrombotic protein, fibrinogen, which seems to confirm the accuracy of the imaging and potentially explains the increased risk of platelet-origin thrombotic events. This study provides new knowledge of the potential existence of the molecular mechanisms responsible for the acceleration of the platelet pro-coagulant function in SPMS. This can help to identify new targets for therapy, which can then be used not only in the second stage of the disease.\", 'CI': ['(c) 2019 The Authors. Journal of Cellular and Molecular Medicine published by', 'John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine.'], 'FAU': ['Bijak, Michal', 'Olejnik, Alicja', 'Rokita, Bozena', 'Morel, Agnieszka', 'Dziedzic, Angela', 'Miller, Elzbieta', 'Saluk-Bijak, Joanna'], 'AU': ['Bijak M', 'Olejnik A', 'Rokita B', 'Morel A', 'Dziedzic A', 'Miller E', 'Saluk-Bijak J'], 'AUID': ['ORCID: 0000-0002-7838-4097'], 'AD': ['Faculty of Biology and Environmental Protection, Department of General Biochemistry, University of Lodz, Lodz, Poland.', 'Chemistry Department, Institute of Applied Radiation Chemistry, Lodz University of Technology, Lodz, Poland.', 'Chemistry Department, Institute of Applied Radiation Chemistry, Lodz University of Technology, Lodz, Poland.', 'Faculty of Biology and Environmental Protection, Department of General Biochemistry, University of Lodz, Lodz, Poland.', 'Faculty of Biology and Environmental Protection, Department of General Biochemistry, University of Lodz, Lodz, Poland.', 'Department of Physical Medicine, Medical University of Lodz, Lodz, Poland.', 'Neurorehabilitation Ward, III General Hospital in Lodz, Lodz, Poland.', 'Faculty of Biology and Environmental Protection, Department of General Biochemistry, University of Lodz, Lodz, Poland.'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20190305', 'PL': 'England', 'TA': 'J Cell Mol Med', 'JT': 'Journal of cellular and molecular medicine', 'JID': '101083777', 'RN': ['0 (Proteome)', '9001-32-5 (Fibrinogen)'], 'SB': 'IM', 'MH': ['Amino Acid Sequence', 'Blood Platelets/*metabolism', 'Female', 'Fibrinogen/chemistry/*metabolism', 'Humans', 'Male', 'Middle Aged', 'Multiple Sclerosis/*blood', 'Proteome/*metabolism'], 'PMC': 'PMC6484326', 'OTO': ['NOTNLM'], 'OT': ['*blood platelets', '*fibrinogen', '*multiple sclerosis', '*proteome', '*thrombosis'], 'EDAT': '2019/03/07 06:00', 'MHDA': '2020/07/17 06:00', 'CRDT': ['2019/03/07 06:00'], 'PHST': ['2017/12/29 00:00 [received]', '2018/11/08 00:00 [revised]', '2019/01/11 00:00 [accepted]', '2019/03/07 06:00 [pubmed]', '2020/07/17 06:00 [medline]', '2019/03/07 06:00 [entrez]'], 'AID': ['10.1111/jcmm.14244 [doi]'], 'PST': 'ppublish', 'SO': 'J Cell Mol Med. 2019 May;23(5):3476-3482. doi: 10.1111/jcmm.14244. Epub 2019 Mar 5.'}\n",
      "{'PMID': '30836973', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20200203', 'LR': '20200309', 'IS': '1752-0509 (Electronic) 1752-0509 (Linking)', 'VI': '13', 'IP': 'Suppl 1', 'DP': '2019 Mar 5', 'TI': 'Urine proteome changes associated with autonomic regulation of heart rate in cosmonauts.', 'PG': '17', 'LID': '10.1186/s12918-019-0688-9 [doi]', 'AB': 'BACKGROUND: The strategy of adaptation of the human body in microgravity is largely associated with the plasticity of cardiovascular system regulatory mechanisms. During long-term space flights the changes in the stroke volume of the heart are observed, the heart rate decreases, the phase structure of cardiac cycle is readjusted The purpose of this work was to clarify urine proteome changes associated with the initial condition of the heart rate autonomic regulation mechanisms in cosmonauts who have participated in long space missions. Urine proteome of each cosmonaut was analyzed before and after space flight, depending on the initial parameters characterizing the regulatory mechanisms of the cardiovascular system. RESULTS: The proteins cadherin-13, mucin-1, alpha-1 of collagen subunit type VI (COL6A1), hemisentin-1, semenogelin-2, SH3 domain-binding protein, transthyretin and serine proteases inhibitors realize a homeostatic role in individuals with different initial type of the cardiovascular system regulation. The role of significantly changed urine proteins in the cardiovascular homeostasis maintenance is associated with complex processes of atherogenesis, neoangiogenesis, activation of calcium channels, changes in cell adhesion and transmembrane properties, changes in extracellular matrix, participation in protection from oxidative stress and leveling the effects of hypoxia. Therefore, the concentrations of these proteins significantly differ between groups with dominant parasympathetic and sympathetic influences. CONCLUSION: The space flight induced urine proteome changes are significantly different in the groups identified by heart rate autonomic regulation peculiarities before space flight. All these proteins regulate the associated biological processes which affect the stiffness of the vascular wall, blood pressure level, the severity of atherosclerotic changes, the rate and degree of age-related involution of elastin and fibulin, age-related increase in collagen stiffness, genetically determined features of elastin fibers. The increased vascular rigidity (including the aorta) and of myocardium may be regarded as a universal response to various extreme factors. Significant differences in the semi-quantitative analysis of signal proteins between groups with different types of autonomic regulation are explained by a common goal: to ensure optimal adaptation regardless of age and of the genetically determined type of responses to the extreme environmental factors effects.', 'FAU': ['Pastushkova, Lyudmila H', 'Rusanov, Vasily B', 'Goncharova, Anna G', 'Brzhozovskiy, Alexander G', 'Kononikhin, Alexey S', 'Chernikova, Anna G', 'Kashirina, Daria N', 'Nosovsky, Andrey M', 'Baevsky, Roman M', 'Nikolaev, Evgeny N', 'Larina, Irina M'], 'AU': ['Pastushkova LH', 'Rusanov VB', 'Goncharova AG', 'Brzhozovskiy AG', 'Kononikhin AS', 'Chernikova AG', 'Kashirina DN', 'Nosovsky AM', 'Baevsky RM', 'Nikolaev EN', 'Larina IM'], 'AD': ['Institute for Biomedical Problems - Russian Federation State Scientific Research Center Russian Academy of Sciences, Moscow, Russia.', 'Institute for Biomedical Problems - Russian Federation State Scientific Research Center Russian Academy of Sciences, Moscow, Russia.', 'Institute for Biomedical Problems - Russian Federation State Scientific Research Center Russian Academy of Sciences, Moscow, Russia.', 'Institute for Biomedical Problems - Russian Federation State Scientific Research Center Russian Academy of Sciences, Moscow, Russia.', 'Institute for Biomedical Problems - Russian Federation State Scientific Research Center Russian Academy of Sciences, Moscow, Russia.', 'V.L. Talrose Institute for Energy Problems of Chemical Physics, Russian Academy of Sciences, Moscow, Russia.', 'Moscow Institute of Physics and Technology, Dolgoprudny, Moscow region, Russia.', 'Institute for Biomedical Problems - Russian Federation State Scientific Research Center Russian Academy of Sciences, Moscow, Russia.', 'Institute for Biomedical Problems - Russian Federation State Scientific Research Center Russian Academy of Sciences, Moscow, Russia.', 'Institute for Biomedical Problems - Russian Federation State Scientific Research Center Russian Academy of Sciences, Moscow, Russia.', 'Institute for Biomedical Problems - Russian Federation State Scientific Research Center Russian Academy of Sciences, Moscow, Russia.', 'V.L. Talrose Institute for Energy Problems of Chemical Physics, Russian Academy of Sciences, Moscow, Russia. ennikolaev@gmail.com.', 'Moscow Institute of Physics and Technology, Dolgoprudny, Moscow region, Russia. ennikolaev@gmail.com.', 'Skolkovo Institute of Science and Technology, Skolkovo, Moscow region, Russia. ennikolaev@gmail.com.', 'Institute for Biomedical Problems - Russian Federation State Scientific Research Center Russian Academy of Sciences, Moscow, Russia.'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20190305', 'PL': 'England', 'TA': 'BMC Syst Biol', 'JT': 'BMC systems biology', 'JID': '101301827', 'RN': ['0 (Proteome)'], 'SB': 'IM', 'MH': ['Adaptation, Physiological/physiology', '*Astronauts', 'Autonomic Nervous System/*physiology', '*Heart Rate', 'Humans', 'Male', 'Middle Aged', '*Proteome', '*Urinalysis'], 'PMC': 'PMC6399814', 'EDAT': '2019/03/07 06:00', 'MHDA': '2020/02/06 06:00', 'CRDT': ['2019/03/07 06:00'], 'PHST': ['2019/03/07 06:00 [entrez]', '2019/03/07 06:00 [pubmed]', '2020/02/06 06:00 [medline]'], 'AID': ['10.1186/s12918-019-0688-9 [doi]', '10.1186/s12918-019-0688-9 [pii]'], 'PST': 'epublish', 'SO': 'BMC Syst Biol. 2019 Mar 5;13(Suppl 1):17. doi: 10.1186/s12918-019-0688-9.'}\n",
      "{'PMID': '30806752', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20190424', 'LR': '20190424', 'IS': '1618-2650 (Electronic) 1618-2642 (Linking)', 'VI': '411', 'IP': '11', 'DP': '2019 Apr', 'TI': 'Differential urinary proteins to diagnose coronary heart disease based on iTRAQ quantitative proteomics.', 'PG': '2273-2282', 'LID': '10.1007/s00216-019-01668-7 [doi]', 'AB': 'Coronary artery disease (CAD) is a manifestation of systemic atherosclerotic disease. It is assessed by intervention or traditional scoring risk factors. Diagnosis is limited by inaccurate and invasive methods. Developing noninvasive methods to screen for the risk of CAD is a major challenge. We aimed to identify urinary proteins associated with CAD. We utilized iTRAQ labeling followed by 2D LC-MS/MS to compare the urinary proteome of CAD patients to healthy cohorts. The multiple reaction monitoring (MRM) was used to verify the differential proteins. ROC analysis based on MRM data was used to evaluate the diagnostic application. A total of 876 proteins were quantified, and 100 differential proteins were found. Functional analysis revealed that the differential proteins were mainly associated with Liver X Receptor/Retinoid X Receptor (LXR/RXR) pathway activation, atherosclerosis signaling, production of nitric oxide and reactive oxygen species, and the top upstream regulator of the differential proteins by IPA analysis indicated to the APOE. Nineteen differential proteins were verified by MRM analysis. ROC based on MRM data revealed that the combination of two proteins (APOD and TFF1) could diagnose CAD with 85% sensitivity and 99% specificity (AUC 0.95). The urinary proteome might reflect the pathophysiological changes in CAD and be used for the clinical study of CAD.', 'FAU': ['Sun, Haidan', 'Wang, Danqi', 'Liu, Dongfang', 'Guo, Zhengguang', 'Shao, Chen', 'Sun, Wei', 'Zeng, Yong'], 'AU': ['Sun H', 'Wang D', 'Liu D', 'Guo Z', 'Shao C', 'Sun W', 'Zeng Y'], 'AD': ['Core facility of instrument, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, School of Basic Medicine, Peking Union Medical College, Beijing, 100005, China.', 'Core facility of instrument, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, School of Basic Medicine, Peking Union Medical College, Beijing, 100005, China.', 'Department of Cardiology, Peking Union Medical College Hospital, Beijing, 100730, China.', 'Core facility of instrument, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, School of Basic Medicine, Peking Union Medical College, Beijing, 100005, China.', 'State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing, 102206, China.', 'Core facility of instrument, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, School of Basic Medicine, Peking Union Medical College, Beijing, 100005, China. sunwei1018@hotmail.com.', 'Department of Cardiology, Peking Union Medical College Hospital, Beijing, 100730, China. zengyong1999@medmail.com.cn.'], 'LA': ['eng'], 'PT': ['Journal Article'], 'DEP': '20190226', 'PL': 'Germany', 'TA': 'Anal Bioanal Chem', 'JT': 'Analytical and bioanalytical chemistry', 'JID': '101134327', 'RN': ['0 (Biomarkers)'], 'SB': 'IM', 'MH': ['Adult', 'Atherosclerosis/diagnosis/urine', 'Biomarkers/urine', 'Coronary Artery Disease/*diagnosis/*urine', 'Female', 'Humans', 'Male', 'Middle Aged', 'Proteinuria/*urine', 'Proteomics/*methods', 'Tandem Mass Spectrometry/*methods', 'Urinalysis/*methods'], 'OTO': ['NOTNLM'], 'OT': ['Atherosclerosis', 'MRM', 'Proteomics', 'Urine', 'iTRAQ'], 'EDAT': '2019/02/27 06:00', 'MHDA': '2019/04/25 06:00', 'CRDT': ['2019/02/27 06:00'], 'PHST': ['2018/11/19 00:00 [received]', '2019/02/04 00:00 [accepted]', '2019/01/28 00:00 [revised]', '2019/02/27 06:00 [pubmed]', '2019/04/25 06:00 [medline]', '2019/02/27 06:00 [entrez]'], 'AID': ['10.1007/s00216-019-01668-7 [doi]', '10.1007/s00216-019-01668-7 [pii]'], 'PST': 'ppublish', 'SO': 'Anal Bioanal Chem. 2019 Apr;411(11):2273-2282. doi: 10.1007/s00216-019-01668-7. Epub 2019 Feb 26.'}\n",
      "{'PMID': '30805593', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20200713', 'LR': '20201218', 'IS': '1873-734X (Electronic) 1010-7940 (Linking)', 'VI': '56', 'IP': '3', 'DP': '2019 Sep 1', 'TI': 'Locally different proteome in aortas from patients with stenotic tricuspid and bicuspid aortic valvesdagger.', 'PG': '458-469', 'LID': '10.1093/ejcts/ezz032 [doi]', 'AB': \"OBJECTIVES: We aimed to compare the intracellular proteome of ascending aortas from patients with stenotic bicuspid (BAV) and tricuspid aortic valves (TAV) to identify BAV-specific pathogenetic mechanisms of aortopathy and to verify the previously reported asymmetric expression of BAV aortopathy [concentrated at the convexity (CVX)] in its 'ascending phenotype' form. METHODS: Samples were collected from the CVX and concavity sides of non-aneurysmal ascending aortas in 26 TAV and 26 BAV patients undergoing stenotic aortic valve replacement. Aortic lysates were subjected to cellular protein enrichment by subfractionation, and to proteome comparison by 2-dimensional fluorescence difference in-gel electrophoresis. Differentially regulated protein spots were identified by liquid chromatography-tandem mass spectrometry and analysed in silico. Selected results were verified by immunofluorescence and reverse transcription-polymerase chain reaction. RESULTS: In BAV samples, 52 protein spots were differentially regulated versus TAV samples at the CVX and 10 spots at the concavity: liquid chromatography-tandem mass spectrometry identified 35 and 10 differentially regulated proteins, respectively. Charge trains of individual proteins (e.g. annexins) suggested the presence of post-translational modifications possibly modulating their activity. At the CVX, 37 of the 52 different protein spots showed decreased expression in BAV versus TAV. The affected biological pathways included those involved in smooth muscle cell contractile phenotype, metabolism and cell stress. CONCLUSIONS: The observed differential proteomics profiles may have a significant impact on the pathogenesis of the aortopathy, pointing the way for further studies. At a preaneurysmal stage, an aorta with BAV shows more protein expression changes and potentially more post-translational modifications at the CVX of the ascending aorta than at the concavity, compared to that of TAV.\", 'CI': ['(c) The Author(s) 2019. Published by Oxford University Press on behalf of the', 'European Association for Cardio-Thoracic Surgery. All rights reserved.'], 'FAU': ['Forte, Amalia', 'Yin, Xiaoke', 'Fava, Marika', 'Bancone, Ciro', 'Cipollaro, Marilena', 'De Feo, Marisa', 'Mayr, Manuel', 'Jahangiri, Marjan', 'Della Corte, Alessandro'], 'AU': ['Forte A', 'Yin X', 'Fava M', 'Bancone C', 'Cipollaro M', 'De Feo M', 'Mayr M', 'Jahangiri M', 'Della Corte A'], 'AD': ['Department of Translational Medical Sciences, Universita della Campania \"L. Vanvitelli\", Naples, Italy.', \"Cardiovascular Division, King's British Heart Foundation Centre, King's College London, London, UK.\", \"Cardiovascular Division, King's British Heart Foundation Centre, King's College London, London, UK.\", 'Division of Cardiology, Department of Medicine, Cardiovascular Research Center, Mount Sinai Hospital, New York, NY, USA.', 'Department of Translational Medical Sciences, Universita della Campania \"L. Vanvitelli\", Naples, Italy.', 'Department of Experimental Medicine, Universita della Campania \"L. Vanvitelli\", Naples, Italy.', 'Department of Translational Medical Sciences, Universita della Campania \"L. Vanvitelli\", Naples, Italy.', \"Cardiovascular Division, King's British Heart Foundation Centre, King's College London, London, UK.\", 'Division of Cardiology, Department of Medicine, Cardiovascular Research Center, Mount Sinai Hospital, New York, NY, USA.', \"Department of Cardiothoracic Surgery, St George's University of London, NHS Trust, London, UK.\", 'Department of Translational Medical Sciences, Universita della Campania \"L. Vanvitelli\", Naples, Italy.'], 'LA': ['eng'], 'GR': ['PG/17/48/32956/BHF_/British Heart Foundation/United Kingdom', 'RG/16/14/32397/BHF_/British Heart Foundation/United Kingdom'], 'PT': ['Comparative Study', 'Journal Article'], 'PL': 'Germany', 'TA': 'Eur J Cardiothorac Surg', 'JT': 'European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery', 'JID': '8804069', 'RN': ['0 (Proteome)', '63231-63-0 (RNA)'], 'SB': 'IM', 'MH': ['Aged', 'Aorta/*metabolism', 'Aortic Valve/*abnormalities/metabolism', 'Aortic Valve Stenosis/*metabolism', 'Bicuspid Aortic Valve Disease', 'Electrophoresis, Gel, Two-Dimensional', 'Female', 'Heart Valve Diseases/*metabolism', 'Humans', 'Male', 'Microscopy, Fluorescence', 'Phenotype', 'Proteome/*metabolism', 'RNA/metabolism', 'Reverse Transcriptase Polymerase Chain Reaction', 'Specimen Handling', 'Tricuspid Valve/*metabolism'], 'OTO': ['NOTNLM'], 'OT': ['2-dimensional fluorescence difference in-gel electrophoresis', 'Aortopathy', 'Bicuspid aortic valve', 'Liquid chromatography-tandem mass spectrometry', 'Proteome subfractionation'], 'EDAT': '2019/02/26 06:00', 'MHDA': '2020/07/14 06:00', 'CRDT': ['2019/02/27 06:00'], 'PHST': ['2018/09/19 00:00 [received]', '2019/01/11 00:00 [revised]', '2019/01/19 00:00 [accepted]', '2019/02/26 06:00 [pubmed]', '2020/07/14 06:00 [medline]', '2019/02/27 06:00 [entrez]'], 'AID': ['5364629 [pii]', '10.1093/ejcts/ezz032 [doi]'], 'PST': 'ppublish', 'SO': 'Eur J Cardiothorac Surg. 2019 Sep 1;56(3):458-469. doi: 10.1093/ejcts/ezz032.'}\n",
      "{'PMID': '30782942', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20200325', 'LR': '20200325', 'IS': '2044-6055 (Electronic) 2044-6055 (Linking)', 'VI': '9', 'IP': '2', 'DP': '2019 Feb 19', 'TI': 'Maternity Log study: a longitudinal lifelog monitoring and multiomics analysis for the early prediction of complicated pregnancy.', 'PG': 'e025939', 'LID': '10.1136/bmjopen-2018-025939 [doi]', 'AB': 'PURPOSE: A prospective cohort study for pregnant women, the Maternity Log study, was designed to construct a time-course high-resolution reference catalogue of bioinformatic data in pregnancy and explore the associations between genomic and environmental factors and the onset of pregnancy complications, such as hypertensive disorders of pregnancy, gestational diabetes mellitus and preterm labour, using continuous lifestyle monitoring combined with multiomics data on the genome, transcriptome, proteome, metabolome and microbiome. PARTICIPANTS: Pregnant women were recruited at the timing of first routine antenatal visits at Tohoku University Hospital, Sendai, Japan, between September 2015 and November 2016. Of the eligible women who were invited, 65.4% agreed to participate, and a total of 302 women were enrolled. The inclusion criteria were age >/=20 years and the ability to access the internet using a smartphone in the Japanese language. FINDINGS TO DATE: Study participants uploaded daily general health information including quality of sleep, condition of bowel movements and the presence of nausea, pain and uterine contractions. Participants also collected physiological data, such as body weight, blood pressure, heart rate and body temperature, using multiple home healthcare devices. The mean upload rate for each lifelog item was ranging from 67.4% (fetal movement) to 85.3% (physical activity), and the total number of data points was over 6 million. Biospecimens, including maternal plasma, serum, urine, saliva, dental plaque and cord blood, were collected for multiomics analysis. FUTURE PLANS: Lifelog and multiomics data will be used to construct a time-course high-resolution reference catalogue of pregnancy. The reference catalogue will allow us to discover relationships among multidimensional phenotypes and novel risk markers in pregnancy for the future personalised early prediction of pregnancy complications.', 'CI': ['(c) Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No', 'commercial re-use. See rights and permissions. Published by BMJ.'], 'FAU': ['Sugawara, Junichi', 'Ochi, Daisuke', 'Yamashita, Riu', 'Yamauchi, Takafumi', 'Saigusa, Daisuke', 'Wagata, Maiko', 'Obara, Taku', 'Ishikuro, Mami', 'Tsunemoto, Yoshiki', 'Harada, Yuki', 'Shibata, Tomoko', 'Mimori, Takahiro', 'Kawashima, Junko', 'Katsuoka, Fumiki', 'Igarashi-Takai, Takako', 'Ogishima, Soichi', 'Metoki, Hirohito', 'Hashizume, Hiroaki', 'Fuse, Nobuo', 'Minegishi, Naoko', 'Koshiba, Seizo', 'Tanabe, Osamu', 'Kuriyama, Shinichi', 'Kinoshita, Kengo', 'Kure, Shigeo', 'Yaegashi, Nobuo', 'Yamamoto, Masayuki', 'Hiyama, Satoshi', 'Nagasaki, Masao'], 'AU': ['Sugawara J', 'Ochi D', 'Yamashita R', 'Yamauchi T', 'Saigusa D', 'Wagata M', 'Obara T', 'Ishikuro M', 'Tsunemoto Y', 'Harada Y', 'Shibata T', 'Mimori T', 'Kawashima J', 'Katsuoka F', 'Igarashi-Takai T', 'Ogishima S', 'Metoki H', 'Hashizume H', 'Fuse N', 'Minegishi N', 'Koshiba S', 'Tanabe O', 'Kuriyama S', 'Kinoshita K', 'Kure S', 'Yaegashi N', 'Yamamoto M', 'Hiyama S', 'Nagasaki M'], 'AUID': ['ORCID: 0000-0001-8026-2550'], 'AD': ['Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.', 'Tohoku University Graduate School of Medicine, Sendai, Japan.', 'Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.', 'Research Laboratories, NTT DoCoMo, Inc, Yokosuka, Japan.', 'Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.', 'Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.', 'Research Laboratories, NTT DoCoMo, Inc, Yokosuka, Japan.', 'Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.', 'Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.', 'Tohoku University Graduate School of Medicine, Sendai, Japan.', 'Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.', 'Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.', 'Research Laboratories, NTT DoCoMo, Inc, Yokosuka, Japan.', 'Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.', 'Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.', 'Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.', 'Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.', 'Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.', 'Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.', 'Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.', 'Tohoku Medical and Pharmaceutical University, Sendai, Japan.', 'Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.', 'Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.', 'Tohoku University Graduate School of Medicine, Sendai, Japan.', 'Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.', 'Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.', 'Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.', 'Radiation Effects Research Foundation, Hiroshima, Japan.', 'Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.', 'Tohoku University Graduate School of Medicine, Sendai, Japan.', 'Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.', 'Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.', 'Tohoku University Graduate School of Medicine, Sendai, Japan.', 'Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.', 'Tohoku University Hospital, Sendai, Japan.', 'Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.', 'Tohoku University Graduate School of Medicine, Sendai, Japan.', 'Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.', 'Research Laboratories, NTT DoCoMo, Inc, Yokosuka, Japan.', 'Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.', 'Tohoku University Graduate School of Medicine, Sendai, Japan.'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20190219', 'PL': 'England', 'TA': 'BMJ Open', 'JT': 'BMJ open', 'JID': '101552874', 'RN': ['0 (Proteome)'], 'SB': 'IM', 'MH': ['Adult', 'Computational Biology', 'Female', 'Humans', 'Japan', '*Life Style', '*Metabolome', '*Microbiota', 'Middle Aged', 'Pregnancy', 'Pregnancy Complications/*diagnosis', 'Prospective Studies', '*Proteome', '*Transcriptome', 'Young Adult'], 'PMC': 'PMC6398744', 'OTO': ['NOTNLM'], 'OT': ['*complicated pregnancy', '*lifelog', '*multi-omics analysis', '*prediction'], 'COIS': ['Competing interests: This study was funded by NTT DoCoMo, Inc. DO, TY and SH are', 'employees of NTT DoCoMo, Inc.'], 'EDAT': '2019/02/21 06:00', 'MHDA': '2020/03/26 06:00', 'CRDT': ['2019/02/21 06:00'], 'PHST': ['2019/02/21 06:00 [entrez]', '2019/02/21 06:00 [pubmed]', '2020/03/26 06:00 [medline]'], 'AID': ['bmjopen-2018-025939 [pii]', '10.1136/bmjopen-2018-025939 [doi]'], 'PST': 'epublish', 'SO': 'BMJ Open. 2019 Feb 19;9(2):e025939. doi: 10.1136/bmjopen-2018-025939.'}\n",
      "{'PMID': '30742448', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20200505', 'LR': '20200505', 'IS': '1535-3907 (Electronic) 1535-3893 (Linking)', 'VI': '18', 'IP': '3', 'DP': '2019 Mar 1', 'TI': 'Cytokine Profiles in Autoantibody Defined Subgroups of Systemic Lupus Erythematosus.', 'PG': '1208-1217', 'LID': '10.1021/acs.jproteome.8b00811 [doi]', 'AB': \"The aim of this study was to evaluate how the cytokine profiles differed between autoantibody based subgroups of systemic lupus erythematosus (SLE). SLE is a systemic autoimmune disease, characterized by periods of flares (active disease) and remission (inactive disease). The disease can affect many organ systems, e.g., skin, joints, kidneys, heart, and the central nervous system (CNS). SLE patients often have an overproduction of cytokines, e.g., interferons, chemokines, and interleukins. The high cytokine levels are part of the systemic inflammation, which can lead to tissue injury. In the present study, SLE patients were divided into five groups based on their autoantibody profiles. We thus defined these five groups: ANA negative, antiphospholipid (aPL) positive, anti-Sm/anti-RNP positive, Sjogren's syndrome (SS) antigen A and B positive, and patients positive for more than one type of autoantibodies (other SLE). Cytokines were measured using Mesoscale Discovery (MSD) multiplex analysis. On the basis of the cytokine data, ANA negative patients were the most deviating subgroup, with lower levels of interferon (IFN)-gamma, tumor necrosis factor (TNF)-alpha, interleukin (IL)-12/IL-23p40, and interferon gamma-induced protein (IP)-10. Despite low cytokine levels in the ANA negative group, autoantibody profiles did not discriminate between different cytokine patterns.\", 'FAU': ['Torell, Frida', 'Eketjall, Susanna', 'Idborg, Helena', 'Jakobsson, Per-Johan', 'Gunnarsson, Iva', 'Svenungsson, Elisabet', 'Trygg, Johan'], 'AU': ['Torell F', 'Eketjall S', 'Idborg H', 'Jakobsson PJ', 'Gunnarsson I', 'Svenungsson E', 'Trygg J'], 'AUID': ['ORCID: 0000-0002-6294-7844', 'ORCID: 0000-0003-2165-1251', 'ORCID: 0000-0003-3396-3244', 'ORCID: 0000-0003-3799-6094'], 'AD': ['Computational Life Science Cluster (CLiC), Department of Chemistry , Umea University , 901 87 Umea , Sweden.', 'Cardiovascular and Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Integrated Cardio Metabolic Centre (ICMC) , Karolinska Institutet , 141 57 Huddinge , Sweden.', 'Science for Life Laboratory, Department of Clinical Neuroscience , Karolinska Institutet , 171 77 Stockholm , Sweden.', 'Rheumatology Unit, Department of Medicine , Karolinska Institutet and Karolinska University Hospital , 171 76 Stockholm , Sweden.', 'Rheumatology Unit, Department of Medicine , Karolinska Institutet and Karolinska University Hospital , 171 76 Stockholm , Sweden.', 'Rheumatology Unit, Department of Medicine , Karolinska Institutet and Karolinska University Hospital , 171 76 Stockholm , Sweden.', 'Rheumatology Unit, Department of Medicine , Karolinska Institutet and Karolinska University Hospital , 171 76 Stockholm , Sweden.', 'Computational Life Science Cluster (CLiC), Department of Chemistry , Umea University , 901 87 Umea , Sweden.', 'Corporate Research , Sartorius AG , 37079 Gottingen , Germany.'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20190218', 'PL': 'United States', 'TA': 'J Proteome Res', 'JT': 'Journal of proteome research', 'JID': '101128775', 'RN': ['0 (Antibodies, Anticardiolipin)', '0 (Autoantibodies)', '0 (Cytokines)', '0 (Interleukins)', '0 (Lupus Coagulation Inhibitor)', '0 (RNA-Binding Proteins)', '9008-11-1 (Interferons)'], 'SB': 'IM', 'MH': ['Adult', 'Antibodies, Anticardiolipin/blood', 'Autoantibodies/*blood', 'Cytokines/*blood', 'Female', 'Humans', 'Interferons/blood', 'Interleukins/blood', 'Lupus Coagulation Inhibitor/blood', 'Lupus Erythematosus, Systemic/*blood/classification/pathology', 'Male', 'Middle Aged', 'RNA-Binding Proteins/blood', \"Sjogren's Syndrome/*blood/classification/pathology\"], 'OTO': ['NOTNLM'], 'OT': ['*HCA', '*OPLS-DA', '*cytokine', '*multivariate data analysis', '*subgrouping', '*systemic lupus erythematosus'], 'EDAT': '2019/02/12 06:00', 'MHDA': '2020/05/06 06:00', 'CRDT': ['2019/02/12 06:00'], 'PHST': ['2019/02/12 06:00 [pubmed]', '2020/05/06 06:00 [medline]', '2019/02/12 06:00 [entrez]'], 'AID': ['10.1021/acs.jproteome.8b00811 [doi]'], 'PST': 'ppublish', 'SO': 'J Proteome Res. 2019 Mar 1;18(3):1208-1217. doi: 10.1021/acs.jproteome.8b00811. Epub 2019 Feb 18.'}\n",
      "{'PMID': '30739867', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20190506', 'LR': '20200309', 'IS': '2352-345X (Electronic) 2352-345X (Linking)', 'VI': '7', 'IP': '2', 'DP': '2019', 'TI': 'Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-beta Signaling and Epigenomics.', 'PG': '411-431', 'LID': 'S2352-345X(18)30157-7 [pii] 10.1016/j.jcmgh.2018.10.011 [doi]', 'AB': 'BACKGROUND & AIMS: A generalized human pacemaking syndrome, chronic atrial and intestinal dysrhythmia (CAID) (OMIM 616201), is caused by a homozygous SGO1 mutation (K23E), leading to chronic intestinal pseudo-obstruction and arrhythmias. Because CAID patients do not show phenotypes consistent with perturbation of known roles of SGO1, we hypothesized that noncanonical roles of SGO1 drive the clinical manifestations observed. METHODS: To identify a molecular signature for CAID syndrome, we achieved unbiased screens in cell lines and gut tissues from CAID patients vs wild-type controls. We performed RNA sequencing along with stable isotope labeling with amino acids in cell culture. In addition, we determined the genome-wide DNA methylation and chromatin accessibility signatures using reduced representative bisulfite sequencing and assay for transposase-accessible chromatin with high-throughput sequencing. Functional studies included patch-clamp, quantitation of transforming growth factor-beta (TGF-beta) signaling, and immunohistochemistry in CAID patient gut biopsy specimens. RESULTS: Proteome and transcriptome studies converge on cell-cycle regulation, cardiac conduction, and smooth muscle regulation as drivers of CAID syndrome. Specifically, the inward rectifier current, an important regulator of cellular function, was disrupted. Immunohistochemistry confirmed overexpression of Budding Uninhibited By Benzimidazoles 1 (BUB1) in patients, implicating the TGF-beta pathway in CAID pathogenesis. Canonical TGF-beta signaling was up-regulated and uncoupled from noncanonical signaling in CAID patients. Reduced representative bisulfite sequencing and assay for transposase-accessible chromatin with high-throughput sequencing experiments showed significant changes of chromatin states in CAID, pointing to epigenetic regulation as a possible pathologic mechanism. CONCLUSIONS: Our findings point to impaired inward rectifier potassium current, dysregulation of canonical TGF-beta signaling, and epigenetic regulation as potential drivers of intestinal and cardiac manifestations of CAID syndrome. Transcript profiling and genomics data are as follows: repository URL: https://www.ncbi.nlm.nih.gov/geo; SuperSeries GSE110612 was composed of the following subseries: GSE110309, GSE110576, and GSE110601.', 'CI': ['Copyright (c) 2019 The Authors. Published by Elsevier Inc. All rights reserved.'], 'FAU': ['Piche, Jessica', 'Gosset, Natacha', 'Legault, Lisa-Marie', 'Pacis, Alain', 'Oneglia, Andrea', 'Caron, Maxime', 'Chetaille, Philippe', 'Barreiro, Luis', 'Liu, Donghai', 'Qi, Xioyan', 'Nattel, Stanley', 'Leclerc, Severine', 'Breton-Larrivee, Melanie', 'McGraw, Serge', 'Andelfinger, Gregor'], 'AU': ['Piche J', 'Gosset N', 'Legault LM', 'Pacis A', 'Oneglia A', 'Caron M', 'Chetaille P', 'Barreiro L', 'Liu D', 'Qi X', 'Nattel S', 'Leclerc S', 'Breton-Larrivee M', 'McGraw S', 'Andelfinger G'], 'AD': ['Cardiovascular Genetics, Department of Pediatrics, Centre Hospitalier Universitaire Sainte Justine Research Center, Universite de Montreal, Montreal, Quebec, Canada.', 'Cardiovascular Genetics, Department of Pediatrics, Centre Hospitalier Universitaire Sainte Justine Research Center, Universite de Montreal, Montreal, Quebec, Canada.', 'Department of Biochemistry and Molecular Medicine, Centre Hospitalier Universitaire Sainte Justine Research Center, Universite de Montreal, Montreal, Quebec, Canada.', 'Department of Genetics, Centre Hospitalier Universitaire Sainte Justine Research Center, Universite de Montreal, Montreal, Quebec, Canada; Department of Biochemistry, Universite de Montreal, Montreal, Quebec, Canada.', 'Cardiovascular Genetics, Department of Pediatrics, Centre Hospitalier Universitaire Sainte Justine Research Center, Universite de Montreal, Montreal, Quebec, Canada.', 'Centre Hospitalier Universitaire Sainte Justine Research Center, Universite de Montreal, Montreal, Quebec, Canada.', \"Service of Pediatric Cardiology, Department of Pediatrics, Centre Mere Enfants Soleil, Centre Hospitalier de l'Universite de Quebec, Quebec City, Quebec, Canada.\", 'Department of Genetics, Centre Hospitalier Universitaire Sainte Justine Research Center, Universite de Montreal, Montreal, Quebec, Canada; Department of Biochemistry, Universite de Montreal, Montreal, Quebec, Canada; Department of Pediatrics, Universite de Montreal, Quebec, Canada.', 'Research Center, Montreal Heart Institute, Universite de Montreal, Montreal, Quebec, Canada.', 'Research Center, Montreal Heart Institute, Universite de Montreal, Montreal, Quebec, Canada.', 'Research Center, Montreal Heart Institute, Universite de Montreal, Montreal, Quebec, Canada.', 'Cardiovascular Genetics, Department of Pediatrics, Centre Hospitalier Universitaire Sainte Justine Research Center, Universite de Montreal, Montreal, Quebec, Canada.', 'Department of Biochemistry and Molecular Medicine, Centre Hospitalier Universitaire Sainte Justine Research Center, Universite de Montreal, Montreal, Quebec, Canada.', 'Department of Biochemistry and Molecular Medicine, Centre Hospitalier Universitaire Sainte Justine Research Center, Universite de Montreal, Montreal, Quebec, Canada; Departement of Obstetrics and Gynecology, Centre Hospitalier Universitaire Sainte Justine Research Center, Universite de Montreal, Montreal, Quebec, Canada.', 'Cardiovascular Genetics, Department of Pediatrics, Centre Hospitalier Universitaire Sainte Justine Research Center, Universite de Montreal, Montreal, Quebec, Canada. Electronic address: gregor.andelfinger@recherche-ste-justine.qc.ca.'], 'CN': ['CoHEART Consortium'], 'LA': ['eng'], 'GR': ['366129/CIHR/Canada'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20181024', 'PL': 'United States', 'TA': 'Cell Mol Gastroenterol Hepatol', 'JT': 'Cellular and molecular gastroenterology and hepatology', 'JID': '101648302', 'RN': ['0 (Cell Cycle Proteins)', '0 (Potassium Channels)', '0 (Proteome)', '0 (SGO1 protein, human)', '0 (Transforming Growth Factor beta)'], 'SB': 'IM', 'MH': ['Abnormalities, Multiple/*genetics/pathology/physiopathology', 'Adult', 'Cell Cycle Proteins/*metabolism', 'DNA Methylation/genetics', 'Dermis/pathology', '*Epigenomics', 'Fibroblasts/metabolism', 'Gene Expression Profiling', 'Gene Ontology', 'Humans', 'Potassium Channels/metabolism', 'Proteome/metabolism', 'Reproducibility of Results', '*Signal Transduction', 'Syndrome', 'Transforming Growth Factor beta/*metabolism'], 'PMC': 'PMC6369230', 'OTO': ['NOTNLM'], 'OT': ['*CAID Syndrome (Chronic Atrial and Intestinal Dysrhythmia)', '*Chronic Intestinal Pseudo-obstruction', '*Epigenetics', '*TGF-beta Signaling'], 'IR': ['Andelfinger G', 'Bakkers J', 'Loeys B', 'Puceat M'], 'FIR': ['Andelfinger, Gregor', 'Bakkers, Jeroen', 'Loeys, Bart', 'Puceat, Michel'], 'EDAT': '2019/02/12 06:00', 'MHDA': '2019/05/07 06:00', 'CRDT': ['2019/02/12 06:00'], 'PHST': ['2018/05/23 00:00 [received]', '2018/10/17 00:00 [revised]', '2018/10/17 00:00 [accepted]', '2019/02/12 06:00 [pubmed]', '2019/05/07 06:00 [medline]', '2019/02/12 06:00 [entrez]'], 'AID': ['S2352-345X(18)30157-7 [pii]', '10.1016/j.jcmgh.2018.10.011 [doi]'], 'PST': 'ppublish', 'SO': 'Cell Mol Gastroenterol Hepatol. 2019;7(2):411-431. doi: 10.1016/j.jcmgh.2018.10.011. Epub 2018 Oct 24.'}\n",
      "{'PMID': '30658193', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20200413', 'LR': '20200413', 'IS': '1879-1484 (Electronic) 0021-9150 (Linking)', 'VI': '281', 'DP': '2019 Feb', 'TI': 'GPVI surface expression and signalling pathway activation are increased in platelets from obese patients: Elucidating potential anti-atherothrombotic targets in obesity.', 'PG': '62-70', 'LID': 'S0021-9150(18)31554-5 [pii] 10.1016/j.atherosclerosis.2018.12.023 [doi]', 'AB': 'BACKGROUND AND AIMS: Platelets play a fundamental role in the increased atherothrombotic risk related to central obesity since they show hyperactivation and lower sensitivity to antiplatelet therapy in obese patients. The main goal of this study was to identify platelet biomarkers related to the risk of atherothrombosis in obese patients, confirm platelet activation levels in these patients, and identify altered activation pathways. METHODS: Platelets were obtained from cohorts of obese patients and age- and sex-matched lean controls. Biochemical and proteome analyses were done by two-dimensional differential in-gel electrophoresis (2D-DIGE), mass spectrometry, and immunoblotting. Functional and mechanistic studies were conducted with aggregation assays and flow cytometry. RESULTS: We confirmed an up-regulation of alphaIIb and fibrinogen isoforms in platelets from obese patients. A complementary platelet aggregation approach showed platelets from obese patients are hyper-reactive in response to collagen and collagen-related peptide (CRP), revealing the collagen receptor Glycoprotein VI (GPVI) signalling as one of the altered pathways. We also found the active form of Src (pTyr418) is up-regulated in platelets from obese individuals, which links proteomics to aggregation data. Moreover, we showed that CRP-activated platelets present higher levels of tyrosine phosphorylated PLCgamma2 in obese patients, confirming alterations in GPVI signalling. In line with the above, flow cytometry studies show higher surface expression levels of total GPVI and GPVI-dimer in obese platelets, both correlating with BMI. CONCLUSIONS: Our results suggest a higher activation state of SFKs-mediated signalling pathways in platelets from obese patients, with a primary involvement of GPVI signalling.', 'CI': ['Copyright (c) 2019 The Authors. Published by Elsevier B.V. All rights reserved.'], 'FAU': ['Barrachina, Maria N', 'Sueiro, Aurelio M', 'Izquierdo, Irene', 'Hermida-Nogueira, Lidia', 'Guitian, Esteban', 'Casanueva, Felipe F', 'Farndale, Richard W', 'Moroi, Masaaki', 'Jung, Stephanie M', 'Pardo, Maria', 'Garcia, Angel'], 'AU': ['Barrachina MN', 'Sueiro AM', 'Izquierdo I', 'Hermida-Nogueira L', 'Guitian E', 'Casanueva FF', 'Farndale RW', 'Moroi M', 'Jung SM', 'Pardo M', 'Garcia A'], 'AD': ['Platelet Proteomics Group, Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), Universidade Santiago de Compostela, Santiago de Compostela, Spain; Instituto de Investigacion Sanitaria de Santiago (IDIS), Santiago de Compostela, Spain.', 'Grupo de Endocrinologia Molecular y Celular - Instituto de Investigacion Sanitaria de Santiago (IDIS)/ Servicio de Endocrinologia, Xerencia de Xestion Integrada de Santiago (XXS), Santiago de Compostela, Spain.', 'Platelet Proteomics Group, Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), Universidade Santiago de Compostela, Santiago de Compostela, Spain; Instituto de Investigacion Sanitaria de Santiago (IDIS), Santiago de Compostela, Spain.', 'Platelet Proteomics Group, Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), Universidade Santiago de Compostela, Santiago de Compostela, Spain; Instituto de Investigacion Sanitaria de Santiago (IDIS), Santiago de Compostela, Spain.', 'Mass Spectrometry and Proteomic Unit, Rede de Infraestructuras de Apoio a Investigacion e ao Desenvolvemento Tecnoloxico, Universidade de Santiago de Compostela, Santiago de Compostela, Spain.', 'Instituto de Investigacion Sanitaria de Santiago (IDIS), Santiago de Compostela, Spain; Grupo de Endocrinologia Molecular y Celular - Instituto de Investigacion Sanitaria de Santiago (IDIS)/ Servicio de Endocrinologia, Xerencia de Xestion Integrada de Santiago (XXS), Santiago de Compostela, Spain.', 'Department of Biochemistry, University of Cambridge, Cambridge, CB2 1QW, United Kingdom.', 'Department of Biochemistry, University of Cambridge, Cambridge, CB2 1QW, United Kingdom.', 'Department of Biochemistry, University of Cambridge, Cambridge, CB2 1QW, United Kingdom.', 'Instituto de Investigacion Sanitaria de Santiago (IDIS), Santiago de Compostela, Spain; Grupo Obesidomica - Instituto de Investigacion Sanitaria de Santiago (IDIS), Santiago de Compostela, Spain.', 'Platelet Proteomics Group, Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), Universidade Santiago de Compostela, Santiago de Compostela, Spain; Instituto de Investigacion Sanitaria de Santiago (IDIS), Santiago de Compostela, Spain. Electronic address: angel.garcia@usc.es.'], 'LA': ['eng'], 'GR': ['PG/10/011/28199/BHF_/British Heart Foundation/United Kingdom', 'RG/15/4/31268/BHF_/British Heart Foundation/United Kingdom', 'SP/13/7/30575/BHF_/British Heart Foundation/United Kingdom'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20181225', 'PL': 'Ireland', 'TA': 'Atherosclerosis', 'JT': 'Atherosclerosis', 'JID': '0242543', 'RN': ['0 (Platelet Membrane Glycoproteins)', '0 (platelet membrane glycoprotein VI)', 'EC 3.1.4.3 (Phospholipase C gamma)'], 'SB': 'IM', 'MH': ['Adolescent', 'Adult', 'Blood Platelets/*metabolism', 'Body Mass Index', 'Case-Control Studies', 'Female', 'Humans', 'Male', 'Obesity/*blood/diagnosis', 'Phospholipase C gamma/blood', 'Phosphorylation', '*Platelet Activation', 'Platelet Aggregation', 'Platelet Membrane Glycoproteins/*metabolism', 'Signal Transduction', 'Up-Regulation', 'Young Adult'], 'PMC': 'PMC6403451', 'OTO': ['NOTNLM'], 'OT': ['*Drug targets', '*GPVI signalling', '*Obesity', '*Platelets', '*Proteomics', '*SFK-Mediated signalling pathways'], 'EDAT': '2019/01/19 06:00', 'MHDA': '2020/04/14 06:00', 'CRDT': ['2019/01/19 06:00'], 'PHST': ['2018/06/29 00:00 [received]', '2018/11/23 00:00 [revised]', '2018/12/21 00:00 [accepted]', '2019/01/19 06:00 [pubmed]', '2020/04/14 06:00 [medline]', '2019/01/19 06:00 [entrez]'], 'AID': ['S0021-9150(18)31554-5 [pii]', '10.1016/j.atherosclerosis.2018.12.023 [doi]'], 'PST': 'ppublish', 'SO': 'Atherosclerosis. 2019 Feb;281:62-70. doi: 10.1016/j.atherosclerosis.2018.12.023. Epub 2018 Dec 25.'}\n",
      "{'PMID': '30571344', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20190927', 'LR': '20191008', 'IS': '1524-4539 (Electronic) 0009-7322 (Linking)', 'VI': '138', 'IP': '22', 'DP': '2018 Nov 27', 'TI': 'Probing the Virtual Proteome to Identify Novel Disease Biomarkers.', 'PG': '2469-2481', 'LID': '10.1161/CIRCULATIONAHA.118.036063 [doi]', 'AB': 'BACKGROUND: Proteomic approaches allow measurement of thousands of proteins in a single specimen, which can accelerate biomarker discovery. However, applying these technologies to massive biobanks is not currently feasible because of the practical barriers and costs of implementing such assays at scale. To overcome these challenges, we used a \"virtual proteomic\" approach, linking genetically predicted protein levels to clinical diagnoses in >40 000 individuals. METHODS: We used genome-wide association data from the Framingham Heart Study (n=759) to construct genetic predictors for 1129 plasma protein levels. We validated the genetic predictors for 268 proteins and used them to compute predicted protein levels in 41 288 genotyped individuals in the Electronic Medical Records and Genomics (eMERGE) cohort. We tested associations for each predicted protein with 1128 clinical phenotypes. Lead associations were validated with directly measured protein levels and either low-density lipoprotein cholesterol or subclinical atherosclerosis in the MDCS (Malmo Diet and Cancer Study; n=651). RESULTS: In the virtual proteomic analysis in eMERGE, 55 proteins were associated with 89 distinct diagnoses at a false discovery rate q<0.1. Among these, 13 associations involved lipid (n=7) or atherosclerosis (n=6) phenotypes. We tested each association for validation in MDCS using directly measured protein levels. At Bonferroni-adjusted significance thresholds, levels of apolipoprotein E isoforms were associated with hyperlipidemia, and circulating C-type lectin domain family 1 member B and platelet-derived growth factor receptor-beta predicted subclinical atherosclerosis. Odds ratios for carotid atherosclerosis were 1.31 (95% CI, 1.08-1.58; P=0.006) per 1-SD increment in C-type lectin domain family 1 member B and 0.79 (0.66-0.94; P=0.008) per 1-SD increment in platelet-derived growth factor receptor-beta. CONCLUSIONS: We demonstrate a biomarker discovery paradigm to identify candidate biomarkers of cardiovascular and other diseases.', 'FAU': ['Mosley, Jonathan D', 'Benson, Mark D', 'Smith, J Gustav', 'Melander, Olle', 'Ngo, Debby', 'Shaffer, Christian M', 'Ferguson, Jane F', 'Herzig, Matthew S', 'McCarty, Catherine A', 'Chute, Christopher G', 'Jarvik, Gail P', 'Gordon, Adam S', 'Palmer, Melody R', 'Crosslin, David R', 'Larson, Eric B', 'Carrell, David S', 'Kullo, Iftikhar J', 'Pacheco, Jennifer A', 'Peissig, Peggy L', 'Brilliant, Murray H', 'Kitchner, Terrie E', 'Linneman, James G', 'Namjou, Bahram', 'Williams, Marc S', 'Ritchie, Marylyn D', 'Borthwick, Kenneth M', 'Kiryluk, Krzysztof', 'Mentch, Frank D', 'Sleiman, Patrick M', 'Karlson, Elizabeth W', 'Verma, Shefali S', 'Zhu, Yineng', 'Vasan, Ramachandran S', 'Yang, Qiong', 'Denny, Josh C', 'Roden, Dan M', 'Gerszten, Robert E', 'Wang, Thomas J'], 'AU': ['Mosley JD', 'Benson MD', 'Smith JG', 'Melander O', 'Ngo D', 'Shaffer CM', 'Ferguson JF', 'Herzig MS', 'McCarty CA', 'Chute CG', 'Jarvik GP', 'Gordon AS', 'Palmer MR', 'Crosslin DR', 'Larson EB', 'Carrell DS', 'Kullo IJ', 'Pacheco JA', 'Peissig PL', 'Brilliant MH', 'Kitchner TE', 'Linneman JG', 'Namjou B', 'Williams MS', 'Ritchie MD', 'Borthwick KM', 'Kiryluk K', 'Mentch FD', 'Sleiman PM', 'Karlson EW', 'Verma SS', 'Zhu Y', 'Vasan RS', 'Yang Q', 'Denny JC', 'Roden DM', 'Gerszten RE', 'Wang TJ'], 'AD': ['Department of Medicine (J.D.M., C.M.S., J.F.F., J.C.D., T.J.W.), Vanderbilt University Medical Center, Nashville, TN.', \"Cardiovascular Division, Brigham and Women's Hospital, Boston, MA (M.D.B.).\", 'Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, MA (M.D.B., M.S.H., R.E.G.).', 'Molecular Epidemiology and Cardiology, Clinical Sciences, Lund University and Skane University Hospital, Malmo, Sweden (J.G.S., O.M.).', 'Molecular Epidemiology and Cardiology, Clinical Sciences, Lund University and Skane University Hospital, Malmo, Sweden (J.G.S., O.M.).', 'Department of Medicine and the Cardiovascular Research Center, Massachusetts General Hospital, Harvard Medical School, Boston (D.N.).', 'Department of Medicine (J.D.M., C.M.S., J.F.F., J.C.D., T.J.W.), Vanderbilt University Medical Center, Nashville, TN.', 'Department of Medicine (J.D.M., C.M.S., J.F.F., J.C.D., T.J.W.), Vanderbilt University Medical Center, Nashville, TN.', 'Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, MA (M.D.B., M.S.H., R.E.G.).', 'University of Minnesota Medical School, Duluth Campus (C.A.M.).', 'Schools of Medicine, Public Health, and Nursing, Johns Hopkins University, Baltimore, MD (C.G.C.).', 'Departments of Medicine (J.P.J., A.S.G., M.R.P., E.B.L.), University of Washington, Seattle.', 'Departments of Medicine (J.P.J., A.S.G., M.R.P., E.B.L.), University of Washington, Seattle.', 'Departments of Medicine (J.P.J., A.S.G., M.R.P., E.B.L.), University of Washington, Seattle.', 'Biomedical Informatics and Medical Education (D.R.C.), University of Washington, Seattle.', 'Departments of Medicine (J.P.J., A.S.G., M.R.P., E.B.L.), University of Washington, Seattle.', 'Kaiser Permanente Washington Health Research Institute, Seattle, WA (E.B.L., D.S.C.).', 'Kaiser Permanente Washington Health Research Institute, Seattle, WA (E.B.L., D.S.C.).', 'Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN (I.J.K.).', 'Center for Genetic Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL (J.A.P.).', 'Biomedical Informatics Research Center (P.L.P., J.G.L.), Marshfield Clinic Research Institute, WI.', 'Center for Computational and Biomedical Informatics (M.H.B., T.E.K.), Marshfield Clinic Research Institute, WI.', 'Center for Computational and Biomedical Informatics (M.H.B., T.E.K.), Marshfield Clinic Research Institute, WI.', 'Biomedical Informatics Research Center (P.L.P., J.G.L.), Marshfield Clinic Research Institute, WI.', \"Cincinnati Children's Hospital Medical Center and University of Cincinnati, OH (B.N.).\", 'Genomic Medicine Institute (M.S.W.), Geisinger Health System, Danville, PA.', 'Departments of Bioinformatics and Genetics (M.D.R.), University of Pennsylvania, Philadelphia.', 'Biomedical and Translational Informatics (K.M.B.), Geisinger Health System, Danville, PA.', 'Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY (K.K.).', \"Center for Applied Genomics, Children's Hospital of Philadelphia, PA (F.D.M., P.M.S.).\", \"Center for Applied Genomics, Children's Hospital of Philadelphia, PA (F.D.M., P.M.S.).\", \"Department of Medicine, Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA (E.W.K.).\", 'Perelman School of Medicine, Department of Genetics (S.S.V.), University of Pennsylvania, Philadelphia.', 'Department of Biostatistics, Boston University School of Public Health, MA (Y.Z., Q.Y.).', 'Department of Medicine, Boston University School of Medicine, MA (R.S.V.).', 'Department of Biostatistics, Boston University School of Public Health, MA (Y.Z., Q.Y.).', 'Department of Medicine (J.D.M., C.M.S., J.F.F., J.C.D., T.J.W.), Vanderbilt University Medical Center, Nashville, TN.', 'Biomedical Informatics (J.C.D., D.M.R.), Vanderbilt University Medical Center, Nashville, TN.', 'Biomedical Informatics (J.C.D., D.M.R.), Vanderbilt University Medical Center, Nashville, TN.', 'Department of Pharmacology (D.M.R.), Vanderbilt University Medical Center, Nashville, TN.', 'Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, MA (M.D.B., M.S.H., R.E.G.).', 'Department of Medicine (J.D.M., C.M.S., J.F.F., J.C.D., T.J.W.), Vanderbilt University Medical Center, Nashville, TN.'], 'LA': ['eng'], 'GR': ['16FTF30130005/American Heart Association-American Stroke Association/United', 'States', 'R01 HL132320/HL/NHLBI NIH HHS/United States'], 'PT': ['Journal Article', 'Research Support, N.I.H., Extramural', \"Research Support, Non-U.S. Gov't\"], 'PL': 'United States', 'TA': 'Circulation', 'JT': 'Circulation', 'JID': '0147763', 'RN': ['0 (Biomarkers)', '0 (CLEC1B protein, human)', '0 (Lectins, C-Type)', '0 (Proteome)', 'EC 2.7.10.1 (Receptor, Platelet-Derived Growth Factor beta)'], 'SB': 'AIM IM', 'CIN': ['Circulation. 2018 Nov 27;138(22):2482-2485. PMID: 30524136'], 'MH': ['Adult', 'Aged', 'Aged, 80 and over', 'Biomarkers/*blood', 'Carotid Artery Diseases/*diagnosis/genetics', 'Female', '*Genome-Wide Association Study', 'Genotype', 'Humans', 'Lectins, C-Type/analysis', 'Male', 'Middle Aged', 'Odds Ratio', 'Phenotype', 'Polymorphism, Single Nucleotide', 'Proteome/*analysis', 'Proteomics', 'Receptor, Platelet-Derived Growth Factor beta/blood'], 'OTO': ['NOTNLM'], 'OT': ['*atherosclerosis', '*biomarkers', '*electronic health records', '*proteomics'], 'EDAT': '2018/12/21 06:00', 'MHDA': '2019/09/29 06:00', 'CRDT': ['2018/12/21 06:00'], 'PHST': ['2018/12/21 06:00 [entrez]', '2018/12/21 06:00 [pubmed]', '2019/09/29 06:00 [medline]'], 'AID': ['10.1161/CIRCULATIONAHA.118.036063 [doi]'], 'PST': 'ppublish', 'SO': 'Circulation. 2018 Nov 27;138(22):2469-2481. doi: 10.1161/CIRCULATIONAHA.118.036063.'}\n",
      "{'PMID': '30562113', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20191011', 'LR': '20191011', 'IS': '2574-8300 (Electronic) 2574-8300 (Linking)', 'VI': '11', 'IP': '12', 'DP': '2018 Dec', 'TI': 'Proteomic Analysis of the Myocardium in Hypertrophic Obstructive Cardiomyopathy.', 'PG': 'e001974', 'LID': '10.1161/CIRCGEN.117.001974 [doi]', 'AB': 'BACKGROUND: Hypertrophic cardiomyopathy (HCM) is characterized by a complex phenotype that is only partly explained by the biological effects of individual genetic variants. The aim of this study was to use proteomic analysis of myocardial tissue to explore the postgenomic phenotype. METHODS: Label-free proteomic analysis was used initially to compare protein profiles in myocardial samples from 11 patients with HCM undergoing surgical myectomy with control samples from 6 healthy unused donor hearts. Differentially expressed proteins of interest were validated in myocardial samples from 65 unrelated individuals (HCM [n=51], controls [n=7], and aortic stenosis [n=7]) by the development and use of targeted multiple reaction monitoring-based triple quadrupole mass spectrometry. RESULTS: In this exploratory study, 1586 proteins were identified with 151 proteins differentially expressed in HCM samples compared with controls ( P<0.05). Protein expression profiling showed that many proteins identified in the initial discovery study were associated with metabolism, muscle contraction, calcium regulation, and oxidative stress. Proteins downregulated in HCM versus controls included creatine kinase M-type, fructose-bisphosphate aldolase A, and phosphoglycerate mutase ( P<0.001). Proteins upregulated in HCM included lumican, carbonic anhydrase 3, desmin, alpha-actin skeletal, and FHL1 (four and a half LIM domain protein 1; P<0.01). Myocardial lumican concentration correlated with the left atrial area (rho=0.34, P=0.015), late gadolinium enhancement on cardiac magnetic resonance imaging ( P=0.03) and the presence of a pathogenic sarcomere mutation ( P=0.04). CONCLUSIONS: The myocardial proteome of HCM provides supporting evidence for dysregulation of metabolic and structural proteins. The finding that lumican is raised in HCM hearts provides insight into the myocardial fibrosis that characterizes this disease.', 'FAU': ['Coats, Caroline J', 'Heywood, Wendy E', 'Virasami, Alex', 'Ashrafi, Nadia', 'Syrris, Petros', 'Dos Remedios, Cris', 'Treibel, Thomas A', 'Moon, James C', 'Lopes, Luis R', 'McGregor, Christopher G A', 'Ashworth, Michael', 'Sebire, Neil J', 'McKenna, William J', 'Mills, Kevin', 'Elliott, Perry M'], 'AU': ['Coats CJ', 'Heywood WE', 'Virasami A', 'Ashrafi N', 'Syrris P', 'Dos Remedios C', 'Treibel TA', 'Moon JC', 'Lopes LR', 'McGregor CGA', 'Ashworth M', 'Sebire NJ', 'McKenna WJ', 'Mills K', 'Elliott PM'], 'AD': ['University College London Institute of Cardiovascular Science, London, United Kingdom (C.J.C., P.S., T.A.T., J.C.M., L.R.L., C.G.A.M., W.J.M., P.M.E.).', 'University College London Great Ormond Street Institute of Child Health, London, United Kingdom (C.J.C., W.E.H., N.A., K.M.).', 'University College London Great Ormond Street Institute of Child Health, London, United Kingdom (C.J.C., W.E.H., N.A., K.M.).', 'Histopathology Unit, Great Ormond Street Hospital for Children, London, United Kingdom (A.V., M.A., N.J.S.).', 'University College London Great Ormond Street Institute of Child Health, London, United Kingdom (C.J.C., W.E.H., N.A., K.M.).', 'University College London Institute of Cardiovascular Science, London, United Kingdom (C.J.C., P.S., T.A.T., J.C.M., L.R.L., C.G.A.M., W.J.M., P.M.E.).', 'Department of Anatomy and Histology, Bosch Institute, The University of Sydney, New South Wales, Australia (C.d.R.).', 'University College London Institute of Cardiovascular Science, London, United Kingdom (C.J.C., P.S., T.A.T., J.C.M., L.R.L., C.G.A.M., W.J.M., P.M.E.).', 'Barts Heart Centre, Barts Health NHS Trust, London, United Kingdom (T.A.T., J.C.M., L.R.L., P.M.E.).', 'University College London Institute of Cardiovascular Science, London, United Kingdom (C.J.C., P.S., T.A.T., J.C.M., L.R.L., C.G.A.M., W.J.M., P.M.E.).', 'Barts Heart Centre, Barts Health NHS Trust, London, United Kingdom (T.A.T., J.C.M., L.R.L., P.M.E.).', 'University College London Institute of Cardiovascular Science, London, United Kingdom (C.J.C., P.S., T.A.T., J.C.M., L.R.L., C.G.A.M., W.J.M., P.M.E.).', 'Barts Heart Centre, Barts Health NHS Trust, London, United Kingdom (T.A.T., J.C.M., L.R.L., P.M.E.).', 'University College London Institute of Cardiovascular Science, London, United Kingdom (C.J.C., P.S., T.A.T., J.C.M., L.R.L., C.G.A.M., W.J.M., P.M.E.).', 'Histopathology Unit, Great Ormond Street Hospital for Children, London, United Kingdom (A.V., M.A., N.J.S.).', 'Histopathology Unit, Great Ormond Street Hospital for Children, London, United Kingdom (A.V., M.A., N.J.S.).', 'University College London Institute of Cardiovascular Science, London, United Kingdom (C.J.C., P.S., T.A.T., J.C.M., L.R.L., C.G.A.M., W.J.M., P.M.E.).', 'University College London Great Ormond Street Institute of Child Health, London, United Kingdom (C.J.C., W.E.H., N.A., K.M.).', 'University College London Institute of Cardiovascular Science, London, United Kingdom (C.J.C., P.S., T.A.T., J.C.M., L.R.L., C.G.A.M., W.J.M., P.M.E.).', 'Barts Heart Centre, Barts Health NHS Trust, London, United Kingdom (T.A.T., J.C.M., L.R.L., P.M.E.).'], 'LA': ['eng'], 'GR': ['FS/10/027/28248/British Heart Foundation/United Kingdom', 'Department of Health/United Kingdom'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'PL': 'United States', 'TA': 'Circ Genom Precis Med', 'JT': 'Circulation. Genomic and precision medicine', 'JID': '101714113', 'RN': ['0 (Proteins)'], 'SB': 'IM', 'MH': ['Adult', 'Aged', 'Cardiomyopathy, Hypertrophic/diagnostic imaging/*genetics/metabolism', 'Female', 'Humans', 'Magnetic Resonance Imaging', 'Male', 'Middle Aged', 'Mutation', 'Myocardium/chemistry/*metabolism', 'Phenotype', 'Proteins/*chemistry/genetics/metabolism', 'Proteomics'], 'OTO': ['NOTNLM'], 'OT': ['*cardiomyopathies', '*fibrosis', '*hypertrophy', '*proteome'], 'EDAT': '2018/12/19 06:00', 'MHDA': '2019/10/12 06:00', 'CRDT': ['2018/12/19 06:00'], 'PHST': ['2018/12/19 06:00 [entrez]', '2018/12/19 06:00 [pubmed]', '2019/10/12 06:00 [medline]'], 'AID': ['10.1161/CIRCGEN.117.001974 [doi]'], 'PST': 'ppublish', 'SO': 'Circ Genom Precis Med. 2018 Dec;11(12):e001974. doi: 10.1161/CIRCGEN.117.001974.'}\n",
      "{'PMID': '30496173', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20190410', 'LR': '20200309', 'IS': '1932-6203 (Electronic) 1932-6203 (Linking)', 'VI': '13', 'IP': '11', 'DP': '2018', 'TI': 'Circulating proteomic patterns in AF related left atrial remodeling indicate involvement of coagulation and complement cascade.', 'PG': 'e0198461', 'LID': '10.1371/journal.pone.0198461 [doi]', 'AB': 'BACKGROUND: Left atrial (LA) electro-anatomical remodeling and diameter increase in atrial fibrillation (AF) indicates disease progression and is associated with poor therapeutic success. Furthermore, AF leads to a hypercoagulable state, which in turn promotes the development of a substrate for AF and disease progression in the experimental setting. The aim of this study was to identify pathways associated with LA remodeling in AF patients using untargeted proteomics approach. METHODS: Peripheral blood samples of 48 patients (62+/-10 years, 63% males, 59% persistent AF) undergoing AF catheter ablation were collected before ablation. 23 patients with left atrial low voltage areas (LVA), defined as <0.5 mV, and 25 patients without LVA were matched for age, gender and CHA2DS2-VASc score. Untargeted proteome analysis was performed using LC-ESI-Tandem mass spectrometry in a label free intensity based workflow. Significantly different abundant proteins were identified and used for pathway analysis and protein-protein interaction analysis. RESULTS: Analysis covered 280 non-redundant circulating plasma proteins. The presence of LVA correlated with 30 differentially abundant proteins of coagulation and complement cascade (q<0.05). CONCLUSIONS: This pilot proteomic study identified plasma protein candidates associated with electro-anatomical remodeling in AF and pointed towards an imbalance in coagulation and complement pathway, tissue remodeling and inflammation.', 'FAU': ['Kornej, Jelena', 'Buttner, Petra', 'Hammer, Elke', 'Engelmann, Beatrice', 'Dinov, Borislav', 'Sommer, Philipp', 'Husser, Daniela', 'Hindricks, Gerhard', 'Volker, Uwe', 'Bollmann, Andreas'], 'AU': ['Kornej J', 'Buttner P', 'Hammer E', 'Engelmann B', 'Dinov B', 'Sommer P', 'Husser D', 'Hindricks G', 'Volker U', 'Bollmann A'], 'AD': ['Department of Electrophysiology, Heart Center Leipzig, University of Leipzig, Leipzig, Germany.', 'Department of Electrophysiology, Heart Center Leipzig, University of Leipzig, Leipzig, Germany.', 'Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Greifswald, Germany.', 'DZHK (German Center for Cardiovascular Research), partner site Greifswald, Greifswald, Germany.', 'Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Greifswald, Germany.', 'Department of Electrophysiology, Heart Center Leipzig, University of Leipzig, Leipzig, Germany.', 'Department of Electrophysiology, Heart Center Leipzig, University of Leipzig, Leipzig, Germany.', 'Department of Electrophysiology, Heart Center Leipzig, University of Leipzig, Leipzig, Germany.', 'Department of Electrophysiology, Heart Center Leipzig, University of Leipzig, Leipzig, Germany.', 'Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Greifswald, Germany.', 'DZHK (German Center for Cardiovascular Research), partner site Greifswald, Greifswald, Germany.', 'Department of Electrophysiology, Heart Center Leipzig, University of Leipzig, Leipzig, Germany.'], 'AUID': ['ORCID: 0000-0003-0799-4725'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20181129', 'PL': 'United States', 'TA': 'PLoS One', 'JT': 'PloS one', 'JID': '101285081', 'RN': ['9007-36-7 (Complement System Proteins)'], 'SB': 'IM', 'MH': ['Aged', 'Atrial Fibrillation/*metabolism/surgery', 'Atrial Remodeling/*physiology', 'Blood Coagulation/*physiology', 'Catheter Ablation', 'Complement System Proteins/*metabolism', 'Female', 'Humans', 'Male', 'Middle Aged', 'Proteomics'], 'PMC': 'PMC6264811', 'COIS': ['The authors have declared that no competing interests exist.'], 'EDAT': '2018/11/30 06:00', 'MHDA': '2019/04/11 06:00', 'CRDT': ['2018/11/30 06:00'], 'PHST': ['2018/05/16 00:00 [received]', '2018/11/12 00:00 [accepted]', '2018/11/30 06:00 [entrez]', '2018/11/30 06:00 [pubmed]', '2019/04/11 06:00 [medline]'], 'AID': ['10.1371/journal.pone.0198461 [doi]', 'PONE-D-18-14723 [pii]'], 'PST': 'epublish', 'SO': 'PLoS One. 2018 Nov 29;13(11):e0198461. doi: 10.1371/journal.pone.0198461. eCollection 2018.'}\n",
      "{'PMID': '30478197', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20190830', 'LR': '20200309', 'IS': '1468-3296 (Electronic) 0040-6376 (Linking)', 'VI': '74', 'IP': '4', 'DP': '2019 Apr', 'TI': 'Reduced plasma levels of small HDL particles transporting fibrinolytic proteins in pulmonary arterial hypertension.', 'PG': '380-389', 'LID': '10.1136/thoraxjnl-2018-212144 [doi]', 'AB': 'BACKGROUND: Aberrant lipoprotein metabolism has been implicated in experimental pulmonary hypertension, but the relevance to patients with pulmonary arterial hypertension (PAH) is inconclusive. OBJECTIVE: To investigate the relationship between circulating lipoprotein subclasses and survival in patients with PAH. METHODS: Using nuclear magnetic resonance spectroscopy, 105 discrete lipoproteins were measured in plasma samples from two cohorts of patients with idiopathic or heritable PAH. Data from 1124 plasma proteins were used to identify proteins linked to lipoprotein subclasses. The physical presence of proteins was confirmed in plasma lipoprotein subfractions separated by ultracentrifugation. RESULTS: Plasma levels of three lipoproteins from the small high-density lipoprotein (HDL) subclass, termed HDL-4, were inversely related to survival in both the discovery (n=127) and validation (n=77) cohorts, independent of exercise capacity, comorbidities, treatment, N-terminal probrain natriuretic peptide, C reactive protein and the principal lipoprotein classes. The small HDL subclass rich in apolipoprotein A-2 content (HDL-4-Apo A-2) exhibited the most significant association with survival. None of the other lipoprotein classes, including principal lipoprotein classes HDL and low-density lipoprotein cholesterol, were prognostic. Three out of nine proteins identified to associate with HDL-4-Apo A-2 are involved in the regulation of fibrinolysis, namely, the plasmin regulator, alpha-2-antiplasmin, and two major components of the kallikrein-kinin pathway (coagulation factor XI and prekallikrein), and their physical presence in the HDL-4 subfraction was confirmed. CONCLUSION: Reduced plasma levels of small HDL particles transporting fibrinolytic proteins are associated with poor outcomes in patients with idiopathic and heritable PAH.', 'CI': ['(c) Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY.', 'Published by BMJ.'], 'FAU': ['Harbaum, Lars', 'Ghataorhe, Pavandeep', 'Wharton, John', 'Jimenez, Beatriz', 'Howard, Luke S G', 'Gibbs, J Simon R', 'Nicholson, Jeremy K', 'Rhodes, Christopher J', 'Wilkins, Martin R'], 'AU': ['Harbaum L', 'Ghataorhe P', 'Wharton J', 'Jimenez B', 'Howard LSG', 'Gibbs JSR', 'Nicholson JK', 'Rhodes CJ', 'Wilkins MR'], 'AD': ['Department of Medicine, Imperial College London, London, UK.', 'Department of Medicine, Imperial College London, London, UK.', 'Department of Medicine, Imperial College London, London, UK.', 'Imperial Clinical Phenome Centre, Department of Surgery and Cancer, Imperial College London, London, UK.', 'National Heart and Lung Institute, Imperial College London, London, UK.', 'National Pulmonary Hypertension Service, Imperial College Healthcare Trust NHS, London, UK.', 'National Heart and Lung Institute, Imperial College London, London, UK.', 'National Pulmonary Hypertension Service, Imperial College Healthcare Trust NHS, London, UK.', 'Division of Computational Systems Medicine, Department of Surgery and Cancer, and Centre for Digestive and Gut Health, Imperial College London, London, UK.', 'Department of Medicine, Imperial College London, London, UK.', 'Department of Medicine, Imperial College London, London, UK.'], 'AUID': ['ORCID: 0000-0003-2822-210X'], 'LA': ['eng'], 'GR': ['Wellcome Trust/United Kingdom', 'FS/15/59/31839/British Heart Foundation/United Kingdom', 'RG/10/16/28575/British Heart Foundation/United Kingdom'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20181126', 'PL': 'England', 'TA': 'Thorax', 'JT': 'Thorax', 'JID': '0417353', 'RN': ['0 (Biomarkers)', '0 (Lipoproteins)', '0 (Lipoproteins, HDL)', '0 (Proteome)'], 'SB': 'IM', 'CIN': ['Thorax. 2019 Apr;74(4):317-318. PMID: 30679265'], 'MH': ['Adult', 'Aged', 'Biomarkers/blood', 'Cohort Studies', 'Female', 'Fibrinolysis/physiology', 'Hemodynamics/physiology', 'Humans', 'Hypertension, Pulmonary/*blood/diagnosis/genetics/physiopathology', 'Kallikrein-Kinin System/physiology', 'Kaplan-Meier Estimate', 'Lipoproteins/blood', 'Lipoproteins, HDL/*blood', 'Magnetic Resonance Spectroscopy/methods', 'Male', 'Metabolomics/methods', 'Middle Aged', 'Prognosis', 'Proteome'], 'PMC': 'PMC6475111', 'OTO': ['NOTNLM'], 'OT': ['*primary pulmonary hypertension'], 'COIS': ['Competing interests: None declared.'], 'EDAT': '2018/11/28 06:00', 'MHDA': '2019/08/31 06:00', 'CRDT': ['2018/11/28 06:00'], 'PHST': ['2018/06/01 00:00 [received]', '2018/10/28 00:00 [revised]', '2018/11/12 00:00 [accepted]', '2018/11/28 06:00 [pubmed]', '2019/08/31 06:00 [medline]', '2018/11/28 06:00 [entrez]'], 'AID': ['thoraxjnl-2018-212144 [pii]', '10.1136/thoraxjnl-2018-212144 [doi]'], 'PST': 'ppublish', 'SO': 'Thorax. 2019 Apr;74(4):380-389. doi: 10.1136/thoraxjnl-2018-212144. Epub 2018 Nov 26.'}\n",
      "{'PMID': '30451909', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20191213', 'LR': '20191217', 'IS': '2045-2322 (Electronic) 2045-2322 (Linking)', 'VI': '8', 'IP': '1', 'DP': '2018 Nov 19', 'TI': 'Obesity shows preserved plasma proteome in large independent clinical cohorts.', 'PG': '16981', 'LID': '10.1038/s41598-018-35321-7 [doi]', 'AB': 'Holistic human proteome maps are expected to complement comprehensive profile assessment of health and disease phenotypes. However, methodologies to analyze proteomes in human tissue or body fluid samples at relevant scale and performance are still limited in clinical research. Their deployment and demonstration in large enough human populations are even sparser. In the present study, we have characterized and compared the plasma proteomes of two large independent cohorts of obese and overweight individuals using shotgun mass spectrometry (MS)-based proteomics. Herein, we showed, in both populations from different continents of about 500 individuals each, the concordance of plasma protein MS measurements in terms of variability, gender-specificity, and age-relationship. Additionally, we replicated several known and new associations between proteins, clinical and molecular variables, such as insulin and glucose concentrations. In conclusion, our MS-based analyses of plasma samples from independent human cohorts proved the practical feasibility and efficiency of a large and unified discovery/replication approach in proteomics, which was also recently coined \"rectangular\" design.', 'FAU': ['Cominetti, Ornella', 'Nunez Galindo, Antonio', 'Corthesy, John', 'Valsesia, Armand', 'Irincheeva, Irina', 'Kussmann, Martin', 'Saris, Wim H M', 'Astrup, Arne', 'McPherson, Ruth', 'Harper, Mary-Ellen', 'Dent, Robert', 'Hager, Jorg', 'Dayon, Loic'], 'AU': ['Cominetti O', 'Nunez Galindo A', 'Corthesy J', 'Valsesia A', 'Irincheeva I', 'Kussmann M', 'Saris WHM', 'Astrup A', 'McPherson R', 'Harper ME', 'Dent R', 'Hager J', 'Dayon L'], 'AD': ['Proteomics, Nestle Institute of Health Sciences, Lausanne, Switzerland.', 'Proteomics, Nestle Institute of Health Sciences, Lausanne, Switzerland.', 'Proteomics, Nestle Institute of Health Sciences, Lausanne, Switzerland.', 'Nutrition Analytics, Nestle Institute of Health Sciences, Lausanne, Switzerland.', 'Nutrition and Metabolic Health, Nestle Institute of Health Sciences, Lausanne, Switzerland.', 'Nutrition and Metabolic Health, Nestle Institute of Health Sciences, Lausanne, Switzerland.', 'Clinical Trial Unit, University of Bern, Bern, Switzerland.', 'Proteomics, Nestle Institute of Health Sciences, Lausanne, Switzerland.', 'The Liggins Institute, University of Auckland, Auckland, New Zealand.', 'NUTRIM, School for Nutrition, Toxicology and Metabolism, Department of Human Biology, Maastricht University Medical Centre, Maastricht, The Netherlands.', 'Department of Nutrition, Exercise and Sports, Faculty of Science, University of Copenhagen, Copenhagen, Denmark.', 'Ruddy Canadian Cardiovascular Genetics Centre, University of Ottawa Heart Institute, Ottawa, Canada.', 'Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Canada.', 'Ottawa Hospital Weight Management Clinic, The Ottawa Hospital, Ottawa, Canada.', 'Nutrition and Metabolic Health, Nestle Institute of Health Sciences, Lausanne, Switzerland.', 'Proteomics, Nestle Institute of Health Sciences, Lausanne, Switzerland. loic.dayon@rd.nestle.com.'], 'AUID': ['ORCID: http://orcid.org/0000-0002-8499-270X'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20181119', 'PL': 'England', 'TA': 'Sci Rep', 'JT': 'Scientific reports', 'JID': '101563288', 'RN': ['0 (Blood Proteins)', '0 (Proteome)'], 'SB': 'IM', 'MH': ['Adult', 'Blood Proteins/*metabolism', 'Chromatography, Liquid/methods', 'Cohort Studies', 'Female', 'Humans', 'Male', 'Middle Aged', 'Obesity/*blood', 'Overweight/*blood', '*Proteome', 'Proteomics/methods', 'Reproducibility of Results', 'Tandem Mass Spectrometry/methods'], 'PMC': 'PMC6242904', 'EDAT': '2018/11/20 06:00', 'MHDA': '2019/12/18 06:00', 'CRDT': ['2018/11/20 06:00'], 'PHST': ['2018/06/29 00:00 [received]', '2018/11/02 00:00 [accepted]', '2018/11/20 06:00 [entrez]', '2018/11/20 06:00 [pubmed]', '2019/12/18 06:00 [medline]'], 'AID': ['10.1038/s41598-018-35321-7 [doi]', '10.1038/s41598-018-35321-7 [pii]'], 'PST': 'epublish', 'SO': 'Sci Rep. 2018 Nov 19;8(1):16981. doi: 10.1038/s41598-018-35321-7.'}\n",
      "{'PMID': '30368668', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20190212', 'LR': '20200225', 'IS': '1432-1203 (Electronic) 0340-6717 (Linking)', 'VI': '138', 'IP': '1', 'DP': '2019 Jan', 'TI': 'Delineation of LZTR1 mutation-positive patients with Noonan syndrome and identification of LZTR1 binding to RAF1-PPP1CB complexes.', 'PG': '21-35', 'LID': '10.1007/s00439-018-1951-7 [doi]', 'AB': 'RASopathies are a group of developmental disorders caused by mutations in genes that regulate the RAS/MAPK pathway and include Noonan syndrome (NS), Costello syndrome, cardiofaciocutaneous syndrome and other related disorders. Whole exome sequencing studies recently identified LZTR1, PPP1CB and MRAS as new causative genes in RASopathies. However, information on the phenotypes of LZTR1 mutation-positive patients and functional properties of the mutations are limited. To identify variants of LZTR1, PPP1CB, and MRAS, we performed a targeted next-generation sequencing and reexamined previously analyzed exome data in 166 patients with suspected RASopathies. We identified eight LZTR1 variants, including a de novo variant, in seven probands who were suspicious for NS and one known de novo PPP1CB variant in a patient with NS. One of the seven probands had two compound heterozygous LZTR1 variants, suggesting autosomal recessive inheritance. All probands with LZTR1 variants had cardiac defects, including hypertrophic cardiomyopathy and atrial septal defect. Five of the seven probands had short stature or intellectual disabilities. Immunoprecipitation of endogenous LZTR1 followed by western blotting showed that LZTR1 bound to the RAF1-PPP1CB complex. Cells transfected with a small interfering RNA against LZTR1 exhibited decreased levels of RAF1 phosphorylated at Ser259. These are the first results to demonstrate LZTR1 in association with the RAF1-PPP1CB complex as a component of the RAS/MAPK pathway.', 'FAU': ['Umeki, Ikumi', 'Niihori, Tetsuya', 'Abe, Taiki', 'Kanno, Shin-Ichiro', 'Okamoto, Nobuhiko', 'Mizuno, Seiji', 'Kurosawa, Kenji', 'Nagasaki, Keisuke', 'Yoshida, Makoto', 'Ohashi, Hirofumi', 'Inoue, Shin-Ichi', 'Matsubara, Yoichi', 'Fujiwara, Ikuma', 'Kure, Shigeo', 'Aoki, Yoko'], 'AU': ['Umeki I', 'Niihori T', 'Abe T', 'Kanno SI', 'Okamoto N', 'Mizuno S', 'Kurosawa K', 'Nagasaki K', 'Yoshida M', 'Ohashi H', 'Inoue SI', 'Matsubara Y', 'Fujiwara I', 'Kure S', 'Aoki Y'], 'AD': ['Department of Medical Genetics, Tohoku University School of Medicine, 1-1 Seiryomachi, Aobaku, Sendai, 980-8574, Japan.', 'Department of Medical Genetics, Tohoku University School of Medicine, 1-1 Seiryomachi, Aobaku, Sendai, 980-8574, Japan.', 'Department of Medical Genetics, Tohoku University School of Medicine, 1-1 Seiryomachi, Aobaku, Sendai, 980-8574, Japan.', 'Division of Dynamic Proteome in Cancer and Aging, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan.', \"Department of Medical Genetics, Osaka Women's and Children's Hospital, Izumi, Japan.\", 'Department of Pediatrics, Central Hospital, Aichi Human Service Center, Kasugai, Japan.', \"Division of Medical Genetics, Kanagawa Children's Medical Center, Yokohama, Japan.\", 'Division of Pediatrics, Department of Homeostatic Regulation and Development, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.', 'Department of Pediatrics, Sano Kosei General Hospital, Sano, Japan.', \"Division of Medical Genetics, Saitama Children's Medical Center, Saitama, Japan.\", 'Department of Medical Genetics, Tohoku University School of Medicine, 1-1 Seiryomachi, Aobaku, Sendai, 980-8574, Japan.', 'National Research Institute for Child Health and Development, Tokyo, Japan.', 'Department of Pediatric Endocrinology and Environmental Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.', 'Department of Pediatrics, Tohoku University School of Medicine, Sendai, Japan.', 'Department of Medical Genetics, Tohoku University School of Medicine, 1-1 Seiryomachi, Aobaku, Sendai, 980-8574, Japan. aokiy@med.tohoku.ac.jp.'], 'LA': ['eng'], 'PT': ['Journal Article'], 'DEP': '20181027', 'PL': 'Germany', 'TA': 'Hum Genet', 'JT': 'Human genetics', 'JID': '7613873', 'RN': ['0 (Biomarkers)', '0 (LZTR1 protein, human)', '0 (Transcription Factors)', 'EC 2.7.11.1 (Proto-Oncogene Proteins c-raf)', 'EC 2.7.11.1 (Raf1 protein, human)', 'EC 3.1.3.16 (PPP1CB protein, human)', 'EC 3.1.3.16 (Protein Phosphatase 1)'], 'SB': 'IM', 'MH': ['Adolescent', 'Adult', 'Biomarkers/*analysis', 'Child', 'Child, Preschool', 'Exome', 'Female', 'Follow-Up Studies', 'Humans', 'Male', '*Mutation', 'Noonan Syndrome/*genetics/metabolism/pathology', 'Phenotype', 'Prognosis', 'Protein Binding', 'Protein Phosphatase 1/genetics/*metabolism', 'Proto-Oncogene Proteins c-raf/genetics/*metabolism', 'Transcription Factors/genetics/*metabolism', 'Young Adult'], 'EDAT': '2018/10/29 06:00', 'MHDA': '2019/02/13 06:00', 'CRDT': ['2018/10/29 06:00'], 'PHST': ['2018/07/20 00:00 [received]', '2018/10/21 00:00 [accepted]', '2018/10/29 06:00 [pubmed]', '2019/02/13 06:00 [medline]', '2018/10/29 06:00 [entrez]'], 'AID': ['10.1007/s00439-018-1951-7 [doi]', '10.1007/s00439-018-1951-7 [pii]'], 'PST': 'ppublish', 'SO': 'Hum Genet. 2019 Jan;138(1):21-35. doi: 10.1007/s00439-018-1951-7. Epub 2018 Oct 27.'}\n",
      "{'PMID': '30347343', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20191121', 'LR': '20191121', 'IS': '1879-1484 (Electronic) 0021-9150 (Linking)', 'VI': '278', 'DP': '2018 Nov', 'TI': 'High density lipoprotein proteome is associated with cardiovascular risk factors and atherosclerosis burden as evaluated by coronary CT angiography.', 'PG': '278-285', 'LID': 'S0021-9150(18)31405-9 [pii] 10.1016/j.atherosclerosis.2018.09.032 [doi]', 'AB': 'BACKGROUND AND AIMS: High density lipoprotein cholesterol (HDL-C) is associated with risk of cardiovascular disease (CVD); however, therapeutic manipulations of HDL-C have failed to reduce CVD events. This suggests that HDL-C and the atheroprotective capacity of HDL are not directly linked. The goal of this study was to evaluate the relationships between HDL-bound proteins and measures of atherosclerosis burden and HDL function. METHODS: The HDL proteome was analyzed using mass spectrometry in 126 human subjects, who had undergone coronary computed tomography angiography (CCTA) to quantify calcified (CB) and non-calcified (NCB) atherosclerosis burden. Partial least squares regression analysis was used to evaluate associations between HDL-bound proteins and CB, NCB, or cholesterol efflux capacity (CEC). RESULTS: Significant overlap was found among proteins associated with NCB and CEC. Proteins that were associated with NCB displayed an inverse relationship with CEC, supporting a link between this protective function of HDL and clinical plaque burden. CB was associated with a set of proteins mostly distinct from NCB and CEC. When CVD risk factors were evaluated, BMI had a stronger influence on important HDL proteins than gender, age, or HDL-C. Most HDL proteins associated with function or atherosclerosis burden were not significantly correlated with HDL-C. CONCLUSIONS: These findings indicate that the HDL proteome contains information not captured by HDL- C and, therefore, has potential for future development as a biomarker for CVD risk. Additionally, the proteome effects detected in this study may provide HDL compositional goals for evaluating new and existing HDL-modification therapies.', 'CI': ['Published by Elsevier B.V.'], 'FAU': ['Gordon, Scott M', 'Chung, Jonathan H', 'Playford, Martin P', 'Dey, Amit K', 'Sviridov, Denis', 'Seifuddin, Fayaz', 'Chen, Yun-Ching', 'Pirooznia, Mehdi', 'Chen, Marcus Y', 'Mehta, Nehal N', 'Remaley, Alan T'], 'AU': ['Gordon SM', 'Chung JH', 'Playford MP', 'Dey AK', 'Sviridov D', 'Seifuddin F', 'Chen YC', 'Pirooznia M', 'Chen MY', 'Mehta NN', 'Remaley AT'], 'AD': ['Lipoprotein Metabolism Section, National Heart, Lung and Blood Institute, Bethesda, MD, USA. Electronic address: scott.gordon@uky.edu.', 'Section of Inflammation and Cardiometabolic Diseases, National Heart, Lung and Blood Institute, Bethesda, MD, USA.', 'Section of Inflammation and Cardiometabolic Diseases, National Heart, Lung and Blood Institute, Bethesda, MD, USA.', 'Section of Inflammation and Cardiometabolic Diseases, National Heart, Lung and Blood Institute, Bethesda, MD, USA.', 'Lipoprotein Metabolism Section, National Heart, Lung and Blood Institute, Bethesda, MD, USA.', 'Bioinformatics and Computational Biology Core Facility, National Heart, Lung and Blood Institute, Bethesda, MD, USA.', 'Bioinformatics and Computational Biology Core Facility, National Heart, Lung and Blood Institute, Bethesda, MD, USA.', 'Bioinformatics and Computational Biology Core Facility, National Heart, Lung and Blood Institute, Bethesda, MD, USA.', 'Advanced Cardiovascular Imaging Laboratory, National Heart, Lung and Blood Institute, Bethesda, MD, USA.', 'Section of Inflammation and Cardiometabolic Diseases, National Heart, Lung and Blood Institute, Bethesda, MD, USA.', 'Lipoprotein Metabolism Section, National Heart, Lung and Blood Institute, Bethesda, MD, USA.'], 'LA': ['eng'], 'GR': ['Z01 HL002058-13/Intramural NIH HHS/United States'], 'PT': ['Journal Article', 'Research Support, N.I.H., Intramural'], 'DEP': '20180925', 'PL': 'Ireland', 'TA': 'Atherosclerosis', 'JT': 'Atherosclerosis', 'JID': '0242543', 'RN': ['0 (Biomarkers)', '0 (Cholesterol, HDL)', '0 (Lipoproteins, HDL)', '0 (Proteome)'], 'SB': 'IM', 'MH': ['Aged', 'Animals', 'Atherosclerosis/*diagnostic imaging/metabolism', 'Biomarkers/metabolism', 'Body Mass Index', 'Cardiovascular Diseases/*diagnostic imaging/metabolism', 'Cell Line', 'Cholesterol, HDL', 'Computed Tomography Angiography', 'Coronary Angiography', 'Female', 'Humans', 'Lipoproteins, HDL/*metabolism', 'Male', 'Mice', 'Middle Aged', 'Plaque, Atherosclerotic', 'Proteome', 'Regression Analysis', 'Risk Factors'], 'PMC': 'PMC6263790', 'MID': ['NIHMS1510119'], 'OTO': ['NOTNLM'], 'OT': ['*Atherosclerosis', '*Cholesterol efflux', '*Computed tomography angiography', '*High density lipoprotein', '*Proteomics'], 'EDAT': '2018/10/23 06:00', 'MHDA': '2019/11/22 06:00', 'CRDT': ['2018/10/23 06:00'], 'PHST': ['2018/06/07 00:00 [received]', '2018/08/24 00:00 [revised]', '2018/09/21 00:00 [accepted]', '2018/10/23 06:00 [pubmed]', '2019/11/22 06:00 [medline]', '2018/10/23 06:00 [entrez]'], 'AID': ['S0021-9150(18)31405-9 [pii]', '10.1016/j.atherosclerosis.2018.09.032 [doi]'], 'PST': 'ppublish', 'SO': 'Atherosclerosis. 2018 Nov;278:278-285. doi: 10.1016/j.atherosclerosis.2018.09.032. Epub 2018 Sep 25.'}\n",
      "{'PMID': '30332462', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20190405', 'LR': '20190405', 'IS': '1932-6203 (Electronic) 1932-6203 (Linking)', 'VI': '13', 'IP': '10', 'DP': '2018', 'TI': 'Functional abnormalities in induced Pluripotent Stem Cell-derived cardiomyocytes generated from titin-mutated patients with dilated cardiomyopathy.', 'PG': 'e0205719', 'LID': '10.1371/journal.pone.0205719 [doi]', 'AB': \"AIMS: Dilated cardiomyopathy (DCM), a myocardial disorder that can result in progressive heart failure and arrhythmias, is defined by ventricular chamber enlargement and dilatation, and systolic dysfunction. Despite extensive research, the pathological mechanisms of DCM are unclear mainly due to numerous mutations in different gene families resulting in the same outcome-decreased ventricular function. Titin (TTN)-a giant protein, expressed in cardiac and skeletal muscles, is an important part of the sarcomere, and thus TTN mutations are the most common cause of adult DCM. To decipher the basis for the cardiac pathology in titin-mutated patients, we investigated the hypothesis that induced Pluripotent Stem Cell (iPSC)-derived cardiomyocytes (iPSC-CM) generated from patients, recapitulate the disease phenotype. The hypothesis was tested by 3 Aims: (1) Investigate key features of the excitation-contraction-coupling machinery; (2) Investigate the responsiveness to positive inotropic interventions; (3) Investigate the proteome profile of the AuP cardiomyocytes using mass-spectrometry (MS). METHODS AND RESULTS: iPSC were generated from the patients' skin fibroblasts. The major findings were: (1) Sarcomeric organization analysis in mutated iPSC-CM showed defects in assembly and maintenance of sarcomeric structure. (2) Mutated iPSC-CM exhibited diminished inotropic and lusitropic responses to beta-adrenergic stimulation with isoproterenol, increased [Ca2+]out and angiotensin-II. Additionally, mutated iPSC-CM displayed prolonged recovery in response to caffeine. These findings may result from defective or lack of interactions of the sarcomeric components with titin through its kinase domain which is absent in the mutated cells. CONCLUSIONS: These findings show that the mutated cardiomyocytes from DCM patients recapitulate abnormalities of the inherited cardiomyopathies, expressed as blunted inotropic response.\", 'FAU': ['Schick, Revital', 'Mekies, Lucy N', 'Shemer, Yuval', 'Eisen, Binyamin', 'Hallas, Tova', 'Ben Jehuda, Ronen', 'Ben-Ari, Meital', 'Szantai, Agnes', 'Willi, Lubna', 'Shulman, Rita', 'Gramlich, Michael', 'Pane, Luna Simona', 'My, Ilaria', 'Freimark, Dov', 'Murgia, Marta', 'Santamaria, Gianluca', 'Gherghiceanu, Mihaela', 'Arad, Michael', 'Moretti, Alessandra', 'Binah, Ofer'], 'AU': ['Schick R', 'Mekies LN', 'Shemer Y', 'Eisen B', 'Hallas T', 'Ben Jehuda R', 'Ben-Ari M', 'Szantai A', 'Willi L', 'Shulman R', 'Gramlich M', 'Pane LS', 'My I', 'Freimark D', 'Murgia M', 'Santamaria G', 'Gherghiceanu M', 'Arad M', 'Moretti A', 'Binah O'], 'AD': ['Department of Physiology, Biophysics and Systems Biology, Technion, Haifa, Israel.', 'The Rappaport Institute, Haifa, Israel.', 'Rappaport Faculty of Medicine, Technion, Haifa, Israel.', 'Department of Physiology, Biophysics and Systems Biology, Technion, Haifa, Israel.', 'The Rappaport Institute, Haifa, Israel.', 'Rappaport Faculty of Medicine, Technion, Haifa, Israel.', 'Department of Physiology, Biophysics and Systems Biology, Technion, Haifa, Israel.', 'The Rappaport Institute, Haifa, Israel.', 'Rappaport Faculty of Medicine, Technion, Haifa, Israel.', 'Department of Physiology, Biophysics and Systems Biology, Technion, Haifa, Israel.', 'The Rappaport Institute, Haifa, Israel.', 'Rappaport Faculty of Medicine, Technion, Haifa, Israel.', 'Department of Physiology, Biophysics and Systems Biology, Technion, Haifa, Israel.', 'The Rappaport Institute, Haifa, Israel.', 'Rappaport Faculty of Medicine, Technion, Haifa, Israel.', 'Department of Physiology, Biophysics and Systems Biology, Technion, Haifa, Israel.', 'The Rappaport Institute, Haifa, Israel.', 'Rappaport Faculty of Medicine, Technion, Haifa, Israel.', 'Department of Biotechnology, Technion, Haifa, Israel.', 'Department of Physiology, Biophysics and Systems Biology, Technion, Haifa, Israel.', 'The Rappaport Institute, Haifa, Israel.', 'Rappaport Faculty of Medicine, Technion, Haifa, Israel.', 'Department of Physiology, Biophysics and Systems Biology, Technion, Haifa, Israel.', 'The Rappaport Institute, Haifa, Israel.', 'Rappaport Faculty of Medicine, Technion, Haifa, Israel.', 'Department of Biochemistry, University of Szeged, Szeged, Hungary.', 'Department of Physiology, Biophysics and Systems Biology, Technion, Haifa, Israel.', 'The Rappaport Institute, Haifa, Israel.', 'Rappaport Faculty of Medicine, Technion, Haifa, Israel.', 'Department of Physiology, Biophysics and Systems Biology, Technion, Haifa, Israel.', 'The Rappaport Institute, Haifa, Israel.', 'Rappaport Faculty of Medicine, Technion, Haifa, Israel.', 'Department of Cardiology and Cardiovascular Diseases, Eberhard Karls University, Tubingen, Germany.', 'Discovery Biology, Discovery Sciences, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden.', 'Medical Department-Cardiology, Klinikum rechts der Isar-Technische Universitat Munchen, Munich, Germany.', 'Heart Failure Institute and Leviev Heart Center, Sheba Medical Center and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.', 'Department of Proteomics and Signal Transduction, Max-Planck-Institute of Biochemistry, Martinsried, Germany.', 'Department of Biomedical Sciences, University of Padova, Padua, Italy.', 'Department of Experimental and Clinical Medicine, University of Magna Grecia, Medical School, Catanzaro, Italy.', 'Victor Babes National Institute of Pathology, Bucharest, Romania.', 'Heart Failure Institute and Leviev Heart Center, Sheba Medical Center and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.', 'Medical Department-Cardiology, Klinikum rechts der Isar-Technische Universitat Munchen, Munich, Germany.', 'German Centre for Cardiovascular Research-partner site Munich Heart Alliance, Munich, Germany.', 'Department of Physiology, Biophysics and Systems Biology, Technion, Haifa, Israel.', 'The Rappaport Institute, Haifa, Israel.', 'Rappaport Faculty of Medicine, Technion, Haifa, Israel.'], 'AUID': ['ORCID: 0000-0002-2185-5054', 'ORCID: 0000-0002-8017-5075', 'ORCID: 0000-0002-0468-8530'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20181017', 'PL': 'United States', 'TA': 'PLoS One', 'JT': 'PloS one', 'JID': '101285081', 'RN': ['0 (Connectin)', '0 (Proteome)', '0 (TTN protein, human)', 'L628TT009W (Isoproterenol)'], 'SB': 'IM', 'EIN': ['PLoS One. 2018 Nov 8;13(11):e0207548. PMID: 30408120'], 'MH': ['Adult', 'Aged', 'Cardiomyopathy, Dilated/*genetics/pathology', 'Cell Differentiation/*genetics', 'Connectin/*genetics', 'Excitation Contraction Coupling/genetics', 'Humans', 'Induced Pluripotent Stem Cells/physiology', 'Isoproterenol/pharmacology', 'Male', 'Mutation', 'Myocardial Contraction/drug effects/*genetics', 'Myocytes, Cardiac/*pathology/physiology', 'Proteome'], 'PMC': 'PMC6192629', 'COIS': ['The authors have declared that no competing interests exist.'], 'EDAT': '2018/10/18 06:00', 'MHDA': '2019/04/06 06:00', 'CRDT': ['2018/10/18 06:00'], 'PHST': ['2018/05/22 00:00 [received]', '2018/10/01 00:00 [accepted]', '2018/10/18 06:00 [entrez]', '2018/10/18 06:00 [pubmed]', '2019/04/06 06:00 [medline]'], 'AID': ['10.1371/journal.pone.0205719 [doi]', 'PONE-D-18-14605 [pii]'], 'PST': 'epublish', 'SO': 'PLoS One. 2018 Oct 17;13(10):e0205719. doi: 10.1371/journal.pone.0205719. eCollection 2018.'}\n",
      "{'PMID': '30261322', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20200226', 'LR': '20200226', 'IS': '1876-7737 (Electronic) 1874-3919 (Linking)', 'VI': '192', 'DP': '2019 Feb 10', 'TI': 'Correlation between chronic venous ulcer exudate proteins and clinical profile: A cross-sectional study.', 'PG': '280-290', 'LID': 'S1874-3919(18)30350-6 [pii] 10.1016/j.jprot.2018.09.009 [doi]', 'AB': 'Chronic venous ulcers affect the quality of life of patients around the world. The aims of this study were to identify the proteins expressed in chronic venous ulcer exudates, to categorize them according to their roles and to correlate them with the clinical and epidemiological aspects of the disease. The study population consisted of 37 ulcers from 28 patients, and the inflammatory exudates of these thirty-seven ulcers were subjected to tryptic digestion and mass spectrometry analysis. Twenty-three patients were female (62.2%), and five (37.8%) were male. The patients had a mean age of 70 (+/-10.1) years. Of the patients, 73% adhered to compression and rest, 81.1% reported a history of primary varices, 54.1% reported a history of systemic arterial hypertension, 54.1% reported a history of devitalized tissue in the wound bed and 64.9% reported ulcers with more than ten years of evolution. Seventy-six proteins were identified, and they were grouped according to their primary role in the healing process. Eight correlations between clinical and epidemiological data and protein expression were noteworthy: diabetes mellitus vs. Ig gamma-2 and apolipoprotein-A1 and albumin; congestive heart failure vs. Ig lambda-2; colonization vs. actin; compressive therapy vs. Ig kappa; systemic arterial hypertension vs. alpha-2-macroglobulin and apolipoprotein-A1; area of ulcer vs. apolipoprotein-A1; race vs. heavy chain Ig and Ig gamma-1 chain; age and race vs. Ig gamma-1 chain. These associations may help to elucidate the prognosis and chronicity of chronic venous ulcers based on secreted proteins.', 'CI': ['Copyright (c) 2018. Published by Elsevier B.V.'], 'FAU': ['Cavassan, Nayara Rodrigues Vieira', 'Camargo, Caio Cavassan', 'de Pontes, Leticia Gomes', 'Barraviera, Benedito', 'Ferreira, Rui Seabra', 'Miot, Helio Amante', 'Abbade, Luciana Patricia Fernandes', 'Dos Santos, Lucilene Delazari'], 'AU': ['Cavassan NRV', 'Camargo CC', 'de Pontes LG', 'Barraviera B', 'Ferreira RS', 'Miot HA', 'Abbade LPF', 'Dos Santos LD'], 'AD': ['Graduate Program in Tropical Diseases, Botucatu Medical School (FMB), Sao Paulo State University (UNESP), Botucatu, Sao Paulo, Brazil.', 'Graduate Program in Tropical Diseases, Botucatu Medical School (FMB), Sao Paulo State University (UNESP), Botucatu, Sao Paulo, Brazil.', 'Graduate Program in Tropical Diseases, Botucatu Medical School (FMB), Sao Paulo State University (UNESP), Botucatu, Sao Paulo, Brazil.', 'Graduate Program in Tropical Diseases, Botucatu Medical School (FMB), Sao Paulo State University (UNESP), Botucatu, Sao Paulo, Brazil; Center for the Study of Venoms and Venomous Animals (CEVAP), Sao Paulo State University (UNESP), Botucatu, Sao Paulo, Brazil.', 'Graduate Program in Tropical Diseases, Botucatu Medical School (FMB), Sao Paulo State University (UNESP), Botucatu, Sao Paulo, Brazil; Center for the Study of Venoms and Venomous Animals (CEVAP), Sao Paulo State University (UNESP), Botucatu, Sao Paulo, Brazil.', 'Department of Dermatology and Radiology, Botucatu Medical School (FMB), Sao Paulo State University (UNESP), Botucatu, Sao Paulo, Brazil.', 'Department of Dermatology and Radiology, Botucatu Medical School (FMB), Sao Paulo State University (UNESP), Botucatu, Sao Paulo, Brazil.', 'Graduate Program in Tropical Diseases, Botucatu Medical School (FMB), Sao Paulo State University (UNESP), Botucatu, Sao Paulo, Brazil; Center for the Study of Venoms and Venomous Animals (CEVAP), Sao Paulo State University (UNESP), Botucatu, Sao Paulo, Brazil. Electronic address: lucilene@cevap.unesp.br.'], 'LA': ['eng'], 'PT': ['Clinical Trial', 'Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20180924', 'PL': 'Netherlands', 'TA': 'J Proteomics', 'JT': 'Journal of proteomics', 'JID': '101475056', 'RN': ['0 (Blood Proteins)', '0 (Proteome)'], 'SB': 'IM', 'MH': ['Aged', 'Aged, 80 and over', 'Blood Proteins/*metabolism', 'Chronic Disease', 'Cross-Sectional Studies', 'Female', '*Gene Expression Regulation', 'Humans', 'Male', 'Middle Aged', 'Proteome/*metabolism', 'Varicose Ulcer/*blood'], 'OTO': ['NOTNLM'], 'OT': ['*Chronic venous ulcers', '*Clinical proteomics', '*Inflammatory exudate', '*Mass spectrometry'], 'EDAT': '2018/09/28 06:00', 'MHDA': '2020/02/27 06:00', 'CRDT': ['2018/09/28 06:00'], 'PHST': ['2018/03/22 00:00 [received]', '2018/09/08 00:00 [revised]', '2018/09/10 00:00 [accepted]', '2018/09/28 06:00 [pubmed]', '2020/02/27 06:00 [medline]', '2018/09/28 06:00 [entrez]'], 'AID': ['S1874-3919(18)30350-6 [pii]', '10.1016/j.jprot.2018.09.009 [doi]'], 'PST': 'ppublish', 'SO': 'J Proteomics. 2019 Feb 10;192:280-290. doi: 10.1016/j.jprot.2018.09.009. Epub 2018 Sep 24.'}\n",
      "{'PMID': '30255987', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20190911', 'LR': '20190911', 'IS': '2157-6564 (Print) 2157-6564 (Linking)', 'VI': '7', 'IP': '12', 'DP': '2018 Dec', 'TI': 'Higher Pericyte Content and Secretory Activity of Microfragmented Human Adipose Tissue Compared to Enzymatically Derived Stromal Vascular Fraction.', 'PG': '876-886', 'LID': '10.1002/sctm.18-0051 [doi]', 'AB': 'Autologous adipose tissue is used for tissue repletion and/or regeneration as an intact lipoaspirate or as enzymatically derived stromal vascular fraction (SVF), which may be first cultured into mesenchymal stem cells (MSCs). Alternatively, transplant of autologous adipose tissue mechanically fragmented into submillimeter clusters has recently showed remarkable efficacy in diverse therapeutic indications. To document the biologic basis of the regenerative potential of microfragmented adipose tissue, we first analyzed the distribution of perivascular presumptive MSCs in adipose tissue processed with the Lipogems technology, observing a significant enrichment in pericytes, at the expense of adventitial cells, as compared to isogenic enzymatically processed lipoaspirates. The importance of MSCs as trophic and immunomodulatory cells, due to the secretion of specific factors, has been described. Therefore, we investigated protein secretion by cultured adipose tissue clusters or enzymatically derived SVF using secretome arrays. In culture, microfragmented adipose tissue releases many more growth factors and cytokines involved in tissue repair and regeneration, noticeably via angiogenesis, compared to isogenic SVF. Therefore, we suggest that the efficient tissue repair/regeneration observed after transplantation of microfragmented adipose tissue is due to the secretory ability of the intact perivascular niche. Stem Cells Translational Medicine 2018;7:876-886.', 'CI': ['(c) 2018 The Authors. Stem Cells Translational Medicine published by Wiley', 'Periodicals, Inc. on behalf of AlphaMed Press.'], 'FAU': ['Vezzani, Bianca', 'Shaw, Isaac', 'Lesme, Hanna', 'Yong, Li', 'Khan, Nusrat', 'Tremolada, Carlo', 'Peault, Bruno'], 'AU': ['Vezzani B', 'Shaw I', 'Lesme H', 'Yong L', 'Khan N', 'Tremolada C', 'Peault B'], 'AUID': ['ORCID: 0000-0001-5869-6301'], 'AD': ['MRC Center for Regenerative Medicine, University of Edinburgh, Edinburgh, United Kingdom.', 'MRC Center for Regenerative Medicine, University of Edinburgh, Edinburgh, United Kingdom.', 'MRC Center for Regenerative Medicine, University of Edinburgh, Edinburgh, United Kingdom.', 'MRC Center for Regenerative Medicine, University of Edinburgh, Edinburgh, United Kingdom.', 'MRC Center for Regenerative Medicine, University of Edinburgh, Edinburgh, United Kingdom.', 'Image Institute, Milan, Italy.', 'MRC Center for Regenerative Medicine, University of Edinburgh, Edinburgh, United Kingdom.', 'Orthopaedic Hospital Research Center and Broad Stem Cell Research Center, David Geffen School of Medicine, University of California, Los Angeles, California, USA.'], 'LA': ['eng'], 'GR': ['G1000816/Medical Research Council/United Kingdom', 'British Heart Foundation/United Kingdom'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20180926', 'PL': 'United States', 'TA': 'Stem Cells Transl Med', 'JT': 'Stem cells translational medicine', 'JID': '101578022', 'RN': ['0 (Agglutinins)', '0 (Angiogenic Proteins)', '0 (Cytokines)', '0 (Intercellular Signaling Peptides and Proteins)', '0 (Proteome)', 'EC 3.4.24.- (Collagenases)'], 'SB': 'IM', 'MH': ['Abdominal Fat/cytology/metabolism', 'Adipose Tissue/cytology/*metabolism', 'Adult', 'Aged', 'Agglutinins/metabolism', 'Angiogenic Proteins/metabolism', 'Collagenases/metabolism', 'Cytokines/metabolism', 'Female', 'Flow Cytometry', 'Humans', 'Intercellular Signaling Peptides and Proteins/metabolism', 'Middle Aged', 'Pericytes/cytology/*metabolism', 'Proteome/analysis'], 'PMC': 'PMC6265639', 'OTO': ['NOTNLM'], 'OT': ['*Adipose stem cell', '*Cytokine', '*Mesenchymal stem cell', '*Pericyte', '*Secretome'], 'EDAT': '2018/09/27 06:00', 'MHDA': '2019/09/12 06:00', 'CRDT': ['2018/09/27 06:00'], 'PHST': ['2018/03/07 00:00 [received]', '2018/07/19 00:00 [accepted]', '2018/09/27 06:00 [pubmed]', '2019/09/12 06:00 [medline]', '2018/09/27 06:00 [entrez]'], 'AID': ['10.1002/sctm.18-0051 [doi]'], 'PST': 'ppublish', 'SO': 'Stem Cells Transl Med. 2018 Dec;7(12):876-886. doi: 10.1002/sctm.18-0051. Epub 2018 Sep 26.'}\n",
      "{'PMID': '30248148', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20190307', 'LR': '20190307', 'IS': '1932-6203 (Electronic) 1932-6203 (Linking)', 'VI': '13', 'IP': '9', 'DP': '2018', 'TI': 'Urinary proteomic signatures associated with beta-blockade and heart rate in heart transplant recipients.', 'PG': 'e0204439', 'LID': '10.1371/journal.pone.0204439 [doi]', 'AB': 'OBJECTIVES: Heart transplant (HTx) recipients have a high heart rate (HR), because of graft denervation and are frequently started on beta-blockade (BB). We assessed whether BB and HR post HTx are associated with a specific urinary proteomic signature. METHODS: In 336 HTx patients (mean age, 56.8 years; 22.3% women), we analyzed cross-sectional data obtained 7.3 years (median) after HTx. We recorded medication use, measured HR during right heart catheterization, and applied capillary electrophoresis coupled with mass spectrometry to determine the multidimensional urinary classifiers HF1 and HF2 (known to be associated with left ventricular dysfunction), ACSP75 (acute coronary syndrome) and CKD273 (renal dysfunction) and 48 sequenced urinary peptides revealing the parental proteins. RESULTS: In adjusted analyses, HF1, HF2 and CKD273 (p </= 0.024) were higher in BB users than non-users with a similar trend for ACSP75 (p = 0.06). Patients started on BB within 1 year after HTx and non-users had similar HF1 and HF2 levels (p >/= 0.098), whereas starting BB later was associated with higher HF1 and HF2 compared with non-users (p </= 0.014). There were no differences in the urinary biomarkers (p >/= 0.27) according to HR. BB use was associated with higher urinary levels of collagen II and III fragments and non-use with higher levels of collagen I fragments. CONCLUSIONS: BB use, but not HR, is associated with a urinary proteomic signature that is usually associated with worse outcome, because unhealthier conditions probably lead to initiation of BB. Starting BB early after HTx surgery might be beneficial.', 'FAU': ['Huang, Qi-Fang', 'Van Keer, Jan', 'Zhang, Zhen-Yu', 'Trenson, Sander', 'Nkuipou-Kenfack, Esther', 'Van Aelst, Lucas N L', 'Yang, Wen-Yi', 'Thijs, Lutgarde', 'Wei, Fang-Fei', 'Ciarka, Agnieszka', 'Vanhaecke, Johan', 'Janssens, Stefan', 'Van Cleemput, Johan', 'Mischak, Harald', 'Staessen, Jan A'], 'AU': ['Huang QF', 'Van Keer J', 'Zhang ZY', 'Trenson S', 'Nkuipou-Kenfack E', 'Van Aelst LNL', 'Yang WY', 'Thijs L', 'Wei FF', 'Ciarka A', 'Vanhaecke J', 'Janssens S', 'Van Cleemput J', 'Mischak H', 'Staessen JA'], 'AD': ['Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium.', 'Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluations, Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.', 'Division of Cardiology, University Hospitals Leuven, Leuven, Belgium.', 'Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium.', 'Department of Cardiology, Shanghai General Hospital, Shanghai, China.', 'Division of Cardiology, University Hospitals Leuven, Leuven, Belgium.', 'Mosaiques Diagnostics GmbH. Hannover, Germany.', 'Division of Cardiology, University Hospitals Leuven, Leuven, Belgium.', 'Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium.', 'Department of Cardiology, Shanghai General Hospital, Shanghai, China.', 'Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium.', 'Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium.', 'Division of Cardiology, University Hospitals Leuven, Leuven, Belgium.', 'Division of Cardiology, University Hospitals Leuven, Leuven, Belgium.', 'Division of Cardiology, University Hospitals Leuven, Leuven, Belgium.', 'Division of Cardiology, University Hospitals Leuven, Leuven, Belgium.', 'Mosaiques Diagnostics GmbH. Hannover, Germany.', 'BHF Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom.', 'Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium.', 'Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands.'], 'AUID': ['ORCID: 0000-0003-4490-5170', 'ORCID: 0000-0002-3026-1637'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20180924', 'PL': 'United States', 'TA': 'PLoS One', 'JT': 'PloS one', 'JID': '101285081', 'RN': ['0 (Adrenergic beta-Antagonists)', '0 (Biomarkers)', '0 (Peptides)', '0 (Proteome)'], 'SB': 'IM', 'MH': ['Adrenergic beta-Antagonists/*therapeutic use', 'Adult', 'Biomarkers/urine', 'Catheterization', 'Cross-Sectional Studies', 'Female', '*Heart Rate/physiology', '*Heart Transplantation', 'Humans', 'Male', 'Middle Aged', 'Peptides/*urine', '*Proteome', 'Proteomics', 'Sensitivity and Specificity'], 'PMC': 'PMC6152976', 'COIS': ['Harald Mischak is the cofounder and a shareholder of Mosaiques Diagnostics AG', '(Hannover, Germany). Esther Nkuipou-Kenfack is an employee of Mosaiques', 'Diagnostics AG. This does not alter our adherence to PLOS ONE policies on sharing', 'data and materials. None of the other authors declares a conflict of interest.'], 'EDAT': '2018/09/25 06:00', 'MHDA': '2019/03/08 06:00', 'CRDT': ['2018/09/25 06:00'], 'PHST': ['2018/05/21 00:00 [received]', '2018/09/08 00:00 [accepted]', '2018/09/25 06:00 [entrez]', '2018/09/25 06:00 [pubmed]', '2019/03/08 06:00 [medline]'], 'AID': ['10.1371/journal.pone.0204439 [doi]', 'PONE-D-18-15163 [pii]'], 'PST': 'epublish', 'SO': 'PLoS One. 2018 Sep 24;13(9):e0204439. doi: 10.1371/journal.pone.0204439. eCollection 2018.'}\n",
      "{'PMID': '30224653', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20190426', 'LR': '20200408', 'IS': '1546-1718 (Electronic) 1061-4036 (Linking)', 'VI': '50', 'IP': '10', 'DP': '2018 Oct', 'TI': 'Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits.', 'PG': '1412-1425', 'LID': '10.1038/s41588-018-0205-x [doi]', 'AB': 'High blood pressure is a highly heritable and modifiable risk factor for cardiovascular disease. We report the largest genetic association study of blood pressure traits (systolic, diastolic and pulse pressure) to date in over 1 million people of European ancestry. We identify 535 novel blood pressure loci that not only offer new biological insights into blood pressure regulation but also highlight shared genetic architecture between blood pressure and lifestyle exposures. Our findings identify new biological pathways for blood pressure regulation with potential for improved cardiovascular disease prevention in the future.', 'FAU': ['Evangelou, Evangelos', 'Warren, Helen R', 'Mosen-Ansorena, David', 'Mifsud, Borbala', 'Pazoki, Raha', 'Gao, He', 'Ntritsos, Georgios', 'Dimou, Niki', 'Cabrera, Claudia P', 'Karaman, Ibrahim', 'Ng, Fu Liang', 'Evangelou, Marina', 'Witkowska, Katarzyna', 'Tzanis, Evan', 'Hellwege, Jacklyn N', 'Giri, Ayush', 'Velez Edwards, Digna R', 'Sun, Yan V', 'Cho, Kelly', 'Gaziano, J Michael', 'Wilson, Peter W F', 'Tsao, Philip S', 'Kovesdy, Csaba P', 'Esko, Tonu', 'Magi, Reedik', 'Milani, Lili', 'Almgren, Peter', 'Boutin, Thibaud', 'Debette, Stephanie', 'Ding, Jun', 'Giulianini, Franco', 'Holliday, Elizabeth G', 'Jackson, Anne U', 'Li-Gao, Ruifang', 'Lin, Wei-Yu', \"Luan, Jian'an\", 'Mangino, Massimo', 'Oldmeadow, Christopher', 'Prins, Bram Peter', 'Qian, Yong', 'Sargurupremraj, Muralidharan', 'Shah, Nabi', 'Surendran, Praveen', 'Theriault, Sebastien', 'Verweij, Niek', 'Willems, Sara M', 'Zhao, Jing-Hua', 'Amouyel, Philippe', 'Connell, John', 'de Mutsert, Renee', 'Doney, Alex S F', 'Farrall, Martin', 'Menni, Cristina', 'Morris, Andrew D', 'Noordam, Raymond', 'Pare, Guillaume', 'Poulter, Neil R', 'Shields, Denis C', 'Stanton, Alice', 'Thom, Simon', 'Abecasis, Goncalo', 'Amin, Najaf', 'Arking, Dan E', 'Ayers, Kristin L', 'Barbieri, Caterina M', 'Batini, Chiara', 'Bis, Joshua C', 'Blake, Tineka', 'Bochud, Murielle', 'Boehnke, Michael', 'Boerwinkle, Eric', 'Boomsma, Dorret I', 'Bottinger, Erwin P', 'Braund, Peter S', 'Brumat, Marco', 'Campbell, Archie', 'Campbell, Harry', 'Chakravarti, Aravinda', 'Chambers, John C', 'Chauhan, Ganesh', 'Ciullo, Marina', 'Cocca, Massimiliano', 'Collins, Francis', 'Cordell, Heather J', 'Davies, Gail', 'de Borst, Martin H', 'de Geus, Eco J', 'Deary, Ian J', 'Deelen, Joris', 'Del Greco M, Fabiola', 'Demirkale, Cumhur Yusuf', 'Dorr, Marcus', 'Ehret, Georg B', 'Elosua, Roberto', 'Enroth, Stefan', 'Erzurumluoglu, A Mesut', 'Ferreira, Teresa', 'Franberg, Mattias', 'Franco, Oscar H', 'Gandin, Ilaria', 'Gasparini, Paolo', 'Giedraitis, Vilmantas', 'Gieger, Christian', 'Girotto, Giorgia', 'Goel, Anuj', 'Gow, Alan J', 'Gudnason, Vilmundur', 'Guo, Xiuqing', 'Gyllensten, Ulf', 'Hamsten, Anders', 'Harris, Tamara B', 'Harris, Sarah E', 'Hartman, Catharina A', 'Havulinna, Aki S', 'Hicks, Andrew A', 'Hofer, Edith', 'Hofman, Albert', 'Hottenga, Jouke-Jan', 'Huffman, Jennifer E', 'Hwang, Shih-Jen', 'Ingelsson, Erik', 'James, Alan', 'Jansen, Rick', 'Jarvelin, Marjo-Riitta', 'Joehanes, Roby', 'Johansson, Asa', 'Johnson, Andrew D', 'Joshi, Peter K', 'Jousilahti, Pekka', 'Jukema, J Wouter', 'Jula, Antti', 'Kahonen, Mika', 'Kathiresan, Sekar', 'Keavney, Bernard D', 'Khaw, Kay-Tee', 'Knekt, Paul', 'Knight, Joanne', 'Kolcic, Ivana', 'Kooner, Jaspal S', 'Koskinen, Seppo', 'Kristiansson, Kati', 'Kutalik, Zoltan', 'Laan, Maris', 'Larson, Marty', 'Launer, Lenore J', 'Lehne, Benjamin', 'Lehtimaki, Terho', 'Liewald, David C M', 'Lin, Li', 'Lind, Lars', 'Lindgren, Cecilia M', 'Liu, YongMei', 'Loos, Ruth J F', 'Lopez, Lorna M', 'Lu, Yingchang', 'Lyytikainen, Leo-Pekka', 'Mahajan, Anubha', 'Mamasoula, Chrysovalanto', 'Marrugat, Jaume', 'Marten, Jonathan', 'Milaneschi, Yuri', 'Morgan, Anna', 'Morris, Andrew P', 'Morrison, Alanna C', 'Munson, Peter J', 'Nalls, Mike A', 'Nandakumar, Priyanka', 'Nelson, Christopher P', 'Niiranen, Teemu', 'Nolte, Ilja M', 'Nutile, Teresa', 'Oldehinkel, Albertine J', 'Oostra, Ben A', \"O'Reilly, Paul F\", 'Org, Elin', 'Padmanabhan, Sandosh', 'Palmas, Walter', 'Palotie, Aarno', 'Pattie, Alison', 'Penninx, Brenda W J H', 'Perola, Markus', 'Peters, Annette', 'Polasek, Ozren', 'Pramstaller, Peter P', 'Nguyen, Quang Tri', 'Raitakari, Olli T', 'Ren, Meixia', 'Rettig, Rainer', 'Rice, Kenneth', 'Ridker, Paul M', 'Ried, Janina S', 'Riese, Harriette', 'Ripatti, Samuli', 'Robino, Antonietta', 'Rose, Lynda M', 'Rotter, Jerome I', 'Rudan, Igor', 'Ruggiero, Daniela', 'Saba, Yasaman', 'Sala, Cinzia F', 'Salomaa, Veikko', 'Samani, Nilesh J', 'Sarin, Antti-Pekka', 'Schmidt, Reinhold', 'Schmidt, Helena', 'Shrine, Nick', 'Siscovick, David', 'Smith, Albert V', 'Snieder, Harold', 'Sober, Siim', 'Sorice, Rossella', 'Starr, John M', 'Stott, David J', 'Strachan, David P', 'Strawbridge, Rona J', 'Sundstrom, Johan', 'Swertz, Morris A', 'Taylor, Kent D', 'Teumer, Alexander', 'Tobin, Martin D', 'Tomaszewski, Maciej', 'Toniolo, Daniela', 'Traglia, Michela', 'Trompet, Stella', 'Tuomilehto, Jaakko', 'Tzourio, Christophe', 'Uitterlinden, Andre G', 'Vaez, Ahmad', 'van der Most, Peter J', 'van Duijn, Cornelia M', 'Vergnaud, Anne-Claire', 'Verwoert, Germaine C', 'Vitart, Veronique', 'Volker, Uwe', 'Vollenweider, Peter', 'Vuckovic, Dragana', 'Watkins, Hugh', 'Wild, Sarah H', 'Willemsen, Gonneke', 'Wilson, James F', 'Wright, Alan F', 'Yao, Jie', 'Zemunik, Tatijana', 'Zhang, Weihua', 'Attia, John R', 'Butterworth, Adam S', 'Chasman, Daniel I', 'Conen, David', 'Cucca, Francesco', 'Danesh, John', 'Hayward, Caroline', 'Howson, Joanna M M', 'Laakso, Markku', 'Lakatta, Edward G', 'Langenberg, Claudia', 'Melander, Olle', 'Mook-Kanamori, Dennis O', 'Palmer, Colin N A', 'Risch, Lorenz', 'Scott, Robert A', 'Scott, Rodney J', 'Sever, Peter', 'Spector, Tim D', 'van der Harst, Pim', 'Wareham, Nicholas J', 'Zeggini, Eleftheria', 'Levy, Daniel', 'Munroe, Patricia B', 'Newton-Cheh, Christopher', 'Brown, Morris J', 'Metspalu, Andres', 'Hung, Adriana M', \"O'Donnell, Christopher J\", 'Edwards, Todd L', 'Psaty, Bruce M', 'Tzoulaki, Ioanna', 'Barnes, Michael R', 'Wain, Louise V', 'Elliott, Paul', 'Caulfield, Mark J'], 'AU': ['Evangelou E', 'Warren HR', 'Mosen-Ansorena D', 'Mifsud B', 'Pazoki R', 'Gao H', 'Ntritsos G', 'Dimou N', 'Cabrera CP', 'Karaman I', 'Ng FL', 'Evangelou M', 'Witkowska K', 'Tzanis E', 'Hellwege JN', 'Giri A', 'Velez Edwards DR', 'Sun YV', 'Cho K', 'Gaziano JM', 'Wilson PWF', 'Tsao PS', 'Kovesdy CP', 'Esko T', 'Magi R', 'Milani L', 'Almgren P', 'Boutin T', 'Debette S', 'Ding J', 'Giulianini F', 'Holliday EG', 'Jackson AU', 'Li-Gao R', 'Lin WY', 'Luan J', 'Mangino M', 'Oldmeadow C', 'Prins BP', 'Qian Y', 'Sargurupremraj M', 'Shah N', 'Surendran P', 'Theriault S', 'Verweij N', 'Willems SM', 'Zhao JH', 'Amouyel P', 'Connell J', 'de Mutsert R', 'Doney ASF', 'Farrall M', 'Menni C', 'Morris AD', 'Noordam R', 'Pare G', 'Poulter NR', 'Shields DC', 'Stanton A', 'Thom S', 'Abecasis G', 'Amin N', 'Arking DE', 'Ayers KL', 'Barbieri CM', 'Batini C', 'Bis JC', 'Blake T', 'Bochud M', 'Boehnke M', 'Boerwinkle E', 'Boomsma DI', 'Bottinger EP', 'Braund PS', 'Brumat M', 'Campbell A', 'Campbell H', 'Chakravarti A', 'Chambers JC', 'Chauhan G', 'Ciullo M', 'Cocca M', 'Collins F', 'Cordell HJ', 'Davies G', 'de Borst MH', 'de Geus EJ', 'Deary IJ', 'Deelen J', 'Del Greco M F', 'Demirkale CY', 'Dorr M', 'Ehret GB', 'Elosua R', 'Enroth S', 'Erzurumluoglu AM', 'Ferreira T', 'Franberg M', 'Franco OH', 'Gandin I', 'Gasparini P', 'Giedraitis V', 'Gieger C', 'Girotto G', 'Goel A', 'Gow AJ', 'Gudnason V', 'Guo X', 'Gyllensten U', 'Hamsten A', 'Harris TB', 'Harris SE', 'Hartman CA', 'Havulinna AS', 'Hicks AA', 'Hofer E', 'Hofman A', 'Hottenga JJ', 'Huffman JE', 'Hwang SJ', 'Ingelsson E', 'James A', 'Jansen R', 'Jarvelin MR', 'Joehanes R', 'Johansson A', 'Johnson AD', 'Joshi PK', 'Jousilahti P', 'Jukema JW', 'Jula A', 'Kahonen M', 'Kathiresan S', 'Keavney BD', 'Khaw KT', 'Knekt P', 'Knight J', 'Kolcic I', 'Kooner JS', 'Koskinen S', 'Kristiansson K', 'Kutalik Z', 'Laan M', 'Larson M', 'Launer LJ', 'Lehne B', 'Lehtimaki T', 'Liewald DCM', 'Lin L', 'Lind L', 'Lindgren CM', 'Liu Y', 'Loos RJF', 'Lopez LM', 'Lu Y', 'Lyytikainen LP', 'Mahajan A', 'Mamasoula C', 'Marrugat J', 'Marten J', 'Milaneschi Y', 'Morgan A', 'Morris AP', 'Morrison AC', 'Munson PJ', 'Nalls MA', 'Nandakumar P', 'Nelson CP', 'Niiranen T', 'Nolte IM', 'Nutile T', 'Oldehinkel AJ', 'Oostra BA', \"O'Reilly PF\", 'Org E', 'Padmanabhan S', 'Palmas W', 'Palotie A', 'Pattie A', 'Penninx BWJH', 'Perola M', 'Peters A', 'Polasek O', 'Pramstaller PP', 'Nguyen QT', 'Raitakari OT', 'Ren M', 'Rettig R', 'Rice K', 'Ridker PM', 'Ried JS', 'Riese H', 'Ripatti S', 'Robino A', 'Rose LM', 'Rotter JI', 'Rudan I', 'Ruggiero D', 'Saba Y', 'Sala CF', 'Salomaa V', 'Samani NJ', 'Sarin AP', 'Schmidt R', 'Schmidt H', 'Shrine N', 'Siscovick D', 'Smith AV', 'Snieder H', 'Sober S', 'Sorice R', 'Starr JM', 'Stott DJ', 'Strachan DP', 'Strawbridge RJ', 'Sundstrom J', 'Swertz MA', 'Taylor KD', 'Teumer A', 'Tobin MD', 'Tomaszewski M', 'Toniolo D', 'Traglia M', 'Trompet S', 'Tuomilehto J', 'Tzourio C', 'Uitterlinden AG', 'Vaez A', 'van der Most PJ', 'van Duijn CM', 'Vergnaud AC', 'Verwoert GC', 'Vitart V', 'Volker U', 'Vollenweider P', 'Vuckovic D', 'Watkins H', 'Wild SH', 'Willemsen G', 'Wilson JF', 'Wright AF', 'Yao J', 'Zemunik T', 'Zhang W', 'Attia JR', 'Butterworth AS', 'Chasman DI', 'Conen D', 'Cucca F', 'Danesh J', 'Hayward C', 'Howson JMM', 'Laakso M', 'Lakatta EG', 'Langenberg C', 'Melander O', 'Mook-Kanamori DO', 'Palmer CNA', 'Risch L', 'Scott RA', 'Scott RJ', 'Sever P', 'Spector TD', 'van der Harst P', 'Wareham NJ', 'Zeggini E', 'Levy D', 'Munroe PB', 'Newton-Cheh C', 'Brown MJ', 'Metspalu A', 'Hung AM', \"O'Donnell CJ\", 'Edwards TL', 'Psaty BM', 'Tzoulaki I', 'Barnes MR', 'Wain LV', 'Elliott P', 'Caulfield MJ'], 'AUID': ['ORCID: http://orcid.org/0000-0002-5488-2999', 'ORCID: http://orcid.org/0000-0001-9341-8155', 'ORCID: http://orcid.org/0000-0001-7479-0920', 'ORCID: http://orcid.org/0000-0002-7786-4670', 'ORCID: http://orcid.org/0000-0002-5323-3102', 'ORCID: http://orcid.org/0000-0002-0473-0241', 'ORCID: http://orcid.org/0000-0003-4754-1675', 'ORCID: http://orcid.org/0000-0002-9672-2547', 'ORCID: http://orcid.org/0000-0002-9267-7988', 'ORCID: http://orcid.org/0000-0002-2167-7470', 'ORCID: http://orcid.org/0000-0003-2764-3615', 'ORCID: http://orcid.org/0000-0001-9088-234X', 'ORCID: http://orcid.org/0000-0001-9790-0571', 'ORCID: http://orcid.org/0000-0002-4961-165X', 'ORCID: http://orcid.org/0000-0002-3020-1351', 'ORCID: http://orcid.org/0000-0002-6442-7754', 'ORCID: http://orcid.org/0000-0003-3268-039X', 'ORCID: http://orcid.org/0000-0003-0198-5078', 'ORCID: http://orcid.org/0000-0002-9621-9984', 'ORCID: http://orcid.org/0000-0002-1127-7596', 'ORCID: http://orcid.org/0000-0002-1023-7410', 'ORCID: http://orcid.org/0000-0002-4127-8733', 'ORCID: http://orcid.org/0000-0001-6022-2666', 'ORCID: http://orcid.org/0000-0003-4483-3701', 'ORCID: http://orcid.org/0000-0002-5730-0675', 'ORCID: http://orcid.org/0000-0002-5056-9137', 'ORCID: http://orcid.org/0000-0003-1322-8138', 'ORCID: http://orcid.org/0000-0003-3423-2021', 'ORCID: http://orcid.org/0000-0003-4507-6589', 'ORCID: http://orcid.org/0000-0003-2307-4021', 'ORCID: http://orcid.org/0000-0002-3320-4531', 'ORCID: http://orcid.org/0000-0002-4787-8959', 'ORCID: http://orcid.org/0000-0001-6320-0411', 'ORCID: http://orcid.org/0000-0002-9672-2491', 'ORCID: http://orcid.org/0000-0002-3333-6737', 'ORCID: http://orcid.org/0000-0001-5549-9054', 'ORCID: http://orcid.org/0000-0002-6361-5059', 'ORCID: http://orcid.org/0000-0002-3246-8359', 'ORCID: http://orcid.org/0000-0001-9573-0812', 'ORCID: http://orcid.org/0000-0002-7148-1660', 'ORCID: http://orcid.org/0000-0003-4688-107X', 'ORCID: http://orcid.org/0000-0001-8285-7523', 'ORCID: http://orcid.org/0000-0002-0544-7368', 'ORCID: http://orcid.org/0000-0002-8532-5087', 'ORCID: http://orcid.org/0000-0002-7200-5455', 'ORCID: http://orcid.org/0000-0001-5585-3420', 'ORCID: http://orcid.org/0000-0001-6290-445X', 'ORCID: http://orcid.org/0000-0001-5047-4077', 'ORCID: http://orcid.org/0000-0001-7062-8352', 'ORCID: http://orcid.org/0000-0003-3925-3913', 'ORCID: http://orcid.org/0000-0001-7515-0845', 'ORCID: http://orcid.org/0000-0001-6993-6884', 'ORCID: http://orcid.org/0000-0001-7563-5324', 'ORCID: http://orcid.org/0000-0003-3641-4371', 'ORCID: http://orcid.org/0000-0003-1942-5845', 'ORCID: http://orcid.org/0000-0002-8530-2600', 'ORCID: http://orcid.org/0000-0001-7854-1366', 'ORCID: http://orcid.org/0000-0003-2247-8454', 'ORCID: http://orcid.org/0000-0002-0979-3401', 'ORCID: http://orcid.org/0000-0002-8309-094X', 'ORCID: http://orcid.org/0000-0002-3596-7874', 'ORCID: http://orcid.org/0000-0001-9048-3795', 'ORCID: http://orcid.org/0000-0001-8450-3518', 'ORCID: http://orcid.org/0000-0001-5751-9178', 'ORCID: http://orcid.org/0000-0001-8120-2891', 'ORCID: http://orcid.org/0000-0001-9800-1308', 'ORCID: http://orcid.org/0000-0002-6915-9015', 'ORCID: http://orcid.org/0000-0002-9405-9550', 'ORCID: http://orcid.org/0000-0001-7618-0050', 'ORCID: http://orcid.org/0000-0002-6415-6560', 'ORCID: http://orcid.org/0000-0002-2713-686X', 'ORCID: http://orcid.org/0000-0003-4238-659X', 'ORCID: http://orcid.org/0000-0002-4176-2947', 'ORCID: http://orcid.org/0000-0003-4318-6119', 'ORCID: http://orcid.org/0000-0002-4275-9328', 'ORCID: http://orcid.org/0000-0001-9097-7381', 'ORCID: http://orcid.org/0000-0003-4951-1867', 'ORCID: http://orcid.org/0000-0002-7511-5684', 'ORCID: http://orcid.org/0000-0001-9295-3594'], 'AD': ['Department of Epidemiology and Biostatistics, Imperial College London, London, UK.', 'Department of Hygiene and Epidemiology, University of Ioannina Medical School, Ioannina, Greece.', 'William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.', 'National Institute for Health Research, Barts Cardiovascular Biomedical Research Center, Queen Mary University of London, London, UK.', 'Department of Epidemiology and Biostatistics, Imperial College London, London, UK.', 'William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.', 'Department of Epidemiology and Biostatistics, Imperial College London, London, UK.', 'Department of Epidemiology and Biostatistics, Imperial College London, London, UK.', 'MRC-PHE Centre for Environment and Health, Imperial College London, London, UK.', 'Department of Hygiene and Epidemiology, University of Ioannina Medical School, Ioannina, Greece.', 'Department of Hygiene and Epidemiology, University of Ioannina Medical School, Ioannina, Greece.', 'William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.', 'National Institute for Health Research, Barts Cardiovascular Biomedical Research Center, Queen Mary University of London, London, UK.', 'Department of Epidemiology and Biostatistics, Imperial College London, London, UK.', 'William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.', 'Department of Epidemiology and Biostatistics, Imperial College London, London, UK.', 'Department of Mathematics, Imperial College London, London, UK.', 'William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.', 'William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.', 'Division of Epidemiology, Department of Medicine, Institute for Medicine and Public Health, Vanderbilt Genetics Institute, Vanderbilt University Medical Center, Tennessee Valley Healthcare System (626)/Vanderbilt University, Nashville, TN, USA.', 'Vanderbilt Genetics Institute, Vanderbilt Epidemiology Center, Department of Obstetrics and Gynecology, Vanderbilt University Medical Center; Tennessee Valley Health Systems VA, Nashville, TN, USA.', 'Vanderbilt Genetics Institute, Vanderbilt Epidemiology Center, Department of Obstetrics and Gynecology, Vanderbilt University Medical Center; Tennessee Valley Health Systems VA, Nashville, TN, USA.', 'Department of Epidemiology, Emory University Rollins School of Public Health, Atlanta, GA, USA.', 'Department of Biomedical Informatics, Emory University School of Medicine, Atlanta, GA, USA.', 'Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, Boston, MA, USA.', \"Division of Aging, Department of Medicine, Brigham and Women's Hospital; Department of Medicine, Harvard Medical School, Boston, MA, USA.\", 'Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, Boston, MA, USA.', \"Division of Aging, Department of Medicine, Brigham and Women's Hospital; Department of Medicine, Harvard Medical School, Boston, MA, USA.\", 'Atlanta VAMC and Emory Clinical Cardiovascular Research Institute, Atlanta, GA, USA.', 'VA Palo Alto Health Care System, Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA, USA.', 'Nephrology Section, Memphis VA Medical Center and University of Tennessee Health Science Center, Memphis, TN, USA.', 'Estonian Genome Center, University of Tartu, Tartu, Estonia.', 'Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, MA, USA.', 'Estonian Genome Center, University of Tartu, Tartu, Estonia.', 'Estonian Genome Center, University of Tartu, Tartu, Estonia.', 'Department Clinical Sciences, Malmo, Lund University, Malmo, Sweden.', 'MRC Human Genetics Unit, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh, Scotland, UK.', 'Department of Neurology, Bordeaux University Hospital, Bordeaux, France.', 'Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, CHU Bordeaux, Bordeaux, France.', 'Laboratory of Genetics and Genomics, NIA/NIH, Baltimore, MD, USA.', \"Division of Preventive Medicine, Brigham and Women's Hospital, Boston, MA, USA.\", 'Hunter Medical Research Institute and Faculty of Health, University of Newcastle, New Lambton Heights, New South Wales, Australia.', 'Department of Biostatistics and Center for Statistical Genetics, University of Michigan, Ann Arbor, MI, USA.', 'Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands.', 'MRC/BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.', 'MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, UK.', 'Department of Twin Research and Genetic Epidemiology, Kings College London, London, UK.', \"NIHR Biomedical Research Centre at Guy's and St Thomas' Foundation Trust, London, UK.\", 'Hunter Medical Research Institute and Faculty of Health, University of Newcastle, New Lambton Heights, New South Wales, Australia.', 'Wellcome Trust Sanger Institute, Hinxton, UK.', 'Laboratory of Genetics and Genomics, NIA/NIH, Baltimore, MD, USA.', 'Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, CHU Bordeaux, Bordeaux, France.', 'Division of Molecular and Clinical Medicine, School of Medicine, University of Dundee, Dundee, UK.', 'Department of Pharmacy, COMSATS Institute of Information Technology, Abbottabad, Pakistan.', 'MRC/BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.', 'Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada.', 'Institut universitaire de cardiologie et de pneumologie de Quebec-Universite Laval, Quebec City, Quebec, Canada.', 'Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, MA, USA.', 'Cardiovascular Research Center and Center for Human Genetic Research, Massachusetts General Hospital, Boston, MA, USA.', 'University of Groningen, University Medical Center Groningen, Department of Cardiology, Groningen, the Netherlands.', 'MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, UK.', 'MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, UK.', 'University of Lille, Inserm, Centre Hosp. Univ. Lille, Institut Pasteur de Lille, UMR1167 - RID-AGE - Risk factors and molecular determinants of aging-related diseases, Epidemiology and Public Health Department, Lille, France.', 'University of Dundee, Ninewells Hospital & Medical School, Dundee, UK.', 'Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands.', 'Division of Molecular and Clinical Medicine, School of Medicine, University of Dundee, Dundee, UK.', 'Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK.', 'Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.', 'Department of Twin Research and Genetic Epidemiology, Kings College London, London, UK.', 'Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK.', 'Department of Internal Medicine, Section Gerontology and Geriatrics, Leiden University Medical Center, Leiden, the Netherlands.', 'Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada.', 'Imperial Clinical Trials Unit, London, UK.', 'School of Medicine, University College Dublin, Dublin, Ireland.', 'Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland.', 'International Centre for Circulatory Health, Imperial College London, London, UK.', 'Center for Statistical Genetics, Department of Biostatistics, SPH II, Washington Heights, Ann Arbor, MI, USA.', 'Genetic Epidemiology Unit, Department of Epidemiology, Erasmus MC, Rotterdam, the Netherlands.', 'Center for Complex Disease Genomics, McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.', 'Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK.', 'Sema4, a Mount Sinai venture, Stamford, CT, USA.', 'Division of Genetics and Cell Biology, San Raffaele Scientific Institute, Milan, Italy.', 'Department of Health Sciences, University of Leicester, Leicester, UK.', 'Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle, WA, USA.', 'Department of Health Sciences, University of Leicester, Leicester, UK.', 'Institute of Social and Preventive Medicine, University Hospital of Lausanne, Lausanne, Switzerland.', 'Department of Biostatistics and Center for Statistical Genetics, University of Michigan, Ann Arbor, MI, USA.', 'Human Genetics Center, School of Public Health, The University of Texas Health Science Center at Houston and Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA.', 'Department of Biological Psychology, Vrije Universiteit Amsterdam, EMGO+ Institute, VU University Medical Center, Amsterdam, the Netherlands.', 'The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.', 'Department of Cardiovascular Sciences, University of Leicester, Leicester, UK.', 'NIHR Leicester Biomedical Research Centre, Glenfield Hospital, Leicester, UK.', 'Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy.', 'Medical Genetics Section, Centre for Genomic and Experimental Medicine, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK.', 'Generation Scotland, Centre for Genomic and Experimental Medicine, University of Edinburgh, Edinburgh, UK.', 'Centre for Global Health Research, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, Scotland, UK.', 'Center for Complex Disease Genomics, McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.', 'Department of Epidemiology and Biostatistics, Imperial College London, London, UK.', 'MRC-PHE Centre for Environment and Health, Imperial College London, London, UK.', 'Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.', 'Department of Cardiology, Ealing Hospital, Middlesex, UK.', 'Imperial College Healthcare NHS Trust, London, UK.', 'Centre for Brain Research, Indian Institute of Science, Bangalore, India.', 'Institute of Genetics and Biophysics \"A. Buzzati-Traverso\", CNR, Napoli, Italy.', 'IRCCS Neuromed, Pozzilli, Isernia, Italy.', 'Institute for Maternal and Child Health IRCCS Burlo Garofolo, Trieste, Italy.', 'Medical Genomics and Metabolic Genetics Branch, National Human Genome Research Institute, NIH, Bethesda, MD, USA.', 'Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK.', 'Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, Edinburgh, UK.', 'Department of Psychology, University of Edinburgh, Edinburgh, UK.', 'Department of Internal Medicine, Division of Nephrology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.', 'Department of Biological Psychology, Vrije Universiteit Amsterdam, EMGO+ Institute, VU University Medical Center, Amsterdam, the Netherlands.', 'Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, Edinburgh, UK.', 'Department of Psychology, University of Edinburgh, Edinburgh, UK.', 'Department of Molecular Epidemiology, Leiden University Medical Center, Leiden, the Netherlands.', 'Institute for Biomedicine, Eurac Research, Bolzano, Italy - Affiliated Institute of the University of Lubeck, Lubeck, Germany.', 'Mathematical and Statistical Computing Laboratory, Office of Intramural Research, Center for Information Technology, National Institutes of Health, Bethesda, MD, USA.', 'Department of Internal Medicine B, University Medicine Greifswald, Greifswald, Germany.', 'DZHK (German Centre for Cardiovascular Research), partner site Greifswald, Greifswald, Germany.', 'Center for Complex Disease Genomics, McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.', 'Cardiology, Department of Medicine, Geneva University Hospital, Geneva, Switzerland.', 'CIBERCV & Cardiovascular Epidemiology and Genetics, IMIM, Barcelona, Spain.', 'Faculty of Medicine, Universitat de Vic-Central de Catalunya, Vic, Spain.', 'Department of Immunology, Genetics and Pathology, Uppsala Universitet, Science for Life Laboratory, Uppsala, Sweden.', 'Department of Health Sciences, University of Leicester, Leicester, UK.', 'Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.', 'Big Data Institute, Li Ka Shing Center for Health for Health Information and Discovery, Oxford University, Oxford, UK.', 'Cardiovascular Medicine Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.', 'Centre for Molecular Medicine, L8:03, Karolinska Universitetsjukhuset, Solna, Sweden.', 'Department of Numerical Analysis and Computer Science, Stockholm University, Stockholm, Sweden.', 'Department of Epidemiology, Erasmus MC, Rotterdam, the Netherlands.', 'Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy.', 'Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy.', 'Institute for Maternal and Child Health IRCCS Burlo Garofolo, Trieste, Italy.', 'Department of Public Health and Caring Sciences, Geriatrics, Uppsala, Sweden.', 'Research Unit of Molecular Epidemiology, Helmholtz Zentrum Munchen, German Research Center for Environmental Health, Neuherberg, Germany.', 'Institute of Epidemiology, Helmholtz Zentrum Munchen, German Research Center for Environmental Health, Neuherberg, Germany.', 'German Center for Diabetes Research (DZD e.V.), Neuherberg, Germany.', 'Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy.', 'Institute for Maternal and Child Health IRCCS Burlo Garofolo, Trieste, Italy.', 'Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK.', 'Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.', 'Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, Edinburgh, UK.', 'Department of Psychology, School of Social Sciences, Heriot-Watt University, Edinburgh, UK.', 'Faculty of Medicine, University of Iceland, Reykjavik, Iceland.', 'Icelandic Heart Association, Kopavogur, Iceland.', 'The Institute for Translational Genomics and Population Sciences, Department of Pediatrics, LABioMed at Harbor-UCLA Medical Center, Torrance, CA, USA.', 'Department of Immunology, Genetics and Pathology, Uppsala Universitet, Science for Life Laboratory, Uppsala, Sweden.', 'Cardiovascular Medicine Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.', 'Centre for Molecular Medicine, L8:03, Karolinska Universitetsjukhuset, Solna, Sweden.', 'Intramural Research Program, Laboratory of Epidemiology, Demography, and Biometry, National Institute on Aging, Bethesda, MD, USA.', 'Medical Genetics Section, Centre for Genomic and Experimental Medicine, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK.', 'Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, Edinburgh, UK.', 'Department of Psychiatry, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.', 'Department of Public Health Solutions, National Institute for Health and Welfare (THL), Helsinki, Finland.', 'Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.', 'Institute for Biomedicine, Eurac Research, Bolzano, Italy - Affiliated Institute of the University of Lubeck, Lubeck, Germany.', 'Clinical Division of Neurogeriatrics, Department of Neurology, Medical University of Graz, Graz, Austria.', 'Institute for Medical Informatics, Statistics and Documentation, Medical University of Graz, Graz, Austria.', 'Department of Epidemiology, Erasmus MC, Rotterdam, the Netherlands.', 'Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.', 'Department of Biological Psychology, Vrije Universiteit Amsterdam, EMGO+ Institute, VU University Medical Center, Amsterdam, the Netherlands.', 'MRC Human Genetics Unit, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh, Scotland, UK.', \"National Heart, Lung and Blood Institute's Framingham Heart Study, Framingham, MA, USA.\", 'The Population Science Branch, Division of Intramural Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.', \"National Heart, Lung and Blood Institute's Framingham Heart Study, Framingham, MA, USA.\", 'The Population Science Branch, Division of Intramural Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.', 'Department of Medical Sciences, Molecular Epidemiology and Science for Life Laboratory, Uppsala University, Uppsala, Sweden.', 'Division of Cardiovascular Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.', 'Department of Pulmonary Physiology and Sleep, Sir Charles Gairdner Hospital, Hospital Avenue, Nedlands, Western Australia, Australia.', 'School of Medicine and Pharmacology, University of Western Australia, Perth, Western Australia, Australia.', 'Department of Psychiatry, VU University Medical Center, Amsterdam Neuroscience, Amsterdam, the Netherlands.', 'Department of Epidemiology and Biostatistics, Imperial College London, London, UK.', 'MRC-PHE Centre for Environment and Health, Imperial College London, London, UK.', 'Biocenter Oulu, University of Oulu, Oulu, Finland.', 'Center For Life-course Health Research, University of Oulu, Oulu, Finland.', 'Unit of Primary Care, Oulu University Hospital, Oulu, Oulu, Finland.', \"National Heart, Lung and Blood Institute's Framingham Heart Study, Framingham, MA, USA.\", 'Hebrew SeniorLife, Harvard Medical School, Boston, MA, USA.', 'Department of Immunology, Genetics and Pathology, Uppsala Universitet, Science for Life Laboratory, Uppsala, Sweden.', \"National Heart, Lung and Blood Institute's Framingham Heart Study, Framingham, MA, USA.\", 'Population Sciences Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.', 'Centre for Global Health Research, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, Scotland, UK.', 'Department of Public Health Solutions, National Institute for Health and Welfare (THL), Helsinki, Finland.', 'Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands.', 'Department of Public Health Solutions, National Institute for Health and Welfare (THL), Helsinki, Finland.', 'Department of Clinical Physiology, Tampere University Hospital, Tampere, Finland.', 'Department of Clinical Physiology, Finnish Cardiovascular Research Center - Tampere, Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland.', 'Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, MA, USA.', 'Cardiovascular Research Center and Center for Human Genetic Research, Massachusetts General Hospital, Boston, MA, USA.', 'Broad Institute of the Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.', 'Division of Cardiovascular Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.', 'Division of Medicine, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.', 'Department of Public Health and Primary Care, Institute of Public Health, University of Cambridge, Cambridge, UK.', 'Department of Public Health Solutions, National Institute for Health and Welfare (THL), Helsinki, Finland.', 'Data Science Institute and Lancaster Medical School, Lancaster, UK.', 'Department of Public Health, Faculty of Medicine, University of Split, Split, Croatia.', 'MRC-PHE Centre for Environment and Health, Imperial College London, London, UK.', 'Department of Cardiology, Ealing Hospital, Middlesex, UK.', 'Imperial College Healthcare NHS Trust, London, UK.', 'National Heart and Lung Institute, Imperial College London, London, UK.', 'Department of Public Health Solutions, National Institute for Health and Welfare (THL), Helsinki, Finland.', 'Department of Public Health Solutions, National Institute for Health and Welfare (THL), Helsinki, Finland.', 'Institute of Social and Preventive Medicine, University Hospital of Lausanne, Lausanne, Switzerland.', 'Swiss Institute of Bioinformatics, Lausanne, Switzerland.', 'Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.', \"National Heart, Lung and Blood Institute's Framingham Heart Study, Framingham, MA, USA.\", 'Intramural Research Program, Laboratory of Epidemiology, Demography, and Biometry, National Institute on Aging, Bethesda, MD, USA.', 'Department of Epidemiology and Biostatistics, Imperial College London, London, UK.', 'Department of Clinical Chemistry, Fimlab Laboratories, Tampere, Finland.', 'Department of Clinical Chemistry, Finnish Cardiovascular Research Center - Tampere, Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland.', 'Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, Edinburgh, UK.', 'Department of Psychology, University of Edinburgh, Edinburgh, UK.', 'Cardiology, Department of Medicine, Geneva University Hospital, Geneva, Switzerland.', 'Department of Medical Sciences, Cardiovascular Epidemiology, Uppsala University, Uppsala, Sweden.', 'Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK.', 'Big Data Institute, Li Ka Shing Center for Health for Health Information and Discovery, Oxford University, Oxford, UK.', 'Program in Medical and Population Genetics, Broad Institute, Cambridge, MA, USA.', 'Division of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, NC, USA.', 'MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, UK.', 'The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.', 'Mindich Child Health Development Institute, The Icahn School of Medicine at Mount Sinai, New York, NY, USA.', 'Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, Edinburgh, UK.', 'Department of Psychiatry, Royal College of Surgeons in Ireland, Education and Research Centre, Beaumont Hospital, Dublin, Ireland.', 'University College Dublin, UCD Conway Institute, Centre for Proteome Research, UCD, Belfield, Dublin, Ireland.', 'The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.', 'Department of Clinical Chemistry, Fimlab Laboratories, Tampere, Finland.', 'Department of Clinical Chemistry, Finnish Cardiovascular Research Center - Tampere, Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland.', 'Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK.', 'Institute of Health and Society, Newcastle University, Newcastle upon Tyne, UK.', 'CIBERCV & Cardiovascular Epidemiology and Genetics, IMIM, Barcelona, Spain.', 'MRC Human Genetics Unit, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh, Scotland, UK.', 'Department of Psychiatry, Amsterdam Public Health and Amsterdam Neuroscience, VU University Medical Center/GGZ inGeest, Amsterdam, the Netherlands.', 'Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy.', 'Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK.', 'Department of Biostatistics, University of Liverpool, Liverpool, UK.', 'Department of Epidemiology, Human Genetics and Environmental Sciences, School of Public Health, University of Texas Health Science Center at Houston, Houston, TX, USA.', 'Mathematical and Statistical Computing Laboratory, Office of Intramural Research, Center for Information Technology, National Institutes of Health, Bethesda, MD, USA.', 'Data Tecnica International, Glen Echo, MD, USA.', 'Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA.', 'Center for Complex Disease Genomics, McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.', 'Department of Cardiovascular Sciences, University of Leicester, Leicester, UK.', 'NIHR Leicester Biomedical Research Centre, Glenfield Hospital, Leicester, UK.', 'Department of Public Health Solutions, National Institute for Health and Welfare (THL), Helsinki, Finland.', 'Department of Medicine, Turku University Hospital and University of Turku, Turku, Finland.', 'Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.', 'Institute of Genetics and Biophysics \"A. Buzzati-Traverso\", CNR, Napoli, Italy.', 'Interdisciplinary Center Psychopathology and Emotion Regulation (ICPE), University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.', 'Genetic Epidemiology Unit, Department of Epidemiology, Erasmus MC, Rotterdam, the Netherlands.', \"SGDP Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.\", 'Estonian Genome Center, University of Tartu, Tartu, Estonia.', 'Generation Scotland, Centre for Genomic and Experimental Medicine, University of Edinburgh, Edinburgh, UK.', 'British Heart Foundation Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.', 'Department of Medicine, Columbia University Medical Center, New York, NY, USA.', 'Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.', 'Analytic and Translational Genetics Unit, Department of Medicine, Department of Neurology and Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.', 'The Stanley Center for Psychiatric Research and Program in Medical and Population Genetics, The Broad Institute of MIT and Harvard, Cambridge, MA, USA.', 'Department of Psychology, University of Edinburgh, Edinburgh, UK.', 'Department of Psychiatry, Amsterdam Public Health and Amsterdam Neuroscience, VU University Medical Center/GGZ inGeest, Amsterdam, the Netherlands.', 'Department of Public Health Solutions, National Institute for Health and Welfare (THL), Helsinki, Finland.', 'Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.', 'University of Tartu, Tartu, Estonia.', 'Institute of Epidemiology, Helmholtz Zentrum Munchen, German Research Center for Environmental Health, Neuherberg, Germany.', 'German Center for Diabetes Research (DZD e.V.), Neuherberg, Germany.', 'German Center for Cardiovascular Disease Research (DZHK), partner site Munich, Neuherberg, Germany.', 'Department of Public Health, Faculty of Medicine, University of Split, Split, Croatia.', 'Psychiatric Hospital \"Sveti Ivan\", Zagreb, Croatia.', 'Institute for Biomedicine, Eurac Research, Bolzano, Italy - Affiliated Institute of the University of Lubeck, Lubeck, Germany.', 'Department of Neurology, General Central Hospital, Bolzano, Italy.', 'Department of Neurology, University of Lubeck, Lubeck, Germany.', 'Mathematical and Statistical Computing Laboratory, Office of Intramural Research, Center for Information Technology, National Institutes of Health, Bethesda, MD, USA.', 'Department of Clinical Physiology and Nuclear Medicine, Turku University Hospital, Turku, Finland.', 'Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, Turku, Finland.', 'Fujian Key Laboratory of Geriatrics, Department of Geriatric Medicine, Fujian Provincial Hospital, Fujian Medical University, Fuzhou, China.', 'Institute of Physiology, University Medicine Greifswald, Karlsburg, Germany.', 'Department of Biostatistics, University of Washington, Seattle, WA, USA.', \"Division of Preventive Medicine, Brigham and Women's Hospital, Boston, MA, USA.\", 'Harvard Medical School, Boston, MA, USA.', 'Institute of Epidemiology, Helmholtz Zentrum Munchen, German Research Center for Environmental Health, Neuherberg, Germany.', 'Interdisciplinary Center Psychopathology and Emotion Regulation (ICPE), University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.', 'Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.', 'Public Health, Faculty of Medicine, University of Helsinki, Helsinki, Finland.', 'Institute for Maternal and Child Health IRCCS Burlo Garofolo, Trieste, Italy.', \"Division of Preventive Medicine, Brigham and Women's Hospital, Boston, MA, USA.\", 'The Institute for Translational Genomics and Population Sciences, Department of Pediatrics, LABioMed at Harbor-UCLA Medical Center, Torrance, CA, USA.', 'Centre for Global Health Research, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, Scotland, UK.', 'Institute of Genetics and Biophysics \"A. Buzzati-Traverso\", CNR, Napoli, Italy.', 'IRCCS Neuromed, Pozzilli, Isernia, Italy.', 'Gottfried Schatz Research Center for Cell Signaling, Metabolism & Aging, Molecular Biology and Biochemistry, Medical University of Graz, Graz, Austria.', 'Division of Genetics and Cell Biology, San Raffaele Scientific Institute, Milan, Italy.', 'Department of Public Health Solutions, National Institute for Health and Welfare (THL), Helsinki, Finland.', 'Department of Cardiovascular Sciences, University of Leicester, Leicester, UK.', 'NIHR Leicester Biomedical Research Centre, Glenfield Hospital, Leicester, UK.', 'Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.', 'Clinical Division of Neurogeriatrics, Department of Neurology, Medical University of Graz, Graz, Austria.', 'Gottfried Schatz Research Center for Cell Signaling, Metabolism & Aging, Molecular Biology and Biochemistry, Medical University of Graz, Graz, Austria.', 'Department of Health Sciences, University of Leicester, Leicester, UK.', 'The New York Academy of Medicine, New York, NY, USA.', 'Faculty of Medicine, University of Iceland, Reykjavik, Iceland.', 'Icelandic Heart Association, Kopavogur, Iceland.', 'Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.', 'Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.', 'Institute of Genetics and Biophysics \"A. Buzzati-Traverso\", CNR, Napoli, Italy.', 'Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, Edinburgh, UK.', 'Alzheimer Scotland Dementia Research Centre, University of Edinburgh, Edinburgh, UK.', 'Institute of Cardiovascular and Medical Sciences, Faculty of Medicine, University of Glasgow, Glasgow, UK.', \"Population Health Research Institute, St George's, University of London, London, UK.\", 'Cardiovascular Medicine Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.', 'Centre for Molecular Medicine, L8:03, Karolinska Universitetsjukhuset, Solna, Sweden.', 'Department of Medical Sciences, Cardiovascular Epidemiology, Uppsala University, Uppsala, Sweden.', 'Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.', 'The Institute for Translational Genomics and Population Sciences, Department of Pediatrics, LABioMed at Harbor-UCLA Medical Center, Torrance, CA, USA.', 'DZHK (German Centre for Cardiovascular Research), partner site Greifswald, Greifswald, Germany.', 'Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany.', 'Department of Health Sciences, University of Leicester, Leicester, UK.', 'Division of Cardiovascular Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.', 'Division of Medicine, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.', 'Division of Genetics and Cell Biology, San Raffaele Scientific Institute, Milan, Italy.', 'Division of Genetics and Cell Biology, San Raffaele Scientific Institute, Milan, Italy.', 'Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands.', 'Department of Gerontology and Geriatrics, Leiden University Medical Center, Leiden, the Netherlands.', 'Dasman Diabetes Institute, Dasman, Kuwait.', 'Chronic Disease Prevention Unit, National Institute for Health and Welfare, Helsinki, Finland.', 'Department of Public Health, University of Helsinki, Helsinki, Finland.', 'Saudi Diabetes Research Group, King Abdulaziz University, Jeddah, Saudi Arabia.', 'Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, CHU Bordeaux, Bordeaux, France.', 'Department of Epidemiology, Erasmus MC, Rotterdam, the Netherlands.', 'Department of Internal Medicine, Erasmus MC, Rotterdam, the Netherlands.', 'Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.', 'Research Institute for Primordial Prevention of Non-communicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran.', 'Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.', 'Genetic Epidemiology Unit, Department of Epidemiology, Erasmus MC, Rotterdam, the Netherlands.', 'Department of Epidemiology and Biostatistics, Imperial College London, London, UK.', 'Department of Epidemiology, Erasmus MC, Rotterdam, the Netherlands.', 'MRC Human Genetics Unit, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh, Scotland, UK.', 'DZHK (German Centre for Cardiovascular Research), partner site Greifswald, Greifswald, Germany.', 'Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Greifswald, Germany.', 'Department of Internal Medicine, University Hospital, CHUV, Lausanne, Switzerland.', 'Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy.', 'Experimental Genetics Division, Sidra Medical and Research Center, Doha, Qatar.', 'Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK.', 'Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.', 'Centre for Population Health Sciences, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, Scotland, UK.', 'Department of Biological Psychology, Vrije Universiteit Amsterdam, EMGO+ Institute, VU University Medical Center, Amsterdam, the Netherlands.', 'MRC Human Genetics Unit, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh, Scotland, UK.', 'Centre for Global Health Research, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, Scotland, UK.', 'MRC Human Genetics Unit, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh, Scotland, UK.', 'The Institute for Translational Genomics and Population Sciences, Department of Pediatrics, LABioMed at Harbor-UCLA Medical Center, Torrance, CA, USA.', 'Department of Biology, Faculty of Medicine, University of Split, Split, Croatia.', 'Department of Epidemiology and Biostatistics, Imperial College London, London, UK.', 'Department of Cardiology, Ealing Hospital, Middlesex, UK.', 'Hunter Medical Research Institute and Faculty of Health, University of Newcastle, New Lambton Heights, New South Wales, Australia.', 'MRC/BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.', 'The National Institute for Health Research Blood and Transplant Research Unit in Donor Health and Genomics, University of Cambridge, Cambridge, UK.', \"Division of Preventive Medicine, Brigham and Women's Hospital, Boston, MA, USA.\", 'Harvard Medical School, Boston, MA, USA.', 'Division of Cardiology, University Hospital, Basel, Switzerland.', 'Division of Cardiology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.', 'Institute of Genetic and Biomedical Research, National Research Council (CNR), Monserrato, Cagliari, Italy.', 'Department of Biomedical Sciences, University of Sassari, Sassari, Italy.', 'MRC/BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.', 'The National Institute for Health Research Blood and Transplant Research Unit in Donor Health and Genomics, University of Cambridge, Cambridge, UK.', 'MRC Human Genetics Unit, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh, Scotland, UK.', 'MRC/BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.', 'Institute of Clinical Medicine, Internal Medicine, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland.', 'Laboratory of Cardiovascular Science, National Institute on Aging, National Institutes of Health, Baltimore, MD, USA.', 'MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, UK.', 'Department Clinical Sciences, Malmo, Lund University, Malmo, Sweden.', 'Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands.', 'Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, the Netherlands.', 'Division of Molecular and Clinical Medicine, School of Medicine, University of Dundee, Dundee, UK.', 'Labormedizinisches Zentrum Dr. Risch, Schaan, Liechtenstein.', 'Private University of the Principality of Liechtenstein, Triesen, Liechtenstein.', 'University Institute of Clinical Chemistry, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.', 'MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, UK.', 'Hunter Medical Research Institute and Faculty of Health, University of Newcastle, New Lambton Heights, New South Wales, Australia.', 'National Heart and Lung Institute, Imperial College London, London, UK.', 'Department of Twin Research and Genetic Epidemiology, Kings College London, London, UK.', 'Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.', 'MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, UK.', 'Wellcome Trust Sanger Institute, Hinxton, UK.', \"National Heart, Lung and Blood Institute's Framingham Heart Study, Framingham, MA, USA.\", 'Population Sciences Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.', 'William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.', 'National Institute for Health Research, Barts Cardiovascular Biomedical Research Center, Queen Mary University of London, London, UK.', 'Program in Medical and Population Genetics, Broad Institute, Cambridge, MA, USA.', 'Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.', 'Cardiovascular Research Center, Massachusetts General Hospital, Boston, MA, USA.', 'William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.', 'National Institute for Health Research, Barts Cardiovascular Biomedical Research Center, Queen Mary University of London, London, UK.', 'Estonian Genome Center, University of Tartu, Tartu, Estonia.', 'Tennessee Valley Healthcare System (Nashville VA) & Vanderbilt University, Nashville, TN, USA.', \"VA Boston Healthcare, Section of Cardiology and Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.\", 'Division of Epidemiology, Department of Medicine, Institute for Medicine and Public Health, Vanderbilt Genetics Institute, Vanderbilt University Medical Center, Tennessee Valley Healthcare System (626)/Vanderbilt University, Nashville, TN, USA.', 'Cardiovascular Health Research Unit, Departments of Medicine, Epidemiology and Health Services, University of Washington, Seattle, WA, USA.', 'Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA.', 'Department of Epidemiology and Biostatistics, Imperial College London, London, UK.', 'Department of Hygiene and Epidemiology, University of Ioannina Medical School, Ioannina, Greece.', 'MRC-PHE Centre for Environment and Health, Imperial College London, London, UK.', 'William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.', 'National Institute for Health Research, Barts Cardiovascular Biomedical Research Center, Queen Mary University of London, London, UK.', 'Department of Health Sciences, University of Leicester, Leicester, UK.', 'NIHR Leicester Biomedical Research Centre, Glenfield Hospital, Leicester, UK.', 'Department of Epidemiology and Biostatistics, Imperial College London, London, UK. p.elliott@imperial.ac.uk.', 'MRC-PHE Centre for Environment and Health, Imperial College London, London, UK. p.elliott@imperial.ac.uk.', 'National Institute for Health Research Imperial Biomedical Research Centre, Imperial College Healthcare NHS Trust and Imperial College London, London, UK. p.elliott@imperial.ac.uk.', 'UK Dementia Research Institute (UK DRI) at Imperial College London, London, UK. p.elliott@imperial.ac.uk.', 'Health Data Research-UK London substantive site, London, UK. p.elliott@imperial.ac.uk.', 'William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK. m.j.caulfield@qmul.ac.uk.', 'National Institute for Health Research, Barts Cardiovascular Biomedical Research Center, Queen Mary University of London, London, UK. m.j.caulfield@qmul.ac.uk.'], 'CN': ['Million Veteran Program'], 'LA': ['eng'], 'GR': ['G1001799/MRC_/Medical Research Council/United Kingdom', 'RG/13/13/30194/BHF_/British Heart Foundation/United Kingdom', 'MR/N015746/1/MRC_/Medical Research Council/United Kingdom', 'MR/N003284/1/MRC_/Medical Research Council/United Kingdom', 'T32 CA160056/CA/NCI NIH HHS/United States', 'MR/N01104X/1/MRC_/Medical Research Council/United Kingdom', 'G0401527/MRC_/Medical Research Council/United Kingdom', 'MC_PC_13040/MRC_/Medical Research Council/United Kingdom', 'M01 RR000070/RR/NCRR NIH HHS/United States', 'U01 DK102163/DK/NIDDK NIH HHS/United States', 'FS/12/82/29736/BHF_/British Heart Foundation/United Kingdom', 'MC_UU_00007/10/MRC_/Medical Research Council/United Kingdom', 'U01 HG007417/HG/NHGRI NIH HHS/United States', 'RG/15/12/31616/BHF_/British Heart Foundation/United Kingdom', 'MR/N01104X/2/MRC_/Medical Research Council/United Kingdom', 'U01 HL130114/HL/NHLBI NIH HHS/United States', 'SP/13/2/30111/BHF_/British Heart Foundation/United Kingdom', 'MR/L01632X/1/MRC_/Medical Research Council/United Kingdom', 'R01 DK110113/DK/NIDDK NIH HHS/United States', 'G1000143/MRC_/Medical Research Council/United Kingdom', 'R01 DK107786/DK/NIDDK NIH HHS/United States', 'R01 DK075787/DK/NIDDK NIH HHS/United States', 'MR/L01341X/1/MRC_/Medical Research Council/United Kingdom', 'MR/L003120/1/MRC_/Medical Research Council/United Kingdom', 'G0601966/MRC_/Medical Research Council/United Kingdom', 'MC_UU_12015/1/MRC_/Medical Research Council/United Kingdom', 'R01 DK062370/DK/NIDDK NIH HHS/United States', 'R01 HL105756/HL/NHLBI NIH HHS/United States', 'R01 DK101855/DK/NIDDK NIH HHS/United States', '14136/CRUK_/Cancer Research UK/United Kingdom', 'MR/S003746/1/MRC_/Medical Research Council/United Kingdom', 'MC_PC_U127561128/MRC_/Medical Research Council/United Kingdom', 'S10 OD023680/OD/NIH HHS/United States', 'MR/M004422/1/MRC_/Medical Research Council/United Kingdom', 'U01 DK062370/DK/NIDDK NIH HHS/United States', 'K12 HD043483/HD/NICHD NIH HHS/United States', 'I01 CX000982/CX/CSRD VA/United States', 'MR/R023484/1/MRC_/Medical Research Council/United Kingdom', 'I01 BX003360/BX/BLRD VA/United States', 'P30 DK020572/DK/NIDDK NIH HHS/United States', 'MR/K007017/1/MRC_/Medical Research Council/United Kingdom', 'WT_/Wellcome Trust/United Kingdom', 'R21 HL121429/HL/NHLBI NIH HHS/United States', 'BB/F019394/1/BB_/Biotechnology and Biological Sciences Research Council/United', 'Kingdom'], 'PT': ['Journal Article', 'Meta-Analysis', 'Research Support, N.I.H., Extramural', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20180917', 'PL': 'United States', 'TA': 'Nat Genet', 'JT': 'Nature genetics', 'JID': '9216904', 'SB': 'IM', 'EIN': ['Nat Genet. 2018 Dec;50(12):1755. PMID: 30429575'], 'MH': ['Adult', 'Aged', 'Aged, 80 and over', 'Blood Pressure/*genetics', 'Cardiovascular Diseases/epidemiology/genetics', 'Cells, Cultured', 'Female', 'Genetic Loci', 'Genetic Predisposition to Disease', 'Genetic Testing/methods', 'Genetics, Population/methods', 'Genome-Wide Association Study', 'Human Umbilical Vein Endothelial Cells', 'Humans', 'Hypertension/genetics', 'Life Style', 'Male', 'Middle Aged', 'Polymorphism, Single Nucleotide', '*Quantitative Trait Loci', 'Risk Factors'], 'PMC': 'PMC6284793', 'MID': ['EMS80726'], 'EDAT': '2018/09/19 06:00', 'MHDA': '2019/04/27 06:00', 'CRDT': ['2018/09/19 06:00'], 'PHST': ['2017/10/03 00:00 [received]', '2018/07/09 00:00 [accepted]', '2018/09/19 06:00 [pubmed]', '2019/04/27 06:00 [medline]', '2018/09/19 06:00 [entrez]'], 'AID': ['10.1038/s41588-018-0205-x [doi]', '10.1038/s41588-018-0205-x [pii]'], 'PST': 'ppublish', 'SO': 'Nat Genet. 2018 Oct;50(10):1412-1425. doi: 10.1038/s41588-018-0205-x. Epub 2018 Sep 17.'}\n",
      "{'PMID': '30212933', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20180925', 'LR': '20181114', 'IS': '1536-5964 (Electronic) 0025-7974 (Linking)', 'VI': '97', 'IP': '37', 'DP': '2018 Sep', 'TI': 'Comprehensive analysis of lysine crotonylation in proteome of maintenance hemodialysis patients.', 'PG': 'e12035', 'LID': '10.1097/MD.0000000000012035 [doi]', 'AB': 'INTRODUCTION: Histone post-translational modifications (PTMs) carry epigenetic information to regulate diverse cellular processes at the chromatin level. Crotonylation, one of the most important and common PTMs, plays a key role in the regulation of various biological processes. However, no study has evaluated the role of lysine crotonylation in maintenance hemodialysis patients (MHP). METHODS: Here, we comparatively evaluated the crotonylation proteome of normal controls (NC) and MHP using liquid chromatography tandem mass spectrometry (LC-MS/MS) coupled with highly sensitive immune-affinity purification. RESULTS: A total of 1109 lysine modification sites distributed on 347 proteins were identified, including 93 and 252 crotonylated upregulated and downregulated proteins, respectively. Thus, a decrease in crotonylation of histone proteins was observed in patients with kidney failure undergoing maintenance hemodialysis. Intensive bioinformatic analysis revealed that most of the crotonylated proteins were distributed in the cytoplasm, nucleus, mitochondria, and extracellular region. Gene ontology enrichment analysis showed that the crotonylated proteins were significantly enriched in the platelet alpha granule lumen, platelet degranulation, and cell adhesion molecule binding. In addition, protein domain, including fibrinogen alpha/beta/gamma chain, zinc finger, and WD40-repeat-containing domain, were significantly enriched in crotonylated proteins. Kyoto Encyclopedia of Genes and Genomes (KEGG)-based functional enrichment analysis revealed that crotonylated proteins were enriched in complement and coagulation cascades, cardiac muscle contraction, and hematopoietic cell lineage, all of which have important associations with hemodialysis complications. CONCLUSIONS: This is the first report on the global crotonylation proteome of MHP. Lysine crotonylation was found to play important regulatory roles in pathophysiological processes in MHP.', 'FAU': ['Chen, Wenbiao', 'Tang, Donge', 'Xu, Yong', 'Zou, Yaoshuang', 'Sui, Weiguo', 'Dai, Yong', 'Diao, Hongyan'], 'AU': ['Chen W', 'Tang D', 'Xu Y', 'Zou Y', 'Sui W', 'Dai Y', 'Diao H'], 'AD': ['State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou.', \"Clinical Medical Research Center, the Second Clinical Medical College of Jinan University (Shenzhen People's Hospital), Shenzhen, Guangdong.\", \"Clinical Medical Research Center, the Second Clinical Medical College of Jinan University (Shenzhen People's Hospital), Shenzhen, Guangdong.\", 'Nephrology Department of Guilin No.181 Hospital, Guangxi Key Laboratory of Metabolic Diseases Research, Guilin Key laboratory of Kidney Diseases Research, Guilin, Guangxi, P.R. China.', 'Nephrology Department of Guilin No.181 Hospital, Guangxi Key Laboratory of Metabolic Diseases Research, Guilin Key laboratory of Kidney Diseases Research, Guilin, Guangxi, P.R. China.', \"Clinical Medical Research Center, the Second Clinical Medical College of Jinan University (Shenzhen People's Hospital), Shenzhen, Guangdong.\", 'State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou.'], 'LA': ['eng'], 'PT': ['Journal Article'], 'PL': 'United States', 'TA': 'Medicine (Baltimore)', 'JT': 'Medicine', 'JID': '2985248R', 'RN': ['0 (Cell Adhesion Molecules)', '0 (Histones)', '0 (Proteome)', 'K3Z4F929H6 (Lysine)'], 'SB': 'AIM IM', 'MH': ['Adult', 'Blood Platelets/metabolism', 'Cell Adhesion Molecules/metabolism', 'Chromatography, High Pressure Liquid', 'Computational Biology', 'Down-Regulation', 'Female', 'Gene Ontology', 'Histones/*metabolism', 'Humans', 'Lysine/*metabolism', 'Male', 'Middle Aged', 'Protein Processing, Post-Translational/*physiology', 'Proteome', 'Renal Dialysis/*methods', 'Renal Insufficiency/metabolism/*therapy', 'Tandem Mass Spectrometry', 'Up-Regulation'], 'PMC': 'PMC6156053', 'EDAT': '2018/09/15 06:00', 'MHDA': '2018/09/27 06:00', 'CRDT': ['2018/09/15 06:00'], 'PHST': ['2018/09/15 06:00 [entrez]', '2018/09/15 06:00 [pubmed]', '2018/09/27 06:00 [medline]'], 'AID': ['10.1097/MD.0000000000012035 [doi]', '00005792-201809140-00010 [pii]'], 'PST': 'ppublish', 'SO': 'Medicine (Baltimore). 2018 Sep;97(37):e12035. doi: 10.1097/MD.0000000000012035.'}\n",
      "{'PMID': '30201848', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20190204', 'LR': '20191102', 'IS': '1935-5548 (Electronic) 0149-5992 (Linking)', 'VI': '41', 'IP': '11', 'DP': '2018 Nov', 'TI': 'Therapeutic Lifestyle Changes Improve HDL Function by Inhibiting Myeloperoxidase-Mediated Oxidation in Patients With Metabolic Syndrome.', 'PG': '2431-2437', 'LID': '10.2337/dc18-0049 [doi]', 'AB': 'OBJECTIVE: Phagocyte-derived myeloperoxidase (MPO) and proinflammatory HDL are associated with metabolic syndrome (MetS) and increased cardiovascular disease risk. Therapeutic lifestyle changes (TLCs), such as a Mediterranean diet and exercise, decrease this risk. However, the link among TLCs, HDL, and MPO-mediated oxidative stress remains unclear. RESEARCH DESIGN AND METHODS: In this study, we characterized changes in cholesterol efflux capacity (CEC), a metric of HDL function; MPO-mediated oxidation; and the HDL proteomic profile in 25 patients with MetS who underwent 12 weeks of TLCs. RESULTS: After 12 weeks, before significant changes to HDL levels, most MetS components improved as a result of the TLCs. CEC was significantly increased, and HDL MPO oxidation products, 3-chlorotyrosine and 3-nitrotyrosine, were decreased with TLCs. The changes in CEC were inversely related to the unit changes in 3-chlorotyrosine after we controlled for changes in the other MetS components. TLCs did not remodel the HDL proteome. CONCLUSIONS: In summary, TLCs improved HDL function by inhibiting MPO-mediated oxidative stress even before appreciable changes in HDL levels.', 'CI': ['(c) 2018 by the American Diabetes Association.'], 'FAU': ['Mathew, Anna V', 'Li, Lei', 'Byun, Jaeman', 'Guo, Yanhong', 'Michailidis, George', 'Jaiswal, Mamta', 'Chen, Y Eugene', 'Pop-Busui, Rodica', 'Pennathur, Subramaniam'], 'AU': ['Mathew AV', 'Li L', 'Byun J', 'Guo Y', 'Michailidis G', 'Jaiswal M', 'Chen YE', 'Pop-Busui R', 'Pennathur S'], 'AD': ['Division of Nephrology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI.', 'Peking University Health Sciences Center, Beijing, China.', 'Division of Nephrology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI.', 'Department of Cardiac Surgery, University of Michigan, Ann Arbor, MI.', 'University of Florida, Gainesville, FL.', 'Division of Metabolism, Endocrinology & Diabetes, Department of Internal Medicine, University of Michigan, Ann Arbor, MI.', 'Department of Cardiac Surgery, University of Michigan, Ann Arbor, MI.', 'Division of Metabolism, Endocrinology & Diabetes, Department of Internal Medicine, University of Michigan, Ann Arbor, MI.', 'Division of Nephrology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI spennath@umich.edu.', 'Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, MI.'], 'AUID': ['ORCID: 0000-0002-2042-1350', 'ORCID: 0000-0003-3628-6883'], 'LA': ['eng'], 'SI': ['ClinicalTrials.gov/NCT00907127'], 'GR': ['P30 DK092926/DK/NIDDK NIH HHS/United States', 'K08 HL130944/HL/NHLBI NIH HHS/United States', 'P30 DK089503/DK/NIDDK NIH HHS/United States', 'P30 DK020572/DK/NIDDK NIH HHS/United States', 'P30 DK081943/DK/NIDDK NIH HHS/United States'], 'PT': ['Clinical Trial', 'Journal Article', 'Research Support, N.I.H., Extramural'], 'DEP': '20180910', 'PL': 'United States', 'TA': 'Diabetes Care', 'JT': 'Diabetes care', 'JID': '7805975', 'RN': ['0 (Cholesterol, HDL)', '0 (Lipoproteins, HDL)', 'EC 1.11.1.7 (MPO protein, human)', 'EC 1.11.1.7 (Peroxidase)'], 'SB': 'IM', 'CIN': ['Diabetes Care. 2019 Feb;42(2):e25. PMID: 30665968', 'Diabetes Care. 2019 Feb;42(2):e26-e27. PMID: 30665969'], 'MH': ['Adolescent', 'Adult', 'Aged', 'Animals', 'Biological Transport', 'Caloric Restriction', 'Cells, Cultured', 'Cholesterol, HDL/*metabolism', 'Diet Therapy', 'Diet, Mediterranean', 'Exercise Therapy', 'Female', 'Humans', '*Life Style', 'Lipoproteins, HDL/*metabolism', 'Male', 'Metabolic Syndrome/metabolism/*therapy', 'Mice', 'Middle Aged', 'Oxidation-Reduction', 'Oxidative Stress/physiology', 'Patient Education as Topic', 'Peroxidase/antagonists & inhibitors/metabolism', 'Pilot Projects', 'Proteomics', 'Risk Reduction Behavior', 'Young Adult'], 'PMC': 'PMC6196832', 'EDAT': '2018/09/12 06:00', 'MHDA': '2019/02/05 06:00', 'CRDT': ['2018/09/12 06:00'], 'PHST': ['2018/01/08 00:00 [received]', '2018/08/17 00:00 [accepted]', '2018/09/12 06:00 [pubmed]', '2019/02/05 06:00 [medline]', '2018/09/12 06:00 [entrez]'], 'AID': ['dc18-0049 [pii]', '10.2337/dc18-0049 [doi]'], 'PST': 'ppublish', 'SO': 'Diabetes Care. 2018 Nov;41(11):2431-2437. doi: 10.2337/dc18-0049. Epub 2018 Sep 10.'}\n",
      "{'PMID': '30192561', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20190805', 'LR': '20190805', 'IS': '1535-3907 (Electronic) 1535-3893 (Linking)', 'VI': '17', 'IP': '10', 'DP': '2018 Oct 5', 'TI': 'Activity-Based Protein Profiling of Intraoperative Serine Hydrolase Activities during Cardiac Surgery.', 'PG': '3547-3556', 'LID': '10.1021/acs.jproteome.8b00500 [doi]', 'AB': 'The processes involved in the initiation of acute kidney injury (AKI) following cardiopulmonary bypass (CPB) are thought to occur during the intraoperative period. Such a rapid development might indicate that some of the inductive events are not dependent on de novo protein synthesis, raising the possibility that changes in activities of pre-existing enzymes could contribute to the development of AKI. Activity-based protein profiling (ABPP) was used to compare the serine hydrolase enzyme activities present in the urines of CPB patients who subsequently developed AKI versus those who did not (non-AKI) during the intra- and immediate postoperative periods. Sequential urines collected from a nested case-control cohort of AKI and non-AKI patients were reacted with a serine hydrolase activity probe, fluorophosphonate-TAMRA, and separated by SDS-PAGE. The patterns and levels of probe-labeled proteins in the two groups were initially comparable. However, within 1 h of CPB there were significant pattern changes in the AKI group. Affinity purification and mass spectrometry-based analysis of probe-labeled enzymes in AKI urines at 1 h CPB and arrival to the intensive care unit (ICU) identified 28 enzymes. Quantitative analysis of the activity of one of the identified enzymes, kallikrein-1, revealed some trends suggesting differences in the levels and temporal patterns of enzyme activity between a subset of patients who developed AKI and those who did not. A comparative analysis of affinity-purified probe reacted urinary proteins from these patient groups during the intraoperative period suggested the presence of both shared and unique enzyme patterns. These results indicate that there are intraoperative changes in the levels and types of serine hydrolase activities in patients who subsequently develop AKI. However, the role of these activity differences in the development of AKI remains to be determined.', 'FAU': ['Navarrete, Mario', 'Ho, Julie', 'Dwivedi, Ravi C', 'Choi, Nora', 'Ezzati, Peyman', 'Spicer, Victor', 'Arora, Rakesh C', 'Rigatto, Claudio', 'Wilkins, John A'], 'AU': ['Navarrete M', 'Ho J', 'Dwivedi RC', 'Choi N', 'Ezzati P', 'Spicer V', 'Arora RC', 'Rigatto C', 'Wilkins JA'], 'AD': ['Manitoba Centre for Proteomics & Systems Biology , University of Manitoba & Health Sciences Centre , Winnipeg , Manitoba R3E 3P4 , Canada.', 'Manitoba Centre for Proteomics & Systems Biology , University of Manitoba & Health Sciences Centre , Winnipeg , Manitoba R3E 3P4 , Canada.', 'Department of Internal Medicine, Section of Nephrology , University of Manitoba , Winnipeg , Manitoba R3T 2N2 , Canada.', 'Department of Internal Medicine, Section of Biomedical Proteomics , University of Manitoba , Winnipeg , Manitoba R3T 2N2 , Canada.', 'Department of Immunology , University of Manitoba , Winnipeg , Manitoba R3T 2N2 , Canada.', 'Manitoba Centre for Proteomics & Systems Biology , University of Manitoba & Health Sciences Centre , Winnipeg , Manitoba R3E 3P4 , Canada.', 'Manitoba Centre for Proteomics & Systems Biology , University of Manitoba & Health Sciences Centre , Winnipeg , Manitoba R3E 3P4 , Canada.', 'Department of Immunology , University of Manitoba , Winnipeg , Manitoba R3T 2N2 , Canada.', 'Manitoba Centre for Proteomics & Systems Biology , University of Manitoba & Health Sciences Centre , Winnipeg , Manitoba R3E 3P4 , Canada.', 'Manitoba Centre for Proteomics & Systems Biology , University of Manitoba & Health Sciences Centre , Winnipeg , Manitoba R3E 3P4 , Canada.', 'Department of Surgery , University of Manitoba , Winnipeg , Manitoba R3T 2N2 , Canada.', 'Cardiac Sciences Program , St Boniface Hospital , Winnipeg , Manitoba R2H 2A6 , Canada.', 'Department of Internal Medicine, Section of Nephrology , University of Manitoba , Winnipeg , Manitoba R3T 2N2 , Canada.', 'Manitoba Centre for Proteomics & Systems Biology , University of Manitoba & Health Sciences Centre , Winnipeg , Manitoba R3E 3P4 , Canada.', 'Department of Internal Medicine, Section of Biomedical Proteomics , University of Manitoba , Winnipeg , Manitoba R3T 2N2 , Canada.'], 'AUID': ['ORCID: 0000-0002-5465-446X'], 'LA': ['eng'], 'GR': ['CIHR/Canada'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20180919', 'PL': 'United States', 'TA': 'J Proteome Res', 'JT': 'Journal of proteome research', 'JID': '101128775', 'RN': ['452VLY9402 (Serine)', 'EC 3.- (Hydrolases)', 'EC 3.4.21.35 (Tissue Kallikreins)'], 'MH': ['Acute Kidney Injury/etiology/*metabolism/urine', 'Aged', 'Cardiopulmonary Bypass/adverse effects/*methods', 'Case-Control Studies', 'Female', 'Humans', 'Hydrolases/*metabolism/urine', 'Intraoperative Period', 'Male', 'Mass Spectrometry/methods', 'Middle Aged', 'Proteomics/*methods', 'Serine/*metabolism', 'Tissue Kallikreins/metabolism'], 'OTO': ['NOTNLM'], 'OT': ['*activity-based protein profiling', '*acute kidney injury', '*cardiopulmonary bypass', '*kallikrein-1', '*proteomics', '*serine hydrolase'], 'EDAT': '2018/09/08 06:00', 'MHDA': '2019/08/06 06:00', 'CRDT': ['2018/09/08 06:00'], 'PHST': ['2018/09/08 06:00 [pubmed]', '2019/08/06 06:00 [medline]', '2018/09/08 06:00 [entrez]'], 'AID': ['10.1021/acs.jproteome.8b00500 [doi]'], 'PST': 'ppublish', 'SO': 'J Proteome Res. 2018 Oct 5;17(10):3547-3556. doi: 10.1021/acs.jproteome.8b00500. Epub 2018 Sep 19.'}\n",
      "{'PMID': '30002058', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20190719', 'LR': '20190719', 'IS': '1524-4636 (Electronic) 1079-5642 (Linking)', 'VI': '38', 'IP': '9', 'DP': '2018 Sep', 'TI': 'Abdominal Aortic Aneurysms Growth Is Associated With High Concentrations of Plasma Proteins in the Intraluminal Thrombus and Diseased Arterial Tissue.', 'PG': '2254-2267', 'LID': '10.1161/ATVBAHA.117.310126 [doi]', 'AB': 'Objective- Porosity of the intraluminal thrombus (ILT) is believed to convey biologically active components from the bloodstream toward the aneurismal wall. Accumulation of molecules in the abdominal aortic aneurysmatic tissue may influence vascular protein turnover and regulate abdominal aortic aneurysm growth. We sought to identify proteins with concentrations in the ILT and the abdominal aortic aneurysm wall which associate with aneurysmal expansion rate. Approach and Results- Proteomic analysis by liquid chromatography tandem-mass spectrometry of separated wall and ILT samples was correlated with preoperative aneurysmal growth rate in 24 individuals operated electively for infrarenal abdominal aortic aneurysm. The median preoperative growth rate was 3.8 mm/y (interquartile range, 3) and the mean observational time was 3.3+/-1.7 years. Plasma components dominated the group of proteins with tissue concentrations, which correlate positively with growth rates ( P<0.001, Fisher exact test, both in the ILT and the wall). In contrast, in the wall and thrombus samples, ECM (extracellular matrix) proteins were significantly more prevalent in the group of proteins with negative correlations to growth rates ( P<0.05, Fisher exact test). Similarly, a long series of proteins, related to cellular functions correlated negatively to growth rates. Conclusions- When the preoperative aneurysmatic growth rate has been high, the concentration of many plasma proteins residing in the ILT and the aneurysmatic tissue is also high, compatible with the hypothesis of increased tissue porosity and accumulation of plasma components as a driver of aneurysm expansion. Moreover, many matrix and cellular proteins which are found in high concentrations in slower-growing aneurysms provides new knowledge about potential treatment targets.', 'FAU': ['Behr Andersen, Carsten', 'Lindholt, Jes S', 'Urbonavicius, Sigitas', 'Halekoh, Ulrich', 'Jensen, Pia Sondergaard', 'Stubbe, Jane', 'Rasmussen, Lars Melholt', 'Beck, Hans Christian'], 'AU': ['Behr Andersen C', 'Lindholt JS', 'Urbonavicius S', 'Halekoh U', 'Jensen PS', 'Stubbe J', 'Rasmussen LM', 'Beck HC'], 'AD': ['From the Cardiovascular Research Unit, Department of Vascular Surgery, Viborg Hospital, Denmark (C.B.A., J.S.L., S.U.).', 'From the Cardiovascular Research Unit, Department of Vascular Surgery, Viborg Hospital, Denmark (C.B.A., J.S.L., S.U.).', 'Department of Heart, Lung and Vascular Surgery T (J.S.L.).', 'Centre for Individualised Medicine of Arterial Diseases, Cardiovascular Centre of Excellence (J.S.L., P.S.J., J.S., L.M.R., H.C.B.).', 'From the Cardiovascular Research Unit, Department of Vascular Surgery, Viborg Hospital, Denmark (C.B.A., J.S.L., S.U.).', 'Epidemiology, Biostatistics and Biodemography (U.H.).', 'Centre for Individualised Medicine of Arterial Diseases, Cardiovascular Centre of Excellence (J.S.L., P.S.J., J.S., L.M.R., H.C.B.).', 'Department of Clinical Biochemistry and Pharmacology, Centre for Clinical Proteomics (P.S.J., L.M.R., H.C.B.), Odense University Hospital, Denmark.', 'Centre for Individualised Medicine of Arterial Diseases, Cardiovascular Centre of Excellence (J.S.L., P.S.J., J.S., L.M.R., H.C.B.).', 'Cardiovascular and Renal Research (J.S.), University of Southern Denmark, Odense.', 'Centre for Individualised Medicine of Arterial Diseases, Cardiovascular Centre of Excellence (J.S.L., P.S.J., J.S., L.M.R., H.C.B.).', 'Department of Clinical Biochemistry and Pharmacology, Centre for Clinical Proteomics (P.S.J., L.M.R., H.C.B.), Odense University Hospital, Denmark.', 'Centre for Individualised Medicine of Arterial Diseases, Cardiovascular Centre of Excellence (J.S.L., P.S.J., J.S., L.M.R., H.C.B.).', 'Department of Clinical Biochemistry and Pharmacology, Centre for Clinical Proteomics (P.S.J., L.M.R., H.C.B.), Odense University Hospital, Denmark.'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'PL': 'United States', 'TA': 'Arterioscler Thromb Vasc Biol', 'JT': 'Arteriosclerosis, thrombosis, and vascular biology', 'JID': '9505803', 'RN': ['0 (Blood Proteins)'], 'SB': 'IM', 'MH': ['Aged', 'Aorta, Abdominal/*pathology', 'Aortic Aneurysm, Abdominal/*blood/*pathology', 'Blood Proteins/*metabolism', 'Chromatography, Liquid', 'Female', 'Humans', 'Male', 'Porosity', 'Proteomics', 'Tandem Mass Spectrometry'], 'OTO': ['NOTNLM'], 'OT': ['*arteries', '*extracellular matrix proteins', '*myocardial infarction', '*porosity', '*proteome'], 'EDAT': '2018/07/14 06:00', 'MHDA': '2019/07/20 06:00', 'CRDT': ['2018/07/14 06:00'], 'PHST': ['2018/07/14 06:00 [pubmed]', '2019/07/20 06:00 [medline]', '2018/07/14 06:00 [entrez]'], 'AID': ['ATVBAHA.117.310126 [pii]', '10.1161/ATVBAHA.117.310126 [doi]'], 'PST': 'ppublish', 'SO': 'Arterioscler Thromb Vasc Biol. 2018 Sep;38(9):2254-2267. doi: 10.1161/ATVBAHA.117.310126.'}\n",
      "{'PMID': '29956481', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20190408', 'LR': '20190408', 'IS': '1862-8354 (Electronic) 1862-8346 (Linking)', 'VI': '12', 'IP': '6', 'DP': '2018 Nov', 'TI': 'Integration of \"Omics\" Strategies for Biomarkers Discovery and for the Elucidation of Molecular Mechanisms Underlying Brugada Syndrome.', 'PG': 'e1800065', 'LID': '10.1002/prca.201800065 [doi]', 'AB': 'PURPOSE: The Brugada syndrome (BrS) is a severe inherited cardiac disorder. Given the high genetic and phenotypic heterogeneity of this disease, three different \"omics\" approaches are integrated in a synergic way to elucidate the molecular mechanisms underlying the pathophysiology of BrS as well as for identifying reliable diagnostic/prognostic markers. EXPERIMENTAL DESIGN: The profiling of plasma Proteome and MiRNome is perfomed in a cohort of Brugada patients that were preliminary subjected to genomic analysis to assess a peculiar gene mutation profile. RESULTS: The integrated analysis of \"omics\" data unveiled a cooperative activity of mutated genes, deregulated miRNAs and proteins in orchestrating transcriptional and post-translational events that are critical determining factors for the development of the Brugada pattern. CONCLUSIONS AND CLINICAL RELEVANCE: This study provides the basis to shed light on the specific molecular fingerprints underlying BrS development and to gain further insights on the pathogenesis of this life-threatening cardiac disease.', 'CI': ['(c) 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.'], 'FAU': ['Scumaci, Domenica', 'Oliva, Antonio', 'Concolino, Antonio', 'Curcio, Antonio', 'Fiumara, Claudia Vincenza', 'Tamme, Laura', 'Campuzano, Oscar', 'Pascali, Vincenzo L', 'Coll, Monica', 'Iglesias, Anna', 'Berne, Paola', 'Casu, Gavino', 'Olivo, Erika', 'Ausania, Francesco', 'Ricci, Pietrantonio', 'Indolfi, Ciro', 'Brugada, Josep', 'Brugada, Ramon', 'Cuda, Giovanni'], 'AU': ['Scumaci D', 'Oliva A', 'Concolino A', 'Curcio A', 'Fiumara CV', 'Tamme L', 'Campuzano O', 'Pascali VL', 'Coll M', 'Iglesias A', 'Berne P', 'Casu G', 'Olivo E', 'Ausania F', 'Ricci P', 'Indolfi C', 'Brugada J', 'Brugada R', 'Cuda G'], 'AD': ['Laboratory of Proteomics, Research Center of Advanced Biochemistry and Molecular Biology, Department of Experimental and Clinical Medicine, Magna Graecia University of Catanzaro, 88100, Catanzaro, Italy.', 'Fondazione Policlinico A. Gemelli IRCCS, Roma, Universita Cattolica del Sacro Cuore, Large Francesco Vito 1, 00168, Rome, Italy.', 'Laboratory of Proteomics, Research Center of Advanced Biochemistry and Molecular Biology, Department of Experimental and Clinical Medicine, Magna Graecia University of Catanzaro, 88100, Catanzaro, Italy.', 'Division of Cardiology, Department of Medical and Surgical Science, University \"Magna Graecia\" of Catanzaro, 88100, Catanzaro, Italy.', 'Laboratory of Proteomics, Research Center of Advanced Biochemistry and Molecular Biology, Department of Experimental and Clinical Medicine, Magna Graecia University of Catanzaro, 88100, Catanzaro, Italy.', 'Laboratory of Proteomics, Research Center of Advanced Biochemistry and Molecular Biology, Department of Experimental and Clinical Medicine, Magna Graecia University of Catanzaro, 88100, Catanzaro, Italy.', \"Cardiovascular Genetics Center, Gencardio Institut d'Investigacions Biomediques de Girona,, 17290, Girona, Spain.\", 'Centro de Investigacion Biomedica en Red de Enfermedades Cardiovasculares (CIBERCV) 17007, Girona, Spain.', 'Department of Medical Sciences, School of Medicine, University of Girona, 17004, Girona, Spain.', 'Fondazione Policlinico A. Gemelli IRCCS, Roma, Universita Cattolica del Sacro Cuore, Large Francesco Vito 1, 00168, Rome, Italy.', \"Cardiovascular Genetics Center, Gencardio Institut d'Investigacions Biomediques de Girona,, 17290, Girona, Spain.\", \"Cardiovascular Genetics Center, Gencardio Institut d'Investigacions Biomediques de Girona,, 17290, Girona, Spain.\", 'Unita Operativa Complessa di Cardiologia Ospedale \"San Francesco\", 08100, Nuoro, Italy.', 'Unita Operativa Complessa di Cardiologia Ospedale \"San Francesco\", 08100, Nuoro, Italy.', 'Laboratory of Proteomics, Research Center of Advanced Biochemistry and Molecular Biology, Department of Experimental and Clinical Medicine, Magna Graecia University of Catanzaro, 88100, Catanzaro, Italy.', 'Fondazione Policlinico A. Gemelli, IRCCS, Universita Cattolica del Sacro Cuore, Roma.', 'Department of Medical Sciences, School of Medicine, University of Girona, 17004, Girona, Spain.', 'Institute of Legal Medicine, University \"Magna Graecia\" of Catanzaro, 88100, Catanzaro, Italy.', 'Division of Cardiology, Department of Medical and Surgical Science, University \"Magna Graecia\" of Catanzaro, 88100, Catanzaro, Italy.', 'Centro de Investigacion Biomedica en Red de Enfermedades Cardiovasculares (CIBERCV) 17007, Girona, Spain.', \"Arrhythmia's Unit, Hospital Clinic, 08036, Barcelona, Spain.\", \"Cardiovascular Genetics Center, Gencardio Institut d'Investigacions Biomediques de Girona,, 17290, Girona, Spain.\", 'Centro de Investigacion Biomedica en Red de Enfermedades Cardiovasculares (CIBERCV) 17007, Girona, Spain.', 'Department of Medical Sciences, School of Medicine, University of Girona, 17004, Girona, Spain.', 'Cardiology Service, Hospital Josep Trueta, 17007, Girona, Spain.', 'Laboratory of Proteomics, Research Center of Advanced Biochemistry and Molecular Biology, Department of Experimental and Clinical Medicine, Magna Graecia University of Catanzaro, 88100, Catanzaro, Italy.'], 'LA': ['eng'], 'GR': ['Obra Social \"La Caixa\", Fondo Investigacion Sanitaria/International', 'Instituto de Salud Carlos III (ISCIII)/International', 'CIBERCV/International', 'Spanish Ministry of Economy and Competitiveness/International'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20180720', 'PL': 'Germany', 'TA': 'Proteomics Clin Appl', 'JT': 'Proteomics. Clinical applications', 'JID': '101298608', 'RN': ['0 (Biomarkers)', '0 (Blood Proteins)', '0 (MicroRNAs)', '0 (Proteome)'], 'SB': 'IM', 'MH': ['Biomarkers/*blood', 'Blood Proteins/*genetics', 'Brugada Syndrome/*blood/genetics/pathology', 'Female', 'Genome, Human/genetics', 'Humans', 'Male', 'MicroRNAs/blood', 'Middle Aged', 'Mutation', 'Proteome/*genetics'], 'OTO': ['NOTNLM'], 'OT': ['*MiRNA', '*brugada syndrome', '*genomics', '*personalized medicine', '*proteomics', '*reactive oxygen species'], 'EDAT': '2018/06/30 06:00', 'MHDA': '2019/04/09 06:00', 'CRDT': ['2018/06/30 06:00'], 'PHST': ['2018/03/23 00:00 [received]', '2018/05/26 00:00 [revised]', '2018/06/30 06:00 [pubmed]', '2019/04/09 06:00 [medline]', '2018/06/30 06:00 [entrez]'], 'AID': ['10.1002/prca.201800065 [doi]'], 'PST': 'ppublish', 'SO': 'Proteomics Clin Appl. 2018 Nov;12(6):e1800065. doi: 10.1002/prca.201800065. Epub 2018 Jul 20.'}\n",
      "{'PMID': '29915101', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20190812', 'LR': '20190812', 'IS': '1524-4539 (Electronic) 0009-7322 (Linking)', 'VI': '137', 'IP': '25', 'DP': '2018 Jun 19', 'TI': 'Proteomic Architecture of Human Coronary and Aortic Atherosclerosis.', 'PG': '2741-2756', 'LID': '10.1161/CIRCULATIONAHA.118.034365 [doi]', 'AB': 'BACKGOUND: The inability to detect premature atherosclerosis significantly hinders implementation of personalized therapy to prevent coronary heart disease. A comprehensive understanding of arterial protein networks and how they change in early atherosclerosis could identify new biomarkers for disease detection and improved therapeutic targets. METHODS: Here we describe the human arterial proteome and proteomic features strongly associated with early atherosclerosis based on mass spectrometry analysis of coronary artery and aortic specimens from 100 autopsied young adults (200 arterial specimens). Convex analysis of mixtures, differential dependent network modeling, and bioinformatic analyses defined the composition, network rewiring, and likely regulatory features of the protein networks associated with early atherosclerosis and how they vary across 2 anatomic distributions. RESULTS: The data document significant differences in mitochondrial protein abundance between coronary and aortic samples (coronary>>aortic), and between atherosclerotic and normal tissues (atherosclerotic<<normal), and major alterations in tumor necrosis factor, insulin receptor, peroxisome proliferator-activated receptor-alpha, and peroxisome proliferator-activated receptor-gamma protein networks, as well, in the setting of early disease. In addition, a subset of tissue protein biomarkers indicative of early atherosclerosis was shown to predict anatomically defined coronary atherosclerosis when measured in plasma samples in a separate clinical cohort (area under the curve=0.92 [0.83-0.96]), thereby validating the use of human tissue proteomics to discover relevant plasma biomarkers for clinical applications. In addition to the specific proteins and pathways identified here, the publicly available data resource and the analysis pipeline used illustrate a strategy for interrogating and interpreting the proteomic architecture of tissues that may be relevant for other chronic diseases characterized by multicellular tissue phenotypes. CONCLUSIONS: The human arterial proteome can be viewed as a complex network whose architectural features vary considerably as a function of anatomic location and the presence or absence of atherosclerosis. The data suggest important reductions in mitochondrial protein abundance in early atherosclerosis and also identify a subset of plasma proteins that are highly predictive of angiographically defined coronary disease.', 'CI': ['(c) 2018 American Heart Association, Inc.'], 'FAU': ['Herrington, David M', 'Mao, Chunhong', 'Parker, Sarah J', 'Fu, Zongming', 'Yu, Guoqiang', 'Chen, Lulu', 'Venkatraman, Vidya', 'Fu, Yi', 'Wang, Yizhi', 'Howard, Timothy D', 'Jun, Goo', 'Zhao, Caroline F', 'Liu, Yongmei', 'Saylor, Georgia', 'Spivia, Weston R', 'Athas, Grace B', 'Troxclair, Dana', 'Hixson, James E', 'Vander Heide, Richard S', 'Wang, Yue', 'Van Eyk, Jennifer E'], 'AU': ['Herrington DM', 'Mao C', 'Parker SJ', 'Fu Z', 'Yu G', 'Chen L', 'Venkatraman V', 'Fu Y', 'Wang Y', 'Howard TD', 'Jun G', 'Zhao CF', 'Liu Y', 'Saylor G', 'Spivia WR', 'Athas GB', 'Troxclair D', 'Hixson JE', 'Vander Heide RS', 'Wang Y', 'Van Eyk JE'], 'AD': ['Section on Cardiovascular Medicine, Department of Internal Medicine (D.M.H., C.F.Z., G.S.) dherring@wakehealth.edu.', 'Biocomplexity Institute of Virginia Tech, Virginia Tech, Blacksburg (C.M.).', 'Advanced Clinical Biosystems Research Institute, Cedars-Sinai Heart Institute, and Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA (S.T.P., V.V., W.R.S., J.E.V.E.).', 'Johns Hopkins Medical Institute, Baltimore, MD (Z.F.).', 'Department of Electrical and Computer Engineering, Virginia Tech, Arlington (G.Y., L.C., Y.F., Yizhi Wang, Yue Wang).', 'Department of Electrical and Computer Engineering, Virginia Tech, Arlington (G.Y., L.C., Y.F., Yizhi Wang, Yue Wang).', 'Advanced Clinical Biosystems Research Institute, Cedars-Sinai Heart Institute, and Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA (S.T.P., V.V., W.R.S., J.E.V.E.).', 'Department of Electrical and Computer Engineering, Virginia Tech, Arlington (G.Y., L.C., Y.F., Yizhi Wang, Yue Wang).', 'Department of Electrical and Computer Engineering, Virginia Tech, Arlington (G.Y., L.C., Y.F., Yizhi Wang, Yue Wang).', 'Department of Biochemistry (T.D.H.).', 'Department of Epidemiology, Human Genetics and Environmental Sciences, Human Genetics Center, School of Public Health, University of Texas Health Science Center at Houston (G.J., J.E.H.).', 'Section on Cardiovascular Medicine, Department of Internal Medicine (D.M.H., C.F.Z., G.S.).', 'Department of Epidemiology, Division of Public Health Sciences (Y.L.), Wake Forest School of Medicine, Winston-Salem, NC.', 'Section on Cardiovascular Medicine, Department of Internal Medicine (D.M.H., C.F.Z., G.S.).', 'Advanced Clinical Biosystems Research Institute, Cedars-Sinai Heart Institute, and Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA (S.T.P., V.V., W.R.S., J.E.V.E.).', 'Department of Pathology, Louisiana State Health Science Center, New Orleans (G.B.A., D.T., R.C.V.H.).', 'Department of Pathology, Louisiana State Health Science Center, New Orleans (G.B.A., D.T., R.C.V.H.).', 'Department of Epidemiology, Human Genetics and Environmental Sciences, Human Genetics Center, School of Public Health, University of Texas Health Science Center at Houston (G.J., J.E.H.).', 'Department of Pathology, Louisiana State Health Science Center, New Orleans (G.B.A., D.T., R.C.V.H.).', 'Department of Electrical and Computer Engineering, Virginia Tech, Arlington (G.Y., L.C., Y.F., Yizhi Wang, Yue Wang).', 'Advanced Clinical Biosystems Research Institute, Cedars-Sinai Heart Institute, and Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA (S.T.P., V.V., W.R.S., J.E.V.E.).'], 'LA': ['eng'], 'GR': ['R01 HL111362/HL/NHLBI NIH HHS/United States'], 'PT': ['Comparative Study', 'Journal Article', 'Research Support, N.I.H., Extramural'], 'PL': 'United States', 'TA': 'Circulation', 'JT': 'Circulation', 'JID': '0147763', 'RN': ['0 (Biomarkers)', '0 (Proteins)'], 'MH': ['Adolescent', 'Adult', 'Aorta/*chemistry/pathology', 'Aortic Diseases/*metabolism/pathology', 'Atherosclerosis/*metabolism/pathology', 'Autopsy', 'Biomarkers/analysis', 'Coronary Artery Disease/*metabolism/pathology', 'Coronary Vessels/*chemistry/pathology', 'Female', 'Humans', 'Male', 'Middle Aged', 'Plaque, Atherosclerotic', 'Protein Interaction Maps', 'Proteins/*analysis', 'Proteomics/*methods', '*Tandem Mass Spectrometry', 'Young Adult'], 'PMC': 'PMC6011234', 'MID': ['NIHMS967476'], 'OTO': ['NOTNLM'], 'OT': ['*atherosclerosis', '*biomarkers', '*mitochondria', '*proteomics'], 'EDAT': '2018/06/20 06:00', 'MHDA': '2019/08/14 06:00', 'CRDT': ['2018/06/20 06:00'], 'PHST': ['2018/02/14 00:00 [received]', '2018/04/12 00:00 [accepted]', '2018/06/20 06:00 [entrez]', '2018/06/20 06:00 [pubmed]', '2019/08/14 06:00 [medline]'], 'AID': ['CIRCULATIONAHA.118.034365 [pii]', '10.1161/CIRCULATIONAHA.118.034365 [doi]'], 'PST': 'ppublish', 'SO': 'Circulation. 2018 Jun 19;137(25):2741-2756. doi: 10.1161/CIRCULATIONAHA.118.034365.'}\n",
      "{'PMID': '29854824', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20181010', 'LR': '20200306', 'IS': '2314-6753 (Electronic)', 'VI': '2018', 'DP': '2018', 'TI': 'Urinary Proteome Analysis Identified Neprilysin and VCAM as Proteins Involved in Diabetic Nephropathy.', 'PG': '6165303', 'LID': '10.1155/2018/6165303 [doi]', 'AB': 'Urinary proteome was analyzed and quantified by tandem mass tag (TMT) labeling followed by bioinformatics analysis to study diabetic nephropathy (DN) pathophysiology and to identify biomarkers of a clinical outcome. We included type 2 diabetic normotensive non-obese males with (n = 9) and without (n = 11) incipient DN (microalbuminuria). Sample collection included blood and urine at baseline (control and DN basal) and, in DN patients, after 3 months of losartan treatment (DN treated). Urinary proteome analysis identified 166 differentially abundant proteins between controls and DN patients, 27 comparing DN-treated and DN-basal patients, and 182 between DN-treated patients and controls. The mathematical modeling analysis predicted 80 key proteins involved in DN pathophysiology and 15 in losartan effect, a total of 95 proteins. Out of these 95, 7 are involved in both processes. VCAM-1 and neprilysin stand out of these 7 for being differentially expressed in the urinary proteome. We observed an increase of VCAM-1 urine levels in DN-basal patients compared to diabetic controls and an increase of urinary neprilysin in DN-treated patients with persistent albuminuria; the latter was confirmed by ELISA. Our results point to neprilysin and VCAM-1 as potential candidates in DN pathology and treatment.', 'FAU': ['Guillen-Gomez, Elena', 'Bardaji-de-Quixano, Beatriz', 'Ferrer, Silvia', 'Brotons, Carlos', 'Knepper, Mark A', 'Carrascal, Montserrat', 'Abian, Joaquin', 'Mas, Jose M', 'Calero, Francesca', 'Ballarin, Jose A', 'Fernandez-Llama, Patricia'], 'AU': ['Guillen-Gomez E', 'Bardaji-de-Quixano B', 'Ferrer S', 'Brotons C', 'Knepper MA', 'Carrascal M', 'Abian J', 'Mas JM', 'Calero F', 'Ballarin JA', 'Fernandez-Llama P'], 'AUID': ['ORCID: 0000-0002-8498-2579', 'ORCID: 0000-0003-2823-5429', 'ORCID: 0000-0002-7472-2124'], 'AD': ['Molecular Biology Laboratory, Fundacio Puigvert, Barcelona, Spain.', \"Universitat Autonoma de Barcelona, Institut d'Investigacio Biomedica Sant Pau (IIB Sant Pau), Barcelona, Spain.\", \"Universitat Autonoma de Barcelona, Institut d'Investigacio Biomedica Sant Pau (IIB Sant Pau), Barcelona, Spain.\", 'Renal Transplantation Unit, Nephrology Department, Fundacio Puigvert, Barcelona, Spain.', 'Maragall Primary Health Care Center, Barcelona, Spain.', \"Universitat Autonoma de Barcelona, Institut d'Investigacio Biomedica Sant Pau (IIB Sant Pau), Barcelona, Spain.\", 'Sardenya Primary Health Care Center, Barcelona, Spain.', 'Epithelial Systems Biology Laboratory, National Heart, Lung, and Blood Institute (NIH), Bethesda, MD, USA.', \"Proteomics Laboratory CSIC/UAB, Institut d'Investigacions Biomediques de Barcelona (IIBB-CSIC-IDIBAPS), Barcelona, Spain.\", \"Proteomics Laboratory CSIC/UAB, Institut d'Investigacions Biomediques de Barcelona (IIBB-CSIC-IDIBAPS), Barcelona, Spain.\", 'Anaxomics Biotech SL, Barcelona, Spain.', \"Universitat Autonoma de Barcelona, Institut d'Investigacio Biomedica Sant Pau (IIB Sant Pau), Barcelona, Spain.\", 'Hypertension Unit, Nephrology Department, Fundacio Puigvert, Barcelona, Spain.', \"Universitat Autonoma de Barcelona, Institut d'Investigacio Biomedica Sant Pau (IIB Sant Pau), Barcelona, Spain.\", 'Hypertension Unit, Nephrology Department, Fundacio Puigvert, Barcelona, Spain.', \"Universitat Autonoma de Barcelona, Institut d'Investigacio Biomedica Sant Pau (IIB Sant Pau), Barcelona, Spain.\", 'Hypertension Unit, Nephrology Department, Fundacio Puigvert, Barcelona, Spain.'], 'LA': ['eng'], 'PT': ['Journal Article'], 'DEP': '20180429', 'PL': 'England', 'TA': 'J Diabetes Res', 'JT': 'Journal of diabetes research', 'JID': '101605237', 'RN': ['0 (Biomarkers)', '0 (Proteome)', '0 (Vascular Cell Adhesion Molecule-1)', 'EC 3.4.24.11 (Neprilysin)'], 'SB': 'IM', 'MH': ['Aged', 'Albuminuria/*urine', 'Biomarkers/urine', 'Diabetes Mellitus, Type 2/urine', 'Diabetic Nephropathies/*urine', 'Female', 'Humans', 'Male', 'Middle Aged', 'Neprilysin/*urine', 'Proteome/*metabolism', 'Proteomics', 'Urinalysis', 'Vascular Cell Adhesion Molecule-1/*urine'], 'PMC': 'PMC5949160', 'EDAT': '2018/06/02 06:00', 'MHDA': '2018/10/12 06:00', 'CRDT': ['2018/06/02 06:00'], 'PHST': ['2017/11/08 00:00 [received]', '2018/02/12 00:00 [revised]', '2018/04/04 00:00 [accepted]', '2018/06/02 06:00 [entrez]', '2018/06/02 06:00 [pubmed]', '2018/10/12 06:00 [medline]'], 'AID': ['10.1155/2018/6165303 [doi]'], 'PST': 'epublish', 'SO': 'J Diabetes Res. 2018 Apr 29;2018:6165303. doi: 10.1155/2018/6165303. eCollection 2018.'}\n",
      "{'PMID': '29853569', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20190715', 'LR': '20191008', 'IS': '1524-4636 (Electronic) 1079-5642 (Linking)', 'VI': '38', 'IP': '7', 'DP': '2018 Jul', 'TI': 'Notch2 and Proteomic Signatures in Mouse Neointimal Lesion Formation.', 'PG': '1576-1593', 'LID': '10.1161/ATVBAHA.118.311092 [doi]', 'AB': 'OBJECTIVE: Vascular remodeling is associated with complex molecular changes, including increased Notch2, which promotes quiescence in human smooth muscle cells. We used unbiased protein profiling to understand molecular signatures related to neointimal lesion formation in the presence or absence of Notch2 and to test the hypothesis that loss of Notch2 would increase neointimal lesion formation because of a hyperproliferative injury response. APPROACH AND RESULTS: Murine carotid arteries isolated at 6 or 14 days after ligation injury were analyzed by mass spectrometry using a data-independent acquisition strategy in comparison to uninjured or sham injured arteries. We used a tamoxifen-inducible, cell-specific Cre recombinase strain to delete the Notch2 gene in smooth muscle cells. Vessel morphometric analysis and immunohistochemical staining were used to characterize lesion formation, assess vascular smooth muscle cell proliferation, and validate proteomic findings. Loss of Notch2 in smooth muscle cells leads to protein profile changes in the vessel wall during remodeling but does not alter overall lesion morphology or cell proliferation. Loss of smooth muscle Notch2 also decreases the expression of enhancer of rudimentary homolog, plectin, and annexin A2 in vascular remodeling. CONCLUSIONS: We identified unique protein signatures that represent temporal changes in the vessel wall during neointimal lesion formation in the presence and absence of Notch2. Overall lesion formation was not affected with loss of smooth muscle Notch2, suggesting compensatory pathways. We also validated the regulation of known injury- or Notch-related targets identified in other vascular contexts, providing additional insight into conserved pathways involved in vascular remodeling.', 'CI': ['(c) 2018 American Heart Association, Inc.'], 'FAU': ['Peterson, Sarah M', 'Turner, Jacqueline E', 'Harrington, Anne', 'Davis-Knowlton, Jessica', 'Lindner, Volkhard', 'Gridley, Thomas', 'Vary, Calvin P H', 'Liaw, Lucy'], 'AU': ['Peterson SM', 'Turner JE', 'Harrington A', 'Davis-Knowlton J', 'Lindner V', 'Gridley T', 'Vary CPH', 'Liaw L'], 'AD': ['From the Maine Medical Center Research Institute, Scarborough (S.M.P., J.E.T., A.H., J.D.-K., V.L., T.G., C.P.H.V., L.L.).', 'University of Maine Graduate School of Biomedical Science and Engineering, Orono (S.M.P., V.L., T.G., C.P.H.V., L.L.).', 'From the Maine Medical Center Research Institute, Scarborough (S.M.P., J.E.T., A.H., J.D.-K., V.L., T.G., C.P.H.V., L.L.).', 'From the Maine Medical Center Research Institute, Scarborough (S.M.P., J.E.T., A.H., J.D.-K., V.L., T.G., C.P.H.V., L.L.).', 'From the Maine Medical Center Research Institute, Scarborough (S.M.P., J.E.T., A.H., J.D.-K., V.L., T.G., C.P.H.V., L.L.).', 'Tufts Sackler School of Graduate Biomedical Sciences, Boston, MA (J.D.-K., V.L., T.G., C.P.H.V., L.L.).', 'From the Maine Medical Center Research Institute, Scarborough (S.M.P., J.E.T., A.H., J.D.-K., V.L., T.G., C.P.H.V., L.L.).', 'University of Maine Graduate School of Biomedical Science and Engineering, Orono (S.M.P., V.L., T.G., C.P.H.V., L.L.).', 'Tufts Sackler School of Graduate Biomedical Sciences, Boston, MA (J.D.-K., V.L., T.G., C.P.H.V., L.L.).', 'From the Maine Medical Center Research Institute, Scarborough (S.M.P., J.E.T., A.H., J.D.-K., V.L., T.G., C.P.H.V., L.L.).', 'University of Maine Graduate School of Biomedical Science and Engineering, Orono (S.M.P., V.L., T.G., C.P.H.V., L.L.).', 'Tufts Sackler School of Graduate Biomedical Sciences, Boston, MA (J.D.-K., V.L., T.G., C.P.H.V., L.L.).', 'From the Maine Medical Center Research Institute, Scarborough (S.M.P., J.E.T., A.H., J.D.-K., V.L., T.G., C.P.H.V., L.L.).', 'University of Maine Graduate School of Biomedical Science and Engineering, Orono (S.M.P., V.L., T.G., C.P.H.V., L.L.).', 'Tufts Sackler School of Graduate Biomedical Sciences, Boston, MA (J.D.-K., V.L., T.G., C.P.H.V., L.L.).', 'From the Maine Medical Center Research Institute, Scarborough (S.M.P., J.E.T., A.H., J.D.-K., V.L., T.G., C.P.H.V., L.L.) liawl@mmc.org.', 'University of Maine Graduate School of Biomedical Science and Engineering, Orono (S.M.P., V.L., T.G., C.P.H.V., L.L.).', 'Tufts Sackler School of Graduate Biomedical Sciences, Boston, MA (J.D.-K., V.L., T.G., C.P.H.V., L.L.).'], 'LA': ['eng'], 'GR': ['14PRE17820000/American Heart Association-American Stroke Association/United', 'States', 'U54 GM115516/GM/NIGMS NIH HHS/United States', 'P20 GM121301/GM/NIGMS NIH HHS/United States', 'R01 HL109652/HL/NHLBI NIH HHS/United States', 'F32 HL136076/HL/NHLBI NIH HHS/United States', 'P30 GM103392/GM/NIGMS NIH HHS/United States', 'R01 HL070865/HL/NHLBI NIH HHS/United States'], 'PT': ['Journal Article', 'Research Support, N.I.H., Extramural', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20180531', 'PL': 'United States', 'TA': 'Arterioscler Thromb Vasc Biol', 'JT': 'Arteriosclerosis, thrombosis, and vascular biology', 'JID': '9505803', 'RN': ['0 (Annexin A2)', '0 (Anxa2 protein, mouse)', '0 (Cell Cycle Proteins)', '0 (ERH protein, mouse)', '0 (Notch2 protein, mouse)', '0 (Plec protein, mouse)', '0 (Plectin)', '0 (Receptor, Notch2)', '0 (Transcription Factors)'], 'SB': 'IM', 'MH': ['Aged', 'Aged, 80 and over', 'Animals', 'Annexin A2/metabolism', 'Carotid Artery Injuries/genetics/*metabolism/pathology', 'Carotid Artery, Common/metabolism/pathology', 'Cell Cycle Proteins/metabolism', 'Cell Proliferation', 'Disease Models, Animal', 'Humans', 'Male', '*Mass Spectrometry', 'Mice, Inbred C57BL', 'Mice, Knockout', 'Muscle, Smooth, Vascular/*metabolism/pathology', 'Myocytes, Smooth Muscle/*metabolism/pathology', '*Neointima', 'Plectin/metabolism', 'Proteomics/*methods', 'Receptor, Notch2/deficiency/genetics/*metabolism', 'Signal Transduction', 'Transcription Factors/metabolism', '*Vascular Remodeling'], 'PMC': 'PMC6023756', 'MID': ['NIHMS968681'], 'OTO': ['NOTNLM'], 'OT': ['*carotid arteries', '*mass spectrometry', '*muscle, smooth', '*proteome', '*vascular remodeling'], 'EDAT': '2018/06/02 06:00', 'MHDA': '2019/07/16 06:00', 'CRDT': ['2018/06/02 06:00'], 'PHST': ['2017/04/17 00:00 [received]', '2018/05/16 00:00 [accepted]', '2018/06/02 06:00 [pubmed]', '2019/07/16 06:00 [medline]', '2018/06/02 06:00 [entrez]'], 'AID': ['ATVBAHA.118.311092 [pii]', '10.1161/ATVBAHA.118.311092 [doi]'], 'PST': 'ppublish', 'SO': 'Arterioscler Thromb Vasc Biol. 2018 Jul;38(7):1576-1593. doi: 10.1161/ATVBAHA.118.311092. Epub 2018 May 31.'}\n",
      "{'PMID': '29784904', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20191125', 'LR': '20191125', 'IS': '2045-2322 (Electronic) 2045-2322 (Linking)', 'VI': '8', 'IP': '1', 'DP': '2018 May 21', 'TI': 'Differential protein profiling as a potential multi-marker approach for obese patients with heart failure: A retrospective study.', 'PG': '7894', 'LID': '10.1038/s41598-018-26118-9 [doi]', 'AB': 'Identification of novel circulating biomarkers predicting death and major cardio-metabolic events in obese patients with heart failure (HF) remains a research priority. In this study, we compared multi-marker profile of non-obese (NOB) and obese (OB) HF patients in relation to mortality outcome. The new multiplex proximity extension assay technology was used to analyze the levels of 92 proteins in plasma samples from HF patients according to body mass index (BMI) categories. At 2-year follow-up, all-cause mortality rates were significantly greater in NOB patients (BMI < 30 kg/m(2)) compared to the OB patients (BMI > 30 kg/m(2)) with HF (odds ratio 26; 95% CI: 1.14-624, p < 0,04). Quantitative proteomic analysis revealed thirteen distinct proteins expression profiles of OB and NOB HF patients. Among these proteins, RAGE, CXCL6, CXCL1, CD40, NEMO, VEGF-A, KLK6, PECAM1, PAR1, MMP1, BNP and NTproBNP were down-regulated, whereas leptin was up-regulated in OB HF patients. In addition, an inverse correlation between plasma BNP levels and leptin in OB HF patients was observed (r = -0.58 p = 0.02). This study identifies specific plasma protein signature in OB and NOB patients with HF in relation to mortality outcome.', 'FAU': ['Timotin, Andrei', 'Cinato, Mathieu', 'Boal, Frederic', 'Dejean, Sebastien', 'Anesia, Rodica', 'Arnaut, Oleg', 'Lagente, Christine', 'Roncalli, Jerome', 'Desmoulin, Franck', 'Tronchere, Helene', 'Kunduzova, Oksana'], 'AU': ['Timotin A', 'Cinato M', 'Boal F', 'Dejean S', 'Anesia R', 'Arnaut O', 'Lagente C', 'Roncalli J', 'Desmoulin F', 'Tronchere H', 'Kunduzova O'], 'AD': ['INSERM U1048, University of Toulouse, Toulouse, Cedex 4, 31432, France.', 'INSERM U1048, University of Toulouse, Toulouse, Cedex 4, 31432, France.', 'INSERM U1048, University of Toulouse, Toulouse, Cedex 4, 31432, France.', 'Toulouse Mathematics Institute, University of Toulouse, Toulouse, Cedex 4, France.', 'INSERM U1048, University of Toulouse, Toulouse, Cedex 4, 31432, France.', 'INSERM U1048, University of Toulouse, Toulouse, Cedex 4, 31432, France.', 'Department of Cardiology, Toulouse University Hospital, Toulouse, Cedex 9, France.', 'INSERM U1048, University of Toulouse, Toulouse, Cedex 4, 31432, France.', 'Department of Cardiology, Toulouse University Hospital, Toulouse, Cedex 9, France.', 'Toulouse NeuroImaging Center, ToNIC, University of Toulouse, Inserm U1214, Toulouse, Cedex 3, France.', 'INSERM U1048, University of Toulouse, Toulouse, Cedex 4, 31432, France.', 'INSERM U1048, University of Toulouse, Toulouse, Cedex 4, 31432, France. Oxana.Koundouzova@inserm.fr.'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20180521', 'PL': 'England', 'TA': 'Sci Rep', 'JT': 'Scientific reports', 'JID': '101563288', 'RN': ['0 (Biomarkers)', '0 (Proteome)'], 'SB': 'IM', 'MH': ['Aged', 'Biomarkers/*blood', 'Heart Failure/blood/*diagnosis/etiology', 'Humans', 'Male', 'Middle Aged', 'Obesity/*complications', 'Proteome/*analysis/*metabolism', 'Retrospective Studies'], 'PMC': 'PMC5962559', 'EDAT': '2018/05/23 06:00', 'MHDA': '2019/11/26 06:00', 'CRDT': ['2018/05/23 06:00'], 'PHST': ['2018/02/02 00:00 [received]', '2018/05/03 00:00 [accepted]', '2018/05/23 06:00 [entrez]', '2018/05/23 06:00 [pubmed]', '2019/11/26 06:00 [medline]'], 'AID': ['10.1038/s41598-018-26118-9 [doi]', '10.1038/s41598-018-26118-9 [pii]'], 'PST': 'epublish', 'SO': 'Sci Rep. 2018 May 21;8(1):7894. doi: 10.1038/s41598-018-26118-9.'}\n",
      "{'PMID': '29717219', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20191007', 'LR': '20191007', 'IS': '2045-2322 (Electronic) 2045-2322 (Linking)', 'VI': '8', 'IP': '1', 'DP': '2018 May 1', 'TI': 'Proteomic differences between focal and diffuse traumatic brain injury in human brain tissue.', 'PG': '6807', 'LID': '10.1038/s41598-018-25060-0 [doi]', 'AB': 'The early molecular response to severe traumatic brain injury (TBI) was evaluated using biopsies of structurally normal-appearing cortex, obtained at location for intracranial pressure (ICP) monitoring, from 16 severe TBI patients. Mass spectrometry (MS; label free and stable isotope dimethyl labeling) quantitation proteomics showed a strikingly different molecular pattern in TBI in comparison to cortical biopsies from 11 idiopathic normal pressure hydrocephalus patients. Diffuse TBI showed increased expression of peptides related to neurodegeneration (Tau and Fascin, p < 0.05), reduced expression related to antioxidant defense (Glutathione S-transferase Mu 3, Peroxiredoxin-6, Thioredoxin-dependent peroxide reductase; p < 0.05) and increased expression of potential biomarkers (e.g. Neurogranin, Fatty acid-binding protein, heart p < 0.05) compared to focal TBI. Proteomics of human brain biopsies displayed considerable molecular heterogeneity among the different TBI subtypes with consequences for the pathophysiology and development of targeted treatments for TBI.', 'FAU': ['Abu Hamdeh, Sami', 'Shevchenko, Ganna', 'Mi, Jia', 'Musunuri, Sravani', 'Bergquist, Jonas', 'Marklund, Niklas'], 'AU': ['Abu Hamdeh S', 'Shevchenko G', 'Mi J', 'Musunuri S', 'Bergquist J', 'Marklund N'], 'AUID': ['ORCID: 0000-0001-6173-8357', 'ORCID: 0000-0002-9797-5626'], 'AD': ['Department of Neuroscience, Neurosurgery, Uppsala University, Uppsala, Sweden.', 'Analytical Chemistry, Department of Chemistry-BMC, Uppsala University, Uppsala, Sweden.', 'Analytical Chemistry, Department of Chemistry-BMC, Uppsala University, Uppsala, Sweden.', 'Medicine and Pharmacy Research Center, Binzhou Medical University, Yantai, China.', 'Analytical Chemistry, Department of Chemistry-BMC, Uppsala University, Uppsala, Sweden.', 'Analytical Chemistry, Department of Chemistry-BMC, Uppsala University, Uppsala, Sweden.', 'Medicine and Pharmacy Research Center, Binzhou Medical University, Yantai, China.', 'Department of Neuroscience, Neurosurgery, Uppsala University, Uppsala, Sweden. niklas.marklund@neuro.uu.se.'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20180501', 'PL': 'England', 'TA': 'Sci Rep', 'JT': 'Scientific reports', 'JID': '101563288', 'RN': ['0 (Carrier Proteins)', '0 (FSCN1 protein, human)', '0 (MAPT protein, human)', '0 (Microfilament Proteins)', '0 (Proteome)', '0 (tau Proteins)', '132654-77-4 (Neurogranin)', 'EC 1.11.1.15 (Peroxiredoxin III)', 'EC 1.11.1.15 (Peroxiredoxins)', 'EC 2.5.1.18 (Glutathione Transferase)'], 'SB': 'IM', 'MH': ['Adult', 'Aged', 'Biopsy', 'Brain/*metabolism/pathology', 'Brain Injuries, Traumatic/diagnosis/*genetics/metabolism/pathology', 'Carrier Proteins/genetics/isolation & purification/metabolism', 'Cohort Studies', 'Female', 'Gene Expression', 'Glutathione Transferase/genetics/isolation & purification/metabolism', 'Humans', 'Hydrocephalus/diagnosis/*genetics/metabolism/pathology', 'Intracranial Pressure', 'Male', 'Microfilament Proteins/genetics/isolation & purification/metabolism', 'Middle Aged', 'Neurogranin/genetics/isolation & purification/metabolism', 'Peroxiredoxin III/genetics/isolation & purification/metabolism', 'Peroxiredoxins/genetics/isolation & purification/metabolism', 'Proteome/classification/*genetics/isolation & purification/metabolism', 'Proteomics/methods', 'Trauma Severity Indices', 'tau Proteins/genetics/isolation & purification/metabolism'], 'PMC': 'PMC5931620', 'EDAT': '2018/05/03 06:00', 'MHDA': '2019/10/08 06:00', 'CRDT': ['2018/05/03 06:00'], 'PHST': ['2017/10/06 00:00 [received]', '2018/04/09 00:00 [accepted]', '2018/05/03 06:00 [entrez]', '2018/05/03 06:00 [pubmed]', '2019/10/08 06:00 [medline]'], 'AID': ['10.1038/s41598-018-25060-0 [doi]', '10.1038/s41598-018-25060-0 [pii]'], 'PST': 'epublish', 'SO': 'Sci Rep. 2018 May 1;8(1):6807. doi: 10.1038/s41598-018-25060-0.'}\n",
      "{'PMID': '29682908', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20190917', 'LR': '20200415', 'IS': '2190-6009 (Electronic) 2190-5991 (Linking)', 'VI': '9', 'IP': '4', 'DP': '2018 Aug', 'TI': 'Tracking disease progression non-invasively in Duchenne and Becker muscular dystrophies.', 'PG': '715-726', 'LID': '10.1002/jcsm.12304 [doi]', 'AB': \"BACKGROUND: Analysis of muscle biopsies allowed to characterize the pathophysiological changes of Duchenne and Becker muscular dystrophies (D/BMD) leading to the clinical phenotype. Muscle tissue is often investigated during interventional dose finding studies to show in situ proof of concept and pharmacodynamics effect of the tested drug. Less invasive readouts are needed to objectively monitor patients' health status, muscle quality, and response to treatment. The identification of serum biomarkers correlating with clinical function and able to anticipate functional scales is particularly needed for personalized patient management and to support drug development programs. METHODS: A large-scale proteomic approach was used to identify serum biomarkers describing pathophysiological changes (e.g. loss of muscle mass), association with clinical function, prediction of disease milestones, association with in vivo (31) P magnetic resonance spectroscopy data and dystrophin levels in muscles. Cross-sectional comparisons were performed to compare DMD patients, BMD patients, and healthy controls. A group of DMD patients was followed up for a median of 4.4 years to allow monitoring of individual disease trajectories based on yearly visits. RESULTS: Cross-sectional comparison enabled to identify 10 proteins discriminating between healthy controls, DMD and BMD patients. Several proteins (285) were able to separate DMD from healthy, while 121 proteins differentiated between BMD and DMD; only 13 proteins separated BMD and healthy individuals. The concentration of specific proteins in serum was significantly associated with patients' performance (e.g. BMP6 serum levels and elbow flexion) or dystrophin levels (e.g. TIMP2) in BMD patients. Analysis of longitudinal trajectories allowed to identify 427 proteins affected over time indicating loss of muscle mass, replacement of muscle by adipose tissue, and cardiac involvement. Over-representation analysis of longitudinal data allowed to highlight proteins that could be used as pharmacodynamic biomarkers for drugs currently in clinical development. CONCLUSIONS: Serum proteomic analysis allowed to not only discriminate among DMD, BMD, and healthy subjects, but it enabled to detect significant associations with clinical function, dystrophin levels, and disease progression.\", 'CI': ['(c) 2018 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by', 'John Wiley & Sons Ltd on behalf of the Society on Sarcopenia, Cachexia and', 'Wasting Disorders.'], 'FAU': ['Spitali, Pietro', 'Hettne, Kristina', 'Tsonaka, Roula', 'Charrout, Mohammed', 'van den Bergen, Janneke', 'Koeks, Zaida', 'Kan, Hermien E', 'Hooijmans, Melissa T', 'Roos, Andreas', 'Straub, Volker', 'Muntoni, Francesco', 'Al-Khalili-Szigyarto, Cristina', 'Koel-Simmelink, Marleen J A', 'Teunissen, Charlotte E', 'Lochmuller, Hanns', 'Niks, Erik H', 'Aartsma-Rus, Annemieke'], 'AU': ['Spitali P', 'Hettne K', 'Tsonaka R', 'Charrout M', 'van den Bergen J', 'Koeks Z', 'Kan HE', 'Hooijmans MT', 'Roos A', 'Straub V', 'Muntoni F', 'Al-Khalili-Szigyarto C', 'Koel-Simmelink MJA', 'Teunissen CE', 'Lochmuller H', 'Niks EH', 'Aartsma-Rus A'], 'AUID': ['ORCID: 0000-0003-2783-688X'], 'AD': ['Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.', 'Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.', 'Department of Medical Statistics and Bioinformatics, Leiden University Medical Center, Leiden, The Netherlands.', 'Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.', 'Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.', 'Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.', 'C.J. Gorter Center for High Field MRI, Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands.', 'C.J. Gorter Center for High Field MRI, Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands.', 'John Walton Muscular Dystrophy Research Centre, MRC Centre for Neuromuscular Diseases, Institute of Genetic Medicine, University of Newcastle, Newcastle upon Tyne, UK.', 'John Walton Muscular Dystrophy Research Centre, MRC Centre for Neuromuscular Diseases, Institute of Genetic Medicine, University of Newcastle, Newcastle upon Tyne, UK.', 'Dubowitz Neuromuscular Centre, University College London Great Ormond Street Institute of Child Health, London, UK.', 'Division of Proteomics, School of Biotechnology, KTH-Royal Institute of Technology, Stockholm, Sweden.', 'Neurochemistry Lab and Biobank, Department of Clinical Chemistry, Amsterdam Neuroscience, VU University Medical Center Amsterdam, The Netherlands.', 'Neurochemistry Lab and Biobank, Department of Clinical Chemistry, Amsterdam Neuroscience, VU University Medical Center Amsterdam, The Netherlands.', 'John Walton Muscular Dystrophy Research Centre, MRC Centre for Neuromuscular Diseases, Institute of Genetic Medicine, University of Newcastle, Newcastle upon Tyne, UK.', 'Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.', 'Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.', 'C.J. Gorter Center for High Field MRI, Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands.'], 'LA': ['eng'], 'GR': ['Department of Health/United Kingdom'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20180416', 'PL': 'Germany', 'TA': 'J Cachexia Sarcopenia Muscle', 'JT': 'Journal of cachexia, sarcopenia and muscle', 'JID': '101552883', 'RN': ['0 (Biomarkers)', '0 (Proteome)'], 'SB': 'IM', 'MH': ['Adult', 'Aged', 'Biomarkers', 'Computational Biology/methods', 'Cross-Sectional Studies', 'Disease Progression', 'Follow-Up Studies', 'Humans', 'Middle Aged', 'Muscle, Skeletal/diagnostic imaging/pathology/physiopathology', 'Muscular Dystrophy, Duchenne/*diagnosis', 'Proteome', 'Proteomics/methods', 'Young Adult'], 'PMC': 'PMC6104105', 'OTO': ['NOTNLM'], 'OT': ['*Becker muscular dystrophy', '*Biomarker', '*Duchenne muscular dystrophy', '*Longitudinal analysis', '*Proteomics', '*Sarcopenia'], 'EDAT': '2018/04/24 06:00', 'MHDA': '2019/09/19 06:00', 'CRDT': ['2018/04/24 06:00'], 'PHST': ['2017/11/14 00:00 [received]', '2018/01/25 00:00 [revised]', '2018/03/10 00:00 [accepted]', '2018/04/24 06:00 [pubmed]', '2019/09/19 06:00 [medline]', '2018/04/24 06:00 [entrez]'], 'AID': ['10.1002/jcsm.12304 [doi]'], 'PST': 'ppublish', 'SO': 'J Cachexia Sarcopenia Muscle. 2018 Aug;9(4):715-726. doi: 10.1002/jcsm.12304. Epub 2018 Apr 16.'}\n",
      "{'PMID': '29676857', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20190403', 'LR': '20190403', 'IS': '1862-8354 (Electronic) 1862-8346 (Linking)', 'VI': '12', 'IP': '5', 'DP': '2018 Sep', 'TI': 'Proteomics Analysis Reveals Abnormal Electron Transport and Excessive Oxidative Stress Cause Mitochondrial Dysfunction in Placental Tissues of Early-Onset Preeclampsia.', 'PG': 'e1700165', 'LID': '10.1002/prca.201700165 [doi]', 'AB': 'PURPOSE: Early-onset preeclampsia (EOS-PE) refers to preeclampsia that occurred before 34 gestation weeks. This study is conducted to explore the relationship between mitochondrial dysfunction and the pathogenesis of EOS-PE using proteomic strategy. EXPERIMENTAL DESIGN: To identify altering expressed mitochondrial proteins between severe EOS-PE and healthy pregnancies, enrichment of mitochondria coupled with iTRAQ-based quantitative proteomic method is performed. Immunohistochemistry (IHC) and western blot are performed to detect the alteration of changing expression proteins, and confirmed the accuracy of proteomic results. RESULTS: A total of 1372 proteins were quantified and 132 altering expressed proteins were screened, including 86 downregulated expression proteins and 46 upregulated expression proteins (p < 0.05). Bioinformatics analysis showed that differentially expressed proteins participated in numerous biological processes, including oxidation-reduction process, respiratory electron transport chain, and oxidative phosphorylation. Especially, mitochondria-related molecules, PRDX2, PARK7, BNIP3, BCL2, PDHA1, SUCLG1, ACADM, and NDUFV1, are involved in energy-production process in the matrix and membrane of mitochondria. CONCLUSIONS AND CLINICAL RELEVANCE: Results of the experiment show that abnormal electron transport, excessive oxidative stress, and mitochondrion disassembly might be the main cause of mitochondrial dysfunction, and is related to the pathogenesis of EOS-PE.', 'CI': ['(c) 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.'], 'FAU': ['Xu, Zhongwei', 'Jin, Xiaohan', 'Cai, Wei', 'Zhou, Maobin', 'Shao, Ping', 'Yang, Zhen', 'Fu, Rong', 'Cao, Jin', 'Liu, Yan', 'Yu, Fang', 'Fan, Rong', 'Zhang, Yan', 'Zou, Shuang', 'Zhou, Xin', 'Yang, Ning', 'Chen, Xu', 'Li, Yuming'], 'AU': ['Xu Z', 'Jin X', 'Cai W', 'Zhou M', 'Shao P', 'Yang Z', 'Fu R', 'Cao J', 'Liu Y', 'Yu F', 'Fan R', 'Zhang Y', 'Zou S', 'Zhou X', 'Yang N', 'Chen X', 'Li Y'], 'AD': [\"Central Laboratory, Logistics University of Chinese People's Armed Police Force, Tianjin, 300309, China.\", 'Tianjin Key Laboratory of Cardiovascular Remodeling & Target Organ Injury, Pingjin Hospital Heart Center, Tianjin, 300162, China.', \"Central Laboratory, Logistics University of Chinese People's Armed Police Force, Tianjin, 300309, China.\", 'Tianjin Key Laboratory of Cardiovascular Remodeling & Target Organ Injury, Pingjin Hospital Heart Center, Tianjin, 300162, China.', 'Tianjin Key Laboratory of Cardiovascular Remodeling & Target Organ Injury, Pingjin Hospital Heart Center, Tianjin, 300162, China.', \"Central Laboratory, Logistics University of Chinese People's Armed Police Force, Tianjin, 300309, China.\", 'Women and Children Health Care Center, Tianjin, 300070, China.', \"Central Laboratory, Logistics University of Chinese People's Armed Police Force, Tianjin, 300309, China.\", \"Central Laboratory, Logistics University of Chinese People's Armed Police Force, Tianjin, 300309, China.\", \"Central Laboratory, Logistics University of Chinese People's Armed Police Force, Tianjin, 300309, China.\", 'Tianjin First Center Hospital, Tianjin, 300192, China.', 'Obstetrics and Gynecology Department, Pingjin Hospital, Tianjin, 300162, China.', \"Central Laboratory, Logistics University of Chinese People's Armed Police Force, Tianjin, 300309, China.\", \"Central Laboratory, Logistics University of Chinese People's Armed Police Force, Tianjin, 300309, China.\", \"Central Laboratory, Logistics University of Chinese People's Armed Police Force, Tianjin, 300309, China.\", 'Tianjin Key Laboratory of Cardiovascular Remodeling & Target Organ Injury, Pingjin Hospital Heart Center, Tianjin, 300162, China.', 'Tianjin Key Laboratory of Cardiovascular Remodeling & Target Organ Injury, Pingjin Hospital Heart Center, Tianjin, 300162, China.', 'Tianjin Central Hospital of Gynecology Obstetrics, Tianjin, 300100, China.', 'Tianjin Key Laboratory of Cardiovascular Remodeling & Target Organ Injury, Pingjin Hospital Heart Center, Tianjin, 300162, China.'], 'LA': ['eng'], 'GR': ['15ZXJZSY00010/Tianjin Science and Technology Support Fund/International', '16ZXMJSY00130/Tianjin Science and Technology Project/International', '81570335/National Natural Science Foundation of China/International'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20180525', 'PL': 'Germany', 'TA': 'Proteomics Clin Appl', 'JT': 'Proteomics. Clinical applications', 'JID': '101298608', 'RN': ['0 (Proteome)'], 'SB': 'IM', 'MH': ['Adult', 'Electron Transport/genetics', 'Female', 'Gene Expression Regulation/genetics', 'Humans', 'Immunohistochemistry', 'Mitochondria/*genetics', 'Oxidation-Reduction', 'Oxidative Stress/*genetics', 'Placenta/metabolism/pathology', 'Pre-Eclampsia/*genetics/metabolism/pathology', 'Pregnancy', 'Proteome/*genetics'], 'OTO': ['NOTNLM'], 'OT': ['*early-onset preeclampsia', '*isobaric tags for relative and absolute quantitation', '*mitochondria', '*oxidation respiratory chain', '*proteomics'], 'EDAT': '2018/04/21 06:00', 'MHDA': '2019/04/04 06:00', 'CRDT': ['2018/04/21 06:00'], 'PHST': ['2017/11/13 00:00 [received]', '2018/04/06 00:00 [revised]', '2018/04/21 06:00 [pubmed]', '2019/04/04 06:00 [medline]', '2018/04/21 06:00 [entrez]'], 'AID': ['10.1002/prca.201700165 [doi]'], 'PST': 'ppublish', 'SO': 'Proteomics Clin Appl. 2018 Sep;12(5):e1700165. doi: 10.1002/prca.201700165. Epub 2018 May 25.'}\n",
      "{'PMID': '29665821', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20190619', 'LR': '20190619', 'IS': '1479-5876 (Electronic) 1479-5876 (Linking)', 'VI': '16', 'IP': '1', 'DP': '2018 Apr 17', 'TI': 'Plasma proteomic analysis reveals altered protein abundances in cardiovascular disease.', 'PG': '104', 'LID': '10.1186/s12967-018-1476-9 [doi]', 'AB': 'BACKGROUND: Cardiovascular disease (CVD) describes the pathological conditions of the heart and blood vessels. Despite the large number of studies on CVD and its etiology, its key modulators remain largely unknown. To this end, we performed a comprehensive proteomic analysis of blood plasma, with the scope to identify disease-associated changes after placing them in the context of existing knowledge, and generate a well characterized dataset for further use in CVD multi-omics integrative analysis. METHODS: LC-MS/MS was employed to analyze plasma from 32 subjects (19 cases of various CVD phenotypes and 13 controls) in two steps: discovery (13 cases and 8 controls) and test (6 cases and 5 controls) set analysis. Following label-free quantification, the detected proteins were correlated to existing plasma proteomics datasets (plasma proteome database; PPD) and functionally annotated (Cytoscape, Ingenuity Pathway Analysis). Differential expression was defined based on identification confidence (>/= 2 peptides per protein), statistical significance (Mann-Whitney p value </= 0.05) and a minimum of twofold change. RESULTS: Peptides detected in at least 50% of samples per group were considered, resulting in a total of 3796 identified proteins (838 proteins based on >/= 2 peptides). Pathway annotation confirmed the functional relevance of the findings (representation of complement cascade, fibrin clot formation, platelet degranulation, etc.). Correlation of the relative abundance of the proteins identified in the discovery set with their reported concentrations in the PPD was significant, confirming the validity of the quantification method. The discovery set analysis revealed 100 differentially expressed proteins between cases and controls, 39 of which were verified (>/= twofold change) in the test set. These included proteins already studied in the context of CVD (such as apolipoprotein B, alpha-2-macroglobulin), as well as novel findings (such as low density lipoprotein receptor related protein 2 [LRP2], protein SZT2) for which a mechanism of action is suggested. CONCLUSIONS: This proteomic study provides a comprehensive dataset to be used for integrative and functional studies in the field. The observed protein changes reflect known CVD-related processes (e.g. lipid uptake, inflammation) but also novel hypotheses for further investigation including a potential pleiotropic role of LPR2 but also links of SZT2 to CVD.', 'FAU': ['Lygirou, Vasiliki', 'Latosinska, Agnieszka', 'Makridakis, Manousos', 'Mullen, William', 'Delles, Christian', 'Schanstra, Joost P', 'Zoidakis, Jerome', 'Pieske, Burkert', 'Mischak, Harald', 'Vlahou, Antonia'], 'AU': ['Lygirou V', 'Latosinska A', 'Makridakis M', 'Mullen W', 'Delles C', 'Schanstra JP', 'Zoidakis J', 'Pieske B', 'Mischak H', 'Vlahou A'], 'AUID': ['ORCID: 0000-0003-1555-1326'], 'AD': ['Biomedical Research Foundation, Academy of Athens, 4 Soranou Ephessiou Street, 115 27, Athens, Greece.', 'Mosaiques Diagnostics GmbH, Rotenburger Strasse 20, 30659, Hannover, Germany.', 'Biomedical Research Foundation, Academy of Athens, 4 Soranou Ephessiou Street, 115 27, Athens, Greece.', 'Institute of Cardiovascular and Medical Sciences, University of Glasgow, 126 University Place, Glasgow, G12 8TA, UK.', 'Institute of Cardiovascular and Medical Sciences, University of Glasgow, 126 University Place, Glasgow, G12 8TA, UK.', 'Institut National de la Sante et de la Recherche Medicale (INSERM), U1048, Institute of Cardiovascular and Metabolic Disease, Toulouse, France.', 'Universite Toulouse III Paul-Sabatier, Toulouse, France.', 'Biomedical Research Foundation, Academy of Athens, 4 Soranou Ephessiou Street, 115 27, Athens, Greece.', 'Deutsches Herzzentrum Berlin, Augustenburger Pl. 1, 13353, Berlin, Germany.', 'Mosaiques Diagnostics GmbH, Rotenburger Strasse 20, 30659, Hannover, Germany.', 'Biomedical Research Foundation, Academy of Athens, 4 Soranou Ephessiou Street, 115 27, Athens, Greece. vlahoua@bioacademy.gr.'], 'LA': ['eng'], 'GR': [\"603288/European Union's Seventh Framework Programme/International\"], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20180417', 'PL': 'England', 'TA': 'J Transl Med', 'JT': 'Journal of translational medicine', 'JID': '101190741', 'RN': ['0 (Proteome)'], 'SB': 'IM', 'MH': ['Adult', 'Aged', 'Cardiovascular Diseases/*blood', 'Databases, Protein', 'Female', 'Humans', 'Male', 'Proteome/*metabolism', '*Proteomics', 'Reproducibility of Results'], 'PMC': 'PMC5905170', 'OTO': ['NOTNLM'], 'OT': ['*Biomarker', '*Cardiovascular disease', '*Drug discovery', '*LC-MS/MS', '*Plasma', '*Proteomic dataset', '*Proteomics'], 'EDAT': '2018/04/19 06:00', 'MHDA': '2019/06/20 06:00', 'CRDT': ['2018/04/19 06:00'], 'PHST': ['2017/11/14 00:00 [received]', '2018/04/06 00:00 [accepted]', '2018/04/19 06:00 [entrez]', '2018/04/19 06:00 [pubmed]', '2019/06/20 06:00 [medline]'], 'AID': ['10.1186/s12967-018-1476-9 [doi]', '10.1186/s12967-018-1476-9 [pii]'], 'PST': 'epublish', 'SO': 'J Transl Med. 2018 Apr 17;16(1):104. doi: 10.1186/s12967-018-1476-9.'}\n",
      "{'PMID': '29649363', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20190610', 'LR': '20190613', 'IS': '1535-3907 (Electronic) 1535-3893 (Linking)', 'VI': '17', 'IP': '6', 'DP': '2018 Jun 1', 'TI': 'A Targeted, Differential Top-Down Proteomic Methodology for Comparison of ApoA-I Proteoforms in Individuals with High and Low HDL Efflux Capacity.', 'PG': '2156-2164', 'LID': '10.1021/acs.jproteome.8b00100 [doi]', 'AB': 'Top-down proteomics (TDP) allows precise determination/characterization of the different proteoforms derived from the expression of a single gene. In this study, we targeted apolipoprotein A-I (ApoA-I), a mediator of high-density-lipoprotein cholesterol efflux (HDL-E), which is inversely associated with coronary heart disease risk. Absolute ApoA-I concentration and allelic variation only partially explain interindividual HDL-E variation. Therefore, we hypothesize that differences in HDL-E are associated with the abundances of different ApoA-I proteoforms. Here, we present a targeted TDP methodology to characterize ApoA-I proteoforms in serum samples and compare their abundances between individuals. We characterized 18 ApoA-I proteoforms using selected-ion monitoring coupled to electron-transfer dissociation mass spectrometry. We then compared the abundances of these proteoforms between two groups of four participants, representing the individuals with highest and lowest HDL-E values within the Chicago Healthy Aging Study ( n = 420). Six proteoforms showed significantly ( p < 0.0005) higher intensity in high HDL-E individuals: canonical ApoA-I [fold difference (fd) = 1.17], carboxymethylated ApoA-I (fd = 1.24) and, with highest difference, four fatty acylated forms: palmitoylated (fd = 2.16), oleoylated (fd = 2.08), arachidonoylated (fd = 2.31) and one bearing two modifications: palmitoylation and truncation (fd = 2.13). These results demonstrate translational potential for targeted TDP in revealing, with high sensitivity, associations between interindividual proteoform variation and physiological differences underlying disease risk.', 'FAU': ['Seckler, Henrique Dos Santos', 'Fornelli, Luca', 'Mutharasan, R Kannan', 'Thaxton, C Shad', 'Fellers, Ryan', 'Daviglus, Martha', 'Sniderman, Allan', 'Rader, Daniel', 'Kelleher, Neil L', 'Lloyd-Jones, Donald M', 'Compton, Philip D', 'Wilkins, John T'], 'AU': ['Seckler HDS', 'Fornelli L', 'Mutharasan RK', 'Thaxton CS', 'Fellers R', 'Daviglus M', 'Sniderman A', 'Rader D', 'Kelleher NL', 'Lloyd-Jones DM', 'Compton PD', 'Wilkins JT'], 'AD': ['Bluhm Cardiovascular Institute , Northwestern Memorial Hospital , Chicago , Illinois 60611 , United States.', 'Institute for Minority Health Research , University of Illinois at Chicago , Chicago , Illinois 60607 , United States.', 'Royal Victoria Hospital-McGill University Health Centre , Montreal , QC H4A 3J1 , Canada.', 'Bluhm Cardiovascular Institute , Northwestern Memorial Hospital , Chicago , Illinois 60611 , United States.', 'Bluhm Cardiovascular Institute , Northwestern Memorial Hospital , Chicago , Illinois 60611 , United States.'], 'AUID': ['ORCID: 0000-0002-8815-3372', 'ORCID: 0000-0002-8781-1329'], 'LA': ['eng'], 'GR': ['K23 HL133601/HL/NHLBI NIH HHS/United States', 'P41 GM108569/GM/NIGMS NIH HHS/United States', 'T32 GM105538/GM/NIGMS NIH HHS/United States'], 'PT': ['Journal Article', 'Research Support, N.I.H., Extramural'], 'DEP': '20180427', 'PL': 'United States', 'TA': 'J Proteome Res', 'JT': 'Journal of proteome research', 'JID': '101128775', 'RN': ['0 (Apolipoprotein A-I)', '0 (Lipoproteins, HDL)', '97C5T2UQ7J (Cholesterol)'], 'SB': 'IM', 'MH': ['Aged', 'Apolipoprotein A-I/*blood', 'Biological Transport', 'Cholesterol/metabolism', 'Female', 'Humans', 'Lipoproteins, HDL/*metabolism', 'Male', 'Mass Spectrometry/methods', 'Precision Medicine', 'Protein Processing, Post-Translational', 'Proteomics/*methods', 'Specimen Handling'], 'PMC': 'PMC6162093', 'MID': ['NIHMS975148'], 'OTO': ['NOTNLM'], 'OT': ['*ApoA-I', '*HDL efflux', '*acylations', '*apolipoproteins', '*atherosclerosis', '*cholesterol', '*palmitoylation', '*proteoforms', '*top-down proteomics'], 'EDAT': '2018/04/13 06:00', 'MHDA': '2019/06/14 06:00', 'CRDT': ['2018/04/13 06:00'], 'PHST': ['2018/04/13 06:00 [pubmed]', '2019/06/14 06:00 [medline]', '2018/04/13 06:00 [entrez]'], 'AID': ['10.1021/acs.jproteome.8b00100 [doi]'], 'PST': 'ppublish', 'SO': 'J Proteome Res. 2018 Jun 1;17(6):2156-2164. doi: 10.1021/acs.jproteome.8b00100. Epub 2018 Apr 27.'}\n",
      "{'PMID': '29540862', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20190613', 'LR': '20190613', 'IS': '1530-0307 (Electronic) 0023-6837 (Linking)', 'VI': '98', 'IP': '10', 'DP': '2018 Oct', 'TI': 'Proteomic signature of circulating extracellular vesicles in dilated cardiomyopathy.', 'PG': '1291-1299', 'LID': '10.1038/s41374-018-0044-5 [doi]', 'AB': 'Dilated cardiomyopathy (DCM) remains a major cause of heart failure and carries a poor prognosis despite important advances in recent years. Better disease characterization using novel molecular techniques is needed to refine its progression. This study explored the proteomic signature of plasma-derived extracellular vesicles (EVs) obtained from DCM patients and healthy controls using size-exclusion chromatography (SEC). EV-enriched fractions were analyzed by liquid chromatography-mass spectrometry (LC-MS/MS). Raw data obtained from LC-MS/MS were analyzed against the Uniprot human database using MaxQuant software. Additional analyses using Perseus software were based on the Intensity-Based Absolute Quantification (iBAQ) values from MaxQuant analyses. A total of 90.07 +/- 21 proteins (227 different proteins) in the DCM group and 96.52 +/- 17.91 proteins (183 different proteins) in the control group were identified. A total of 176 proteins (74.6%) were shared by controls and DCM patients, whereas 51 proteins were exclusive for the DCM group and 7 proteins were exclusive for the control group. Fibrinogen (alpha, beta and gamma chain), serotransferrin, alpha-1-antitrypsin, and a variety of apolipoprotein family members (C-I, C-III, D, H or beta-2-glycoprotein, and J or clusterin) were clustered in SEC-EVs derived from DCM patients relative to controls (p < 0.05). Regarding Gene Ontology analysis, response to stress and protein activation-related proteins were enriched in DCM-EVs compared with controls. Thus, the present study reports the distinct proteomic signature of circulating DCM-EVs compared with control-EVs. Furthermore, we confirm that SEC obtains highly purified EV fractions from peripheral blood samples for subsequent use in determining disease-specific proteomic signatures.', 'FAU': ['Roura, Santiago', 'Gamez-Valero, Ana', 'Lupon, Josep', 'Galvez-Monton, Carolina', 'Borras, Francesc E', 'Bayes-Genis, Antoni'], 'AU': ['Roura S', 'Gamez-Valero A', 'Lupon J', 'Galvez-Monton C', 'Borras FE', 'Bayes-Genis A'], 'AD': ['Heart Failure and Cardiac Regeneration (ICREC) Research Program, Health Science Research Institute Germans Trias i Pujol (IGTP), Badalona, Spain.', 'Center of Regenerative Medicine in Barcelona, Barcelona, Spain.', 'CIBERCV, Instituto de Salud Carlos III, Madrid, Spain.', 'REMAR-IVECAT Group, Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, Badalona, Spain.', 'Department of Pathology, Hospital Universitari and Health Sciences Research Institute Germans Trias i Pujol, Universitat Autonoma de Badalona, Badalona, Spain.', 'CIBERCV, Instituto de Salud Carlos III, Madrid, Spain.', 'Cardiology Service, HUGTiP, Badalona, Spain.', 'Department of Medicine, Universitat Autonoma de Badalona, Badalona, Spain.', 'Heart Failure and Cardiac Regeneration (ICREC) Research Program, Health Science Research Institute Germans Trias i Pujol (IGTP), Badalona, Spain.', 'CIBERCV, Instituto de Salud Carlos III, Madrid, Spain.', 'REMAR-IVECAT Group, Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, Badalona, Spain. feborras@igtp.cat.', 'Department of Cell Biology, Physiology and Immunology, Universitat Autonoma de Barcelona, Barcelona, Spain. feborras@igtp.cat.', 'Nephrology Service, Hospital Universitari Germans Trias i Pujol, Badalona, Spain. feborras@igtp.cat.', 'Heart Failure and Cardiac Regeneration (ICREC) Research Program, Health Science Research Institute Germans Trias i Pujol (IGTP), Badalona, Spain. abayes.germanstrias@gencat.cat.', 'CIBERCV, Instituto de Salud Carlos III, Madrid, Spain. abayes.germanstrias@gencat.cat.', 'Cardiology Service, HUGTiP, Badalona, Spain. abayes.germanstrias@gencat.cat.', 'Department of Medicine, Universitat Autonoma de Badalona, Badalona, Spain. abayes.germanstrias@gencat.cat.'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20180314', 'PL': 'United States', 'TA': 'Lab Invest', 'JT': 'Laboratory investigation; a journal of technical methods and pathology', 'JID': '0376617', 'RN': ['0 (Proteome)'], 'SB': 'IM', 'MH': ['Aged', 'Cardiomyopathy, Dilated/*blood', 'Case-Control Studies', 'Extracellular Vesicles/*metabolism', 'Female', 'Humans', 'Male', 'Middle Aged', 'Proteome'], 'EDAT': '2018/03/16 06:00', 'MHDA': '2019/06/14 06:00', 'CRDT': ['2018/03/16 06:00'], 'PHST': ['2017/10/31 00:00 [received]', '2018/01/30 00:00 [accepted]', '2018/01/29 00:00 [revised]', '2018/03/16 06:00 [pubmed]', '2019/06/14 06:00 [medline]', '2018/03/16 06:00 [entrez]'], 'AID': ['10.1038/s41374-018-0044-5 [doi]', '10.1038/s41374-018-0044-5 [pii]'], 'PST': 'ppublish', 'SO': 'Lab Invest. 2018 Oct;98(10):1291-1299. doi: 10.1038/s41374-018-0044-5. Epub 2018 Mar 14.'}\n",
      "{'PMID': '29505607', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20180628', 'LR': '20201214', 'IS': '1932-6203 (Electronic) 1932-6203 (Linking)', 'VI': '13', 'IP': '3', 'DP': '2018', 'TI': 'Myeloperoxidase mediated HDL oxidation and HDL proteome changes do not contribute to dysfunctional HDL in Chinese subjects with coronary artery disease.', 'PG': 'e0193782', 'LID': '10.1371/journal.pone.0193782 [doi]', 'AB': 'High density lipoprotein (HDL) cholesterol levels and cholesterol efflux capacity (CEC) are inversely correlated with coronary artery disease (CAD) risk. Myeloperoxidase (MPO) derived oxidants and HDL proteome changes are implicated in HDL dysfunction in subjects with CAD in the United States; however, the effect of MPO on HDL function and HDL proteome in ethnic Chinese population is unknown. We recruited four matched ethnic Chinese groups (20 patients each): subjects with 1) low HDL levels (HDL levels in men <40mg/dL and women <50mg/dL) and non-CAD (identified by coronary angiography or cardiac CT angiography); 2) low HDL and CAD; 3) high HDL (men >50mg/dL; women >60mg/dL) with no CAD; and 4) high HDL with CAD. Serum cytokines, serum MPO levels, serum CEC, MPO-oxidized HDL tyrosine moieties, and HDL proteome were assessed by mass spectrometry individually in the four groups. The cytokines, MPO levels, and HDL proteome profiles were not significantly different between the four groups. As expected, CEC was depressed in the entire CAD group but more specifically in the CAD low-HDL group. HDL of CAD subjects had significantly higher 3-nitrotyrosine than non-CAD subjects, but the MPO-specific 3-chlorotyrosine was unchanged; CEC in the CAD low-HDL group did not correlate with either HDL 3-chlorotyrosine or 3-nitrotyrosine levels. Neither 3-chlorotyrosine, which is MPO-specific, nor 3-nitrotyrosine generated from MPO or other reactive nitrogen species was associated with CEC. MPO mediated oxidative stress and HDL proteome composition changes are not the primary cause HDL dysfunction in Chinese subjects with CAD. These studies highlight ethnic differences in HDL dysfunction between United States and Chinese cohorts raising possibility of unique pathways of HDL dysfunction in this cohort.', 'FAU': ['Wang, Guisong', 'Mathew, Anna Vachaparampil', 'Yu, Haiyi', 'Li, Lei', 'He, Liyun', 'Gao, Wei', 'Liu, Xiaodan', 'Guo, Yanhong', 'Byun, Jaeman', 'Zhang, Jifeng', 'Chen, Y Eugene', 'Pennathur, Subramaniam'], 'AU': ['Wang G', 'Mathew AV', 'Yu H', 'Li L', 'He L', 'Gao W', 'Liu X', 'Guo Y', 'Byun J', 'Zhang J', 'Chen YE', 'Pennathur S'], 'AD': ['Department of Cardiology and Institute of Vascular Medicine, Peking University Third Hospital, Beijing, China.', 'Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides, Ministry of Health, Beijing, China.', 'Key Laboratory of Molecular Cardiovascular Science, Ministry of Education, Beijing, China.', 'Beijing Key Laboratory of Cardiovascular Receptors Research, Beijing, China.', 'Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, United States of America.', 'Department of Cardiology and Institute of Vascular Medicine, Peking University Third Hospital, Beijing, China.', 'Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides, Ministry of Health, Beijing, China.', 'Key Laboratory of Molecular Cardiovascular Science, Ministry of Education, Beijing, China.', 'Beijing Key Laboratory of Cardiovascular Receptors Research, Beijing, China.', 'Department of Cardiology and Institute of Vascular Medicine, Peking University Third Hospital, Beijing, China.', 'Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides, Ministry of Health, Beijing, China.', 'Key Laboratory of Molecular Cardiovascular Science, Ministry of Education, Beijing, China.', 'Beijing Key Laboratory of Cardiovascular Receptors Research, Beijing, China.', 'Department of Cardiology and Institute of Vascular Medicine, Peking University Third Hospital, Beijing, China.', 'Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides, Ministry of Health, Beijing, China.', 'Key Laboratory of Molecular Cardiovascular Science, Ministry of Education, Beijing, China.', 'Beijing Key Laboratory of Cardiovascular Receptors Research, Beijing, China.', 'Department of Cardiology and Institute of Vascular Medicine, Peking University Third Hospital, Beijing, China.', 'Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides, Ministry of Health, Beijing, China.', 'Key Laboratory of Molecular Cardiovascular Science, Ministry of Education, Beijing, China.', 'Beijing Key Laboratory of Cardiovascular Receptors Research, Beijing, China.', 'Department of Medicine, Nephrology, First Affiliated Hospital, China Medical University, Shenyang, China.', 'Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, United States of America.', 'Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, United States of America.', 'Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, United States of America.', 'Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, United States of America.', 'Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, United States of America.'], 'AUID': ['ORCID: 0000-0003-3628-6883'], 'LA': ['eng'], 'GR': ['K08 HL130944/HL/NHLBI NIH HHS/United States', 'P30 DK081943/DK/NIDDK NIH HHS/United States', 'P30DK081943 /NH/NIH HHS/United States'], 'PT': ['Journal Article', 'Research Support, N.I.H., Extramural', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20180305', 'PL': 'United States', 'TA': 'PLoS One', 'JT': 'PloS one', 'JID': '101285081', 'RN': ['0 (Cytokines)', '0 (Lipoproteins, HDL)', '0 (Proteome)', 'EC 1.11.1.7 (Peroxidase)'], 'SB': 'IM', 'MH': ['Animals', 'Case-Control Studies', 'Cell Line', 'China', 'Cohort Studies', 'Coronary Artery Disease/*blood/*enzymology/ethnology', 'Cross-Sectional Studies', 'Cytokines/blood', 'Female', 'Humans', 'Lipoproteins, HDL/*blood', 'Male', 'Mice', 'Middle Aged', 'Oxidation-Reduction', 'Peroxidase/*blood', '*Proteome'], 'PMC': 'PMC5837105', 'EDAT': '2018/03/06 06:00', 'MHDA': '2018/06/29 06:00', 'CRDT': ['2018/03/06 06:00'], 'PHST': ['2017/11/27 00:00 [received]', '2018/02/17 00:00 [accepted]', '2018/03/06 06:00 [entrez]', '2018/03/06 06:00 [pubmed]', '2018/06/29 06:00 [medline]'], 'AID': ['10.1371/journal.pone.0193782 [doi]', 'PONE-D-17-41758 [pii]'], 'PST': 'epublish', 'SO': 'PLoS One. 2018 Mar 5;13(3):e0193782. doi: 10.1371/journal.pone.0193782. eCollection 2018.'}\n",
      "{'PMID': '29484645', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20191106', 'LR': '20200601', 'IS': '1469-7580 (Electronic) 0021-8782 (Linking)', 'VI': '232', 'IP': '6', 'DP': '2018 Jun', 'TI': 'Comparative iTRAQ analysis of protein abundance in the human sinoatrial node and working cardiomyocytes.', 'PG': '956-964', 'LID': '10.1111/joa.12798 [doi]', 'AB': 'Our objective was to assess the changes in protein abundance in the human sinoatrial node (SAN) compared with working cardiomyocytes to identify SAN-specific protein signatures. Four pairs of samples (the SAN and working cardiomyocytes) were obtained postmortem from four human donors with no evidence of cardiovascular disease. We performed protein identification and quantitation using two-dimensional chromatography-tandem mass spectrometry with isobaric peptide labeling (iTRAQ). We identified 451 different proteins expressed in both the SAN and working cardiomyocytes, 166 of which were differentially regulated (110 were upregulated in the SAN and 56 in the working cardiomyocytes). We identified sarcomere structural proteins in both tissues, although they were differently distributed among the tested samples. For example, myosin light chain 4, myosin regulatory light chain 2-atrial isoform, and tropomyosin alpha-3 chain levels were twofold higher in the SAN than in working cardiomyocytes, and myosin light chain 3 and myosin regulatory light chain 2-ventricular/cardiac muscle isoform levels were twofold higher in the ventricle tissue than in SAN. We identified many mitochondrial oxidative phosphorylation, beta-oxidation, and tricarboxylic acid cycle proteins that were predominantly associated with working cardiomyocytes tissue. We detected upregulation of the fatty acid omega activation pathway proteins in the SAN samples. Some proteins specific for smooth muscle tissue were highly upregulated in the SAN (e.g. transgelin), which indicates that the SAN tissue might act as the bridge between the working myocardium and the smooth muscle. Our results show possible implementation of proteomic strategies to identify in-depth functional differences between various heart sub-structures.', 'CI': ['(c) 2018 Anatomical Society.'], 'FAU': ['Klimek-Piotrowska, Wieslawa', 'Krawczyk-Ozog, Agata', 'Suski, Maciej', 'Kapusta, Przemyslaw', 'Wolkow, Pawel P', 'Holda, Mateusz K'], 'AU': ['Klimek-Piotrowska W', 'Krawczyk-Ozog A', 'Suski M', 'Kapusta P', 'Wolkow PP', 'Holda MK'], 'AD': ['HEART - Heart Embryology and Anatomy Research Team, Department of Anatomy, Faculty of Medicine, Jagiellonian University Medical College, Cracow, Poland.', 'HEART - Heart Embryology and Anatomy Research Team, Department of Anatomy, Faculty of Medicine, Jagiellonian University Medical College, Cracow, Poland.', 'Department of Pharmacology, Faculty of Medicine, Jagiellonian University Medical College, Cracow, Poland.', 'Center for Medical Genomics OMICRON, Faculty of Medicine, Jagiellonian University Medical College, Cracow, Poland.', 'Center for Medical Genomics OMICRON, Faculty of Medicine, Jagiellonian University Medical College, Cracow, Poland.', 'Department of Pharmacology, Faculty of Medicine, Jagiellonian University Medical College, Cracow, Poland.', 'HEART - Heart Embryology and Anatomy Research Team, Department of Anatomy, Faculty of Medicine, Jagiellonian University Medical College, Cracow, Poland.'], 'AUID': ['ORCID: 0000-0001-5754-594X'], 'LA': ['eng'], 'PT': ['Comparative Study', 'Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20180227', 'PL': 'England', 'TA': 'J Anat', 'JT': 'Journal of anatomy', 'JID': '0137162', 'RN': ['0 (Proteins)'], 'SB': 'IM', 'MH': ['Adult', 'Humans', 'Male', 'Myocytes, Cardiac/chemistry/*metabolism', 'Proteins/*analysis', 'Proteomics/methods', 'Sinoatrial Node/chemistry/*metabolism'], 'PMC': 'PMC5978942', 'OTO': ['NOTNLM'], 'OT': ['*cardiac system', '*electrical cardiac conduction system', '*heart proteome', '*omega-oxidation', '*sinoatrial node artery', '*smooth muscle'], 'EDAT': '2018/02/28 06:00', 'MHDA': '2019/11/07 06:00', 'CRDT': ['2018/02/28 06:00'], 'PHST': ['2018/01/30 00:00 [accepted]', '2018/02/28 06:00 [pubmed]', '2019/11/07 06:00 [medline]', '2018/02/28 06:00 [entrez]'], 'AID': ['10.1111/joa.12798 [doi]'], 'PST': 'ppublish', 'SO': 'J Anat. 2018 Jun;232(6):956-964. doi: 10.1111/joa.12798. Epub 2018 Feb 27.'}\n",
      "{'PMID': '29369166', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20190919', 'LR': '20190919', 'IS': '1473-5571 (Electronic) 0269-9370 (Linking)', 'VI': '32', 'IP': '7', 'DP': '2018 Apr 24', 'TI': 'Novel mediators of statin effects on plaque in HIV: a proteomics approach.', 'PG': '867-876', 'LID': '10.1097/QAD.0000000000001762 [doi]', 'AB': 'OBJECTIVE: HIV patients have increased atherosclerotic coronary vascular disease (ASCVD), thought to be mediated through inflammatory mechanisms. We hypothesized that among asymptomatic HIV-infected patients with subclinical coronary plaque, statin therapy would modulate unique inflammatory and cardiovascular proteins in relation to change in subclinical coronary plaque volume. We tested this hypothesis using a novel proteomics approach. DESIGN: Forty HIV-infected participants were randomized to atorvastatin (40 mg/day) versus placebo, and underwent computed tomography coronary angiography to quantify plaque volume at baseline and 1 year. METHODS: We used Olink Cardiovascular III and Cardiometabolic panels based on dual antibody epitope recognition with linked DNA amplification to compare change over time in 184 proteins in treatment versus placebo and in relation to change in coronary plaque volume. RESULTS: Six proteins (TFPI, CCL24, NT-Pro BNP, MBL2, LTBR, PCOLCE) changed significantly in the atorvastatin versus placebo group, many in innate immune and other novel inflammatory pathways. Twenty-six proteins changed significantly in relationship to total coronary plaque volume over 1 year. Notably, many of these proteins changed only weakly in relationship to change in low-density lipoprotein (LDL). Overlapping these two broad discovery approaches, proteins involved in myocardial fibrosis/collagen formation and monocyte chemoattraction changed with statin treatment, in relationship to plaque volume, but not LDL. CONCLUSION: This proof-of-concept study employing a proteomic discovery platform offers insight into statin effects on novel immune pathways relevant to ASCVD progression in HIV. Novel biomarker discovery may enhance precision medicine strategies to estimate the efficacy of targeted therapies to reduce ASCVD progression and events in HIV.', 'FAU': ['deFilippi, Chris', 'Lo, Janet', 'Christenson, Robert', 'Grundberg, Ida', 'Stone, Lauren', 'Zanni, Markella V', 'Lee, Hang', 'Grinspoon, Steven K'], 'AU': ['deFilippi C', 'Lo J', 'Christenson R', 'Grundberg I', 'Stone L', 'Zanni MV', 'Lee H', 'Grinspoon SK'], 'AD': ['Inova Heart and Vascular Institute, Falls Church, Virginia.', 'Program in Nutritional Metabolism, MGH and Harvard Medical School, Boston.', 'Department of Pathology, University of Maryland School of Medicine, Baltimore, Maryland, USA.', 'Olink Proteomics, Watertown.', 'Program in Nutritional Metabolism, MGH and Harvard Medical School, Boston.', 'Program in Nutritional Metabolism, MGH and Harvard Medical School, Boston.', 'MGH Biostatistics Center, MGH and Harvard Medical School, Boston, Massachusetts.', 'Program in Nutritional Metabolism, MGH and Harvard Medical School, Boston.'], 'LA': ['eng'], 'GR': ['P30 DK040561/DK/NIDDK NIH HHS/United States'], 'PT': ['Clinical Trial', 'Journal Article', 'Randomized Controlled Trial', 'Research Support, N.I.H., Extramural'], 'PL': 'England', 'TA': 'AIDS', 'JT': 'AIDS (London, England)', 'JID': '8710219', 'RN': ['0 (Anticholesteremic Agents)', '0 (Placebos)', '0 (Proteome)', 'A0JWA85V8F (Atorvastatin)'], 'SB': 'IM X', 'MH': ['Adult', 'Aged', 'Anticholesteremic Agents/*administration & dosage', 'Atorvastatin/*administration & dosage', 'Coronary Angiography', 'Coronary Artery Disease/diagnostic imaging/*drug therapy/*pathology', 'Double-Blind Method', 'Female', 'HIV Infections/*complications', 'Humans', 'Male', 'Middle Aged', 'Placebos/administration & dosage', 'Proteome/*analysis', 'Proteomics', 'Tomography, X-Ray Computed', 'Treatment Outcome'], 'PMC': 'PMC5869115', 'MID': ['NIHMS939270'], 'EDAT': '2018/01/26 06:00', 'MHDA': '2019/09/20 06:00', 'CRDT': ['2018/01/26 06:00'], 'PHST': ['2018/01/26 06:00 [pubmed]', '2019/09/20 06:00 [medline]', '2018/01/26 06:00 [entrez]'], 'AID': ['10.1097/QAD.0000000000001762 [doi]'], 'PST': 'ppublish', 'SO': 'AIDS. 2018 Apr 24;32(7):867-876. doi: 10.1097/QAD.0000000000001762.'}\n",
      "{'PMID': '29320704', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20190527', 'LR': '20190527', 'IS': '1932-7420 (Electronic) 1550-4131 (Linking)', 'VI': '27', 'IP': '1', 'DP': '2018 Jan 9', 'TI': 'Extracellular Vesicles Provide a Means for Tissue Crosstalk during Exercise.', 'PG': '237-251.e4', 'LID': 'S1550-4131(17)30711-8 [pii] 10.1016/j.cmet.2017.12.001 [doi]', 'AB': 'Exercise stimulates the release of molecules into the circulation, supporting the concept that inter-tissue signaling proteins are important mediators of adaptations to exercise. Recognizing that many circulating proteins are packaged in extracellular vesicles (EVs), we employed quantitative proteomic techniques to characterize the exercise-induced secretion of EV-contained proteins. Following a 1-hr bout of cycling exercise in healthy humans, we observed an increase in the circulation of over 300 proteins, with a notable enrichment of several classes of proteins that compose exosomes and small vesicles. Pulse-chase and intravital imaging experiments suggested EVs liberated by exercise have a propensity to localize in the liver and can transfer their protein cargo. Moreover, by employing arteriovenous balance studies across the contracting human limb, we identified several novel candidate myokines, released into circulation independently of classical secretion. These data identify a new paradigm by which tissue crosstalk during exercise can exert systemic biological effects.', 'CI': ['Copyright (c) 2017 Elsevier Inc. All rights reserved.'], 'FAU': ['Whitham, Martin', 'Parker, Benjamin L', 'Friedrichsen, Martin', 'Hingst, Janne R', 'Hjorth, Marit', 'Hughes, William E', 'Egan, Casey L', 'Cron, Lena', 'Watt, Kevin I', 'Kuchel, Rhiannon P', 'Jayasooriah, Navind', 'Estevez, Emma', 'Petzold, Tim', 'Suter, Catherine M', 'Gregorevic, Paul', 'Kiens, Bente', 'Richter, Erik A', 'James, David E', 'Wojtaszewski, Jorgen F P', 'Febbraio, Mark A'], 'AU': ['Whitham M', 'Parker BL', 'Friedrichsen M', 'Hingst JR', 'Hjorth M', 'Hughes WE', 'Egan CL', 'Cron L', 'Watt KI', 'Kuchel RP', 'Jayasooriah N', 'Estevez E', 'Petzold T', 'Suter CM', 'Gregorevic P', 'Kiens B', 'Richter EA', 'James DE', 'Wojtaszewski JFP', 'Febbraio MA'], 'AD': [\"Cellular and Molecular Metabolism, Garvan Institute of Medical Research, Sydney, NSW, Australia; St Vincent's Clinical School, University of New South Wales, Sydney, NSW, Australia. Electronic address: martwhitham@gmail.com.\", 'Charles Perkins Centre, School of Life and Environmental Sciences, University of Sydney, Sydney, NSW, Australia.', 'Department of Nutrition, Exercise and Sports, Faculty of Science, University of Copenhagen, Copenhagen, Denmark.', 'Department of Nutrition, Exercise and Sports, Faculty of Science, University of Copenhagen, Copenhagen, Denmark.', \"Cellular and Molecular Metabolism, Garvan Institute of Medical Research, Sydney, NSW, Australia; St Vincent's Clinical School, University of New South Wales, Sydney, NSW, Australia.\", \"Cellular and Molecular Metabolism, Garvan Institute of Medical Research, Sydney, NSW, Australia; St Vincent's Clinical School, University of New South Wales, Sydney, NSW, Australia.\", 'Cellular and Molecular Metabolism, Garvan Institute of Medical Research, Sydney, NSW, Australia.', 'Cellular and Molecular Metabolism, Garvan Institute of Medical Research, Sydney, NSW, Australia.', 'Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.', 'Electron Microscope Unit, University of New South Wales, Sydney, NSW, Australia.', 'Epigenetics Laboratory, Victor Chang Cardiac Research Institute, Sydney, NSW, Australia; School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW, Australia.', 'Cellular and Molecular Metabolism, Garvan Institute of Medical Research, Sydney, NSW, Australia.', 'Cellular and Molecular Metabolism, Garvan Institute of Medical Research, Sydney, NSW, Australia.', 'Epigenetics Laboratory, Victor Chang Cardiac Research Institute, Sydney, NSW, Australia.', 'Baker Heart and Diabetes Institute, Melbourne, VIC, Australia; Department of Physiology, University of Melbourne, Melbourne, VIC, Australia; Department of Biochemistry and Molecular Biology, Monash University, Melbourne, VIC, Australia; Department of Neurology, University of Washington School of Medicine, Seattle, WA, USA.', 'Department of Nutrition, Exercise and Sports, Faculty of Science, University of Copenhagen, Copenhagen, Denmark.', 'Department of Nutrition, Exercise and Sports, Faculty of Science, University of Copenhagen, Copenhagen, Denmark.', 'Charles Perkins Centre, School of Life and Environmental Sciences, University of Sydney, Sydney, NSW, Australia.', 'Department of Nutrition, Exercise and Sports, Faculty of Science, University of Copenhagen, Copenhagen, Denmark.', \"Cellular and Molecular Metabolism, Garvan Institute of Medical Research, Sydney, NSW, Australia; St Vincent's Clinical School, University of New South Wales, Sydney, NSW, Australia. Electronic address: m.febbraio@garvan.org.au.\"], 'LA': ['eng'], 'PT': ['Clinical Trial', 'Journal Article', \"Research Support, Non-U.S. Gov't\"], 'PL': 'United States', 'TA': 'Cell Metab', 'JT': 'Cell metabolism', 'JID': '101233170', 'RN': ['0 (Cytokines)', '0 (Proteome)'], 'SB': 'IM', 'MH': ['Adult', 'Animals', 'Chromatography, High Pressure Liquid', 'Cytokines/metabolism', 'Endocytosis', 'Exercise/*physiology', 'Exosomes/metabolism', 'Extracellular Vesicles/*metabolism', 'Female', 'Glycolysis', 'Humans', 'Intravital Microscopy', 'Isotope Labeling', 'Liver/metabolism', 'Male', 'Mice', 'Mice, Inbred C57BL', 'Nanotechnology', '*Organ Specificity', 'Proteome/metabolism', '*Proteomics', 'Tandem Mass Spectrometry'], 'OTO': ['NOTNLM'], 'OT': ['*arteriovenous', '*exercise', '*exosome', '*extracellular vesicle', '*integrin', '*muscle', '*myokine', '*proteomics'], 'EDAT': '2018/01/11 06:00', 'MHDA': '2019/05/28 06:00', 'CRDT': ['2018/01/11 06:00'], 'PHST': ['2017/04/20 00:00 [received]', '2017/10/10 00:00 [revised]', '2017/11/30 00:00 [accepted]', '2018/01/11 06:00 [entrez]', '2018/01/11 06:00 [pubmed]', '2019/05/28 06:00 [medline]'], 'AID': ['S1550-4131(17)30711-8 [pii]', '10.1016/j.cmet.2017.12.001 [doi]'], 'PST': 'ppublish', 'SO': 'Cell Metab. 2018 Jan 9;27(1):237-251.e4. doi: 10.1016/j.cmet.2017.12.001.'}\n",
      "{'PMID': '29258991', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20190422', 'LR': '20191220', 'IS': '1524-4539 (Electronic) 0009-7322 (Linking)', 'VI': '137', 'IP': '11', 'DP': '2018 Mar 13', 'TI': 'Genetic Architecture of the Cardiovascular Risk Proteome.', 'PG': '1158-1172', 'LID': '10.1161/CIRCULATIONAHA.117.029536 [doi]', 'AB': 'BACKGROUND: We recently identified 156 proteins in human plasma that were each associated with the net Framingham Cardiovascular Disease Risk Score using an aptamer-based proteomic platform in Framingham Heart Study Offspring participants. Here we hypothesized that performing genome-wide association studies and exome array analyses on the levels of each of these 156 proteins might identify genetic determinants of risk-associated circulating factors and provide insights into early cardiovascular pathophysiology. METHODS: We studied the association of genetic variants with the plasma levels of each of the 156 Framingham Cardiovascular Disease Risk Score-associated proteins using linear mixed-effects models in 2 population-based cohorts. We performed discovery analyses on plasma samples from 759 participants of the Framingham Heart Study Offspring cohort, an observational study of the offspring of the original Framingham Heart Study and their spouses, and validated these findings in plasma samples from 1421 participants of the MDCS (Malmo Diet and Cancer Study). To evaluate the utility of this strategy in identifying new biological pathways relevant to cardiovascular disease pathophysiology, we performed studies in a cell-model system to experimentally validate the functional significance of an especially novel genetic association with circulating apolipoprotein E levels. RESULTS: We identified 120 locus-protein associations in genome-wide analyses and 41 associations in exome array analyses, the majority of which have not been described previously. These loci explained up to 66% of interindividual plasma protein-level variation and, on average, accounted for 3 times the amount of variation explained by common clinical factors, such as age, sex, and diabetes mellitus status. We described overlap among many of these loci and cardiovascular disease genetic risk variants. Finally, we experimentally validated a novel association between circulating apolipoprotein E levels and the transcription factor phosphatase 1G. Knockdown of phosphatase 1G in a human liver cell model resulted in decreased apolipoprotein E transcription and apolipoprotein E protein levels in cultured supernatants. CONCLUSIONS: We identified dozens of novel genetic determinants of proteins associated with the Framingham Cardiovascular Disease Risk Score and experimentally validated a new role for phosphatase 1G in lipoprotein biology. Further, genome-wide and exome array data for each protein have been made publicly available as a resource for cardiovascular disease research.', 'CI': ['(c) 2017 American Heart Association, Inc.'], 'FAU': ['Benson, Mark D', 'Yang, Qiong', 'Ngo, Debby', 'Zhu, Yineng', 'Shen, Dongxiao', 'Farrell, Laurie A', 'Sinha, Sumita', 'Keyes, Michelle J', 'Vasan, Ramachandran S', 'Larson, Martin G', 'Smith, J Gustav', 'Wang, Thomas J', 'Gerszten, Robert E'], 'AU': ['Benson MD', 'Yang Q', 'Ngo D', 'Zhu Y', 'Shen D', 'Farrell LA', 'Sinha S', 'Keyes MJ', 'Vasan RS', 'Larson MG', 'Smith JG', 'Wang TJ', 'Gerszten RE'], 'AD': [\"Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA (M.D.B.).\", 'Cardiovascular Research Center (M.D.B., D.N., D.S., L.A.F., S.S., M.J.K., R.E.G.).', 'Department of Biostatistics, Boston University School of Public Health, MA (Q.Y., Y.Z., M.G.L.).', 'Cardiovascular Research Center (M.D.B., D.N., D.S., L.A.F., S.S., M.J.K., R.E.G.).', 'Division of Pulmonary and Critical Care Medicine (D.N.).', 'Framingham Heart Study, Department of Medicine, Divisions of Preventive Medicine and Cardiology, Boston University School of Medicine, MA (R.S.V.).', 'Cardiovascular Research Center (M.D.B., D.N., D.S., L.A.F., S.S., M.J.K., R.E.G.).', 'Cardiovascular Research Center (M.D.B., D.N., D.S., L.A.F., S.S., M.J.K., R.E.G.).', 'Cardiovascular Research Center (M.D.B., D.N., D.S., L.A.F., S.S., M.J.K., R.E.G.).', 'Cardiovascular Research Center (M.D.B., D.N., D.S., L.A.F., S.S., M.J.K., R.E.G.).', 'Framingham Heart Study, Department of Medicine, Divisions of Preventive Medicine and Cardiology, Boston University School of Medicine, MA (R.S.V.).', 'Department of Biostatistics, Boston University School of Public Health, MA (Q.Y., Y.Z., M.G.L.).', \"The National Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham, MA (M.G.L.).\", 'Department of Cardiology, Clinical Sciences, Lund University and Skane University Hospital, Sweden (J.G.S.).', 'Program in Medical and Population Genetics, Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA (J.G.S.).', 'Division of Cardiovascular Medicine, Vanderbilt University, Nashville, TN (T.J.W.).', 'Cardiovascular Research Center (M.D.B., D.N., D.S., L.A.F., S.S., M.J.K., R.E.G.) rgerszte@bidmc.harvard.edu.', 'Division of Cardiovascular Medicine (R.E.G.), Beth Israel Deaconess Medical Center, Boston, MA.'], 'LA': ['eng'], 'GR': ['P30 DK040561/DK/NIDDK NIH HHS/United States', 'N01 HC025195/HC/NHLBI NIH HHS/United States', 'T32 HL007208/HL/NHLBI NIH HHS/United States', 'K01 GM103817/GM/NIGMS NIH HHS/United States', 'HHSN268201000033C/HL/NHLBI NIH HHS/United States', 'R01 HL132320/HL/NHLBI NIH HHS/United States', 'R01 HL133870/HL/NHLBI NIH HHS/United States', 'N01HC25195/HL/NHLBI NIH HHS/United States'], 'PT': ['Journal Article', 'Research Support, N.I.H., Extramural', \"Research Support, Non-U.S. Gov't\", 'Validation Study'], 'DEP': '20171219', 'PL': 'United States', 'TA': 'Circulation', 'JT': 'Circulation', 'JID': '0147763', 'RN': ['0 (ApoE protein, human)', '0 (Apolipoproteins E)', '0 (Blood Proteins)', 'EC 3.1.3.16 (PPM1G protein, human)', 'EC 3.1.3.16 (Protein Phosphatase 2C)'], 'SB': 'AIM IM', 'CIN': ['Circulation. 2018 Mar 13;137(11):1173-1175. PMID: 29530892'], 'MH': ['Aged', 'Apolipoproteins E/genetics/metabolism', 'Blood Proteins/*genetics/metabolism', 'Cardiovascular Diseases/blood/diagnosis/*genetics', 'Databases, Genetic', 'Female', 'Gene Expression Profiling', 'Genetic Predisposition to Disease', '*Genetic Variation', 'Genome-Wide Association Study', 'Hep G2 Cells', 'Heredity', 'Humans', 'Male', 'Mendelian Randomization Analysis', 'Middle Aged', 'Phenotype', 'Protein Phosphatase 2C/genetics/metabolism', 'Quantitative Trait Loci', 'Risk Factors'], 'PMC': 'PMC5849518', 'MID': ['NIHMS936031'], 'OTO': ['NOTNLM'], 'OT': ['*APOE', '*cardiovascular genomics', '*genome-wide analysis', '*proteomics', '*systems biology'], 'EDAT': '2017/12/21 06:00', 'MHDA': '2019/04/23 06:00', 'CRDT': ['2017/12/21 06:00'], 'PHST': ['2017/05/16 00:00 [received]', '2017/11/06 00:00 [accepted]', '2017/12/21 06:00 [pubmed]', '2019/04/23 06:00 [medline]', '2017/12/21 06:00 [entrez]'], 'AID': ['CIRCULATIONAHA.117.029536 [pii]', '10.1161/CIRCULATIONAHA.117.029536 [doi]'], 'PST': 'ppublish', 'SO': 'Circulation. 2018 Mar 13;137(11):1158-1172. doi: 10.1161/CIRCULATIONAHA.117.029536. Epub 2017 Dec 19.'}\n",
      "{'PMID': '29258006', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20190528', 'LR': '20191210', 'IS': '1879-1484 (Electronic) 0021-9150 (Linking)', 'VI': '269', 'DP': '2018 Feb', 'TI': 'Genetic variants in PPARGC1B and CNTN4 are associated with thromboxane A2 formation and with cardiovascular event free survival in the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).', 'PG': '42-49', 'LID': 'S0021-9150(17)31432-6 [pii] 10.1016/j.atherosclerosis.2017.12.013 [doi]', 'AB': 'BACKGROUND AND AIMS: Elevated urinary 11-dehydro thromboxane B2 (TxB2), a measure of thromboxane A2 formation in vivo, predicts future atherothrombotic events. To further understand this relationship, the genetic determinants of 11-dehydro TxB2 and their associations with cardiovascular morbidity were investigated in this study. METHODS: Genome-wide and targeted genetic association studies of urinary 11-dehydro TxB2 were conducted in 806 Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) participants. RESULTS: The strongest associations were in PPARGC1B (rs4235745, rs32582, rs10515638) and CNTN4 (rs10510230, rs4684343), these 5 single nucleotide polymorphisms (SNPs) were independently associated with 11-dehydro TxB2 formation. Haplotypes of 11-dehydro TxB2 increasing alleles for both PPARGC1B and CNTN4 were significantly associated with 11-dehydro TxB2, explaining 5.2% and 4.5% of the variation in the whole cohort, and 8.8% and 7.9% in participants not taking aspirin, respectively. In a second ASCOT population (n = 6199), addition of these 5 SNPs significantly improved the covariate-only Cox proportional hazards model for cardiovascular events (chisq = 14.7, p=0.01). Two of the risk alleles associated with increased urinary 11-dehydro TxB2 were individually associated with greater incidences of cardiovascular events - rs10515638 (HR = 1.31, p=0.01) and rs10510230 (HR = 1.25, p=0.007); effect sizes were larger in those not taking aspirin. CONCLUSIONS: PPARGC1B and CNTN4 genotypes are associated with elevated thromboxane A2 formation and with an excess of cardiovascular events. Aspirin appears to blunt these associations. If specific protection of PPARGC1B and CNTN4 variant carriers by aspirin is confirmed by additional studies, PPARGC1B and CNTN4 genotyping could potentially assist in clinical decision making regarding the use of aspirin in primary prevention.', 'CI': ['Copyright (c) 2017 Elsevier B.V. All rights reserved.'], 'FAU': ['McCarthy, Nina S', 'Vangjeli, Ciara', 'Surendran, Praveen', 'Treumann, Achim', 'Rooney, Cathy', 'Ho, Emily', 'Sever, Peter', 'Thom, Simon', 'Hughes, Alun D', 'Munroe, Patricia B', 'Howard, Philip', 'Johnson, Toby', 'Caulfield, Mark', 'Shields, Denis C', \"O'Brien, Eoin\", 'Fitzgerald, Desmond J', 'Stanton, Alice V'], 'AU': ['McCarthy NS', 'Vangjeli C', 'Surendran P', 'Treumann A', 'Rooney C', 'Ho E', 'Sever P', 'Thom S', 'Hughes AD', 'Munroe PB', 'Howard P', 'Johnson T', 'Caulfield M', 'Shields DC', \"O'Brien E\", 'Fitzgerald DJ', 'Stanton AV'], 'AD': ['Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, RCSI, Dublin, Ireland; Centre for the Genetic Origins of Health and Disease, University of Western Australia, Perth, Australia. Electronic address: nina.mccarthy@uwa.edu.', 'Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, RCSI, Dublin, Ireland.', 'Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, RCSI, Dublin, Ireland; School of Medicine, UCD Conway Institute, University College Dublin, Dublin, Ireland.', 'Newcastle University Protein and Proteome Analysis (NUPPA), University of Newcastle, Newcastle upon Tyne, UK.', 'Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, RCSI, Dublin, Ireland.', 'Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, RCSI, Dublin, Ireland.', 'International Centre for Circulatory Health, Imperial College London, London, UK.', 'International Centre for Circulatory Health, Imperial College London, London, UK.', 'International Centre for Circulatory Health, Imperial College London, London, UK.', 'Clinical Pharmacology, William Harvey Research Institute, Barts and the London Medical School, Queen Mary University of London and NIHR Barts Cardiovascular Biomedical Research Unit, London, UK.', 'Clinical Pharmacology, William Harvey Research Institute, Barts and the London Medical School, Queen Mary University of London and NIHR Barts Cardiovascular Biomedical Research Unit, London, UK.', 'Clinical Pharmacology, William Harvey Research Institute, Barts and the London Medical School, Queen Mary University of London and NIHR Barts Cardiovascular Biomedical Research Unit, London, UK; GlaxoSmithKline, Gunnels Wood Road, Stevenage SG1 2NY, UK.', 'Clinical Pharmacology, William Harvey Research Institute, Barts and the London Medical School, Queen Mary University of London and NIHR Barts Cardiovascular Biomedical Research Unit, London, UK.', 'School of Medicine, UCD Conway Institute, University College Dublin, Dublin, Ireland.', 'School of Medicine, UCD Conway Institute, University College Dublin, Dublin, Ireland.', 'School of Medicine, UCD Conway Institute, University College Dublin, Dublin, Ireland.', 'Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, RCSI, Dublin, Ireland.'], 'LA': ['eng'], 'GR': ['G9521010/Medical Research Council/United Kingdom', 'CS/15/6/31468/British Heart Foundation/United Kingdom', 'RG/08/014/24067/British Heart Foundation/United Kingdom', 'MR/L003120/1/Medical Research Council/United Kingdom', 'MR/K006584/1/Medical Research Council/United Kingdom', 'G0600237/Medical Research Council/United Kingdom'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20171208', 'PL': 'Ireland', 'TA': 'Atherosclerosis', 'JT': 'Atherosclerosis', 'JID': '0242543', 'RN': ['0 (CNTN4 protein, human)', '0 (Cardiovascular Agents)', '0 (Carrier Proteins)', '0 (Contactins)', '0 (Genetic Markers)', '0 (PPARGC1B protein, human)', '0 (RNA-Binding Proteins)', '54397-85-2 (Thromboxane B2)', '57576-52-0 (Thromboxane A2)', '67910-12-7 (11-dehydro-thromboxane B2)', 'R16CO5Y76E (Aspirin)'], 'SB': 'IM', 'MH': ['Aged', 'Aspirin/therapeutic use', 'Cardiovascular Agents/therapeutic use', 'Cardiovascular Diseases/*blood/ethnology/*genetics/prevention & control', 'Carrier Proteins/*genetics', 'Contactins/*genetics', 'Europe/epidemiology', 'European Continental Ancestry Group/genetics', 'Female', 'Gene Frequency', 'Genetic Markers', 'Genetic Predisposition to Disease', 'Genome-Wide Association Study', 'Haplotypes', 'Humans', 'Incidence', 'Male', 'Middle Aged', 'Multicenter Studies as Topic', 'Phenotype', '*Polymorphism, Single Nucleotide', 'Primary Prevention', 'Progression-Free Survival', 'RNA-Binding Proteins', 'Randomized Controlled Trials as Topic', 'Risk Factors', 'Thromboxane A2/*metabolism', 'Thromboxane B2/analogs & derivatives/urine', 'Time Factors'], 'PMC': 'PMC5813793', 'MID': ['EMS75545'], 'OTO': ['NOTNLM'], 'OT': ['*Genome wide association study', '*Thrombosis', '*Thromboxane'], 'EDAT': '2017/12/20 06:00', 'MHDA': '2019/05/29 06:00', 'CRDT': ['2017/12/20 06:00'], 'PHST': ['2017/08/25 00:00 [received]', '2017/11/17 00:00 [revised]', '2017/12/07 00:00 [accepted]', '2017/12/20 06:00 [pubmed]', '2019/05/29 06:00 [medline]', '2017/12/20 06:00 [entrez]'], 'AID': ['S0021-9150(17)31432-6 [pii]', '10.1016/j.atherosclerosis.2017.12.013 [doi]'], 'PST': 'ppublish', 'SO': 'Atherosclerosis. 2018 Feb;269:42-49. doi: 10.1016/j.atherosclerosis.2017.12.013. Epub 2017 Dec 8.'}\n",
      "{'PMID': '29251807', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20181211', 'LR': '20190220', 'IS': '1879-0844 (Electronic) 1388-9842 (Linking)', 'VI': '20', 'IP': '2', 'DP': '2018 Feb', 'TI': 'Proteomic diversity of high-density lipoprotein explains its association with clinical outcome in patients with heart failure.', 'PG': '260-267', 'LID': '10.1002/ejhf.1101 [doi]', 'AB': 'AIMS: Previously, low high-density lipoprotein (HDL) cholesterol was found to be one of the strongest predictors of mortality and/or heart failure (HF) hospitalisation in patients with HF. We therefore performed in-depth investigation of the multifunctional HDL proteome to reveal underlying pathophysiological mechanisms explaining the association between HDL and clinical outcome. METHODS AND RESULTS: We selected a cohort of 90 HF patients with 1:1 cardiovascular death/survivor ratio from BIOSTAT-CHF. A novel optimised protocol for selective enrichment of lipoproteins was used to prepare plasma. Enriched lipoprotein content of samples was analysed using high resolution nanoscale liquid chromatography-mass spectrometry-based proteomics, utilising a label free approach. Within the HDL proteome, 49 proteins significantly differed between deaths and survivors. An optimised model of 12 proteins predicted death with 76% accuracy (Nagelkerke R(2) =0.37, P < 0.001). The strongest contributors to this model were filamin-A (related to crosslinking of actin filaments) [odds ratio (OR) 0.31, 95% confidence interval (CI) 0.15-0.61, P = 0.001] and pulmonary surfactant-associated protein B (related to alveolar capillary membrane function) (OR 2.50, 95% CI 1.57-3.98, P < 0.001). The model predicted mortality with an area under the curve of 0.82 (95% CI 0.77-0.87, P < 0.001). Internal cross validation resulted in 73.3 +/- 7.2% accuracy. CONCLUSION: This study shows marked differences in composition of the HDL proteome between HF survivors and deaths. The strongest differences were seen in proteins reflecting crosslinking of actin filaments and alveolar capillary membrane function, posing potential pathophysiological mechanisms underlying the association between HDL and clinical outcome in HF.', 'CI': ['(c) 2017 The Authors. European Journal of Heart Failure (c) 2017 European Society', 'of Cardiology.'], 'FAU': ['Emmens, Johanna Elisabeth', 'Jones, Donald J L', 'Cao, Thong H', 'Chan, Daniel C S', 'Romaine, Simon P R', 'Quinn, Paulene A', 'Anker, Stefan D', 'Cleland, John G', 'Dickstein, Kenneth', 'Filippatos, Gerasimos', 'Hillege, Hans L', 'Lang, Chim C', 'Ponikowski, Piotr', 'Samani, Nilesh J', 'van Veldhuisen, Dirk J', 'Zannad, Faiz', 'Zwinderman, Aeilko H', 'Metra, Marco', 'de Boer, Rudolf A', 'Voors, Adriaan A', 'Ng, Leong L'], 'AU': ['Emmens JE', 'Jones DJL', 'Cao TH', 'Chan DCS', 'Romaine SPR', 'Quinn PA', 'Anker SD', 'Cleland JG', 'Dickstein K', 'Filippatos G', 'Hillege HL', 'Lang CC', 'Ponikowski P', 'Samani NJ', 'van Veldhuisen DJ', 'Zannad F', 'Zwinderman AH', 'Metra M', 'de Boer RA', 'Voors AA', 'Ng LL'], 'AD': ['Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.', 'Department of Cancer Studies, University of Leicester, Leicester Royal Infirmary, Leicester, UK.', 'Department of Cardiovascular Sciences, University of Leicester, NIHR Leicester Biomedical Research Centre, Glenfield Hospital, Leicester, UK.', 'Department of General Internal Medicine, University of Medicine and Pharmacy, Ho Chi Minh City, Vietnam.', 'Department of Cardiovascular Sciences, University of Leicester, NIHR Leicester Biomedical Research Centre, Glenfield Hospital, Leicester, UK.', 'Department of Cardiovascular Sciences, University of Leicester, NIHR Leicester Biomedical Research Centre, Glenfield Hospital, Leicester, UK.', 'Department of Cardiovascular Sciences, University of Leicester, NIHR Leicester Biomedical Research Centre, Glenfield Hospital, Leicester, UK.', 'Division of Cardiology and Metabolism - Heart Failure, Cachexia and Sarcopenia, Department of Cardiology (CVK); and Berlin-Brandenburg Center for Regenerative Therapies (BCRT), Deutsches Zentrum fur Herz-Kreislauf-Forschung (DZHK) Berlin, Charite Universitatsmedizin Berlin, Germany.', 'Department of Cardiology and Pneumology, University Medical Center Gottingen (UMG), Gottingen, Germany.', 'National Heart and Lung Institute, Royal Brompton and Harefield Hospitals, Imperial College, London, UK.', 'University of Bergen, Bergen, Norway.', 'Stavanger University Hospital, Stavanger, Norway.', 'National and Kapodistrian University of Athens, School of Medicine, Heart Failure Unit, Department of Cardiology, Athens University Hospital Attikon, Athens, Greece.', 'Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.', 'School of Medicine Centre for Cardiovascular and Lung Biology, Division of Medical Sciences, University of Dundee, Ninewells Hospital & Medical School, Dundee, UK.', 'Department of Heart Diseases, Wroclaw Medical University, and Cardiology Department, Military Hospital, Wroclaw, Poland.', 'Department of Cardiovascular Sciences, University of Leicester, NIHR Leicester Biomedical Research Centre, Glenfield Hospital, Leicester, UK.', 'Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.', 'Inserm CIC 1433, Universite de Lorrain, CHU de Nancy, Nancy, France.', 'Department of Epidemiology, Biostatistics and Bioinformatics, Academic Medical Centre, Amsterdam, The Netherlands.', 'Institute of Cardiology, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia, Italy.', 'Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.', 'Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.', 'Department of Cardiovascular Sciences, University of Leicester, NIHR Leicester Biomedical Research Centre, Glenfield Hospital, Leicester, UK.'], 'LA': ['eng'], 'GR': ['FS/12/30/29474/British Heart Foundation/United Kingdom', 'FS/15/10/31223/British Heart Foundation/United Kingdom'], 'PT': ['Journal Article', 'Multicenter Study', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20171218', 'PL': 'England', 'TA': 'Eur J Heart Fail', 'JT': 'European journal of heart failure', 'JID': '100887595', 'RN': ['0 (Biomarkers)', '0 (Lipoproteins, HDL)', '0 (Proteome)'], 'SB': 'IM', 'CIN': ['Eur J Heart Fail. 2018 Jun;20(6):1077-1078. PMID: 29498159', 'Eur J Heart Fail. 2018 Jun;20(6):1077. PMID: 29498173'], 'MH': ['Aged', 'Biomarkers/blood', 'Cause of Death/trends', 'Female', 'Heart Failure/*blood/mortality', 'Humans', 'Lipoproteins, HDL/*blood', 'Male', 'Prognosis', 'Proteome/*metabolism', 'Proteomics/*methods', 'Risk Assessment/*methods', 'Survival Rate/trends', 'United Kingdom/epidemiology'], 'OTO': ['NOTNLM'], 'OT': ['*Heart failure', '*High-density lipoprotein', '*Proteome'], 'EDAT': '2017/12/19 06:00', 'MHDA': '2018/12/12 06:00', 'CRDT': ['2017/12/19 06:00'], 'PHST': ['2017/08/06 00:00 [received]', '2017/10/26 00:00 [revised]', '2017/11/09 00:00 [accepted]', '2017/12/19 06:00 [pubmed]', '2018/12/12 06:00 [medline]', '2017/12/19 06:00 [entrez]'], 'AID': ['10.1002/ejhf.1101 [doi]'], 'PST': 'ppublish', 'SO': 'Eur J Heart Fail. 2018 Feb;20(2):260-267. doi: 10.1002/ejhf.1101. Epub 2017 Dec 18.'}\n",
      "{'PMID': '29235871', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20180913', 'LR': '20180913', 'IS': '1535-3907 (Electronic) 1535-3893 (Linking)', 'VI': '17', 'IP': '2', 'DP': '2018 Feb 2', 'TI': 'Increased Levels of Circulating Fatty Acids Are Associated with Protective Effects against Future Cardiovascular Events in Nondiabetics.', 'PG': '870-878', 'LID': '10.1021/acs.jproteome.7b00671 [doi]', 'AB': 'Cardiovascular disease (CVD) is a major cause of morbidity and mortality worldwide, particularly in individuals with diabetes. The current study objective was to determine the circulating metabolite profiles associated with the risk of future cardiovascular events, with emphasis on diabetes status. Nontargeted metabolomics analysis was performed by LC-HRMS in combination with targeted quantification of eicosanoids and endocannabinoids. Plasma from 375 individuals from the IMPROVE pan-European cohort was included in a case-control study design. Following data processing, the three metabolite data sets were concatenated to produce a single data set of 267 identified metabolites. Factor analysis identified six factors that described 26.6% of the variability in the given set of predictors. An association with cardiovascular events was only observed for one factor following adjustment (p = 0.026). From this factor, we identified a free fatty acid signature (n = 10 lipids, including saturated, monounsaturated, and polyunsaturated fatty acids) that was associated with lower risk of future cardiovascular events in nondiabetics only (OR = 0.65, 0.27-0.80 95% CI, p = 0.030), whereas no association was observed among diabetic individuals. These observations support the hypothesis that increased levels of circulating omega-6 and omega-3 fatty acids are associated with protective effects against future cardiovascular events. However, these effects were only observed in the nondiabetic population, further highlighting the need for patient stratification in clinical investigations.', 'FAU': ['Kamleh, Muhammad Anas', 'McLeod, Olga', 'Checa, Antonio', 'Baldassarre, Damiano', 'Veglia, Fabrizio', 'Gertow, Karl', 'Humphries, Steve E', 'Rauramaa, Rainer', 'de Faire, Ulf', 'Smit, Andries J', 'Giral, Philippe', 'Kurl, Sudhir', 'Mannarino, Elmo', 'Tremoli, Elena', 'Silveira, Angela', 'Orvik, John', 'Hamsten, Anders', 'Wheelock, Craig E'], 'AU': ['Kamleh MA', 'McLeod O', 'Checa A', 'Baldassarre D', 'Veglia F', 'Gertow K', 'Humphries SE', 'Rauramaa R', 'de Faire U', 'Smit AJ', 'Giral P', 'Kurl S', 'Mannarino E', 'Tremoli E', 'Silveira A', 'Orvik J', 'Hamsten A', 'Wheelock CE'], 'AD': ['Division of Physiological Chemistry 2, Department of Medical Biochemistry and Biophysics, Karolinska Institutet , 17177 Stockholm, Sweden.', 'Cardiovascular Medicine Unit, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet and Department of Cardiology, Karolinska University Hospital Solna , 17176 Stockholm, Sweden.', 'Division of Physiological Chemistry 2, Department of Medical Biochemistry and Biophysics, Karolinska Institutet , 17177 Stockholm, Sweden.', 'Department of Medical Biotechnology and Translational Medicine, Universita degli Studi di Milano , 20133 Milan, Italy.', 'Centro Cardiologico Monzino, I.R.C.C.S. , 20138 Milan, Italy.', 'Centro Cardiologico Monzino, I.R.C.C.S. , 20138 Milan, Italy.', 'Cardiovascular Medicine Unit, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet and Department of Cardiology, Karolinska University Hospital Solna , 17176 Stockholm, Sweden.', 'Cardiovascular Genetics, Institute of Cardiovascular Science, University College of London , London WC1E 6BT, United Kingdom.', 'Foundation for Research in Health Exercise and Nutrition, Kuopio Research Institute of Exercise Medicine , 70100 Kuopio, Finland.', 'Department of Cardiology, Karolinska University Hospital Solna , 17176 Stockholm, Sweden.', 'Division of Cardiovascular Epidemiology, Institute of Environmental Medicine, Karolinska Institutet , 17177 Stockholm, Sweden.', 'Department of Medicine, University Medical Center Groningen , 9713 GZ Groningen, The Netherlands.', 'Assistance Publique - Hopitaux de Paris ; Service Endocrinologie-Metabolisme, Groupe Hopitalier Pitie-Salpetriere, Unites de Prevention Cardiovasculaire, 75004 Paris, France.', 'Institute of Public Health and Clinical Nutrition, University of Eastern Finland , Kuopio Campus, 70211 Kuopio, Finland.', 'Internal Medicine, Angiology and Arteriosclerosis Diseases, Department of Clinical and Experimental Medicine, University of Perugia , Perugia 06132, Italy.', 'Department of Medical Biotechnology and Translational Medicine, Universita degli Studi di Milano , 20133 Milan, Italy.', 'Centro Cardiologico Monzino, I.R.C.C.S. , 20138 Milan, Italy.', 'Cardiovascular Medicine Unit, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet and Department of Cardiology, Karolinska University Hospital Solna , 17176 Stockholm, Sweden.', 'Cardiovascular Medicine Unit, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet and Department of Cardiology, Karolinska University Hospital Solna , 17176 Stockholm, Sweden.', 'Cardiovascular Medicine Unit, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet and Department of Cardiology, Karolinska University Hospital Solna , 17176 Stockholm, Sweden.', 'Division of Physiological Chemistry 2, Department of Medical Biochemistry and Biophysics, Karolinska Institutet , 17177 Stockholm, Sweden.'], 'AUID': ['ORCID: 0000-0002-8113-0653'], 'LA': ['eng'], 'GR': ['RG/08/008/25291/British Heart Foundation/United Kingdom', 'PG008/08/British Heart Foundation/United Kingdom'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20180122', 'PL': 'United States', 'TA': 'J Proteome Res', 'JT': 'Journal of proteome research', 'JID': '101128775', 'RN': ['0 (Biomarkers)', '0 (Eicosanoids)', '0 (Endocannabinoids)', '0 (Fatty Acids, Omega-3)', '0 (Fatty Acids, Omega-6)', '0 (Oxylipins)'], 'SB': 'IM', 'MH': ['Aged', 'Biomarkers/blood', 'Cardiovascular Diseases/*blood/diagnosis', 'Case-Control Studies', 'Diabetes Mellitus/blood/diagnosis', 'Eicosanoids/blood', 'Endocannabinoids/blood', 'Factor Analysis, Statistical', 'Fatty Acids, Omega-3/*blood', 'Fatty Acids, Omega-6/*blood', 'Female', 'Humans', 'Male', 'Middle Aged', 'Oxylipins/blood', 'Prognosis', 'Protective Factors', 'Risk Factors'], 'OTO': ['NOTNLM'], 'OT': ['*cardiovascular disease', '*diabetes', '*eicosanoids', '*endocannabinoids', '*fatty acids', '*metabolomics'], 'EDAT': '2017/12/14 06:00', 'MHDA': '2018/09/14 06:00', 'CRDT': ['2017/12/14 06:00'], 'PHST': ['2017/12/14 06:00 [pubmed]', '2018/09/14 06:00 [medline]', '2017/12/14 06:00 [entrez]'], 'AID': ['10.1021/acs.jproteome.7b00671 [doi]'], 'PST': 'ppublish', 'SO': 'J Proteome Res. 2018 Feb 2;17(2):870-878. doi: 10.1021/acs.jproteome.7b00671. Epub 2018 Jan 22.'}\n",
      "{'PMID': '29215023', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20190724', 'LR': '20190724', 'IS': '2045-2322 (Electronic) 2045-2322 (Linking)', 'VI': '7', 'IP': '1', 'DP': '2017 Dec 7', 'TI': 'A Pilot Characterization of the Human Chronobiome.', 'PG': '17141', 'LID': '10.1038/s41598-017-17362-6 [doi]', 'AB': 'Physiological function, disease expression and drug effects vary by time-of-day. Clock disruption in mice results in cardio-metabolic, immunological and neurological dysfunction; circadian misalignment using forced desynchrony increases cardiovascular risk factors in humans. Here we integrated data from remote sensors, physiological and multi-omics analyses to assess the feasibility of detecting time dependent signals - the chronobiome - despite the \"noise\" attributable to the behavioral differences of free-living human volunteers. The majority (62%) of sensor readouts showed time-specific variability including the expected variation in blood pressure, heart rate, and cortisol. While variance in the multi-omics is dominated by inter-individual differences, temporal patterns are evident in the metabolome (5.4% in plasma, 5.6% in saliva) and in several genera of the oral microbiome. This demonstrates, despite a small sample size and limited sampling, the feasibility of characterizing at scale the human chronobiome \"in the wild\". Such reference data at scale are a prerequisite to detect and mechanistically interpret discordant data derived from patients with temporal patterns of disease expression, to develop time-specific therapeutic strategies and to refine existing treatments.', 'FAU': ['Skarke, Carsten', 'Lahens, Nicholas F', 'Rhoades, Seth D', 'Campbell, Amy', 'Bittinger, Kyle', 'Bailey, Aubrey', 'Hoffmann, Christian', 'Olson, Randal S', 'Chen, Lihong', 'Yang, Guangrui', 'Price, Thomas S', 'Moore, Jason H', 'Bushman, Frederic D', 'Greene, Casey S', 'Grant, Gregory R', 'Weljie, Aalim M', 'FitzGerald, Garret A'], 'AU': ['Skarke C', 'Lahens NF', 'Rhoades SD', 'Campbell A', 'Bittinger K', 'Bailey A', 'Hoffmann C', 'Olson RS', 'Chen L', 'Yang G', 'Price TS', 'Moore JH', 'Bushman FD', 'Greene CS', 'Grant GR', 'Weljie AM', 'FitzGerald GA'], 'AUID': ['ORCID: 0000-0001-5145-3681', 'ORCID: 0000-0002-0712-217X', 'ORCID: 0000-0003-1736-8007', 'ORCID: 0000-0003-4740-4056', 'ORCID: 0000-0001-8713-9213'], 'AD': ['Department of Systems Pharmacology and Translational Therapeutics, at the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA. cskarke@pennmedicine.upenn.edu.', 'Department of Medicine, at the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA. cskarke@pennmedicine.upenn.edu.', 'Institute for Translational Medicine and Therapeutics (ITMAT), at the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA. cskarke@pennmedicine.upenn.edu.', 'Department of Systems Pharmacology and Translational Therapeutics, at the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.', 'Institute for Translational Medicine and Therapeutics (ITMAT), at the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.', 'Department of Systems Pharmacology and Translational Therapeutics, at the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.', 'Department of Systems Pharmacology and Translational Therapeutics, at the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.', 'Department of Microbiology, at the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.', \"Division of Gastroenterology, Hepatology, and Nutrition, at Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.\", 'Department of Microbiology, at the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.', 'Department of Microbiology, at the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.', 'Department of Food Science and Experimental Nutrition, Food Research Center (FoRC), School of Pharmaceutical Sciences, University of Sao Paulo, Sao Paulo, Brazil.', 'Institute for Biomedical Informatics, at the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.', 'Department of Systems Pharmacology and Translational Therapeutics, at the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.', 'Department of Systems Pharmacology and Translational Therapeutics, at the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.', 'Department of Systems Pharmacology and Translational Therapeutics, at the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.', 'Institute for Biomedical Informatics, at the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.', 'Institute for Translational Medicine and Therapeutics (ITMAT), at the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.', 'Department of Microbiology, at the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.', 'Institute for Translational Medicine and Therapeutics (ITMAT), at the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.', 'Department of Systems Pharmacology and Translational Therapeutics, at the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.', 'Institute for Translational Medicine and Therapeutics (ITMAT), at the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.', 'Institute for Translational Medicine and Therapeutics (ITMAT), at the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.', 'Department of Genetics, at the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.', 'Department of Systems Pharmacology and Translational Therapeutics, at the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.', 'Institute for Translational Medicine and Therapeutics (ITMAT), at the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.', 'Department of Systems Pharmacology and Translational Therapeutics, at the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA. garret@upenn.edu.', 'Department of Medicine, at the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA. garret@upenn.edu.', 'Institute for Translational Medicine and Therapeutics (ITMAT), at the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA. garret@upenn.edu.'], 'LA': ['eng'], 'GR': ['P30 ES013508/ES/NIEHS NIH HHS/United States', 'UL1 RR024134/RR/NCRR NIH HHS/United States', 'UL1 TR000003/TR/NCATS NIH HHS/United States'], 'PT': ['Journal Article', 'Research Support, N.I.H., Extramural', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20171207', 'PL': 'England', 'TA': 'Sci Rep', 'JT': 'Scientific reports', 'JID': '101563288', 'RN': ['0 (Blood Proteins)', '0 (Proteome)', 'WI4X0X7BPJ (Hydrocortisone)'], 'MH': ['Adult', 'Blood Pressure', 'Blood Proteins/metabolism', '*Circadian Rhythm', 'Heart Rate', 'Humans', 'Hydrocortisone/metabolism', 'Male', '*Metabolome', '*Microbiota', 'Mouth/metabolism', 'Pilot Projects', '*Proteome', 'Saliva/metabolism', 'Time Factors', '*Transcriptome'], 'PMC': 'PMC5719427', 'EDAT': '2017/12/08 06:00', 'MHDA': '2019/07/25 06:00', 'CRDT': ['2017/12/08 06:00'], 'PHST': ['2017/09/05 00:00 [received]', '2017/11/23 00:00 [accepted]', '2017/12/08 06:00 [entrez]', '2017/12/08 06:00 [pubmed]', '2019/07/25 06:00 [medline]'], 'AID': ['10.1038/s41598-017-17362-6 [doi]', '10.1038/s41598-017-17362-6 [pii]'], 'PST': 'epublish', 'SO': 'Sci Rep. 2017 Dec 7;7(1):17141. doi: 10.1038/s41598-017-17362-6.'}\n",
      "{'PMID': '29158831', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20180319', 'LR': '20181113', 'IS': '1838-7640 (Electronic) 1838-7640 (Linking)', 'VI': '7', 'IP': '18', 'DP': '2017', 'TI': 'Identification and Validation of a Salivary Protein Panel to Detect Heart Failure Early.', 'PG': '4350-4358', 'LID': '10.7150/thno.21727 [doi]', 'AB': 'BACKGROUND: Over 26 million people suffer from heart failure (HF) globally. Current diagnosis of HF relies on clinical evaluation, blood assays and imaging techniques. Our aim is to develop a diagnostic assay to detect HF in at risk individuals within the community using human saliva as a medium, potentially leading to a simple, safe early warning system. METHODS: Saliva samples were collected from healthy controls (n=36) and HF patients (n=75). Salivary proteome profiles were analysed by Sequential Window Acquisition of All Theoretical fragment ion spectra - Mass Spectrometry (SWATH-MS). A total of 738 proteins were quantified and 177 proteins demonstrated significant differences between HF patients and healthy controls. Candidate biomarkers were chosen based on their abundance and difference between the two cohorts. A multi-protein panel was developed using logistic regression analysis. The diagnostic performance of the multi-protein panel was assessed using receiver operative characteristic curves. The candidate proteins were further confirmed, using western blot analysis, and validated technically, using an independent biological cohort. RESULTS: A group of six proteins were chosen in the discovery phase as potential candidates based on their differences in the abundance between the two cohorts. During the validation phase, two of the proteins were not detected with western blotting and as such were removed. The final panel consists of four proteins with sensitivity of 83.3%, specificity of 62.5% with an area under ROC curve of 0.78 in discriminating healthy controls from NYHA class I/II HF patients, and was validated in a second independent cohort study. CONCLUSION: Analysis of salivary proteome using SWATH-MS revealed novel HF-specific protein candidates yielding high diagnostic performance. A multi-centre longitudinal clinical trial will be the next step before clinical implementation of this panel.', 'FAU': ['Zhang, Xi', 'Walsh, Terry', 'Atherton, John J', 'Kostner, Karam', 'Schulz, Benjamin', 'Punyadeera, Chamindie'], 'AU': ['Zhang X', 'Walsh T', 'Atherton JJ', 'Kostner K', 'Schulz B', 'Punyadeera C'], 'AD': ['The School of Biomedical Sciences, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia.', 'The School of Biomedical Sciences, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia.', \"Cardiology Department, Royal Brisbane and Women's Hospital; University of Queensland School of Medicine; School of Nursing, Queensland University of Technology, Brisbane, Australia.\", 'Department of Cardiology, Mater Adult Hospital, Brisbane, Queensland, Australia.', 'School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Queensland, Australia.', 'The School of Biomedical Sciences, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia.'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20170926', 'PL': 'Australia', 'TA': 'Theranostics', 'JT': 'Theranostics', 'JID': '101552395', 'RN': ['0 (Biomarkers)', '0 (Proteome)', '0 (Salivary Proteins and Peptides)'], 'SB': 'IM', 'MH': ['Adult', 'Aged', 'Aged, 80 and over', 'Biomarkers/metabolism', 'Case-Control Studies', 'Cohort Studies', 'Female', 'Heart Failure/*diagnosis/*metabolism', 'Humans', 'Male', 'Mass Spectrometry/methods', 'Middle Aged', 'Proteome/metabolism', 'ROC Curve', 'Saliva/*metabolism', 'Salivary Proteins and Peptides/*metabolism', 'Sensitivity and Specificity'], 'PMC': 'PMC5695135', 'OTO': ['NOTNLM'], 'OT': ['*diagnosis', '*heart failure', '*mass spectrometry', '*multi-biomarker strategies.', '*saliva'], 'COIS': ['Competing Interests: XZ, BS and CP are inventors of a PCT patent application', 'Australian provisional patent application number is 2016903387.'], 'EDAT': '2017/11/22 06:00', 'MHDA': '2018/03/20 06:00', 'CRDT': ['2017/11/22 06:00'], 'PHST': ['2017/07/03 00:00 [received]', '2017/08/24 00:00 [accepted]', '2017/11/22 06:00 [entrez]', '2017/11/22 06:00 [pubmed]', '2018/03/20 06:00 [medline]'], 'AID': ['10.7150/thno.21727 [doi]', 'thnov07p4350 [pii]'], 'PST': 'epublish', 'SO': 'Theranostics. 2017 Sep 26;7(18):4350-4358. doi: 10.7150/thno.21727. eCollection 2017.'}\n",
      "{'PMID': '29151592', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20190315', 'LR': '20190315', 'IS': '1476-5497 (Electronic) 0307-0565 (Linking)', 'VI': '42', 'IP': '3', 'DP': '2018 Mar', 'TI': 'Diet-resistant obesity is characterized by a distinct plasma proteomic signature and impaired muscle fiber metabolism.', 'PG': '353-362', 'LID': '10.1038/ijo.2017.286 [doi]', 'AB': 'BACKGROUND/OBJECTIVES: Inter-individual variability in weight loss during obesity treatment is complex and poorly understood. Here we use whole body and tissue approaches to investigate fuel oxidation characteristics in skeletal muscle fibers, cells and distinct circulating protein biomarkers before and after a high fat meal (HFM) challenge in those who lost the most (obese diet-sensitive; ODS) vs the least (obese diet-resistant; ODR) amount of weight in a highly controlled weight management program. SUBJECTS/METHODS: In 20 weight stable-matched ODS and ODR women who previously completed a standardized clinical weight loss program, we analyzed whole-body energetics and metabolic parameters in vastus lateralis biopsies and plasma samples that were obtained in the fasting state and 6 h after a defined HFM, equivalent to 35% of total daily energy requirements. RESULTS: At baseline (fasting) and post-HFM, muscle fatty acid oxidation and maximal oxidative phosphorylation were significantly greater in ODS vs ODR, as was reactive oxygen species emission. Plasma proteomics of 1130 proteins pre and 1, 2, 5 and 6 h after the HFM demonstrated distinct group and interaction differences. Group differences identified S-formyl glutathione hydratase, heat shock 70 kDA protein 1A/B (HSP72), and eukaryotic translation initiation factor 5 (eIF5) to be higher in ODS vs ODR. Group-time differences included aryl hydrocarbon interacting protein (AIP), peptidylpropyl isomerase D (PPID) and tyrosine protein-kinase Fgr, which increased in ODR vs ODS over time. HSP72 levels correlated with muscle oxidation and citrate synthase activity. These proteins circulate in exosomes; exosomes isolated from ODS plasma increased resting, leak and maximal respiration rates in C2C12 myotubes by 58%, 21% and 51%, respectively, vs those isolated from ODR plasma. CONCLUSIONS: Findings demonstrate distinct muscle metabolism and plasma proteomics in fasting and post-HFM states corresponding in diet-sensitive vs diet-resistant obese women.', 'FAU': ['Thrush, A B', 'Antoun, G', 'Nikpay, M', 'Patten, D A', 'DeVlugt, C', 'Mauger, J-F', 'Beauchamp, B L', 'Lau, P', 'Reshke, R', 'Doucet, E', 'Imbeault, P', 'Boushel, R', 'Gibbings, D', 'Hager, J', 'Valsesia, A', 'Slack, R S', 'Al-Dirbashi, O Y', 'Dent, R', 'McPherson, R', 'Harper, M-E'], 'AU': ['Thrush AB', 'Antoun G', 'Nikpay M', 'Patten DA', 'DeVlugt C', 'Mauger JF', 'Beauchamp BL', 'Lau P', 'Reshke R', 'Doucet E', 'Imbeault P', 'Boushel R', 'Gibbings D', 'Hager J', 'Valsesia A', 'Slack RS', 'Al-Dirbashi OY', 'Dent R', 'McPherson R', 'Harper ME'], 'AD': ['Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.', 'Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.', 'Ruddy Canadian Cardiovascular Genetics Centre, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.', 'Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.', 'Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.', 'Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.', 'School of Human Kinetics, Faculty of Health Sciences, University of Ottawa, Ottawa, Ontario, Canada.', 'Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.', 'Ruddy Canadian Cardiovascular Genetics Centre, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.', 'Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.', 'School of Human Kinetics, Faculty of Health Sciences, University of Ottawa, Ottawa, Ontario, Canada.', 'School of Human Kinetics, Faculty of Health Sciences, University of Ottawa, Ottawa, Ontario, Canada.', 'School of Kinesiology, University of British Columbia, Vancouver, British Columbia, Canada.', 'Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.', 'Nestle Institute of Health Sciences, Lausanne, Switzerland.', 'Nestle Institute of Health Sciences, Lausanne, Switzerland.', 'Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.', \"Newborn Screening Ontario, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada.\", 'Faculty of Medicine and Health Sciences, United Arab Emirates University, Al-Ain, United Arab Emirates.', 'Ottawa Hospital Weight Management Clinic, Ottawa, Ontario, Canada.', 'Ruddy Canadian Cardiovascular Genetics Centre, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.', 'Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.'], 'LA': ['eng'], 'GR': ['MOP57810/CIHR/Canada', 'MOP136936/CIHR/Canada'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20171120', 'PL': 'England', 'TA': 'Int J Obes (Lond)', 'JT': 'International journal of obesity (2005)', 'JID': '101256108', 'RN': ['0 (Biomarkers)', '0 (Blood Proteins)', '0 (Proteome)'], 'SB': 'IM', 'MH': ['Biomarkers/blood', 'Blood Proteins/analysis/*metabolism', 'Case-Control Studies', 'Diet', 'Exosomes/metabolism', 'Female', 'Humans', 'Middle Aged', 'Muscle Fibers, Skeletal/*metabolism', 'Muscle, Skeletal/metabolism/physiopathology', '*Obesity/blood/diet therapy/epidemiology/metabolism', 'Proteome/analysis/*metabolism', 'Treatment Failure'], 'PMC': 'PMC5880582', 'EDAT': '2017/11/21 06:00', 'MHDA': '2019/03/16 06:00', 'CRDT': ['2017/11/21 06:00'], 'PHST': ['2017/07/21 00:00 [received]', '2017/10/11 00:00 [revised]', '2017/10/30 00:00 [accepted]', '2017/11/21 06:00 [pubmed]', '2019/03/16 06:00 [medline]', '2017/11/21 06:00 [entrez]'], 'AID': ['ijo2017286 [pii]', '10.1038/ijo.2017.286 [doi]'], 'PST': 'ppublish', 'SO': 'Int J Obes (Lond). 2018 Mar;42(3):353-362. doi: 10.1038/ijo.2017.286. Epub 2017 Nov 20.'}\n",
      "{'PMID': '28922609', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20180801', 'LR': '20181118', 'IS': '1535-3907 (Electronic) 1535-3893 (Linking)', 'VI': '16', 'IP': '11', 'DP': '2017 Nov 3', 'TI': 'Serum Proteomic Variability Associated with Clinical Phenotype in Familial Transthyretin Amyloidosis (ATTRm).', 'PG': '4104-4112', 'LID': '10.1021/acs.jproteome.7b00479 [doi]', 'AB': 'Transthyretin (TTR), normally a plasma circulating protein, can become misfolded and aggregated, ultimately leading to extracellular deposition of amyloid fibrils usually targeted to heart or nerve tissues. Referred to as TTR-associated amyloidoses (ATTR), this group of diseases is frequently life threatening and fatal if untreated. ATTR, caused by amyloid-forming variant TTR proteins (ATTRm) that arise from point mutations in the TTR gene, were classically referred to as familial amyloid cardiomyopathy (FAC) or familial amyloid polyneuropathy (FAP), reflecting the clinical phenotype. FAC and FAP are pathologies that can be challenging to diagnose as there are no definitive biomarkers of disease; moreover, disease-specific measures of progression are lacking, and treatment options are limited. Thus, the discovery of sensitive and specific indicators of disease has the potential to improve recognition, enable accurate measurement of amyloid progression and response to treatment, and reveal key information regarding FAC and FAP pathobiological mechanisms. In this study, the goal was to investigate serum proteomic features unique to FAC and FAP types of ATTRm. Multiple-reaction monitoring mass spectrometry (MRM-MS), a powerful technique in profiling proteomes, was used to measure the serum concentrations of 160 proteins in samples from FAC and FAP patients. Results were compared to data from healthy control sera obtained from individuals matched to age (>/=60 years), gender (male), and race (Caucasian). Proteomic analyses of ATTRm (FAC and FAP) and control samples showed significant concentration differences in 107 of 192 (56%) of the serum proteins that were studied. In comparing FAC to FAP, differences in concentrations as well as interactions and functions of several proteins were identified as unique to each disease; significantly lower levels of TTR were specific to FAC, but not to FAP. Annotated functional clustering identified extracellular region, signal, and signal peptide as terms common to FAC and FAP. Conversely, disulfide bond was unique to FAC; secreted, glycosylation site: N-linked, glycosylation, glycoprotein, polymorphism, and sequence variant were associated solely with FAP. Predicted protein-protein associations in FAC were seen for reaction, binding, and activation processes; no associations were found in FAP. This study demonstrates significant proteomic differences between ATTRm patient and control sera, as well as ATTRm phenotype-associated variations in the circulating levels of several proteins including TTR. The identification of serum proteins unique to FAC and FAP may have diagnostic and prognostic utility and could possibly provide important clues about disease mechanisms.', 'FAU': ['Chan, Gloria G', 'Koch, Clarissa M', 'Connors, Lawreen H'], 'AU': ['Chan GG', 'Koch CM', 'Connors LH'], 'AUID': ['ORCID: 0000-0003-4541-9713'], 'AD': ['Amyloidosis Center and double daggerDepartment of Pathology and Laboratory Medicine, Boston University School of Medicine , Boston, Massachusetts 02118, United States.', 'Amyloidosis Center and double daggerDepartment of Pathology and Laboratory Medicine, Boston University School of Medicine , Boston, Massachusetts 02118, United States.', 'Amyloidosis Center and double daggerDepartment of Pathology and Laboratory Medicine, Boston University School of Medicine , Boston, Massachusetts 02118, United States.'], 'LA': ['eng'], 'GR': ['R01 AG031804/AG/NIA NIH HHS/United States'], 'PT': ['Journal Article', 'Research Support, N.I.H., Extramural', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20170927', 'PL': 'United States', 'TA': 'J Proteome Res', 'JT': 'Journal of proteome research', 'JID': '101128775', 'RN': ['0 (Blood Proteins)', '0 (Prealbumin)', 'Amyloidosis, Hereditary, Transthyretin-Related'], 'SB': 'IM', 'MH': ['Aged', 'Aged, 80 and over', 'Amyloid Neuropathies, Familial/*blood/diagnosis', 'Blood Proteins/*analysis', 'Cardiomyopathies/diagnosis', 'Case-Control Studies', 'Humans', 'Male', 'Middle Aged', 'Phenotype', 'Prealbumin/genetics', 'Protein Binding', 'Proteomics/methods'], 'OTO': ['NOTNLM'], 'OT': ['*DAVID', '*MRM-MS', '*PANTHER', '*STRING', '*UniprotKB', '*biomarker', '*cardiomyopathy', '*familial amyloidosis', '*neuropathy', '*transthyretin'], 'EDAT': '2017/09/19 06:00', 'MHDA': '2018/08/02 06:00', 'CRDT': ['2017/09/19 06:00'], 'PHST': ['2017/09/19 06:00 [pubmed]', '2018/08/02 06:00 [medline]', '2017/09/19 06:00 [entrez]'], 'AID': ['10.1021/acs.jproteome.7b00479 [doi]'], 'PST': 'ppublish', 'SO': 'J Proteome Res. 2017 Nov 3;16(11):4104-4112. doi: 10.1021/acs.jproteome.7b00479. Epub 2017 Sep 27.'}\n",
      "{'PMID': '28800743', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20180507', 'LR': '20190329', 'IS': '1756-6606 (Electronic) 1756-6606 (Linking)', 'VI': '10', 'IP': '1', 'DP': '2017 Aug 11', 'TI': 'An iTRAQ-based proteomic analysis reveals dysregulation of neocortical synaptopodin in Lewy body dementias.', 'PG': '36', 'LID': '10.1186/s13041-017-0316-9 [doi]', 'AB': \"Lewy body dementias are the second most common cause of neurodegenerative dementia in the elderly after Alzheimer's disease (AD). The two clinical subgroups of Lewy body dementias, namely, dementia with Lewy bodies (DLB) and Parkinson's disease dementia (PDD), are differentiated by the chronology of cognitive symptoms relative to parkinsonism. At present, there remains a debate on whether DLB and PDD are separate disease entities, or fall within the same spectrum of Lewy body dementias. In this study, we compared the detergent-soluble proteome via an 8-plex isobaric tag for relative and absolute quantitation (iTRAQ) analysis of pooled lysates from the prefrontal cortex (BA9) of DLB (n = 19) and PDD (n = 21) patients matched a priori for amyloid (total Abeta42) burden, semi-quantitative scores for Lewy bodies and neurofibrillary tangles together with age-matched control (n = 21) subjects. A total of 1914 proteins were confidently identified by iTRAQ (false discovery rate = 0%). None of the proteins showed a significant yet opposite regulation in between DLB and PDD when compared to aged controls in the proteomic data set as well as following immunoblot analysis of the pooled and individual lysates involving all 61 subjects. The postsynaptic protein, synaptopodin (SYNPO) was significantly down-regulated in both DLB and PDD subgroups, suggesting a defective synaptic transmission in the demented patients. In conclusion, the largely similar proteome of DLB and PDD matched for amyloid burden suggests that variations in concomitant AD-related pathology, abnormal post-translational modifications or protein-protein interactions, defective intracellular trafficking or misfolding of proteins could play a part in driving the clinically observed differences between these two subgroups of Lewy body dementias. This further indicates that amyloid-targeting therapeutic strategies may show different efficacies in DLB versus PDD.\", 'FAU': ['Datta, Arnab', 'Chai, Yuek Ling', 'Tan, Jing Min', 'Lee, Jasinda H', 'Francis, Paul T', 'Chen, Christopher P', 'Sze, Siu Kwan', 'Lai, Mitchell K P'], 'AU': ['Datta A', 'Chai YL', 'Tan JM', 'Lee JH', 'Francis PT', 'Chen CP', 'Sze SK', 'Lai MKP'], 'AUID': ['ORCID: 0000-0002-9220-7812'], 'AD': ['Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Unit 09-01, Centre for Translational Medicine (MD6), 14 Medical Drive, Kent Ridge, Singapore 117599, Singapore. arnab.datta@nih.gov.', 'Epithelial Systems Biology Laboratory, National Heart, Lung, and Blood Institute, Building 10 Room 6N318, Bethesda, MD 20814, USA. arnab.datta@nih.gov.', 'Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Unit 09-01, Centre for Translational Medicine (MD6), 14 Medical Drive, Kent Ridge, Singapore 117599, Singapore.', 'Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Unit 09-01, Centre for Translational Medicine (MD6), 14 Medical Drive, Kent Ridge, Singapore 117599, Singapore.', 'Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Unit 09-01, Centre for Translational Medicine (MD6), 14 Medical Drive, Kent Ridge, Singapore 117599, Singapore.', \"Wolfson Centre for Age-related Diseases, King's College London, Guy's Campus, St Thomas Street, London SE1 1UL, UK.\", 'Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Unit 09-01, Centre for Translational Medicine (MD6), 14 Medical Drive, Kent Ridge, Singapore 117599, Singapore.', 'School of Biological Sciences, Nanyang Technological University, Singapore 637551, Singapore.', 'Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Unit 09-01, Centre for Translational Medicine (MD6), 14 Medical Drive, Kent Ridge, Singapore 117599, Singapore. mitchell.lai@dementia-research.org.', \"Wolfson Centre for Age-related Diseases, King's College London, Guy's Campus, St Thomas Street, London SE1 1UL, UK. mitchell.lai@dementia-research.org.\"], 'LA': ['eng'], 'GR': ['G0400074/Medical Research Council/United Kingdom'], 'PT': ['Journal Article'], 'DEP': '20170811', 'PL': 'England', 'TA': 'Mol Brain', 'JT': 'Molecular brain', 'JID': '101468876', 'RN': ['0 (Amyloid beta-Peptides)', '0 (Microfilament Proteins)', '0 (SYNPO protein, human)'], 'SB': 'IM', 'MH': ['Aged, 80 and over', 'Amyloid beta-Peptides/metabolism', 'Demography', 'Female', 'Humans', 'Immunoblotting', '*Isotope Labeling', 'Lewy Body Disease/*metabolism/pathology', 'Male', 'Microfilament Proteins', 'Neocortex/*metabolism/pathology', 'Proteomics/*methods', 'Quality Control'], 'PMC': 'PMC5553757', 'OTO': ['NOTNLM'], 'OT': ['*Abeta42', '*Clinical proteomics', '*Dementia with Lewy bodies', '*Lewy body dementias', \"*Parkinson's disease dementia\", '*Synaptopodin', '*iTRAQ', '*beta-amyloid'], 'EDAT': '2017/08/13 06:00', 'MHDA': '2018/05/08 06:00', 'CRDT': ['2017/08/13 06:00'], 'PHST': ['2017/06/06 00:00 [received]', '2017/07/21 00:00 [accepted]', '2017/08/13 06:00 [entrez]', '2017/08/13 06:00 [pubmed]', '2018/05/08 06:00 [medline]'], 'AID': ['10.1186/s13041-017-0316-9 [doi]', '10.1186/s13041-017-0316-9 [pii]'], 'PST': 'epublish', 'SO': 'Mol Brain. 2017 Aug 11;10(1):36. doi: 10.1186/s13041-017-0316-9.'}\n",
      "{'PMID': '28794502', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20190219', 'LR': '20190320', 'IS': '2045-2322 (Electronic) 2045-2322 (Linking)', 'VI': '7', 'IP': '1', 'DP': '2017 Aug 9', 'TI': 'Proteomics/phosphoproteomics of left ventricular biopsies from patients with surgical coronary revascularization and pigs with coronary occlusion/reperfusion: remote ischemic preconditioning.', 'PG': '7629', 'LID': '10.1038/s41598-017-07883-5 [doi]', 'AB': \"Remote ischemic preconditioning (RIPC) by repeated brief cycles of limb ischemia/reperfusion reduces myocardial ischemia/reperfusion injury. In left ventricular (LV) biopsies from patients undergoing coronary artery bypass grafting (CABG), only the activation of signal transducer and activator of transcription 5 was associated with RIPC's cardioprotection. We have now used an unbiased, non-hypothesis-driven proteomics and phosphoproteomics approach to analyze LV biopsies from patients undergoing CABG and from pigs undergoing coronary occlusion/reperfusion without (sham) and with RIPC. False discovery rate-based statistics identified a higher prostaglandin reductase 2 expression at early reperfusion with RIPC than with sham in patients. In pigs, the phosphorylation of 116 proteins was different between baseline and early reperfusion with RIPC and/or with sham. The identified proteins were not identical for patients and pigs, but in-silico pathway analysis of proteins with >/=2-fold higher expression/phosphorylation at early reperfusion with RIPC in comparison to sham revealed a relation to mitochondria and cytoskeleton in both species. Apart from limitations of the proteomics analysis per se, the small cohorts, the sampling/sample processing and the number of uncharacterized/unverifiable porcine proteins may have contributed to this largely unsatisfactory result.\", 'FAU': ['Gedik, Nilgun', 'Kruger, Marcus', 'Thielmann, Matthias', 'Kottenberg, Eva', 'Skyschally, Andreas', 'Frey, Ulrich H', 'Cario, Elke', 'Peters, Jurgen', 'Jakob, Heinz', 'Heusch, Gerd', 'Kleinbongard, Petra'], 'AU': ['Gedik N', 'Kruger M', 'Thielmann M', 'Kottenberg E', 'Skyschally A', 'Frey UH', 'Cario E', 'Peters J', 'Jakob H', 'Heusch G', 'Kleinbongard P'], 'AD': ['Institute for Pathophysiology, West German Heart and Vascular Center Essen, Universitatsklinikum Essen, Universitat Duisburg-Essen, Essen, Germany.', 'Institute for Genetics Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), and University of Cologne, Cologne, Germany.', 'Department of Thoracic and Cardiovascular Surgery, West German Heart and Vascular Center Essen, Universitatsklinikum Essen, Universitat Duisburg- Essen, Essen, Germany.', 'Klinik fur Anasthesiologie und Intensivmedizin, Universitatsklinikum Essen, Universitat Duisburg-Essen, Essen, Germany.', 'Institute for Pathophysiology, West German Heart and Vascular Center Essen, Universitatsklinikum Essen, Universitat Duisburg-Essen, Essen, Germany.', 'Klinik fur Anasthesiologie und Intensivmedizin, Universitatsklinikum Essen, Universitat Duisburg-Essen, Essen, Germany.', 'Experimental Gastroenterology, Department of Gastroenterology and Hepatology, Universitatsklinikum Essen, Universitat Duisburg-Essen, Essen, Germany.', 'Klinik fur Anasthesiologie und Intensivmedizin, Universitatsklinikum Essen, Universitat Duisburg-Essen, Essen, Germany.', 'Department of Thoracic and Cardiovascular Surgery, West German Heart and Vascular Center Essen, Universitatsklinikum Essen, Universitat Duisburg- Essen, Essen, Germany.', 'Institute for Pathophysiology, West German Heart and Vascular Center Essen, Universitatsklinikum Essen, Universitat Duisburg-Essen, Essen, Germany.', 'Institute for Pathophysiology, West German Heart and Vascular Center Essen, Universitatsklinikum Essen, Universitat Duisburg-Essen, Essen, Germany. petra.kleinbongard@uk-essen.de.'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20170809', 'PL': 'England', 'TA': 'Sci Rep', 'JT': 'Scientific reports', 'JID': '101563288', 'RN': ['0 (Phosphoproteins)', '0 (Proteome)'], 'SB': 'IM', 'MH': ['Aged', 'Animals', 'Biopsy', 'Computational Biology', '*Coronary Artery Bypass', 'Coronary Occlusion/*pathology', 'Female', 'Heart Ventricles/*pathology', 'Humans', '*Ischemic Preconditioning, Myocardial', 'Male', 'Models, Animal', '*Myocardial Reperfusion', 'Phosphoproteins/*analysis', 'Proteome/*analysis', 'Proteomics', 'Swine'], 'PMC': 'PMC5550488', 'EDAT': '2017/08/11 06:00', 'MHDA': '2019/03/21 06:00', 'CRDT': ['2017/08/11 06:00'], 'PHST': ['2017/01/31 00:00 [received]', '2017/06/22 00:00 [accepted]', '2017/08/11 06:00 [entrez]', '2017/08/11 06:00 [pubmed]', '2019/03/21 06:00 [medline]'], 'AID': ['10.1038/s41598-017-07883-5 [doi]', '10.1038/s41598-017-07883-5 [pii]'], 'PST': 'epublish', 'SO': 'Sci Rep. 2017 Aug 9;7(1):7629. doi: 10.1038/s41598-017-07883-5.'}\n",
      "{'PMID': '28784649', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20180430', 'LR': '20190116', 'IS': '2047-9980 (Electronic) 2047-9980 (Linking)', 'VI': '6', 'IP': '8', 'DP': '2017 Aug 7', 'TI': 'Novel Urinary Peptidomic Classifier Predicts Incident Heart Failure.', 'LID': 'e005432 [pii] 10.1161/JAHA.116.005432 [doi]', 'AB': 'BACKGROUND: Detection of preclinical cardiac dysfunction and prognosis of left ventricular heart failure (HF) would allow targeted intervention, and appears to be the most promising approach in its management. Novel biomarker panels may support this approach and provide new insights into the pathophysiology. METHODS AND RESULTS: A retrospective comparison of urinary proteomic profiles generated by mass spectrometric analysis from 49 HF patients, 36 patients who progressed to HF within 2.6+/-1.6 years, and 192 sex- and age-matched controls who did not progress to HF enabled identification of 96 potentially HF-specific peptide biomarkers. Based on these 96 peptides, the classifier called Heart Failure Predictor (HFP) was established by support vector machine modeling. The incremental prognostic value of HFP was subsequently evaluated in urine samples from 175 individuals with asymptomatic diastolic dysfunction from an independent population cohort. Within 4.8 years, 17 of these individuals progressed to overt HF. The area under receiver-operating characteristic curve was 0.70 (95% CI, 0.56-0.82); P=0.0047 for HFP and 0.57 (0.42-0.72; P=0.62) for N-terminal pro b-type natriuretic peptide. Hazard ratios were 1.63 (CI, 1.04-2.55; P=0.032) per 1-SD increment in HFP and 0.70 (CI, 0.35-1.41; P=0.32) for a doubling of the logarithmically transformed N-terminal pro b-type natriuretic peptide. CONCLUSIONS: HFP is a novel biomarker derived from the urinary proteome and might serve as a sensitive tool to improve risk stratification, patient management, and understanding of the pathophysiology of HF.', 'CI': ['(c) 2017 The Authors. Published on behalf of the American Heart Association,', 'Inc., by Wiley.'], 'FAU': ['Zhang, Zhen-Yu', 'Ravassa, Susana', 'Nkuipou-Kenfack, Esther', 'Yang, Wen-Yi', 'Kerr, Shona M', 'Koeck, Thomas', 'Campbell, Archie', 'Kuznetsova, Tatiana', 'Mischak, Harald', 'Padmanabhan, Sandosh', 'Dominiczak, Anna F', 'Delles, Christian', 'Staessen, Jan A'], 'AU': ['Zhang ZY', 'Ravassa S', 'Nkuipou-Kenfack E', 'Yang WY', 'Kerr SM', 'Koeck T', 'Campbell A', 'Kuznetsova T', 'Mischak H', 'Padmanabhan S', 'Dominiczak AF', 'Delles C', 'Staessen JA'], 'AD': ['Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium.', 'Program of Cardiovascular Diseases, Centre for Applied Medical Research, Navarra Institute for Health Research, University of Navarra, Pamplona, Spain.', 'CIBERCV Carlos III Institute of Health, Madrid, Spain.', 'Mosaiques Diagnostics and Therapeutics AG, Hanover, Germany.', 'Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium.', 'Generation Scotland, Centre for Genomic and Experimental Medicine, Institute of Genetics and Molecular Medicine, University of Edinburgh, United Kingdom.', 'Mosaiques Diagnostics and Therapeutics AG, Hanover, Germany.', 'Generation Scotland, Centre for Genomic and Experimental Medicine, Institute of Genetics and Molecular Medicine, University of Edinburgh, United Kingdom.', 'Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium.', 'Mosaiques Diagnostics and Therapeutics AG, Hanover, Germany.', 'Institute of Cardiovascular and Medical Sciences, University of Glasgow, United Kingdom.', 'Institute of Cardiovascular and Medical Sciences, University of Glasgow, United Kingdom.', 'Institute of Cardiovascular and Medical Sciences, University of Glasgow, United Kingdom.', 'Institute of Cardiovascular and Medical Sciences, University of Glasgow, United Kingdom.', 'Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium jan.staessen@med.kuleuven.be ja.staessen@maastrichtuniversity.nl.', 'R & D Group VitaK, Maastricht University, Maastricht, The Netherlands.'], 'LA': ['eng'], 'GR': ['294713/European Research Council/International', 'MR/N005813/1/Medical Research Council/United Kingdom'], 'PT': ['Journal Article', 'Multicenter Study'], 'DEP': '20170807', 'PL': 'England', 'TA': 'J Am Heart Assoc', 'JT': 'Journal of the American Heart Association', 'JID': '101580524', 'RN': ['0 (Biomarkers)', '0 (Peptides)'], 'SB': 'IM', 'MH': ['Aged', 'Area Under Curve', 'Asymptomatic Diseases', 'Biomarkers/urine', '*Decision Support Techniques', 'Disease Progression', 'Europe/epidemiology', 'Female', 'Heart Failure/diagnosis/*epidemiology/physiopathology/*urine', 'Humans', 'Incidence', 'Male', 'Mass Spectrometry', 'Middle Aged', 'Peptides/*urine', 'Predictive Value of Tests', 'Prognosis', 'Proteomics/*methods', 'ROC Curve', 'Risk Factors', 'Support Vector Machine', 'Time Factors', 'Urinalysis', 'Ventricular Dysfunction, Left/diagnosis/*epidemiology/physiopathology/*urine', 'Ventricular Function, Left'], 'PMC': 'PMC5586413', 'OTO': ['NOTNLM'], 'OT': ['biomarker', 'heart failure', 'proteomics', 'risk stratification'], 'EDAT': '2017/08/09 06:00', 'MHDA': '2018/05/01 06:00', 'CRDT': ['2017/08/09 06:00'], 'PHST': ['2017/08/09 06:00 [entrez]', '2017/08/09 06:00 [pubmed]', '2018/05/01 06:00 [medline]'], 'AID': ['JAHA.116.005432 [pii]', '10.1161/JAHA.116.005432 [doi]'], 'PST': 'epublish', 'SO': 'J Am Heart Assoc. 2017 Aug 7;6(8). pii: JAHA.116.005432. doi: 10.1161/JAHA.116.005432.'}\n",
      "{'PMID': '28720870', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20190218', 'LR': '20190219', 'IS': '2045-2322 (Electronic) 2045-2322 (Linking)', 'VI': '7', 'IP': '1', 'DP': '2017 Jul 18', 'TI': 'Monocyte adhesion to atherosclerotic matrix proteins is enhanced by Asn-Gly-Arg deamidation.', 'PG': '5765', 'LID': '10.1038/s41598-017-06202-2 [doi]', 'AB': 'Atherosclerosis arises from leukocyte infiltration and thickening of the artery walls and constitutes a major component of vascular disease pathology, but the molecular events underpinning this process are not fully understood. Proteins containing an Asn-Gly-Arg (NGR) motif readily undergo deamidation of asparagine to generate isoDGR structures that bind to integrin alphavbeta3 on circulating leukocytes. Here we report the identification of isoDGR motifs in human atherosclerotic plaque components including extracellular matrix (ECM) proteins fibronectin and tenascin C, which have been strongly implicated in human atherosclerosis. We further demonstrate that deamidation of NGR motifs in fibronectin and tenascin C leads to increased adhesion of the monocytic cell line U937 and enhanced binding of primary human monocytes, except in the presence of a alphavbeta3-blocking antibody or the alphav-selective inhibitor cilengitide. In contrast, under the same deamidating conditions monocyte-macrophages displayed only weak binding to the alternative ECM component vitronectin which lacks NGR motifs. Together, these findings confirm a critical role for isoDGR motifs in mediating leukocyte adhesion to the ECM via integrin alphavbeta3 and suggest that protein deamidation may promote the pathological progression of human atherosclerosis by enhancing monocyte recruitment to developing plaques.', 'FAU': ['Dutta, Bamaprasad', 'Park, Jung Eun', 'Kumar, Subodh', 'Hao, Piliang', 'Gallart-Palau, Xavier', 'Serra, Aida', 'Ren, Yan', 'Sorokin, Vitaly', 'Lee, Chuen Neng', 'Ho, Hee Hwa', 'de Kleijn, Dominique', 'Sze, Siu Kwan'], 'AU': ['Dutta B', 'Park JE', 'Kumar S', 'Hao P', 'Gallart-Palau X', 'Serra A', 'Ren Y', 'Sorokin V', 'Lee CN', 'Ho HH', 'de Kleijn D', 'Sze SK'], 'AD': ['School of Biological Sciences, Nanyang Technological University, 60 Nanyang Drive, Singapore, 637551, Singapore.', 'School of Biological Sciences, Nanyang Technological University, 60 Nanyang Drive, Singapore, 637551, Singapore.', 'School of Biological Sciences, Nanyang Technological University, 60 Nanyang Drive, Singapore, 637551, Singapore.', 'School of Biological Sciences, Nanyang Technological University, 60 Nanyang Drive, Singapore, 637551, Singapore.', 'School of Biological Sciences, Nanyang Technological University, 60 Nanyang Drive, Singapore, 637551, Singapore.', 'School of Biological Sciences, Nanyang Technological University, 60 Nanyang Drive, Singapore, 637551, Singapore.', 'School of Biological Sciences, Nanyang Technological University, 60 Nanyang Drive, Singapore, 637551, Singapore.', 'Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 119228, Singapore.', 'Department of Cardiac, Thoracic and Vascular Surgery, National University Heart Centre, National University Health System, Singapore, 119228, Singapore.', 'Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 119228, Singapore.', 'Department of Cardiac, Thoracic and Vascular Surgery, National University Heart Centre, National University Health System, Singapore, 119228, Singapore.', 'Department of Cardiology, Tan Tock Seng Hospital, 11 Jalan Tan Tock Seng, Singapore, 308433, Singapore.', 'Department of Cardiac, Thoracic and Vascular Surgery, National University Heart Centre, National University Health System, Singapore, 119228, Singapore.', 'School of Biological Sciences, Nanyang Technological University, 60 Nanyang Drive, Singapore, 637551, Singapore. sksze@ntu.edu.sg.'], 'AUID': ['ORCID: 0000-0002-5652-1687'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20170718', 'PL': 'England', 'TA': 'Sci Rep', 'JT': 'Scientific reports', 'JID': '101563288', 'RN': ['0 (Amides)', '0 (FN1 protein, human)', '0 (Fibronectins)', '0 (NGR peptide)', '0 (Oligopeptides)', '0 (Proteome)'], 'SB': 'IM', 'MH': ['Aged', 'Aged, 80 and over', 'Amides/chemistry/metabolism', 'Amino Acid Sequence', 'Atherosclerosis/*metabolism', 'Cell Adhesion', 'Female', 'Fibronectins/*metabolism', 'Humans', 'Male', 'Middle Aged', 'Monocytes/*metabolism', 'Oligopeptides/chemistry/*metabolism', 'Proteome/metabolism', 'Proteomics/methods', 'U937 Cells'], 'PMC': 'PMC5515959', 'EDAT': '2017/07/20 06:00', 'MHDA': '2019/02/20 06:00', 'CRDT': ['2017/07/20 06:00'], 'PHST': ['2017/01/05 00:00 [received]', '2017/06/09 00:00 [accepted]', '2017/07/20 06:00 [entrez]', '2017/07/20 06:00 [pubmed]', '2019/02/20 06:00 [medline]'], 'AID': ['10.1038/s41598-017-06202-2 [doi]', '10.1038/s41598-017-06202-2 [pii]'], 'PST': 'epublish', 'SO': 'Sci Rep. 2017 Jul 18;7(1):5765. doi: 10.1038/s41598-017-06202-2.'}\n",
      "{'PMID': '28679606', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20180510', 'LR': '20201209', 'IS': '1399-3003 (Electronic) 0903-1936 (Linking)', 'VI': '50', 'IP': '1', 'DP': '2017 Jul', 'TI': 'Proteomic profile of cystic fibrosis sputum cells in adults chronically infected with Pseudomonas aeruginosa.', 'LID': '1601569 [pii] 10.1183/13993003.01569-2016 [doi]', 'AB': 'Lung disease is the main cause of morbidity and mortality in cystic fibrosis (CF), and involves chronic infection and perturbed immune responses. Tissue damage is mediated mostly by extracellular proteases, but other cellular proteins may also contribute to damage through their effect on cell activities and/or release into sputum fluid by means of active secretion or cell death.We employed MudPIT (multidimensional protein identification technology) to identify sputum cellular proteins with consistently altered abundance in adults with CF, chronically infected with Pseudomonas aeruginosa, compared with healthy controls. Ingenuity Pathway Analysis, Gene Ontology, protein abundance and correlation with lung function were used to infer their potential clinical significance.Differentially abundant proteins relate to Rho family small GTPase activity, immune cell movement/activation, generation of reactive oxygen species, and dysregulation of cell death and proliferation. Compositional breakdown identified high abundance of proteins previously associated with neutrophil extracellular traps. Furthermore, negative correlations with lung function were detected for 17 proteins, many of which have previously been associated with lung injury.These findings expand our current understanding of the mechanisms driving CF lung disease and identify sputum cellular proteins with potential for use as indicators of disease status/prognosis, stratification determinants for treatment prescription or therapeutic targets.', 'CI': ['Copyright (c)ERS 2017.'], 'FAU': ['Pattison, Sally H', 'Gibson, David S', 'Johnston, Elinor', 'Peacock, Samantha', 'Rivera, Keith', 'Tunney, Michael M', 'Pappin, Darryl J', 'Elborn, J Stuart'], 'AU': ['Pattison SH', 'Gibson DS', 'Johnston E', 'Peacock S', 'Rivera K', 'Tunney MM', 'Pappin DJ', 'Elborn JS'], 'AD': [\"Centre for Experimental Medicine, Queen's University Belfast, Belfast, UK j.elborn@imperial.ac.uk.\", \"Centre for Experimental Medicine, Queen's University Belfast, Belfast, UK.\", 'Northern Ireland Centre for Stratified Medicine, Biomedical Sciences Research Institute, University of Ulster, Londonderry, UK.', \"Centre for Experimental Medicine, Queen's University Belfast, Belfast, UK.\", 'Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA.', 'Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA.', \"School of Pharmacy, Queen's University Belfast, Belfast, UK.\", 'Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA.', \"Centre for Experimental Medicine, Queen's University Belfast, Belfast, UK.\", 'National Heart and Lung Institute, Imperial College and Royal Brompton Hospital, London, UK.'], 'LA': ['eng'], 'GR': ['P30 CA045508/CA/NCI NIH HHS/United States'], 'PT': ['Journal Article'], 'DEP': '20170705', 'PL': 'England', 'TA': 'Eur Respir J', 'JT': 'The European respiratory journal', 'JID': '8803460', 'RN': ['0 (Anti-Bacterial Agents)', '0 (Biomarkers)', '0 (Proteome)'], 'SB': 'IM', 'MH': ['Adolescent', 'Adult', 'Anti-Bacterial Agents/therapeutic use', 'Biomarkers/metabolism', 'Case-Control Studies', 'Chronic Disease', 'Cystic Fibrosis/*complications/*metabolism/microbiology', 'Extracellular Traps/metabolism', 'Female', 'Humans', 'Lung/physiopathology', 'Male', 'Neutrophils/*metabolism', 'Prognosis', 'Proteome/*metabolism', 'Pseudomonas Infections/*complications/drug therapy', 'Pseudomonas aeruginosa', 'Sputum/cytology', 'United Kingdom', 'Young Adult'], 'COIS': ['Conflict of interest: None declared.'], 'EDAT': '2017/07/07 06:00', 'MHDA': '2018/05/11 06:00', 'CRDT': ['2017/07/07 06:00'], 'PHST': ['2016/08/05 00:00 [received]', '2017/03/29 00:00 [accepted]', '2017/07/07 06:00 [entrez]', '2017/07/07 06:00 [pubmed]', '2018/05/11 06:00 [medline]'], 'AID': ['50/1/1601569 [pii]', '10.1183/13993003.01569-2016 [doi]'], 'PST': 'epublish', 'SO': 'Eur Respir J. 2017 Jul 5;50(1). pii: 50/1/1601569. doi: 10.1183/13993003.01569-2016. Print 2017 Jul.'}\n",
      "{'PMID': '28624389', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20180516', 'LR': '20181113', 'IS': '2213-2619 (Electronic) 2213-2600 (Linking)', 'VI': '5', 'IP': '9', 'DP': '2017 Sep', 'TI': 'Plasma proteome analysis in patients with pulmonary arterial hypertension: an observational cohort study.', 'PG': '717-726', 'LID': 'S2213-2600(17)30161-3 [pii] 10.1016/S2213-2600(17)30161-3 [doi]', 'AB': \"BACKGROUND: Idiopathic and heritable pulmonary arterial hypertension form a rare but molecularly heterogeneous disease group. We aimed to measure and validate differences in plasma concentrations of proteins that are associated with survival in patients with idiopathic or heritable pulmonary arterial hypertension to improve risk stratification. METHODS: In this observational cohort study, we enrolled patients with idiopathic or heritable pulmonary arterial hypertension from London (UK; cohorts 1 and 2), Giessen (Germany; cohort 3), and Paris (France; cohort 4). Blood samples were collected at routine clinical appointment visits, clinical data were collected within 30 days of blood sampling, and biochemical data were collected within 7 days of blood sampling. We used an aptamer-based assay of 1129 plasma proteins, and patient clinical details were concealed to the technicians. We identified a panel of prognostic proteins, confirmed with alternative targeted assays, which we evaluated against the established prognostic risk equation for pulmonary arterial hypertension derived from the REVEAL registry. All-cause mortality was the primary endpoint. FINDINGS: 20 proteins differentiated survivors and non-survivors in 143 consecutive patients with idiopathic or heritable pulmonary arterial hypertension with 2 years' follow-up (cohort 1) and in a further 75 patients with 2.5 years' follow-up (cohort 2). Nine proteins were both prognostic independent of plasma NT-proBNP concentrations and confirmed by targeted assays. The functions of these proteins relate to myocardial stress, inflammation, pulmonary vascular cellular dysfunction and structural dysregulation, iron status, and coagulation. A cutoff-based score using the panel of nine proteins provided prognostic information independent of the REVEAL equation, improving the C statistic from area under the curve 0.83 (for REVEAL risk score, 95% CI 0.77-0.89; p<0.0001) to 0.91 (for panel and REVEAL 0.87-0.96; p<0.0001) and improving reclassification indices without detriment to calibration. Poor survival was preceded by an adverse change in panel score in paired samples from 43 incident patients with pulmonary arterial hypertension in cohort 3 (p=0.0133). The protein panel was validated in 93 patients with idiopathic or heritable pulmonary arterial hypertension in cohort 4, with 4.4 years' follow-up and improved risk estimates, providing complementary information to the clinical risk equation. INTERPRETATION: A combination of nine circulating proteins identifies patients with pulmonary arterial hypertension with a high risk of mortality, independent of existing clinical assessments, and might have a use in clinical management and the evaluation of new therapies. FUNDING: National Institute for Health Research, Wellcome Trust, British Heart Foundation, Assistance Publique-Hopitaux de Paris, Inserm, Universite Paris-Sud, and Agence Nationale de la Recherche.\", 'CI': ['Copyright (c) 2017 The Author(s). Published by Elsevier Ltd. This is an Open', 'Access article under the CC BY 4.0 licence. Published by Elsevier Ltd.. All', 'rights reserved.'], 'FAU': ['Rhodes, Christopher J', 'Wharton, John', 'Ghataorhe, Pavandeep', 'Watson, Geoffrey', 'Girerd, Barbara', 'Howard, Luke S', 'Gibbs, J Simon R', 'Condliffe, Robin', 'Elliot, Charles A', 'Kiely, David G', 'Simonneau, Gerald', 'Montani, David', 'Sitbon, Olivier', 'Gall, Henning', 'Schermuly, Ralph T', 'Ghofrani, H Ardeschir', 'Lawrie, Allan', 'Humbert, Marc', 'Wilkins, Martin R'], 'AU': ['Rhodes CJ', 'Wharton J', 'Ghataorhe P', 'Watson G', 'Girerd B', 'Howard LS', 'Gibbs JSR', 'Condliffe R', 'Elliot CA', 'Kiely DG', 'Simonneau G', 'Montani D', 'Sitbon O', 'Gall H', 'Schermuly RT', 'Ghofrani HA', 'Lawrie A', 'Humbert M', 'Wilkins MR'], 'AD': ['Department of Medicine, Imperial College London, Hammersmith Campus, London, UK.', 'Department of Medicine, Imperial College London, Hammersmith Campus, London, UK.', 'Department of Medicine, Imperial College London, Hammersmith Campus, London, UK.', 'Department of Medicine, Imperial College London, Hammersmith Campus, London, UK.', 'University Paris-Sud, Universite Paris-Saclay, Le Kremlin-Bicetre, Paris, France; AP-HP, Service de Pneumologie, Hopital Bicetre, Le Kremlin-Bicetre, Paris, France; Inserm UMR_S 999, Hopital Marie Lannelongue, Le Plessis-Robinson, Paris, France.', 'National Heart and Lung Institute, Imperial College London, Hammersmith Campus, London, UK; National Pulmonary Hypertension Service, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK.', 'National Heart and Lung Institute, Imperial College London, Hammersmith Campus, London, UK; National Pulmonary Hypertension Service, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK.', 'Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, UK.', 'Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, UK.', 'Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, UK.', 'University Paris-Sud, Universite Paris-Saclay, Le Kremlin-Bicetre, Paris, France; AP-HP, Service de Pneumologie, Hopital Bicetre, Le Kremlin-Bicetre, Paris, France; Inserm UMR_S 999, Hopital Marie Lannelongue, Le Plessis-Robinson, Paris, France.', 'University Paris-Sud, Universite Paris-Saclay, Le Kremlin-Bicetre, Paris, France; AP-HP, Service de Pneumologie, Hopital Bicetre, Le Kremlin-Bicetre, Paris, France; Inserm UMR_S 999, Hopital Marie Lannelongue, Le Plessis-Robinson, Paris, France.', 'University Paris-Sud, Universite Paris-Saclay, Le Kremlin-Bicetre, Paris, France; AP-HP, Service de Pneumologie, Hopital Bicetre, Le Kremlin-Bicetre, Paris, France; Inserm UMR_S 999, Hopital Marie Lannelongue, Le Plessis-Robinson, Paris, France.', 'University of Giessen and Marburg Lung Center, Member of the German Center for Lung Research (DZL), Giessen, Germany.', 'University of Giessen and Marburg Lung Center, Member of the German Center for Lung Research (DZL), Giessen, Germany.', 'University of Giessen and Marburg Lung Center, Member of the German Center for Lung Research (DZL), Giessen, Germany.', 'Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.', 'University Paris-Sud, Universite Paris-Saclay, Le Kremlin-Bicetre, Paris, France; AP-HP, Service de Pneumologie, Hopital Bicetre, Le Kremlin-Bicetre, Paris, France; Inserm UMR_S 999, Hopital Marie Lannelongue, Le Plessis-Robinson, Paris, France.', 'Department of Medicine, Imperial College London, Hammersmith Campus, London, UK. Electronic address: m.wilkins@imperial.ac.uk.'], 'LA': ['eng'], 'GR': ['Wellcome Trust/United Kingdom', 'FS/13/48/30453/British Heart Foundation/United Kingdom', 'PG/11/116/29288/British Heart Foundation/United Kingdom', 'RG/10/16/28575/British Heart Foundation/United Kingdom'], 'PT': ['Journal Article', 'Multicenter Study', 'Observational Study'], 'DEP': '20170615', 'PL': 'England', 'TA': 'Lancet Respir Med', 'JT': 'The Lancet. Respiratory medicine', 'JID': '101605555', 'RN': ['0 (Biomarkers)', '0 (Blood Proteins)', '0 (Proteome)'], 'SB': 'IM', 'CIN': ['Lancet Respir Med. 2017 Sep;5(9):671-672. PMID: 28624387'], 'MH': ['Adult', 'Aged', 'Arterial Pressure', 'Biomarkers/blood', 'Blood Proteins/*analysis', 'Cohort Studies', 'Familial Primary Pulmonary Hypertension/*blood/mortality', 'Female', 'Humans', 'Hypertension/*blood/mortality', 'Male', 'Middle Aged', 'Proteome/*analysis', 'Risk Assessment', 'Risk Factors'], 'PMC': 'PMC5573768', 'EDAT': '2017/06/19 06:00', 'MHDA': '2018/05/17 06:00', 'CRDT': ['2017/06/19 06:00'], 'PHST': ['2017/03/03 00:00 [received]', '2017/04/07 00:00 [revised]', '2017/04/11 00:00 [accepted]', '2017/06/19 06:00 [pubmed]', '2018/05/17 06:00 [medline]', '2017/06/19 06:00 [entrez]'], 'AID': ['S2213-2600(17)30161-3 [pii]', '10.1016/S2213-2600(17)30161-3 [doi]'], 'PST': 'ppublish', 'SO': 'Lancet Respir Med. 2017 Sep;5(9):717-726. doi: 10.1016/S2213-2600(17)30161-3. Epub 2017 Jun 15.'}\n",
      "{'PMID': '28501389', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20180315', 'LR': '20180315', 'IS': '1873-3492 (Electronic) 0009-8981 (Linking)', 'VI': '471', 'DP': '2017 Aug', 'TI': 'Differential proteome profile in ischemic heart disease: Prognostic value in chronic angina versus myocardial infarction. A proof of concept.', 'PG': '68-75', 'LID': 'S0009-8981(17)30174-2 [pii] 10.1016/j.cca.2017.05.010 [doi]', 'AB': 'The initial clinical manifestation of ischemic heart disease (IHD) i.e. unheralded myocardial infarction (MI) versus chronic angina pectoris (AP) is statistically associated with adverse or mild disease progression respectively in the long-term follow-up. Here, we subjected AP and MI patients to blood proteomic analysis by Surface-Enhanced Laser Desorption/Ionization Time-of-Flight Mass Spectrometry (SELDI-TOF-MS) in order to investigate putative new prognostic biomarkers of IHD manifestation. We found several differentially expressed peaks but four of them (4176, 4475, 14,158m/z and 8922m/z for AP and MI, respectively) were most reliable. Two of them were identified; 14,158m/z peak was the double-charged form of Apolipoprotein A-I and its vasoprotective action accords with prominence in AP. The 4176m/z peak was related to FAM83C protein, while neither the 4475m/z peak nor the MI-linked 8922m/z peak could be identified. We conclude that SELDI-TOF-MS analysis may yield a panel of molecular signals able to retrospectively classify patients according to their clinical and molecular features, exploitable for predicting the natural course of IHD.', 'CI': ['Copyright (c) 2017 Elsevier B.V. All rights reserved.'], 'FAU': ['Scebba, Francesca', 'Papale, Massimo', 'Rocchiccioli, Silvia', 'Ucciferri, Nadia', 'Bigazzi, Federico', 'Sampietro, Tiziana', 'Carpeggiani, Clara', \"L'Abbate, Antonio\", 'Coceani, Flavio', 'Angeloni, Debora'], 'AU': ['Scebba F', 'Papale M', 'Rocchiccioli S', 'Ucciferri N', 'Bigazzi F', 'Sampietro T', 'Carpeggiani C', \"L'Abbate A\", 'Coceani F', 'Angeloni D'], 'AD': [\"Institute of Life Sciences, Scuola Superiore Sant'Anna, P.zza Martiri della Liberta 33, 56127 Pisa, Italy. Electronic address: f.scebba@santannapisa.it.\", 'Molecular Medicine Centre, Department of Surgery and Medical Sciences, University of Foggia, Viale Pinto 1, 71122 Foggia, Italy. Electronic address: m.papale@unifg.it.', 'Institute of Clinical Physiology, Consiglio Nazionale delle Ricerche, Via Moruzzi 1, 56124 Pisa, Italy. Electronic address: silvia.rocchiccioli@ifc.cnr.it.', 'Institute of Clinical Physiology, Consiglio Nazionale delle Ricerche, Via Moruzzi 1, 56124 Pisa, Italy. Electronic address: nadia.ucciferri@ifc.cnr.it.', 'Dyslipidemias & Atherosclerosis Laboratory, Fondazione Toscana Gabriele Monasterio, Via Moruzzi 1, 56124 Pisa, Italy. Electronic address: federicobigazzi@ftgm.it.', 'Dyslipidemias & Atherosclerosis Laboratory, Fondazione Toscana Gabriele Monasterio, Via Moruzzi 1, 56124 Pisa, Italy. Electronic address: tiziana.sampietro@ftgm.it.', 'Institute of Clinical Physiology, Consiglio Nazionale delle Ricerche, Via Moruzzi 1, 56124 Pisa, Italy. Electronic address: clara@ifc.cnr.it.', \"Institute of Life Sciences, Scuola Superiore Sant'Anna, P.zza Martiri della Liberta 33, 56127 Pisa, Italy; Institute of Clinical Physiology, Consiglio Nazionale delle Ricerche, Via Moruzzi 1, 56124 Pisa, Italy. Electronic address: segrlabb@ifc.cnr.it.\", \"Institute of Life Sciences, Scuola Superiore Sant'Anna, P.zza Martiri della Liberta 33, 56127 Pisa, Italy. Electronic address: coceani@santannapisa.it.\", \"Institute of Life Sciences, Scuola Superiore Sant'Anna, P.zza Martiri della Liberta 33, 56127 Pisa, Italy; Institute of Clinical Physiology, Consiglio Nazionale delle Ricerche, Via Moruzzi 1, 56124 Pisa, Italy. Electronic address: d.angeloni@santannapisa.it.\"], 'LA': ['eng'], 'PT': ['Journal Article'], 'DEP': '20170510', 'PL': 'Netherlands', 'TA': 'Clin Chim Acta', 'JT': 'Clinica chimica acta; international journal of clinical chemistry', 'JID': '1302422', 'RN': ['0 (Biomarkers)', '0 (Blood Proteins)'], 'SB': 'IM', 'MH': ['Angina, Stable/blood/*diagnosis/*metabolism', 'Biomarkers/blood', 'Blood Proteins/metabolism', 'Female', 'Humans', 'Male', 'Middle Aged', 'Myocardial Infarction/blood/*diagnosis/*metabolism', 'Prognosis', '*Proteomics'], 'OTO': ['NOTNLM'], 'OT': ['Angina pectoris', 'Biomarkers', 'Ischemic heart disease', 'Myocardial infarction', 'SELDI-TOF'], 'EDAT': '2017/05/16 06:00', 'MHDA': '2018/03/16 06:00', 'CRDT': ['2017/05/15 06:00'], 'PHST': ['2017/02/20 00:00 [received]', '2017/05/09 00:00 [revised]', '2017/05/09 00:00 [accepted]', '2017/05/16 06:00 [pubmed]', '2018/03/16 06:00 [medline]', '2017/05/15 06:00 [entrez]'], 'AID': ['S0009-8981(17)30174-2 [pii]', '10.1016/j.cca.2017.05.010 [doi]'], 'PST': 'ppublish', 'SO': 'Clin Chim Acta. 2017 Aug;471:68-75. doi: 10.1016/j.cca.2017.05.010. Epub 2017 May 10.'}\n",
      "{'PMID': '28437237', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20180529', 'LR': '20180529', 'IS': '2153-7933 (Electronic) 2153-7658 (Linking)', 'VI': '7', 'IP': '3', 'DP': '2017 Sep', 'TI': 'Proteomics in Hypothermia as Adjunctive Therapy in Patients with ST-Segment Elevation Myocardial Infarction: A CHILL-MI Substudy.', 'PG': '152-161', 'LID': '10.1089/ther.2016.0041 [doi]', 'AB': 'Cardiovascular and inflammatory biomarkers in therapeutic hypothermia have been studied in cardiac arrest, but data on patients with ST-segment elevation myocardial infarction (STEMI) treated with therapeutic hypothermia are currently unavailable. A multiplex proximity extension assay allowed us to measure 157 cardiovascular disease (CVD) and inflammatory disease-related biomarkers in patients from the international, multicenter, and randomized trial; CHILL-myocardial infarction (MI) and to explore the associations of cardiovascular and inflammatory biomarkers. Blood samples were obtained from 119 patients with STEMI, randomized to hypothermia as adjunctive therapy to percutaneous coronary intervention (PCI) or standard care with PCI only. Blood samples were obtained at baseline (0 hour), 6, 24, and 96 hours post PCI, and stored at -80 degrees C until they were analyzed by PROSEEK Multiplex CVD and PROSEEK Multiplex INF (Olink Bioscience, Uppsala, Sweden). Peak values from 6, 24, and 96 hours postrandomization were compared between treatment groups. One hundred fifty-seven cardiovascular and inflammatory biomarkers were evaluated. Peak values of four biomarkers (BDNF, DNER, CCL20, MMP3) were reduced in the hypothermia group as compared with the control group. In addition, seven markers were slightly elevated in the hypothermia group (OPG, FGF21, FS, IL12B, PRL, TIM, IL6). In a prespecified subgroup analysis of anterior infarctions, two additional markers were reduced (PTX3 and SELE). In this explorative proteomic study from the randomized trial CHILL-MI, four biomarkers were identified as having reduced peak plasma values in patients with STEMI treated with therapeutic hypothermia as adjunctive therapy to PCI as compared with patients treated with standard care of PCI. In addition, seven biomarkers were elevated in the group treated with hypothermia therapy. The effect of hypothermia on biomarker peak values was modest, possibly due to a low reduction in mean body temperature. Whether a faster and deeper cooling results in more pronounced effects is yet to be established.', 'FAU': ['Mohammad, Moman A', 'Noc, Marco', 'Lang, Irene', 'Holzer, Michael', 'Clemmensen, Peter', 'Jensen, Ulf', 'Metzler, Bernhard', 'Erlinge, David'], 'AU': ['Mohammad MA', 'Noc M', 'Lang I', 'Holzer M', 'Clemmensen P', 'Jensen U', 'Metzler B', 'Erlinge D'], 'AD': ['1 Department of Cardiology and Clinical Sciences, Skane University Hospital, Lund University , Lund, Sweden .', '2 Center for Intensive Internal Medicine, University Medical Center , Ljubliana, Slovenia .', '3 Department of Cardiology, Medical University of Vienna , Vienna, Austria .', '4 Department of Emergency Medicine, Medical University of Vienna , Vienna, Austria .', '5 Department of General and Interventional Cardiology, University Heart Center , Hamburg-Eppendorf, Hamburg, Germany .', '6 Division of Cardiology, Department of Medicine, Nykoebing Falster Hospital, University of Southern Denmark , Odense, Denmark .', '7 Cardiology Unit, Department of Medicine, Karolinska University Hospital , Stockholm, Sweden .', '8 Department of Cardiology, Medical University Innsbruck , Innsbruck, Austria .', '1 Department of Cardiology and Clinical Sciences, Skane University Hospital, Lund University , Lund, Sweden .'], 'LA': ['eng'], 'PT': ['Journal Article', 'Randomized Controlled Trial'], 'DEP': '20170302', 'PL': 'United States', 'TA': 'Ther Hypothermia Temp Manag', 'JT': 'Therapeutic hypothermia and temperature management', 'JID': '101543518', 'RN': ['0 (Biomarkers)', '0 (Blood Proteins)', '0 (Proteome)'], 'SB': 'IM', 'MH': ['Aged', 'Biomarkers/analysis/metabolism', 'Blood Proteins/analysis/metabolism', 'Cluster Analysis', 'Female', 'Humans', '*Hypothermia, Induced', 'Male', 'Middle Aged', 'Myocardial Infarction/*metabolism/*therapy', 'Proteome/*analysis', 'Proteomics/*methods'], 'OTO': ['NOTNLM'], 'OT': ['STEMI', 'biomarkers', 'hypothermia', 'myocardial infarction', 'proteomic'], 'EDAT': '2017/04/25 06:00', 'MHDA': '2018/05/31 06:00', 'CRDT': ['2017/04/25 06:00'], 'PHST': ['2017/04/25 06:00 [pubmed]', '2018/05/31 06:00 [medline]', '2017/04/25 06:00 [entrez]'], 'AID': ['10.1089/ther.2016.0041 [pii]', '10.1089/ther.2016.0041 [doi]'], 'PST': 'ppublish', 'SO': 'Ther Hypothermia Temp Manag. 2017 Sep;7(3):152-161. doi: 10.1089/ther.2016.0041. Epub 2017 Mar 2.'}\n",
      "{'PMID': '28427148', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20180423', 'LR': '20181113', 'IS': '1949-2553 (Electronic) 1949-2553 (Linking)', 'VI': '8', 'IP': '29', 'DP': '2017 Jul 18', 'TI': 'In-depth proteomic profiling of left ventricular tissues in human end-stage dilated cardiomyopathy.', 'PG': '48321-48332', 'LID': '10.18632/oncotarget.15689 [doi]', 'AB': 'Dilated cardiomyopathy (DCM) is caused by reduced left ventricular (LV) myocardial function, which is one of the most common causes of heart failure (HF). We performed iTRAQ-coupled 2D-LC-MS/MS to profile the cardiac proteome of LV tissues from healthy controls and patients with end-stage DCM. We identified 4263 proteins, of which 125 were differentially expressed in DCM tissues compared to LV controls. The majority of these were membrane proteins related to cellular junctions and neuronal metabolism. In addition, these proteins were involved in membrane organization, mitochondrial organization, translation, protein transport, and cell death process. Four key proteins involved in the cell death process were also detected by western blotting, indicated that cell death was activated in DCM tissues. Furthermore, S100A1 and eEF2 were enriched in the \"cellular assembly and organization\" and \"cell cycle\" networks, respectively. We verified decreases in these two proteins in end-stage DCM LV samples through multiple reaction monitoring (MRM). These observations demonstrate that our understanding of the mechanisms underlying DCM can be deepened through comparison of the proteomes of normal LV tissues with that from end-stage DCM in humans.', 'FAU': ['Liu, Shanshan', 'Xia, Yan', 'Liu, Xiaohui', 'Wang, Yi', 'Chen, Zhangwei', 'Xie, Juanjuan', 'Qian, Juying', 'Shen, Huali', 'Yang, Pengyuan'], 'AU': ['Liu S', 'Xia Y', 'Liu X', 'Wang Y', 'Chen Z', 'Xie J', 'Qian J', 'Shen H', 'Yang P'], 'AD': ['Institutes of Biomedical Sciences of Shanghai Medical School and Minhang Hospital, Fudan University, Shanghai, China.', 'Department of Systems Biology for Medicine and School of Basic Medical Sciences, Fudan University, Shanghai, China.', 'Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, China.', 'Department of chemistry, Fudan University, Shanghai, China.', 'Institutes of Biomedical Sciences of Shanghai Medical School and Minhang Hospital, Fudan University, Shanghai, China.', 'Department of Systems Biology for Medicine and School of Basic Medical Sciences, Fudan University, Shanghai, China.', 'Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, China.', 'Institutes of Biomedical Sciences of Shanghai Medical School and Minhang Hospital, Fudan University, Shanghai, China.', 'Department of Systems Biology for Medicine and School of Basic Medical Sciences, Fudan University, Shanghai, China.', 'Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, China.', 'Institutes of Biomedical Sciences of Shanghai Medical School and Minhang Hospital, Fudan University, Shanghai, China.', 'Department of Systems Biology for Medicine and School of Basic Medical Sciences, Fudan University, Shanghai, China.', 'Department of chemistry, Fudan University, Shanghai, China.', 'Institutes of Biomedical Sciences of Shanghai Medical School and Minhang Hospital, Fudan University, Shanghai, China.', 'Department of Systems Biology for Medicine and School of Basic Medical Sciences, Fudan University, Shanghai, China.', 'Department of chemistry, Fudan University, Shanghai, China.'], 'LA': ['eng'], 'PT': ['Journal Article'], 'PL': 'United States', 'TA': 'Oncotarget', 'JT': 'Oncotarget', 'JID': '101532965', 'RN': ['0 (Biomarkers)', '0 (Proteome)', '0 (S100 Proteins)', '0 (S100A1 protein)', 'EC 2.7.11.20 (Elongation Factor 2 Kinase)'], 'SB': 'IM', 'MH': ['Adult', 'Aged', 'Biomarkers', 'Cardiomyopathy, Dilated/*metabolism/*pathology/physiopathology', 'Cell Cycle/genetics', 'Chromatography, Liquid', 'Computational Biology/methods', 'Elongation Factor 2 Kinase/metabolism', 'Female', 'Gene Ontology', 'Heart Function Tests', 'Heart Ventricles/*metabolism', 'Humans', 'Male', 'Mass Spectrometry', 'Middle Aged', '*Proteome', '*Proteomics/methods', 'S100 Proteins/metabolism', 'Young Adult'], 'PMC': 'PMC5564650', 'OTO': ['NOTNLM'], 'OT': ['S100A1', 'cell death', 'dilated cardiomyopathy', 'eEF2', 'left ventricle'], 'EDAT': '2017/04/22 06:00', 'MHDA': '2018/04/24 06:00', 'CRDT': ['2017/04/22 06:00'], 'PHST': ['2016/12/15 00:00 [received]', '2017/02/12 00:00 [accepted]', '2017/04/22 06:00 [pubmed]', '2018/04/24 06:00 [medline]', '2017/04/22 06:00 [entrez]'], 'AID': ['15689 [pii]', '10.18632/oncotarget.15689 [doi]'], 'PST': 'ppublish', 'SO': 'Oncotarget. 2017 Jul 18;8(29):48321-48332. doi: 10.18632/oncotarget.15689.'}\n",
      "{'PMID': '28341603', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20170926', 'LR': '20180917', 'IS': '1570-9639 (Print) 1570-9639 (Linking)', 'VI': '1865', 'IP': '7', 'DP': '2017 Jul', 'TI': 'Different desmin peptides are distinctly deposited in cytoplasmic aggregations and cytoplasm of desmin-related cardiomyopathy patients.', 'PG': '828-836', 'LID': 'S1570-9639(17)30048-1 [pii] 10.1016/j.bbapap.2017.03.006 [doi]', 'AB': 'Desmin-related cardiomyopathy is a heterogeneous group of myofibrillar myopathies characterized by aggregates of desmin and related proteins in myocytes. It has been debated how the expression and protein structure are altered in the aggregates and other parts of myocytes in patients. To address this question, we investigated the proteome quantification as well as localization in formalin-fixed and paraffin-embedded specimens of the heart of patients by imaging mass spectrometry and liquid chromatography-mass spectrometry analyses. Fifteen tryptic peptide signals were enriched in the desmin-related cardiomyopathy myocardium, twelve of which were identified as desmin peptides with 14.3- to 27.3-fold increase compared to normal hearts. High-intensity signals at m/z 1032.5 and 1002.5, which were desmin peptides 59-70 at the head portion and 213-222 at the 1B domain, were with infrequent colocalization distributed not only in desmin-positive intracytoplasmic aggregates but also in histologically normal cytoplasm, indicating that desmin protein is fragmented and different types of naturally-occurring truncated proteins ectopically assemble throughout the heart of patients. Thus, in addition to conventional histological identification of protein aggregates, specific desmin peptides show a marked difference in quantity and localization in a tissue section of desmin-related cardiomyopathy and differentiate from other cardiomyopathies. This article is part of a Special Issue entitled: MALDI Imaging, edited by Dr. Corinna Henkel and Prof. Peter Hoffmann.', 'CI': ['Copyright (c) 2017 The Authors. Published by Elsevier B.V. All rights reserved.'], 'FAU': ['Shintani-Domoto, Yukako', 'Hayasaka, Takahiro', 'Maeda, Daichi', 'Masaki, Noritaka', 'Ito, Takashi K', 'Sakuma, Kei', 'Tanaka, Michio', 'Kabashima, Katsuya', 'Takei, Shiro', 'Setou, Mitsutoshi', 'Fukayama, Masashi'], 'AU': ['Shintani-Domoto Y', 'Hayasaka T', 'Maeda D', 'Masaki N', 'Ito TK', 'Sakuma K', 'Tanaka M', 'Kabashima K', 'Takei S', 'Setou M', 'Fukayama M'], 'AD': ['Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.', 'Laboratory for Advanced Lipid Analysis, Health Innovation & Technology Center, Faculty of Health Sciences, Hokkaido University, Sapporo, Japan; Department of Cellular and Molecular Anatomy, Hamamatsu University School of Medicine, Hamamatsu, Japan.', 'Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; Department of Cellular and Organ Pathology, Akita University, Akita, Japan.', 'Department of Medical Spectroscopy, Institute for Medical Photonics Research, Preeminent Medical Photonics Education &Research Center, Hamamatsu University School of Medicine, Hamamatsu, Japan; Department of Cellular and Molecular Anatomy, Hamamatsu University School of Medicine, Hamamatsu, Japan.', 'Department of Cellular and Molecular Anatomy, Hamamatsu University School of Medicine, Hamamatsu, Japan; International Mass Imaging Center, Hamamatsu University School of Medicine, Hamamatsu, Japan.', 'Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.', 'Department of Pathology, Tokyo Metropolitan Hiroo Hospital, Tokyo, Japan.', 'Department of Cellular and Molecular Anatomy, Hamamatsu University School of Medicine, Hamamatsu, Japan; International Mass Imaging Center, Hamamatsu University School of Medicine, Hamamatsu, Japan.', 'Department of Cellular and Molecular Anatomy, Hamamatsu University School of Medicine, Hamamatsu, Japan; International Mass Imaging Center, Hamamatsu University School of Medicine, Hamamatsu, Japan.', 'Department of Cellular and Molecular Anatomy, Hamamatsu University School of Medicine, Hamamatsu, Japan; International Mass Imaging Center, Hamamatsu University School of Medicine, Hamamatsu, Japan; Preeminent Medical Photonics Education & Research Center, Hamamatsu University School of Medicine, Hamamatsu, Japan; Riken Center for Molecular Imaging Science, Kobe, Japan; Department of Anatomy, The University of Hong Kong, Hong Kong, China; Division of Neural Systematics, National Institute for Physiological Sciences, Okazaki, Japan. Electronic address: setou@hama-med.ac.jp.', 'Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. Electronic address: mfukayama-tky@umin.net.'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20170321', 'PL': 'Netherlands', 'TA': 'Biochim Biophys Acta Proteins Proteom', 'JT': 'Biochimica et biophysica acta. Proteins and proteomics', 'JID': '101731734', 'RN': ['0 (Desmin)', '0 (Peptides)', '0 (Protein Aggregates)', '0 (Proteome)'], 'SB': 'IM', 'MH': ['Adult', 'Cardiomyopathies/*metabolism/*pathology', 'Chromatography, Liquid/methods', 'Cytoplasm/*metabolism', 'Desmin/*metabolism', 'Female', 'Humans', 'Intermediate Filaments/metabolism', 'Male', 'Middle Aged', 'Muscle Cells/metabolism/pathology', 'Muscular Diseases/metabolism/pathology', 'Myocardium/*metabolism/pathology', 'Peptides/*metabolism', 'Protein Aggregates/*physiology', 'Proteome/metabolism', 'Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization/methods', 'Young Adult'], 'OTO': ['NOTNLM'], 'OT': ['*Cardiomyopathy', '*Desmin protein', '*Imaging mass', '*Pathology', '*Spectrometry'], 'EDAT': '2017/03/28 06:00', 'MHDA': '2017/09/28 06:00', 'CRDT': ['2017/03/26 06:00'], 'PHST': ['2016/04/02 00:00 [received]', '2017/03/15 00:00 [revised]', '2017/03/16 00:00 [accepted]', '2017/03/28 06:00 [pubmed]', '2017/09/28 06:00 [medline]', '2017/03/26 06:00 [entrez]'], 'AID': ['S1570-9639(17)30048-1 [pii]', '10.1016/j.bbapap.2017.03.006 [doi]'], 'PST': 'ppublish', 'SO': 'Biochim Biophys Acta Proteins Proteom. 2017 Jul;1865(7):828-836. doi: 10.1016/j.bbapap.2017.03.006. Epub 2017 Mar 21.'}\n",
      "{'PMID': '28329269', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20180319', 'LR': '20180319', 'IS': '1873-734X (Electronic) 1010-7940 (Linking)', 'VI': '51', 'IP': '6', 'DP': '2017 Jun 1', 'TI': 'Proteomics highlights decrease of matricellular proteins in left ventricular assist device therapydagger.', 'PG': '1063-1071', 'LID': '10.1093/ejcts/ezx023 [doi]', 'AB': \"OBJECTIVES: We investigated the impact of mechanical unloading with a left ventricular assist device (LVAD) on the myocardial proteome. METHODS: We collected 11 patient-matched samples of myocardial left ventricular tissue of patients with non-ischaemic dilate cardiomyopathy, harvested at time of LVAD implant ('pre-LVAD') and heart transplant ('post-LVAD'). Samples were studied by quantitative proteomics. Further we performed histological assessment of deposited collagens and immune infiltration in both pre- and post-LVAD samples. RESULTS: A core set of >1700 proteins was identified and quantified at a false discovery rate <1%. The previously established decrease post-LVAD of alpha-1-antichymotrypsin was corroborated. We noted a post-LVAD decrease of matricellular proteins and proteoglycans such as periostin and versican. Also, proteins of the complement system and precursors of cardiac peptide hormones were decreased post-LVAD. An increase post-LVAD was evident for individual proteins linked to the innate immune response, proteins involved in diverse metabolic pathways, and proteins involved in protein synthesis. Histological analysis did not reveal significant alterations post-LVAD of deposited collagens or immune infiltration. The proteomic data further highlighted a pronounced inter-patient heterogeneity with regards to the impact of LVAD therapy on the left ventricular myocardial proteome. Finally, the proteomic data showed differential proteolytic processing in response to LVAD therapy. CONCLUSIONS: Our findings underline a strong impact of LVAD therapy on the left ventricular myocardial proteome. Together with previous studies, protein markers of LVAD therapy such as alpha-1-antichymotrypsin are becoming apparent. Further, matricellular proteins are emerging as important components in response to LVAD therapy.\", 'CI': ['(c) The Author 2017. Published by Oxford University Press on behalf of the', 'European Association for Cardio-Thoracic Surgery. All rights reserved.'], 'FAU': ['Shahinian, Jasmin Hasmik', 'Mayer, Bettina', 'Tholen, Stefan', 'Brehm, Kerstin', 'Biniossek, Martin L', 'Fullgraf, Hannah', 'Kiefer, Selina', 'Heizmann, Ulrike', 'Heilmann, Claudia', 'Ruter, Florian', 'Grapow, Martin', 'Reuthebuch, Oliver Thomas', 'Eckstein, Friedrich', 'Beyersdorf, Friedhelm', 'Schilling, Oliver', 'Siepe, Matthias'], 'AU': ['Shahinian JH', 'Mayer B', 'Tholen S', 'Brehm K', 'Biniossek ML', 'Fullgraf H', 'Kiefer S', 'Heizmann U', 'Heilmann C', 'Ruter F', 'Grapow M', 'Reuthebuch OT', 'Eckstein F', 'Beyersdorf F', 'Schilling O', 'Siepe M'], 'AD': ['Deparment of Cardiac Surgery, University Hospital Basel, Basel, Switzerland.', 'Institute for Molecular Medicine and Cell Research, University of Freiburg, Freiburg, Germany.', 'Institute for Molecular Medicine and Cell Research, University of Freiburg, Freiburg, Germany.', 'Institute of Surgical Pathology, University Medical Center Freiburg, Freiburg, Germany.', 'Institute for Molecular Medicine and Cell Research, University of Freiburg, Freiburg, Germany.', 'Institute of Surgical Pathology, University Medical Center Freiburg, Freiburg, Germany.', 'Institute of Surgical Pathology, University Medical Center Freiburg, Freiburg, Germany.', 'Institute of Surgical Pathology, University Medical Center Freiburg, Freiburg, Germany.', 'Institute of Surgical Pathology, University Medical Center Freiburg, Freiburg, Germany.', 'Deparment of Cardiac Surgery, University Hospital Basel, Basel, Switzerland.', 'Deparment of Cardiac Surgery, University Hospital Basel, Basel, Switzerland.', 'Deparment of Cardiac Surgery, University Hospital Basel, Basel, Switzerland.', 'Deparment of Cardiac Surgery, University Hospital Basel, Basel, Switzerland.', 'Department of Cardiovascular Surgery, Heart Centre Freiburg University, Freiburg, Germany.', 'Institute for Molecular Medicine and Cell Research, University of Freiburg, Freiburg, Germany.', 'BIOSS Centre for Biological Signaling Studies, University of Freiburg, Freiburg, Germany.', 'Department of Cardiovascular Surgery, Heart Centre Freiburg University, Freiburg, Germany.'], 'LA': ['eng'], 'PT': ['Journal Article'], 'PL': 'Germany', 'TA': 'Eur J Cardiothorac Surg', 'JT': 'European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery', 'JID': '8804069', 'RN': ['0 (Proteins)'], 'SB': 'IM', 'MH': ['Adult', 'Aged', 'Cluster Analysis', 'Extracellular Matrix/chemistry/*metabolism', 'Female', '*Heart Ventricles/chemistry/metabolism/surgery', '*Heart-Assist Devices', 'Humans', 'Male', 'Middle Aged', 'Models, Cardiovascular', 'Proteins/*analysis/chemistry/metabolism', 'Proteomics/*methods'], 'OTO': ['NOTNLM'], 'OT': ['Left ventricular assist device', 'Matrisome', 'Mechanical unloading', 'Reverse remodelling'], 'EDAT': '2017/03/23 06:00', 'MHDA': '2018/03/20 06:00', 'CRDT': ['2017/03/23 06:00'], 'PHST': ['2016/09/01 00:00 [received]', '2017/01/10 00:00 [accepted]', '2017/03/23 06:00 [pubmed]', '2018/03/20 06:00 [medline]', '2017/03/23 06:00 [entrez]'], 'AID': ['3037993 [pii]', '10.1093/ejcts/ezx023 [doi]'], 'PST': 'ppublish', 'SO': 'Eur J Cardiothorac Surg. 2017 Jun 1;51(6):1063-1071. doi: 10.1093/ejcts/ezx023.'}\n",
      "{'PMID': '28273075', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20170830', 'LR': '20200111', 'IS': '1932-6203 (Electronic) 1932-6203 (Linking)', 'VI': '12', 'IP': '3', 'DP': '2017', 'TI': 'Prediction of acute coronary syndromes by urinary proteome analysis.', 'PG': 'e0172036', 'LID': '10.1371/journal.pone.0172036 [doi]', 'AB': 'Identification of individuals who are at risk of suffering from acute coronary syndromes (ACS) may allow to introduce preventative measures. We aimed to identify ACS-related urinary peptides, that combined as a pattern can be used as prognostic biomarker. Proteomic data of 252 individuals enrolled in four prospective studies from Australia, Europe and North America were analyzed. 126 of these had suffered from ACS within a period of up to 5 years post urine sampling (cases). Proteomic analysis of 84 cases and 84 matched controls resulted in the discovery of 75 ACS-related urinary peptides. Combining these to a peptide pattern, we established a prognostic biomarker named Acute Coronary Syndrome Predictor 75 (ACSP75). ACSP75 demonstrated reasonable prognostic discrimination (c-statistic = 0.664), which was similar to Framingham risk scoring (c-statistics = 0.644) in a validation cohort of 42 cases and 42 controls. However, generating by a composite algorithm named Acute Coronary Syndrome Composite Predictor (ACSCP), combining the biomarker pattern ACSP75 with the previously established urinary proteomic biomarker CAD238 characterizing coronary artery disease as the underlying aetiology, and age as a risk factor, further improved discrimination (c-statistic = 0.751) resulting in an added prognostic value over Framingham risk scoring expressed by an integrated discrimination improvement of 0.273 +/- 0.048 (P < 0.0001) and net reclassification improvement of 0.405 +/- 0.113 (P = 0.0007). In conclusion, we demonstrate that urinary peptide biomarkers have the potential to predict future ACS events in asymptomatic patients. Further large scale studies are warranted to determine the role of urinary biomarkers in clinical practice.', 'FAU': ['Htun, Nay M', 'Magliano, Dianna J', 'Zhang, Zhen-Yu', 'Lyons, Jasmine', 'Petit, Thibault', 'Nkuipou-Kenfack, Esther', 'Ramirez-Torres, Adela', 'von Zur Muhlen, Constantin', 'Maahs, David', 'Schanstra, Joost P', 'Pontillo, Claudia', 'Pejchinovski, Martin', 'Snell-Bergeon, Janet K', 'Delles, Christian', 'Mischak, Harald', 'Staessen, Jan A', 'Shaw, Jonathan E', 'Koeck, Thomas', 'Peter, Karlheinz'], 'AU': ['Htun NM', 'Magliano DJ', 'Zhang ZY', 'Lyons J', 'Petit T', 'Nkuipou-Kenfack E', 'Ramirez-Torres A', 'von Zur Muhlen C', 'Maahs D', 'Schanstra JP', 'Pontillo C', 'Pejchinovski M', 'Snell-Bergeon JK', 'Delles C', 'Mischak H', 'Staessen JA', 'Shaw JE', 'Koeck T', 'Peter K'], 'AD': ['Atherothrombosis and Vascular Biology, Baker IDI Heart and Diabetes Institute, Melbourne, Australia.', 'Department of Medicine, Monash University, Melbourne, Australia.', 'Clinical Diabetes and Epidemiology, Baker IDI Heart and Diabetes Institute, Melbourne, Australia.', 'Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium.', 'Clinical Diabetes and Epidemiology, Baker IDI Heart and Diabetes Institute, Melbourne, Australia.', 'Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium.', 'Mosaiques Diagnostics GmbH, Hanover, Germany.', 'Mosaiques Diagnostics GmbH, Hanover, Germany.', 'Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California, United States of America.', 'Department of Cardiology, University Heart Centre Freiburg, Germany.', 'Department of Paediatrics, Stanford School of Medicine, Stanford, California, United States of America.', 'Barbara Davis Centre for Diabetes, University of Colorado School of Medicine, Aurora, Colorado, United States of America.', 'Institut National de la Sante et de la Recherche Medicale (INSERM), U1048, Institut of Cardiovascular and Metabolic Disease, Toulouse, France.', 'Universite Toulouse III Paul-Sabatier, Toulouse, France.', 'Mosaiques Diagnostics GmbH, Hanover, Germany.', 'Mosaiques Diagnostics GmbH, Hanover, Germany.', 'Barbara Davis Centre for Diabetes, University of Colorado School of Medicine, Aurora, Colorado, United States of America.', 'Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom.', 'Mosaiques Diagnostics GmbH, Hanover, Germany.', 'Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom.', 'Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium.', 'R&D VitaK Group, Maastricht University, Maastricht, Netherlands.', 'Clinical Diabetes and Epidemiology, Baker IDI Heart and Diabetes Institute, Melbourne, Australia.', 'Mosaiques Diagnostics GmbH, Hanover, Germany.', 'Atherothrombosis and Vascular Biology, Baker IDI Heart and Diabetes Institute, Melbourne, Australia.', 'Department of Medicine, Monash University, Melbourne, Australia.'], 'LA': ['eng'], 'GR': ['R01 HL113029/HL/NHLBI NIH HHS/United States'], 'PT': ['Journal Article'], 'DEP': '20170308', 'PL': 'United States', 'TA': 'PLoS One', 'JT': 'PloS one', 'JID': '101285081', 'RN': ['0 (Biomarkers)', '0 (Peptides)', '0 (Proteome)'], 'SB': 'IM', 'MH': ['Acute Coronary Syndrome/*diagnosis/metabolism/mortality/urine', 'Age Factors', 'Aged', 'Area Under Curve', 'Biomarkers/urine', 'Case-Control Studies', 'Electrophoresis, Capillary', 'Female', 'Humans', 'Male', 'Mass Spectrometry', 'Middle Aged', 'Peptides/*urine', 'Prognosis', 'Proteome/*analysis', '*Proteomics', 'ROC Curve', 'Risk Factors', 'Support Vector Machine', 'Survival Analysis'], 'PMC': 'PMC5342174', 'EDAT': '2017/03/09 06:00', 'MHDA': '2017/08/31 06:00', 'CRDT': ['2017/03/09 06:00'], 'PHST': ['2016/11/13 00:00 [received]', '2017/01/30 00:00 [accepted]', '2017/03/09 06:00 [entrez]', '2017/03/09 06:00 [pubmed]', '2017/08/31 06:00 [medline]'], 'AID': ['10.1371/journal.pone.0172036 [doi]', 'PONE-D-16-45061 [pii]'], 'PST': 'epublish', 'SO': 'PLoS One. 2017 Mar 8;12(3):e0172036. doi: 10.1371/journal.pone.0172036. eCollection 2017.'}\n",
      "{'PMID': '28256566', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20181106', 'LR': '20181113', 'IS': '2045-2322 (Electronic) 2045-2322 (Linking)', 'VI': '7', 'DP': '2017 Mar 3', 'TI': 'Aberrant Epicardial Adipose Tissue Extracellular Matrix Remodeling in Patients with Severe Ischemic Cardiomyopathy: Insight from Comparative Quantitative Proteomics.', 'PG': '43787', 'LID': '10.1038/srep43787 [doi]', 'AB': 'There is ample evidence indicating that epicardial adipose tissue (EAT) volume and thickness is positively associated with coronary artery disease (CAD). However, the exact pathological changes in the human EAT after myocardial ischemia remains largely unclear. In the current study, we applied a comparative quantitative proteomics to elucidate the altered biological processes in the EAT of ischemic cardiomyopathy (ICM) patients. A total of 1649 proteins were successfully quantified in our study, among which 165 proteins were significantly changed (ratio <0.8 or >1.2 fold and p < 0.05 in both repetitions) in EAT of ICM individuals. Gene ontology (GO) enrichment analysis revealed that cardiac structure and cellular metabolism were over-represented among these regulated proteins. The hypertrophic cardiomyopathy, adrenergic signaling in cardiomyocytes, extracellular matrix (ECM)-receptor interaction, phagosome, Glycolysis/Gluconeogenesis, and PPAR signaling pathway were highlighted by the KEGG PATHWAY analysis. More importantly, we found that the proteins responsible for extracellular matrix organization were dramatically increased in EAT of ICM patients. In addition, the picrosirius red (PSR) staining results showed that the collagen fiber content was prominently increased, which indicated the EAT of ICM individuals underwent extracellular matrix remodeling and ERK1/2 activation maybe responsible for these pathological changes partially.', 'FAU': ['Jiang, Ding-Sheng', 'Zeng, Hao-Long', 'Li, Rui', 'Huo, Bo', 'Su, Yun-Shu', 'Fang, Jing', 'Yang, Qing', 'Liu, Li-Gang', 'Hu, Min', 'Cheng, Cai', 'Zhu, Xue-Hai', 'Yi, Xin', 'Wei, Xiang'], 'AU': ['Jiang DS', 'Zeng HL', 'Li R', 'Huo B', 'Su YS', 'Fang J', 'Yang Q', 'Liu LG', 'Hu M', 'Cheng C', 'Zhu XH', 'Yi X', 'Wei X'], 'AD': ['Division of Cardiothoracic and Vascular Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.', 'Key Laboratory of Organ Transplantation, Ministry of Education, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.', 'Key Laboratory of Organ Transplantation, Ministry of Health, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.', 'Department of Laboratory Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.', 'Division of Cardiothoracic and Vascular Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.', 'Division of Cardiothoracic and Vascular Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.', 'Division of Cardiothoracic and Vascular Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.', 'Division of Cardiothoracic and Vascular Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.', 'College of life science, Wuhan University, Wuhan, Wuhan 430072, China.', 'Division of Cardiothoracic and Vascular Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.', 'Division of Cardiothoracic and Vascular Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.', 'Division of Cardiothoracic and Vascular Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.', 'Division of Cardiothoracic and Vascular Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.', 'Key Laboratory of Organ Transplantation, Ministry of Education, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.', 'Key Laboratory of Organ Transplantation, Ministry of Health, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.', 'Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, China.', 'Cardiovascular Research Institute, Wuhan University, Wuhan 430060, China.', 'Hubei Key Laboratory of Cardiology, Wuhan 430060, P.R. China.', 'Division of Cardiothoracic and Vascular Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.', 'Key Laboratory of Organ Transplantation, Ministry of Education, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.', 'Key Laboratory of Organ Transplantation, Ministry of Health, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.'], 'LA': ['eng'], 'PT': ['Comparative Study', 'Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20170303', 'PL': 'England', 'TA': 'Sci Rep', 'JT': 'Scientific reports', 'JID': '101563288', 'RN': ['0 (Proteome)', '9007-34-5 (Collagen)'], 'SB': 'IM', 'MH': ['Adipose Tissue/*metabolism', 'Cardiomyopathies/genetics/*metabolism', 'Collagen/genetics/metabolism', 'Extracellular Matrix/*metabolism', 'Female', 'Gene Expression', 'Gene Regulatory Networks', 'Humans', 'Male', 'Middle Aged', 'Myocardial Ischemia/genetics/*metabolism', 'Pericardium/*metabolism', 'Protein Interaction Maps', 'Proteome/genetics/metabolism', 'Proteomics/*methods', 'Signal Transduction/genetics'], 'PMC': 'PMC5335613', 'EDAT': '2017/03/04 06:00', 'MHDA': '2018/11/07 06:00', 'CRDT': ['2017/03/04 06:00'], 'PHST': ['2016/10/21 00:00 [received]', '2017/01/30 00:00 [accepted]', '2017/03/04 06:00 [entrez]', '2017/03/04 06:00 [pubmed]', '2018/11/07 06:00 [medline]'], 'AID': ['srep43787 [pii]', '10.1038/srep43787 [doi]'], 'PST': 'epublish', 'SO': 'Sci Rep. 2017 Mar 3;7:43787. doi: 10.1038/srep43787.'}\n",
      "{'PMID': '28223106', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20180402', 'LR': '20180807', 'IS': '1878-4216 (Electronic) 0278-5846 (Linking)', 'VI': '76', 'DP': '2017 Jun 2', 'TI': 'Diagnosis of major depressive disorder by combining multimodal information from heart rate dynamics and serum proteomics using machine-learning algorithm.', 'PG': '65-71', 'LID': 'S0278-5846(16)30200-7 [pii] 10.1016/j.pnpbp.2017.02.014 [doi]', 'AB': 'OBJECTIVE: Major depressive disorder (MDD) is a systemic and multifactorial disorder that involves abnormalities in multiple biochemical pathways and the autonomic nervous system. This study applied a machine-learning method to classify MDD and control groups by incorporating data from serum proteomic analysis and heart rate variability (HRV) analysis for the identification of novel peripheral biomarkers. METHODS: The study subjects consisted of 25 drug-free female MDD patients and 25 age- and sex-matched healthy controls. First, quantitative serum proteome profiles were analyzed by liquid chromatography-tandem mass spectrometry using pooled serum samples from 10 patients and 10 controls. Next, candidate proteins were quantified with multiple reaction monitoring (MRM) in 50 subjects. We also analyzed 22 linear and nonlinear HRV parameters in 50 subjects. Finally, we identified a combined biomarker panel consisting of proteins and HRV indexes using a support vector machine with recursive feature elimination. RESULTS: A separation between MDD and control groups was achieved using five parameters (apolipoprotein B, group-specific component, ceruloplasmin, RMSSD, and SampEn) at 80.1% classification accuracy. A combination of HRV and proteomic data achieved better classification accuracy. CONCLUSIONS: A high classification accuracy can be achieved by combining multimodal information from heart rate dynamics and serum proteomics in MDD. Our approach can be helpful for accurate clinical diagnosis of MDD. Further studies using larger, independent cohorts are needed to verify the role of these candidate biomarkers for MDD diagnosis.', 'CI': ['Copyright (c) 2017 Elsevier Inc. All rights reserved.'], 'FAU': ['Kim, Eun Young', 'Lee, Min Young', 'Kim, Se Hyun', 'Ha, Kyooseob', 'Kim, Kwang Pyo', 'Ahn, Yong Min'], 'AU': ['Kim EY', 'Lee MY', 'Kim SH', 'Ha K', 'Kim KP', 'Ahn YM'], 'AD': ['Department of Medicine, Seoul National University Hospital, Seoul, Republic of Korea.', 'Institute for Systems Biology, Seattle, WA, United States; Department of Applied Chemistry, College of Applied Science, Kyung Hee University, Yongin, Republic of Korea.', 'Department of Neuropsychiatry, Dongguk University Medical School, Dongguk University International Hospital, Goyang, Republic of Korea.', 'Institute of Human Behavioral Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea; Department of Psychiatry, Seoul National University Hospital, Seoul, Republic of Korea.', 'Department of Applied Chemistry, College of Applied Science, Kyung Hee University, Yongin, Republic of Korea.', 'Institute of Human Behavioral Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea; Department of Psychiatry, Seoul National University Hospital, Seoul, Republic of Korea. Electronic address: aym@snu.ac.kr.'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20170220', 'PL': 'England', 'TA': 'Prog Neuropsychopharmacol Biol Psychiatry', 'JT': 'Progress in neuro-psychopharmacology & biological psychiatry', 'JID': '8211617', 'RN': ['0 (Biomarkers)', '0 (Proteome)'], 'SB': 'IM', 'MH': ['Adult', '*Biomarkers', 'Depressive Disorder, Major/blood/*diagnosis/physiopathology', 'Female', 'Heart Rate/*physiology', 'Humans', '*Machine Learning', 'Middle Aged', 'Proteome/*metabolism'], 'OTO': ['NOTNLM'], 'OT': ['*Biomarker', '*Heart rate variability', '*Machine-learning', '*Major depressive disorder', '*Proteomics'], 'EDAT': '2017/02/23 06:00', 'MHDA': '2018/04/03 06:00', 'CRDT': ['2017/02/23 06:00'], 'PHST': ['2016/09/08 00:00 [received]', '2017/02/02 00:00 [revised]', '2017/02/16 00:00 [accepted]', '2017/02/23 06:00 [pubmed]', '2018/04/03 06:00 [medline]', '2017/02/23 06:00 [entrez]'], 'AID': ['S0278-5846(16)30200-7 [pii]', '10.1016/j.pnpbp.2017.02.014 [doi]'], 'PST': 'ppublish', 'SO': 'Prog Neuropsychopharmacol Biol Psychiatry. 2017 Jun 2;76:65-71. doi: 10.1016/j.pnpbp.2017.02.014. Epub 2017 Feb 20.'}\n",
      "{'PMID': '28209220', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20170717', 'LR': '20200311', 'IS': '1558-3597 (Electronic) 0735-1097 (Linking)', 'VI': '69', 'IP': '7', 'DP': '2017 Feb 21', 'TI': 'Very-Low-Density Lipoprotein-Associated Apolipoproteins Predict Cardiovascular Events and Are Lowered by Inhibition of APOC-III.', 'PG': '789-800', 'LID': 'S0735-1097(16)37409-5 [pii] 10.1016/j.jacc.2016.11.065 [doi]', 'AB': 'BACKGROUND: Routine apolipoprotein (apo) measurements for cardiovascular disease (CVD) are restricted to apoA-I and apoB. Here, the authors measured an unprecedented range of apolipoproteins in a prospective, population-based study and relate their plasma levels to risk of CVD. OBJECTIVES: This study sought to measure apolipoproteins directly by mass spectrometry and compare their associations with incident CVD and to obtain a system-level understanding of the correlations of apolipoproteins with the plasma lipidome and proteome. METHODS: Associations of 13 apolipoproteins, 135 lipid species, and 211 other plasma proteins with incident CVD (91 events), defined as stroke, myocardial infarction, or sudden cardiac death, were assessed prospectively over a 10-year period in the Bruneck Study (N = 688) using multiple-reaction monitoring mass spectrometry. Changes in apolipoprotein and lipid levels following treatment with volanesorsen, a second-generation antisense drug targeting apoC-III, were determined in 2 human intervention trials, one of which was randomized. RESULTS: The apolipoproteins most significantly associated with incident CVD were apoC-II (hazard ratio per 1 SD [HR/SD]: 1.40; 95% confidence interval [CI]: 1.17 to 1.67), apoC-III (HR/SD: 1.38; 95% CI: 1.17 to 1.63), and apoE (HR/SD: 1.31; 95% CI: 1.13 to 1.52). Associations were independent of high-density lipoprotein (HDL) and non-HDL cholesterol, and extended to stroke and myocardial infarction. Lipidomic and proteomic profiles implicated these 3 very-low-density lipoprotein (VLDL)-associated apolipoproteins in de novo lipogenesis, glucose metabolism, complement activation, blood coagulation, and inflammation. Notably, apoC-II/apoC-III/apoE correlated with a pattern of lipid species previously linked to CVD risk. ApoC-III inhibition by volanesorsen reduced plasma levels of apoC-II, apoC-III, triacylglycerols, and diacylglycerols, and increased apoA-I, apoA-II, and apoM (all p < 0.05 vs. placebo) without affecting apoB-100 (p = 0.73). CONCLUSIONS: The strong associations of VLDL-associated apolipoproteins with incident CVD in the general community support the concept of targeting triacylglycerol-rich lipoproteins to reduce risk of CVD.', 'CI': ['Copyright (c) 2017 The Authors. Published by Elsevier Inc. All rights reserved.'], 'FAU': ['Pechlaner, Raimund', 'Tsimikas, Sotirios', 'Yin, Xiaoke', 'Willeit, Peter', 'Baig, Ferheen', 'Santer, Peter', 'Oberhollenzer, Friedrich', 'Egger, Georg', 'Witztum, Joseph L', 'Alexander, Veronica J', 'Willeit, Johann', 'Kiechl, Stefan', 'Mayr, Manuel'], 'AU': ['Pechlaner R', 'Tsimikas S', 'Yin X', 'Willeit P', 'Baig F', 'Santer P', 'Oberhollenzer F', 'Egger G', 'Witztum JL', 'Alexander VJ', 'Willeit J', 'Kiechl S', 'Mayr M'], 'AD': ['Department of Neurology, Medical University Innsbruck, Innsbruck, Austria.', 'University of California San Diego, La Jolla, California; Ionis Pharmaceuticals, Carlsbad, California.', \"King's British Heart Foundation Centre, King's College London, London, United Kingdom.\", 'Department of Neurology, Medical University Innsbruck, Innsbruck, Austria; Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.', \"King's British Heart Foundation Centre, King's College London, London, United Kingdom.\", 'Department of Laboratory Medicine, Hospital of Bruneck, Bruneck, Italy.', 'Department of Laboratory Medicine, Hospital of Bruneck, Bruneck, Italy.', 'Department of Internal Medicine, Hospital of Bruneck, Bruneck, Italy.', 'University of California San Diego, La Jolla, California.', 'Ionis Pharmaceuticals, Carlsbad, California.', 'Department of Neurology, Medical University Innsbruck, Innsbruck, Austria.', 'Department of Neurology, Medical University Innsbruck, Innsbruck, Austria. Electronic address: stefan.kiechl@i-med.ac.at.', \"King's British Heart Foundation Centre, King's College London, London, United Kingdom. Electronic address: manuel.mayr@kcl.ac.uk.\"], 'LA': ['eng'], 'GR': ['P01 HL088093/HL/NHLBI NIH HHS/United States', 'R01 HL106579/HL/NHLBI NIH HHS/United States', 'RG/16/14/32397/BHF_/British Heart Foundation/United Kingdom', 'R01 HL078610/HL/NHLBI NIH HHS/United States', 'R01 HL119828/HL/NHLBI NIH HHS/United States', 'P01 HL055798/HL/NHLBI NIH HHS/United States', 'FS/13/2/29892/BHF_/British Heart Foundation/United Kingdom', 'R01 HL124174/HL/NHLBI NIH HHS/United States'], 'PT': ['Journal Article'], 'PL': 'United States', 'TA': 'J Am Coll Cardiol', 'JT': 'Journal of the American College of Cardiology', 'JID': '8301365', 'RN': ['0 (Apolipoprotein C-III)', '0 (Apolipoproteins)', '0 (Lipoproteins, VLDL)'], 'SB': 'AIM IM', 'CIN': ['J Am Coll Cardiol. 2017 Feb 21;69(7):801-804. PMID: 28209221'], 'MH': ['Aged', 'Apolipoprotein C-III/*antagonists & inhibitors', 'Apolipoproteins/*blood', 'Cardiovascular Diseases/*blood/*epidemiology/prevention & control', 'Female', 'Humans', 'Incidence', 'Lipoproteins, VLDL/*blood', 'Male', 'Mass Spectrometry', 'Middle Aged', 'Prospective Studies'], 'PMC': 'PMC5314136', 'OTO': ['NOTNLM'], 'OT': ['lipidomics', 'mass spectrometry', 'proteomics', 'triglycerides'], 'EDAT': '2017/02/18 06:00', 'MHDA': '2017/07/18 06:00', 'CRDT': ['2017/02/18 06:00'], 'PHST': ['2016/08/08 00:00 [received]', '2016/10/17 00:00 [revised]', '2016/11/17 00:00 [accepted]', '2017/02/18 06:00 [entrez]', '2017/02/18 06:00 [pubmed]', '2017/07/18 06:00 [medline]'], 'AID': ['S0735-1097(16)37409-5 [pii]', '10.1016/j.jacc.2016.11.065 [doi]'], 'PST': 'ppublish', 'SO': 'J Am Coll Cardiol. 2017 Feb 21;69(7):789-800. doi: 10.1016/j.jacc.2016.11.065.'}\n",
      "{'PMID': '28196416', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20171017', 'LR': '20180403', 'IS': '1535-3907 (Electronic) 1535-3893 (Linking)', 'VI': '16', 'IP': '4', 'DP': '2017 Apr 7', 'TI': 'Blood Proteomic Profiling in Inherited (ATTRm) and Acquired (ATTRwt) Forms of Transthyretin-Associated Cardiac Amyloidosis.', 'PG': '1659-1668', 'LID': '10.1021/acs.jproteome.6b00998 [doi]', 'AB': 'Transthyretin-associated forms of cardiac amyloidosis are fatal protein misfolding diseases that can be inherited (ATTRm) or acquired (ATTRwt). An accurate diagnosis of ATTR amyloidosis can be challenging as biopsy evidence, usually from the affected organ, is required. Precise biomarkers for ATTR disease identification and monitoring are undiscovered, disease-specific therapeutic options are needed, and the current understanding of ATTR molecular pathogenesis is limited. The aim of this study was to investigate and compare the serum proteomes in ATTRm and ATTRwt cardiac amyloidosis to identify differentially expressed blood proteins that were disease-specific. Using multiple-reaction monitoring mass spectrometry (MRM-MS), the concentrations of 160 proteins were analyzed in serum samples from ATTRm and ATTRwt patients, and a healthy control group. Patient and control sera were matched to age (>/=60 years), gender (male), and race (Caucasian). The circulating concentrations of 123/160 proteins were significantly different in patient vs control sera; TTR and retinol-binding protein (RBP4) levels were significantly decreased (p < 0.03) in ATTRm compared to controls. In ATTRm, 14/123 proteins were identified as unique to that group and found generally to be lower than controls; moreover, the concentrations of RBP4 and 6 other proteins in this group were significantly different (p < 0.04) compared to ATTRwt. Predicted interactions among the 14 proteins unique to ATTRm were categorized as reaction and binding associations. Alternatively, 27 proteins were found to be unique to ATTRwt with associated interactions defined as activation, catalysis, and inhibition, in addition to reaction and binding. This study demonstrates significant proteomic differences between ATTR patient and control sera, and disease-associated variations in circulating levels of several proteins including TTR and RBP4. The identification of serum proteins unique to ATTRm and ATTRwt cardiac amyloidosis may have diagnostic and prognostic utility, and may provide important clues about disease mechanisms.', 'FAU': ['Chan, Gloria G', 'Koch, Clarissa M', 'Connors, Lawreen H'], 'AU': ['Chan GG', 'Koch CM', 'Connors LH'], 'AUID': ['ORCID: 0000-0003-4541-9713'], 'AD': ['Amyloidosis Center and double daggerDepartment of Pathology and Laboratory Medicine, Boston University School of Medicine , Boston, Massachusetts 02118, United States.', 'Amyloidosis Center and double daggerDepartment of Pathology and Laboratory Medicine, Boston University School of Medicine , Boston, Massachusetts 02118, United States.', 'Amyloidosis Center and double daggerDepartment of Pathology and Laboratory Medicine, Boston University School of Medicine , Boston, Massachusetts 02118, United States.'], 'LA': ['eng'], 'GR': ['R01 AG031804/AG/NIA NIH HHS/United States'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\", 'Research Support, N.I.H., Extramural'], 'DEP': '20170223', 'PL': 'United States', 'TA': 'J Proteome Res', 'JT': 'Journal of proteome research', 'JID': '101128775', 'RN': ['0 (Biomarkers)', '0 (Blood Proteins)', '0 (Proteome)', 'Amyloidosis, Hereditary, Transthyretin-Related'], 'SB': 'IM', 'MH': ['Aged', 'Amyloid Neuropathies, Familial/*blood/genetics/pathology', 'Biomarkers/*blood', 'Biopsy', 'Blood Proteins/*genetics', 'Female', 'Humans', 'Male', 'Middle Aged', 'Prognosis', 'Proteome/genetics', 'Proteostasis Deficiencies/*blood/genetics/pathology'], 'OTO': ['NOTNLM'], 'OT': ['*DAVID', '*MRM-MS', '*PANTHER', '*STRING', '*UniprotKB', '*amyloidosis', '*biomarker', '*cardiomyopathy', '*familial ATTR', '*serum', '*wild-type ATTR'], 'EDAT': '2017/02/16 06:00', 'MHDA': '2017/10/19 06:00', 'CRDT': ['2017/02/16 06:00'], 'PHST': ['2017/02/16 06:00 [pubmed]', '2017/10/19 06:00 [medline]', '2017/02/16 06:00 [entrez]'], 'AID': ['10.1021/acs.jproteome.6b00998 [doi]'], 'PST': 'ppublish', 'SO': 'J Proteome Res. 2017 Apr 7;16(4):1659-1668. doi: 10.1021/acs.jproteome.6b00998. Epub 2017 Feb 23.'}\n",
      "{'PMID': '27908912', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20170508', 'LR': '20181113', 'IS': '1524-4571 (Electronic) 0009-7330 (Linking)', 'VI': '120', 'IP': '5', 'DP': '2017 Mar 3', 'TI': 'A Deep Proteome Analysis Identifies the Complete Secretome as the Functional Unit of Human Cardiac Progenitor Cells.', 'PG': '816-834', 'LID': '10.1161/CIRCRESAHA.116.309782 [doi]', 'AB': 'RATIONALE: Cardiac progenitor cells are an attractive cell type for tissue regeneration, but their mechanism for myocardial remodeling is still unclear. OBJECTIVE: This investigation determines how chronological age influences the phenotypic characteristics and the secretome of human cardiac progenitor cells (CPCs), and their potential to recover injured myocardium. METHODS AND RESULTS: Adult (aCPCs) and neonatal (nCPCs) cells were derived from patients aged >40 years or <1 month, respectively, and their functional potential was determined in a rodent myocardial infarction model. A more robust in vitro proliferative capacity of nCPCs, compared with aCPCs, correlated with significantly greater myocardial recovery mediated by nCPCs in vivo. Strikingly, a single injection of nCPC-derived total conditioned media was significantly more effective than nCPCs, aCPC-derived TCM, or nCPC-derived exosomes in recovering cardiac function, stimulating neovascularization, and promoting myocardial remodeling. High-resolution accurate mass spectrometry with reverse phase liquid chromatography fractionation and mass spectrometry was used to identify proteins in the secretome of aCPCs and nCPCs, and the literature-based networking software identified specific pathways affected by the secretome of CPCs in the setting of myocardial infarction. Examining the TCM, we quantified changes in the expression pattern of 804 proteins in nCPC-derived TCM and 513 proteins in aCPC-derived TCM. The literature-based proteomic network analysis identified that 46 and 6 canonical signaling pathways were significantly targeted by nCPC-derived TCM and aCPC-derived TCM, respectively. One leading candidate pathway is heat-shock factor-1, potentially affecting 8 identified pathways for nCPC-derived TCM but none for aCPC-derived TCM. To validate this prediction, we demonstrated that the modulation of heat-shock factor-1 by knockdown in nCPCs or overexpression in aCPCs significantly altered the quality of their secretome. CONCLUSIONS: A deep proteomic analysis revealed both detailed and global mechanisms underlying the chronological age-based differences in the ability of CPCs to promote myocardial recovery via the components of their secretome.', 'CI': ['(c) 2016 American Heart Association, Inc.'], 'FAU': ['Sharma, Sudhish', 'Mishra, Rachana', 'Bigham, Grace E', 'Wehman, Brody', 'Khan, Mohd M', 'Xu, Huichun', 'Saha, Progyaparamita', 'Goo, Young Ah', 'Datla, Srinivasa Raju', 'Chen, Ling', 'Tulapurkar, Mohan E', 'Taylor, Bradley S', 'Yang, Peixin', 'Karathanasis, Sotirios', 'Goodlett, David R', 'Kaushal, Sunjay'], 'AU': ['Sharma S', 'Mishra R', 'Bigham GE', 'Wehman B', 'Khan MM', 'Xu H', 'Saha P', 'Goo YA', 'Datla SR', 'Chen L', 'Tulapurkar ME', 'Taylor BS', 'Yang P', 'Karathanasis S', 'Goodlett DR', 'Kaushal S'], 'AD': ['From the Division of Cardiac Surgery, School of Medicine (S.S., R.M., G.E.B., B.W., P.S., S.R.D., B.S.T., S.K.), Department of Pharmaceutical Sciences, School of Pharmacy (M.M.K., Y.A.G., D.R.G.), Division of Endocrinology, Diabetes and Nutrition, Department of Medicine (H.X.), Department of Physiology and Medicine, School of Medicine (L.C.), Department of OB/GYN & Reproductive Science, Department of Biochemistry and Molecular Biology, School of Medicine (P.Y.), and Pulmonary and Critical Care Medicine, Department of Medicine, School of Medicine (M.E.T.), University of Maryland, Baltimore; and Cardiovascular and Metabolic Diseases, Innovative Medicines Biotech Unit MedImmune, Inc., Gaithersburg, MD (S.K.).', 'From the Division of Cardiac Surgery, School of Medicine (S.S., R.M., G.E.B., B.W., P.S., S.R.D., B.S.T., S.K.), Department of Pharmaceutical Sciences, School of Pharmacy (M.M.K., Y.A.G., D.R.G.), Division of Endocrinology, Diabetes and Nutrition, Department of Medicine (H.X.), Department of Physiology and Medicine, School of Medicine (L.C.), Department of OB/GYN & Reproductive Science, Department of Biochemistry and Molecular Biology, School of Medicine (P.Y.), and Pulmonary and Critical Care Medicine, Department of Medicine, School of Medicine (M.E.T.), University of Maryland, Baltimore; and Cardiovascular and Metabolic Diseases, Innovative Medicines Biotech Unit MedImmune, Inc., Gaithersburg, MD (S.K.).', 'From the Division of Cardiac Surgery, School of Medicine (S.S., R.M., G.E.B., B.W., P.S., S.R.D., B.S.T., S.K.), Department of Pharmaceutical Sciences, School of Pharmacy (M.M.K., Y.A.G., D.R.G.), Division of Endocrinology, Diabetes and Nutrition, Department of Medicine (H.X.), Department of Physiology and Medicine, School of Medicine (L.C.), Department of OB/GYN & Reproductive Science, Department of Biochemistry and Molecular Biology, School of Medicine (P.Y.), and Pulmonary and Critical Care Medicine, Department of Medicine, School of Medicine (M.E.T.), University of Maryland, Baltimore; and Cardiovascular and Metabolic Diseases, Innovative Medicines Biotech Unit MedImmune, Inc., Gaithersburg, MD (S.K.).', 'From the Division of Cardiac Surgery, School of Medicine (S.S., R.M., G.E.B., B.W., P.S., S.R.D., B.S.T., S.K.), Department of Pharmaceutical Sciences, School of Pharmacy (M.M.K., Y.A.G., D.R.G.), Division of Endocrinology, Diabetes and Nutrition, Department of Medicine (H.X.), Department of Physiology and Medicine, School of Medicine (L.C.), Department of OB/GYN & Reproductive Science, Department of Biochemistry and Molecular Biology, School of Medicine (P.Y.), and Pulmonary and Critical Care Medicine, Department of Medicine, School of Medicine (M.E.T.), University of Maryland, Baltimore; and Cardiovascular and Metabolic Diseases, Innovative Medicines Biotech Unit MedImmune, Inc., Gaithersburg, MD (S.K.).', 'From the Division of Cardiac Surgery, School of Medicine (S.S., R.M., G.E.B., B.W., P.S., S.R.D., B.S.T., S.K.), Department of Pharmaceutical Sciences, School of Pharmacy (M.M.K., Y.A.G., D.R.G.), Division of Endocrinology, Diabetes and Nutrition, Department of Medicine (H.X.), Department of Physiology and Medicine, School of Medicine (L.C.), Department of OB/GYN & Reproductive Science, Department of Biochemistry and Molecular Biology, School of Medicine (P.Y.), and Pulmonary and Critical Care Medicine, Department of Medicine, School of Medicine (M.E.T.), University of Maryland, Baltimore; and Cardiovascular and Metabolic Diseases, Innovative Medicines Biotech Unit MedImmune, Inc., Gaithersburg, MD (S.K.).', 'From the Division of Cardiac Surgery, School of Medicine (S.S., R.M., G.E.B., B.W., P.S., S.R.D., B.S.T., S.K.), Department of Pharmaceutical Sciences, School of Pharmacy (M.M.K., Y.A.G., D.R.G.), Division of Endocrinology, Diabetes and Nutrition, Department of Medicine (H.X.), Department of Physiology and Medicine, School of Medicine (L.C.), Department of OB/GYN & Reproductive Science, Department of Biochemistry and Molecular Biology, School of Medicine (P.Y.), and Pulmonary and Critical Care Medicine, Department of Medicine, School of Medicine (M.E.T.), University of Maryland, Baltimore; and Cardiovascular and Metabolic Diseases, Innovative Medicines Biotech Unit MedImmune, Inc., Gaithersburg, MD (S.K.).', 'From the Division of Cardiac Surgery, School of Medicine (S.S., R.M., G.E.B., B.W., P.S., S.R.D., B.S.T., S.K.), Department of Pharmaceutical Sciences, School of Pharmacy (M.M.K., Y.A.G., D.R.G.), Division of Endocrinology, Diabetes and Nutrition, Department of Medicine (H.X.), Department of Physiology and Medicine, School of Medicine (L.C.), Department of OB/GYN & Reproductive Science, Department of Biochemistry and Molecular Biology, School of Medicine (P.Y.), and Pulmonary and Critical Care Medicine, Department of Medicine, School of Medicine (M.E.T.), University of Maryland, Baltimore; and Cardiovascular and Metabolic Diseases, Innovative Medicines Biotech Unit MedImmune, Inc., Gaithersburg, MD (S.K.).', 'From the Division of Cardiac Surgery, School of Medicine (S.S., R.M., G.E.B., B.W., P.S., S.R.D., B.S.T., S.K.), Department of Pharmaceutical Sciences, School of Pharmacy (M.M.K., Y.A.G., D.R.G.), Division of Endocrinology, Diabetes and Nutrition, Department of Medicine (H.X.), Department of Physiology and Medicine, School of Medicine (L.C.), Department of OB/GYN & Reproductive Science, Department of Biochemistry and Molecular Biology, School of Medicine (P.Y.), and Pulmonary and Critical Care Medicine, Department of Medicine, School of Medicine (M.E.T.), University of Maryland, Baltimore; and Cardiovascular and Metabolic Diseases, Innovative Medicines Biotech Unit MedImmune, Inc., Gaithersburg, MD (S.K.).', 'From the Division of Cardiac Surgery, School of Medicine (S.S., R.M., G.E.B., B.W., P.S., S.R.D., B.S.T., S.K.), Department of Pharmaceutical Sciences, School of Pharmacy (M.M.K., Y.A.G., D.R.G.), Division of Endocrinology, Diabetes and Nutrition, Department of Medicine (H.X.), Department of Physiology and Medicine, School of Medicine (L.C.), Department of OB/GYN & Reproductive Science, Department of Biochemistry and Molecular Biology, School of Medicine (P.Y.), and Pulmonary and Critical Care Medicine, Department of Medicine, School of Medicine (M.E.T.), University of Maryland, Baltimore; and Cardiovascular and Metabolic Diseases, Innovative Medicines Biotech Unit MedImmune, Inc., Gaithersburg, MD (S.K.).', 'From the Division of Cardiac Surgery, School of Medicine (S.S., R.M., G.E.B., B.W., P.S., S.R.D., B.S.T., S.K.), Department of Pharmaceutical Sciences, School of Pharmacy (M.M.K., Y.A.G., D.R.G.), Division of Endocrinology, Diabetes and Nutrition, Department of Medicine (H.X.), Department of Physiology and Medicine, School of Medicine (L.C.), Department of OB/GYN & Reproductive Science, Department of Biochemistry and Molecular Biology, School of Medicine (P.Y.), and Pulmonary and Critical Care Medicine, Department of Medicine, School of Medicine (M.E.T.), University of Maryland, Baltimore; and Cardiovascular and Metabolic Diseases, Innovative Medicines Biotech Unit MedImmune, Inc., Gaithersburg, MD (S.K.).', 'From the Division of Cardiac Surgery, School of Medicine (S.S., R.M., G.E.B., B.W., P.S., S.R.D., B.S.T., S.K.), Department of Pharmaceutical Sciences, School of Pharmacy (M.M.K., Y.A.G., D.R.G.), Division of Endocrinology, Diabetes and Nutrition, Department of Medicine (H.X.), Department of Physiology and Medicine, School of Medicine (L.C.), Department of OB/GYN & Reproductive Science, Department of Biochemistry and Molecular Biology, School of Medicine (P.Y.), and Pulmonary and Critical Care Medicine, Department of Medicine, School of Medicine (M.E.T.), University of Maryland, Baltimore; and Cardiovascular and Metabolic Diseases, Innovative Medicines Biotech Unit MedImmune, Inc., Gaithersburg, MD (S.K.).', 'From the Division of Cardiac Surgery, School of Medicine (S.S., R.M., G.E.B., B.W., P.S., S.R.D., B.S.T., S.K.), Department of Pharmaceutical Sciences, School of Pharmacy (M.M.K., Y.A.G., D.R.G.), Division of Endocrinology, Diabetes and Nutrition, Department of Medicine (H.X.), Department of Physiology and Medicine, School of Medicine (L.C.), Department of OB/GYN & Reproductive Science, Department of Biochemistry and Molecular Biology, School of Medicine (P.Y.), and Pulmonary and Critical Care Medicine, Department of Medicine, School of Medicine (M.E.T.), University of Maryland, Baltimore; and Cardiovascular and Metabolic Diseases, Innovative Medicines Biotech Unit MedImmune, Inc., Gaithersburg, MD (S.K.).', 'From the Division of Cardiac Surgery, School of Medicine (S.S., R.M., G.E.B., B.W., P.S., S.R.D., B.S.T., S.K.), Department of Pharmaceutical Sciences, School of Pharmacy (M.M.K., Y.A.G., D.R.G.), Division of Endocrinology, Diabetes and Nutrition, Department of Medicine (H.X.), Department of Physiology and Medicine, School of Medicine (L.C.), Department of OB/GYN & Reproductive Science, Department of Biochemistry and Molecular Biology, School of Medicine (P.Y.), and Pulmonary and Critical Care Medicine, Department of Medicine, School of Medicine (M.E.T.), University of Maryland, Baltimore; and Cardiovascular and Metabolic Diseases, Innovative Medicines Biotech Unit MedImmune, Inc., Gaithersburg, MD (S.K.).', 'From the Division of Cardiac Surgery, School of Medicine (S.S., R.M., G.E.B., B.W., P.S., S.R.D., B.S.T., S.K.), Department of Pharmaceutical Sciences, School of Pharmacy (M.M.K., Y.A.G., D.R.G.), Division of Endocrinology, Diabetes and Nutrition, Department of Medicine (H.X.), Department of Physiology and Medicine, School of Medicine (L.C.), Department of OB/GYN & Reproductive Science, Department of Biochemistry and Molecular Biology, School of Medicine (P.Y.), and Pulmonary and Critical Care Medicine, Department of Medicine, School of Medicine (M.E.T.), University of Maryland, Baltimore; and Cardiovascular and Metabolic Diseases, Innovative Medicines Biotech Unit MedImmune, Inc., Gaithersburg, MD (S.K.).', 'From the Division of Cardiac Surgery, School of Medicine (S.S., R.M., G.E.B., B.W., P.S., S.R.D., B.S.T., S.K.), Department of Pharmaceutical Sciences, School of Pharmacy (M.M.K., Y.A.G., D.R.G.), Division of Endocrinology, Diabetes and Nutrition, Department of Medicine (H.X.), Department of Physiology and Medicine, School of Medicine (L.C.), Department of OB/GYN & Reproductive Science, Department of Biochemistry and Molecular Biology, School of Medicine (P.Y.), and Pulmonary and Critical Care Medicine, Department of Medicine, School of Medicine (M.E.T.), University of Maryland, Baltimore; and Cardiovascular and Metabolic Diseases, Innovative Medicines Biotech Unit MedImmune, Inc., Gaithersburg, MD (S.K.).', 'From the Division of Cardiac Surgery, School of Medicine (S.S., R.M., G.E.B., B.W., P.S., S.R.D., B.S.T., S.K.), Department of Pharmaceutical Sciences, School of Pharmacy (M.M.K., Y.A.G., D.R.G.), Division of Endocrinology, Diabetes and Nutrition, Department of Medicine (H.X.), Department of Physiology and Medicine, School of Medicine (L.C.), Department of OB/GYN & Reproductive Science, Department of Biochemistry and Molecular Biology, School of Medicine (P.Y.), and Pulmonary and Critical Care Medicine, Department of Medicine, School of Medicine (M.E.T.), University of Maryland, Baltimore; and Cardiovascular and Metabolic Diseases, Innovative Medicines Biotech Unit MedImmune, Inc., Gaithersburg, MD (S.K.). skaushal@smail.umaryland.edu.'], 'LA': ['eng'], 'GR': ['K08 HL097069/HL/NHLBI NIH HHS/United States', 'P30 DK072488/DK/NIDDK NIH HHS/United States', 'R01 HL118491/HL/NHLBI NIH HHS/United States', 'R01 HL139060/HL/NHLBI NIH HHS/United States'], 'PT': ['Journal Article'], 'DEP': '20161201', 'PL': 'United States', 'TA': 'Circ Res', 'JT': 'Circulation research', 'JID': '0047103', 'RN': ['0 (Proteome)'], 'SB': 'IM', 'CIN': ['Circ Res. 2017 Mar 3;120(5):751-752. PMID: 28254793'], 'MH': ['Adult', 'Amino Acid Sequence', 'Animals', 'Base Sequence', 'Humans', 'Infant, Newborn', 'Male', 'Myocytes, Cardiac/*physiology', 'Proteome/*biosynthesis/*genetics', 'Proteomics/*methods', 'Rats', 'Stem Cells/*physiology'], 'PMC': 'PMC5834230', 'MID': ['NIHMS834110'], 'OTO': ['NOTNLM'], 'OT': ['adult stem cells', 'exosomes', 'heat-shock proteins', 'myocardial ischemia', 'proteomics', 'stem cells'], 'EDAT': '2016/12/03 06:00', 'MHDA': '2017/05/10 06:00', 'CRDT': ['2016/12/03 06:00'], 'PHST': ['2016/08/18 00:00 [received]', '2016/11/28 00:00 [revised]', '2016/12/01 00:00 [accepted]', '2016/12/03 06:00 [pubmed]', '2017/05/10 06:00 [medline]', '2016/12/03 06:00 [entrez]'], 'AID': ['CIRCRESAHA.116.309782 [pii]', '10.1161/CIRCRESAHA.116.309782 [doi]'], 'PST': 'ppublish', 'SO': 'Circ Res. 2017 Mar 3;120(5):816-834. doi: 10.1161/CIRCRESAHA.116.309782. Epub 2016 Dec 1.'}\n",
      "{'PMID': '27616206', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20171204', 'LR': '20180118', 'IS': '1876-7737 (Electronic) 1874-3919 (Linking)', 'VI': '150', 'DP': '2017 Jan 6', 'TI': 'Endomyocardial proteomic signature corresponding to the response of patients with dilated cardiomyopathy to immunoadsorption therapy.', 'PG': '121-129', 'LID': 'S1874-3919(16)30402-X [pii] 10.1016/j.jprot.2016.09.001 [doi]', 'AB': 'Dilated cardiomyopathy (DCM) is a disease of the myocardium with reduced left ventricular ejection fraction (LVEF). Cardiac autoantibodies (AAbs) play a causal role in the development and progression of DCM. Removal of AAbs using immunoadsorption (IA/IgG) has been shown as a therapeutic option to improve cardiac function. However, the response to therapy differs significantly among patients. The reasons for this variability are not completely understood. Hitherto, no potential biomarker is available to predict improvement of cardiac function after therapy accurately. This shotgun proteome study aims to disclose the differences in the endomyocardial proteome between patients with improved LVEF after IA/IgG (responders) and those without improvement (non-responders) before therapy start. Comparative analysis revealed 54 differentially abundant proteins that were mostly confined to carbohydrate and lipid metabolism, energy and immune regulation, and cardioprotection. Selected proteins representing various functional categories were further confirmed by multiple reaction monitoring (MRM). Among those, protein S100-A8, perilipin-4, and kininogen-1 were found the most robust candidates differentiating responders and non-responders. Receiver operating characteristic curve (ROC) analysis of these proteins revealed highest potential for protein S100-A8 (AUC 0.92) with high sensitivity and specificity to be developed as a classifier for the prediction of cardiac improvement after IA/IgG therapy. SIGNIFICANCE: We evaluated the differences in the myocardial proteome of responder and non-responder DCM patients before immunoadsorption therapy and identified a number of differentially abundant proteins involved in energy and lipid metabolism, immune system, and cardioprotection. MRM was used for verification of results. Proteins S100-A8, perilipin-4, and kininogen-1 were found to display the largest differences. The results provide a lead for further studies to screen for protein biomarker candidates in plasma that might be helpful to stratify patients for immunoadsorption therapy treatment.', 'CI': ['Copyright (c) 2016. Published by Elsevier B.V.'], 'FAU': ['Bhardwaj, Gourav', 'Dorr, Marcus', 'Sappa, Praveen Kumar', 'Ameling, Sabine', 'Dhople, Vishnu', 'Steil, Leif', 'Klingel, Karin', 'Empen, Klaus', 'Beug, Daniel', 'Volker, Uwe', 'Felix, Stephan B', 'Hammer, Elke'], 'AU': ['Bhardwaj G', 'Dorr M', 'Sappa PK', 'Ameling S', 'Dhople V', 'Steil L', 'Klingel K', 'Empen K', 'Beug D', 'Volker U', 'Felix SB', 'Hammer E'], 'AD': ['Department of Functional Genomics, Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Germany; DZHK (German Centre for Cardiovascular Research), partner site Greifswald, Greifswald, Germany.', 'Department of Internal Medicine B (Cardiology), University Medicine Greifswald, Greifswald, Germany; DZHK (German Centre for Cardiovascular Research), partner site Greifswald, Greifswald, Germany.', 'Department of Functional Genomics, Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Germany.', 'Department of Functional Genomics, Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Germany; DZHK (German Centre for Cardiovascular Research), partner site Greifswald, Greifswald, Germany.', 'Department of Functional Genomics, Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Germany.', 'Department of Functional Genomics, Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Germany.', 'Department of Molecular Pathology, University Hospital Tubingen, Germany.', 'Department of Internal Medicine B (Cardiology), University Medicine Greifswald, Greifswald, Germany.', 'Department of Internal Medicine B (Cardiology), University Medicine Greifswald, Greifswald, Germany.', 'Department of Functional Genomics, Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Germany; DZHK (German Centre for Cardiovascular Research), partner site Greifswald, Greifswald, Germany.', 'Department of Internal Medicine B (Cardiology), University Medicine Greifswald, Greifswald, Germany; DZHK (German Centre for Cardiovascular Research), partner site Greifswald, Greifswald, Germany. Electronic address: felix@uni-greifswald.de.', 'Department of Functional Genomics, Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Germany; DZHK (German Centre for Cardiovascular Research), partner site Greifswald, Greifswald, Germany. Electronic address: hammer@uni-greifswald.de.'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20160909', 'PL': 'Netherlands', 'TA': 'J Proteomics', 'JT': 'Journal of proteomics', 'JID': '101475056', 'RN': ['0 (Autoantibodies)', '0 (Biomarkers)', '0 (Proteome)'], 'SB': 'IM', 'MH': ['Adult', 'Autoantibodies/*isolation & purification', 'Biomarkers/metabolism', 'Cardiomyopathy, Dilated/diagnosis/immunology/metabolism/*therapy', 'Female', 'Humans', '*Immunosorbent Techniques', 'Male', 'Middle Aged', 'Myocardium/immunology/*metabolism', 'Pilot Projects', 'Prognosis', 'Proteome/*analysis/metabolism', 'Proteomics/*methods', 'Retrospective Studies', 'Treatment Outcome'], 'OTO': ['NOTNLM'], 'OT': ['*Dilated cardiomyopathy', '*Endomyocardial biopsies', '*Label-free tandem mass spectrometry', '*Multiple reaction monitoring', '*Therapy response'], 'EDAT': '2016/10/25 06:00', 'MHDA': '2017/12/05 06:00', 'CRDT': ['2016/09/13 06:00'], 'PHST': ['2016/05/30 00:00 [received]', '2016/08/28 00:00 [revised]', '2016/09/07 00:00 [accepted]', '2016/10/25 06:00 [pubmed]', '2017/12/05 06:00 [medline]', '2016/09/13 06:00 [entrez]'], 'AID': ['S1874-3919(16)30402-X [pii]', '10.1016/j.jprot.2016.09.001 [doi]'], 'PST': 'ppublish', 'SO': 'J Proteomics. 2017 Jan 6;150:121-129. doi: 10.1016/j.jprot.2016.09.001. Epub 2016 Sep 9.'}\n",
      "{'PMID': '27711126', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20170620', 'LR': '20190212', 'IS': '1932-6203 (Electronic) 1932-6203 (Linking)', 'VI': '11', 'IP': '10', 'DP': '2016', 'TI': 'Integrated Left Ventricular Global Transcriptome and Proteome Profiling in Human End-Stage Dilated Cardiomyopathy.', 'PG': 'e0162669', 'LID': '10.1371/journal.pone.0162669 [doi]', 'AB': \"AIMS: The disease pathways leading to idiopathic dilated cardiomyopathy (DCM) are still elusive. The present study investigated integrated global transcriptional and translational changes in human DCM for disease biomarker discovery. METHODS: We used identical myocardial tissues from five DCM hearts compared to five non-failing (NF) donor hearts for both transcriptome profiling using the ABI high-density oligonucleotide microarrays and proteome expression with One-Dimensional Nano Acquity liquid chromatography coupled with tandem mass spectrometry on the Synapt G2 system. RESULTS: We identified 1262 differentially expressed genes (DEGs) and 269 proteins (DEPs) between DCM cases and healthy controls. Among the most significantly upregulated (>5-fold) proteins were GRK5, APOA2, IGHG3, ANXA6, HSP90AA1, and ATP5C1 (p< 0.01). On the other hand, the most significantly downregulated proteins were GSTM5, COX17, CAV1 and ANXA3. At least ten entities were concomitantly upregulated on the two analysis platforms: GOT1, ALDH4A1, PDHB, BDH1, SLC2A11, HSP90AA1, HSP90AB1, H2AFV, HSPA5 and NDUFV1. Gene ontology analyses of DEGs and DEPs revealed significant overlap with enrichment of genes/proteins related to metabolic process, biosynthetic process, cellular component organization, oxidative phosphorylation, alterations in glycolysis and ATP synthesis, Alzheimer's disease, chemokine-mediated inflammation and cytokine signalling pathways. CONCLUSION: The concomitant use of transcriptome and proteome expression to evaluate global changes in DCM has led to the identification of sixteen commonly altered entities as well as novel genes, proteins and pathways whose cardiac functions have yet to be deciphered. This data should contribute towards better management of the disease.\", 'FAU': ['Colak, Dilek', 'Alaiya, Ayodele A', 'Kaya, Namik', 'Muiya, Nzioka P', 'AlHarazi, Olfat', 'Shinwari, Zakia', 'Andres, Editha', 'Dzimiri, Nduna'], 'AU': ['Colak D', 'Alaiya AA', 'Kaya N', 'Muiya NP', 'AlHarazi O', 'Shinwari Z', 'Andres E', 'Dzimiri N'], 'AD': ['Biostatistics, Epidemiology and Scientific Computing Department, King Faisal Specialist Hospital and Research Centre, Riyadh, 11211, Saudi Arabia.', 'Proteomics Unit, Stem Cell Tissue Re-Engineering Program, King Faisal Specialist Hospital and Research Centre, Riyadh, 11211, Saudi Arabia.', 'Genetics Department, King Faisal Specialist Hospital and Research Centre, Riyadh, 11211, Saudi Arabia.', 'Genetics Department, King Faisal Specialist Hospital and Research Centre, Riyadh, 11211, Saudi Arabia.', 'Biostatistics, Epidemiology and Scientific Computing Department, King Faisal Specialist Hospital and Research Centre, Riyadh, 11211, Saudi Arabia.', 'Proteomics Unit, Stem Cell Tissue Re-Engineering Program, King Faisal Specialist Hospital and Research Centre, Riyadh, 11211, Saudi Arabia.', 'Genetics Department, King Faisal Specialist Hospital and Research Centre, Riyadh, 11211, Saudi Arabia.', 'Genetics Department, King Faisal Specialist Hospital and Research Centre, Riyadh, 11211, Saudi Arabia.'], 'AUID': ['ORCID: http://orcid.org/0000-0003-3395-5754'], 'LA': ['eng'], 'PT': ['Journal Article'], 'DEP': '20161006', 'PL': 'United States', 'TA': 'PLoS One', 'JT': 'PloS one', 'JID': '101285081', 'SB': 'IM', 'MH': ['Adult', 'Cardiomyopathy, Dilated/*genetics/*metabolism', 'Female', '*Gene Expression Profiling', 'Gene Ontology', 'Gene Regulatory Networks', 'Heart Ventricles/*metabolism', 'Humans', 'Male', '*Proteomics'], 'PMC': 'PMC5053516', 'COIS': ['The authors have declared that no competing interests exist.'], 'EDAT': '2016/10/07 06:00', 'MHDA': '2017/06/21 06:00', 'CRDT': ['2016/10/07 06:00'], 'PHST': ['2016/06/26 00:00 [received]', '2016/08/28 00:00 [accepted]', '2016/10/07 06:00 [entrez]', '2016/10/07 06:00 [pubmed]', '2017/06/21 06:00 [medline]'], 'AID': ['10.1371/journal.pone.0162669 [doi]', 'PONE-D-16-25557 [pii]'], 'PST': 'epublish', 'SO': 'PLoS One. 2016 Oct 6;11(10):e0162669. doi: 10.1371/journal.pone.0162669. eCollection 2016.'}\n",
      "{'PMID': '27624754', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20171019', 'LR': '20180131', 'IS': '1533-0338 (Electronic) 1533-0338 (Linking)', 'VI': '15', 'IP': '5', 'DP': '2016 Oct', 'TI': 'Identification of Differentiation-Related Proteins in Gastric Adenocarcinoma Tissues by Proteomics.', 'PG': '697-706', 'LID': '10.1177/1533034615595792 [doi]', 'AB': 'There is a significant correlation between the degree of tumor differentiation and the survival of patients with gastric cancers. In this report, we compared proteomic differences between poorly differentiated gastric adenocarcinoma tissues and well-differentiated gastric adenocarcinoma tissues in order to identify differentiation-related proteins that may be closely correlated with differentiation of gastric cancer pathogenesis. We identified 7 proteins, of which calreticulin precursor, tapasinERP57 heterodimer, pyruvate kinase isozymes M1/M2 isoform M2, class Pi glutathione S-transferase, and chain A crystal structure of human enolase 1 were upregulated in poorly differentiated gastric adenocarcinoma compared with well-differentiated gastric adenocarcinoma, while myosin-11 isoform SM2A and actin alpha cardiac were downregulated. Two of them, pyruvate kinase isozymes M1/M2 isoform M2 and enolase 1 are enzymes involved in glycolytic pathway. The upregulation of pyruvate kinase isozymes M1/M2 isoform M2 and enolase 1 in poorly differentiated gastric adenocarcinoma was confirmed by Western blotting and immunohistochemistry. Furthermore, we observed 107 cases with gastric adenocarcinoma and found that the high expression of pyruvate kinase isozymes M1/M2 isoform M2 and enolase 1 correlates with tumor size (P = .0001 and P = .0017, respectively), depth of invasion (P = .0024 and P = .0261, respectively), and poor prognosis of patients. In conclusion, with this proteomic analysis, pyruvate kinase isozymes M1/M2 isoform M2 and enolase 1 were identified upregulated in poorly differentiated gastric adenocarcinoma comparing with well-differentiated gastric adenocarcinoma. The expression level of pyruvate kinase isozymes M1/M2 isoform M2 and enolase 1 was significantly correlated with overall survival. Some of them would be differentiation-related cancer biomarkers and are associated with tumor metastasis, invasion, and prognosis.', 'CI': ['(c) The Author(s) 2015.'], 'FAU': ['Zhou, Xin', 'Yao, Kun', 'Zhang, Lang', 'Zhang, Ying', 'Han, Yin', 'Liu, Hui-Ling', 'Liu, Xiang-Wen', 'Su, Gang', 'Yuan, Wen-Zhen', 'Wei, Xiao-Dong', 'Guan, Quan-Lin', 'Zhu, Bing-Dong'], 'AU': ['Zhou X', 'Yao K', 'Zhang L', 'Zhang Y', 'Han Y', 'Liu HL', 'Liu XW', 'Su G', 'Yuan WZ', 'Wei XD', 'Guan QL', 'Zhu BD'], 'AD': ['Department of the First Clinical Medical College of Lanzhou University, Lanzhou, China Department of Oncology, the First Affiliated Hospital, Beilun Branch of Zhejiang University, Ningbo, Zhejiang, China Xin Zhou and Kun Yao contributed equally to this article.', \"Department of the First Clinical Medical College of Lanzhou University, Lanzhou, China Department of Obstetrics and Gynecology, Gansu Provincial People's Hospital, Lanzhou, China Xin Zhou and Kun Yao contributed equally to this article.\", 'Institute of Anatomy, Histology and Embryology, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.', 'Institute of Anatomy, Histology and Embryology, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China.', 'Institute of Pathogenic Biology, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China.', \"Department of Obstetrics and Gynecology, Gansu Provincial People's Hospital, Lanzhou, China.\", 'Institute of Anatomy, Histology and Embryology, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China.', \"Department of Obstetrics and Gynecology, Gansu Provincial People's Hospital, Lanzhou, China Institute of Genetics, School of Basic Medical, Lanzhou University, Lanzhou, China.\", 'Department of Surgical Oncology, the First Affiliated Hospital of Lanzhou University, Lanzhou, China.', \"Department of Obstetrics and Gynecology, Gansu Provincial People's Hospital, Lanzhou, China.\", 'Department of Surgical Oncology, the First Affiliated Hospital of Lanzhou University, Lanzhou, China guanquanlin@163.com.', 'Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA Institute of Pathogenic Biology, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China bdzhu@lzu.edu.cn.'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'PL': 'United States', 'TA': 'Technol Cancer Res Treat', 'JT': 'Technology in cancer research & treatment', 'JID': '101140941', 'RN': ['0 (Biomarkers, Tumor)', '0 (Proteome)'], 'SB': 'IM', 'MH': ['Adenocarcinoma/*metabolism/mortality/*pathology', 'Adult', 'Aged', 'Biomarkers, Tumor', 'Female', 'Humans', 'Immunohistochemistry', 'Male', 'Middle Aged', 'Neoplasm Grading', 'Neoplasm Staging', 'Prognosis', '*Proteome', '*Proteomics', 'Reproducibility of Results', 'Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization', 'Stomach Neoplasms/*metabolism/mortality/*pathology', 'Tandem Mass Spectrometry'], 'OTO': ['NOTNLM'], 'OT': ['*Image-Pro Plus', '*differentiation', '*gastric adenocarcinoma', '*glycolysis', '*immunohistochemistry', '*overall survival', '*proteomics'], 'EDAT': '2016/09/15 06:00', 'MHDA': '2017/10/20 06:00', 'CRDT': ['2016/09/15 06:00'], 'PHST': ['2015/01/05 00:00 [received]', '2015/05/25 00:00 [accepted]', '2016/09/15 06:00 [entrez]', '2016/09/15 06:00 [pubmed]', '2017/10/20 06:00 [medline]'], 'AID': ['15/5/697 [pii]', '10.1177/1533034615595792 [doi]'], 'PST': 'ppublish', 'SO': 'Technol Cancer Res Treat. 2016 Oct;15(5):697-706. doi: 10.1177/1533034615595792.'}\n",
      "{'PMID': '27450324', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20170822', 'LR': '20171105', 'IS': '1522-2683 (Electronic) 0173-0835 (Linking)', 'VI': '37', 'IP': '20', 'DP': '2016 Oct', 'TI': 'Normal human mitral valve proteome: A preliminary investigation by gel-based and gel-free proteomic approaches.', 'PG': '2633-2643', 'LID': '10.1002/elps.201600081 [doi]', 'AB': 'The mitral valve is a highly complex structure which regulates blood flow from the left atrium to the left ventricle (LV) avoiding a significant forward gradient during diastole or regurgitation during systole. The integrity of the mitral valve is also essential for the maintenance of normal LV size, geometry, and function. Significant advances in the comprehension of the biological, functional, and mechanical behavior of the mitral valve have recently been made. However, current knowledge of protein components in the normal human mitral valve is still limited and complicated by the low cellularity of this tissue and the presence of high abundant proteins from the extracellular matrix. We employed here an integrated proteomic approach to analyse the protein composition of the normal human mitral valve and reported confident identification of 422 proteins, some of which have not been previously described in this tissue. In particular, we described the ability of pre-MS separation technique based on liquid-phase IEF and SDS-PAGE to identify the largest number of proteins. We also demonstrated that some of these proteins, e.g. alphaB-Crystallin, septin-11, four-and-a-half LIM domains protein 1, and dermatopontin, are synthesised by interstitial cells isolated from human mitral valves. These initial results provide a valuable basis for future studies aimed at analysing in depth the mitral valve protein composition and at investigating potential pathogenetic molecular mechanisms. Data are available via ProteomeXchange with identifier PXD004397.', 'CI': ['(c) 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.'], 'FAU': ['Brioschi, Maura', 'Baetta, Roberta', 'Ghilardi, Stefania', 'Gianazza, Erica', 'Guarino, Anna', 'Parolari, Alessandro', 'Polvani, Gianluca', 'Tremoli, Elena', 'Banfi, Cristina'], 'AU': ['Brioschi M', 'Baetta R', 'Ghilardi S', 'Gianazza E', 'Guarino A', 'Parolari A', 'Polvani G', 'Tremoli E', 'Banfi C'], 'AD': ['Centro Cardiologico Monzino, IRCCS, Milan, Italy.', 'Centro Cardiologico Monzino, IRCCS, Milan, Italy.', 'Centro Cardiologico Monzino, IRCCS, Milan, Italy.', 'Centro Cardiologico Monzino, IRCCS, Milan, Italy.', 'Centro Cardiologico Monzino, IRCCS, Milan, Italy.', 'Banca Tessuti Cardiovascolari Regione Lombardia, Centro Cardiologico Monzino IRCCS Milan, Milan, Italy.', 'Dipartimento di Chirurgia cardiaca, IRCCS Policlinico San Donato, Milan, Italy.', 'Centro Cardiologico Monzino, IRCCS, Milan, Italy.', 'Universita degli Studi di Milano, Dipartimento di Scienze Cliniche e di Comunita, Sezione Cardiovascolare, Milan, Italy.', 'Centro Cardiologico Monzino, IRCCS, Milan, Italy.', 'Centro Cardiologico Monzino, IRCCS, Milan, Italy. cristina.banfi@ccfm.it.'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20160907', 'PL': 'Germany', 'TA': 'Electrophoresis', 'JT': 'Electrophoresis', 'JID': '8204476', 'RN': ['0 (Proteome)'], 'SB': 'IM', 'MH': ['Adult', 'Electrophoresis, Gel, Two-Dimensional/*methods', 'Female', 'Humans', 'Immunohistochemistry/methods', 'Male', 'Middle Aged', 'Mitral Valve/*chemistry', 'Proteome/*analysis/chemistry', 'Proteomics/*methods'], 'OTO': ['NOTNLM'], 'OT': ['*2-dimensional electrophoresis (2-DE)', '*Human normal mitral valve', '*LC/MSE', '*Liquid-phase IEF', '*Valvular interstitial cells'], 'EDAT': '2016/07/28 06:00', 'MHDA': '2017/08/23 06:00', 'CRDT': ['2016/07/25 06:00'], 'PHST': ['2016/02/25 00:00 [received]', '2016/06/27 00:00 [revised]', '2016/07/14 00:00 [accepted]', '2016/07/28 06:00 [pubmed]', '2017/08/23 06:00 [medline]', '2016/07/25 06:00 [entrez]'], 'AID': ['10.1002/elps.201600081 [doi]'], 'PST': 'ppublish', 'SO': 'Electrophoresis. 2016 Oct;37(20):2633-2643. doi: 10.1002/elps.201600081. Epub 2016 Sep 7.'}\n",
      "{'PMID': '27429122', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20170403', 'LR': '20200228', 'IS': '1802-9973 (Electronic) 0862-8408 (Linking)', 'VI': '65', 'IP': '5', 'DP': '2016 Nov 23', 'TI': 'Identification of novel biomarker candidates for hypertrophic cardiomyopathy and other cardiovascular diseases leading to heart failure.', 'PG': '751-762', 'AB': 'In-depth proteome discovery analysis represents new strategy in an effort to identify novel reliable specific protein markers for hypertrophic cardiomyopathy and other life threatening cardiovascular diseases. To systematically identify novel protein biomarkers of cardiovascular diseases with high mortality we employed an isobaric tag for relative and absolute quantitation (iTRAQ) proteome technology to make comparative analysis of plasma samples obtained from patients suffering from non-obstructive hypertrophic cardiomyopathy, stable dilated cardiomyopathy, aortic valve stenosis, chronic stable coronary artery disease and stable arterial hypertension. We found 128 plasma proteins whose abundances were uniquely regulated among the analyzed cardiovascular pathologies. 49 of them have not been described yet. Additionally, application of statistical exploratory analyses of the measured protein profiles indicated the relationship in pathophysiology of the examined cardiovascular pathologies.', 'FAU': ['Rehulkova, H', 'Rehulka, P', 'Myslivcova Fucikova, A', 'Stulik, J', 'Pudil, R'], 'AU': ['Rehulkova H', 'Rehulka P', 'Myslivcova Fucikova A', 'Stulik J', 'Pudil R'], 'AD': ['Department of Molecular Pathology and Biology, Faculty of Military Health Sciences, University of Defence, Hradec Kralove, Czech Republic. jiri.stulik@unob.cz.'], 'LA': ['eng'], 'PT': ['Journal Article'], 'DEP': '20160715', 'PL': 'Czech Republic', 'TA': 'Physiol Res', 'JT': 'Physiological research', 'JID': '9112413', 'RN': ['0 (Biomarkers)', '0 (Proteome)'], 'SB': 'IM', 'MH': ['Adult', 'Aged', 'Aged, 80 and over', 'Biomarkers/*blood', 'Cardiomyopathy, Hypertrophic/*blood/complications', 'Case-Control Studies', 'Female', 'Heart Failure/*blood/etiology', 'Humans', 'Male', 'Middle Aged', 'Proteome', 'Proteomics/methods'], 'EDAT': '2016/07/19 06:00', 'MHDA': '2017/04/04 06:00', 'CRDT': ['2016/07/19 06:00'], 'PHST': ['2016/07/19 06:00 [pubmed]', '2017/04/04 06:00 [medline]', '2016/07/19 06:00 [entrez]'], 'AID': ['933253 [pii]', '10.33549/physiolres.933253 [doi]'], 'PST': 'ppublish', 'SO': 'Physiol Res. 2016 Nov 23;65(5):751-762. doi: 10.33549/physiolres.933253. Epub 2016 Jul 15.'}\n",
      "{'PMID': '27412778', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20170925', 'LR': '20200401', 'IS': '1435-1803 (Electronic) 0300-8428 (Linking)', 'VI': '111', 'IP': '5', 'DP': '2016 Sep', 'TI': 'Changes of myocardial gene expression and protein composition in patients with dilated cardiomyopathy after immunoadsorption with subsequent immunoglobulin substitution.', 'PG': '53', 'LID': '10.1007/s00395-016-0569-y [doi]', 'AB': 'Immunoadsorption with subsequent immunoglobulin substitution (IA/IgG) represents a therapeutic approach for patients with dilated cardiomyopathy (DCM). Here, we studied which molecular cardiac alterations are initiated after this treatment. Transcription profiling of endomyocardial biopsies with Affymetrix whole genome arrays was performed on 33 paired samples of DCM patients collected before and 6 months after IA/IgG. Therapy-related effects on myocardial protein levels were analysed by label-free proteome profiling for a subset of 23 DCM patients. Data were analysed regarding therapy-associated differences in gene expression and protein levels by comparing responders (defined by improvement of left ventricular ejection fraction >/=20 % relative and >/=5 % absolute) and non-responders. Responders to IA/IgG showed a decrease in serum N-terminal proBNP levels in comparison with baseline which was accompanied by a decreased expression of heart failure markers, such as angiotensin converting enzyme 2 or periostin. However, despite clinical improvement even in responders, IA/IgG did not trigger general inversion of DCM-associated molecular alterations in myocardial tissue. Transcriptome profiling revealed reduced gene expression for connective tissue growth factor, fibronectin, and collagen type I in responders. In contrast, in non-responders after IA/IgG, fibrosis-associated genes and proteins showed elevated levels, whereas values were reduced or maintained in responders. Thus, improvement of LV function after IA/IgG seems to be related to a reduced gene expression of heart failure markers and pro-fibrotic molecules as well as reduced fibrosis progression.', 'FAU': ['Ameling, Sabine', 'Bhardwaj, Gourav', 'Hammer, Elke', 'Beug, Daniel', 'Steil, Leif', 'Reinke, Yvonne', 'Weitmann, Kerstin', 'Grube, Markus', 'Trimpert, Christiane', 'Klingel, Karin', 'Kandolf, Reinhard', 'Hoffmann, Wolfgang', 'Nauck, Matthias', 'Dorr, Marcus', 'Empen, Klaus', 'Felix, Stephan B', 'Volker, Uwe'], 'AU': ['Ameling S', 'Bhardwaj G', 'Hammer E', 'Beug D', 'Steil L', 'Reinke Y', 'Weitmann K', 'Grube M', 'Trimpert C', 'Klingel K', 'Kandolf R', 'Hoffmann W', 'Nauck M', 'Dorr M', 'Empen K', 'Felix SB', 'Volker U'], 'AD': ['Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Friedrich-Ludwig-Jahn-Strasse 15a, 17475, Greifswald, Germany.', 'DZHK (German Centre for Cardiovascular Research), Partner Site Greifswald, Greifswald, Germany.', 'Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Friedrich-Ludwig-Jahn-Strasse 15a, 17475, Greifswald, Germany.', 'DZHK (German Centre for Cardiovascular Research), Partner Site Greifswald, Greifswald, Germany.', 'Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Friedrich-Ludwig-Jahn-Strasse 15a, 17475, Greifswald, Germany.', 'DZHK (German Centre for Cardiovascular Research), Partner Site Greifswald, Greifswald, Germany.', 'Department of Internal Medicine B, University Medicine Greifswald, Ferdinand-Sauerbruch-Strasse, 17475, Greifswald, Germany.', 'Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Friedrich-Ludwig-Jahn-Strasse 15a, 17475, Greifswald, Germany.', 'Department of Internal Medicine B, University Medicine Greifswald, Ferdinand-Sauerbruch-Strasse, 17475, Greifswald, Germany.', 'DZHK (German Centre for Cardiovascular Research), Partner Site Greifswald, Greifswald, Germany.', 'Institute for Community Medicine, University Medicine Greifswald, Ellernholzstr. 1-2, 17487, Greifswald, Germany.', 'DZHK (German Centre for Cardiovascular Research), Partner Site Greifswald, Greifswald, Germany.', 'Department of Pharmacology, Centre of Drug Absorption and Transport (C_DAT), University Medicine Greifswald, Felix-Hausdorff-Str. 3, 17487, Greifswald, Germany.', 'Department of Internal Medicine B, University Medicine Greifswald, Ferdinand-Sauerbruch-Strasse, 17475, Greifswald, Germany.', 'Department of Molecular Pathology, University Hospital Tubingen, Liebermeisterstr. 8, 72076, Tubingen, Germany.', 'Department of Molecular Pathology, University Hospital Tubingen, Liebermeisterstr. 8, 72076, Tubingen, Germany.', 'Institute for Community Medicine, University Medicine Greifswald, Ellernholzstr. 1-2, 17487, Greifswald, Germany.', 'DZHK (German Centre for Cardiovascular Research), Partner Site Greifswald, Greifswald, Germany.', 'Institute of Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, Ferdinand-Sauerbruch-Strasse, 17475, Greifswald, Germany.', 'DZHK (German Centre for Cardiovascular Research), Partner Site Greifswald, Greifswald, Germany.', 'Department of Internal Medicine B, University Medicine Greifswald, Ferdinand-Sauerbruch-Strasse, 17475, Greifswald, Germany.', 'DZHK (German Centre for Cardiovascular Research), Partner Site Greifswald, Greifswald, Germany.', 'Department of Internal Medicine B, University Medicine Greifswald, Ferdinand-Sauerbruch-Strasse, 17475, Greifswald, Germany.', 'Department of Internal Medicine B, University Medicine Greifswald, Ferdinand-Sauerbruch-Strasse, 17475, Greifswald, Germany. felix@uni-greifswald.de.', 'DZHK (German Centre for Cardiovascular Research), Partner Site Greifswald, Greifswald, Germany. felix@uni-greifswald.de.', 'Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Friedrich-Ludwig-Jahn-Strasse 15a, 17475, Greifswald, Germany. voelker@uni-greifswald.de.', 'DZHK (German Centre for Cardiovascular Research), Partner Site Greifswald, Greifswald, Germany. voelker@uni-greifswald.de.'], 'LA': ['eng'], 'PT': ['Clinical Trial', 'Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20160713', 'PL': 'Germany', 'TA': 'Basic Res Cardiol', 'JT': 'Basic research in cardiology', 'JID': '0360342', 'RN': ['0 (Immunoglobulin G)'], 'SB': 'IM', 'EIN': ['Basic Res Cardiol. 2017 Jul;112(4):40. PMID: 28730386'], 'MH': ['Adult', 'Cardiomyopathy, Dilated/*genetics/*pathology/*therapy', 'Female', 'Humans', 'Immunoglobulin G/*therapeutic use', 'Immunosorbent Techniques', 'Male', 'Middle Aged', 'Myocardium/metabolism/pathology', 'Oligonucleotide Array Sequence Analysis', 'Pilot Projects', 'Proteomics', 'Transcriptome'], 'PMC': 'PMC7101709', 'OTO': ['NOTNLM'], 'OT': ['*Cardiomyopathy', '*Fibrosis', '*Proteome', '*Responder', '*Transcriptome'], 'EDAT': '2016/07/15 06:00', 'MHDA': '2017/09/26 06:00', 'CRDT': ['2016/07/15 06:00'], 'PHST': ['2015/12/10 00:00 [received]', '2016/06/16 00:00 [accepted]', '2016/07/15 06:00 [entrez]', '2016/07/15 06:00 [pubmed]', '2017/09/26 06:00 [medline]'], 'AID': ['10.1007/s00395-016-0569-y [doi]', '10.1007/s00395-016-0569-y [pii]'], 'PST': 'ppublish', 'SO': 'Basic Res Cardiol. 2016 Sep;111(5):53. doi: 10.1007/s00395-016-0569-y. Epub 2016 Jul 13.'}\n",
      "{'PMID': '27363418', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20171010', 'LR': '20181113', 'IS': '1615-6692 (Electronic) 0340-9937 (Linking)', 'VI': '42', 'IP': '1', 'DP': '2017 Feb', 'TI': 'Identifying disrupted pathways by tracking altered modules in type 2 DM-related heart failure.', 'PG': '98-106', 'LID': '10.1007/s00059-016-4445-1 [doi]', 'AB': \"BACKGROUND: This study aimed to screen disrupted pathways in type 2 diabetes mellitus (T2DM) heart failure by systematically tracking the altered modules of reweighted protein-protein interaction (PPI) networks. METHODS: We implemented systematic identification and comparison of modules across non-T2DM and T2DM heart failure subjects by integrating gene expression data and PPI networks. The PPI networks of non-T2DM heart failure and T2DM heart failure were constructed and reweighted by means of Spearman's correlation coefficient (SCC). Subsequently, a clique-merging algorithm was used to explore the modules in the PPI network, followed by the identification of disrupted modules based on a maximum-weight bipartite matching and sorting in descending order. Finally, pathway enrichment analyses were conducted for genes in disrupted modules to determine the biological pathways in T2DM heart failure. RESULTS: By comparing the modules of non-T2DM heart failure and T2DM heart failure, 804 disrupted modules were explored. The genes in disrupted modules were significantly enriched in 39 categories (p < 1.00E-06). Of these, the most significant pathways were the focal adhesion, vascular endothelial growth factor (VEGF) signaling, and mitogen-activated protein kinase (MAPK) signaling pathways. CONCLUSION: The identified disrupted pathways - focal adhesion, VEGF signaling, and MAPK signaling - might play important roles in the progression of T2DM heart failure.\", 'FAU': ['Liu, H', 'Han, X', 'Li, Y'], 'AU': ['Liu H', 'Han X', 'Li Y'], 'AD': [\"Department of Cardiology, Binzhou People's Hospital, No. 515 Huanghe Qi Road, 256610, Binzhou, Shandong Province, China. liuhaitaobinzhou@sina.com.\", \"Out-patient Department, Binzhou People's Hospital, 256610, Binzhou, Shandong Province, China.\", \"Department of Orthopedic Surgery, Binzhou People's Hospital, 256610, Binzhou, Shandong Province, China.\"], 'LA': ['eng'], 'PT': ['Journal Article'], 'TT': 'Erkennung gestorter Signalwege durch Nachverfolgung alterierter Module einer Herzinsuffizienz bei Diabetes mellitus Typ 2.', 'DEP': '20160630', 'PL': 'Germany', 'TA': 'Herz', 'JT': 'Herz', 'JID': '7801231', 'RN': ['0 (Proteome)'], 'SB': 'IM', 'MH': ['Accessory Atrioventricular Bundle', 'Diabetes Mellitus, Type 2/complications/*metabolism', 'Female', 'Gene Expression Profiling', 'Heart Failure/etiology/*metabolism', 'Humans', 'Male', 'Middle Aged', 'Protein Interaction Mapping/*methods', '*Protein Interaction Maps', 'Proteome/*metabolism'], 'OTO': ['NOTNLM'], 'OT': ['Diabetes mellitus, type 2', 'Gene expression', 'Heart failure', 'Protein interaction networks', 'Signaling pathways'], 'EDAT': '2016/07/02 06:00', 'MHDA': '2017/10/11 06:00', 'CRDT': ['2016/07/02 06:00'], 'PHST': ['2015/11/18 00:00 [received]', '2016/05/13 00:00 [accepted]', '2016/04/21 00:00 [revised]', '2016/07/02 06:00 [pubmed]', '2017/10/11 06:00 [medline]', '2016/07/02 06:00 [entrez]'], 'AID': ['10.1007/s00059-016-4445-1 [doi]', '10.1007/s00059-016-4445-1 [pii]'], 'PST': 'ppublish', 'SO': 'Herz. 2017 Feb;42(1):98-106. doi: 10.1007/s00059-016-4445-1. Epub 2016 Jun 30.'}\n",
      "{'PMID': '27308822', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20170710', 'LR': '20181113', 'IS': '1932-6203 (Electronic) 1932-6203 (Linking)', 'VI': '11', 'IP': '6', 'DP': '2016', 'TI': 'Urinary Proteomics Pilot Study for Biomarker Discovery and Diagnosis in Heart Failure with Reduced Ejection Fraction.', 'PG': 'e0157167', 'LID': '10.1371/journal.pone.0157167 [doi]', 'AB': 'BACKGROUND: Biomarker discovery and new insights into the pathophysiology of heart failure with reduced ejection fraction (HFrEF) may emerge from recent advances in high-throughput urinary proteomics. This could lead to improved diagnosis, risk stratification and management of HFrEF. METHODS AND RESULTS: Urine samples were analyzed by on-line capillary electrophoresis coupled to electrospray ionization micro time-of-flight mass spectrometry (CE-MS) to generate individual urinary proteome profiles. In an initial biomarker discovery cohort, analysis of urinary proteome profiles from 33 HFrEF patients and 29 age- and sex-matched individuals without HFrEF resulted in identification of 103 peptides that were significantly differentially excreted in HFrEF. These 103 peptides were used to establish the support vector machine-based HFrEF classifier HFrEF103. In a subsequent validation cohort, HFrEF103 very accurately (area under the curve, AUC = 0.972) discriminated between HFrEF patients (N = 94, sensitivity = 93.6%) and control individuals with and without impaired renal function and hypertension (N = 552, specificity = 92.9%). Interestingly, HFrEF103 showed low sensitivity (12.6%) in individuals with diastolic left ventricular dysfunction (N = 176). The HFrEF-related peptide biomarkers mainly included fragments of fibrillar type I and III collagen but also, e.g., of fibrinogen beta and alpha-1-antitrypsin. CONCLUSION: CE-MS based urine proteome analysis served as a sensitive tool to determine a vast array of HFrEF-related urinary peptide biomarkers which might help improving our understanding and diagnosis of heart failure.', 'FAU': ['Rossing, Kasper', 'Bosselmann, Helle Skovmand', 'Gustafsson, Finn', 'Zhang, Zhen-Yu', 'Gu, Yu-Mei', 'Kuznetsova, Tatiana', 'Nkuipou-Kenfack, Esther', 'Mischak, Harald', 'Staessen, Jan A', 'Koeck, Thomas', 'Schou, Morten'], 'AU': ['Rossing K', 'Bosselmann HS', 'Gustafsson F', 'Zhang ZY', 'Gu YM', 'Kuznetsova T', 'Nkuipou-Kenfack E', 'Mischak H', 'Staessen JA', 'Koeck T', 'Schou M'], 'AD': ['Department of Cardiology, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark.', 'Department of Cardio-, Nephro-, and Endocrinology, North Zealand Hospital, University of Copenhagen, Copenhagen, Denmark.', 'Department of Cardiology, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark.', 'Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium.', 'Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium.', 'Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium.', 'Mosaiques Diagnostics and Therapeutics AG, Hanover, Germany.', 'Mosaiques Diagnostics and Therapeutics AG, Hanover, Germany.', 'Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom.', 'Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium.', 'Mosaiques Diagnostics and Therapeutics AG, Hanover, Germany.', 'Institute for Clinical Medicine, Herlev Hospital, Herlev, Denmark.'], 'LA': ['eng'], 'PT': ['Journal Article'], 'DEP': '20160616', 'PL': 'United States', 'TA': 'PLoS One', 'JT': 'PloS one', 'JID': '101285081', 'RN': ['0 (Biomarkers)', '0 (Peptide Fragments)'], 'SB': 'IM', 'MH': ['Adult', 'Aged', 'Biomarkers/*urine', 'Female', 'Heart Failure/genetics/pathology/*urine', 'Humans', 'Male', 'Middle Aged', 'Peptide Fragments/genetics/*urine', '*Proteomics', 'Spectrometry, Mass, Electrospray Ionization', 'Stroke Volume', 'Support Vector Machine'], 'PMC': 'PMC4911082', 'EDAT': '2016/06/17 06:00', 'MHDA': '2017/07/14 06:00', 'CRDT': ['2016/06/17 06:00'], 'PHST': ['2016/01/25 00:00 [received]', '2016/05/25 00:00 [accepted]', '2016/06/17 06:00 [entrez]', '2016/06/17 06:00 [pubmed]', '2017/07/14 06:00 [medline]'], 'AID': ['10.1371/journal.pone.0157167 [doi]', 'PONE-D-16-02237 [pii]'], 'PST': 'epublish', 'SO': 'PLoS One. 2016 Jun 16;11(6):e0157167. doi: 10.1371/journal.pone.0157167. eCollection 2016.'}\n",
      "{'PMID': '27230659', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20170117', 'LR': '20191210', 'IS': '1466-609X (Electronic) 1364-8535 (Linking)', 'VI': '20', 'IP': '1', 'DP': '2016 May 26', 'TI': 'Acute kidney injury prediction in cardiac surgery patients by a urinary peptide pattern: a case-control validation study.', 'PG': '157', 'LID': '10.1186/s13054-016-1344-z [doi]', 'AB': 'BACKGROUND: Acute kidney injury (AKI) is a prominent problem in hospitalized patients and associated with increased morbidity and mortality. Clinical medicine is currently hampered by the lack of accurate and early biomarkers for diagnosis of AKI and the evaluation of the severity of the disease. In 2010, we established a multivariate peptide marker pattern consisting of 20 naturally occurring urinary peptides to screen patients for early signs of renal failure. The current study now aims to evaluate if, in a different study population and potentially various AKI causes, AKI can be detected early and accurately by proteome analysis. METHODS: Urine samples from 60 patients who developed AKI after cardiac surgery were analyzed by capillary electrophoresis-mass spectrometry (CE-MS). The obtained peptide profiles were screened by the AKI peptide marker panel for early signs of AKI. Accuracy of the proteomic model in this patient collective was compared to that based on urinary neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule-1 (KIM-1) ELISA levels. Sixty patients who did not develop AKI served as negative controls. RESULTS: From the 120 patients, 110 were successfully analyzed by CE-MS (59 with AKI, 51 controls). Application of the AKI panel demonstrated an AUC in receiver operating characteristics (ROC) analysis of 0.81 (95 % confidence interval: 0.72-0.88). Compared to the proteomic model, ROC analysis revealed poorer classification accuracy of NGAL and KIM-1 with the respective AUC values being outside the statistical significant range (0.63 for NGAL and 0.57 for KIM-1). CONCLUSIONS: This study gives further proof for the general applicability of our proteomic multimarker model for early and accurate prediction of AKI irrespective of its underlying disease cause.', 'FAU': ['Metzger, Jochen', 'Mullen, William', 'Husi, Holger', 'Stalmach, Angelique', 'Herget-Rosenthal, Stefan', 'Groesdonk, Heiner V', 'Mischak, Harald', 'Klingele, Matthias'], 'AU': ['Metzger J', 'Mullen W', 'Husi H', 'Stalmach A', 'Herget-Rosenthal S', 'Groesdonk HV', 'Mischak H', 'Klingele M'], 'AD': ['Mosaiques Diagnostics GmbH, Hannover, Germany. metzger@mosaiques-diagnostics.com.', 'Institute of Cardiovascular and Medical Sciences, Glasgow, UK.', 'Institute of Cardiovascular and Medical Sciences, Glasgow, UK.', 'Institute of Cardiovascular and Medical Sciences, Glasgow, UK.', 'Department of Medicine and Nephrology, Rotes Kreuz Krankenhaus, Bremen, Germany.', 'Department of Anaesthesiology, Intensive Care and Pain Medicine, Saarland University Medical Centre, Homburg-Saar, Germany.', 'Mosaiques Diagnostics GmbH, Hannover, Germany.', 'Institute of Cardiovascular and Medical Sciences, Glasgow, UK.', 'Department of Internal Medicine, Nephrology and Hypertension, Saarland University Medical Centre, Homburg-Saar, Germany.', 'Department of Internal Medicine, Hochtaunus-Kliniken, Usingen, Germany.'], 'LA': ['eng'], 'GR': ['G1000791/Medical Research Council/United Kingdom'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\", 'Validation Study'], 'DEP': '20160526', 'PL': 'England', 'TA': 'Crit Care', 'JT': 'Critical care (London, England)', 'JID': '9801902', 'RN': ['0 (Biomarkers)', '0 (Peptides)'], 'SB': 'IM', 'MH': ['Acute Kidney Injury/*diagnosis/mortality', 'Adult', 'Aged', 'Biomarkers/urine', 'Cardiac Surgical Procedures/mortality', 'Case-Control Studies', 'Cohort Studies', 'Female', 'Humans', 'Male', 'Middle Aged', 'Peptides/urine', '*Predictive Value of Tests', 'Prospective Studies', 'Proteomics/methods'], 'PMC': 'PMC4882859', 'OTO': ['NOTNLM'], 'OT': ['Acute kidney injury', 'Cardiac surgery', 'Prediction', 'Test validation', 'Urinary peptide pattern'], 'EDAT': '2016/05/28 06:00', 'MHDA': '2017/01/18 06:00', 'CRDT': ['2016/05/28 06:00'], 'PHST': ['2016/02/22 00:00 [received]', '2016/05/12 00:00 [accepted]', '2016/05/28 06:00 [entrez]', '2016/05/28 06:00 [pubmed]', '2017/01/18 06:00 [medline]'], 'AID': ['10.1186/s13054-016-1344-z [doi]', '10.1186/s13054-016-1344-z [pii]'], 'PST': 'epublish', 'SO': 'Crit Care. 2016 May 26;20(1):157. doi: 10.1186/s13054-016-1344-z.'}\n",
      "{'PMID': '27220540', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20171031', 'LR': '20180209', 'IS': '1879-0844 (Electronic) 1388-9842 (Linking)', 'VI': '18', 'IP': '7', 'DP': '2016 Jul', 'TI': 'Urine proteome analysis in heart failure with reduced ejection fraction complicated by chronic kidney disease: feasibility, and clinical and pathogenetic correlates.', 'PG': '822-9', 'LID': '10.1002/ejhf.544 [doi]', 'AB': \"AIMS: Urine proteome analysis (UPA) has already provided accurate discriminatory patterns of urinary peptides for renal disease, coronary artery disease, and asymptomatic LV diastolic dysfunction. UPA has now been used to characterize a discriminatory peptide biomarker pattern and establish a diagnostic classifier for heart failure patients with reduced ejection fraction (HFrEF) in the presence of chronic kidney disease (CKD). METHODS AND RESULTS: We analysed the urine proteome profiles obtained by capillary electrophoresis online coupled to micro-TOF (time of flight) mass spectrometry of 126 individuals, 59 HFrEF patients and 67 controls matched for age, sex, and renal function. In total, 107 significant discriminatory peptides were identified and used to establish a support vector machine-based classifier that was successfully applied to a test set of 25 HFrEF patients and 33 controls, achieving 84% sensitivity and 91% specificity. The majority of sequenced peptides were fragments of collagen type I and III. CONCLUSION: UPA was able to identify a set of HFrEF-specific urinary peptide biomarkers on a background of CKD that were successfully utilized to establish a syndrome's classifier.\", 'CI': ['(c) 2016 The Authors. European Journal of Heart Failure (c) 2016 European Society', 'of Cardiology.'], 'FAU': ['Farmakis, Dimitrios', 'Koeck, Thomas', 'Mullen, William', 'Parissis, John', 'Gogas, Bill D', 'Nikolaou, Maria', 'Lekakis, John', 'Mischak, Harald', 'Filippatos, Gerasimos'], 'AU': ['Farmakis D', 'Koeck T', 'Mullen W', 'Parissis J', 'Gogas BD', 'Nikolaou M', 'Lekakis J', 'Mischak H', 'Filippatos G'], 'AD': ['Heart Failure Unit, Department of Cardiology, Athens University Hospital Attikon, Athens, Greece.', 'Mosaiques Diagnostics and Therapeutics AG, Hanover, Germany.', 'BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.', 'Heart Failure Unit, Department of Cardiology, Athens University Hospital Attikon, Athens, Greece.', 'Heart Failure Unit, Department of Cardiology, Athens University Hospital Attikon, Athens, Greece.', 'Heart Failure Unit, Department of Cardiology, Athens University Hospital Attikon, Athens, Greece.', 'Heart Failure Unit, Department of Cardiology, Athens University Hospital Attikon, Athens, Greece.', 'Mosaiques Diagnostics and Therapeutics AG, Hanover, Germany.', 'Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.', 'Heart Failure Unit, Department of Cardiology, Athens University Hospital Attikon, Athens, Greece.'], 'LA': ['eng'], 'PT': ['Journal Article'], 'DEP': '20160525', 'PL': 'England', 'TA': 'Eur J Heart Fail', 'JT': 'European journal of heart failure', 'JID': '100887595', 'RN': ['0 (Biomarkers)', '0 (Collagen Type I)', '0 (Collagen Type III)', '0 (Peptide Fragments)', '0 (Proteome)'], 'SB': 'IM', 'MH': ['Aged', 'Biomarkers/urine', 'Case-Control Studies', 'Collagen Type I/urine', 'Collagen Type III/urine', 'Electrophoresis, Capillary', 'Feasibility Studies', 'Female', 'Heart Failure/complications/diagnosis/physiopathology/*urine', 'Humans', 'Male', 'Mass Spectrometry', 'Middle Aged', 'Peptide Fragments/urine', 'Proteome/*analysis', '*Proteomics', 'Renal Insufficiency, Chronic/complications/*urine', 'Sensitivity and Specificity', 'Stroke Volume', 'Support Vector Machine'], 'OTO': ['NOTNLM'], 'OT': ['*Biomarkers', '*Heart failure', '*Proteomics', '*Urine'], 'EDAT': '2016/05/26 06:00', 'MHDA': '2017/11/01 06:00', 'CRDT': ['2016/05/26 06:00'], 'PHST': ['2015/11/19 00:00 [received]', '2016/03/12 00:00 [revised]', '2016/03/12 00:00 [accepted]', '2016/05/26 06:00 [entrez]', '2016/05/26 06:00 [pubmed]', '2017/11/01 06:00 [medline]'], 'AID': ['10.1002/ejhf.544 [doi]'], 'PST': 'ppublish', 'SO': 'Eur J Heart Fail. 2016 Jul;18(7):822-9. doi: 10.1002/ejhf.544. Epub 2016 May 25.'}\n",
      "{'PMID': '27122311', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20170724', 'LR': '20180112', 'IS': '1742-2051 (Electronic) 1742-2051 (Linking)', 'VI': '12', 'IP': '7', 'DP': '2016 Jun 21', 'TI': 'Redox proteomic analysis of serum from aortic anerurysm patients: insights on oxidation of specific protein target.', 'PG': '2168-77', 'LID': '10.1039/c6mb00152a [doi]', 'AB': 'OBJECTIVES: oxidative stress is undoubtedly one of the main players in abdominal aortic aneurysm (AAA) pathophysiology. Recent studies in AAA patients reported an increase in the indices of oxidative damage at the tissue level and in biological fluids coupled with the loss of counter-regulatory mechanisms of protection from oxidative stress. We recently reported, in a proteomic analysis of AAA patient sera, changes in the expression of several proteins exerting important modulatory activities on cellular proliferation, differentiation and response to damage. This study aimed to explore the involvement of protein oxidation, at peripheral levels, in AAA. METHODS: a redox proteomic approach was used to investigate total and specific protein carbonylation and protein-bound 4-hydroxy-2-nonenal (HNE) in the serum of AAA patients compared with age-matched controls. RESULTS: our results show increased oxidative damage to protein as indexed by the total carbonyl levels and total protein-bound HNE. By redox proteomics we identified specific carbonylation of three serum proteins: serum retinol-binding protein, vitamin D-binding protein and fibrinogen alpha-chain HNE. We also identified increased protein-bound HNE levels for hemopexin, IgK chain C region and IgK chain V-III region SIE. In addition we found a high correlation between specific protein carbonylation and protein-bound HNE and the aortic diameter. Moreover the analysis of serum proteins with antioxidant activity demonstrates the oxidation of albumin together with the overexpression of transferrin, haptoglobin and HSPs 90, 70, 60 and 32. CONCLUSIONS: this study support the involvement of oxidative stress in the pathogenesis of AAA and might provide a further degree of knowledge in the cause-effect role of oxidative stress shedding new light on the molecular candidates involved in the disease.', 'FAU': ['Spadaccio, Cristiano', 'Coccia, Raffaella', 'Perluigi, Marzia', 'Pupo, Gilda', 'Schinina, Maria Eugenia', 'Giorgi, Alessandra', 'Blarzino, Carla', 'Nappi, Francesco', 'Sutherland, Fraser W', 'Chello, Massimo', 'Di Domenico, Fabio'], 'AU': ['Spadaccio C', 'Coccia R', 'Perluigi M', 'Pupo G', 'Schinina ME', 'Giorgi A', 'Blarzino C', 'Nappi F', 'Sutherland FW', 'Chello M', 'Di Domenico F'], 'AD': ['Department of Cardiothoracic Surgery, West of Scotland Heart and Lung Centre, Golden Jubilee National Hospital, Agamemnon Street Clydebank, Glasgow G81 4DY, UK. Cristiano.spadaccio@gjnh.scot.nhs.uk and Department of Cardiovascular Sciences, University Campus Bio Medico of Rome, Italy.', 'Department of Biochemical Sciences, Sapienza University of Rome, Italy.', 'Department of Biochemical Sciences, Sapienza University of Rome, Italy.', 'Department of Biochemical Sciences, Sapienza University of Rome, Italy.', 'Department of Biochemical Sciences, Sapienza University of Rome, Italy.', 'Department of Biochemical Sciences, Sapienza University of Rome, Italy.', 'Department of Biochemical Sciences, Sapienza University of Rome, Italy.', 'Cardiac Surgery Centre Cardiologique du Nord de Saint-Denis, Paris, France.', 'Department of Cardiothoracic Surgery, West of Scotland Heart and Lung Centre, Golden Jubilee National Hospital, Agamemnon Street Clydebank, Glasgow G81 4DY, UK. Cristiano.spadaccio@gjnh.scot.nhs.uk.', 'Department of Cardiovascular Sciences, University Campus Bio Medico of Rome, Italy.', 'Department of Biochemical Sciences, Sapienza University of Rome, Italy.'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'PL': 'England', 'TA': 'Mol Biosyst', 'JT': 'Molecular bioSystems', 'JID': '101251620', 'RN': ['0 (Antioxidants)', '0 (Biomarkers)', '0 (Blood Proteins)', '0 (Proteome)'], 'SB': 'IM', 'MH': ['Aged', 'Antioxidants/metabolism', 'Aortic Aneurysm/*blood', 'Biomarkers', '*Blood Proteins', 'Case-Control Studies', 'Female', 'Humans', 'Male', '*Oxidation-Reduction', '*Proteome', '*Proteomics/methods', 'Reproducibility of Results', 'Stress, Physiological'], 'EDAT': '2016/04/29 06:00', 'MHDA': '2017/07/25 06:00', 'CRDT': ['2016/04/29 06:00'], 'PHST': ['2016/04/29 06:00 [entrez]', '2016/04/29 06:00 [pubmed]', '2017/07/25 06:00 [medline]'], 'AID': ['10.1039/c6mb00152a [doi]'], 'PST': 'ppublish', 'SO': 'Mol Biosyst. 2016 Jun 21;12(7):2168-77. doi: 10.1039/c6mb00152a.'}\n",
      "{'PMID': '27095521', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20170911', 'LR': '20180426', 'IS': '1862-8354 (Electronic) 1862-8346 (Linking)', 'VI': '10', 'IP': '8', 'DP': '2016 Aug', 'TI': '2D-DIGE-based proteomic analysis of intracoronary versus peripheral arterial blood platelets from acute myocardial infarction patients: Upregulation of platelet activation biomarkers at the culprit site.', 'PG': '851-8', 'LID': '10.1002/prca.201500120 [doi]', 'AB': 'PURPOSE: Platelets play a fundamental role in the atherothrombotic events that lead to an acute myocardial infarction. In the present study we compared the proteome of intracoronary and peripheral arterial platelets from ST-elevation myocardial infarction (STEMI) patients in the search for potential platelet biomarkers/drug targets related to what is happening at the culprit site. EXPERIMENTAL DESIGN: Ten STEMI patients were recruited and blood collected from the occluded coronary artery, at the culprit site, in the moment of reperfusion. Systemic blood obtained from the radial artery of the same patients was used as control. Proteome analysis was based on high-resolution 2D-DIGE and mass spectrometry. Validations were by western blotting in a group of 11 patients. RESULTS: Sixteen differentially regulated protein features were identified, corresponding to 15 ORFs, mostly related to cytoskeletal and signaling proteins. We demonstrate the up-regulation of integrin alphaIIb (ITA2B), the adapter Src kinase-associated phosphoprotein-2 (SKAP2), and thrombospondin-1 isoforms in intracoronary platelets. CONCLUSION AND CLINICAL RELEVANCE: This study constitutes the first analyzing in detail the proteome of arterial intracoronary platelets from STEMI patients. We show variations in the platelet proteome when comparing intracoronary and peripheral platelets. Observed differences might be related to platelet activation events at the culprit site.', 'CI': ['(c) 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.'], 'FAU': ['Velez, Paula', 'Ocaranza-Sanchez, Raymundo', 'Lopez-Otero, Diego', 'Grigorian-Shamagian, Lilian', 'Rosa, Isaac', 'Bravo, Susana Belen', 'Gonzalez-Juanatey, Jose Ramon', 'Garcia, Angel'], 'AU': ['Velez P', 'Ocaranza-Sanchez R', 'Lopez-Otero D', 'Grigorian-Shamagian L', 'Rosa I', 'Bravo SB', 'Gonzalez-Juanatey JR', 'Garcia A'], 'AD': ['Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), Universidade de Santiago de Compostela, Santiago de Compostela, Spain.', 'Instituto de Investigacion Sanitaria de Santiago de Compostela (IDIS), Santiago de Compostela, Spain.', 'Instituto de Investigacion Sanitaria de Santiago de Compostela (IDIS), Santiago de Compostela, Spain.', 'Cardiology Department and Coronary Care Unit, Hospital Clinico Universitario de Santiago, Santiago de Compostela, Spain.', 'Instituto de Investigacion Sanitaria de Santiago de Compostela (IDIS), Santiago de Compostela, Spain.', 'Cardiology Department and Coronary Care Unit, Hospital Clinico Universitario de Santiago, Santiago de Compostela, Spain.', 'Heart Institute, Cedars-Sinai Medical Center, Los Angeles, USA.', 'Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), Universidade de Santiago de Compostela, Santiago de Compostela, Spain.', 'Instituto de Investigacion Sanitaria de Santiago de Compostela (IDIS), Santiago de Compostela, Spain.', 'Proteomic Unit, Instituto de Investigacion Sanitaria de Santiago de Compostela (IDIS), Hospital Clinico Universitario de Santiago, Santiago de Compostela, Spain.', 'Instituto de Investigacion Sanitaria de Santiago de Compostela (IDIS), Santiago de Compostela, Spain.', 'Cardiology Department and Coronary Care Unit, Hospital Clinico Universitario de Santiago, Santiago de Compostela, Spain.', 'Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), Universidade de Santiago de Compostela, Santiago de Compostela, Spain.', 'Instituto de Investigacion Sanitaria de Santiago de Compostela (IDIS), Santiago de Compostela, Spain.'], 'LA': ['eng'], 'PT': ['Comparative Study', 'Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20160523', 'PL': 'Germany', 'TA': 'Proteomics Clin Appl', 'JT': 'Proteomics. Clinical applications', 'JID': '101298608', 'RN': ['0 (Intracellular Signaling Peptides and Proteins)', '0 (Platelet Membrane Glycoprotein IIb)', '0 (TLN1 protein, human)', '0 (Talin)', '0 (Thrombospondin 1)', '0 (src kinase associated phosphoprotein 2)'], 'SB': 'IM', 'MH': ['Acute Disease', 'Aged', 'Artifacts', 'Blood Platelets/*metabolism/physiology', 'Coronary Vessels/*pathology', 'Female', 'Humans', 'Intracellular Signaling Peptides and Proteins/metabolism', 'Male', 'Myocardial Infarction/*blood/metabolism/physiopathology', '*Platelet Activation', 'Platelet Membrane Glycoprotein IIb/metabolism', 'Proteomics/*methods', 'Talin/metabolism', 'Thrombospondin 1/metabolism', '*Two-Dimensional Difference Gel Electrophoresis', '*Up-Regulation'], 'OTO': ['NOTNLM'], 'OT': ['*Acute myocardial infarction', '*Integrin alphaIIb', '*Intracoronary', '*Platelet proteome', '*SKAP-2', '*Thrombospondin-1'], 'EDAT': '2016/04/21 06:00', 'MHDA': '2017/09/12 06:00', 'CRDT': ['2016/04/21 06:00'], 'PHST': ['2015/10/23 00:00 [received]', '2016/04/01 00:00 [revised]', '2016/04/14 00:00 [accepted]', '2016/04/21 06:00 [entrez]', '2016/04/21 06:00 [pubmed]', '2017/09/12 06:00 [medline]'], 'AID': ['10.1002/prca.201500120 [doi]'], 'PST': 'ppublish', 'SO': 'Proteomics Clin Appl. 2016 Aug;10(8):851-8. doi: 10.1002/prca.201500120. Epub 2016 May 23.'}\n",
      "{'PMID': '27084846', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20170515', 'LR': '20200930', 'IS': '1522-1504 (Electronic) 1040-0605 (Linking)', 'VI': '310', 'IP': '11', 'DP': '2016 Jun 1', 'TI': 'Lung tissue proteomics identifies elevated transglutaminase 2 levels in stable chronic obstructive pulmonary disease.', 'PG': 'L1155-65', 'LID': '10.1152/ajplung.00021.2016 [doi]', 'AB': 'Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease characterized by irreversible airflow limitation. Cigarette smoking represents the main risk factor, but the specific mechanisms of COPD are not completely understood. Our aim was to identify COPD-specific proteomic changes involved in disease onset and severity. A comparative proteomic analysis of 51 lung tissues from nonsmokers, smokers, smokers with mild to moderate (stage I-II) COPD, severe to very severe COPD (stage III-IV), and patients with alpha-1-antitrypsin deficiency (AATD) and idiopathic pulmonary fibrosis (IPF) was performed by cysteine-specific two-dimensional difference gel electrophoresis (2D-DIGE) coupled with mass spectrometry. Selected COPD-specific changes were validated by immunoblotting and further by ELISA in 120 induced sputum and plasma samples from nonsmokers, smokers, and patients with COPD (stage I-III). Altogether 82 altered proteins were identified comprising COPD-, AATD-, and IPF-specific, overlapping, and unspecific changes. Cathepsin D (CTSD), dihydropyrimidinase-related protein 2 (DPYSL2), transglutaminase 2 (TGM2), and tripeptidyl-peptidase 1 (TPP1) were validated as COPD-specific. TGM2 was not associated with smoking and correlated with COPD severity in lung tissue. TGM2 levels in sputum and plasma were elevated in patients with COPD (stage II-III) and correlated with lung function. In conclusion, new proteins related to COPD onset and severity could be identified with TGM2 being a novel potential diagnostic and therapeutic target for COPD. Further studies in carefully characterized cohorts are required to validate the identified changes.', 'CI': ['Copyright (c) 2016 the American Physiological Society.'], 'FAU': ['Ohlmeier, Steffen', 'Nieminen, Pentti', 'Gao, Jing', 'Kanerva, Tinja', 'Ronty, Mikko', 'Toljamo, Tuula', 'Bergmann, Ulrich', 'Mazur, Witold', 'Pulkkinen, Ville'], 'AU': ['Ohlmeier S', 'Nieminen P', 'Gao J', 'Kanerva T', 'Ronty M', 'Toljamo T', 'Bergmann U', 'Mazur W', 'Pulkkinen V'], 'AD': ['Proteomics Core Facility, Biocenter Oulu, Faculty of Biochemistry and Molecular Medicine, University of Oulu, Oulu;', 'Medical Informatics and Statistics Group, University of Oulu, Oulu;', 'Heart and Lung Center, Division of Pulmonary Medicine, University of Helsinki and Helsinki University Hospital, Helsinki;', 'Heart and Lung Center, Division of Pulmonary Medicine, University of Helsinki and Helsinki University Hospital, Helsinki;', 'HUSLAB, University of Helsinki and Helsinki University Hospital, Helsinki; and.', 'Department of Pulmonary Medicine, Lapland Central Hospital, Rovaniemi, Finland.', 'Proteomics Core Facility, Biocenter Oulu, Faculty of Biochemistry and Molecular Medicine, University of Oulu, Oulu;', 'Heart and Lung Center, Division of Pulmonary Medicine, University of Helsinki and Helsinki University Hospital, Helsinki;', 'Heart and Lung Center, Division of Pulmonary Medicine, University of Helsinki and Helsinki University Hospital, Helsinki; ville.pulkkinen@helsinki.fi.'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20160415', 'PL': 'United States', 'TA': 'Am J Physiol Lung Cell Mol Physiol', 'JT': 'American journal of physiology. Lung cellular and molecular physiology', 'JID': '100901229', 'RN': ['0 (Proteome)', 'EC 2.3.2.- (transglutaminase 2)', 'EC 2.3.2.13 (Transglutaminases)', 'EC 3.6.1.- (GTP-Binding Proteins)'], 'SB': 'IM', 'MH': ['Aged', 'Case-Control Studies', 'Female', 'GTP-Binding Proteins/*blood', 'Humans', 'Lung/*enzymology/physiopathology', 'Male', 'Middle Aged', 'Proteome/metabolism', 'Proteomics', 'Pulmonary Disease, Chronic Obstructive/*enzymology/pathology/physiopathology', 'Smoking/adverse effects/blood', 'Transglutaminases/*blood'], 'OTO': ['NOTNLM'], 'OT': ['*chronic obstructive pulmonary disease (COPD)', '*difference gel electrophoresis (DIGE)', '*idiopathic pulmonary fibrosis (IPF)', '*lung tissue', '*two-dimensional gel electrophoresis (2-DE)', '*alpha-1-antitrypsin deficiency (AATD)'], 'EDAT': '2016/04/17 06:00', 'MHDA': '2017/05/16 06:00', 'CRDT': ['2016/04/17 06:00'], 'PHST': ['2016/01/13 00:00 [received]', '2016/04/05 00:00 [accepted]', '2016/04/17 06:00 [entrez]', '2016/04/17 06:00 [pubmed]', '2017/05/16 06:00 [medline]'], 'AID': ['ajplung.00021.2016 [pii]', '10.1152/ajplung.00021.2016 [doi]'], 'PST': 'ppublish', 'SO': 'Am J Physiol Lung Cell Mol Physiol. 2016 Jun 1;310(11):L1155-65. doi: 10.1152/ajplung.00021.2016. Epub 2016 Apr 15.'}\n",
      "{'PMID': '26898369', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20170421', 'LR': '20170421', 'IS': '1862-8354 (Electronic) 1862-8346 (Linking)', 'VI': '10', 'IP': '5', 'DP': '2016 May', 'TI': 'Urine proteome analysis as a discovery tool in patients with deep vein thrombosis and pulmonary embolism.', 'PG': '574-84', 'LID': '10.1002/prca.201500105 [doi]', 'AB': 'PURPOSE: Early and accurate detection of deep vein thrombosis (DVT) is an important clinical need. Based on the hypothesis that urinary peptides may hold information on DVT in conjunction with pulmonary embolism (PE), the study was aimed at identifying such peptide biomarkers using capillary electrophoresis coupled mass spectrometry. EXPERIMENTAL DESIGN: Patients with symptoms of unprovoked/idiopathic DVT and/or PE were examined by doppler-sonography or angio-computed tomography. Urinary proteome analysis allowed for identification of respective peptide biomarkers. To confirm their biological relevance, we induced PE in mice and assessed human ex vivo thrombi. RESULTS: We identified 62 urinary peptides as DVT-specific biomarkers, i.e. fragments of collagen type I and a fragment of fibrinogen beta-chain. The presence of fibrinogen alpha/beta in the acute thrombus, and collagen type I and osteopontin in the older, organized thrombus was demonstrated. The classifier DVT62 established through support vector machine (SVM) modeling based on the 62 identified peptides was validated in an independent cohort of 47 subjects (six cases and 41 controls) with a sensitivity of 100% and specificity of 83%. CONCLUSIONS AND CLINICAL RELEVANCE: Urine proteome analysis enabled the detection of DVT-specific peptides, which were validated in human and mouse tissue. Furthermore, it allowed for the establishment of an urinary-proteome based classifier that is relatively specific for DVT. The data provide the basis for assessment of these biomarkers in a prospective clinical study.', 'CI': ['(c) 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.'], 'FAU': ['von Zur Muhlen, Constantin', 'Koeck, Thomas', 'Schiffer, Eric', 'Sackmann, Christine', 'Zurbig, Petra', 'Hilgendorf, Ingo', 'Reinohl, Jochen', 'Rivera, Jennifer', 'Zirlik, Andreas', 'Hehrlein, Christoph', 'Mischak, Harald', 'Bode, Christoph', 'Peter, Karlheinz'], 'AU': ['von Zur Muhlen C', 'Koeck T', 'Schiffer E', 'Sackmann C', 'Zurbig P', 'Hilgendorf I', 'Reinohl J', 'Rivera J', 'Zirlik A', 'Hehrlein C', 'Mischak H', 'Bode C', 'Peter K'], 'AD': ['Department of Cardiology and Angiology I, University Heart Center Freiburg, Freiburg, Germany.', 'Mosaiques Diagnostics GmbH, Hannover, Germany.', 'Mosaiques Diagnostics GmbH, Hannover, Germany.', 'Department of Cardiology and Angiology I, University Heart Center Freiburg, Freiburg, Germany.', 'Mosaiques Diagnostics GmbH, Hannover, Germany.', 'Department of Cardiology and Angiology I, University Heart Center Freiburg, Freiburg, Germany.', 'Department of Cardiology and Angiology I, University Heart Center Freiburg, Freiburg, Germany.', 'Baker IDI Heart and Diabetes Institute, Melbourne, Australia.', 'Department of Cardiology and Angiology I, University Heart Center Freiburg, Freiburg, Germany.', 'Department of Cardiology and Angiology I, University Heart Center Freiburg, Freiburg, Germany.', 'Mosaiques Diagnostics GmbH, Hannover, Germany.', 'BHF Glasgow Cardiovascular Research, University of Glasgow, UK.', 'Department of Cardiology and Angiology I, University Heart Center Freiburg, Freiburg, Germany.', 'Baker IDI Heart and Diabetes Institute, Melbourne, Australia.'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20160404', 'PL': 'Germany', 'TA': 'Proteomics Clin Appl', 'JT': 'Proteomics. Clinical applications', 'JID': '101298608', 'RN': ['0 (BBeta fibrinogen)', '0 (Biomarkers)', '0 (Collagen Type I)', '0 (Proteome)', '0 (SPP1 protein, human)', '106441-73-0 (Osteopontin)', '9001-32-5 (Fibrinogen)'], 'SB': 'IM', 'MH': ['Adult', 'Aged', 'Animals', 'Biomarkers/urine', 'Case-Control Studies', 'Collagen Type I/genetics/*urine', 'Electrophoresis, Capillary', 'Female', 'Fibrinogen/genetics/*urine', 'Gene Expression', 'Humans', 'Male', 'Mass Spectrometry', 'Mice', 'Mice, Inbred C57BL', 'Middle Aged', 'Osteopontin/genetics/*urine', 'Proteome/*metabolism', 'Pulmonary Embolism/complications/*diagnosis/genetics/urine', 'Sensitivity and Specificity', 'Support Vector Machine', 'Urinalysis/instrumentation/methods', 'Venous Thrombosis/complications/*diagnosis/genetics/urine'], 'OTO': ['NOTNLM'], 'OT': ['*Biomarker', '*Discovery Tool', '*Pulmonary Embolism', '*Thrombosis'], 'EDAT': '2016/02/24 06:00', 'MHDA': '2017/04/22 06:00', 'CRDT': ['2016/02/23 06:00'], 'PHST': ['2015/08/24 00:00 [received]', '2015/12/15 00:00 [revised]', '2016/02/08 00:00 [accepted]', '2016/02/23 06:00 [entrez]', '2016/02/24 06:00 [pubmed]', '2017/04/22 06:00 [medline]'], 'AID': ['10.1002/prca.201500105 [doi]'], 'PST': 'ppublish', 'SO': 'Proteomics Clin Appl. 2016 May;10(5):574-84. doi: 10.1002/prca.201500105. Epub 2016 Apr 4.'}\n",
      "{'PMID': '26834087', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20161227', 'LR': '20181113', 'IS': '1615-9861 (Electronic) 1615-9853 (Linking)', 'VI': '16', 'IP': '7', 'DP': '2016 Apr', 'TI': 'Defining the proteome of human iris, ciliary body, retinal pigment epithelium, and choroid.', 'PG': '1146-53', 'LID': '10.1002/pmic.201500188 [doi]', 'AB': 'The iris is a fine structure that controls the amount of light that enters the eye. The ciliary body controls the shape of the lens and produces aqueous humor. The retinal pigment epithelium and choroid (RPE/choroid) are essential in supporting the retina and absorbing light energy that enters the eye. Proteins were extracted from iris, ciliary body, and RPE/choroid tissues of eyes from five individuals and fractionated using SDS-PAGE. After in-gel digestion, peptides were analyzed using LC-MS/MS on an Orbitrap Elite mass spectrometer. In iris, ciliary body, and RPE/choroid, we identified 2959, 2867, and 2755 nonredundant proteins with peptide and protein false-positive rates of <0.1% and <1%, respectively. Forty-three unambiguous protein isoforms were identified in iris, ciliary body, and RPE/choroid. Four \"missing proteins\" were identified in ciliary body based on >/=2 proteotypic peptides. The mass spectrometric proteome database of the human iris, ciliary body, and RPE/choroid may serve as a valuable resource for future investigations of the eye in health and disease. The MS proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository with the dataset identifiers PXD001424 and PXD002194.', 'CI': ['(c) 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.'], 'FAU': ['Zhang, Pingbo', 'Kirby, David', 'Dufresne, Craig', 'Chen, Yan', 'Turner, Randi', 'Ferri, Sara', 'Edward, Deepak P', 'Van Eyk, Jennifer E', 'Semba, Richard D'], 'AU': ['Zhang P', 'Kirby D', 'Dufresne C', 'Chen Y', 'Turner R', 'Ferri S', 'Edward DP', 'Van Eyk JE', 'Semba RD'], 'AD': ['Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.', 'Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.', 'Thermo Fisher Scientific, West Palm Beach, FL, USA.', 'Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.', 'Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.', 'Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.', 'Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.', 'King Khaled Eye Specialist Hospital, Riyadh, Kingdom of Saudi Arabia.', 'Advanced Clinical Biosystems Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.', 'Department of Medicine, The Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.', 'Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.'], 'LA': ['eng'], 'GR': ['R01 AG027012/AG/NIA NIH HHS/United States', 'R01 EY024596/EY/NEI NIH HHS/United States', 'R01 HL111271/HL/NHLBI NIH HHS/United States'], 'PT': ['Journal Article', 'Research Support, N.I.H., Extramural', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20160311', 'PL': 'Germany', 'TA': 'Proteomics', 'JT': 'Proteomics', 'JID': '101092707', 'RN': ['0 (Eye Proteins)', '0 (Proteome)'], 'SB': 'IM', 'CIN': ['Proteomics. 2017 Jan;17(1-2):. PMID: 27860232'], 'MH': ['Aged', 'Electrophoresis, Gel, Two-Dimensional', 'Eye Proteins/*analysis/chemistry', 'Female', 'Humans', 'Male', 'Middle Aged', 'Proteome/*analysis/chemistry', 'Proteomics', 'Retinal Pigment Epithelium/*chemistry', 'Uvea/*chemistry'], 'PMC': 'PMC4833206', 'MID': ['NIHMS760467'], 'OTO': ['NOTNLM'], 'OT': ['Biomedicine', 'Choroid', 'Ciliary body', 'Eye', 'Iris', 'Retinal pigment epithelium'], 'EDAT': '2016/02/03 06:00', 'MHDA': '2016/12/28 06:00', 'CRDT': ['2016/02/03 06:00'], 'PHST': ['2015/05/19 00:00 [received]', '2015/11/19 00:00 [revised]', '2016/01/25 00:00 [accepted]', '2016/02/03 06:00 [entrez]', '2016/02/03 06:00 [pubmed]', '2016/12/28 06:00 [medline]'], 'AID': ['10.1002/pmic.201500188 [doi]'], 'PST': 'ppublish', 'SO': 'Proteomics. 2016 Apr;16(7):1146-53. doi: 10.1002/pmic.201500188. Epub 2016 Mar 11.'}\n",
      "{'PMID': '26792056', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20161010', 'LR': '20181113', 'IS': '1479-5876 (Electronic) 1479-5876 (Linking)', 'VI': '14', 'DP': '2016 Jan 20', 'TI': 'Combining patient proteomics and in vitro cardiomyocyte phenotype testing to identify potential mediators of heart failure with preserved ejection fraction.', 'PG': '18', 'LID': '10.1186/s12967-016-0774-3 [doi]', 'AB': 'BACKGROUND: Heart failure with ejection fraction (HFpEF) is a syndrome resulting from several co-morbidities in which specific mediators are unknown. The platelet proteome responds to disease processes. We hypothesize that the platelet proteome will change composition in patients with HFpEF and may uncover mediators of the syndrome. METHODS AND RESULTS: Proteomic changes were assessed in platelets from hospitalized subjects with symptoms of HFpEF (n = 9), the same subjects several weeks later without symptoms (n = 7) and control subjects (n = 8). Mass spectrometry identified 6102 proteins with five scans with peptide probabilities of >/=0.85. Of the 6102 proteins, 165 were present only in symptomatic subjects, 78 were only found in outpatient subjects and 157 proteins were unique to the control group. The S100A8 protein was identified consistently in HFpEF samples when compared with controls. We validated the fining that plasma S100A8 levels are increased in subjects with HFpEF (654 +/- 391) compared to controls (352 +/- 204) in an external cohort (p = 0.002). Recombinant S100A8 had direct effects on the electrophysiological and calcium handling profile in human induced pluripotent stem cell-derived cardiomyocytes. CONCLUSIONS: Platelets may harbor proteins associated with HFpEF. S100A8 is present in the platelets of subjects with HFpEF and increased in the plasma of the same subjects. We further established a bedside-to-bench translational system that can be utilized as a secondary screen to ascertain whether the biomarkers may be an associated finding or causal to the disease process. S100A8 has been linked with other cardiovascular disease such as atherosclerosis and risk for myocardial infarction, stroke, or death. This is the first report on association of S100A8 with HFpEF.', 'FAU': ['Raphael, Roseanne', 'Purushotham, Diana', 'Gastonguay, Courtney', 'Chesnik, Marla A', 'Kwok, Wai-Meng', 'Wu, Hsiang-En', 'Shah, Sanjiv J', 'Mirza, Shama P', 'Strande, Jennifer L'], 'AU': ['Raphael R', 'Purushotham D', 'Gastonguay C', 'Chesnik MA', 'Kwok WM', 'Wu HE', 'Shah SJ', 'Mirza SP', 'Strande JL'], 'AD': ['Cardiovascular Center, Medical College of Wisconsin, Milwaukee, WI, USA. rraphael@mcw.edu.', 'Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA. Purushotham.diana@mayo.edu.', 'Cardiovascular Center, Medical College of Wisconsin, Milwaukee, WI, USA. vandusen.courtney@gmail.com.', 'Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA. vandusen.courtney@gmail.com.', 'Division of Cardiovascular Medicine, Medical College of Wisconsin, Milwaukee, WI, USA. vandusen.courtney@gmail.com.', 'Biotechnology and Bioengineering, Medical College of Wisconsin, Milwaukee, WI, USA. mchesnik@mcw.edu.', 'Department of Anesthesiology, Medical College of Wisconsin, Milwaukee, WI, USA. wmkwok@mcw.edu.', 'Department of Anesthesiology, Medical College of Wisconsin, Milwaukee, WI, USA. hsiang4070@gmail.com.', 'Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. sanjiv.shah@northwestern.edu.', 'Biotechnology and Bioengineering, Medical College of Wisconsin, Milwaukee, WI, USA. smirza@mcw.edu.', 'Cardiovascular Center, Medical College of Wisconsin, Milwaukee, WI, USA. jstrande@mcw.edu.', 'Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA. jstrande@mcw.edu.', 'Division of Cardiovascular Medicine, Medical College of Wisconsin, Milwaukee, WI, USA. jstrande@mcw.edu.', ', MEB/CVC 4579, 8701 Watertown Plank Road, Milwaukee, WI, 53226, USA. jstrande@mcw.edu.'], 'LA': ['eng'], 'GR': ['1UL1RR031973/RR/NCRR NIH HHS/United States', 'T35 HL072483/HL/NHLBI NIH HHS/United States', 'R01 HL107577/HL/NHLBI NIH HHS/United States', 'UL1 RR031973/RR/NCRR NIH HHS/United States', 'K08 HL111148/HL/NHLBI NIH HHS/United States'], 'PT': ['Journal Article', 'Research Support, N.I.H., Extramural', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20160120', 'PL': 'England', 'TA': 'J Transl Med', 'JT': 'Journal of translational medicine', 'JID': '101190741', 'RN': ['0 (Calgranulin A)', '0 (Peptides)', '0 (Proteome)', '0 (Recombinant Proteins)'], 'SB': 'IM', 'MH': ['Aged', 'Amino Acid Sequence', 'Calgranulin A/blood', 'Case-Control Studies', 'Enzyme-Linked Immunosorbent Assay', 'Female', 'Heart Failure/diagnostic imaging/*metabolism/pathology/*physiopathology', 'Humans', 'Induced Pluripotent Stem Cells/cytology/drug effects', 'Male', 'Middle Aged', 'Molecular Sequence Data', 'Myocytes, Cardiac/drug effects/*metabolism/*pathology', 'Peptides/chemistry', 'Phenotype', 'Proteome/metabolism', 'Proteomics/*methods', 'Recombinant Proteins/pharmacology', 'Reproducibility of Results', '*Stroke Volume/drug effects', 'Tandem Mass Spectrometry', 'Ultrasonography'], 'PMC': 'PMC4719542', 'EDAT': '2016/01/23 06:00', 'MHDA': '2016/10/11 06:00', 'CRDT': ['2016/01/22 06:00'], 'PHST': ['2015/09/02 00:00 [received]', '2016/01/06 00:00 [accepted]', '2016/01/22 06:00 [entrez]', '2016/01/23 06:00 [pubmed]', '2016/10/11 06:00 [medline]'], 'AID': ['10.1186/s12967-016-0774-3 [doi]', '10.1186/s12967-016-0774-3 [pii]'], 'PST': 'epublish', 'SO': 'J Transl Med. 2016 Jan 20;14:18. doi: 10.1186/s12967-016-0774-3.'}\n",
      "{'PMID': '26750556', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20161226', 'LR': '20181113', 'IS': '2045-2322 (Electronic) 2045-2322 (Linking)', 'VI': '6', 'DP': '2016 Jan 11', 'TI': 'Comprehensive maternal serum proteomics identifies the cytoskeletal proteins as non-invasive biomarkers in prenatal diagnosis of congenital heart defects.', 'PG': '19248', 'LID': '10.1038/srep19248 [doi]', 'AB': 'Congenital heart defects (CHDs) are the most common group of major birth defects. Presently there are no clinically used biomarkers for prenatally detecting CHDs. Here, we performed a comprehensive maternal serum proteomics assessment, combined with immunoassays, for the discovery of non-invasive biomarkers for prenatal diagnosis of CHDs. A total of 370 women were included in this study. An isobaric tagging for relative and absolute quantification (iTRAQ) proteomic approach was used first to compare protein profiles in pooled serum collected from women who had CHD-possessing or normal fetuses, and 47 proteins displayed significant differential expressions. Targeted verifications were performed on 11 proteins using multiple reaction monitoring mass spectrometry (MRM-MS), and the resultant candidate biomarkers were then further validated using ELISA analysis. Finally, we identified a biomarker panel composed of 4 cytoskeletal proteins capable of differentiating CHD-pregnancies from normal ones [with an area under the receiver operating characteristic curve (AUC) of 0.938, P < 0.0001]. The discovery of cytoskeletal protein changes in maternal serum not only could help us in prenatal diagnosis of CHDs, but also may shed new light on CHD embryogenesis studies.', 'FAU': ['Chen, Lizhu', 'Gu, Hui', 'Li, Jun', 'Yang, Ze-Yu', 'Sun, Xiao', 'Zhang, Li', 'Shan, Liping', 'Wu, Lina', 'Wei, Xiaowei', 'Zhao, Yili', 'Ma, Wei', 'Zhang, Henan', 'Cao, Songying', 'Huang, Tianchu', 'Miao, Jianing', 'Yuan, Zhengwei'], 'AU': ['Chen L', 'Gu H', 'Li J', 'Yang ZY', 'Sun X', 'Zhang L', 'Shan L', 'Wu L', 'Wei X', 'Zhao Y', 'Ma W', 'Zhang H', 'Cao S', 'Huang T', 'Miao J', 'Yuan Z'], 'AD': ['Key Laboratory of Health Ministry for Congenital Malformation, Shengjing Hospital, China Medical University, Shenyang 110004, China.', 'Department of Ultrasound, Shengjing Hospital, China Medical University, Shenyang, China.', 'Key Laboratory of Health Ministry for Congenital Malformation, Shengjing Hospital, China Medical University, Shenyang 110004, China.', 'Department of gynaecology and obstetrics, Shengjing Hospital, China Medical University, Shenyang, China.', 'Department of Ultrasound, Shengjing Hospital, China Medical University, Shenyang, China.', \"Department of gynaecology and obstetrics, Shenyang women's and children's Hospital, Shenyang, China.\", 'Department of genetics, Shenyang Women and Children Health Care Centre, Shenyang, China.', 'Department of Urologic Surgery, Shengjing Hospital, China Medical University, Shenyang, China.', 'Department of Laboratory Medicine, Shengjing Hospital, China Medical University, Shenyang, China.', 'Key Laboratory of Health Ministry for Congenital Malformation, Shengjing Hospital, China Medical University, Shenyang 110004, China.', 'Department of Obstetrics and Gynecology, Eastern Virginia Medical School, Norfolk 23507, USA.', 'Key Laboratory of Health Ministry for Congenital Malformation, Shengjing Hospital, China Medical University, Shenyang 110004, China.', 'Key Laboratory of Health Ministry for Congenital Malformation, Shengjing Hospital, China Medical University, Shenyang 110004, China.', 'Key Laboratory of Health Ministry for Congenital Malformation, Shengjing Hospital, China Medical University, Shenyang 110004, China.', 'Key Laboratory of Health Ministry for Congenital Malformation, Shengjing Hospital, China Medical University, Shenyang 110004, China.', 'Key Laboratory of Health Ministry for Congenital Malformation, Shengjing Hospital, China Medical University, Shenyang 110004, China.', 'Key Laboratory of Health Ministry for Congenital Malformation, Shengjing Hospital, China Medical University, Shenyang 110004, China.'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20160111', 'PL': 'England', 'TA': 'Sci Rep', 'JT': 'Scientific reports', 'JID': '101563288', 'RN': ['0 (Biomarkers)', '0 (Cytoskeletal Proteins)', '0 (LMNA protein, human)', '0 (Lamin Type A)', '0 (Proteome)'], 'SB': 'IM', 'MH': ['Adult', 'Biomarkers', 'Case-Control Studies', 'Chromatography, Liquid', 'Cytoskeletal Proteins/*blood', 'Enzyme-Linked Immunosorbent Assay', 'Female', 'Gas Chromatography-Mass Spectrometry', 'Heart Defects, Congenital/*diagnosis', 'Humans', 'Lamin Type A/blood/metabolism', 'Pregnancy', 'Prenatal Diagnosis', '*Proteome', '*Proteomics/methods', 'ROC Curve', 'Reproducibility of Results', 'Spectrometry, Mass, Electrospray Ionization', 'Young Adult'], 'PMC': 'PMC4707500', 'EDAT': '2016/01/12 06:00', 'MHDA': '2016/12/27 06:00', 'CRDT': ['2016/01/12 06:00'], 'PHST': ['2015/08/27 00:00 [received]', '2015/12/09 00:00 [accepted]', '2016/01/12 06:00 [entrez]', '2016/01/12 06:00 [pubmed]', '2016/12/27 06:00 [medline]'], 'AID': ['srep19248 [pii]', '10.1038/srep19248 [doi]'], 'PST': 'epublish', 'SO': 'Sci Rep. 2016 Jan 11;6:19248. doi: 10.1038/srep19248.'}\n",
      "{'PMID': '26688386', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20161017', 'LR': '20161230', 'IS': '1873-3492 (Electronic) 0009-8981 (Linking)', 'VI': '453', 'DP': '2016 Jan 30', 'TI': 'Proteome profiles of HDL particles of patients with chronic heart failure are associated with immune response and also include bacteria proteins.', 'PG': '114-22', 'LID': '10.1016/j.cca.2015.12.005 [doi] S0009-8981(15)30074-7 [pii]', 'AB': 'Besides modulation of reverse cholesterol transport, high density lipoprotein (HDL) is able to modulate vascular function by stimulating endothelial nitric oxide synthase. Recently, it could be documented that this function of HDL was significantly impaired in patients with chronic heart failure (CHF). We investigated alterations in the HDL proteome in CHF patients. Therefore, HDL was isolated from 5 controls (HDLhealthy) and 5 CHF patients of NYHA-class IIIb (HDLCHF). Proteome analysis of HDL particles was performed by two-dimensional liquid chromatography-mass spectrometry (SCX/RP LC-MS/MS). In total, we identified 494 distinct proteins, of which 107 proteins were commonly found in both groups (HDLCHF and HDLhealthy) indicating a high inter-subject variability across HDL particles. Several important proteins (e.g. ITGA2, APBA1 or A2M) varied in level. Functional analysis revealed regulated pathways. A minor proportion of bacteria-derived proteins were also identified in the HDL-particles. The extension of the list of HDL-associated proteins allows besides their mere description new insights into alterations in HDL function in diseases. In addition, the detection of bacterial proteins bound to HDL will broaden our view of HDL not only as a cholesterol carrier but also as a carrier of proteins.', 'CI': ['Copyright (c) 2015 Elsevier B.V. All rights reserved.'], 'FAU': ['Oberbach, Andreas', 'Adams, Volker', 'Schlichting, Nadine', 'Heinrich, Marco', 'Kullnick, Yvonne', 'Lehmann, Stefanie', 'Lehmann, Sven', 'Feder, Stefan', 'Correia, Joao Carlos', 'Mohr, Friedrich-Wilhelm', 'Volker, Uwe', 'Jehmlich, Nico'], 'AU': ['Oberbach A', 'Adams V', 'Schlichting N', 'Heinrich M', 'Kullnick Y', 'Lehmann S', 'Lehmann S', 'Feder S', 'Correia JC', 'Mohr FW', 'Volker U', 'Jehmlich N'], 'AD': ['Department of Cardiac Surgery, University of Leipzig, Heart Center Leipzig, Germany; Division of Diagnostics, Experimental Surgery/CardiOMICs, Fraunhofer-Institute for Cell Therapy and Immunology IZI, Leipzig, Germany.', 'Department of Cardiology, University of Leipzig, Heart Center Leipzig, Germany.', 'Department of Cardiac Surgery, University of Leipzig, Heart Center Leipzig, Germany; Department of Pediatric Surgery, University of Leipzig, Germany.', 'Department of Cardiac Surgery, University of Leipzig, Heart Center Leipzig, Germany.', 'Department of Cardiac Surgery, University of Leipzig, Heart Center Leipzig, Germany.', 'Department of Cardiac Surgery, University of Leipzig, Heart Center Leipzig, Germany.', 'Department of Cardiac Surgery, University of Leipzig, Heart Center Leipzig, Germany.', 'Department of Cardiac Surgery, University of Leipzig, Heart Center Leipzig, Germany.', 'Department of Cardiac Surgery, University of Leipzig, Heart Center Leipzig, Germany.', 'Department of Cardiac Surgery, University of Leipzig, Heart Center Leipzig, Germany.', 'Department of Functional Genomics, Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Germany; DZHK (German Center for Cardiovascular Research) Partner Site Greifswald, Germany.', 'Department of Functional Genomics, Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Germany. Electronic address: nico.jehmlich@ufz.de.'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20151211', 'PL': 'Netherlands', 'TA': 'Clin Chim Acta', 'JT': 'Clinica chimica acta; international journal of clinical chemistry', 'JID': '1302422', 'RN': ['0 (Bacterial Proteins)', '0 (Lipoproteins, HDL)'], 'SB': 'IM', 'MH': ['Bacterial Proteins/*metabolism', 'Case-Control Studies', 'Chronic Disease', 'Female', 'Heart Failure/*immunology/*metabolism/microbiology', 'Humans', 'Lipoproteins, HDL/*metabolism', 'Male', 'Middle Aged', 'Proteolysis', '*Proteomics'], 'OTO': ['NOTNLM'], 'OT': ['(Meta)proteomics', 'HDL functionality', 'HDL variability', 'High density lipoprotein (HDL)'], 'EDAT': '2015/12/22 06:00', 'MHDA': '2016/10/19 06:00', 'CRDT': ['2015/12/22 06:00'], 'PHST': ['2015/07/29 00:00 [received]', '2015/12/02 00:00 [revised]', '2015/12/04 00:00 [accepted]', '2015/12/22 06:00 [entrez]', '2015/12/22 06:00 [pubmed]', '2016/10/19 06:00 [medline]'], 'AID': ['S0009-8981(15)30074-7 [pii]', '10.1016/j.cca.2015.12.005 [doi]'], 'PST': 'ppublish', 'SO': 'Clin Chim Acta. 2016 Jan 30;453:114-22. doi: 10.1016/j.cca.2015.12.005. Epub 2015 Dec 11.'}\n",
      "{'PMID': '26653129', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20161114', 'LR': '20161230', 'IS': '1535-3907 (Electronic) 1535-3893 (Linking)', 'VI': '15', 'IP': '2', 'DP': '2016 Feb 5', 'TI': 'Diagnostic and Prognostic Metabolites Identified for Joint Symptoms in the KORA Population.', 'PG': '554-62', 'LID': '10.1021/acs.jproteome.5b00951 [doi]', 'AB': 'This study aims at identifying metabolites that significantly associate with self-reported joint symptoms (diagnostic) and metabolites that can predict the change from a symptom-free status to the development of self-reported joint symptoms after a 7 years period (prognostic). More than 300 metabolites were analyzed for 2246 subjects from the longitudinal study of the KORA (Cooperative Health Research in the Region of Augsburg, Germany), specifically the fourth survey S4 and its 7-year follow-up study F4. Two types of self-reported symptoms, chronic joint inflammation and worn out joints, were used for the analyses. Diagnostic analysis identified dysregulated metabolites in cases with symptoms compared with controls. Prognostic analysis identified metabolites that differentiate subjects in S4 who remained symptom-free after 7 years (F4) from those who developed any combination of symptoms. 48 metabolites were identified as nominally significantly (p < 0.05) associated with the self-reported symptoms in the diagnostic analysis, among which steroids show Bonferroni significance. 45 metabolites were identified as nominally significantly associated with developing symptoms after 7 years, among which hippurate showed Bonferroni significance. We show that metabolic profiles of self-reported joint symptoms are in line with metabolites known to associate with various forms of arthritis and suggest that future studies may benefit from that by investigating the possible use of self-reporting/questionnaire along with metabolic markers for the early referral of patients for further diagnostic workup and treatment of arthritis.', 'FAU': ['Yousri, Noha A', 'Kastenmuller, Gabi', 'AlHaq, Wessam G', 'Holle, Rolf', 'Kaab, Stefan', 'Mohney, Robert P', 'Gieger, Christian', 'Peters, Annette', 'Adamski, Jerzy', 'Suhre, Karsten', 'Arayssi, Thurayya'], 'AU': ['Yousri NA', 'Kastenmuller G', 'AlHaq WG', 'Holle R', 'Kaab S', 'Mohney RP', 'Gieger C', 'Peters A', 'Adamski J', 'Suhre K', 'Arayssi T'], 'AD': ['Department of Physiology and Biophysics, Weill Cornell Medical College - Qatar , Doha 24144, Qatar.', 'Department of Computer and Systems Engineering, Alexandria University , Alexandria 21526, Egypt.', 'Institute of Bioinformatics and Systems Biology, Helmholtz Zentrum Munchen, German Research Center for Environment Health , 85764 Neuherberg, Germany.', 'German Center for Diabetes Research (DZD) , 85764 Neuherberg, Germany.', 'Department of Medicine, Weill Cornell Medical College - Qatar , Doha 24144, Qatar.', 'Institute of Health Economics and Health Care Management Helmholtz Zentrum , Munich, Germany.', 'Department of Medicine, University Hospital Munich , Campus Grosshadern, 80539 Munich, Germany.', 'Innenstadt, Ludwig-Maximilians University & German Center for Cardiovascular Research (DZHK) , , Munich Heart Alliance, 80337 Munich, Germany.', 'Metabolon, Inc. , Durham, North Carolina 27713, United States.', 'Institute of Genetic Epidemiology, Helmholtz Zentrum Munchen - German Research Center for Environmental Health , Ingolstadter Landstrasse 1, 85764 Neuherberg, Germany.', 'German Center for Diabetes Research (DZD) , 85764 Neuherberg, Germany.', 'Institute of Epidemiology II, Helmholtz Zentrum Munchen, German Research Center for Environmental Health , Ingolstadter Landstrasse 1, 85764 Neuherberg, Germany.', 'German Center for Diabetes Research (DZD) , 85764 Neuherberg, Germany.', 'Institute of Experimental Genetics, Genome Analysis Center, Helmholtz Zentrum Munchen, German Research Center for Environmental Health, Ingolstadter Landstrasse 1, 85764 Neuherberg, Germany.', 'Lehrstuhl fur Experimentelle Genetik, Technische Universitat Munchen , 85354 Freising-Weihenstephan, Germany.', 'Department of Physiology and Biophysics, Weill Cornell Medical College - Qatar , Doha 24144, Qatar.', 'Institute of Bioinformatics and Systems Biology, Helmholtz Zentrum Munchen, German Research Center for Environment Health , 85764 Neuherberg, Germany.', 'Department of Medicine, Weill Cornell Medical College - Qatar , Doha 24144, Qatar.'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20160107', 'PL': 'United States', 'TA': 'J Proteome Res', 'JT': 'Journal of proteome research', 'JID': '101128775', 'RN': ['0 (Biomarkers)'], 'SB': 'IM', 'MH': ['Aged', 'Biomarkers/metabolism', 'Chromatography, High Pressure Liquid', 'Female', 'Follow-Up Studies', 'Gas Chromatography-Mass Spectrometry', 'Germany/epidemiology', 'Humans', 'Joint Diseases/*diagnosis/epidemiology/*metabolism', 'Male', '*Metabolome', 'Metabolomics/*methods', 'Middle Aged', 'Prognosis', 'Regression Analysis', 'Surveys and Questionnaires', 'Tandem Mass Spectrometry', 'Time Factors'], 'OTO': ['NOTNLM'], 'OT': ['arthritis', 'diagnosis', 'joint inflammation', 'metabolomics', 'prognosis', 'rheumatoid arthritis'], 'EDAT': '2015/12/15 06:00', 'MHDA': '2016/11/15 06:00', 'CRDT': ['2015/12/15 06:00'], 'PHST': ['2015/12/15 06:00 [entrez]', '2015/12/15 06:00 [pubmed]', '2016/11/15 06:00 [medline]'], 'AID': ['10.1021/acs.jproteome.5b00951 [doi]'], 'PST': 'ppublish', 'SO': 'J Proteome Res. 2016 Feb 5;15(2):554-62. doi: 10.1021/acs.jproteome.5b00951. Epub 2016 Jan 7.'}\n",
      "{'PMID': '26620461', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20160923', 'LR': '20181113', 'IS': '2045-2322 (Electronic) 2045-2322 (Linking)', 'VI': '5', 'DP': '2015 Dec 1', 'TI': 'iTRAQ proteomic analysis of extracellular matrix remodeling in aortic valve disease.', 'PG': '17290', 'LID': '10.1038/srep17290 [doi]', 'AB': 'Degenerative aortic stenosis (AS) is the most common worldwide cause of valve replacement. The aortic valve is a thin, complex, layered connective tissue with compartmentalized extracellular matrix (ECM) produced by specialized cell types, which directs blood flow in one direction through the heart. There is evidence suggesting remodeling of such ECM during aortic stenosis development. Thus, a better characterization of the role of ECM proteins in this disease would increase our understanding of the underlying molecular mechanisms. Aortic valve samples were collected from 18 patients which underwent aortic valve replacement (50% males, mean age of 74 years) and 18 normal control valves were obtained from necropsies (40% males, mean age of 69 years). The proteome of the samples was analyzed by 2D-LC MS/MS iTRAQ methodology. The results showed an altered expression of 13 ECM proteins of which 3 (biglycan, periostin, prolargin) were validated by Western blotting and/or SRM analyses. These findings are substantiated by our previous results demonstrating differential ECM protein expression. The present study has demonstrated a differential ECM protein pattern in individuals with AS, therefore supporting previous evidence of a dynamic ECM remodeling in human aortic valves during AS development.', 'FAU': ['Martin-Rojas, Tatiana', 'Mourino-Alvarez, Laura', 'Alonso-Orgaz, Sergio', 'Rosello-Lleti, Esther', 'Calvo, Enrique', 'Lopez-Almodovar, Luis Fernando', 'Rivera, Miguel', 'Padial, Luis R', 'Lopez, Juan Antonio', 'de la Cuesta, Fernando', 'Barderas, Maria G'], 'AU': ['Martin-Rojas T', 'Mourino-Alvarez L', 'Alonso-Orgaz S', 'Rosello-Lleti E', 'Calvo E', 'Lopez-Almodovar LF', 'Rivera M', 'Padial LR', 'Lopez JA', 'de la Cuesta F', 'Barderas MG'], 'AD': ['Department of Vascular Physiopathology, Hospital Nacional de Paraplejicos, SESCAM, Toledo, Spain.', 'Department of Vascular Physiopathology, Hospital Nacional de Paraplejicos, SESCAM, Toledo, Spain.', 'Department of Vascular Physiopathology, Hospital Nacional de Paraplejicos, SESCAM, Toledo, Spain.', 'Cardiocirculatory Unit, Health Research Institute, Hospital La Fe, Valencia, Spain.', 'Proteomics Core Facility, CNIC, Madrid, Spain.', 'Cardiac Surgery, Hospital Virgen de la Salud, SESCAM, Toledo, Spain.', 'Cardiocirculatory Unit, Health Research Institute, Hospital La Fe, Valencia, Spain.', 'Department of Cardiology, Hospital Virgen de la Salud, SESCAM, Toledo, Spain.', 'Proteomics Core Facility, CNIC, Madrid, Spain.', 'Department of Vascular Physiopathology, Hospital Nacional de Paraplejicos, SESCAM, Toledo, Spain.', 'Department of Vascular Physiopathology, Hospital Nacional de Paraplejicos, SESCAM, Toledo, Spain.'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20151201', 'PL': 'England', 'TA': 'Sci Rep', 'JT': 'Scientific reports', 'JID': '101563288', 'RN': ['0 (Extracellular Matrix Proteins)'], 'SB': 'IM', 'MH': ['Aged', 'Aortic Valve Stenosis/*metabolism/pathology', 'Extracellular Matrix/*metabolism/pathology', 'Extracellular Matrix Proteins/*metabolism', 'Female', 'Humans', 'Male', '*Proteomics'], 'PMC': 'PMC4664895', 'EDAT': '2015/12/02 06:00', 'MHDA': '2016/09/24 06:00', 'CRDT': ['2015/12/02 06:00'], 'PHST': ['2015/06/23 00:00 [received]', '2015/10/28 00:00 [accepted]', '2015/12/02 06:00 [entrez]', '2015/12/02 06:00 [pubmed]', '2016/09/24 06:00 [medline]'], 'AID': ['srep17290 [pii]', '10.1038/srep17290 [doi]'], 'PST': 'epublish', 'SO': 'Sci Rep. 2015 Dec 1;5:17290. doi: 10.1038/srep17290.'}\n",
      "{'PMID': '26603189', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20161019', 'LR': '20161230', 'IS': '1932-7420 (Electronic) 1550-4131 (Linking)', 'VI': '22', 'IP': '6', 'DP': '2015 Dec 1', 'TI': 'Fetuin B Is a Secreted Hepatocyte Factor Linking Steatosis to Impaired Glucose Metabolism.', 'PG': '1078-89', 'LID': '10.1016/j.cmet.2015.09.023 [doi] S1550-4131(15)00480-5 [pii]', 'AB': 'Liver steatosis is associated with the development of insulin resistance and the pathogenesis of type 2 diabetes. We tested the hypothesis that protein signals originating from steatotic hepatocytes communicate with other cells to modulate metabolic phenotypes. We show that the secreted factors from steatotic hepatocytes induce pro-inflammatory signaling and insulin resistance in cultured cells. Next, we identified 168 hepatokines, of which 32 were differentially secreted in steatotic versus non-steatotic hepatocytes. Targeted analysis showed that fetuin B was increased in humans with liver steatosis and patients with type 2 diabetes. Fetuin B impaired insulin action in myotubes and hepatocytes and caused glucose intolerance in mice. Silencing of fetuin B in obese mice improved glucose tolerance. We conclude that the protein secretory profile of hepatocytes is altered with steatosis and is linked to inflammation and insulin resistance. Therefore, preventing steatosis may limit the development of dysregulated glucose metabolism in settings of overnutrition.', 'CI': ['Copyright (c) 2015 Elsevier Inc. All rights reserved.'], 'FAU': ['Meex, Ruth C', 'Hoy, Andrew J', 'Morris, Alexander', 'Brown, Russell D', 'Lo, Jennifer C Y', 'Burke, Melissa', 'Goode, Robert J A', 'Kingwell, Bronwyn A', 'Kraakman, Michael J', 'Febbraio, Mark A', 'Greve, Jan Willem', 'Rensen, Sander S', 'Molloy, Mark P', 'Lancaster, Graeme I', 'Bruce, Clinton R', 'Watt, Matthew J'], 'AU': ['Meex RC', 'Hoy AJ', 'Morris A', 'Brown RD', 'Lo JC', 'Burke M', 'Goode RJ', 'Kingwell BA', 'Kraakman MJ', 'Febbraio MA', 'Greve JW', 'Rensen SS', 'Molloy MP', 'Lancaster GI', 'Bruce CR', 'Watt MJ'], 'AD': ['Monash Biomedicine Discovery Institute, Metabolic Disease and Obesity Program, and Biology of Lipid Metabolism Laboratory, Department of Physiology, Monash University, Clayton, VIC 3800, Australia.', 'Monash Biomedicine Discovery Institute, Metabolic Disease and Obesity Program, and Biology of Lipid Metabolism Laboratory, Department of Physiology, Monash University, Clayton, VIC 3800, Australia.', 'Monash Biomedicine Discovery Institute, Metabolic Disease and Obesity Program, and Biology of Lipid Metabolism Laboratory, Department of Physiology, Monash University, Clayton, VIC 3800, Australia.', 'Monash Biomedicine Discovery Institute, Metabolic Disease and Obesity Program, and Biology of Lipid Metabolism Laboratory, Department of Physiology, Monash University, Clayton, VIC 3800, Australia.', 'Monash Biomedicine Discovery Institute, Metabolic Disease and Obesity Program, and Biology of Lipid Metabolism Laboratory, Department of Physiology, Monash University, Clayton, VIC 3800, Australia.', 'Biotechnology Research Laboratories, Department of Physiology, Monash University, Clayton, VIC 3800, Australia; Mill Hill Laboratory, The Francis Crick Institute, London NW7 1AA, UK.', 'Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC 3800, Australia.', 'Baker IDI Heart and Diabetes Institute, Melbourne, VIC 3004, Australia.', 'Baker IDI Heart and Diabetes Institute, Melbourne, VIC 3004, Australia.', 'Baker IDI Heart and Diabetes Institute, Melbourne, VIC 3004, Australia; The Garvan Institute of Medical Research, Sydney, NSW 2010, Australia.', 'NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Centre, Department of General Surgery, Maastricht, the Netherlands.', 'NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Centre, Department of General Surgery, Maastricht, the Netherlands.', 'Australian Proteome Analysis Facility, Macquarie University, Sydney, NSW 2109, Australia.', 'Baker IDI Heart and Diabetes Institute, Melbourne, VIC 3004, Australia.', 'Monash Biomedicine Discovery Institute, Metabolic Disease and Obesity Program, and Biology of Lipid Metabolism Laboratory, Department of Physiology, Monash University, Clayton, VIC 3800, Australia.', 'Monash Biomedicine Discovery Institute, Metabolic Disease and Obesity Program, and Biology of Lipid Metabolism Laboratory, Department of Physiology, Monash University, Clayton, VIC 3800, Australia. Electronic address: matthew.watt@monash.edu.'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20151022', 'PL': 'United States', 'TA': 'Cell Metab', 'JT': 'Cell metabolism', 'JID': '101233170', 'RN': ['0 (Fetuin-B)', 'EC 2.6.1.1 (Aspartate Aminotransferases)', 'EC 2.6.1.2 (Alanine Transaminase)', 'EC 2.7.11.10 (I-kappa B Kinase)', 'EC 2.7.11.24 (JNK Mitogen-Activated Protein Kinases)', 'IY9XDZ35W2 (Glucose)'], 'SB': 'IM', 'MH': ['Adult', 'Alanine Transaminase/blood', 'Animals', 'Aspartate Aminotransferases/blood', 'Cells, Cultured', 'Diabetes Mellitus, Type 2/complications/metabolism/pathology', 'Diet, High-Fat', 'Fatty Liver/complications/metabolism/*pathology', 'Female', 'Fetuin-B/antagonists & inhibitors/genetics/*metabolism', 'Glucose/*metabolism', 'Hepatocytes/cytology/metabolism', 'Humans', 'I-kappa B Kinase/metabolism', 'Insulin Resistance', 'JNK Mitogen-Activated Protein Kinases/metabolism', 'Liver/enzymology/metabolism', 'Male', 'Mice', 'Mice, Inbred C57BL', 'Mice, Obese', 'Middle Aged', 'RNA Interference', 'Up-Regulation/drug effects'], 'EDAT': '2015/11/26 06:00', 'MHDA': '2016/11/12 06:00', 'CRDT': ['2015/11/26 06:00'], 'PHST': ['2015/04/21 00:00 [received]', '2015/08/04 00:00 [revised]', '2015/09/23 00:00 [accepted]', '2015/11/26 06:00 [entrez]', '2015/11/26 06:00 [pubmed]', '2016/11/12 06:00 [medline]'], 'AID': ['S1550-4131(15)00480-5 [pii]', '10.1016/j.cmet.2015.09.023 [doi]'], 'PST': 'ppublish', 'SO': 'Cell Metab. 2015 Dec 1;22(6):1078-89. doi: 10.1016/j.cmet.2015.09.023. Epub 2015 Oct 22.'}\n",
      "{'PMID': '26564600', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20160225', 'LR': '20181113', 'IS': '1558-3597 (Electronic) 0735-1097 (Linking)', 'VI': '66', 'IP': '20', 'DP': '2015 Nov 17', 'TI': 'Enhanced Cardiac Regenerative Ability of Stem Cells After Ischemia-Reperfusion Injury: Role of Human CD34+ Cells Deficient in MicroRNA-377.', 'PG': '2214-2226', 'LID': 'S0735-1097(15)06147-1 [pii] 10.1016/j.jacc.2015.09.009 [doi]', 'AB': 'BACKGROUND: MicroRNA (miR) dysregulation in the myocardium has been implicated in cardiac remodeling after injury or stress. OBJECTIVES: The aim of this study was to explore the role of miR in human CD34(+) cell (hCD34(+)) dysfunction in vivo after transplantation into the myocardium under ischemia-reperfusion (I-R) conditions. METHODS: In response to inflammatory stimuli, the miR array profile of endothelial progenitor cells was analyzed using a polymerase chain reaction-based miR microarray. miR-377 expression was assessed in myocardial tissue from human patients with heart failure (HF). We investigated the effect of miR-377 inhibition on an hCD34(+) cell angiogenic proteome profile in vitro and on cardiac repair and function after I-R injury in immunodeficient mice. RESULTS: The miR array data from endothelial progenitor cells in response to inflammatory stimuli indicated changes in numerous miR, with a robust decrease in the levels of miR-377. Human cardiac biopsies from patients with HF showed significant increases in miR-377 expression compared with nonfailing control hearts. The proteome profile of hCD34(+) cells transfected with miR-377 mimics showed significant decrease in the levels of proangiogenic proteins versus nonspecific control-transfected cells. We also validated that serine/threonine kinase 35 is a target of miR-377 using a dual luciferase reporter assay. In a mouse model of myocardial I-R, intramyocardial transplantation of miR-377 silenced hCD34(+) cells in immunodeficient mice, promoting neovascularization (at 28 days, post-I-R) and lower interstitial fibrosis, leading to improved left ventricular function. CONCLUSIONS: These findings indicate that HF increased miR-377 expression in the myocardium, which is detrimental to stem cell function, and transplantation of miR-377 knockdown hCD34(+) cells into ischemic myocardium promoted their angiogenic ability, attenuating left ventricular remodeling and cardiac fibrosis.', 'CI': ['Copyright (c) 2015 American College of Cardiology Foundation. Published by', 'Elsevier Inc. All rights reserved.'], 'FAU': ['Joladarashi, Darukeshwara', 'Garikipati, Venkata Naga Srikanth', 'Thandavarayan, Rajarajan A', 'Verma, Suresh K', 'Mackie, Alexander R', 'Khan, Mohsin', 'Gumpert, Anna M', 'Bhimaraj, Arvind', 'Youker, Keith A', 'Uribe, Cesar', 'Suresh Babu, Sahana', 'Jeyabal, Prince', 'Kishore, Raj', 'Krishnamurthy, Prasanna'], 'AU': ['Joladarashi D', 'Garikipati VNS', 'Thandavarayan RA', 'Verma SK', 'Mackie AR', 'Khan M', 'Gumpert AM', 'Bhimaraj A', 'Youker KA', 'Uribe C', 'Suresh Babu S', 'Jeyabal P', 'Kishore R', 'Krishnamurthy P'], 'AD': ['Department of Cardiovascular Sciences, Center for Cardiovascular Regeneration, Houston Methodist Research Institute, Houston, Texas.', 'Center for Translational Medicine, Temple University School of Medicine, Philadelphia, Pennsylvania.', 'Department of Cardiovascular Sciences, Center for Cardiovascular Regeneration, Houston Methodist Research Institute, Houston, Texas.', 'Center for Translational Medicine, Temple University School of Medicine, Philadelphia, Pennsylvania.', 'Feinberg Cardiovascular Research Institute, Northwestern University, Chicago, Illinois.', 'Center for Translational Medicine, Temple University School of Medicine, Philadelphia, Pennsylvania.', 'Center for Translational Medicine, Temple University School of Medicine, Philadelphia, Pennsylvania.', 'Houston Methodist DeBakey Heart & Vascular Center, Houston Methodist Hospital, Houston, Texas.', 'Houston Methodist DeBakey Heart & Vascular Center, Houston Methodist Hospital, Houston, Texas.', 'Houston Methodist DeBakey Heart & Vascular Center, Houston Methodist Hospital, Houston, Texas.', 'Department of Cardiovascular Sciences, Center for Cardiovascular Regeneration, Houston Methodist Research Institute, Houston, Texas.', 'Department of Cardiovascular Sciences, Center for Cardiovascular Regeneration, Houston Methodist Research Institute, Houston, Texas.', 'Center for Translational Medicine, Temple University School of Medicine, Philadelphia, Pennsylvania.', 'Department of Cardiovascular Sciences, Center for Cardiovascular Regeneration, Houston Methodist Research Institute, Houston, Texas; Department of Cell and Developmental Biology, Department of Cardiothoracic Surgery, Weill Cornell Medical College, New York, New York. Electronic address: pkrishnamurthy@houstonmethodist.org.'], 'LA': ['eng'], 'GR': ['R01 HL126186/HL/NHLBI NIH HHS/United States', '1R01HL116729/HL/NHLBI NIH HHS/United States', 'HL053354/HL/NHLBI NIH HHS/United States', 'R01 HL091983/HL/NHLBI NIH HHS/United States', 'HL091983/HL/NHLBI NIH HHS/United States', 'P01 HL108795/HL/NHLBI NIH HHS/United States', 'HL108795/HL/NHLBI NIH HHS/United States', 'P01 HL108806/HL/NHLBI NIH HHS/United States', 'HL108806/HL/NHLBI NIH HHS/United States', 'R21 AA014575/AA/NIAAA NIH HHS/United States', 'R01 HL116729/HL/NHLBI NIH HHS/United States', 'R01 HL095874/HL/NHLBI NIH HHS/United States', 'R01 HL105597/HL/NHLBI NIH HHS/United States', 'R37 HL053354/HL/NHLBI NIH HHS/United States', 'R01 HL053354/HL/NHLBI NIH HHS/United States'], 'PT': ['Journal Article', 'Research Support, N.I.H., Extramural', \"Research Support, Non-U.S. Gov't\"], 'PL': 'United States', 'TA': 'J Am Coll Cardiol', 'JT': 'Journal of the American College of Cardiology', 'JID': '8301365', 'RN': ['0 (Antigens, CD34)', '0 (MIRN377 microRNA, human)', '0 (MicroRNAs)'], 'SB': 'AIM IM', 'CIN': ['J Am Coll Cardiol. 2015 Nov 17;66(20):2227-9. PMID: 26564601'], 'MH': ['Adult', 'Animals', 'Antigens, CD34', 'Endothelial Progenitor Cells/*metabolism', 'Female', 'Heart', 'Heart Failure/*metabolism', 'Humans', 'Inflammation/pathology', 'Male', 'Mice', 'Mice, Inbred C57BL', 'Mice, Knockout', 'MicroRNAs/*metabolism', 'Myocardium/cytology/*metabolism/pathology', 'Neovascularization, Physiologic/physiology', 'Reperfusion Injury/*metabolism/pathology', 'Reverse Transcriptase Polymerase Chain Reaction'], 'PMC': 'PMC4644493', 'MID': ['NIHMS723634'], 'OTO': ['NOTNLM'], 'OT': ['*endothelial progenitor cells', '*heart failure', '*neovascularization'], 'EDAT': '2015/11/14 06:00', 'MHDA': '2016/02/26 06:00', 'CRDT': ['2015/11/14 06:00'], 'PHST': ['2015/08/17 00:00 [received]', '2015/09/02 00:00 [accepted]', '2015/11/14 06:00 [entrez]', '2015/11/14 06:00 [pubmed]', '2016/02/26 06:00 [medline]'], 'AID': ['S0735-1097(15)06147-1 [pii]', '10.1016/j.jacc.2015.09.009 [doi]'], 'PST': 'ppublish', 'SO': 'J Am Coll Cardiol. 2015 Nov 17;66(20):2214-2226. doi: 10.1016/j.jacc.2015.09.009.'}\n",
      "{'PMID': '26561523', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20161017', 'LR': '20190417', 'IS': '1460-2083 (Electronic) 0964-6906 (Linking)', 'VI': '25', 'IP': '2', 'DP': '2016 Jan 15', 'TI': 'A meta-analysis of 120 246 individuals identifies 18 new loci for fibrinogen concentration.', 'PG': '358-70', 'LID': '10.1093/hmg/ddv454 [doi]', 'AB': 'Genome-wide association studies have previously identified 23 genetic loci associated with circulating fibrinogen concentration. These studies used HapMap imputation and did not examine the X-chromosome. 1000 Genomes imputation provides better coverage of uncommon variants, and includes indels. We conducted a genome-wide association analysis of 34 studies imputed to the 1000 Genomes Project reference panel and including approximately 120 000 participants of European ancestry (95 806 participants with data on the X-chromosome). Approximately 10.7 million single-nucleotide polymorphisms and 1.2 million indels were examined. We identified 41 genome-wide significant fibrinogen loci; of which, 18 were newly identified. There were no genome-wide significant signals on the X-chromosome. The lead variants of five significant loci were indels. We further identified six additional independent signals, including three rare variants, at two previously characterized loci: FGB and IRF1. Together the 41 loci explain 3% of the variance in plasma fibrinogen concentration.', 'CI': ['(c) The Author 2015. Published by Oxford University Press. All rights reserved.', 'For Permissions, please email: journals.permissions@oup.com.'], 'FAU': ['de Vries, Paul S', 'Chasman, Daniel I', 'Sabater-Lleal, Maria', 'Chen, Ming-Huei', 'Huffman, Jennifer E', 'Steri, Maristella', 'Tang, Weihong', 'Teumer, Alexander', 'Marioni, Riccardo E', 'Grossmann, Vera', 'Hottenga, Jouke J', 'Trompet, Stella', 'Muller-Nurasyid, Martina', 'Zhao, Jing Hua', 'Brody, Jennifer A', 'Kleber, Marcus E', 'Guo, Xiuqing', 'Wang, Jie Jin', 'Auer, Paul L', 'Attia, John R', 'Yanek, Lisa R', 'Ahluwalia, Tarunveer S', 'Lahti, Jari', 'Venturini, Cristina', 'Tanaka, Toshiko', 'Bielak, Lawrence F', 'Joshi, Peter K', 'Rocanin-Arjo, Ares', 'Kolcic, Ivana', 'Navarro, Pau', 'Rose, Lynda M', 'Oldmeadow, Christopher', 'Riess, Helene', 'Mazur, Johanna', 'Basu, Saonli', 'Goel, Anuj', 'Yang, Qiong', 'Ghanbari, Mohsen', 'Willemsen, Gonneke', 'Rumley, Ann', 'Fiorillo, Edoardo', 'de Craen, Anton J M', 'Grotevendt, Anne', 'Scott, Robert', 'Taylor, Kent D', 'Delgado, Graciela E', 'Yao, Jie', 'Kifley, Annette', 'Kooperberg, Charles', 'Qayyum, Rehan', 'Lopez, Lorna M', 'Berentzen, Tina L', 'Raikkonen, Katri', 'Mangino, Massimo', 'Bandinelli, Stefania', 'Peyser, Patricia A', 'Wild, Sarah', 'Tregouet, David-Alexandre', 'Wright, Alan F', 'Marten, Jonathan', 'Zemunik, Tatijana', 'Morrison, Alanna C', 'Sennblad, Bengt', 'Tofler, Geoffrey', 'de Maat, Moniek P M', 'de Geus, Eco J C', 'Lowe, Gordon D', 'Zoledziewska, Magdalena', 'Sattar, Naveed', 'Binder, Harald', 'Volker, Uwe', 'Waldenberger, Melanie', 'Khaw, Kay-Tee', 'Mcknight, Barbara', 'Huang, Jie', 'Jenny, Nancy S', 'Holliday, Elizabeth G', 'Qi, Lihong', 'Mcevoy, Mark G', 'Becker, Diane M', 'Starr, John M', 'Sarin, Antti-Pekka', 'Hysi, Pirro G', 'Hernandez, Dena G', 'Jhun, Min A', 'Campbell, Harry', 'Hamsten, Anders', 'Rivadeneira, Fernando', 'Mcardle, Wendy L', 'Slagboom, P Eline', 'Zeller, Tanja', 'Koenig, Wolfgang', 'Psaty, Bruce M', 'Haritunians, Talin', 'Liu, Jingmin', 'Palotie, Aarno', 'Uitterlinden, Andre G', 'Stott, David J', 'Hofman, Albert', 'Franco, Oscar H', 'Polasek, Ozren', 'Rudan, Igor', 'Morange, Pierre-Emmanuel', 'Wilson, James F', 'Kardia, Sharon L R', 'Ferrucci, Luigi', 'Spector, Tim D', 'Eriksson, Johan G', 'Hansen, Torben', 'Deary, Ian J', 'Becker, Lewis C', 'Scott, Rodney J', 'Mitchell, Paul', 'Marz, Winfried', 'Wareham, Nick J', 'Peters, Annette', 'Greinacher, Andreas', 'Wild, Philipp S', 'Jukema, J Wouter', 'Boomsma, Dorret I', 'Hayward, Caroline', 'Cucca, Francesco', 'Tracy, Russell', 'Watkins, Hugh', 'Reiner, Alex P', 'Folsom, Aaron R', 'Ridker, Paul M', \"O'Donnell, Christopher J\", 'Smith, Nicholas L', 'Strachan, David P', 'Dehghan, Abbas'], 'AU': ['de Vries PS', 'Chasman DI', 'Sabater-Lleal M', 'Chen MH', 'Huffman JE', 'Steri M', 'Tang W', 'Teumer A', 'Marioni RE', 'Grossmann V', 'Hottenga JJ', 'Trompet S', 'Muller-Nurasyid M', 'Zhao JH', 'Brody JA', 'Kleber ME', 'Guo X', 'Wang JJ', 'Auer PL', 'Attia JR', 'Yanek LR', 'Ahluwalia TS', 'Lahti J', 'Venturini C', 'Tanaka T', 'Bielak LF', 'Joshi PK', 'Rocanin-Arjo A', 'Kolcic I', 'Navarro P', 'Rose LM', 'Oldmeadow C', 'Riess H', 'Mazur J', 'Basu S', 'Goel A', 'Yang Q', 'Ghanbari M', 'Willemsen G', 'Rumley A', 'Fiorillo E', 'de Craen AJ', 'Grotevendt A', 'Scott R', 'Taylor KD', 'Delgado GE', 'Yao J', 'Kifley A', 'Kooperberg C', 'Qayyum R', 'Lopez LM', 'Berentzen TL', 'Raikkonen K', 'Mangino M', 'Bandinelli S', 'Peyser PA', 'Wild S', 'Tregouet DA', 'Wright AF', 'Marten J', 'Zemunik T', 'Morrison AC', 'Sennblad B', 'Tofler G', 'de Maat MP', 'de Geus EJ', 'Lowe GD', 'Zoledziewska M', 'Sattar N', 'Binder H', 'Volker U', 'Waldenberger M', 'Khaw KT', 'Mcknight B', 'Huang J', 'Jenny NS', 'Holliday EG', 'Qi L', 'Mcevoy MG', 'Becker DM', 'Starr JM', 'Sarin AP', 'Hysi PG', 'Hernandez DG', 'Jhun MA', 'Campbell H', 'Hamsten A', 'Rivadeneira F', 'Mcardle WL', 'Slagboom PE', 'Zeller T', 'Koenig W', 'Psaty BM', 'Haritunians T', 'Liu J', 'Palotie A', 'Uitterlinden AG', 'Stott DJ', 'Hofman A', 'Franco OH', 'Polasek O', 'Rudan I', 'Morange PE', 'Wilson JF', 'Kardia SL', 'Ferrucci L', 'Spector TD', 'Eriksson JG', 'Hansen T', 'Deary IJ', 'Becker LC', 'Scott RJ', 'Mitchell P', 'Marz W', 'Wareham NJ', 'Peters A', 'Greinacher A', 'Wild PS', 'Jukema JW', 'Boomsma DI', 'Hayward C', 'Cucca F', 'Tracy R', 'Watkins H', 'Reiner AP', 'Folsom AR', 'Ridker PM', \"O'Donnell CJ\", 'Smith NL', 'Strachan DP', 'Dehghan A'], 'AD': ['Department of Epidemiology.', \"Division of Preventive Medicine, Brigham and Women's Hospital, Boston, MA, USA, Harvard Medical School, Boston, MA, USA.\", 'Department of Medicine, Cardiovascular Genetics and Genomics Group, Atherosclerosis Research Unit and.', 'Department of Neurology, Boston University School of Medicine, Boston, MA, USA, Framingham Heart Study, Population Sciences Branch, Division of Intramural Research National Heart Lung and Blood Institute, National Institutes of Health, Framingham, MA, USA.', 'Framingham Heart Study, Population Sciences Branch, Division of Intramural Research National Heart Lung and Blood Institute, National Institutes of Health, Framingham, MA, USA, MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine.', 'Istituto di Ricerca Genetica e Biomedica, Consiglio Nazionaledelle Ricerche, Monserrato, Cagliari, Italy.', 'Division of Epidemiology and Community Health and.', 'Institute for Community Medicine.', 'Centre for Cognitive Ageing and Cognitive Epidemiology, Centre for Genomic and Experimental Medicine, Queensland Brain Institute, University of Queensland, Brisbane, Australia.', 'Center for Thrombosis and Hemostasis (CTH).', 'Department of Biological Psychology, Netherlands Twin Register, VU University, Amsterdam, The Netherlands.', 'Department of Cardiology, Department of Gerontology and Geriatrics and.', 'Institute of Genetic Epidemiology, Department of Medicine I, Ludwig-Maximilians-University Munich, Munich, Germany, DZHK (German Centre for Cardiovascular Research) and.', 'MRC Epidemiology Unit, School of Clinical Medicine and.', 'Department of Medicine.', 'Vth Department of Medicine, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.', 'Institute for Translational Genomics and Population Sciences and Department of Pediatrics, Los Angeles Biomedical Research Institute at Harbor/UCLA Medical Center, Torrance, CA, USA.', 'Department of Ophthalmology, Centre for Vision Research, Westmead Millennium Institute for Medical Research, University of Sydney, Sydney, Australia.', 'Zilber School of Public Health, University of Wisconsin-Milwaukee, Milwaukee, WI, USA.', 'Public Health Stream and School of Medicine and Public Health and.', 'Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.', 'Novo Nordisk Foundation Centre for Basic Metabolic Research, Section of Metabolic Genetics, Faculty of Health and Medical Sciences and Copenhagen Prospective Studies on Asthma in Childhood, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark, The Danish Pediatric Asthma Center, Gentofte Hospital, The Capital Region, Copenhagen, Denmark.', 'Institute of Behavioural Sciences, Folkhalsan Research Centre, Helsinki, Finland.', 'Institute of Opthalmology, UCL, London, UK, Department of Twin Research and Genetic Epidemiology, Kings College London, London, UK.', 'Translational Gerontology Branch, National Institute on Aging, Baltimore, MD, USA.', 'Department of Epidemiology, University of Michigan, Ann Arbor, MI, USA.', 'Centre for Population Health Sciences, Usher Institute of Population Health Sciences and Informatics, Centre for Global Health Research, Usher Institute of Population Health Sciences and Informatics.', 'Institut National pour la Sante et la Recherche Medicale (INSERM), Unite Mixte de Recherche en Sante (UMR_S) 1166, Paris F-75013, France, Sorbonne Universites, Universite Pierre et Marie Curie (UPMC Univ Paris 06), UMR_S 1166, Team Genomics & Pathophysiology of Cardiovascular Diseases, Paris F-75013, France, Institute for Cardiometabolism and Nutrition (ICAN), Paris F-75013, France.', 'Department of Public Health, Faculty of Medicine.', 'MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine.', \"Division of Preventive Medicine, Brigham and Women's Hospital, Boston, MA, USA.\", 'Public Health Stream and School of Medicine and Public Health and.', 'Institute of Epidemiology II and.', 'Institute of Medical Biostatistics, Epidemiology and Informatics and.', 'Division of Biostatistics, University of Minnesota, Minneapolis, MN, USA.', 'Cardiovascular Medicine Department/Radcliffe Department of Medicine, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK.', 'Framingham Heart Study, Population Sciences Branch, Division of Intramural Research National Heart Lung and Blood Institute, National Institutes of Health, Framingham, MA, USA, Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA.', 'Department of Epidemiology, Department of Genetics, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.', 'Department of Biological Psychology, Netherlands Twin Register, VU University, Amsterdam, The Netherlands.', 'Institute of Cardiovascular and Medical Sciences and.', 'Istituto di Ricerca Genetica e Biomedica, Consiglio Nazionaledelle Ricerche, Monserrato, Cagliari, Italy.', 'Department of Gerontology and Geriatrics and.', 'Institute of Clinical Chemistry and Laboratory Medicine.', 'MRC Epidemiology Unit, School of Clinical Medicine and.', 'Institute for Translational Genomics and Population Sciences and.', 'Vth Department of Medicine, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.', 'Institute for Translational Genomics and Population Sciences and.', 'Department of Ophthalmology, Centre for Vision Research, Westmead Millennium Institute for Medical Research, University of Sydney, Sydney, Australia.', 'Fred Hutchinson Cancer Research Center, Seattle, WA, USA.', 'Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.', 'Centre for Cognitive Ageing and Cognitive Epidemiology, Department of Psychiatry, Royal College of Surgeons in Ireland, Education and Research Centre, Beaumont Hospital, Dublin, Ireland, University College Dublin, UCD Conway Institute, Centre for Proteome Research, UCD, Belfield, Dublin, Ireland.', 'Institute of Preventive Medicine, Bispebjerg and Frederiksberg Hospital, The Capital Region, Copenhagen, Denmark.', 'Institute of Behavioural Sciences.', 'Department of Twin Research and Genetic Epidemiology, Kings College London, London, UK.', 'Geriatric Unit, Azienda Sanitaria Firenze (ASF), Florence, Italy.', 'Department of Epidemiology, University of Michigan, Ann Arbor, MI, USA.', 'Centre for Population Health Sciences, Usher Institute of Population Health Sciences and Informatics.', 'Institut National pour la Sante et la Recherche Medicale (INSERM), Unite Mixte de Recherche en Sante (UMR_S) 1166, Paris F-75013, France, Sorbonne Universites, Universite Pierre et Marie Curie (UPMC Univ Paris 06), UMR_S 1166, Team Genomics & Pathophysiology of Cardiovascular Diseases, Paris F-75013, France, Institute for Cardiometabolism and Nutrition (ICAN), Paris F-75013, France.', 'MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine.', 'MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine.', 'Department of Biology, School of Medicine and.', 'Human Genetics Center, University of Texas Health Science Center at Houston, Houston, TX, USA.', 'Department of Medicine, Cardiovascular Genetics and Genomics Group, Atherosclerosis Research Unit and Science for Life Laboratory, Karolinska Institutet, Stockholm, Sweden.', 'Royal North Shore Hospital, Sydney University, Sydney, Australia.', 'Department of Hematology and.', 'Department of Biological Psychology, Netherlands Twin Register, VU University, Amsterdam, The Netherlands, EMGO+ institute, VU University & VU Medical Center, Amsterdam.', 'Institute of Cardiovascular and Medical Sciences and.', 'Istituto di Ricerca Genetica e Biomedica, Consiglio Nazionaledelle Ricerche, Monserrato, Cagliari, Italy.', 'Faculty of Medicine, BHF Glasgow Cardiovascular Research Centre, Glasgow, UK.', 'Institute of Medical Biostatistics, Epidemiology and Informatics and.', 'Interfaculty Institute for Genetics and Functional Genomics and.', 'Institute of Epidemiology II and Research Unit of Molecular Epidemiology, Helmholtz ZentrumMunchen - German Research Center for Environmental Health, Neuherberg, Germany.', 'Clinical Gerontology Unit, School of Clinical Medicine, University of Cambridge, Cambridge, UK.', 'Department of Biostatistics.', 'Department of Human Genetics, Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK.', 'Department of Pathology and Laboratory Medicine and.', 'Public Health Stream, Hunter Medical Research Institute, School of Medicine and Public Health and.', 'Division of Biostatistics, Department of Public Health Sciences, UC Davis, Davis, CA, USA.', 'School of Medicine and Public Health, University of Newcastle, Newcastle, Australia.', 'Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.', 'Centre for Cognitive Ageing and Cognitive Epidemiology, Alzheimer Scotland Dementia Research Centre and.', 'Institute for Molecular Medicine Finland (FIMM) and Public Health Genomics Unit, National Institute for Health and Welfare, Helsinki, Finland.', 'Department of Twin Research and Genetic Epidemiology, Kings College London, London, UK.', 'Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA.', 'Department of Epidemiology, University of Michigan, Ann Arbor, MI, USA.', 'Centre for Global Health Research, Usher Institute of Population Health Sciences and Informatics.', 'Department of Medicine, Cardiovascular Genetics and Genomics Group, Atherosclerosis Research Unit and.', 'Department of Epidemiology, Department of Internal Medicine, Erasmus MC, Wytemaweg 80, Rotterdam, The Netherlands.', 'School of Social and Community Medicine, University of Bristol, Bristol, UK.', 'Department of Molecular Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.', 'Department of General and Interventional Cardiology, University Heart Centre, University Medical Center Hamburg-Eppendorf, Hamburg, Germany, German Center for Cardiovascular Research (DZHK), Partner Site Hamburg, Lubeck, Kiel, Hamburg, Germany.', 'German Centre for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Munich, Germany, Department of Internal Medicine II - Cardiology, University of Ulm Medical Centre, Ulm, Germany, Deutsches Herzzentrum Munchen, Technische Universitat Munchen, Munich, Germany.', 'Department of Medicine, Epidemiology, and Health Services and Group Health Research Institute, Group Health Cooperative, Seattle, WA, USA.', 'Inflammatory Bowel & Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.', 'Fred Hutchinson Cancer Research Center, Seattle, WA, USA.', 'Institute for Molecular Medicine Finland (FIMM) and.', 'Department of Epidemiology, Department of Internal Medicine, Erasmus MC, Wytemaweg 80, Rotterdam, The Netherlands.', 'Institute of Cardiovascular and Medical Sciences, Faculty of Medicine, University of Glasgow, Glasgow, UK.', 'Department of Epidemiology.', 'Department of Epidemiology.', 'Centre for Global Health Research, Usher Institute of Population Health Sciences and Informatics, Department of Public Health, Faculty of Medicine, Centre for Global Health, University of Split, Split, Croatia.', 'Centre for Global Health Research, Usher Institute of Population Health Sciences and Informatics.', 'Laboratory of Haematology, La Timone Hospital, Marseille F-13385, France, INSERM, UMR_S 1062, Nutrition Obesity and Risk of Thrombosis, Marseille F-13385, France, Aix-Marseille University, UMR_S 1062, Nutrition Obesity and Risk of Thrombosis, Marseille F-13385, France.', 'MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, Centre for Global Health Research, Usher Institute of Population Health Sciences and Informatics.', 'Department of Epidemiology, University of Michigan, Ann Arbor, MI, USA.', 'Translational Gerontology Branch, National Institute on Aging, Baltimore, MD, USA.', 'Department of Twin Research and Genetic Epidemiology, Kings College London, London, UK.', 'Department of General Practice and Primary Health Care, University of Helsinki, Helsinki, Finland, Folkhalsan Research Centre, Helsinki, Finland, National Institute for Health and Welfare, Helsinki, Finland, Unit of General Practice, Helsinki University Central Hospital, Helsinki, Finland.', 'Novo Nordisk Foundation Centre for Basic Metabolic Research, Section of Metabolic Genetics, Faculty of Health and Medical Sciences and.', 'Centre for Cognitive Ageing and Cognitive Epidemiology, Department of Psychology, University of Edinburgh, Edinburgh, UK.', 'Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.', 'Information based Medicine Program, Hunter Medical Research Institute, New Lambton Heights, Australia, School of Biomedical Sciences and Pharmacy, University of Newcastle, New Lambton Heights, Australia.', 'Department of Ophthalmology, Centre for Vision Research, Westmead Millennium Institute for Medical Research, University of Sydney, Sydney, Australia.', 'Vth Department of Medicine, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany, Synlab Academy, Synlab Services LLC, Mannheim, Germany, Clinical Institute of Medical, Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria.', 'MRC Epidemiology Unit, School of Clinical Medicine and.', 'Institute of Epidemiology II and DZHK (German Centre for Cardiovascular Research) and.', 'Institute for Immunology and Transfusion Medicine, University Medicine Greifswald, Greifswald, Germany.', 'Center for Thrombosis and Hemostasis (CTH), Preventive Cardiology and Preventive Medicine, Department of Medicine 2, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany, German Center for Cardiovascular Research (DZHK), Partner Site RheinMain, Mainz, Germany.', 'Department of Cardiology, Durrer Center for Cardiogenetic Research, Amsterdam, The Netherlands, Interuniversity Cardiology Institute of The Netherlands, Utrecht, The Netherlands.', 'Department of Biological Psychology, Netherlands Twin Register, VU University, Amsterdam, The Netherlands.', 'MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine.', 'Istituto di Ricerca Genetica e Biomedica, Consiglio Nazionaledelle Ricerche, Monserrato, Cagliari, Italy.', 'Department of Pathology and Laboratory Medicine, Center for Clinical and Translational Sciences, University of Vermont College of Medicine, Colchester, VT, USA.', 'Cardiovascular Medicine Department/Radcliffe Department of Medicine, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK.', 'Fred Hutchinson Cancer Research Center, Seattle, WA, USA, University of Washington, Seattle, WA, USA.', 'Division of Epidemiology and Community Health and.', \"Division of Preventive Medicine, Brigham and Women's Hospital, Boston, MA, USA, Harvard Medical School, Boston, MA, USA.\", 'Framingham Heart Study, Population Sciences Branch, Division of Intramural Research National Heart Lung and Blood Institute, National Institutes of Health, Framingham, MA, USA, National Heart, Lung and Blood Institute, Division of Intramural Research, Cardiology Division, Massachusetts General Hospital, Boston, MA, USA.', 'Department of Epidemiology, University of Washington, Seattle, WA, USA, Institute of Cardiovascular and Medical Sciences, Faculty of Medicine, University of Glasgow, Glasgow, UK, Department of Veterans Affairs, Office of Research and Development, Seattle Epidemiologic Research and Information Center, Seattle, WA, USA and.', \"Population Health Research Institute, St George's University of London, London, UK.\", 'Department of Epidemiology, a.dehghan@erasmusmc.nl.'], 'LA': ['eng'], 'GR': ['ETM/55/Chief Scientist Office/United Kingdom', 'UL1RR025005/RR/NCRR NIH HHS/United States', 'CZB/4/505/Chief Scientist Office/United Kingdom', 'G1001799/Medical Research Council/United Kingdom', 'UL1TR000124/TR/NCATS NIH HHS/United States', 'British Heart Foundation/United Kingdom', 'HL59684/HL/NHLBI NIH HHS/United States', 'HL043851/HL/NHLBI NIH HHS/United States', 'R01 HL120393/HL/NHLBI NIH HHS/United States', 'R01HL59367/HL/NHLBI NIH HHS/United States', 'HL071025-01A1/HL/NHLBI NIH HHS/United States', '1RC2 MH089951/MH/NIMH NIH HHS/United States', 'HL097698/HL/NHLBI NIH HHS/United States', 'R01 HL059367/HL/NHLBI NIH HHS/United States', 'K24 DK080140/DK/NIDDK NIH HHS/United States', 'CA137088/CA/NCI NIH HHS/United States', 'G1000143/Medical Research Council/United Kingdom', 'Department of Health/United Kingdom', 'M01-RR000052/RR/NCRR NIH HHS/United States', 'UL1 TR000124/TR/NCATS NIH HHS/United States', 'MR/K026992/1/Medical Research Council/United Kingdom', 'MC_UU_12015/1/Medical Research Council/United Kingdom', 'R01 HL119443/HL/NHLBI NIH HHS/United States', 'R01 HL105756/HL/NHLBI NIH HHS/United States', 'U01HG004402/HG/NHGRI NIH HHS/United States', 'MC_U106179471/Medical Research Council/United Kingdom', 'CA047988/CA/NCI NIH HHS/United States', 'MR/N01104X/1/Medical Research Council/United Kingdom', 'P30 DK063491/DK/NIDDK NIH HHS/United States', 'RC2 HL-102924/HL/NHLBI NIH HHS/United States', 'Intramural NIH HHS/United States', 'Cancer Research UK/United Kingdom', 'R01HL087641/HL/NHLBI NIH HHS/United States', 'MC_PC_U127592696/Medical Research Council/United Kingdom', 'FP7/2007-2013/Wellcome Trust/United Kingdom', 'HL087660/HL/NHLBI NIH HHS/United States', 'G0401527/Medical Research Council/United Kingdom', 'R01HL105756/HL/NHLBI NIH HHS/United States', 'R25CA094880/CA/NCI NIH HHS/United States', 'NR0224103/NR/NINR NIH HHS/United States', 'R01D0042157-01A/PHS HHS/United States', 'U01 HL72518/HL/NHLBI NIH HHS/United States', 'MC_PC_U127561128/Medical Research Council/United Kingdom', 'UM1 CA182913/CA/NCI NIH HHS/United States', 'R01AG023629/AG/NIA NIH HHS/United States', 'R01 AG033193/AG/NIA NIH HHS/United States', 'Arthritis Research UK/United Kingdom', 'HL100245/HL/NHLBI NIH HHS/United States', 'R01HL087652/HL/NHLBI NIH HHS/United States', 'HL080467/HL/NHLBI NIH HHS/United States', 'DK063491/DK/NIDDK NIH HHS/United States', 'S10 OD020069/OD/NIH HHS/United States', 'NS017950/NS/NINDS NIH HHS/United States', 'U24 MH068457-06/MH/NIMH NIH HHS/United States', 'U01DK062418/DK/NIDDK NIH HHS/United States', '068545/Z/02/Wellcome Trust/United Kingdom', 'BB/F019394/1/Biotechnology and Biological Sciences Research Council/United', 'Kingdom', 'U01HL080295/HL/NHLBI NIH HHS/United States', 'U01-HG005152/HG/NHGRI NIH HHS/United States', 'R01HL103612/HL/NHLBI NIH HHS/United States', '076113/B/04/Z/Wellcome Trust/United Kingdom', 'G0000934/Medical Research Council/United Kingdom', 'R01HL120393/HL/NHLBI NIH HHS/United States', 'R01HL086694/HL/NHLBI NIH HHS/United States', 'MH081802/MH/NIMH NIH HHS/United States'], 'PT': ['Journal Article', 'Meta-Analysis', 'Multicenter Study', 'Research Support, N.I.H., Extramural', 'Research Support, N.I.H., Intramural', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20151110', 'PL': 'England', 'TA': 'Hum Mol Genet', 'JT': 'Human molecular genetics', 'JID': '9208958', 'RN': ['9001-32-5 (Fibrinogen)'], 'SB': 'IM', 'MH': ['Adult', 'Aged', 'Aged, 80 and over', 'European Continental Ancestry Group/genetics', 'Female', 'Fibrinogen/*analysis/genetics', '*Genetic Loci', 'Genome-Wide Association Study', 'Humans', 'INDEL Mutation', 'Male', 'Middle Aged', '*Polymorphism, Single Nucleotide'], 'PMC': 'PMC4715256', 'EDAT': '2015/11/13 06:00', 'MHDA': '2016/10/19 06:00', 'CRDT': ['2015/11/13 06:00'], 'PHST': ['2015/07/14 00:00 [received]', '2015/10/27 00:00 [accepted]', '2015/11/13 06:00 [entrez]', '2015/11/13 06:00 [pubmed]', '2016/10/19 06:00 [medline]'], 'AID': ['ddv454 [pii]', '10.1093/hmg/ddv454 [doi]'], 'PST': 'ppublish', 'SO': 'Hum Mol Genet. 2016 Jan 15;25(2):358-70. doi: 10.1093/hmg/ddv454. Epub 2015 Nov 10.'}\n",
      "{'PMID': '26535788', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20160928', 'LR': '20151205', 'IS': '1535-3907 (Electronic) 1535-3893 (Linking)', 'VI': '14', 'IP': '12', 'DP': '2015 Dec 4', 'TI': 'Combined High-Density Lipoprotein Proteomic and Glycomic Profiles in Patients at Risk for Coronary Artery Disease.', 'PG': '5109-18', 'LID': '10.1021/acs.jproteome.5b00730 [doi]', 'AB': \"OBJECTIVES: To test whether recently developed methods for comprehensive profiling of the high-density lipoprotein (HDL) glycome combined with the HDL proteome can distinguish individuals with coronary artery disease (CAD) from those without. METHODS: Twenty subjects at risk for CAD, who underwent diagnostic coronary arteriography, were analyzed. Ten subjects had CAD, and ten did not. HDL was extracted from fasting plasma samples by ultracentrifugation, followed by shotgun proteomic, glycomic, and ganglioside analyses using LC-MS. CAD vs non-CAD subjects' data were compared using univariate and multivariate statistics. RESULTS: Principal components analysis showed a clear separation of CAD and non-CAD subjects, confirming that combined HDL proteomic and glycomic profiles distinguished at-risk subjects with atherosclerosis from those without. CAD patients had lower HDL apolipoprotein content (specifically ApoA-I, A-II, and E, p < 0.05), and lower serum amyloid A2 (SAA2, p = 0.020) and SAA4 (p = 0.007) but higher sialylated glycans (p < 0.05). CONCLUSION: Combined proteomic and glycomic profiling of isolated HDL was tested as a novel analytical approach for developing biomarkers of disease. In this pilot study we found that HDL proteome and glycome distinguished between individuals who had CAD from those who did not within a group of individuals equally at risk for heart disease.\", 'FAU': ['Krishnan, Sridevi', 'Huang, Jincui', 'Lee, Hyeyoung', 'Guerrero, Andres', 'Berglund, Lars', 'Anuurad, Erdembileg', 'Lebrilla, Carlito B', 'Zivkovic, Angela M'], 'AU': ['Krishnan S', 'Huang J', 'Lee H', 'Guerrero A', 'Berglund L', 'Anuurad E', 'Lebrilla CB', 'Zivkovic AM'], 'AD': ['Department of Veterans Affairs, Northern California Health Care System , Sacramento, California 95655, United States.'], 'LA': ['eng'], 'GR': ['R01GM049077/GM/NIGMS NIH HHS/United States'], 'PT': ['Journal Article', 'Research Support, N.I.H., Extramural', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20151118', 'PL': 'United States', 'TA': 'J Proteome Res', 'JT': 'Journal of proteome research', 'JID': '101128775', 'RN': ['0 (Gangliosides)', '0 (Lipoproteins, HDL)'], 'SB': 'IM', 'MH': ['Adult', 'Aged', 'Atherosclerosis/blood', 'Case-Control Studies', 'Coronary Angiography', 'Coronary Artery Disease/*blood/diagnosis', 'Female', 'Gangliosides/analysis', 'Glycomics/methods', 'Humans', 'Lipoproteins, HDL/analysis/*blood/chemistry', 'Male', 'Middle Aged', 'Principal Component Analysis', 'Proteomics/methods', 'Random Allocation', 'Risk Factors'], 'OTO': ['NOTNLM'], 'OT': ['HDL', 'apolipoproteins', 'atherosclerosis', 'cardiovascular disease', 'coronary artery disease', 'glycolipids', 'glycomics', 'proteomics'], 'EDAT': '2015/11/05 06:00', 'MHDA': '2016/09/30 06:00', 'CRDT': ['2015/11/05 06:00'], 'PHST': ['2015/11/05 06:00 [entrez]', '2015/11/05 06:00 [pubmed]', '2016/09/30 06:00 [medline]'], 'AID': ['10.1021/acs.jproteome.5b00730 [doi]'], 'PST': 'ppublish', 'SO': 'J Proteome Res. 2015 Dec 4;14(12):5109-18. doi: 10.1021/acs.jproteome.5b00730. Epub 2015 Nov 18.'}\n",
      "{'PMID': '26483418', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20161014', 'LR': '20181113', 'IS': '1535-9484 (Electronic) 1535-9476 (Linking)', 'VI': '14', 'IP': '12', 'DP': '2015 Dec', 'TI': 'Rosuvastatin Alters the Proteome of High Density Lipoproteins: Generation of alpha-1-antitrypsin Enriched Particles with Anti-inflammatory Properties.', 'PG': '3247-57', 'LID': '10.1074/mcp.M115.054031 [doi]', 'AB': 'Statins lower plasma cholesterol by as much as 50%, thus reducing future cardiovascular events. However, the physiological effects of statins are diverse and not all are related to low density lipoprotein cholesterol (LDL-C) lowering. We performed a small clinical pilot study to assess the impact of statins on lipoprotein-associated proteins in healthy individuals (n = 10) with normal LDL-C (<130 mg/dL), who were treated with rosuvastatin (20 mg/day) for 28 days. Proteomic analysis of size-exclusion chromatography isolated LDL, large high density lipoprotein (HDL-L), and small HDL (HDL-S) fractions and spectral counting was used to compare relative protein detection before and after statin therapy. Significant protein changes were found in each lipoprotein pool and included both increases and decreases in several proteins involved in lipoprotein metabolism, complement regulation and acute phase response. The most dramatic effect of the rosuvastatin treatment was an increase in alpha-1-antirypsin (A1AT) spectral counts associated with HDL-L particles. Quantitative measurement by ELISA confirmed an average 5.7-fold increase in HDL-L associated A1AT. Molecular modeling predictions indicated that the hydrophobic reactive center loop of A1AT, the functional domain responsible for its protease inhibitor activity, is likely involved in lipid binding and association with HDL was found to protect A1AT against oxidative inactivation. Cell culture experiments, using J774 macrophages, demonstrated that the association of A1AT with HDL enhances its antiprotease activity, preventing elastase induced production of tumor necrosis factor alpha. In conclusion, we show that statins can significantly alter the protein composition of both LDL and HDL and our studies reveal a novel functional relationship between A1AT and HDL. The up-regulation of A1AT on HDL enhances its anti-inflammatory functionality, which may contribute to the non-lipid lowering beneficial effects of statins.', 'CI': ['(c) 2015 by The American Society for Biochemistry and Molecular Biology, Inc.'], 'FAU': ['Gordon, Scott M', 'McKenzie, Benjamin', 'Kemeh, Georgina', 'Sampson, Maureen', 'Perl, Shira', 'Young, Neal S', 'Fessler, Michael B', 'Remaley, Alan T'], 'AU': ['Gordon SM', 'McKenzie B', 'Kemeh G', 'Sampson M', 'Perl S', 'Young NS', 'Fessler MB', 'Remaley AT'], 'AD': ['From the double daggerLipoprotein Metabolism Section, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland; scott.gordon@nih.gov.', 'From the double daggerLipoprotein Metabolism Section, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland;', 'From the double daggerLipoprotein Metabolism Section, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland;', 'From the double daggerLipoprotein Metabolism Section, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland;', 'section signCell Biology Section, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland;', 'section signCell Biology Section, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland;', 'paragraph signImmunity, Inflammation and Disease Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina.', 'From the double daggerLipoprotein Metabolism Section, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland;'], 'LA': ['eng'], 'GR': ['Intramural NIH HHS/United States'], 'PT': ['Comparative Study', 'Journal Article', 'Research Support, N.I.H., Intramural'], 'DEP': '20151019', 'PL': 'United States', 'TA': 'Mol Cell Proteomics', 'JT': 'Molecular & cellular proteomics : MCP', 'JID': '101125647', 'RN': ['0 (Lipoproteins, HDL)', '0 (Lipoproteins, LDL)', '0 (Proteome)', '0 (alpha 1-Antitrypsin)', '83MVU38M7Q (Rosuvastatin Calcium)'], 'SB': 'IM', 'MH': ['Adult', 'Animals', 'Binding Sites/drug effects', 'Cell Line', 'Female', 'Healthy Volunteers', 'Humans', 'Lipoproteins, HDL/*metabolism', 'Lipoproteins, LDL/metabolism', 'Macrophages/cytology/metabolism', 'Male', 'Mice', 'Middle Aged', 'Models, Molecular', 'Pilot Projects', 'Proteome/*drug effects', 'Proteomics', 'Rosuvastatin Calcium/*administration & dosage/pharmacology', 'Up-Regulation/drug effects', 'alpha 1-Antitrypsin/chemistry/*metabolism'], 'PMC': 'PMC4762624', 'EDAT': '2015/10/21 06:00', 'MHDA': '2016/10/16 06:00', 'CRDT': ['2015/10/21 06:00'], 'PHST': ['2015/07/30 00:00 [received]', '2015/10/21 06:00 [entrez]', '2015/10/21 06:00 [pubmed]', '2016/10/16 06:00 [medline]'], 'AID': ['M115.054031 [pii]', '10.1074/mcp.M115.054031 [doi]'], 'PST': 'ppublish', 'SO': 'Mol Cell Proteomics. 2015 Dec;14(12):3247-57. doi: 10.1074/mcp.M115.054031. Epub 2015 Oct 19.'}\n",
      "{'PMID': '26476107', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20160404', 'LR': '20161126', 'IS': '1097-6868 (Electronic) 0002-9378 (Linking)', 'VI': '213', 'IP': '6', 'DP': '2015 Dec', 'TI': 'Alterations to the maternal circulating proteome after preeclampsia.', 'PG': '853.e1-9', 'LID': '10.1016/j.ajog.2015.10.008 [doi] S0002-9378(15)01271-5 [pii]', 'AB': 'OBJECTIVE: The long-term maternal cardiovascular and metabolic implications associated with preeclampsia (PE) include risk of hypertension, heart disease, and metabolic syndrome. The objective of this study was to investigate if a recent history of PE was associated with detectable alterations in the circulating maternal proteome. STUDY DESIGN: Six-month postpartum plasma from women with a history of PE (n = 12) and women with uncomplicated obstetrical history (n = 12) were used for analysis. Depleted maternal plasma was analyzed by label-free liquid chromatography-mass spectrometry assay. Identified peptides were searched against the International Protein Index human database version 3.87. Exponentially modified protein abundance indices were used for comparison. Results were analyzed using pathway analysis software. RESULTS: A total of 126 eligible peptides were identified for analysis; 3 peptides were differentially expressed in the PE proteome, and an additional 5 peptides were unique to control subjects and 7 to PE subjects. PE peptide profiles were more strongly associated with markers of coagulation and complement activation compared to controls and mapped more significantly to cardiovascular disease (CVD) functions. Stratification of subjects by low (<39%) and high (>/=39%) lifetime risk of CVD rather than by diagnosis produced similar findings. Comparison of controls (n = 6) to PE subjects (n = 6) without traditional cardiovascular risk factors found that while similar for body mass indices, blood pressure, and fasting lipid profiles at 6 months postpartum, PE peptide profiles continued to display stronger associations for coagulation and CVD functions. Global network analysis found that unique peptides to low-risk PE subjects were associated with cardiac infarction, CVD, and organismal injury and abnormalities. CONCLUSION: Markers of CVD risk and progression are evident in the maternal circulating proteome 6 months postpartum after PE. Augmentations in circulating peptide profiles occur in patients with previous PE who otherwise do not have clinically measurable cardiovascular risk factors. Our data highlight the need for the implementation of postpartum prevention programs in the PE population and identifies molecules that may be targeted for screening or therapeutic benefit.', 'CI': ['Copyright (c) 2015 Elsevier Inc. All rights reserved.'], 'FAU': ['Murphy, Malia Su-Qin', 'Bytautiene, Egle', 'Saade, George', 'Smith, Graeme Neil'], 'AU': ['Murphy MS', 'Bytautiene E', 'Saade G', 'Smith GN'], 'AD': [\"Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada.\", 'Department of Obstetrics and Gynecology, University of Texas Medical Branch, Galveston, TX.', 'Department of Obstetrics and Gynecology, University of Texas Medical Branch, Galveston, TX.', \"Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada; Department of Obstetrics and Gynecology, Kingston General Hospital, Kingston, Ontario, Canada. Electronic address: gns@queensu.ca.\"], 'LA': ['eng'], 'GR': ['K12HD052023/HD/NICHD NIH HHS/United States'], 'PT': ['Journal Article', 'Research Support, N.I.H., Extramural', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20151022', 'PL': 'United States', 'TA': 'Am J Obstet Gynecol', 'JT': 'American journal of obstetrics and gynecology', 'JID': '0370476', 'RN': ['0 (14-3-3 Proteins)', '0 (Blood Proteins)', '0 (Cytoskeletal Proteins)', '0 (Proteome)', '0 (YWHAZ protein, human)', 'EC 3.4.22.- (CASP12 protein, human)', 'EC 3.4.22.- (Caspase 12)'], 'SB': 'AIM IM', 'MH': ['14-3-3 Proteins/blood', 'Adult', 'Blood Proteins/analysis', 'Cardiovascular Diseases/blood', 'Case-Control Studies', 'Caspase 12/blood', 'Cytoskeletal Proteins/blood', 'Female', 'Humans', 'Postpartum Period/*blood', 'Pre-Eclampsia/*blood', 'Pregnancy', 'Proteome/*analysis', 'Risk Assessment'], 'OTO': ['NOTNLM'], 'OT': ['cardiovascular risk', 'maternal health', 'preeclampsia', 'proteome'], 'EDAT': '2015/10/18 06:00', 'MHDA': '2016/04/05 06:00', 'CRDT': ['2015/10/18 06:00'], 'PHST': ['2015/03/20 00:00 [received]', '2015/07/03 00:00 [revised]', '2015/10/07 00:00 [accepted]', '2015/10/18 06:00 [entrez]', '2015/10/18 06:00 [pubmed]', '2016/04/05 06:00 [medline]'], 'AID': ['S0002-9378(15)01271-5 [pii]', '10.1016/j.ajog.2015.10.008 [doi]'], 'PST': 'ppublish', 'SO': 'Am J Obstet Gynecol. 2015 Dec;213(6):853.e1-9. doi: 10.1016/j.ajog.2015.10.008. Epub 2015 Oct 22.'}\n",
      "{'PMID': '26437904', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20160907', 'LR': '20151126', 'IS': '1347-4820 (Electronic) 1346-9843 (Linking)', 'VI': '79', 'IP': '12', 'DP': '2015', 'TI': 'Does the Rewarmed Heart Restore the Myocardial Proteome to That of the Pre-Cooled State?--A Proteomic Analysis of Surgical Samples.', 'PG': '2648-58', 'LID': '10.1253/circj.CJ-15-0541 [doi]', 'AB': 'BACKGROUND: Hypothermia is utilized in cardiac and aortic surgery to protect organs from ischemic reperfusion injury. Although the cooled body is invariably rewarmed after the procedure, it is still unknown whether the rewarmed body regains its former biological state. This study determined the modulatory effects of hypothermia on the human myocardial proteome and whether subsequent rewarming restores the proteome to the state prior to cooling. METHODS AND RESULTS: A quantitative proteomic analysis was performed using isobaric tags for relative and absolute quantification labeling tandem mass spectrometry. Right atrial samples were taken 3 times (pre, during and post cooling) during deep hypothermic cardiopulmonary bypass (CPB) from 8 patients with aortic arch aneurysms and 3 corresponding time points during normothermic CPB from 8 patients with ascending aortic or valsalva aneurysms. In total, 697 proteins were identified, with 222 proteins having high protein confidence. Bioinformatic analyses revealed significant downregulation of 19 proteins associated with energy production at hypothermic cardioplegic arrest. On rewarmed beating, 10 proteins remained downregulated, including those regulating cardiac contraction and adaptor proteins, although levels of the aforementioned 19 downregulated proteins returned to their initial values. Additional echocardiographic evaluation demonstrated that hypothermia preserved the variables of diastolic function to a greater extent than normothermic surgery. CONCLUSIONS: Rewarming restores the human myocardial proteome to the pre-cooled state, except for proteins regulating cardiac contraction and adaptor proteins.', 'FAU': ['Oda, Teiji', 'Yamaguchi, Akane', 'Shimizu, Koji', 'Nikai, Tetsuro', 'Matsumoto, Ken-ichi'], 'AU': ['Oda T', 'Yamaguchi A', 'Shimizu K', 'Nikai T', 'Matsumoto K'], 'AD': ['Division of Thoracic and Cardiovascular Surgery, Department of Surgery, Shimane University Faculty of Medicine.'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20151002', 'PL': 'Japan', 'TA': 'Circ J', 'JT': 'Circulation journal : official journal of the Japanese Circulation Society', 'JID': '101137683', 'RN': ['0 (Muscle Proteins)', '0 (Proteome)'], 'SB': 'IM', 'CIN': ['Circ J. 2015;79(12):2549-50. PMID: 26511464'], 'MH': ['Aged', 'Cardiopulmonary Bypass', 'Female', '*Hot Temperature', 'Humans', 'Hypothermia, Induced', 'Male', 'Middle Aged', 'Muscle Proteins/*metabolism', 'Myocardium/*metabolism/pathology', 'Proteome/*metabolism', 'Proteomics/*methods'], 'EDAT': '2015/10/07 06:00', 'MHDA': '2016/09/08 06:00', 'CRDT': ['2015/10/07 06:00'], 'PHST': ['2015/10/07 06:00 [entrez]', '2015/10/07 06:00 [pubmed]', '2016/09/08 06:00 [medline]'], 'AID': ['10.1253/circj.CJ-15-0541 [doi]'], 'PST': 'ppublish', 'SO': 'Circ J. 2015;79(12):2648-58. doi: 10.1253/circj.CJ-15-0541. Epub 2015 Oct 2.'}\n",
      "{'PMID': '26285659', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20151216', 'LR': '20181202', 'IS': '2157-6564 (Print) 2157-6564 (Linking)', 'VI': '4', 'IP': '10', 'DP': '2015 Oct', 'TI': 'In Vivo Effects of Mesenchymal Stromal Cells in Two Patients With Severe Acute Respiratory Distress Syndrome.', 'PG': '1199-213', 'LID': '10.5966/sctm.2015-0021 [doi]', 'AB': 'UNLABELLED: Mesenchymal stromal cells (MSCs) have been investigated as a treatment for various inflammatory diseases because of their immunomodulatory and reparative properties. However, many basic questions concerning their mechanisms of action after systemic infusion remain unanswered. We performed a detailed analysis of the immunomodulatory properties and proteomic profile of MSCs systemically administered to two patients with severe refractory acute respiratory distress syndrome (ARDS) on a compassionate use basis and attempted to correlate these with in vivo anti-inflammatory actions. Both patients received 2x10(6) cells per kilogram, and each subsequently improved with resolution of respiratory, hemodynamic, and multiorgan failure. In parallel, a decrease was seen in multiple pulmonary and systemic markers of inflammation, including epithelial apoptosis, alveolar-capillary fluid leakage, and proinflammatory cytokines, microRNAs, and chemokines. In vitro studies of the MSCs demonstrated a broad anti-inflammatory capacity, including suppression of T-cell responses and induction of regulatory phenotypes in T cells, monocytes, and neutrophils. Some of these in vitro potency assessments correlated with, and were relevant to, the observed in vivo actions. These experiences highlight both the mechanistic information that can be gained from clinical experience and the value of correlating in vitro potency assessments with clinical effects. The findings also suggest, but do not prove, a beneficial effect of lung protective strategies using adoptively transferred MSCs in ARDS. Appropriate randomized clinical trials are required to further assess any potential clinical efficacy and investigate the effects on in vivo inflammation. SIGNIFICANCE: This article describes the cases of two patients with severe refractory adult respiratory syndrome (ARDS) who failed to improve after both standard life support measures, including mechanical ventilation, and additional measures, including extracorporeal ventilation (i.e., in a heart-lung machine). Unlike acute forms of ARDS (such in the current NIH-sponsored study of mesenchymal stromal cells in ARDS), recovery does not generally occur in such patients.', 'CI': ['(c)AlphaMed Press.'], 'FAU': ['Simonson, Oscar E', 'Mougiakakos, Dimitrios', 'Heldring, Nina', 'Bassi, Giulio', 'Johansson, Henrik J', 'Dalen, Magnus', 'Jitschin, Regina', 'Rodin, Sergey', 'Corbascio, Matthias', 'El Andaloussi, Samir', 'Wiklander, Oscar P B', 'Nordin, Joel Z', 'Skog, Johan', 'Romain, Charlotte', 'Koestler, Tina', 'Hellgren-Johansson, Laila', 'Schiller, Petter', 'Joachimsson, Per-Olof', 'Hagglund, Hans', 'Mattsson, Mattias', 'Lehtio, Janne', 'Faridani, Omid R', 'Sandberg, Rickard', 'Korsgren, Olle', 'Krampera, Mauro', 'Weiss, Daniel J', 'Grinnemo, Karl-Henrik', 'Le Blanc, Katarina'], 'AU': ['Simonson OE', 'Mougiakakos D', 'Heldring N', 'Bassi G', 'Johansson HJ', 'Dalen M', 'Jitschin R', 'Rodin S', 'Corbascio M', 'El Andaloussi S', 'Wiklander OP', 'Nordin JZ', 'Skog J', 'Romain C', 'Koestler T', 'Hellgren-Johansson L', 'Schiller P', 'Joachimsson PO', 'Hagglund H', 'Mattsson M', 'Lehtio J', 'Faridani OR', 'Sandberg R', 'Korsgren O', 'Krampera M', 'Weiss DJ', 'Grinnemo KH', 'Le Blanc K'], 'AD': ['Departments of Molecular Medicine and Surgery, Cardiothoracic Surgery and Anesthesia, and Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden; Department of Internal Medicine, Hematology and Oncology, University of Erlangen-Nuremberg, Erlangen, Germany; Stem Cell Research Laboratory, Section of Hematology, Department of Medicine, University of Verona, Verona, Italy; Cancer Proteomics Mass Spectrometry, Science for Life Laboratory, Department of Oncology-Pathology, Department of Medical Biochemistry and Biophysics, and Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden; Center for Diseases of Aging, Vaccine and Gene Therapy Institute Florida, Port St. Lucie, Florida, USA; Exosome Diagnostics Inc., New York, New York, USA; Departments of Cardiothoracic Surgery, Hematology, and Immunology, Genetics and Pathology, Uppsala University Hospital, Uppsala, Sweden; Ludwig Institute for Cancer Research, Stockholm, Sweden; Health Sciences Research Facility, Department of Medicine, University of Vermont, Burlington, Vermont, USA.', 'Departments of Molecular Medicine and Surgery, Cardiothoracic Surgery and Anesthesia, and Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden; Department of Internal Medicine, Hematology and Oncology, University of Erlangen-Nuremberg, Erlangen, Germany; Stem Cell Research Laboratory, Section of Hematology, Department of Medicine, University of Verona, Verona, Italy; Cancer Proteomics Mass Spectrometry, Science for Life Laboratory, Department of Oncology-Pathology, Department of Medical Biochemistry and Biophysics, and Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden; Center for Diseases of Aging, Vaccine and Gene Therapy Institute Florida, Port St. Lucie, Florida, USA; Exosome Diagnostics Inc., New York, New York, USA; Departments of Cardiothoracic Surgery, Hematology, and Immunology, Genetics and Pathology, Uppsala University Hospital, Uppsala, Sweden; Ludwig Institute for Cancer Research, Stockholm, Sweden; Health Sciences Research Facility, Department of Medicine, University of Vermont, Burlington, Vermont, USA.', 'Departments of Molecular Medicine and Surgery, Cardiothoracic Surgery and Anesthesia, and Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden; Department of Internal Medicine, Hematology and Oncology, University of Erlangen-Nuremberg, Erlangen, Germany; Stem Cell Research Laboratory, Section of Hematology, Department of Medicine, University of Verona, Verona, Italy; Cancer Proteomics Mass Spectrometry, Science for Life Laboratory, Department of Oncology-Pathology, Department of Medical Biochemistry and Biophysics, and Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden; Center for Diseases of Aging, Vaccine and Gene Therapy Institute Florida, Port St. Lucie, Florida, USA; Exosome Diagnostics Inc., New York, New York, USA; Departments of Cardiothoracic Surgery, Hematology, and Immunology, Genetics and Pathology, Uppsala University Hospital, Uppsala, Sweden; Ludwig Institute for Cancer Research, Stockholm, Sweden; Health Sciences Research Facility, Department of Medicine, University of Vermont, Burlington, Vermont, USA.', 'Departments of Molecular Medicine and Surgery, Cardiothoracic Surgery and Anesthesia, and Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden; Department of Internal Medicine, Hematology and Oncology, University of Erlangen-Nuremberg, Erlangen, Germany; Stem Cell Research Laboratory, Section of Hematology, Department of Medicine, University of Verona, Verona, Italy; Cancer Proteomics Mass Spectrometry, Science for Life Laboratory, Department of Oncology-Pathology, Department of Medical Biochemistry and Biophysics, and Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden; Center for Diseases of Aging, Vaccine and Gene Therapy Institute Florida, Port St. Lucie, Florida, USA; Exosome Diagnostics Inc., New York, New York, USA; Departments of Cardiothoracic Surgery, Hematology, and Immunology, Genetics and Pathology, Uppsala University Hospital, Uppsala, Sweden; Ludwig Institute for Cancer Research, Stockholm, Sweden; Health Sciences Research Facility, Department of Medicine, University of Vermont, Burlington, Vermont, USA.', 'Departments of Molecular Medicine and Surgery, Cardiothoracic Surgery and Anesthesia, and Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden; Department of Internal Medicine, Hematology and Oncology, University of Erlangen-Nuremberg, Erlangen, Germany; Stem Cell Research Laboratory, Section of Hematology, Department of Medicine, University of Verona, Verona, Italy; Cancer Proteomics Mass Spectrometry, Science for Life Laboratory, Department of Oncology-Pathology, Department of Medical Biochemistry and Biophysics, and Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden; Center for Diseases of Aging, Vaccine and Gene Therapy Institute Florida, Port St. Lucie, Florida, USA; Exosome Diagnostics Inc., New York, New York, USA; Departments of Cardiothoracic Surgery, Hematology, and Immunology, Genetics and Pathology, Uppsala University Hospital, Uppsala, Sweden; Ludwig Institute for Cancer Research, Stockholm, Sweden; Health Sciences Research Facility, Department of Medicine, University of Vermont, Burlington, Vermont, USA.', 'Departments of Molecular Medicine and Surgery, Cardiothoracic Surgery and Anesthesia, and Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden; Department of Internal Medicine, Hematology and Oncology, University of Erlangen-Nuremberg, Erlangen, Germany; Stem Cell Research Laboratory, Section of Hematology, Department of Medicine, University of Verona, Verona, Italy; Cancer Proteomics Mass Spectrometry, Science for Life Laboratory, Department of Oncology-Pathology, Department of Medical Biochemistry and Biophysics, and Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden; Center for Diseases of Aging, Vaccine and Gene Therapy Institute Florida, Port St. Lucie, Florida, USA; Exosome Diagnostics Inc., New York, New York, USA; Departments of Cardiothoracic Surgery, Hematology, and Immunology, Genetics and Pathology, Uppsala University Hospital, Uppsala, Sweden; Ludwig Institute for Cancer Research, Stockholm, Sweden; Health Sciences Research Facility, Department of Medicine, University of Vermont, Burlington, Vermont, USA.', 'Departments of Molecular Medicine and Surgery, Cardiothoracic Surgery and Anesthesia, and Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden; Department of Internal Medicine, Hematology and Oncology, University of Erlangen-Nuremberg, Erlangen, Germany; Stem Cell Research Laboratory, Section of Hematology, Department of Medicine, University of Verona, Verona, Italy; Cancer Proteomics Mass Spectrometry, Science for Life Laboratory, Department of Oncology-Pathology, Department of Medical Biochemistry and Biophysics, and Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden; Center for Diseases of Aging, Vaccine and Gene Therapy Institute Florida, Port St. Lucie, Florida, USA; Exosome Diagnostics Inc., New York, New York, USA; Departments of Cardiothoracic Surgery, Hematology, and Immunology, Genetics and Pathology, Uppsala University Hospital, Uppsala, Sweden; Ludwig Institute for Cancer Research, Stockholm, Sweden; Health Sciences Research Facility, Department of Medicine, University of Vermont, Burlington, Vermont, USA.', 'Departments of Molecular Medicine and Surgery, Cardiothoracic Surgery and Anesthesia, and Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden; Department of Internal Medicine, Hematology and Oncology, University of Erlangen-Nuremberg, Erlangen, Germany; Stem Cell Research Laboratory, Section of Hematology, Department of Medicine, University of Verona, Verona, Italy; Cancer Proteomics Mass Spectrometry, Science for Life Laboratory, Department of Oncology-Pathology, Department of Medical Biochemistry and Biophysics, and Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden; Center for Diseases of Aging, Vaccine and Gene Therapy Institute Florida, Port St. Lucie, Florida, USA; Exosome Diagnostics Inc., New York, New York, USA; Departments of Cardiothoracic Surgery, Hematology, and Immunology, Genetics and Pathology, Uppsala University Hospital, Uppsala, Sweden; Ludwig Institute for Cancer Research, Stockholm, Sweden; Health Sciences Research Facility, Department of Medicine, University of Vermont, Burlington, Vermont, USA.', 'Departments of Molecular Medicine and Surgery, Cardiothoracic Surgery and Anesthesia, and Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden; Department of Internal Medicine, Hematology and Oncology, University of Erlangen-Nuremberg, Erlangen, Germany; Stem Cell Research Laboratory, Section of Hematology, Department of Medicine, University of Verona, Verona, Italy; Cancer Proteomics Mass Spectrometry, Science for Life Laboratory, Department of Oncology-Pathology, Department of Medical Biochemistry and Biophysics, and Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden; Center for Diseases of Aging, Vaccine and Gene Therapy Institute Florida, Port St. Lucie, Florida, USA; Exosome Diagnostics Inc., New York, New York, USA; Departments of Cardiothoracic Surgery, Hematology, and Immunology, Genetics and Pathology, Uppsala University Hospital, Uppsala, Sweden; Ludwig Institute for Cancer Research, Stockholm, Sweden; Health Sciences Research Facility, Department of Medicine, University of Vermont, Burlington, Vermont, USA.', 'Departments of Molecular Medicine and Surgery, Cardiothoracic Surgery and Anesthesia, and Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden; Department of Internal Medicine, Hematology and Oncology, University of Erlangen-Nuremberg, Erlangen, Germany; Stem Cell Research Laboratory, Section of Hematology, Department of Medicine, University of Verona, Verona, Italy; Cancer Proteomics Mass Spectrometry, Science for Life Laboratory, Department of Oncology-Pathology, Department of Medical Biochemistry and Biophysics, and Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden; Center for Diseases of Aging, Vaccine and Gene Therapy Institute Florida, Port St. Lucie, Florida, USA; Exosome Diagnostics Inc., New York, New York, USA; Departments of Cardiothoracic Surgery, Hematology, and Immunology, Genetics and Pathology, Uppsala University Hospital, Uppsala, Sweden; Ludwig Institute for Cancer Research, Stockholm, Sweden; Health Sciences Research Facility, Department of Medicine, University of Vermont, Burlington, Vermont, USA.', 'Departments of Molecular Medicine and Surgery, Cardiothoracic Surgery and Anesthesia, and Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden; Department of Internal Medicine, Hematology and Oncology, University of Erlangen-Nuremberg, Erlangen, Germany; Stem Cell Research Laboratory, Section of Hematology, Department of Medicine, University of Verona, Verona, Italy; Cancer Proteomics Mass Spectrometry, Science for Life Laboratory, Department of Oncology-Pathology, Department of Medical Biochemistry and Biophysics, and Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden; Center for Diseases of Aging, Vaccine and Gene Therapy Institute Florida, Port St. Lucie, Florida, USA; Exosome Diagnostics Inc., New York, New York, USA; Departments of Cardiothoracic Surgery, Hematology, and Immunology, Genetics and Pathology, Uppsala University Hospital, Uppsala, Sweden; Ludwig Institute for Cancer Research, Stockholm, Sweden; Health Sciences Research Facility, Department of Medicine, University of Vermont, Burlington, Vermont, USA.', 'Departments of Molecular Medicine and Surgery, Cardiothoracic Surgery and Anesthesia, and Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden; Department of Internal Medicine, Hematology and Oncology, University of Erlangen-Nuremberg, Erlangen, Germany; Stem Cell Research Laboratory, Section of Hematology, Department of Medicine, University of Verona, Verona, Italy; Cancer Proteomics Mass Spectrometry, Science for Life Laboratory, Department of Oncology-Pathology, Department of Medical Biochemistry and Biophysics, and Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden; Center for Diseases of Aging, Vaccine and Gene Therapy Institute Florida, Port St. Lucie, Florida, USA; Exosome Diagnostics Inc., New York, New York, USA; Departments of Cardiothoracic Surgery, Hematology, and Immunology, Genetics and Pathology, Uppsala University Hospital, Uppsala, Sweden; Ludwig Institute for Cancer Research, Stockholm, Sweden; Health Sciences Research Facility, Department of Medicine, University of Vermont, Burlington, Vermont, USA.', 'Departments of Molecular Medicine and Surgery, Cardiothoracic Surgery and Anesthesia, and Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden; Department of Internal Medicine, Hematology and Oncology, University of Erlangen-Nuremberg, Erlangen, Germany; Stem Cell Research Laboratory, Section of Hematology, Department of Medicine, University of Verona, Verona, Italy; Cancer Proteomics Mass Spectrometry, Science for Life Laboratory, Department of Oncology-Pathology, Department of Medical Biochemistry and Biophysics, and Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden; Center for Diseases of Aging, Vaccine and Gene Therapy Institute Florida, Port St. Lucie, Florida, USA; Exosome Diagnostics Inc., New York, New York, USA; Departments of Cardiothoracic Surgery, Hematology, and Immunology, Genetics and Pathology, Uppsala University Hospital, Uppsala, Sweden; Ludwig Institute for Cancer Research, Stockholm, Sweden; Health Sciences Research Facility, Department of Medicine, University of Vermont, Burlington, Vermont, USA.', 'Departments of Molecular Medicine and Surgery, Cardiothoracic Surgery and Anesthesia, and Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden; Department of Internal Medicine, Hematology and Oncology, University of Erlangen-Nuremberg, Erlangen, Germany; Stem Cell Research Laboratory, Section of Hematology, Department of Medicine, University of Verona, Verona, Italy; Cancer Proteomics Mass Spectrometry, Science for Life Laboratory, Department of Oncology-Pathology, Department of Medical Biochemistry and Biophysics, and Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden; Center for Diseases of Aging, Vaccine and Gene Therapy Institute Florida, Port St. Lucie, Florida, USA; Exosome Diagnostics Inc., New York, New York, USA; Departments of Cardiothoracic Surgery, Hematology, and Immunology, Genetics and Pathology, Uppsala University Hospital, Uppsala, Sweden; Ludwig Institute for Cancer Research, Stockholm, Sweden; Health Sciences Research Facility, Department of Medicine, University of Vermont, Burlington, Vermont, USA.', 'Departments of Molecular Medicine and Surgery, Cardiothoracic Surgery and Anesthesia, and Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden; Department of Internal Medicine, Hematology and Oncology, University of Erlangen-Nuremberg, Erlangen, Germany; Stem Cell Research Laboratory, Section of Hematology, Department of Medicine, University of Verona, Verona, Italy; Cancer Proteomics Mass Spectrometry, Science for Life Laboratory, Department of Oncology-Pathology, Department of Medical Biochemistry and Biophysics, and Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden; Center for Diseases of Aging, Vaccine and Gene Therapy Institute Florida, Port St. Lucie, Florida, USA; Exosome Diagnostics Inc., New York, New York, USA; Departments of Cardiothoracic Surgery, Hematology, and Immunology, Genetics and Pathology, Uppsala University Hospital, Uppsala, Sweden; Ludwig Institute for Cancer Research, Stockholm, Sweden; Health Sciences Research Facility, Department of Medicine, University of Vermont, Burlington, Vermont, USA.', 'Departments of Molecular Medicine and Surgery, Cardiothoracic Surgery and Anesthesia, and Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden; Department of Internal Medicine, Hematology and Oncology, University of Erlangen-Nuremberg, Erlangen, Germany; Stem Cell Research Laboratory, Section of Hematology, Department of Medicine, University of Verona, Verona, Italy; Cancer Proteomics Mass Spectrometry, Science for Life Laboratory, Department of Oncology-Pathology, Department of Medical Biochemistry and Biophysics, and Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden; Center for Diseases of Aging, Vaccine and Gene Therapy Institute Florida, Port St. Lucie, Florida, USA; Exosome Diagnostics Inc., New York, New York, USA; Departments of Cardiothoracic Surgery, Hematology, and Immunology, Genetics and Pathology, Uppsala University Hospital, Uppsala, Sweden; Ludwig Institute for Cancer Research, Stockholm, Sweden; Health Sciences Research Facility, Department of Medicine, University of Vermont, Burlington, Vermont, USA.', 'Departments of Molecular Medicine and Surgery, Cardiothoracic Surgery and Anesthesia, and Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden; Department of Internal Medicine, Hematology and Oncology, University of Erlangen-Nuremberg, Erlangen, Germany; Stem Cell Research Laboratory, Section of Hematology, Department of Medicine, University of Verona, Verona, Italy; Cancer Proteomics Mass Spectrometry, Science for Life Laboratory, Department of Oncology-Pathology, Department of Medical Biochemistry and Biophysics, and Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden; Center for Diseases of Aging, Vaccine and Gene Therapy Institute Florida, Port St. Lucie, Florida, USA; Exosome Diagnostics Inc., New York, New York, USA; Departments of Cardiothoracic Surgery, Hematology, and Immunology, Genetics and Pathology, Uppsala University Hospital, Uppsala, Sweden; Ludwig Institute for Cancer Research, Stockholm, Sweden; Health Sciences Research Facility, Department of Medicine, University of Vermont, Burlington, Vermont, USA.', 'Departments of Molecular Medicine and Surgery, Cardiothoracic Surgery and Anesthesia, and Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden; Department of Internal Medicine, Hematology and Oncology, University of Erlangen-Nuremberg, Erlangen, Germany; Stem Cell Research Laboratory, Section of Hematology, Department of Medicine, University of Verona, Verona, Italy; Cancer Proteomics Mass Spectrometry, Science for Life Laboratory, Department of Oncology-Pathology, Department of Medical Biochemistry and Biophysics, and Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden; Center for Diseases of Aging, Vaccine and Gene Therapy Institute Florida, Port St. Lucie, Florida, USA; Exosome Diagnostics Inc., New York, New York, USA; Departments of Cardiothoracic Surgery, Hematology, and Immunology, Genetics and Pathology, Uppsala University Hospital, Uppsala, Sweden; Ludwig Institute for Cancer Research, Stockholm, Sweden; Health Sciences Research Facility, Department of Medicine, University of Vermont, Burlington, Vermont, USA.', 'Departments of Molecular Medicine and Surgery, Cardiothoracic Surgery and Anesthesia, and Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden; Department of Internal Medicine, Hematology and Oncology, University of Erlangen-Nuremberg, Erlangen, Germany; Stem Cell Research Laboratory, Section of Hematology, Department of Medicine, University of Verona, Verona, Italy; Cancer Proteomics Mass Spectrometry, Science for Life Laboratory, Department of Oncology-Pathology, Department of Medical Biochemistry and Biophysics, and Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden; Center for Diseases of Aging, Vaccine and Gene Therapy Institute Florida, Port St. Lucie, Florida, USA; Exosome Diagnostics Inc., New York, New York, USA; Departments of Cardiothoracic Surgery, Hematology, and Immunology, Genetics and Pathology, Uppsala University Hospital, Uppsala, Sweden; Ludwig Institute for Cancer Research, Stockholm, Sweden; Health Sciences Research Facility, Department of Medicine, University of Vermont, Burlington, Vermont, USA.', 'Departments of Molecular Medicine and Surgery, Cardiothoracic Surgery and Anesthesia, and Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden; Department of Internal Medicine, Hematology and Oncology, University of Erlangen-Nuremberg, Erlangen, Germany; Stem Cell Research Laboratory, Section of Hematology, Department of Medicine, University of Verona, Verona, Italy; Cancer Proteomics Mass Spectrometry, Science for Life Laboratory, Department of Oncology-Pathology, Department of Medical Biochemistry and Biophysics, and Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden; Center for Diseases of Aging, Vaccine and Gene Therapy Institute Florida, Port St. Lucie, Florida, USA; Exosome Diagnostics Inc., New York, New York, USA; Departments of Cardiothoracic Surgery, Hematology, and Immunology, Genetics and Pathology, Uppsala University Hospital, Uppsala, Sweden; Ludwig Institute for Cancer Research, Stockholm, Sweden; Health Sciences Research Facility, Department of Medicine, University of Vermont, Burlington, Vermont, USA.', 'Departments of Molecular Medicine and Surgery, Cardiothoracic Surgery and Anesthesia, and Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden; Department of Internal Medicine, Hematology and Oncology, University of Erlangen-Nuremberg, Erlangen, Germany; Stem Cell Research Laboratory, Section of Hematology, Department of Medicine, University of Verona, Verona, Italy; Cancer Proteomics Mass Spectrometry, Science for Life Laboratory, Department of Oncology-Pathology, Department of Medical Biochemistry and Biophysics, and Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden; Center for Diseases of Aging, Vaccine and Gene Therapy Institute Florida, Port St. Lucie, Florida, USA; Exosome Diagnostics Inc., New York, New York, USA; Departments of Cardiothoracic Surgery, Hematology, and Immunology, Genetics and Pathology, Uppsala University Hospital, Uppsala, Sweden; Ludwig Institute for Cancer Research, Stockholm, Sweden; Health Sciences Research Facility, Department of Medicine, University of Vermont, Burlington, Vermont, USA.', 'Departments of Molecular Medicine and Surgery, Cardiothoracic Surgery and Anesthesia, and Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden; Department of Internal Medicine, Hematology and Oncology, University of Erlangen-Nuremberg, Erlangen, Germany; Stem Cell Research Laboratory, Section of Hematology, Department of Medicine, University of Verona, Verona, Italy; Cancer Proteomics Mass Spectrometry, Science for Life Laboratory, Department of Oncology-Pathology, Department of Medical Biochemistry and Biophysics, and Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden; Center for Diseases of Aging, Vaccine and Gene Therapy Institute Florida, Port St. Lucie, Florida, USA; Exosome Diagnostics Inc., New York, New York, USA; Departments of Cardiothoracic Surgery, Hematology, and Immunology, Genetics and Pathology, Uppsala University Hospital, Uppsala, Sweden; Ludwig Institute for Cancer Research, Stockholm, Sweden; Health Sciences Research Facility, Department of Medicine, University of Vermont, Burlington, Vermont, USA.', 'Departments of Molecular Medicine and Surgery, Cardiothoracic Surgery and Anesthesia, and Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden; Department of Internal Medicine, Hematology and Oncology, University of Erlangen-Nuremberg, Erlangen, Germany; Stem Cell Research Laboratory, Section of Hematology, Department of Medicine, University of Verona, Verona, Italy; Cancer Proteomics Mass Spectrometry, Science for Life Laboratory, Department of Oncology-Pathology, Department of Medical Biochemistry and Biophysics, and Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden; Center for Diseases of Aging, Vaccine and Gene Therapy Institute Florida, Port St. Lucie, Florida, USA; Exosome Diagnostics Inc., New York, New York, USA; Departments of Cardiothoracic Surgery, Hematology, and Immunology, Genetics and Pathology, Uppsala University Hospital, Uppsala, Sweden; Ludwig Institute for Cancer Research, Stockholm, Sweden; Health Sciences Research Facility, Department of Medicine, University of Vermont, Burlington, Vermont, USA.', 'Departments of Molecular Medicine and Surgery, Cardiothoracic Surgery and Anesthesia, and Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden; Department of Internal Medicine, Hematology and Oncology, University of Erlangen-Nuremberg, Erlangen, Germany; Stem Cell Research Laboratory, Section of Hematology, Department of Medicine, University of Verona, Verona, Italy; Cancer Proteomics Mass Spectrometry, Science for Life Laboratory, Department of Oncology-Pathology, Department of Medical Biochemistry and Biophysics, and Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden; Center for Diseases of Aging, Vaccine and Gene Therapy Institute Florida, Port St. Lucie, Florida, USA; Exosome Diagnostics Inc., New York, New York, USA; Departments of Cardiothoracic Surgery, Hematology, and Immunology, Genetics and Pathology, Uppsala University Hospital, Uppsala, Sweden; Ludwig Institute for Cancer Research, Stockholm, Sweden; Health Sciences Research Facility, Department of Medicine, University of Vermont, Burlington, Vermont, USA.', 'Departments of Molecular Medicine and Surgery, Cardiothoracic Surgery and Anesthesia, and Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden; Department of Internal Medicine, Hematology and Oncology, University of Erlangen-Nuremberg, Erlangen, Germany; Stem Cell Research Laboratory, Section of Hematology, Department of Medicine, University of Verona, Verona, Italy; Cancer Proteomics Mass Spectrometry, Science for Life Laboratory, Department of Oncology-Pathology, Department of Medical Biochemistry and Biophysics, and Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden; Center for Diseases of Aging, Vaccine and Gene Therapy Institute Florida, Port St. Lucie, Florida, USA; Exosome Diagnostics Inc., New York, New York, USA; Departments of Cardiothoracic Surgery, Hematology, and Immunology, Genetics and Pathology, Uppsala University Hospital, Uppsala, Sweden; Ludwig Institute for Cancer Research, Stockholm, Sweden; Health Sciences Research Facility, Department of Medicine, University of Vermont, Burlington, Vermont, USA.', 'Departments of Molecular Medicine and Surgery, Cardiothoracic Surgery and Anesthesia, and Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden; Department of Internal Medicine, Hematology and Oncology, University of Erlangen-Nuremberg, Erlangen, Germany; Stem Cell Research Laboratory, Section of Hematology, Department of Medicine, University of Verona, Verona, Italy; Cancer Proteomics Mass Spectrometry, Science for Life Laboratory, Department of Oncology-Pathology, Department of Medical Biochemistry and Biophysics, and Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden; Center for Diseases of Aging, Vaccine and Gene Therapy Institute Florida, Port St. Lucie, Florida, USA; Exosome Diagnostics Inc., New York, New York, USA; Departments of Cardiothoracic Surgery, Hematology, and Immunology, Genetics and Pathology, Uppsala University Hospital, Uppsala, Sweden; Ludwig Institute for Cancer Research, Stockholm, Sweden; Health Sciences Research Facility, Department of Medicine, University of Vermont, Burlington, Vermont, USA.', 'Departments of Molecular Medicine and Surgery, Cardiothoracic Surgery and Anesthesia, and Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden; Department of Internal Medicine, Hematology and Oncology, University of Erlangen-Nuremberg, Erlangen, Germany; Stem Cell Research Laboratory, Section of Hematology, Department of Medicine, University of Verona, Verona, Italy; Cancer Proteomics Mass Spectrometry, Science for Life Laboratory, Department of Oncology-Pathology, Department of Medical Biochemistry and Biophysics, and Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden; Center for Diseases of Aging, Vaccine and Gene Therapy Institute Florida, Port St. Lucie, Florida, USA; Exosome Diagnostics Inc., New York, New York, USA; Departments of Cardiothoracic Surgery, Hematology, and Immunology, Genetics and Pathology, Uppsala University Hospital, Uppsala, Sweden; Ludwig Institute for Cancer Research, Stockholm, Sweden; Health Sciences Research Facility, Department of Medicine, University of Vermont, Burlington, Vermont, USA.', 'Departments of Molecular Medicine and Surgery, Cardiothoracic Surgery and Anesthesia, and Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden; Department of Internal Medicine, Hematology and Oncology, University of Erlangen-Nuremberg, Erlangen, Germany; Stem Cell Research Laboratory, Section of Hematology, Department of Medicine, University of Verona, Verona, Italy; Cancer Proteomics Mass Spectrometry, Science for Life Laboratory, Department of Oncology-Pathology, Department of Medical Biochemistry and Biophysics, and Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden; Center for Diseases of Aging, Vaccine and Gene Therapy Institute Florida, Port St. Lucie, Florida, USA; Exosome Diagnostics Inc., New York, New York, USA; Departments of Cardiothoracic Surgery, Hematology, and Immunology, Genetics and Pathology, Uppsala University Hospital, Uppsala, Sweden; Ludwig Institute for Cancer Research, Stockholm, Sweden; Health Sciences Research Facility, Department of Medicine, University of Vermont, Burlington, Vermont, USA Katarina.Leblanc@ki.se.'], 'LA': ['eng'], 'PT': ['Case Reports', 'Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20150818', 'PL': 'United States', 'TA': 'Stem Cells Transl Med', 'JT': 'Stem cells translational medicine', 'JID': '101578022', 'RN': ['0 (MicroRNAs)', '0 (Proteome)'], 'SB': 'IM', 'EIN': ['Stem Cells Transl Med. 2016 Jun;5(6):845. PMID: 27221332'], 'MH': ['Adult', 'Allografts', 'Catheterization, Central Venous', 'Cells, Cultured', 'Combined Modality Therapy', 'Compassionate Use Trials', 'Epithelium/pathology', 'Extracellular Vesicles', 'Extracorporeal Membrane Oxygenation', 'Histocompatibility', 'Humans', 'Leukemia, Myeloid, Acute/complications/therapy', 'Living Donors', 'Lung/pathology', 'Lymphocyte Culture Test, Mixed', 'Male', '*Mesenchymal Stem Cell Transplantation/methods', 'Mesenchymal Stem Cells/chemistry', 'MicroRNAs/blood', 'Middle Aged', 'Myeloid Cells/immunology', 'Proteome', 'Salvage Therapy', 'Severe Acute Respiratory Syndrome/complications/*therapy'], 'PMC': 'PMC4572899', 'OTO': ['NOTNLM'], 'OT': ['Acute respiratory distress syndrome', 'Bone marrow stromal cells', 'Cell transplantation', 'Cellular therapy', 'Clinical translation', 'Pulmonary diseases', 'Respiratory tract', 'Stem cells'], 'EDAT': '2015/08/20 06:00', 'MHDA': '2015/12/19 06:00', 'CRDT': ['2015/08/20 06:00'], 'PHST': ['2015/02/10 00:00 [received]', '2015/04/13 00:00 [accepted]', '2015/08/20 06:00 [entrez]', '2015/08/20 06:00 [pubmed]', '2015/12/19 06:00 [medline]'], 'AID': ['sctm.2015-0021 [pii]', '10.5966/sctm.2015-0021 [doi]'], 'PST': 'ppublish', 'SO': 'Stem Cells Transl Med. 2015 Oct;4(10):1199-213. doi: 10.5966/sctm.2015-0021. Epub 2015 Aug 18.'}\n",
      "{'PMID': '26160894', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20160607', 'LR': '20181202', 'IS': '1460-2385 (Electronic) 0931-0509 (Linking)', 'VI': '30', 'IP': '11', 'DP': '2015 Nov', 'TI': 'New insights in molecular mechanisms involved in chronic kidney disease using high-resolution plasma proteome analysis.', 'PG': '1842-52', 'LID': '10.1093/ndt/gfv254 [doi]', 'AB': 'BACKGROUND: The reduced glomerular filtration rate in the advanced stages of chronic kidney disease (CKD) leads to plasma accumulation of uraemic retention solutes including proteins. It has been hypothesized that these changes may, at least in part, be responsible for CKD-associated morbidity and mortality. However, most studies focused on the role of individual proteins, while a holistic, large-scale, integrative approach may generate significant additional insight. METHODS: In a discovery study, we analysed the plasma proteome of patients with stage 2-3 CKD (n = 14) and stage 5 CKD with haemodialysis (HD) (n = 15), using high-resolution LC-MS/MS analysis. Selected results were validated in a cohort of 40 patients with different CKD stages with or without HD, using ELISA. RESULTS: Of a total of 2054 detected proteins, 127 displayed lower, while 206 displayed higher abundance in the plasma of patients on HD. Molecular pathway analysis confirmed the modification of known processes involved in CKD complications, including decreased haemostasis and increased inflammation, complement activation and vascular damage. In addition, we identified the plasma increase during CKD progression of lysozyme C and leucine-rich alpha-2 glycoprotein, two proteins related to vascular damage and heart failure. High level of leucine-rich alpha-2 glycoprotein was associated with higher mortality in stage 5 CKD patients on HD. CONCLUSIONS: This study provides for the first time a comprehensive assessment of CKD plasma proteome, contributing to new knowledge and potential markers of CKD. These results will serve as a basis for future studies investigating the relevance of these molecules in CKD associated morbidity and mortality.', 'CI': ['(c) The Author 2015. Published by Oxford University Press on behalf of ERA-EDTA.', 'All rights reserved.'], 'FAU': ['Glorieux, Griet', 'Mullen, William', 'Duranton, Flore', 'Filip, Szymon', 'Gayrard, Nathalie', 'Husi, Holger', 'Schepers, Eva', 'Neirynck, Nathalie', 'Schanstra, Joost P', 'Jankowski, Joachim', 'Mischak, Harald', 'Argiles, Angel', 'Vanholder, Raymond', 'Vlahou, Antonia', 'Klein, Julie'], 'AU': ['Glorieux G', 'Mullen W', 'Duranton F', 'Filip S', 'Gayrard N', 'Husi H', 'Schepers E', 'Neirynck N', 'Schanstra JP', 'Jankowski J', 'Mischak H', 'Argiles A', 'Vanholder R', 'Vlahou A', 'Klein J'], 'AD': ['Nephrology Section, Ghent University Hospital, Gent, Belgium.', 'BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.', 'RD Nephrologie, Montpellier, France.', 'Biomedical Research Foundation, Academy of Athens, Athens, Greece Charite - Universitatsmedizin Berlin, Berlin, Germany.', 'RD Nephrologie, Montpellier, France.', 'BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.', 'Nephrology Section, Ghent University Hospital, Gent, Belgium.', 'Nephrology Section, Ghent University Hospital, Gent, Belgium.', 'Institut National de la Sante et de la Recherche Medicale (INSERM), U1048, Institute of Cardiovascular and Metabolic Disease, Toulouse, France Universite Toulouse III Paul-Sabatier, Toulouse, France.', 'University Hospital RWTH, Institute for Molecular Cardiovascular Research, Aachen, Germany.', 'BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK Mosaiques Diagnostics, Hannover, Germany.', 'RD Nephrologie, Montpellier, France.', 'Nephrology Section, Ghent University Hospital, Gent, Belgium.', 'Biomedical Research Foundation, Academy of Athens, Athens, Greece School of Biomedical & Healthcare Sciences, Plymouth University Peninsula Schools of Medicine and Dentistry, Plymouth, UK.', 'Institut National de la Sante et de la Recherche Medicale (INSERM), U1048, Institute of Cardiovascular and Metabolic Disease, Toulouse, France Universite Toulouse III Paul-Sabatier, Toulouse, France.'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20150709', 'PL': 'England', 'TA': 'Nephrol Dial Transplant', 'JT': 'Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association', 'JID': '8706402', 'RN': ['0 (Biomarkers)', '0 (Proteome)'], 'SB': 'IM', 'MH': ['Aged', 'Biomarkers/*blood', 'Chromatography, Liquid/methods', 'Female', 'Humans', 'Male', 'Middle Aged', 'Proteome/*analysis', 'Renal Insufficiency, Chronic/*blood', 'Tandem Mass Spectrometry/*methods'], 'OTO': ['NOTNLM'], 'OT': ['biomarkers', 'chronic kidney disease', 'haemodialysis', 'mechanisms', 'proteomics', 'uraemic solutes'], 'EDAT': '2015/07/15 06:00', 'MHDA': '2016/06/09 06:00', 'CRDT': ['2015/07/11 06:00'], 'PHST': ['2015/01/23 00:00 [received]', '2015/05/21 00:00 [accepted]', '2015/07/11 06:00 [entrez]', '2015/07/15 06:00 [pubmed]', '2016/06/09 06:00 [medline]'], 'AID': ['gfv254 [pii]', '10.1093/ndt/gfv254 [doi]'], 'PST': 'ppublish', 'SO': 'Nephrol Dial Transplant. 2015 Nov;30(11):1842-52. doi: 10.1093/ndt/gfv254. Epub 2015 Jul 9.'}\n",
      "{'PMID': '26078484', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20160229', 'LR': '20201209', 'IS': '1875-8630 (Electronic) 0278-0240 (Linking)', 'VI': '2015', 'DP': '2015', 'TI': 'Monitoring of Serial Presurgical and Postsurgical Changes in the Serum Proteome in a Series of Patients with Calcific Aortic Stenosis.', 'PG': '694120', 'LID': '10.1155/2015/694120 [doi]', 'AB': \"BACKGROUND: Comprehensive analysis of proteome differentially expressed in response to surgery or drug treatment is useful to understand biological responses to dispensed interventions. Here we investigated expression changes in sera of patients who suffered from calcific aortic stenosis (CAS), before and after surgery for aortic valve replacement. MATERIALS AND METHODS: Sera obtained before and after surgery with depletion of highly abundant proteins were analyzed with iTRAQ labeling followed by nanoLC-MALDI-TOF/TOF-MS/MS. RESULTS: Fifty-one proteins shared in five patients were identified with differential levels in postsurgical and presurgical sera. Finally, 16 proteins that show statistically significant levels in patients' sera compared with those in control sera (P < 0.05) were identified. Most of the identified proteins were positive acute-phase proteins. Among three proteins other than acute-phase proteins, we confirmed increased levels of antithrombin-III and zinc-alpha-2-glycoprotein in postsurgical sera by Western blot analysis using other CAS patients' sera. Furthermore, antithrombin-III and zinc-alpha-2-glycoprotein were not found among proteins with differential levels in postsurgical and presurgical sera of patients with aortic aneurysms that we identified in a previous study. CONCLUSIONS: The results indicated that antithrombin-III and zinc-alpha-2-glycoprotein would become unique monitoring proteins for evaluating pathophysiological and biochemical processes occurring before and after surgery for CAS.\", 'FAU': ['Satoh, Kazumi', 'Yamada, Kazuo', 'Maniwa, Tomoko', 'Oda, Teiji', 'Matsumoto, Ken-ichi'], 'AU': ['Satoh K', 'Yamada K', 'Maniwa T', 'Oda T', 'Matsumoto K'], 'AD': ['Department of Biosignaling and Radioisotope Experiment, Interdisciplinary Center for Science Research, Organization for Research, Shimane University, Izumo, Shimane 693-8501, Japan.', 'Department of Biosignaling and Radioisotope Experiment, Interdisciplinary Center for Science Research, Organization for Research, Shimane University, Izumo, Shimane 693-8501, Japan ; Department of Biochemistry, Faculty of Medicine, Shimane University, Izumo, Shimane 693-8501, Japan.', 'Department of Biosignaling and Radioisotope Experiment, Interdisciplinary Center for Science Research, Organization for Research, Shimane University, Izumo, Shimane 693-8501, Japan.', 'Division of Cardiovascular and Thoracic Surgery, Department of Surgery, Faculty of Medicine, Shimane University, Izumo, Shimane 693-8501, Japan.', 'Department of Biosignaling and Radioisotope Experiment, Interdisciplinary Center for Science Research, Organization for Research, Shimane University, Izumo, Shimane 693-8501, Japan.'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20150520', 'PL': 'United States', 'TA': 'Dis Markers', 'JT': 'Disease markers', 'JID': '8604127', 'RN': ['0 (AZGP1 protein, human)', '0 (Acute-Phase Proteins)', '0 (Adipokines)', '0 (Biomarkers)', '0 (Carrier Proteins)', '0 (Glycoproteins)', '0 (Proteome)', '9000-94-6 (Antithrombin III)', 'Aortic Valve, Calcification of'], 'SB': 'IM', 'MH': ['Acute-Phase Proteins/metabolism', 'Adipokines', 'Aged', 'Antithrombin III/*metabolism', 'Aortic Valve/*pathology/surgery', 'Aortic Valve Stenosis/blood/*surgery', 'Biomarkers/*blood', 'Calcinosis/blood/*surgery', 'Carrier Proteins/*blood', 'Female', 'Glycoproteins/*blood', 'Humans', 'Male', 'Proteome/*metabolism', 'Transcatheter Aortic Valve Replacement'], 'PMC': 'PMC4452854', 'EDAT': '2015/06/17 06:00', 'MHDA': '2016/03/02 06:00', 'CRDT': ['2015/06/17 06:00'], 'PHST': ['2015/01/29 00:00 [received]', '2015/05/08 00:00 [accepted]', '2015/06/17 06:00 [entrez]', '2015/06/17 06:00 [pubmed]', '2016/03/02 06:00 [medline]'], 'AID': ['10.1155/2015/694120 [doi]'], 'PST': 'ppublish', 'SO': 'Dis Markers. 2015;2015:694120. doi: 10.1155/2015/694120. Epub 2015 May 20.'}\n",
      "{'PMID': '26063667', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20150825', 'LR': '20160726', 'IS': '1524-4563 (Electronic) 0194-911X (Linking)', 'VI': '66', 'IP': '1', 'DP': '2015 Jul', 'TI': 'Urinary Proteome and Systolic Blood Pressure as Predictors of 5-Year Cardiovascular and Cardiac Outcomes in a General Population.', 'PG': '52-60', 'LID': '10.1161/HYPERTENSIONAHA.115.05296 [doi]', 'AB': \"In a previous cross-sectional study, we identified a multidimensional urinary classifier (HF1), which was associated with left ventricular dysfunction. We investigated whether HF1 predicts cardiovascular end points over and beyond traditional risk factors. In 791 randomly recruited Flemish (mean age, 51.2 years; 50.6% women), we quantified HF1 by capillary electrophoresis coupled with mass spectrometry. In addition, we measured cardiovascular risk factors. HF1 averaged -0.97 U (range, -3.26 to 2.60). Over 6.1 years (median), 35 participants died and 63, 45, and 22 experienced fatal or nonfatal cardiovascular, cardiac, or coronary events, respectively. The incidence of fatal combined with nonfatal cardiovascular and cardiac end points, standardized for sex and age, increased across thirds of the HF1 distribution (P</=0.014), whereas trends for all-cause mortality and coronary events were nonsignificant (P>/=0.10). The multivariable-adjusted hazard ratios (+1-SD) were 1.30 (95% confidence interval, 1.03-1.65; P=0.029) and 1.39 (1.06-1.84; P=0.018) for cardiovascular and cardiac events in relation to HF1. For systolic pressure, the corresponding estimates were 0.97 (0.74-1.28; P=0.85) and 0.93 (0.67-1.29; P=0.66), respectively. The HF1 upper thresholds optimized by maximizing Younden's index were -0.50 and -0.36 U for cardiovascular and cardiac end points, respectively. Prognostic accuracy significantly (P</=0.006) improved by adding HF1 to Cox models already including the other baseline predictors. Sensitivity analyses, from which we excluded 71 participants with previous cardiovascular disease, were confirmatory. In conclusion, over a 6-year period, the urinary proteome, but not systolic pressure, predicted cardiovascular and cardiac disease.\", 'CI': ['(c) 2015 American Heart Association, Inc.'], 'FAU': ['Zhang, Zhen-Yu', 'Thijs, Lutgarde', 'Petit, Thibault', 'Gu, Yu-Mei', 'Jacobs, Lotte', 'Yang, Wen-Yi', 'Liu, Yan-Ping', 'Koeck, Thomas', 'Zurbig, Petra', 'Jin, Yu', 'Verhamme, Peter', 'Voigt, Jens-Uwe', 'Kuznetsova, Tatiana', 'Mischak, Harald', 'Staessen, Jan A'], 'AU': ['Zhang ZY', 'Thijs L', 'Petit T', 'Gu YM', 'Jacobs L', 'Yang WY', 'Liu YP', 'Koeck T', 'Zurbig P', 'Jin Y', 'Verhamme P', 'Voigt JU', 'Kuznetsova T', 'Mischak H', 'Staessen JA'], 'AD': ['From the Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology (Z.-Y.Z., L.T., T.P., Y.-M.G., L.J., W.-Y.Y., Y.-P.L., Y.J., T. Kuznetsova, J.A.S.), Centre for Molecular and Vascular Biology (P.V.), and Research Unit Cardiology (J.-U.V.), KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; Mosaiques Diagnostic and Therapeutics GmbH, Hannover, Germany (T. Koeck, P.Z., H.M.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, United Kingdom (H.M.); and R&D VitaK Group, Maastricht University, Maastricht, The Netherlands (J.A.S.).', 'From the Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology (Z.-Y.Z., L.T., T.P., Y.-M.G., L.J., W.-Y.Y., Y.-P.L., Y.J., T. Kuznetsova, J.A.S.), Centre for Molecular and Vascular Biology (P.V.), and Research Unit Cardiology (J.-U.V.), KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; Mosaiques Diagnostic and Therapeutics GmbH, Hannover, Germany (T. Koeck, P.Z., H.M.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, United Kingdom (H.M.); and R&D VitaK Group, Maastricht University, Maastricht, The Netherlands (J.A.S.).', 'From the Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology (Z.-Y.Z., L.T., T.P., Y.-M.G., L.J., W.-Y.Y., Y.-P.L., Y.J., T. Kuznetsova, J.A.S.), Centre for Molecular and Vascular Biology (P.V.), and Research Unit Cardiology (J.-U.V.), KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; Mosaiques Diagnostic and Therapeutics GmbH, Hannover, Germany (T. Koeck, P.Z., H.M.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, United Kingdom (H.M.); and R&D VitaK Group, Maastricht University, Maastricht, The Netherlands (J.A.S.).', 'From the Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology (Z.-Y.Z., L.T., T.P., Y.-M.G., L.J., W.-Y.Y., Y.-P.L., Y.J., T. Kuznetsova, J.A.S.), Centre for Molecular and Vascular Biology (P.V.), and Research Unit Cardiology (J.-U.V.), KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; Mosaiques Diagnostic and Therapeutics GmbH, Hannover, Germany (T. Koeck, P.Z., H.M.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, United Kingdom (H.M.); and R&D VitaK Group, Maastricht University, Maastricht, The Netherlands (J.A.S.).', 'From the Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology (Z.-Y.Z., L.T., T.P., Y.-M.G., L.J., W.-Y.Y., Y.-P.L., Y.J., T. Kuznetsova, J.A.S.), Centre for Molecular and Vascular Biology (P.V.), and Research Unit Cardiology (J.-U.V.), KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; Mosaiques Diagnostic and Therapeutics GmbH, Hannover, Germany (T. Koeck, P.Z., H.M.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, United Kingdom (H.M.); and R&D VitaK Group, Maastricht University, Maastricht, The Netherlands (J.A.S.).', 'From the Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology (Z.-Y.Z., L.T., T.P., Y.-M.G., L.J., W.-Y.Y., Y.-P.L., Y.J., T. Kuznetsova, J.A.S.), Centre for Molecular and Vascular Biology (P.V.), and Research Unit Cardiology (J.-U.V.), KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; Mosaiques Diagnostic and Therapeutics GmbH, Hannover, Germany (T. Koeck, P.Z., H.M.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, United Kingdom (H.M.); and R&D VitaK Group, Maastricht University, Maastricht, The Netherlands (J.A.S.).', 'From the Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology (Z.-Y.Z., L.T., T.P., Y.-M.G., L.J., W.-Y.Y., Y.-P.L., Y.J., T. Kuznetsova, J.A.S.), Centre for Molecular and Vascular Biology (P.V.), and Research Unit Cardiology (J.-U.V.), KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; Mosaiques Diagnostic and Therapeutics GmbH, Hannover, Germany (T. Koeck, P.Z., H.M.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, United Kingdom (H.M.); and R&D VitaK Group, Maastricht University, Maastricht, The Netherlands (J.A.S.).', 'From the Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology (Z.-Y.Z., L.T., T.P., Y.-M.G., L.J., W.-Y.Y., Y.-P.L., Y.J., T. Kuznetsova, J.A.S.), Centre for Molecular and Vascular Biology (P.V.), and Research Unit Cardiology (J.-U.V.), KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; Mosaiques Diagnostic and Therapeutics GmbH, Hannover, Germany (T. Koeck, P.Z., H.M.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, United Kingdom (H.M.); and R&D VitaK Group, Maastricht University, Maastricht, The Netherlands (J.A.S.).', 'From the Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology (Z.-Y.Z., L.T., T.P., Y.-M.G., L.J., W.-Y.Y., Y.-P.L., Y.J., T. Kuznetsova, J.A.S.), Centre for Molecular and Vascular Biology (P.V.), and Research Unit Cardiology (J.-U.V.), KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; Mosaiques Diagnostic and Therapeutics GmbH, Hannover, Germany (T. Koeck, P.Z., H.M.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, United Kingdom (H.M.); and R&D VitaK Group, Maastricht University, Maastricht, The Netherlands (J.A.S.).', 'From the Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology (Z.-Y.Z., L.T., T.P., Y.-M.G., L.J., W.-Y.Y., Y.-P.L., Y.J., T. Kuznetsova, J.A.S.), Centre for Molecular and Vascular Biology (P.V.), and Research Unit Cardiology (J.-U.V.), KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; Mosaiques Diagnostic and Therapeutics GmbH, Hannover, Germany (T. Koeck, P.Z., H.M.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, United Kingdom (H.M.); and R&D VitaK Group, Maastricht University, Maastricht, The Netherlands (J.A.S.).', 'From the Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology (Z.-Y.Z., L.T., T.P., Y.-M.G., L.J., W.-Y.Y., Y.-P.L., Y.J., T. Kuznetsova, J.A.S.), Centre for Molecular and Vascular Biology (P.V.), and Research Unit Cardiology (J.-U.V.), KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; Mosaiques Diagnostic and Therapeutics GmbH, Hannover, Germany (T. Koeck, P.Z., H.M.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, United Kingdom (H.M.); and R&D VitaK Group, Maastricht University, Maastricht, The Netherlands (J.A.S.).', 'From the Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology (Z.-Y.Z., L.T., T.P., Y.-M.G., L.J., W.-Y.Y., Y.-P.L., Y.J., T. Kuznetsova, J.A.S.), Centre for Molecular and Vascular Biology (P.V.), and Research Unit Cardiology (J.-U.V.), KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; Mosaiques Diagnostic and Therapeutics GmbH, Hannover, Germany (T. Koeck, P.Z., H.M.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, United Kingdom (H.M.); and R&D VitaK Group, Maastricht University, Maastricht, The Netherlands (J.A.S.).', 'From the Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology (Z.-Y.Z., L.T., T.P., Y.-M.G., L.J., W.-Y.Y., Y.-P.L., Y.J., T. Kuznetsova, J.A.S.), Centre for Molecular and Vascular Biology (P.V.), and Research Unit Cardiology (J.-U.V.), KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; Mosaiques Diagnostic and Therapeutics GmbH, Hannover, Germany (T. Koeck, P.Z., H.M.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, United Kingdom (H.M.); and R&D VitaK Group, Maastricht University, Maastricht, The Netherlands (J.A.S.).', 'From the Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology (Z.-Y.Z., L.T., T.P., Y.-M.G., L.J., W.-Y.Y., Y.-P.L., Y.J., T. Kuznetsova, J.A.S.), Centre for Molecular and Vascular Biology (P.V.), and Research Unit Cardiology (J.-U.V.), KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; Mosaiques Diagnostic and Therapeutics GmbH, Hannover, Germany (T. Koeck, P.Z., H.M.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, United Kingdom (H.M.); and R&D VitaK Group, Maastricht University, Maastricht, The Netherlands (J.A.S.).', 'From the Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology (Z.-Y.Z., L.T., T.P., Y.-M.G., L.J., W.-Y.Y., Y.-P.L., Y.J., T. Kuznetsova, J.A.S.), Centre for Molecular and Vascular Biology (P.V.), and Research Unit Cardiology (J.-U.V.), KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; Mosaiques Diagnostic and Therapeutics GmbH, Hannover, Germany (T. Koeck, P.Z., H.M.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, United Kingdom (H.M.); and R&D VitaK Group, Maastricht University, Maastricht, The Netherlands (J.A.S.). jan.staessen@med.kuleuven.be ja.staessen@maastrichtuniversity.nl.'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20150511', 'PL': 'United States', 'TA': 'Hypertension', 'JT': 'Hypertension (Dallas, Tex. : 1979)', 'JID': '7906255', 'RN': ['0 (Antihypertensive Agents)', '0 (Peptides)', '0 (Proteome)', '97C5T2UQ7J (Cholesterol)'], 'SB': 'IM', 'MH': ['Adult', 'Antihypertensive Agents/therapeutic use', 'Belgium/epidemiology', '*Blood Pressure', 'Body Mass Index', 'Cardiovascular Diseases/*epidemiology', 'Cholesterol/blood', 'Coronary Disease/epidemiology', 'Diabetes Mellitus/epidemiology', 'Electrophoresis, Capillary', 'Female', 'Follow-Up Studies', 'Humans', 'Hypertension/drug therapy/epidemiology', 'Incidence', 'Male', 'Mass Spectrometry', 'Middle Aged', 'Mortality', 'Peptides/*urine', 'Prognosis', 'Proportional Hazards Models', 'Proteome', 'Sensitivity and Specificity', 'Survival Analysis', 'Systole', 'Urinalysis/methods'], 'OTO': ['NOTNLM'], 'OT': ['biomarker', 'cardiovascular disease', 'morbidity', 'mortality', 'proteomics'], 'EDAT': '2015/06/13 06:00', 'MHDA': '2015/08/26 06:00', 'CRDT': ['2015/06/12 06:00'], 'PHST': ['2015/02/27 00:00 [received]', '2015/04/17 00:00 [accepted]', '2015/06/12 06:00 [entrez]', '2015/06/13 06:00 [pubmed]', '2015/08/26 06:00 [medline]'], 'AID': ['HYPERTENSIONAHA.115.05296 [pii]', '10.1161/HYPERTENSIONAHA.115.05296 [doi]'], 'PST': 'ppublish', 'SO': 'Hypertension. 2015 Jul;66(1):52-60. doi: 10.1161/HYPERTENSIONAHA.115.05296. Epub 2015 May 11.'}\n",
      "{'PMID': '26037829', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20151001', 'LR': '20161126', 'IS': '0006-3002 (Print) 0006-3002 (Linking)', 'VI': '1851', 'IP': '9', 'DP': '2015 Sep', 'TI': 'Defective functionality of small, dense HDL3 subpopulations in ST segment elevation myocardial infarction: Relevance of enrichment in lysophosphatidylcholine, phosphatidic acid and serum amyloid A.', 'PG': '1254-61', 'LID': '10.1016/j.bbalip.2015.05.007 [doi] S1388-1981(15)00121-3 [pii]', 'AB': 'BACKGROUND: Low plasma levels of high-density lipoprotein-cholesterol (HDL-C) are typical of acute myocardial infarction (MI) and predict risk of recurrent cardiovascular events. The potential relationships between modifications in the molecular composition and the functionality of HDL subpopulations in acute MI however remain indeterminate. METHODS AND RESULTS: ST segment elevation MI (STEMI) patients were recruited within 24h after diagnosis (n=16) and featured low HDL-C (-31%, p<0.05) and acute-phase inflammation (determined as marked elevations in C-reactive protein, serum amyloid A (SAA) and interleukin-6) as compared to age- and sex-matched controls (n=10). STEMI plasma HDL and its subpopulations (HDL2b, 2a, 3a, 3b, 3c) displayed attenuated cholesterol efflux capacity from THP-1 cells (up to -32%, p<0.01, on a unit phospholipid mass basis) vs. CONTROLS: Plasma HDL and small, dense HDL3b and 3c subpopulations from STEMI patients exhibited reduced anti-oxidative activity (up to -68%, p<0.05, on a unit HDL mass basis). HDL subpopulations in STEMI were enriched in two proinflammatory bioactive lipids, lysophosphatidylcholine (up to 3.0-fold, p<0.05) and phosphatidic acid (up to 8.4-fold, p<0.05), depleted in apolipoprotein A-I (up to -23%, p<0.05) and enriched in SAA (up to +10.2-fold, p<0.05); such changes were most marked in the HDL3b subfraction. In vitro HDL enrichment in both lysophosphatidylcholine and phosphatidic acid exerted deleterious effects on HDL functionality. CONCLUSIONS: In the early phase of STEMI, HDL particle subpopulations display marked, concomitant alterations in both lipidome and proteome which are implicated in impaired HDL functionality. Such modifications may act synergistically to confer novel deleterious biological activities to STEMI HDL. SIGNIFICANCE: Our present data highlight complex changes in the molecular composition and functionality of HDL particle subpopulations in the acute phase of STEMI, and for the first time, reveal that concomitant modifications in both the lipidome and proteome contribute to functional deficiencies in cholesterol efflux and antioxidative activities of HDL particles. These findings may provide new biomarkers and new insights in therapeutic strategy to reduce cardiovascular risk in this clinical setting where such net deficiency in HDL function, multiplied by low circulating HDL concentrations, can be expected to contribute to accelerated atherogenesis.', 'CI': ['Copyright (c) 2015 Elsevier B.V. All rights reserved.'], 'FAU': ['Rached, Fabiana', 'Lhomme, Marie', 'Camont, Laurent', 'Gomes, Fernando', 'Dauteuille, Carolane', 'Robillard, Paul', 'Santos, Raul D', 'Lesnik, Philippe', 'Serrano, Carlos V Jr', 'Chapman, M John', 'Kontush, Anatol'], 'AU': ['Rached F', 'Lhomme M', 'Camont L', 'Gomes F', 'Dauteuille C', 'Robillard P', 'Santos RD', 'Lesnik P', 'Serrano CV Jr', 'Chapman MJ', 'Kontush A'], 'AD': ['National Institute of Health and Medical Research (INSERM), UMR-ICAN 1166, University of Pierre and Marie Curie - Paris 6; Pitie-Salpetriere University Hospital, ICAN, Paris, France; Heart Institute-InCor, University of Sao Paulo Medical School Hospital, Sao Paulo, Brazil.', 'National Institute of Health and Medical Research (INSERM), UMR-ICAN 1166, University of Pierre and Marie Curie - Paris 6; Pitie-Salpetriere University Hospital, ICAN, Paris, France.', 'National Institute of Health and Medical Research (INSERM), UMR-ICAN 1166, University of Pierre and Marie Curie - Paris 6; Pitie-Salpetriere University Hospital, ICAN, Paris, France.', 'Heart Institute-InCor, University of Sao Paulo Medical School Hospital, Sao Paulo, Brazil.', 'National Institute of Health and Medical Research (INSERM), UMR-ICAN 1166, University of Pierre and Marie Curie - Paris 6; Pitie-Salpetriere University Hospital, ICAN, Paris, France.', 'National Institute of Health and Medical Research (INSERM), UMR-ICAN 1166, University of Pierre and Marie Curie - Paris 6; Pitie-Salpetriere University Hospital, ICAN, Paris, France.', 'Heart Institute-InCor, University of Sao Paulo Medical School Hospital, Sao Paulo, Brazil.', 'National Institute of Health and Medical Research (INSERM), UMR-ICAN 1166, University of Pierre and Marie Curie - Paris 6; Pitie-Salpetriere University Hospital, ICAN, Paris, France.', 'Heart Institute-InCor, University of Sao Paulo Medical School Hospital, Sao Paulo, Brazil.', 'National Institute of Health and Medical Research (INSERM), UMR-ICAN 1166, University of Pierre and Marie Curie - Paris 6; Pitie-Salpetriere University Hospital, ICAN, Paris, France.', 'National Institute of Health and Medical Research (INSERM), UMR-ICAN 1166, University of Pierre and Marie Curie - Paris 6; Pitie-Salpetriere University Hospital, ICAN, Paris, France. Electronic address: anatol.kontush@upmc.fr.'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20150530', 'PL': 'Netherlands', 'TA': 'Biochim Biophys Acta', 'JT': 'Biochimica et biophysica acta', 'JID': '0217513', 'RN': ['0 (Apolipoprotein A-I)', '0 (IL6 protein, human)', '0 (Interleukin-6)', '0 (Lipoproteins, HDL3)', '0 (Lysophosphatidylcholines)', '0 (Phosphatidic Acids)', '0 (Proteome)', '0 (Serum Amyloid A Protein)', '9007-41-4 (C-Reactive Protein)'], 'SB': 'IM', 'MH': ['Adult', 'Aged', 'Apolipoprotein A-I/chemistry/deficiency/metabolism', 'C-Reactive Protein/metabolism', 'Case-Control Studies', 'Cell Line', 'Female', 'Humans', 'Interleukin-6/blood', 'Lipoproteins, HDL3/*blood/chemistry', 'Lysophosphatidylcholines/*blood/chemistry', 'Male', 'Middle Aged', 'Monocytes/metabolism', 'Myocardial Infarction/*blood/pathology', 'Phosphatidic Acids/*blood/chemistry', 'Proteome/chemistry/metabolism', 'Serum Amyloid A Protein/*metabolism'], 'OTO': ['NOTNLM'], 'OT': ['Acute myocardial infarction', 'Antioxidative activity', 'Cholesterol efflux', 'HDL', 'Inflammation', 'Lipidomics'], 'EDAT': '2015/06/04 06:00', 'MHDA': '2015/10/02 06:00', 'CRDT': ['2015/06/04 06:00'], 'PHST': ['2014/07/16 00:00 [received]', '2015/05/13 00:00 [revised]', '2015/05/27 00:00 [accepted]', '2015/06/04 06:00 [entrez]', '2015/06/04 06:00 [pubmed]', '2015/10/02 06:00 [medline]'], 'AID': ['S1388-1981(15)00121-3 [pii]', '10.1016/j.bbalip.2015.05.007 [doi]'], 'PST': 'ppublish', 'SO': 'Biochim Biophys Acta. 2015 Sep;1851(9):1254-61. doi: 10.1016/j.bbalip.2015.05.007. Epub 2015 May 30.'}\n",
      "{'PMID': '26028931', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20160314', 'LR': '20181113', 'IS': '1598-6357 (Electronic) 1011-8934 (Linking)', 'VI': '30', 'IP': '6', 'DP': '2015 Jun', 'TI': 'The Proteomic Analysis of Human Placenta with Pre-eclampsia and Normal Pregnancy.', 'PG': '770-8', 'LID': '10.3346/jkms.2015.30.6.770 [doi]', 'AB': \"Preeclampsia is one of the most important and complexed disorders for women's health. Searching for novel proteins as biomarkers to reveal pathogenesis, proteomic approaches using 2DE has become a valuable tool to understanding of preeclampsia. To analyze the proteomic profiling of preclamptic placenta compared to that of normal pregnancy for better understanding of pathogenesis in preeclampsia, placentas from each group were handled by use of proteomics approach using 2DE combined with MALDI-TOF-MS. The 20 spots of showing differences were analysed and identified. Among differentially expressed protein spots Hsp 27 and Hsp 70 were selected for validation using Western blot analysis. In preeclamptic placenta 9 differentially expressed proteins were down-regulated with Hsp 70, serum albumin crystal structure chain A, lamin B2, cytokeratin 18, actin cytoplasmic, alpha fibrinogen precursor, septin 2, dihydrolipoamide branched chain transacylase E2 and firbrinogen beta chain. The 11 up-regulated proteins were fibrinogen gamma, cardiac muscle alpha actin proprotein, cytokeratin 8, calumenin, fibrinogen fragment D, F-actin capping protein alpha-1 subunit, Hsp 27, Hsp 40, annexin A4, enoyl-CoA delta isomerase and programmed cell death protein 6. The western blot analysis for validation also showed significant up-regulation of Hsp 27 and down-regulation of Hsp 70 in the placental tissues with preeclmaptic pregnancies. This proteomic profiling of placenta using 2DE in preeclampsia successfully identifies various proteins involved in apoptosis, mitochondrial dysfunction, as well as three Hsps with altered expression, which might play a important role for the understanding of pathogenesis in preeclampsia.\", 'FAU': ['Yang, Jeong In', 'Kong, Tae Wook', 'Kim, Haeng Soo', 'Kim, Ho Yeon'], 'AU': ['Yang JI', 'Kong TW', 'Kim HS', 'Kim HY'], 'AUID': ['ORCID: 0000-0001-5646-9009', 'ORCID: 0000-0002-9007-565X', 'ORCID: 0000-0002-8251-1175', 'ORCID: 0000-0003-1140-1689'], 'AD': ['Department of Obstetrics and Gynecology, Ajou University Medical School, Suwon, Korea.', 'Department of Obstetrics and Gynecology, Ajou University Medical School, Suwon, Korea.', 'Department of Obstetrics and Gynecology, Ajou University Medical School, Suwon, Korea.', 'Department of Obstetrics and Gynecology, Kangdong Sacred Heart Hospital, Hallym University Medical School, Seoul, Korea.'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20150513', 'PL': 'Korea (South)', 'TA': 'J Korean Med Sci', 'JT': 'Journal of Korean medical science', 'JID': '8703518', 'RN': ['0 (Proteome)'], 'SB': 'IM', 'MH': ['Adult', 'Female', 'Humans', 'Placenta/*metabolism', 'Pre-Eclampsia/*metabolism', 'Pregnancy/*metabolism', 'Proteome/*metabolism', 'Reproducibility of Results', 'Sensitivity and Specificity'], 'PMC': 'PMC4444479', 'OTO': ['NOTNLM'], 'OT': ['Blotting, Western', 'Placenta', 'Pre-eclampsia', 'Proteomics', 'Spectrometry, Mass, Matrix-assisted Laser Desorption-ionization'], 'EDAT': '2015/06/02 06:00', 'MHDA': '2016/03/15 06:00', 'CRDT': ['2015/06/02 06:00'], 'PHST': ['2014/11/17 00:00 [received]', '2015/02/03 00:00 [accepted]', '2015/06/02 06:00 [entrez]', '2015/06/02 06:00 [pubmed]', '2016/03/15 06:00 [medline]'], 'AID': ['10.3346/jkms.2015.30.6.770 [doi]'], 'PST': 'ppublish', 'SO': 'J Korean Med Sci. 2015 Jun;30(6):770-8. doi: 10.3346/jkms.2015.30.6.770. Epub 2015 May 13.'}\n",
      "{'PMID': '25995210', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20160426', 'LR': '20181113', 'IS': '1539-7262 (Electronic) 0022-2275 (Linking)', 'VI': '56', 'IP': '8', 'DP': '2015 Aug', 'TI': 'Inflammatory remodeling of the HDL proteome impairs cholesterol efflux capacity.', 'PG': '1519-30', 'LID': '10.1194/jlr.M059089 [doi]', 'AB': \"Recent studies demonstrate that HDL's ability to promote cholesterol efflux from macrophages associates strongly with cardioprotection in humans independently of HDL-cholesterol (HDL-C) and apoA-I, HDL's major protein. However, the mechanisms that impair cholesterol efflux capacity during vascular disease are unclear. Inflammation, a well-established risk factor for cardiovascular disease, has been shown to impair HDL's cholesterol efflux capacity. We therefore tested the hypothesis that HDL's impaired efflux capacity is mediated by specific changes of its protein cargo. Humans with acute inflammation induced by low-level endotoxin had unchanged HDL-C levels, but their HDL-C efflux capacity was significantly impaired. Proteomic analyses demonstrated that HDL's cholesterol efflux capacity correlated inversely with HDL content of serum amyloid A (SAA)1 and SAA2. In mice, acute inflammation caused a marked impairment of HDL-C efflux capacity that correlated with a large increase in HDL SAA. In striking contrast, the efflux capacity of mouse inflammatory HDL was preserved with genetic ablation of SAA1 and SAA2. Our observations indicate that the inflammatory impairment of HDL-C efflux capacity is due in part to SAA-mediated remodeling of HDL's protein cargo.\", 'FAU': ['Vaisar, Tomas', 'Tang, Chongren', 'Babenko, Ilona', 'Hutchins, Patrick', 'Wimberger, Jake', 'Suffredini, Anthony F', 'Heinecke, Jay W'], 'AU': ['Vaisar T', 'Tang C', 'Babenko I', 'Hutchins P', 'Wimberger J', 'Suffredini AF', 'Heinecke JW'], 'AD': ['Department of Medicine, University of Washington, Seattle, WA 98105.', 'Department of Medicine, University of Washington, Seattle, WA 98105.', 'Department of Medicine, University of Washington, Seattle, WA 98105.', 'Department of Medicine, University of Washington, Seattle, WA 98105.', 'Department of Medicine, University of Washington, Seattle, WA 98105.', 'Critical Care Medicine Department, National Institutes of Health, Bethesda, MD 20892.', 'Department of Medicine, University of Washington, Seattle, WA 98105.'], 'LA': ['eng'], 'GR': ['R01 HL112625/HL/NHLBI NIH HHS/United States', 'HL089504/HL/NHLBI NIH HHS/United States', 'R01 HL108897/HL/NHLBI NIH HHS/United States', 'DK002456/DK/NIDDK NIH HHS/United States', 'R01 HL086798/HL/NHLBI NIH HHS/United States', 'HL112625/HL/NHLBI NIH HHS/United States', 'HL086798/HL/NHLBI NIH HHS/United States', 'P01 DK002456/DK/NIDDK NIH HHS/United States', 'HL108897/HL/NHLBI NIH HHS/United States', 'P30 DK035816/DK/NIDDK NIH HHS/United States', 'DK035816/DK/NIDDK NIH HHS/United States', 'P01 HL092969/HL/NHLBI NIH HHS/United States', 'R01 HL089504/HL/NHLBI NIH HHS/United States', 'P30 DK017047/DK/NIDDK NIH HHS/United States'], 'PT': ['Journal Article', 'Research Support, N.I.H., Extramural', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20150520', 'PL': 'United States', 'TA': 'J Lipid Res', 'JT': 'Journal of lipid research', 'JID': '0376606', 'RN': ['0 (Cholesterol, HDL)', '0 (Endotoxins)', '0 (Proteome)', '0 (Serum Amyloid A Protein)'], 'SB': 'IM', 'CIN': ['J Lipid Res. 2015 Aug;56(8):1383-5. PMID: 26078331'], 'MH': ['Adult', 'Animals', 'Cholesterol, HDL/blood/chemistry/*metabolism', 'Cytoprotection', 'Endotoxins/toxicity', 'Humans', 'Inflammation/blood/metabolism', 'Macrophages/drug effects/metabolism', 'Male', 'Mice', 'Myocardium/cytology/metabolism', 'Proteome/*metabolism', 'Serum Amyloid A Protein/deficiency/metabolism'], 'PMC': 'PMC4513993', 'OTO': ['NOTNLM'], 'OT': ['apolipoproteins', 'atherosclerosis', 'high density lipoprotein', 'inflammation', 'mass spectrometry', 'proteomics'], 'EDAT': '2015/05/23 06:00', 'MHDA': '2016/04/27 06:00', 'CRDT': ['2015/05/22 06:00'], 'PHST': ['2015/03/09 00:00 [received]', '2015/05/22 06:00 [entrez]', '2015/05/23 06:00 [pubmed]', '2016/04/27 06:00 [medline]'], 'AID': ['jlr.M059089 [pii]', '10.1194/jlr.M059089 [doi]'], 'PST': 'ppublish', 'SO': 'J Lipid Res. 2015 Aug;56(8):1519-30. doi: 10.1194/jlr.M059089. Epub 2015 May 20.'}\n",
      "{'PMID': '25945665', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20150611', 'LR': '20150507', 'IS': '2375-6314 (Print) 2375-6314 (Linking)', 'VI': '86', 'IP': '5', 'DP': '2015 May', 'TI': 'Kidney function and urine protein composition in healthy volunteers during space station fitness tests.', 'PG': '472-6', 'LID': '10.3357/AMHP.4154.2015 [doi]', 'AB': 'BACKGROUND: There is a close physiological connection between muscular activity and kidney function. During physical exercise (PE) the qualitative and quantitative composition of urine changes. This paper explores the influence of moderate PE on urine protein composition. The study of urine protein composition will help to make corrections to the existing methods of countermeasures. METHODS: There were 10 healthy men who exercised on a treadmill similar to the one onboard the International Space Station. We analyzed their urinary proteome composition, potassium level, sodium level, and their level of osmotically active substances before and after PE. RESULTS: After moderate PE, a small increase in urine flow speed and a constant glomerular filtration rate were noted. The average-group index of total protein excretion within the urine was reliably increased. From the 148 proteins identified in the urine, 64 were associated with known tissue origin. We found that protein penetration into the urine had a positive correlation with their tissue expression. Selectivity of the glomerular barrier during PE decreased and high-molecular weight proteins penetrated through the glomerular barrier more easily after PE. DISCUSSION: Performance of moderate intensity physical exercise of short duration did not lead to an increase in the glomerular filtration rate nor did diuresis increase above the limits of baseline variability. However, the protein excretion rate increased after PE. We also observed that protein composition drift indicated a change in the set of biological processes in which a given protein participated, in some cases activating, in some cases inactivating them.', 'FAU': ['Fomina, Elena V', 'Lisova, Natalia Iu', 'Kireev, Kirill S', 'Tiys, Evgeny S', 'Kononikhin, Alexey S', 'Larina, Irina M'], 'AU': ['Fomina EV', 'Lisova NIu', 'Kireev KS', 'Tiys ES', 'Kononikhin AS', 'Larina IM'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'PL': 'United States', 'TA': 'Aerosp Med Hum Perform', 'JT': 'Aerospace medicine and human performance', 'JID': '101654770', 'RN': ['0 (Proteome)', '9NEZ333N27 (Sodium)', 'RWP5GA015D (Potassium)'], 'SB': 'IM S', 'MH': ['Adult', '*Aerospace Medicine', 'Exercise/*physiology', 'Glomerular Filtration Rate', 'Healthy Volunteers', 'Heart Rate/physiology', 'Humans', 'Kidney/*physiology', 'Kidney Function Tests', 'Male', 'Potassium/urine', 'Proteinuria/*urine', 'Proteome/*analysis', 'Sodium/urine', 'Space Flight', 'Young Adult'], 'EDAT': '2015/05/07 06:00', 'MHDA': '2015/06/13 06:00', 'CRDT': ['2015/05/07 06:00'], 'PHST': ['2015/05/07 06:00 [entrez]', '2015/05/07 06:00 [pubmed]', '2015/06/13 06:00 [medline]'], 'AID': ['10.3357/AMHP.4154.2015 [doi]'], 'PST': 'ppublish', 'SO': 'Aerosp Med Hum Perform. 2015 May;86(5):472-6. doi: 10.3357/AMHP.4154.2015.'}\n",
      "{'PMID': '25944670', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20150916', 'LR': '20161125', 'IS': '1524-4571 (Electronic) 0009-7330 (Linking)', 'VI': '117', 'IP': '2', 'DP': '2015 Jul 3', 'TI': 'Dicer cleavage by calpain determines platelet microRNA levels and function in diabetes.', 'PG': '157-65', 'LID': '10.1161/CIRCRESAHA.117.305784 [doi]', 'AB': 'RATIONALE: MicroRNAs (miRNAs) are short noncoding RNA species generated by the processing of longer precursors by the ribonucleases Drosha and Dicer. Platelets contain large amounts of miRNA that are altered by disease, in particular diabetes mellitus. OBJECTIVE: This study determined why platelet miRNA levels are attenuated in diabetic individuals and how decreased levels of the platelet-enriched miRNA, miR-223, affect platelet function. METHODS AND RESULTS: Dicer levels were altered in platelets from diabetic mice and patients, a change that could be attributed to the cleavage of the enzyme by calpain, resulting in loss of function. Diabetes mellitus in human subjects as well as in mice resulted in decreased levels of platelet miR-142, miR-143, miR-155, and miR-223. Focusing on only 1 of these miRNAs, miR-223 deletion in mice resulted in modestly enhanced platelet aggregation, the formation of large thrombi and delayed clot retraction compared with wild-type littermates. A similar dysregulation was detected in platelets from diabetic patients. Proteomic analysis of platelets from miR-223 knockout mice revealed increased levels of several proteins, including kindlin-3 and coagulation factor XIII-A. Whereas, kindlin-3 was indirectly regulated by miR-223, factor XIII was a direct target and both proteins were also altered in diabetic platelets. Treating diabetic mice with a calpain inhibitor prevented loss of platelet dicer as well as the diabetes mellitus-induced decrease in platelet miRNA levels and the upregulation of miR-223 target proteins. CONCLUSIONS: Thus, calpain inhibition may be one means of normalizing platelet miRNA processing as well as platelet function in diabetes mellitus.', 'CI': ['(c) 2015 American Heart Association, Inc.'], 'FAU': ['Elgheznawy, Amro', 'Shi, Lei', 'Hu, Jiong', 'Wittig, Ilka', 'Laban, Hebatullah', 'Pircher, Joachim', 'Mann, Alexander', 'Provost, Patrick', 'Randriamboavonjy, Voahanginirina', 'Fleming, Ingrid'], 'AU': ['Elgheznawy A', 'Shi L', 'Hu J', 'Wittig I', 'Laban H', 'Pircher J', 'Mann A', 'Provost P', 'Randriamboavonjy V', 'Fleming I'], 'AD': ['From the Institute for Vascular Signaling, Centre for Molecular Medicine, and DZHK (German Centre for Cardiovascular Research) partner site Rhine-Main, Frankfurt, Germany (A.E., L.S., J.H., H.L., V.R., I.F.); Functional Proteomics, SFB 815 Core Unit, Goethe-University, Frankfurt, Germany (I.W.); Walter-Brendel-Centre of Experimental Medicine and DZHK partner site Munich Heart Alliance, Ludwig-Maximilians-Universitat, Munich, Germany (J.P.); Endokrinologikum Frankfurt, Frankfurt, Germany (A.M.); and Centre Hospitalier Universitaire de Quebec Research Center, and Faculty of Medicine, Universite Laval, Quebec, Canada (P.P.).', 'From the Institute for Vascular Signaling, Centre for Molecular Medicine, and DZHK (German Centre for Cardiovascular Research) partner site Rhine-Main, Frankfurt, Germany (A.E., L.S., J.H., H.L., V.R., I.F.); Functional Proteomics, SFB 815 Core Unit, Goethe-University, Frankfurt, Germany (I.W.); Walter-Brendel-Centre of Experimental Medicine and DZHK partner site Munich Heart Alliance, Ludwig-Maximilians-Universitat, Munich, Germany (J.P.); Endokrinologikum Frankfurt, Frankfurt, Germany (A.M.); and Centre Hospitalier Universitaire de Quebec Research Center, and Faculty of Medicine, Universite Laval, Quebec, Canada (P.P.).', 'From the Institute for Vascular Signaling, Centre for Molecular Medicine, and DZHK (German Centre for Cardiovascular Research) partner site Rhine-Main, Frankfurt, Germany (A.E., L.S., J.H., H.L., V.R., I.F.); Functional Proteomics, SFB 815 Core Unit, Goethe-University, Frankfurt, Germany (I.W.); Walter-Brendel-Centre of Experimental Medicine and DZHK partner site Munich Heart Alliance, Ludwig-Maximilians-Universitat, Munich, Germany (J.P.); Endokrinologikum Frankfurt, Frankfurt, Germany (A.M.); and Centre Hospitalier Universitaire de Quebec Research Center, and Faculty of Medicine, Universite Laval, Quebec, Canada (P.P.).', 'From the Institute for Vascular Signaling, Centre for Molecular Medicine, and DZHK (German Centre for Cardiovascular Research) partner site Rhine-Main, Frankfurt, Germany (A.E., L.S., J.H., H.L., V.R., I.F.); Functional Proteomics, SFB 815 Core Unit, Goethe-University, Frankfurt, Germany (I.W.); Walter-Brendel-Centre of Experimental Medicine and DZHK partner site Munich Heart Alliance, Ludwig-Maximilians-Universitat, Munich, Germany (J.P.); Endokrinologikum Frankfurt, Frankfurt, Germany (A.M.); and Centre Hospitalier Universitaire de Quebec Research Center, and Faculty of Medicine, Universite Laval, Quebec, Canada (P.P.).', 'From the Institute for Vascular Signaling, Centre for Molecular Medicine, and DZHK (German Centre for Cardiovascular Research) partner site Rhine-Main, Frankfurt, Germany (A.E., L.S., J.H., H.L., V.R., I.F.); Functional Proteomics, SFB 815 Core Unit, Goethe-University, Frankfurt, Germany (I.W.); Walter-Brendel-Centre of Experimental Medicine and DZHK partner site Munich Heart Alliance, Ludwig-Maximilians-Universitat, Munich, Germany (J.P.); Endokrinologikum Frankfurt, Frankfurt, Germany (A.M.); and Centre Hospitalier Universitaire de Quebec Research Center, and Faculty of Medicine, Universite Laval, Quebec, Canada (P.P.).', 'From the Institute for Vascular Signaling, Centre for Molecular Medicine, and DZHK (German Centre for Cardiovascular Research) partner site Rhine-Main, Frankfurt, Germany (A.E., L.S., J.H., H.L., V.R., I.F.); Functional Proteomics, SFB 815 Core Unit, Goethe-University, Frankfurt, Germany (I.W.); Walter-Brendel-Centre of Experimental Medicine and DZHK partner site Munich Heart Alliance, Ludwig-Maximilians-Universitat, Munich, Germany (J.P.); Endokrinologikum Frankfurt, Frankfurt, Germany (A.M.); and Centre Hospitalier Universitaire de Quebec Research Center, and Faculty of Medicine, Universite Laval, Quebec, Canada (P.P.).', 'From the Institute for Vascular Signaling, Centre for Molecular Medicine, and DZHK (German Centre for Cardiovascular Research) partner site Rhine-Main, Frankfurt, Germany (A.E., L.S., J.H., H.L., V.R., I.F.); Functional Proteomics, SFB 815 Core Unit, Goethe-University, Frankfurt, Germany (I.W.); Walter-Brendel-Centre of Experimental Medicine and DZHK partner site Munich Heart Alliance, Ludwig-Maximilians-Universitat, Munich, Germany (J.P.); Endokrinologikum Frankfurt, Frankfurt, Germany (A.M.); and Centre Hospitalier Universitaire de Quebec Research Center, and Faculty of Medicine, Universite Laval, Quebec, Canada (P.P.).', 'From the Institute for Vascular Signaling, Centre for Molecular Medicine, and DZHK (German Centre for Cardiovascular Research) partner site Rhine-Main, Frankfurt, Germany (A.E., L.S., J.H., H.L., V.R., I.F.); Functional Proteomics, SFB 815 Core Unit, Goethe-University, Frankfurt, Germany (I.W.); Walter-Brendel-Centre of Experimental Medicine and DZHK partner site Munich Heart Alliance, Ludwig-Maximilians-Universitat, Munich, Germany (J.P.); Endokrinologikum Frankfurt, Frankfurt, Germany (A.M.); and Centre Hospitalier Universitaire de Quebec Research Center, and Faculty of Medicine, Universite Laval, Quebec, Canada (P.P.).', 'From the Institute for Vascular Signaling, Centre for Molecular Medicine, and DZHK (German Centre for Cardiovascular Research) partner site Rhine-Main, Frankfurt, Germany (A.E., L.S., J.H., H.L., V.R., I.F.); Functional Proteomics, SFB 815 Core Unit, Goethe-University, Frankfurt, Germany (I.W.); Walter-Brendel-Centre of Experimental Medicine and DZHK partner site Munich Heart Alliance, Ludwig-Maximilians-Universitat, Munich, Germany (J.P.); Endokrinologikum Frankfurt, Frankfurt, Germany (A.M.); and Centre Hospitalier Universitaire de Quebec Research Center, and Faculty of Medicine, Universite Laval, Quebec, Canada (P.P.).', 'From the Institute for Vascular Signaling, Centre for Molecular Medicine, and DZHK (German Centre for Cardiovascular Research) partner site Rhine-Main, Frankfurt, Germany (A.E., L.S., J.H., H.L., V.R., I.F.); Functional Proteomics, SFB 815 Core Unit, Goethe-University, Frankfurt, Germany (I.W.); Walter-Brendel-Centre of Experimental Medicine and DZHK partner site Munich Heart Alliance, Ludwig-Maximilians-Universitat, Munich, Germany (J.P.); Endokrinologikum Frankfurt, Frankfurt, Germany (A.M.); and Centre Hospitalier Universitaire de Quebec Research Center, and Faculty of Medicine, Universite Laval, Quebec, Canada (P.P.). fleming@em.uni-frankfurt.de.'], 'LA': ['eng'], 'GR': ['Canadian Institutes of Health Research/Canada'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20150505', 'PL': 'United States', 'TA': 'Circ Res', 'JT': 'Circulation research', 'JID': '0047103', 'RN': ['0 (Cytoskeletal Proteins)', '0 (MIG2B protein, human)', '0 (Membrane Proteins)', '0 (MicroRNAs)', '0 (Neoplasm Proteins)', '0 (Proteome)', '0 (kindlin-3 protein, mouse)', '56092-81-0 (Ionomycin)', '9013-56-3 (Factor XIII)', 'EC 3.1.26.3 (DICER1 protein, human)', 'EC 3.1.26.3 (Dicer1 protein, mouse)', 'EC 3.1.26.3 (Ribonuclease III)', 'EC 3.4.22.- (Calpain)', 'EC 3.4.22.52 (Capn1 protein, mouse)', 'EC 3.6.4.13 (DEAD-box RNA Helicases)', 'SY7Q814VUP (Calcium)'], 'SB': 'IM', 'CIN': ['Circ Res. 2015 Jul 3;117(2):116-8. PMID: 26139856'], 'MH': ['Adult', 'Animals', 'Blood Platelets/drug effects/*enzymology/metabolism/physiology', 'Calcium/pharmacology', 'Calpain/*blood/deficiency', 'Cytoskeletal Proteins/blood', 'DEAD-box RNA Helicases/*blood', 'Diabetes Mellitus, Experimental/blood/enzymology', 'Diabetes Mellitus, Type 2/*blood/enzymology', 'Factor XIII/metabolism', 'Female', 'Humans', 'Ionomycin/pharmacology', 'Male', 'Membrane Proteins/blood', 'Mice', 'Mice, Inbred C57BL', 'Mice, Knockout', 'MicroRNAs/*blood/genetics', 'Microsatellite Repeats', 'Middle Aged', 'Neoplasm Proteins/blood', 'Platelet Aggregation/drug effects/*physiology', 'Proteome', 'Ribonuclease III/*blood'], 'OTO': ['NOTNLM'], 'OT': ['diabetes mellitus', 'microRNA', 'platelets', 'signal transduction'], 'EDAT': '2015/05/07 06:00', 'MHDA': '2015/09/17 06:00', 'CRDT': ['2015/05/07 06:00'], 'PHST': ['2014/12/04 00:00 [received]', '2015/05/05 00:00 [accepted]', '2015/05/07 06:00 [entrez]', '2015/05/07 06:00 [pubmed]', '2015/09/17 06:00 [medline]'], 'AID': ['CIRCRESAHA.117.305784 [pii]', '10.1161/CIRCRESAHA.117.305784 [doi]'], 'PST': 'ppublish', 'SO': 'Circ Res. 2015 Jul 3;117(2):157-65. doi: 10.1161/CIRCRESAHA.117.305784. Epub 2015 May 5.'}\n",
      "{'PMID': '25905469', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20160408', 'LR': '20181113', 'IS': '1932-6203 (Electronic) 1932-6203 (Linking)', 'VI': '10', 'IP': '4', 'DP': '2015', 'TI': 'Multimarker proteomic profiling for the prediction of cardiovascular mortality in patients with chronic heart failure.', 'PG': 'e0119265', 'LID': '10.1371/journal.pone.0119265 [doi]', 'AB': 'Risk stratification of patients with systolic chronic heart failure (HF) is critical to better identify those who may benefit from invasive therapeutic strategies such as cardiac transplantation. Proteomics has been used to provide prognostic information in various diseases. Our aim was to investigate the potential value of plasma proteomic profiling for risk stratification in HF. A proteomic profiling using surface enhanced laser desorption ionization - time of flight - mass spectrometry was performed in a case/control discovery population of 198 patients with systolic HF (left ventricular ejection fraction <45%): 99 patients who died from cardiovascular cause within 3 years and 99 patients alive at 3 years. Proteomic scores predicting cardiovascular death were developed using 3 regression methods: support vector machine, sparse partial least square discriminant analysis, and lasso logistic regression. Forty two ion m/z peaks were differentially intense between cases and controls in the discovery population and were used to develop proteomic scores. In the validation population, score levels were higher in patients who subsequently died within 3 years. Similar areas under the curves (0.66 - 0.68) were observed for the 3 methods. After adjustment on confounders, proteomic scores remained significantly associated with cardiovascular mortality. Use of the proteomic scores allowed a significant improvement in discrimination of HF patients as determined by integrated discrimination improvement and net reclassification improvement indexes. In conclusion, proteomic analysis of plasma proteins may help to improve risk prediction in HF patients.', 'FAU': ['Lemesle, Gilles', 'Maury, Fleur', 'Beseme, Olivia', 'Ovart, Lionel', 'Amouyel, Philippe', 'Lamblin, Nicolas', 'de Groote, Pascal', 'Bauters, Christophe', 'Pinet, Florence'], 'AU': ['Lemesle G', 'Maury F', 'Beseme O', 'Ovart L', 'Amouyel P', 'Lamblin N', 'de Groote P', 'Bauters C', 'Pinet F'], 'AD': ['INSERM UMR1167, Lille, France; Institut Pasteur de Lille, Lille, France; Universite Lille Nord de France, Lille, France; Centre Hospitalier Regional et Universitaire de Lille, Lille, France; Faculte de Medecine de Lille, Lille, France.', 'INSERM UMR1167, Lille, France; Institut Pasteur de Lille, Lille, France; Centre Hospitalier Regional et Universitaire de Lille, Lille, France.', 'INSERM UMR1167, Lille, France; Institut Pasteur de Lille, Lille, France; Universite Lille Nord de France, Lille, France.', 'INSERM UMR1167, Lille, France; Institut Pasteur de Lille, Lille, France; Centre Hospitalier Regional et Universitaire de Lille, Lille, France.', 'INSERM UMR1167, Lille, France; Institut Pasteur de Lille, Lille, France; Universite Lille Nord de France, Lille, France; Centre Hospitalier Regional et Universitaire de Lille, Lille, France; Faculte de Medecine de Lille, Lille, France.', 'INSERM UMR1167, Lille, France; Institut Pasteur de Lille, Lille, France; Universite Lille Nord de France, Lille, France; Centre Hospitalier Regional et Universitaire de Lille, Lille, France; Faculte de Medecine de Lille, Lille, France.', 'INSERM UMR1167, Lille, France; Institut Pasteur de Lille, Lille, France; Universite Lille Nord de France, Lille, France; Centre Hospitalier Regional et Universitaire de Lille, Lille, France.', 'INSERM UMR1167, Lille, France; Institut Pasteur de Lille, Lille, France; Universite Lille Nord de France, Lille, France; Centre Hospitalier Regional et Universitaire de Lille, Lille, France; Faculte de Medecine de Lille, Lille, France.', 'INSERM UMR1167, Lille, France; Institut Pasteur de Lille, Lille, France; Universite Lille Nord de France, Lille, France.'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20150423', 'PL': 'United States', 'TA': 'PLoS One', 'JT': 'PloS one', 'JID': '101285081', 'RN': ['0 (Biomarkers)', '0 (Proteome)'], 'SB': 'IM', 'MH': ['Biomarkers/*metabolism', 'Cardiovascular System/*metabolism/*pathology', 'Chronic Disease/*mortality', 'Female', 'Heart Failure/*metabolism/*mortality', 'Heart Transplantation/methods', 'Humans', 'Male', 'Middle Aged', 'Proteome/*metabolism', 'Proteomics/methods', 'Risk Assessment', 'Risk Factors', 'Ventricular Function, Left/physiology'], 'PMC': 'PMC4408082', 'EDAT': '2015/04/24 06:00', 'MHDA': '2016/04/09 06:00', 'CRDT': ['2015/04/24 06:00'], 'PHST': ['2014/11/04 00:00 [received]', '2015/01/12 00:00 [accepted]', '2015/04/24 06:00 [entrez]', '2015/04/24 06:00 [pubmed]', '2016/04/09 06:00 [medline]'], 'AID': ['10.1371/journal.pone.0119265 [doi]', 'PONE-D-14-48884 [pii]'], 'PST': 'epublish', 'SO': 'PLoS One. 2015 Apr 23;10(4):e0119265. doi: 10.1371/journal.pone.0119265. eCollection 2015.'}\n",
      "{'PMID': '25857276', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20160204', 'LR': '20160518', 'IS': '1876-7737 (Electronic) 1874-3919 (Linking)', 'VI': '122', 'DP': '2015 Jun 3', 'TI': 'Basal and exercise induced label-free quantitative protein profiling of m. vastus lateralis in trained and untrained individuals.', 'PG': '119-32', 'LID': '10.1016/j.jprot.2015.03.028 [doi] S1874-3919(15)00139-6 [pii]', 'AB': 'UNLABELLED: Morphological and metabolic adaptations of the human skeletal muscle to exercise are crucial to improve performance and prevent chronic diseases and metabolic disorders. In this study we investigated human skeletal muscle protein composition in endurance trained (ET) versus untrained individuals (UT) and its modulation by an acute bout of endurance exercise. Participants were recruited based on their VO2max and subjected to a bicycle exercise test. M. vastus lateralis biopsies were taken before and three hours after exercise. Muscle lysates were analyzed using off-gel LC-MS/MS. Relative protein abundances were compared between ET and UT at rest and after exercise. Comparing UT and ET, we identified 92 significantly changed proteins under resting conditions. Specifically, fiber-type-specific and proteins of the oxidative phosphorylation and tricarboxylic acid cycle were increased in ET. In response to acute exercise, 71 proteins in ET and 44 in UT were altered. Here, a decrease of proteins involved in energy metabolism accompanied with alterations of heat shock and proteasomal proteins could be observed. In summary, long-term endurance training increased the basal level of structural and mitochondrial proteins in skeletal muscle. In contrast, acute exercise resulted in a depletion of proteins related to substrate utilization, especially in trained athletes. BIOLOGICAL SIGNIFICANCE: The investigation of the human skeletal muscle proteome in response to exercise may provide novel insights into the process of muscular plasticity. It is of importance in the development of exercise-based strategies in the prevention and therapy of many chronic inflammatory and degenerative diseases which are often accompanied by muscular deconditioning. Up to date, proteomic investigations of the human muscle proteome in adaptation to exercise are mainly focused on untrained individuals and often restricted to animal studies. In the present study we compare the protein composition in endurance trained athletes and untrained individuals in the resting muscle and its modulation in response to acute exercise. To our knowledge, we present the first comprehensive analysis of skeletal muscle proteome alterations in response to acute and long-term exercise intervention.', 'CI': ['Copyright (c) 2015 Elsevier B.V. All rights reserved.'], 'FAU': ['Schild, Marius', 'Ruhs, Aaron', 'Beiter, Thomas', 'Zugel, Martina', 'Hudemann, Jens', 'Reimer, Anna', 'Krumholz-Wagner, Ilke', 'Wagner, Carola', 'Keller, Janine', 'Eder, Klaus', 'Kruger, Karsten', 'Kruger, Marcus', 'Braun, Thomas', 'Niess, Andreas', 'Steinacker, Jurgen', 'Mooren, Frank C'], 'AU': ['Schild M', 'Ruhs A', 'Beiter T', 'Zugel M', 'Hudemann J', 'Reimer A', 'Krumholz-Wagner I', 'Wagner C', 'Keller J', 'Eder K', 'Kruger K', 'Kruger M', 'Braun T', 'Niess A', 'Steinacker J', 'Mooren FC'], 'AD': ['Department of Sports Medicine, Justus-Liebig University Giessen, Kugelberg 62, 35394 Giessen, Germany.', 'Max-Planck-Institute for Heart and Lung Research, Bad Nauheim, Parkstr. 1, 61231 Bad Nauheim, Germany.', 'Department of Sports Medicine, University Hospital of Tuebingen, Otfried-Muller-Str. 10, 72076 Tuebingen, Germany.', 'Division of Sport and Rehabilitation Medicine, University Hospital Ulm, Parkstr. 11, 89075 Ulm, Germany.', 'Department of Sports Medicine, University Hospital of Tuebingen, Otfried-Muller-Str. 10, 72076 Tuebingen, Germany.', 'Department of Sports Medicine, Justus-Liebig University Giessen, Kugelberg 62, 35394 Giessen, Germany.', 'Department of Sports Medicine, Justus-Liebig University Giessen, Kugelberg 62, 35394 Giessen, Germany.', 'Division of Sport and Rehabilitation Medicine, University Hospital Ulm, Parkstr. 11, 89075 Ulm, Germany.', 'Institute of Animal Nutrition and Nutrition Physiology, Justus-Liebig-University Giessen, Heinrich-Buff-Ring 26-32, 35392 Giessen, Germany.', 'Institute of Animal Nutrition and Nutrition Physiology, Justus-Liebig-University Giessen, Heinrich-Buff-Ring 26-32, 35392 Giessen, Germany.', 'Department of Sports Medicine, Justus-Liebig University Giessen, Kugelberg 62, 35394 Giessen, Germany.', 'CECAD Research Center, Institute of Genetics, University of Cologne, Joseph-Stelzmann-Str. 26, 50931 Cologne, Germany.', 'Max-Planck-Institute for Heart and Lung Research, Bad Nauheim, Parkstr. 1, 61231 Bad Nauheim, Germany.', 'Department of Sports Medicine, University Hospital of Tuebingen, Otfried-Muller-Str. 10, 72076 Tuebingen, Germany.', 'Division of Sport and Rehabilitation Medicine, University Hospital Ulm, Parkstr. 11, 89075 Ulm, Germany.', 'Department of Sports Medicine, Justus-Liebig University Giessen, Kugelberg 62, 35394 Giessen, Germany. Electronic address: Frank-Christoph.Mooren@sport.uni-giessen.de.'], 'LA': ['eng'], 'PT': ['Clinical Trial', 'Comparative Study', 'Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20150406', 'PL': 'Netherlands', 'TA': 'J Proteomics', 'JT': 'Journal of proteomics', 'JID': '101475056', 'RN': ['0 (Mitochondrial Proteins)', '0 (Muscle Proteins)'], 'SB': 'IM', 'MH': ['Adult', 'Citric Acid Cycle/physiology', 'Exercise/*physiology', 'Humans', 'Male', 'Mitochondria, Muscle/*metabolism', 'Mitochondrial Proteins/*metabolism', 'Muscle Proteins/*metabolism', 'Muscle, Skeletal/*metabolism', 'Oxidative Phosphorylation', 'Physical Endurance/*physiology', 'Proteomics'], 'OTO': ['NOTNLM'], 'OT': ['Endurance exercise', 'Energy metabolism', 'Label free mass spectrometry', 'Muscular plasticity', 'Oxidative phosphorylation', 'Skeletal muscle proteome'], 'EDAT': '2015/04/11 06:00', 'MHDA': '2016/02/05 06:00', 'CRDT': ['2015/04/11 06:00'], 'PHST': ['2015/01/14 00:00 [received]', '2015/03/13 00:00 [revised]', '2015/03/28 00:00 [accepted]', '2015/04/11 06:00 [entrez]', '2015/04/11 06:00 [pubmed]', '2016/02/05 06:00 [medline]'], 'AID': ['S1874-3919(15)00139-6 [pii]', '10.1016/j.jprot.2015.03.028 [doi]'], 'PST': 'ppublish', 'SO': 'J Proteomics. 2015 Jun 3;122:119-32. doi: 10.1016/j.jprot.2015.03.028. Epub 2015 Apr 6.'}\n",
      "{'PMID': '25786980', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20160304', 'LR': '20150617', 'IS': '1862-8354 (Electronic) 1862-8346 (Linking)', 'VI': '9', 'IP': '5-6', 'DP': '2015 Jun', 'TI': 'Urinary proteomic biomarkers to predict cardiovascular events.', 'PG': '610-7', 'LID': '10.1002/prca.201400195 [doi]', 'AB': 'PURPOSE: We have previously demonstrated associations between the urinary proteome profile and coronary artery disease (CAD) in cross-sectional studies. Here, we evaluate the potential of a urinary proteomic panel as a predictor of CAD in the hypertensive atherosclerotic cardiovascular disease (HACVD) substudy population of the Anglo-Scandinavian Cardiac Outcomes Trial study. EXPERIMENTAL DESIGN: Thirty-seven cases with primary CAD endpoint were matched for sex and age to controls who had not reached a CAD endpoint during the study. Spot urine samples were analyzed using CE coupled to Micro-TOF MS. A previously developed 238-marker CE-MS model for diagnosis of CAD (CAD238 ) was assessed for its predictive potential. RESULTS: Sixty urine samples (32 cases; 28 controls; 88% male, mean age 64 +/- 5 years) were analyzed. There was a trend toward healthier values in controls for the CAD model classifier (-0.432 +/- 0.326 versus -0.587 +/- 0.297, p = 0.170), and the CAD model showed statistical significance on Kaplan-Meier survival analysis p = 0.021. We found 190 individual markers out of 1501 urinary peptides that separated cases and controls (AUC >0.6). Of these, 25 peptides were also components of CAD238 . CONCLUSION AND CLINICAL RELEVANCE: A urinary proteome panel originally developed in a cross-sectional study predicts CAD endpoints independent of age and sex in a well-controlled prospective study.', 'CI': ['(c) 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.'], 'FAU': ['Brown, Catriona E', 'McCarthy, Nina S', 'Hughes, Alun D', 'Sever, Peter', 'Stalmach, Angelique', 'Mullen, William', 'Dominiczak, Anna F', 'Sattar, Naveed', 'Mischak, Harald', 'Thom, Simon', 'Mayet, Jamil', 'Stanton, Alice V', 'Delles, Christian'], 'AU': ['Brown CE', 'McCarthy NS', 'Hughes AD', 'Sever P', 'Stalmach A', 'Mullen W', 'Dominiczak AF', 'Sattar N', 'Mischak H', 'Thom S', 'Mayet J', 'Stanton AV', 'Delles C'], 'AD': ['Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.', 'Royal College of Surgeons in Ireland, Dublin, Ireland.', 'University of Western Australia, Perth, Western Australia.', 'Imperial College London, London, UK.', 'Imperial College London, London, UK.', 'Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.', 'Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.', 'Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.', 'Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.', 'Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.', 'Mosaiques Diagnostics, Hannover, Germany.', 'Imperial College London, London, UK.', 'Imperial College London, London, UK.', 'Royal College of Surgeons in Ireland, Dublin, Ireland.', 'Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20150515', 'PL': 'Germany', 'TA': 'Proteomics Clin Appl', 'JT': 'Proteomics. Clinical applications', 'JID': '101298608', 'RN': ['0 (Biomarkers)', '0 (Peptide Fragments)', '0 (Proteome)'], 'SB': 'IM', 'MH': ['Aged', 'Atherosclerosis/mortality/urine', 'Biomarkers/urine', 'Case-Control Studies', 'Coronary Artery Disease/mortality/*urine', 'Cross-Sectional Studies', 'Female', 'Humans', 'Hypertension/mortality/urine', 'Kaplan-Meier Estimate', 'Male', 'Middle Aged', 'Peptide Fragments/*urine', 'Prospective Studies', 'Proteome/metabolism', 'Proteomics'], 'OTO': ['NOTNLM'], 'OT': ['Biomarker', 'Cardiovascular risk', 'Urinary proteomics'], 'EDAT': '2015/03/20 06:00', 'MHDA': '2016/03/05 06:00', 'CRDT': ['2015/03/20 06:00'], 'PHST': ['2014/11/28 00:00 [received]', '2015/02/21 00:00 [revised]', '2015/03/16 00:00 [accepted]', '2015/03/20 06:00 [entrez]', '2015/03/20 06:00 [pubmed]', '2016/03/05 06:00 [medline]'], 'AID': ['10.1002/prca.201400195 [doi]'], 'PST': 'ppublish', 'SO': 'Proteomics Clin Appl. 2015 Jun;9(5-6):610-7. doi: 10.1002/prca.201400195. Epub 2015 May 15.'}\n",
      "{'PMID': '25684225', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20160112', 'LR': '20200306', 'IS': '2213-6711 (Electronic) 2213-6711 (Linking)', 'VI': '4', 'IP': '3', 'DP': '2015 Mar 10', 'TI': 'Comparative quantification of the surfaceome of human multipotent mesenchymal progenitor cells.', 'PG': '473-88', 'LID': '10.1016/j.stemcr.2015.01.007 [doi] S2213-6711(15)00028-4 [pii]', 'AB': 'Mesenchymal progenitor cells have great therapeutic potential, yet incomplete characterization of their cell-surface interface limits their clinical exploitation. We have employed subcellular fractionation with quantitative discovery proteomics to define the cell-surface interface proteome of human bone marrow mesenchymal stromal/stem cells (MSCs) and human umbilical cord perivascular cells (HUCPVCs). We compared cell-surface-enriched fractions from MSCs and HUCPVCs (three donors each) with adult mesenchymal fibroblasts using eight-channel isobaric-tagging mass spectrometry, yielding relative quantification on >6,000 proteins with high confidence. This approach identified 186 upregulated mesenchymal progenitor biomarkers. Validation of 10 of these markers, including ROR2, EPHA2, and PLXNA2, confirmed upregulated expression in mesenchymal progenitor populations and distinct roles in progenitor cell proliferation, migration, and differentiation. Our approach has delivered a cell-surface proteome repository that now enables improved selection and characterization of human mesenchymal progenitor populations.', 'CI': ['Copyright (c) 2015 The Authors. Published by Elsevier Inc. All rights reserved.'], 'FAU': ['Holley, Rebecca J', 'Tai, Guangping', 'Williamson, Andrew J K', 'Taylor, Samuel', 'Cain, Stuart A', 'Richardson, Stephen M', 'Merry, Catherine L R', 'Whetton, Anthony D', 'Kielty, Cay M', 'Canfield, Ann E'], 'AU': ['Holley RJ', 'Tai G', 'Williamson AJ', 'Taylor S', 'Cain SA', 'Richardson SM', 'Merry CL', 'Whetton AD', 'Kielty CM', 'Canfield AE'], 'AD': ['Faculty of Life Sciences, University of Manchester, Manchester M13 9PT, UK.', 'Faculty of Life Sciences, University of Manchester, Manchester M13 9PT, UK.', 'Faculty of Medical and Human Sciences, University of Manchester, Manchester M13 9PT, UK.', 'Faculty of Medical and Human Sciences, University of Manchester, Manchester M13 9PT, UK.', 'Faculty of Life Sciences, University of Manchester, Manchester M13 9PT, UK.', 'Faculty of Medical and Human Sciences, University of Manchester, Manchester M13 9PT, UK.', 'Faculty of Engineering and Physical Sciences, University of Manchester, Manchester M13 9PT, UK.', 'Faculty of Medical and Human Sciences, University of Manchester, Manchester M13 9PT, UK.', 'Faculty of Life Sciences, University of Manchester, Manchester M13 9PT, UK. Electronic address: cay.kielty@manchester.ac.uk.', 'Faculty of Medical and Human Sciences, University of Manchester, Manchester M13 9PT, UK. Electronic address: ann.canfield@manchester.ac.uk.'], 'LA': ['eng'], 'GR': ['G0902170/MRC_/Medical Research Council/United Kingdom', '088785/WT_/Wellcome Trust/United Kingdom', 'BB_/Biotechnology and Biological Sciences Research Council/United Kingdom', 'MR/K026666/1/MRC_/Medical Research Council/United Kingdom', 'G0902170/BHF_/British Heart Foundation/United Kingdom', 'WT_/Wellcome Trust/United Kingdom'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20150213', 'PL': 'United States', 'TA': 'Stem Cell Reports', 'JT': 'Stem cell reports', 'JID': '101611300', 'RN': ['0 (Antigens, Surface)', '0 (Biomarkers)', '0 (Proteome)', '0 (RNA, Small Interfering)'], 'SB': 'IM', 'MH': ['Adult', 'Antigens, Surface/*metabolism', 'Biomarkers', 'Cell Lineage/genetics', 'Cluster Analysis', 'Female', 'Gene Expression Profiling', 'Humans', 'Immunophenotyping', 'Male', 'Mesenchymal Stem Cells/cytology/*metabolism', 'Multipotent Stem Cells/cytology/*metabolism', 'Phenotype', '*Proteome', '*Proteomics/methods', 'RNA Interference', 'RNA, Small Interfering/genetics', 'Reproducibility of Results', 'Stem Cell Niche', 'Young Adult'], 'PMC': 'PMC4375938', 'EDAT': '2015/02/17 06:00', 'MHDA': '2016/01/13 06:00', 'CRDT': ['2015/02/17 06:00'], 'PHST': ['2014/05/23 00:00 [received]', '2015/01/12 00:00 [revised]', '2015/01/12 00:00 [accepted]', '2015/02/17 06:00 [entrez]', '2015/02/17 06:00 [pubmed]', '2016/01/13 06:00 [medline]'], 'AID': ['S2213-6711(15)00028-4 [pii]', '10.1016/j.stemcr.2015.01.007 [doi]'], 'PST': 'ppublish', 'SO': 'Stem Cell Reports. 2015 Mar 10;4(3):473-88. doi: 10.1016/j.stemcr.2015.01.007. Epub 2015 Feb 13.'}\n",
      "{'PMID': '25666440', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20160219', 'LR': '20150520', 'IS': '1742-2051 (Electronic) 1742-2051 (Linking)', 'VI': '11', 'IP': '6', 'DP': '2015 Jun', 'TI': 'Early markers of Fabry disease revealed by proteomics.', 'PG': '1543-51', 'LID': '10.1039/c4mb00707g [doi]', 'AB': 'Fabry disease (FD) is an X-linked lysosomal storage disorder caused by a deficiency of the lysosomal hydrolase alpha-galactosidase A (alpha-GalA) that leads to the intra-lysosomal accumulation of globotriaosylceramide (Gb3) in various organ systems. As a consequence, a multisystems disorder develops, culminating in stroke, progressive renal and cardiac dysfunction. Enzyme replacement therapy (ERT) offers a specific treatment for patients affected by FD, though the monitoring of treatment is hindered by a lack of surrogate markers of response. Remarkably, due to the high heterogeneity of the Fabry phenotype, both diagnostic testing and treatment decisions are more challenging in females than in males; thus, reliable biomarkers for Fabry disease are needed, particularly for female patients. Here, we use a proteomic approach for the identification of disease-associated markers that can be used for the early diagnosis of FD as well as for monitoring the effectiveness of ERT. Our data show that the urinary proteome of Fabry naive patients is different from that of normal subjects. In addition, biological pathways mainly affected by FD are related to immune response, inflammation, and energetic metabolism. In particular, the up-regulation of uromodulin, prostaglandin H2 d-isomerase and prosaposin in the urine of FD patients was demonstrated; these proteins might be involved in kidney damage at the tubular level, inflammation and immune response. Furthermore, comparing the expression of these proteins in Fabry patients before and after ERT treatment, a decrease of their concentration was observed, thus demonstrating the correlation between the identified markers and the effectiveness of the pharmacological treatment.', 'FAU': ['Matafora, V', 'Cuccurullo, M', 'Beneduci, A', 'Petrazzuolo, O', 'Simeone, A', 'Anastasio, P', 'Mignani, R', 'Feriozzi, S', 'Pisani, A', 'Comotti, C', 'Bachi, A', 'Capasso, G'], 'AU': ['Matafora V', 'Cuccurullo M', 'Beneduci A', 'Petrazzuolo O', 'Simeone A', 'Anastasio P', 'Mignani R', 'Feriozzi S', 'Pisani A', 'Comotti C', 'Bachi A', 'Capasso G'], 'AD': ['Department of Cardiovascular Medicine, Second University of Naples, Naples, Italy.'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'PL': 'England', 'TA': 'Mol Biosyst', 'JT': 'Molecular bioSystems', 'JID': '101251620', 'RN': ['0 (Biomarkers)', '0 (Proteome)', '0 (Uromodulin)'], 'SB': 'IM', 'MH': ['Adolescent', 'Adult', 'Aged', 'Biomarkers/blood/urine', 'Child', 'Cluster Analysis', 'Early Diagnosis', 'Fabry Disease/blood/*diagnosis/urine', 'Female', 'Humans', 'Male', 'Middle Aged', 'Proteome/*analysis/metabolism', 'Proteomics/methods', 'Reproducibility of Results', 'Uromodulin/blood/urine', 'Young Adult'], 'EDAT': '2015/02/11 06:00', 'MHDA': '2016/02/20 06:00', 'CRDT': ['2015/02/11 06:00'], 'PHST': ['2015/02/11 06:00 [entrez]', '2015/02/11 06:00 [pubmed]', '2016/02/20 06:00 [medline]'], 'AID': ['10.1039/c4mb00707g [doi]'], 'PST': 'ppublish', 'SO': 'Mol Biosyst. 2015 Jun;11(6):1543-51. doi: 10.1039/c4mb00707g.'}\n",
      "{'PMID': '25548805', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20160112', 'LR': '20181113', 'IS': '1432-1440 (Electronic) 0946-2716 (Linking)', 'VI': '93', 'IP': '5', 'DP': '2015 May', 'TI': 'Skeletal muscle proteomic signature and metabolic impairment in pulmonary hypertension.', 'PG': '573-84', 'LID': '10.1007/s00109-014-1244-0 [doi]', 'AB': 'UNLABELLED: Exercise limitation comes from a close interaction between cardiovascular and skeletal muscle impairments. To better understand the implication of possible peripheral oxidative metabolism dysfunction, we studied the proteomic signature of skeletal muscle in pulmonary arterial hypertension (PAH). Eight idiopathic PAH patients and eight matched healthy sedentary subjects were evaluated for exercise capacity, skeletal muscle proteomic profile, metabolism, and mitochondrial function. Skeletal muscle proteins were extracted, and fractioned peptides were tagged using an iTRAQ protocol. Proteomic analyses have documented a total of 9 downregulated proteins in PAH skeletal muscles and 10 upregulated proteins compared to healthy subjects. Most of the downregulated proteins were related to mitochondrial structure and function. Focusing on skeletal muscle metabolism and mitochondrial health, PAH patients presented a decreased expression of oxidative enzymes (pyruvate dehydrogenase, p < 0.01) and an increased expression of glycolytic enzymes (lactate dehydrogenase activity, p < 0.05). These findings were supported by abnormal mitochondrial morphology on electronic microscopy, lower citrate synthase activity (p < 0.01) and lower expression of the transcription factor A of the mitochondria (p < 0.05), confirming a more glycolytic metabolism in PAH skeletal muscles. We provide evidences that impaired mitochondrial and metabolic functions found in the lungs and the right ventricle are also present in skeletal muscles of patients. KEY MESSAGE: * Proteomic and metabolic analysis show abnormal oxidative metabolism in PAH skeletal muscle. * EM of PAH patients reveals abnormal mitochondrial structure and distribution. * Abnormal mitochondrial health and function contribute to exercise impairments of PAH. * PAH may be considered a vascular affliction of heart and lungs with major impact on peripheral muscles.', 'FAU': ['Malenfant, Simon', 'Potus, Francois', 'Fournier, Frederic', 'Breuils-Bonnet, Sandra', 'Pflieger, Aude', 'Bourassa, Sylvie', 'Tremblay, Eve', 'Nehme, Benjamin', 'Droit, Arnaud', 'Bonnet, Sebastien', 'Provencher, Steeve'], 'AU': ['Malenfant S', 'Potus F', 'Fournier F', 'Breuils-Bonnet S', 'Pflieger A', 'Bourassa S', 'Tremblay E', 'Nehme B', 'Droit A', 'Bonnet S', 'Provencher S'], 'AD': [\"Pulmonary Hypertension Research Group, Centre de Recherche de l'Institut de Cardiologie et de Pneumologie de Quebec, Service de Pneumologie, 2725 Chemin Sainte-Foy, Quebec City, QC, G1V 4G5, Canada.\"], 'LA': ['eng'], 'GR': ['Canadian Institutes of Health Research/Canada'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20141230', 'PL': 'Germany', 'TA': 'J Mol Med (Berl)', 'JT': 'Journal of molecular medicine (Berlin, Germany)', 'JID': '9504370', 'RN': ['0 (Proteome)'], 'SB': 'IM', 'MH': ['Adult', 'Biopsy', 'Cluster Analysis', 'Exercise Tolerance', 'Female', 'Humans', 'Hypertension, Pulmonary/*metabolism/physiopathology', 'Male', 'Metabolic Networks and Pathways', '*Metabolomics/methods', 'Middle Aged', 'Mitochondria/metabolism', 'Muscle, Skeletal/*metabolism/pathology', 'Oxidation-Reduction', 'Oxidative Stress', '*Proteome', '*Proteomics/methods'], 'EDAT': '2014/12/31 06:00', 'MHDA': '2016/01/13 06:00', 'CRDT': ['2014/12/31 06:00'], 'PHST': ['2014/10/27 00:00 [received]', '2014/12/14 00:00 [accepted]', '2014/11/27 00:00 [revised]', '2014/12/31 06:00 [entrez]', '2014/12/31 06:00 [pubmed]', '2016/01/13 06:00 [medline]'], 'AID': ['10.1007/s00109-014-1244-0 [doi]'], 'PST': 'ppublish', 'SO': 'J Mol Med (Berl). 2015 May;93(5):573-84. doi: 10.1007/s00109-014-1244-0. Epub 2014 Dec 30.'}\n",
      "{'PMID': '25424990', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20151030', 'LR': '20181202', 'IS': '1555-905X (Electronic) 1555-9041 (Linking)', 'VI': '10', 'IP': '2', 'DP': '2015 Feb 6', 'TI': 'Quantification of HDL proteins, cardiac events, and mortality in patients with type 2 diabetes on hemodialysis.', 'PG': '224-31', 'LID': '10.2215/CJN.06560714 [doi]', 'AB': 'BACKGROUND AND OBJECTIVES: Impairment of HDL function has been associated with cardiovascular events in patients with kidney failure. The protein composition of HDLs is altered in these patients, presumably compromising the cardioprotective effects of HDLs. This post hoc study assessed the relation of distinct HDL-bound proteins with cardiovascular outcomes in a dialysis population. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: The concentrations of HDL-associated serum amyloid A (SAA) and surfactant protein B (SP-B) were measured in 1152 patients with type 2 diabetes mellitus on hemodialysis participating in The German Diabetes Dialysis Study who were randomly assigned to double-blind treatment of 20 mg atorvastatin daily or matching placebo. The association of SAA(HDL) and SP-B(HDL) with cardiovascular outcomes was assessed in multivariate regression models adjusted for known clinical risk factors. RESULTS: High concentrations of SAA(HDL) were significantly and positively associated with the risk of cardiac events (hazard ratio per 1 SD higher, 1.09; 95% confidence interval, 1.01 to 1.19). High concentrations of SP-B(HDL) were significantly associated with all-cause mortality (hazard ratio per 1 SD higher, 1.10; 95% confidence interval, 1.02 to 1.19). Adjustment for HDL cholesterol did not affect these associations. CONCLUSIONS: In patients with diabetes on hemodialysis, SAA(HDL) and SP-B(HDL) were related to cardiac events and all-cause mortality, respectively, and they were independent of HDL cholesterol. These findings indicate that a remodeling of the HDL proteome was associated with a higher risk for cardiovascular events and mortality in patients with ESRD.', 'CI': ['Copyright (c) 2015 by the American Society of Nephrology.'], 'FAU': ['Kopecky, Chantal', 'Genser, Bernd', 'Drechsler, Christiane', 'Krane, Vera', 'Kaltenecker, Christopher C', 'Hengstschlager, Markus', 'Marz, Winfried', 'Wanner, Christoph', 'Saemann, Marcus D', 'Weichhart, Thomas'], 'AU': ['Kopecky C', 'Genser B', 'Drechsler C', 'Krane V', 'Kaltenecker CC', 'Hengstschlager M', 'Marz W', 'Wanner C', 'Saemann MD', 'Weichhart T'], 'AD': ['Department of Internal Medicine III, Division of Nephrology and Dialysis and.', 'BGStats Consulting, Vienna, Austria; Mannheim Institute of Public Health, Social and Preventive Medicine, Medical Faculty Mannheim, Heidelberg University, Heidelberg, Germany; Institute of Public Health, Federal University of Bahia, Salvador, Brazil;', 'Department of Medicine, Division of Nephrology, University Hospital, Wurzburg, Germany;', 'Department of Medicine, Division of Nephrology, University Hospital, Wurzburg, Germany;', 'Department of Internal Medicine III, Division of Nephrology and Dialysis and.', 'Institute of Medical Genetics, Medical University of Vienna, Vienna, Austria;', 'Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria; Medical Clinic V (Nephrology, Hypertensiology, Endocrinology, Diabetology, Rheumatology), Mannheim Medical Faculty, Heidelberg University, Mannheim, Germany; and Synlab Academy, Synlab Laboratory Services GmbH, Mannheim, Germany.', 'Department of Medicine, Division of Nephrology, University Hospital, Wurzburg, Germany;', 'Department of Internal Medicine III, Division of Nephrology and Dialysis and.', 'Institute of Medical Genetics, Medical University of Vienna, Vienna, Austria; thomas.weichhart@meduniwien.ac.at.'], 'LA': ['eng'], 'PT': ['Journal Article', 'Multicenter Study', 'Randomized Controlled Trial', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20141125', 'PL': 'United States', 'TA': 'Clin J Am Soc Nephrol', 'JT': 'Clinical journal of the American Society of Nephrology : CJASN', 'JID': '101271570', 'RN': ['0 (Biomarkers)', '0 (Heptanoic Acids)', '0 (Hydroxymethylglutaryl-CoA Reductase Inhibitors)', '0 (Lipoproteins, HDL)', '0 (Pulmonary Surfactant-Associated Protein B)', '0 (Pyrroles)', '0 (Serum Amyloid A Protein)', 'A0JWA85V8F (Atorvastatin)'], 'SB': 'IM', 'CIN': ['Blood Purif. 2015 ;40(4):326-31. PMID: 26657510'], 'MH': ['Aged', 'Atorvastatin', 'Biomarkers/blood', 'Diabetes Mellitus, Type 2/blood/complications/diagnosis/*mortality/therapy', 'Diabetic Nephropathies/blood/diagnosis/etiology/*mortality/*therapy', 'Double-Blind Method', 'Female', 'Germany', 'Heart Diseases/blood/diagnosis/etiology/*mortality/therapy', 'Heptanoic Acids/therapeutic use', 'Humans', 'Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use', 'Kidney Failure, Chronic/blood/diagnosis/etiology/*mortality/*therapy', 'Lipoproteins, HDL/*blood', 'Male', 'Middle Aged', 'Proportional Hazards Models', 'Pulmonary Surfactant-Associated Protein B/blood', 'Pyrroles/therapeutic use', 'Renal Dialysis/adverse effects/*mortality', 'Risk Factors', 'Serum Amyloid A Protein/metabolism', 'Time Factors', 'Treatment Outcome'], 'PMC': 'PMC4317744', 'OTO': ['NOTNLM'], 'OT': ['cardiovascular disease', 'dialysis', 'lipids'], 'EDAT': '2014/11/27 06:00', 'MHDA': '2015/10/31 06:00', 'CRDT': ['2014/11/27 06:00'], 'PHST': ['2014/11/27 06:00 [entrez]', '2014/11/27 06:00 [pubmed]', '2015/10/31 06:00 [medline]'], 'AID': ['CJN.06560714 [pii]', '10.2215/CJN.06560714 [doi]'], 'PST': 'ppublish', 'SO': 'Clin J Am Soc Nephrol. 2015 Feb 6;10(2):224-31. doi: 10.2215/CJN.06560714. Epub 2014 Nov 25.'}\n",
      "{'PMID': '25397948', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20151221', 'LR': '20181113', 'IS': '1932-6203 (Electronic) 1932-6203 (Linking)', 'VI': '9', 'IP': '11', 'DP': '2014', 'TI': 'Heart mitochondrial proteome study elucidates changes in cardiac energy metabolism and antioxidant PRDX3 in human dilated cardiomyopathy.', 'PG': 'e112971', 'LID': '10.1371/journal.pone.0112971 [doi]', 'AB': 'BACKGROUND: Dilated cardiomyopathy (DCM) is a public health problem with no available curative treatment, and mitochondrial dysfunction plays a critical role in its development. The present study is the first to analyze the mitochondrial proteome in cardiac tissue of patients with DCM to identify potential molecular targets for its therapeutic intervention. METHODS AND RESULTS: 16 left ventricular (LV) samples obtained from explanted human hearts with DCM (n = 8) and control donors (n = 8) were extracted to perform a proteomic approach to investigate the variations in mitochondrial protein expression. The proteome of the samples was analyzed by quantitative differential electrophoresis and Mass Spectrometry. These changes were validated by classical techniques and by novel and precise selected reaction monitoring analysis and RNA sequencing approach increasing the total heart samples up to 25. We found significant alterations in energy metabolism, especially in molecules involved in substrate utilization (ODPA, ETFD, DLDH), energy production (ATPA), other metabolic pathways (AL4A1) and protein synthesis (EFTU), obtaining considerable and specific relationships between the alterations detected in these processes. Importantly, we observed that the antioxidant PRDX3 overexpression is associated with impaired ventricular function. PRDX3 is significantly related to LV end systolic and diastolic diameter (r = 0.73, p value<0.01; r = 0.71, p value<0.01), fractional shortening, and ejection fraction (r = -0.61, p value<0.05; and r = -0.62, p value<0.05, respectively). CONCLUSION: This work could be a pivotal study to gain more knowledge on the cellular mechanisms related to the pathophysiology of this disease and may lead to the development of etiology-specific heart failure therapies. We suggest new molecular targets for therapeutic interventions, something that up to now has been lacking.', 'FAU': ['Rosello-Lleti, Esther', 'Tarazon, Estefania', 'Barderas, Maria G', 'Ortega, Ana', 'Otero, Manuel', 'Molina-Navarro, Maria Micaela', 'Lago, Francisca', 'Gonzalez-Juanatey, Jose Ramon', 'Salvador, Antonio', 'Portoles, Manuel', 'Rivera, Miguel'], 'AU': ['Rosello-Lleti E', 'Tarazon E', 'Barderas MG', 'Ortega A', 'Otero M', 'Molina-Navarro MM', 'Lago F', 'Gonzalez-Juanatey JR', 'Salvador A', 'Portoles M', 'Rivera M'], 'AD': ['Cardiocirculatory Unit, Health Research Institute Hospital La Fe, Valencia, Spain.', 'Cardiocirculatory Unit, Health Research Institute Hospital La Fe, Valencia, Spain.', 'Department of Vascular Physiopathology, Hospital Nacional de Paraplejicos, SESCAM, Toledo, Spain.', 'Cardiocirculatory Unit, Health Research Institute Hospital La Fe, Valencia, Spain.', 'Cellular and Molecular Cardiology Research Unit, Department of Cardiology and Institute of Biomedical Research, University Clinical Hospital, Santiago de Compostela, Spain.', 'Cardiocirculatory Unit, Health Research Institute Hospital La Fe, Valencia, Spain.', 'Cellular and Molecular Cardiology Research Unit, Department of Cardiology and Institute of Biomedical Research, University Clinical Hospital, Santiago de Compostela, Spain.', 'Cellular and Molecular Cardiology Research Unit, Department of Cardiology and Institute of Biomedical Research, University Clinical Hospital, Santiago de Compostela, Spain.', 'Cardiology Service, Hospital La Fe, Valencia, Spain.', 'Cell Biology and Pathology Unit, Health Research Institute Hospital La Fe, Valencia, Spain.', 'Cardiocirculatory Unit, Health Research Institute Hospital La Fe, Valencia, Spain.'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20141114', 'PL': 'United States', 'TA': 'PLoS One', 'JT': 'PloS one', 'JID': '101285081', 'RN': ['0 (Antioxidants)', '0 (Mitochondrial Proteins)', '0 (Proteome)', '0 (RNA, Messenger)', '63231-63-0 (RNA)', 'EC 1.11.1.15 (Peroxiredoxin III)'], 'SB': 'IM', 'MH': ['Adult', 'Aged', 'Antioxidants/metabolism', 'Cardiomyopathy, Dilated/metabolism/pathology', 'Case-Control Studies', 'Echocardiography', 'Energy Metabolism/*physiology', 'Female', 'Heart Ventricles/metabolism/physiopathology', 'Humans', 'Male', 'Microscopy, Electron, Transmission', 'Middle Aged', 'Mitochondria, Heart/genetics/*metabolism', 'Mitochondrial Proteins/genetics/metabolism', 'Myocardium/*metabolism', 'Peroxiredoxin III/genetics/*metabolism', 'Proteome/*analysis', 'RNA/chemistry/isolation & purification/metabolism', 'RNA, Messenger/metabolism'], 'PMC': 'PMC4232587', 'EDAT': '2014/11/15 06:00', 'MHDA': '2015/12/22 06:00', 'CRDT': ['2014/11/15 06:00'], 'PHST': ['2014/07/05 00:00 [received]', '2014/10/17 00:00 [accepted]', '2014/11/15 06:00 [entrez]', '2014/11/15 06:00 [pubmed]', '2015/12/22 06:00 [medline]'], 'AID': ['10.1371/journal.pone.0112971 [doi]', 'PONE-D-14-30105 [pii]'], 'PST': 'epublish', 'SO': 'PLoS One. 2014 Nov 14;9(11):e112971. doi: 10.1371/journal.pone.0112971. eCollection 2014.'}\n",
      "{'PMID': '25382018', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20150831', 'LR': '20181113', 'IS': '1582-4934 (Electronic) 1582-1838 (Linking)', 'VI': '19', 'IP': '2', 'DP': '2015 Feb', 'TI': 'ATP synthase subunit alpha and LV mass in ischaemic human hearts.', 'PG': '442-51', 'LID': '10.1111/jcmm.12477 [doi]', 'AB': 'Mitochondrial dysfunction plays a critical role in the development of ischaemic cardiomyopathy (ICM). In this study, the mitochondrial proteome in the cardiac tissue of ICM patients was analysed by quantitative differential electrophoresis (2D-DIGE) and mass spectrometry (MS) for the first time to provide new insights into cardiac dysfunction in this cardiomyopathy. We isolated mitochondria from LV samples of explanted hearts of ICM patients (n = 8) and control donors (n = 8) and used a proteomic approach to investigate the variations in mitochondrial protein expression. We found that most of the altered proteins were involved in cardiac energy metabolism (82%). We focused on ATPA, which is involved in energy production, and dihydrolipoyl dehydrogenase, implicated in substrate utilization, and observed that these molecules were overexpressed and that the changes detected in the processes mediated by these proteins were closely related. Notably, we found that ATPA overexpression was associated with reduction in LV mass (r = -0.74, P < 0.01). We also found a substantial increase in the expression of elongation factor Tu, a molecule implicated in protein synthesis, and PRDX3, involved in the stress response. All of these changes were validated using classical techniques and by using novel and precise selected reaction monitoring analysis and an RNA sequencing approach, with the total heart samples being increased to 24. This study provides key insights that enhance our understanding of the cellular mechanisms related to the pathophysiology of ICM and could lead to the development of aetiology-specific heart failure therapies. ATPA could serve as a molecular target suitable for new therapeutic interventions.', 'CI': ['(c) 2014 The Authors. Journal of Cellular and Molecular Medicine published by', 'John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine.'], 'FAU': ['Rosello-Lleti, Esther', 'Tarazon, Estefania', 'Barderas, Maria G', 'Ortega, Ana', 'Molina-Navarro, Maria Micaela', 'Martinez, Alba', 'Lago, Francisca', 'Martinez-Dolz, Luis', 'Gonzalez-Juanatey, Jose Ramon', 'Salvador, Antonio', 'Portoles, Manuel', 'Rivera, Miguel'], 'AU': ['Rosello-Lleti E', 'Tarazon E', 'Barderas MG', 'Ortega A', 'Molina-Navarro MM', 'Martinez A', 'Lago F', 'Martinez-Dolz L', 'Gonzalez-Juanatey JR', 'Salvador A', 'Portoles M', 'Rivera M'], 'AD': ['Cardiocirculatory Unit, Health Research Institute Hospital La Fe, Valencia, Spain.'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20141109', 'PL': 'England', 'TA': 'J Cell Mol Med', 'JT': 'Journal of cellular and molecular medicine', 'JID': '101083777', 'RN': ['0 (Proteome)', 'EC 3.6.1.- (Adenosine Triphosphatases)'], 'SB': 'IM', 'MH': ['Adenosine Triphosphatases/*metabolism', 'Female', 'Heart', 'Heart Ventricles/*metabolism', 'Humans', 'Male', 'Mass Spectrometry/methods', 'Middle Aged', 'Mitochondria/metabolism', 'Myocardial Ischemia/*metabolism', 'Proteome/metabolism'], 'PMC': 'PMC4407605', 'OTO': ['NOTNLM'], 'OT': ['heart failure', 'ischaemic cardiomyopathy', 'mitochondria', 'tissue', 'transplantation'], 'EDAT': '2014/11/11 06:00', 'MHDA': '2015/09/01 06:00', 'CRDT': ['2014/11/11 06:00'], 'PHST': ['2014/07/14 00:00 [received]', '2014/10/01 00:00 [accepted]', '2014/11/11 06:00 [entrez]', '2014/11/11 06:00 [pubmed]', '2015/09/01 06:00 [medline]'], 'AID': ['10.1111/jcmm.12477 [doi]'], 'PST': 'ppublish', 'SO': 'J Cell Mol Med. 2015 Feb;19(2):442-51. doi: 10.1111/jcmm.12477. Epub 2014 Nov 9.'}\n",
      "{'PMID': '25341944', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20151019', 'LR': '20181113', 'IS': '1539-7262 (Electronic) 0022-2275 (Linking)', 'VI': '55', 'IP': '12', 'DP': '2014 Dec', 'TI': 'Defective functionality of HDL particles in familial apoA-I deficiency: relevance of alterations in HDL lipidome and proteome.', 'PG': '2509-20', 'LID': '10.1194/jlr.M051631 [doi]', 'AB': 'To evaluate functional and compositional properties of HDL in subjects from a kindred of genetic apoA-I deficiency, two homozygotes and six heterozygotes, with a nonsense mutation at APOA1 codon -2, Q[-2]X, were recruited together with age- and sex-matched healthy controls (n = 11). Homozygotes displayed undetectable plasma levels of apoA-I and reduced levels of HDL-cholesterol (HDL-C) and apoC-III (5.4% and 42.6% of controls, respectively). Heterozygotes displayed low HDL-C (21 +/- 9 mg/dl), low apoA-I (79 +/- 24 mg/dl), normal LDL-cholesterol (132 +/- 25 mg/dl), and elevated TG (130 +/- 45 mg/dl) levels. Cholesterol efflux capacity of ultracentrifugally isolated HDL subpopulations was reduced (up to -25%, P < 0.01, on a glycerophospholipid [GP] basis) in heterozygotes versus controls. Small, dense HDL3 and total HDL from heterozygotes exhibited diminished antioxidative activity (up to -48%, P < 0.001 on a total mass basis) versus controls. HDL subpopulations from both homozygotes and heterozygotes displayed altered chemical composition, with depletion in apoA-I, GP, and cholesteryl ester; enrichment in apoA-II, free cholesterol, and TG; and altered phosphosphingolipidome. The defective atheroprotective activities of HDL were correlated with altered lipid and apo composition. These data reveal that atheroprotective activities of HDL particles are impaired in homozygous and heterozygous apoA-I deficiency and are intimately related to marked alterations in protein and lipid composition.', 'CI': ['Copyright (c) 2014 by the American Society for Biochemistry and Molecular', 'Biology, Inc.'], 'FAU': ['Rached, Fabiana', 'Santos, Raul D', 'Camont, Laurent', 'Miname, Marcio H', 'Lhomme, Marie', 'Dauteuille, Carolane', 'Lecocq, Sora', 'Serrano, Carlos V Jr', 'Chapman, M John', 'Kontush, Anatol'], 'AU': ['Rached F', 'Santos RD', 'Camont L', 'Miname MH', 'Lhomme M', 'Dauteuille C', 'Lecocq S', 'Serrano CV Jr', 'Chapman MJ', 'Kontush A'], 'AD': ['National Institute for Health and Medical Research (INSERM), UMR-ICAN 1166, University of Pierre and Marie Curie - Paris 6, Pitie - Salpetriere University Hospital, ICAN, Paris, France Heart Institute-InCor, University of Sao Paulo, Sao Paulo, Brazil.', 'Heart Institute-InCor, University of Sao Paulo, Sao Paulo, Brazil.', 'National Institute for Health and Medical Research (INSERM), UMR-ICAN 1166, University of Pierre and Marie Curie - Paris 6, Pitie - Salpetriere University Hospital, ICAN, Paris, France.', 'Heart Institute-InCor, University of Sao Paulo, Sao Paulo, Brazil.', 'National Institute for Health and Medical Research (INSERM), UMR-ICAN 1166, University of Pierre and Marie Curie - Paris 6, Pitie - Salpetriere University Hospital, ICAN, Paris, France.', 'National Institute for Health and Medical Research (INSERM), UMR-ICAN 1166, University of Pierre and Marie Curie - Paris 6, Pitie - Salpetriere University Hospital, ICAN, Paris, France.', 'National Institute for Health and Medical Research (INSERM), UMR-ICAN 1166, University of Pierre and Marie Curie - Paris 6, Pitie - Salpetriere University Hospital, ICAN, Paris, France.', 'Heart Institute-InCor, University of Sao Paulo, Sao Paulo, Brazil.', 'National Institute for Health and Medical Research (INSERM), UMR-ICAN 1166, University of Pierre and Marie Curie - Paris 6, Pitie - Salpetriere University Hospital, ICAN, Paris, France.', 'National Institute for Health and Medical Research (INSERM), UMR-ICAN 1166, University of Pierre and Marie Curie - Paris 6, Pitie - Salpetriere University Hospital, ICAN, Paris, France.'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20141023', 'PL': 'United States', 'TA': 'J Lipid Res', 'JT': 'Journal of lipid research', 'JID': '0376606', 'RN': ['0 (APOA1 protein, human)', '0 (Apolipoprotein A-I)', '0 (Apolipoprotein C-III)', '0 (CETP protein, human)', '0 (Cholesterol Ester Transfer Proteins)', '0 (Cholesterol Esters)', '0 (Cholesterol, HDL)', '0 (Cholesterol, LDL)', '0 (Codon, Nonsense)', '0 (Lipoproteins, HDL)', '0 (Lipoproteins, HDL3)', '0 (Phospholipids)', '0 (Sphingolipids)', '0 (Triglycerides)'], 'SB': 'IM', 'MH': ['Adult', 'Apolipoprotein A-I/blood/*deficiency/genetics/metabolism', 'Apolipoprotein C-III/*blood/metabolism', 'Brazil', 'Cholesterol Ester Transfer Proteins/*blood/metabolism', 'Cholesterol Esters/blood/metabolism', 'Cholesterol, HDL/*blood/metabolism', 'Cholesterol, LDL/blood/metabolism', 'Codon, Nonsense', 'Family Health', 'Female', 'Heterozygote', 'Homozygote', 'Humans', 'Hypoalphalipoproteinemias/*blood/genetics/metabolism', 'Lipoproteins, HDL/*blood/metabolism', 'Lipoproteins, HDL3/blood/metabolism', 'Male', 'Phospholipids/blood/metabolism', 'Sphingolipids/blood/metabolism', 'Triglycerides/blood/metabolism'], 'PMC': 'PMC4242444', 'OTO': ['NOTNLM'], 'OT': ['HDL functionality', 'antioxidative activity', 'apolipoprotein A-I', 'cellular cholesterol efflux', 'familial deficiency', 'genetics', 'high density lipoprotein', 'lipidomics'], 'EDAT': '2014/10/25 06:00', 'MHDA': '2015/10/20 06:00', 'CRDT': ['2014/10/25 06:00'], 'PHST': ['2014/10/25 06:00 [entrez]', '2014/10/25 06:00 [pubmed]', '2015/10/20 06:00 [medline]'], 'AID': ['jlr.M051631 [pii]', '10.1194/jlr.M051631 [doi]'], 'PST': 'ppublish', 'SO': 'J Lipid Res. 2014 Dec;55(12):2509-20. doi: 10.1194/jlr.M051631. Epub 2014 Oct 23.'}\n",
      "{'PMID': '25318410', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20151026', 'LR': '20151119', 'IS': '1535-3907 (Electronic) 1535-3893 (Linking)', 'VI': '13', 'IP': '12', 'DP': '2014 Dec 5', 'TI': 'Establishing a reliable multiple reaction monitoring-based method for the quantification of obesity-associated comorbidities in serum and adipose tissue requires intensive clinical validation.', 'PG': '5784-800', 'LID': '10.1021/pr500722k [doi]', 'AB': 'Multiple reaction monitoring (MRM)-based mass spectrometric quantification of peptides and their corresponding proteins has been successfully applied for biomarker validation in serum. The option of multiplexing offers the chance to analyze various proteins in parallel, which is especially important in obesity research. Here, biomarkers that reflect multiple comorbidities and allow monitoring of therapy outcomes are required. Besides the suitability of established MRM assays for serum protein quantification, it is also feasible for analysis of tissues secreting the markers of interest. Surprisingly, studies comparing MRM data sets with established methods are rare, and therefore the biological and clinical value of most analytes remains questionable. A MRM method using nano-UPLC-MS/MS for the quantification of obesity related surrogate markers for several comorbidities in serum, plasma, visceral and subcutaneous adipose tissue was established. Proteotypic peptides for complement C3, adiponectin, angiotensinogen, and plasma retinol binding protein (RBP4) were quantified using isotopic dilution analysis and compared to the standard ELISA method. MRM method variabilities were mainly below 10%. The comparison with other MS-based approaches showed a good correlation. However, large differences in absolute quantification for complement C3 and adiponectin were obtained compared to ELISA, while less marked differences were observed for angiotensinogen and RBP4. The verification of MRM in obesity was performed to discriminate first lean and obese phenotype and second to monitor excessive weight loss after gastric bypass surgery in a seven-month follow-up. The presented MRM assay was able to discriminate obese phenotype from lean and monitor weight loss related changes of surrogate markers. However, inclusion of additional biomarkers was necessary to interpret the MRM data on obesity phenotype properly. In summary, the development of disease-related MRMs should include a step of matching the MRM data with clinically approved standard methods and defining reference values in well-sized representative age, gender, and disease-matched cohorts.', 'FAU': ['Oberbach, Andreas', 'Schlichting, Nadine', 'Neuhaus, Jochen', 'Kullnick, Yvonne', 'Lehmann, Stefanie', 'Heinrich, Marco', 'Dietrich, Arne', 'Mohr, Friedrich Wilhelm', 'von Bergen, Martin', 'Baumann, Sven'], 'AU': ['Oberbach A', 'Schlichting N', 'Neuhaus J', 'Kullnick Y', 'Lehmann S', 'Heinrich M', 'Dietrich A', 'Mohr FW', 'von Bergen M', 'Baumann S'], 'AD': ['Department of Cardiac Surgery, University of Leipzig , Heart Center Leipzig, Leipzig, Germany.'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20141117', 'PL': 'United States', 'TA': 'J Proteome Res', 'JT': 'Journal of proteome research', 'JID': '101128775', 'RN': ['0 (Adiponectin)', '0 (Biomarkers)', '0 (Blood Proteins)', '0 (Complement C3)', '0 (Peptides)', '0 (RBP4 protein, human)', '0 (Retinol-Binding Proteins, Plasma)', '11002-13-4 (Angiotensinogen)'], 'SB': 'IM', 'MH': ['Adiponectin/blood/metabolism', 'Adipose Tissue/*metabolism', 'Adult', 'Aged', 'Angiotensinogen/blood/metabolism', 'Biomarkers/blood/metabolism', 'Blood Proteins/*metabolism', 'Chromatography, High Pressure Liquid/*methods', 'Comorbidity', 'Complement C3/metabolism', 'Enzyme-Linked Immunosorbent Assay', 'Female', 'Humans', 'Male', 'Middle Aged', 'Obesity/blood/epidemiology/*metabolism', 'Peptides/blood/metabolism', 'Proteomics/*methods', 'Reproducibility of Results', 'Retinol-Binding Proteins, Plasma/metabolism', 'Tandem Mass Spectrometry/methods', 'Weight Loss'], 'OTO': ['NOTNLM'], 'OT': ['comorbidities', 'mass spectrometry', 'multiple reaction monitoring', 'obesity', 'peptide quantification', 'surrogate markers', 'validation'], 'EDAT': '2014/10/17 06:00', 'MHDA': '2015/10/27 06:00', 'CRDT': ['2014/10/17 06:00'], 'PHST': ['2014/10/17 06:00 [entrez]', '2014/10/17 06:00 [pubmed]', '2015/10/27 06:00 [medline]'], 'AID': ['10.1021/pr500722k [doi]'], 'PST': 'ppublish', 'SO': 'J Proteome Res. 2014 Dec 5;13(12):5784-800. doi: 10.1021/pr500722k. Epub 2014 Nov 17.'}\n",
      "{'PMID': '25226522', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20150622', 'LR': '20181113', 'IS': '1932-6203 (Electronic) 1932-6203 (Linking)', 'VI': '9', 'IP': '9', 'DP': '2014', 'TI': 'Endoplasmic reticulum stress induces different molecular structural alterations in human dilated and ischemic cardiomyopathy.', 'PG': 'e107635', 'LID': '10.1371/journal.pone.0107635 [doi]', 'AB': \"BACKGROUND: The endoplasmic reticulum (ER) is a multifunctional organelle responsible for the synthesis and folding of proteins as well as for signalling and calcium storage, that has been linked to the contraction-relaxation process. Perturbations of its homeostasis activate a stress response in diseases such as heart failure (HF). To elucidate the alterations in ER molecular components, we analyze the levels of ER stress and structure proteins in human dilated (DCM) and ischemic (ICM) cardiomyopathies, and its relationship with patient's functional status. METHODS AND RESULTS: We examined 52 explanted human hearts from DCM (n = 21) and ICM (n = 21) subjects and 10 non-failing hearts as controls. Our results showed specific changes in stress (IRE1, p<0.05; p-IRE1, p<0.05) and structural (Reticulon 1, p<0.01) protein levels. The stress proteins GRP78, XBP1 and ATF6 as well as the structural proteins RRBP1, kinectin, and Nogo A and B, were upregulated in both DCM and ICM patients. Immunofluorescence results were concordant with quantified Western blot levels. Moreover, we show a novel relationship between stress and structural proteins. RRBP1, involved in procollagen synthesis and remodeling, was related with left ventricular function. CONCLUSIONS: In the present study, we report the existence of alterations in ER stress response and shaping proteins. We show a plausible effect of the ER stress on ER structure in a suitable sample of DCM and ICM subjects. Patients with higher values of RRBP1 had worse left ventricular function.\", 'FAU': ['Ortega, Ana', 'Rosello-Lleti, Esther', 'Tarazon, Estefania', 'Molina-Navarro, Maria Micaela', 'Martinez-Dolz, Luis', 'Gonzalez-Juanatey, Jose Ramon', 'Lago, Francisca', 'Montoro-Mateos, Jose David', 'Salvador, Antonio', 'Rivera, Miguel', 'Portoles, Manuel'], 'AU': ['Ortega A', 'Rosello-Lleti E', 'Tarazon E', 'Molina-Navarro MM', 'Martinez-Dolz L', 'Gonzalez-Juanatey JR', 'Lago F', 'Montoro-Mateos JD', 'Salvador A', 'Rivera M', 'Portoles M'], 'AD': ['Cardiocirculatory Unit, Health Research Institute of La Fe University Hospital, Valencia, Spain.', 'Cardiocirculatory Unit, Health Research Institute of La Fe University Hospital, Valencia, Spain.', 'Cardiocirculatory Unit, Health Research Institute of La Fe University Hospital, Valencia, Spain.', 'Cardiocirculatory Unit, Health Research Institute of La Fe University Hospital, Valencia, Spain.', 'Heart Failure and Transplantation Unit, Cardiology Department, La Fe University Hospital, Valencia, Spain.', 'Cellular and Molecular Cardiology Research Unit, Department of Cardiology and Institute of Biomedical Research, University Clinical Hospital, Santiago de Compostela, Spain.', 'Cellular and Molecular Cardiology Research Unit, Department of Cardiology and Institute of Biomedical Research, University Clinical Hospital, Santiago de Compostela, Spain.', 'Cardiocirculatory Unit, Health Research Institute of La Fe University Hospital, Valencia, Spain.', 'Heart Failure and Transplantation Unit, Cardiology Department, La Fe University Hospital, Valencia, Spain.', 'Cardiocirculatory Unit, Health Research Institute of La Fe University Hospital, Valencia, Spain.', 'Cardiocirculatory Unit, Health Research Institute of La Fe University Hospital, Valencia, Spain.'], 'LA': ['eng'], 'PT': ['Journal Article', 'Research Support, N.I.H., Extramural', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20140916', 'PL': 'United States', 'TA': 'PLoS One', 'JT': 'PloS one', 'JID': '101285081', 'RN': ['0 (Proteome)'], 'SB': 'IM', 'MH': ['Adult', 'Cardiomyopathy, Dilated/diagnosis/etiology/*metabolism', 'Endoplasmic Reticulum/*metabolism', '*Endoplasmic Reticulum Stress', 'Female', 'Heart Ventricles/metabolism/physiopathology', 'Humans', 'Male', 'Middle Aged', 'Myocardial Ischemia/diagnosis/etiology/*metabolism', 'Protein Transport', 'Proteome'], 'PMC': 'PMC4166610', 'EDAT': '2014/09/17 06:00', 'MHDA': '2015/06/24 06:00', 'CRDT': ['2014/09/17 06:00'], 'PHST': ['2014/02/03 00:00 [received]', '2014/08/20 00:00 [accepted]', '2014/09/17 06:00 [entrez]', '2014/09/17 06:00 [pubmed]', '2015/06/24 06:00 [medline]'], 'AID': ['10.1371/journal.pone.0107635 [doi]', 'PONE-D-14-05127 [pii]'], 'PST': 'epublish', 'SO': 'PLoS One. 2014 Sep 16;9(9):e107635. doi: 10.1371/journal.pone.0107635. eCollection 2014.'}\n",
      "{'PMID': '25217443', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20160126', 'LR': '20181202', 'IS': '1522-9645 (Electronic) 0195-668X (Linking)', 'VI': '36', 'IP': '16', 'DP': '2015 Apr 21', 'TI': 'Changes in thrombus composition and profilin-1 release in acute myocardial infarction.', 'PG': '965-75', 'LID': '10.1093/eurheartj/ehu356 [doi]', 'AB': 'AIM: Thrombus formation is a dynamic process regulated by flow, blood cells, and plasma proteins. The present study was performed to investigate the characteristics of human coronary thrombus in ST-segment elevation myocardial infarction (STEMI). METHODS AND RESULTS: Patients admitted with ST-elevation myocardial infarction, in which thrombectomy was performed, were included (n = 86). Intracoronary thrombi and blood from the culprit coronary site and the systemic circulation were obtained during percutaneous coronary intervention (PCI). Thrombi were categorized by onset-of-pain-to-PCI elapsed time in thrombus of <3 (T3) and more than 6 h of evolution (T6). Clinical, morphological, and proteomic variables were investigated. While T3 were mainly composed by platelets and fibrin(ogen), T6 were characterized by a reduced platelet content, increased leucocytes infiltration (including monocytes, neutrophils, T-cells, and B-cells), and appearance of undifferentiated progenitor cells. Significant differences between T3 and T6 were found in the cell cytoskeleton-associated proteome (beta-actin and tropomyosin 3 and 4). By discovery proteomics, we have identified profilin-1 (Pfn-1) in the coronary thrombi and detected higher levels in T3 than in T6. While plasma Pfn-1 levels were low in T3 patients, levels significantly increased in both coronary and peripheral circulation in T6 patients indicating release. In vitro platelet aggregation studies showed that platelets secrete Pfn-1 upon complete activation. CONCLUSION: Coronary thrombi show rapid dynamic changes both in structure and cell composition as a function of elapsed onset-of-pain-to-PCI time. Aged ischaemic thrombi were more likely to have reduced Pfn-1 content releasing Pfn-1 to the circulation. Onset-of-pain-to-PCI elapsed time in STEMI patients and hence age of occlusive thrombus can be profiled by Pfn-1 levels found in the peripheral circulation.', 'CI': ['Published on behalf of the European Society of Cardiology. All rights reserved.', '(c) The Author 2014. For permissions please email: journals.permissions@oup.com.'], 'FAU': ['Ramaiola, Ilaria', 'Padro, Teresa', 'Pena, Esther', 'Juan-Babot, Oriol', 'Cubedo, Judit', 'Martin-Yuste, Victoria', 'Sabate, Manel', 'Badimon, Lina'], 'AU': ['Ramaiola I', 'Padro T', 'Pena E', 'Juan-Babot O', 'Cubedo J', 'Martin-Yuste V', 'Sabate M', 'Badimon L'], 'AD': ['Cardiovascular Research Center (CSIC-ICCC), IIB SantPau, c/Sant Antoni M feminine Claret 167, 08025 Barcelona, Spain.', 'Cardiovascular Research Center (CSIC-ICCC), IIB SantPau, c/Sant Antoni M feminine Claret 167, 08025 Barcelona, Spain.', 'Cardiovascular Research Center (CSIC-ICCC), IIB SantPau, c/Sant Antoni M feminine Claret 167, 08025 Barcelona, Spain.', 'Cardiovascular Research Center (CSIC-ICCC), IIB SantPau, c/Sant Antoni M feminine Claret 167, 08025 Barcelona, Spain.', 'Cardiovascular Research Center (CSIC-ICCC), IIB SantPau, c/Sant Antoni M feminine Claret 167, 08025 Barcelona, Spain.', 'Hospital Clinic, Barcelona, Spain.', 'Hospital Clinic, Barcelona, Spain.', 'Cardiovascular Research Center (CSIC-ICCC), IIB SantPau, c/Sant Antoni M feminine Claret 167, 08025 Barcelona, Spain Cardiovascular Research Chair UAB, Barcelona, Spain lbadimon@csic-iccc.org.'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20140912', 'PL': 'England', 'TA': 'Eur Heart J', 'JT': 'European heart journal', 'JID': '8006263', 'RN': ['0 (Platelet Aggregation Inhibitors)', '0 (Profilins)', '9001-32-5 (Fibrinogen)', 'A74586SNO7 (Clopidogrel)', 'EC 3.4.21.5 (Thrombin)', 'OM90ZUW7M1 (Ticlopidine)'], 'SB': 'IM', 'MH': ['Analysis of Variance', 'Blood Platelets/pathology', 'Clopidogrel', 'Coronary Thrombosis/metabolism/*pathology/therapy', 'Female', 'Fibrinogen/metabolism', 'Humans', 'Leukocytes/pathology', 'Male', 'Middle Aged', 'Myocardial Infarction/metabolism/*pathology/therapy', 'Percutaneous Coronary Intervention', 'Platelet Aggregation/physiology', 'Platelet Aggregation Inhibitors/therapeutic use', 'Profilins/*metabolism', 'Thrombectomy/methods', 'Thrombin/physiology', 'Ticlopidine/analogs & derivatives/therapeutic use', 'Time-to-Treatment'], 'OTO': ['NOTNLM'], 'OT': ['Occlusive thrombus ageing', 'PCI', 'Platelets', 'Profilin-1'], 'EDAT': '2014/09/14 06:00', 'MHDA': '2016/01/27 06:00', 'CRDT': ['2014/09/14 06:00'], 'PHST': ['2013/10/10 00:00 [received]', '2014/08/08 00:00 [accepted]', '2014/09/14 06:00 [entrez]', '2014/09/14 06:00 [pubmed]', '2016/01/27 06:00 [medline]'], 'AID': ['ehu356 [pii]', '10.1093/eurheartj/ehu356 [doi]'], 'PST': 'ppublish', 'SO': 'Eur Heart J. 2015 Apr 21;36(16):965-75. doi: 10.1093/eurheartj/ehu356. Epub 2014 Sep 12.'}\n",
      "{'PMID': '25117565', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20150423', 'LR': '20201217', 'IS': '1932-6203 (Electronic) 1932-6203 (Linking)', 'VI': '9', 'IP': '8', 'DP': '2014', 'TI': 'Phosphoproteomic profiling of human myocardial tissues distinguishes ischemic from non-ischemic end stage heart failure.', 'PG': 'e104157', 'LID': '10.1371/journal.pone.0104157 [doi]', 'AB': 'The molecular differences between ischemic (IF) and non-ischemic (NIF) heart failure are poorly defined. A better understanding of the molecular differences between these two heart failure etiologies may lead to the development of more effective heart failure therapeutics. In this study extensive proteomic and phosphoproteomic profiles of myocardial tissue from patients diagnosed with IF or NIF were assembled and compared. Proteins extracted from left ventricular sections were proteolyzed and phosphopeptides were enriched using titanium dioxide resin. Gel- and label-free nanoscale capillary liquid chromatography coupled to high resolution accuracy mass tandem mass spectrometry allowed for the quantification of 4,436 peptides (corresponding to 450 proteins) and 823 phosphopeptides (corresponding to 400 proteins) from the unenriched and phospho-enriched fractions, respectively. Protein abundance did not distinguish NIF from IF. In contrast, 37 peptides (corresponding to 26 proteins) exhibited a >/= 2-fold alteration in phosphorylation state (p<0.05) when comparing IF and NIF. The degree of protein phosphorylation at these 37 sites was specifically dependent upon the heart failure etiology examined. Proteins exhibiting phosphorylation alterations were grouped into functional categories: transcriptional activation/RNA processing; cytoskeleton structure/function; molecular chaperones; cell adhesion/signaling; apoptosis; and energetic/metabolism. Phosphoproteomic analysis demonstrated profound post-translational differences in proteins that are involved in multiple cellular processes between different heart failure phenotypes. Understanding the roles these phosphorylation alterations play in the development of NIF and IF has the potential to generate etiology-specific heart failure therapeutics, which could be more effective than current therapeutics in addressing the growing concern of heart failure.', 'FAU': ['Schechter, Matthew A', 'Hsieh, Michael K H', 'Njoroge, Linda W', 'Thompson, J Will', 'Soderblom, Erik J', 'Feger, Bryan J', 'Troupes, Constantine D', 'Hershberger, Kathleen A', 'Ilkayeva, Olga R', 'Nagel, Whitney L', 'Landinez, Gina P', 'Shah, Kishan M', 'Burns, Virginia A', 'Santacruz, Lucia', 'Hirschey, Matthew D', 'Foster, Matthew W', 'Milano, Carmelo A', 'Moseley, M Arthur', 'Piacentino, Valentino 3rd', 'Bowles, Dawn E'], 'AU': ['Schechter MA', 'Hsieh MK', 'Njoroge LW', 'Thompson JW', 'Soderblom EJ', 'Feger BJ', 'Troupes CD', 'Hershberger KA', 'Ilkayeva OR', 'Nagel WL', 'Landinez GP', 'Shah KM', 'Burns VA', 'Santacruz L', 'Hirschey MD', 'Foster MW', 'Milano CA', 'Moseley MA', 'Piacentino V 3rd', 'Bowles DE'], 'AD': ['Department of Surgery, Duke University Medical Center, Durham, North Carolina, United States of America.', 'Department of Surgery, Duke University Medical Center, Durham, North Carolina, United States of America.', 'Department of Surgery, Duke University Medical Center, Durham, North Carolina, United States of America.', 'Duke Proteomics Core, Duke University Medical Center, Durham, North Carolina, United States of America.', 'Duke Proteomics Core, Duke University Medical Center, Durham, North Carolina, United States of America.', 'Department of Surgery, Duke University Medical Center, Durham, North Carolina, United States of America.', 'Department of Surgery, Duke University Medical Center, Durham, North Carolina, United States of America.', 'Sarah W. Stedman Nutrition and Metabolism Center, Duke University Medical Center, Durham, North Carolina, United States of America; Department of Medicine, Duke University Medical Center, Durham, North Carolina, United States of America.', 'Sarah W. Stedman Nutrition and Metabolism Center, Duke University Medical Center, Durham, North Carolina, United States of America.', 'Department of Surgery, Duke University Medical Center, Durham, North Carolina, United States of America.', 'Department of Surgery, Duke University Medical Center, Durham, North Carolina, United States of America.', 'Department of Surgery, Duke University Medical Center, Durham, North Carolina, United States of America.', 'Duke Translational Research Institute, Duke University Medical Center, Durham, North Carolina, United States of America.', 'Department of Surgery, Duke University Medical Center, Durham, North Carolina, United States of America.', 'Sarah W. Stedman Nutrition and Metabolism Center, Duke University Medical Center, Durham, North Carolina, United States of America; Department of Medicine, Duke University Medical Center, Durham, North Carolina, United States of America.', 'Division of Pulmonary, Allergy and Critical Care, Medicine, Duke University Medical Center, Durham, North Carolina, United States of America.', 'Department of Surgery, Duke University Medical Center, Durham, North Carolina, United States of America.', 'Duke Proteomics Core, Duke University Medical Center, Durham, North Carolina, United States of America.', 'Department of Surgery, Duke University Medical Center, Durham, North Carolina, United States of America.', 'Department of Surgery, Duke University Medical Center, Durham, North Carolina, United States of America.'], 'LA': ['eng'], 'GR': ['UL1 RR024128/RR/NCRR NIH HHS/United States', 'ImNIH/Intramural NIH HHS/United States', 'R01 AG045351/AG/NIA NIH HHS/United States', 'T32 GM007105/GM/NIGMS NIH HHS/United States', 'UL1RR024128/RR/NCRR NIH HHS/United States'], 'PT': ['Journal Article', 'Research Support, N.I.H., Intramural', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20140812', 'PL': 'United States', 'TA': 'PLoS One', 'JT': 'PloS one', 'JID': '101285081', 'RN': ['0 (Phosphopeptides)', '0 (Phosphoproteins)', '0 (Proteome)'], 'SB': 'IM', 'MH': ['Aged', 'Cluster Analysis', 'Computational Biology', 'Diagnosis, Differential', 'Gene Expression Profiling', 'Heart Failure/diagnosis/*etiology/*metabolism', 'Heart Ventricles/metabolism', 'Humans', 'Male', 'Metabolome', 'Metabolomics', 'Middle Aged', 'Myocardial Ischemia/complications', 'Myocardium/*metabolism', 'Phosphopeptides/metabolism', 'Phosphoproteins/*metabolism', 'Protein Interaction Mapping', 'Protein Interaction Maps', '*Proteome', '*Proteomics/methods', 'Reproducibility of Results'], 'PMC': 'PMC4130503', 'EDAT': '2014/08/15 06:00', 'MHDA': '2015/04/24 06:00', 'CRDT': ['2014/08/14 06:00'], 'PHST': ['2014/05/01 00:00 [received]', '2014/07/06 00:00 [accepted]', '2014/08/14 06:00 [entrez]', '2014/08/15 06:00 [pubmed]', '2015/04/24 06:00 [medline]'], 'AID': ['10.1371/journal.pone.0104157 [doi]', 'PONE-D-14-19226 [pii]'], 'PST': 'epublish', 'SO': 'PLoS One. 2014 Aug 12;9(8):e104157. doi: 10.1371/journal.pone.0104157. eCollection 2014.'}\n",
      "{'PMID': '25099258', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20150330', 'LR': '20181113', 'IS': '1365-2125 (Electronic) 0306-5251 (Linking)', 'VI': '78', 'IP': '2', 'DP': '2014 Aug', 'TI': 'Increased platelet expression of glycoprotein IIIa following aspirin treatment in aspirin-resistant but not aspirin-sensitive subjects.', 'PG': '320-8', 'LID': '10.1111/bcp.12335 [doi]', 'AB': 'AIMS: Aspirin is widely used as an anti-platelet agent for cardiovascular prophylaxis. Despite aspirin treatment, many patients experience recurrent thrombotic events, and aspirin resistance may contribute to this. We examined the prevalence of aspirin resistance in a healthy population, and investigated whether the platelet proteome differed in aspirin-resistant subjects. METHODS: Ninety-three healthy subjects received aspirin 300 mg daily for 28 days. Before and at the end of treatment, urine was taken to determine 11-dehydrothromboxane B2 , and blood was taken to measure arachidonic acid (AA)-induced aggregation of platelet-rich plasma and to interrogate the platelet proteome by mass spectrometric analysis with further confirmation of findings using Western blotting. RESULTS: In two of the 93 subjects, neither AA-induced aggregation nor urinary 11-dehydrothromboxane B2 was effectively suppressed by aspirin, despite measurable plasma salicylate concentrations, suggesting the presence of true aspirin resistance. Despite no detectable differences in the platelet proteome at baseline, following aspirin a marked increase was seen in platelet glycoprotein IIIa expression in the aspirin-resistant but not aspirin-sensitive subjects. An increase in platelet glycoprotein IIIa expression with aspirin resistance was confirmed in a separate cohort of 17 patients with stable coronary artery disease on long term aspirin treatment, four of whom exhibited aspirin resistance. CONCLUSIONS: In a healthy population, true aspirin resistance is uncommon but exists. Resistance is associated with an increase in platelet glycoprotein IIIa expression in response to aspirin. These data shed new light on the mechanism of aspirin resistance, and provide the potential to identify aspirin-resistant subjects using a novel biomarker.', 'CI': ['(c) 2014 The British Pharmacological Society.'], 'FAU': ['Floyd, Christopher N', 'Goodman, Timothy', 'Becker, Silke', 'Chen, Nan', 'Mustafa, Agnesa', 'Schofield, Emma', 'Campbell, James', 'Ward, Malcolm', 'Sharma, Pankaj', 'Ferro, Albert'], 'AU': ['Floyd CN', 'Goodman T', 'Becker S', 'Chen N', 'Mustafa A', 'Schofield E', 'Campbell J', 'Ward M', 'Sharma P', 'Ferro A'], 'AD': [\"Department of Clinical Pharmacology, Cardiovascular Division, British Heart Foundation Centre of Research Excellence, King's College London, London, UK.\"], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'PL': 'England', 'TA': 'Br J Clin Pharmacol', 'JT': 'British journal of clinical pharmacology', 'JID': '7503323', 'RN': ['0 (Integrin beta3)', '27YG812J1I (Arachidonic Acid)', '54397-85-2 (Thromboxane B2)', '67910-12-7 (11-dehydro-thromboxane B2)', 'R16CO5Y76E (Aspirin)'], 'SB': 'IM', 'MH': ['Adult', 'Arachidonic Acid/pharmacology', 'Aspirin/administration & dosage/blood/*pharmacology/urine', 'Blood Platelets/cytology/*drug effects/metabolism', 'Cohort Studies', 'Coronary Artery Disease/blood/drug therapy', 'Dose-Response Relationship, Drug', '*Drug Resistance', 'Female', 'Healthy Volunteers', 'Humans', 'Integrin beta3/*biosynthesis', 'Male', 'Platelet Aggregation/*drug effects', 'Thromboxane B2/analogs & derivatives/urine'], 'PMC': 'PMC4137824', 'OTO': ['NOTNLM'], 'OT': ['aspirin resistance', 'glycoprotein IIIa', 'platelets', 'proteomics'], 'EDAT': '2014/08/08 06:00', 'MHDA': '2015/03/31 06:00', 'CRDT': ['2014/08/08 06:00'], 'PHST': ['2013/12/09 00:00 [received]', '2014/01/18 00:00 [accepted]', '2014/08/08 06:00 [entrez]', '2014/08/08 06:00 [pubmed]', '2015/03/31 06:00 [medline]'], 'AID': ['10.1111/bcp.12335 [doi]'], 'PST': 'ppublish', 'SO': 'Br J Clin Pharmacol. 2014 Aug;78(2):320-8. doi: 10.1111/bcp.12335.'}\n",
      "{'PMID': '25083839', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20160411', 'LR': '20181113', 'IS': '1473-5830 (Electronic) 0954-6928 (Linking)', 'VI': '25', 'IP': '7', 'DP': '2014 Nov', 'TI': 'Predicting coronary no-reflow in patients with acute ST-segment elevation myocardial infarction using Bayesian approaches.', 'PG': '582-8', 'LID': '10.1097/MCA.0000000000000135 [doi]', 'AB': 'OBJECTIVE: The no-reflow phenomenon is associated with a worse prognosis at follow-up for ST-segment elevation myocardial infarction (STEMI) patients with a primary percutaneous coronary intervention. To date, there is no effective method to predict no-reflow. The aim of this study was to establish a predictive system to evaluate the risk of no-reflow by integrating multiple types of information using Bayesian methods. PATIENTS AND METHODS: STEMI patients undergoing primary percutaneous coronary intervention within 12 h from the symptom onset between January 2008 and May 2013 were initially screened from the registry database of Anzhen Hospital (Beijing, China). Baseline clinical data, laboratory studies, and procedural characteristics were recorded. The Bayesian Model and Ten-Factor Model were used and compared with the Single-Factor Models. A receiver operating characteristic curve was used to show the efficacy by presenting both sensitivity and specificity for different cutoff points. RESULTS: A total of 1059 consecutive STEMI patients were enrolled. Seventy-nine factors were collected to assess the confidence of the no-reflow phenomenon. The combined likelihood ratios were used to measure the reliability of the no-reflow phenomenon. The area under the curve (AUC) was 0.85 and 0.79 for the Bayesian Model and Ten-Factors Model, respectively, whereas the Single-Factor Model yielded a maximum AUC of 0.67. CONCLUSION: The Bayesian Model showed high sensitivity and good specificity in predicting true relations between multiple factors and the no-reflow outcome.', 'FAU': ['Zhang, Dongfeng', 'Song, Xiantao', 'Lv, Shuzheng', 'Li, Dong', 'Yan, Shuai', 'Zhang, Min'], 'AU': ['Zhang D', 'Song X', 'Lv S', 'Li D', 'Yan S', 'Zhang M'], 'AD': ['aDepartment of Cardiology, Capital Medical University affiliated Beijing Anzhen Hospital, Beijing Institute of Heart, Lung and Blood Vessel Disease bThe State Key Laboratory of Proteomics, Beijing Proteome Research Center, Beijing Institute of Radiation Medicine, Beijing, China.'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'PL': 'England', 'TA': 'Coron Artery Dis', 'JT': 'Coronary artery disease', 'JID': '9011445', 'SB': 'IM', 'MH': ['Aged', 'Bayes Theorem', 'Cohort Studies', 'Female', 'Humans', 'Likelihood Functions', 'Male', 'Middle Aged', 'Models, Statistical', 'Myocardial Infarction/*therapy', 'No-Reflow Phenomenon/*epidemiology', '*Percutaneous Coronary Intervention', 'ROC Curve', 'Reproducibility of Results', 'Retrospective Studies'], 'PMC': 'PMC4222349', 'EDAT': '2014/08/02 06:00', 'MHDA': '2016/04/12 06:00', 'CRDT': ['2014/08/02 06:00'], 'PHST': ['2014/08/02 06:00 [entrez]', '2014/08/02 06:00 [pubmed]', '2016/04/12 06:00 [medline]'], 'AID': ['10.1097/MCA.0000000000000135 [doi]'], 'PST': 'ppublish', 'SO': 'Coron Artery Dis. 2014 Nov;25(7):582-8. doi: 10.1097/MCA.0000000000000135.'}\n",
      "{'PMID': '25072840', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20150518', 'LR': '20151119', 'IS': '1535-3907 (Electronic) 1535-3893 (Linking)', 'VI': '13', 'IP': '9', 'DP': '2014 Sep 5', 'TI': 'Pleural effusion lipoproteins measured by NMR spectroscopy for diagnosis of exudative pleural effusions: a novel tool for pore-size estimation.', 'PG': '4104-12', 'LID': '10.1021/pr5004856 [doi]', 'AB': \"High-resolution proton nuclear magnetic resonance (NMR) spectrometry of biofluids has been increasingly used in laboratory diagnosis of various diseases. In this study, we extended the use of (1)H NMR spectroscopy for laboratory diagnosis of exudative pleural effusions using pleural fluids. We compared this new NMR-based test with Light's criteria, the current gold standard for laboratory diagnosis of exudative pleural effusions. We analyzed 67 samples of pleural effusions from patients with pulmonary malignancy (N = 32), pulmonary tuberculosis (N = 18), and congestive heart failure (N = 17). The metabolomes of pleural effusions were analyzed using (1)H NMR spectroscopy on a Bruker 600 MHz spectrometer. Through a metabolome-wide association approach with filtering of insignificant markers (p value <4 x 10(-6)) and multivariate analysis (principal component analysis and orthogonal partial least squares-discriminant analysis), lipoprotein was found to be the best biomarker that distinguished exudates from transudates. Using NMR-based lipoprotein profiling to classify exudative pleural effusions from transudates, the area-under-receiver operating characteristic (ROC) curve was 0.96 with sensitivity of 98%, specificity of 88%, and accuracy of 98%. In contrast, the current gold standard, Light's criteria, give a specificity of only 65% at the same sensitivity level of 98%. Using the principle of size exclusion, NMR-based lipoprotein profiling of pleural fluids has an unprecedented diagnostic performance superiority over the Light's criteria. The capillary leaks secondary to inflammation result in a larger pleural pore-size, which allows the large-sized lipoproteins to accumulate in exudative pleural effusions. In contrast, the pleural permeability is intact in transudates, which allow only small-sized lipoproteins to pass into the pleural effusions. The average capillary pore-size of the pleura can therefore be determined by using NMR-based lipoprotein profiling of pleural fluids. We believe this new test will change the current clinical practice for management of pleural effusions and will become a new standard for clinical practice.\", 'FAU': ['Lam, Ching-Wan', 'Law, Chun-Yiu'], 'AU': ['Lam CW', 'Law CY'], 'AD': ['Department of Pathology, The University of Hong Kong , Pokfulam Road, Hong Kong, China.'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20140805', 'PL': 'United States', 'TA': 'J Proteome Res', 'JT': 'Journal of proteome research', 'JID': '101128775', 'RN': ['0 (Biomarkers)', '0 (Lipoproteins)'], 'SB': 'IM', 'MH': ['Aged', 'Aged, 80 and over', 'Biomarkers/analysis/chemistry', 'Female', 'Heart Failure/metabolism', 'Humans', 'Lipoproteins/*analysis/*chemistry', 'Magnetic Resonance Spectroscopy/*methods', 'Male', 'Metabolomics/methods', 'Middle Aged', 'Pleural Effusion/*metabolism', 'Pleural Effusion, Malignant/metabolism', 'Porosity', 'Principal Component Analysis'], 'EDAT': '2014/07/30 06:00', 'MHDA': '2015/05/20 06:00', 'CRDT': ['2014/07/30 06:00'], 'PHST': ['2014/07/30 06:00 [entrez]', '2014/07/30 06:00 [pubmed]', '2015/05/20 06:00 [medline]'], 'AID': ['10.1021/pr5004856 [doi]'], 'PST': 'ppublish', 'SO': 'J Proteome Res. 2014 Sep 5;13(9):4104-12. doi: 10.1021/pr5004856. Epub 2014 Aug 5.'}\n",
      "{'PMID': '25065337', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20150512', 'LR': '20181113', 'IS': '1874-1754 (Electronic) 0167-5273 (Linking)', 'VI': '176', 'IP': '1', 'DP': '2014 Sep', 'TI': 'Left ventricular diastolic function in relation to the urinary proteome: a proof-of-concept study in a general population.', 'PG': '158-65', 'LID': '10.1016/j.ijcard.2014.07.014 [doi] S0167-5273(14)01206-6 [pii]', 'AB': \"BACKGROUND: In previous studies, we identified two urinary proteomic classifiers, termed HF1 and HF2, which discriminated subclinical diastolic left ventricular (LV) dysfunction from normal. HF1 and HF2 combine information from 85 and 671 urinary peptides, mainly up- or down-regulated collagen fragments. We sought to validate these classifiers in a population study. METHODS: In 745 people randomly recruited from a Flemish population (49.8 years; 51.3% women), we measured early and late diastolic peak velocities of mitral inflow (E and A) and mitral annular velocities (e' and a') by conventional and tissue Doppler echocardiography, and the urinary proteome by capillary electrophoresis coupled with mass spectrometry. RESULTS: In the analyses adjusted for sex, age, body mass index, blood pressure, heart rate, LV mass index and intake of medications, we expressed effect sizes per 1-SD increment in the classifiers. HF1 was associated with 0.204 cm/s lower e' peak velocity (95% confidence interval, 0.057-0.351; p=0.007) and 0.145 higher E/e' ratio (0.023-0.268; p=0.020), while HF2 was associated with a 0.174 higher E/e' ratio (0.046-0.302; p=0.008). According to published definitions, 67 (9.0%) participants had impaired LV relaxation and 96 (12.9%) had elevated LV filling pressure. The odds of impaired relaxation associated with HF1 was 1.38 (1.01-1.88; p=0.043) and that of increased LV filling pressure associated with HF2 was 1.38 (1.00-1.90; p=0.052). CONCLUSIONS: In a general population, the urinary proteome correlated with diastolic LV dysfunction, proving its utility for early diagnosis of this condition.\", 'CI': ['Copyright (c) 2014 The Authors. Published by Elsevier Ireland Ltd.. All rights', 'reserved.'], 'FAU': ['Zhang, Zhenyu', 'Staessen, Jan A', 'Thijs, Lutgarde', 'Gu, Yumei', 'Liu, Yanping', 'Jacobs, Lotte', 'Koeck, Thomas', 'Zurbig, Petra', 'Mischak, Harald', 'Kuznetsova, Tatiana'], 'AU': ['Zhang Z', 'Staessen JA', 'Thijs L', 'Gu Y', 'Liu Y', 'Jacobs L', 'Koeck T', 'Zurbig P', 'Mischak H', 'Kuznetsova T'], 'AD': ['Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium.', 'Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium; Department of Epidemiology, Maastricht University, Maastricht, Netherlands. Electronic address: jan.staessen@med.kuleuven.be.', 'Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium.', 'Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium.', 'Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium.', 'Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium.', 'Mosaiques Diagnostic and Therapeutics AG, Hannover, Germany.', 'Mosaiques Diagnostic and Therapeutics AG, Hannover, Germany.', 'Mosaiques Diagnostic and Therapeutics AG, Hannover, Germany; BHF Glasgow Cardiovascular Research Centre, University of Glasgow, United Kingdom.', 'Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium.'], 'LA': ['eng'], 'GR': ['294713/European Research Council/International'], 'PT': ['Journal Article', 'Randomized Controlled Trial', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20140712', 'PL': 'Netherlands', 'TA': 'Int J Cardiol', 'JT': 'International journal of cardiology', 'JID': '8200291', 'RN': ['0 (Biomarkers)', '0 (Proteome)'], 'SB': 'IM', 'MH': ['Adolescent', 'Adult', 'Aged', 'Aged, 80 and over', 'Belgium/epidemiology', 'Biomarkers/analysis/urine', 'Cross-Sectional Studies', 'Female', 'Follow-Up Studies', 'Humans', 'Male', 'Middle Aged', '*Population Surveillance/methods', 'Proteome/*analysis', 'Ventricular Dysfunction, Left/*diagnosis/*urine', 'Young Adult'], 'PMC': 'PMC4155932', 'OTO': ['NOTNLM'], 'OT': ['Diastolic dysfunction', 'Population science', 'Urinary proteomics'], 'EDAT': '2014/07/30 06:00', 'MHDA': '2015/05/13 06:00', 'CRDT': ['2014/07/29 06:00'], 'PHST': ['2014/04/02 00:00 [received]', '2014/05/06 00:00 [revised]', '2014/07/05 00:00 [accepted]', '2014/07/29 06:00 [entrez]', '2014/07/30 06:00 [pubmed]', '2015/05/13 06:00 [medline]'], 'AID': ['S0167-5273(14)01206-6 [pii]', '10.1016/j.ijcard.2014.07.014 [doi]'], 'PST': 'ppublish', 'SO': 'Int J Cardiol. 2014 Sep;176(1):158-65. doi: 10.1016/j.ijcard.2014.07.014. Epub 2014 Jul 12.'}\n",
      "{'PMID': '24859250', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20150611', 'LR': '20181113', 'IS': '1932-6203 (Electronic) 1932-6203 (Linking)', 'VI': '9', 'IP': '5', 'DP': '2014', 'TI': 'A pro-atherogenic HDL profile in coronary heart disease patients: an iTRAQ labelling-based proteomic approach.', 'PG': 'e98368', 'LID': '10.1371/journal.pone.0098368 [doi]', 'AB': 'OBJECTIVES: This study aims to compare the protein composition of high-density lipoprotein (HDL) particles in coronary heart disease (CHD) patients and controls by proteomic methods. BACKGROUND: HDL has been reported to exert pro-atherogenic properties in CHD patients. Accumulating evidence indicates that HDL composition, rather than the HDL-C level, determines its functions. The changes in HDL composition involved in the conversion of anti-atherogenic to pro-atherogenic properties in CHD patients are currently unknown. METHODS AND RESULTS: iTRAQ combined with nanoLC-MS/MS was performed to obtain a differential expression profile of the HDL pooled samples of the male age-matched CHD patients and controls (n = 10/group). Of the 196 proteins identified in the examined HDL, 12 were differentially expressed between the CHD patients and the controls, including five up-regulated proteins and seven down-regulated proteins. Using GO analysis, we determined that the up-regulated proteins were mostly involved in inflammatory reactions, displaying a potential pro-atherogenic profile. In contrast, the down-regulated proteins were mostly involved in lipid metabolism processes, displaying anti-atherogenic properties. To confirm the proteomic results, serum amyloid A (SAA) and apoC-I were selected and quantified by ELISA, in the same population as the proteomic analysis, as well as another independent population (n = 120/group). Consistent with the proteomic results, the amount of SAA was significantly increased, and apoC-I was significantly decreased in the HDL particles of CHD patients compared with those of controls (P<0.05). CONCLUSIONS: Our study shows that the HDL proteome changes to a pro-atherogenic profile in CHD patients, which might compromise the protective effects of HDL. Proteomic analysis of HDL composition may provide more relevant information regarding their functional properties than steady-state HDL-C levels.', 'FAU': ['Yan, Li-rong', 'Wang, Dong-xue', 'Liu, Hong', 'Zhang, Xiao-xing', 'Zhao, Hui', 'Hua, Lu', 'Xu, Ping', 'Li, Yi-shi'], 'AU': ['Yan LR', 'Wang DX', 'Liu H', 'Zhang XX', 'Zhao H', 'Hua L', 'Xu P', 'Li YS'], 'AD': ['Key Laboratory of Clinical Trial Research in Cardiovascular Drugs, Ministry of Health, State Key Laboratory of Cardiovascular Diseases, FuWai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.', \"Key Laboratory of Clinical Trial Research in Cardiovascular Drugs, Ministry of Health, State Key Laboratory of Cardiovascular Diseases, FuWai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; Department of Cardiology, Wuxi People' Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu, China.\", 'Key Laboratory of Clinical Trial Research in Cardiovascular Drugs, Ministry of Health, State Key Laboratory of Cardiovascular Diseases, FuWai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.', 'Key Laboratory of Clinical Trial Research in Cardiovascular Drugs, Ministry of Health, State Key Laboratory of Cardiovascular Diseases, FuWai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.', 'Key Laboratory of Clinical Trial Research in Cardiovascular Drugs, Ministry of Health, State Key Laboratory of Cardiovascular Diseases, FuWai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.', 'Key Laboratory of Clinical Trial Research in Cardiovascular Drugs, Ministry of Health, State Key Laboratory of Cardiovascular Diseases, FuWai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.', 'Key Laboratory of Clinical Trial Research in Cardiovascular Drugs, Ministry of Health, State Key Laboratory of Cardiovascular Diseases, FuWai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.', 'Key Laboratory of Clinical Trial Research in Cardiovascular Drugs, Ministry of Health, State Key Laboratory of Cardiovascular Diseases, FuWai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.'], 'LA': ['eng'], 'PT': ['Clinical Trial', 'Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20140523', 'PL': 'United States', 'TA': 'PLoS One', 'JT': 'PloS one', 'JID': '101285081', 'RN': ['0 (Apolipoprotein C-I)', '0 (Cholesterol, HDL)', '0 (Serum Amyloid A Protein)', '0 (apolipoprotein C-I, human)'], 'SB': 'IM', 'MH': ['Apolipoprotein C-I/*metabolism', 'Cholesterol, HDL/*blood', 'Coronary Disease/*blood', 'Female', 'Humans', 'Male', 'Middle Aged', '*Proteomics', 'Serum Amyloid A Protein/*metabolism', '*Up-Regulation'], 'PMC': 'PMC4032332', 'EDAT': '2014/05/27 06:00', 'MHDA': '2015/06/13 06:00', 'CRDT': ['2014/05/27 06:00'], 'PHST': ['2013/12/25 00:00 [received]', '2014/05/01 00:00 [accepted]', '2014/05/27 06:00 [entrez]', '2014/05/27 06:00 [pubmed]', '2015/06/13 06:00 [medline]'], 'AID': ['10.1371/journal.pone.0098368 [doi]', 'PONE-D-13-54283 [pii]'], 'PST': 'epublish', 'SO': 'PLoS One. 2014 May 23;9(5):e98368. doi: 10.1371/journal.pone.0098368. eCollection 2014.'}\n",
      "{'PMID': '24780726', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20150220', 'LR': '20160518', 'IS': '1876-7737 (Electronic) 1874-3919 (Linking)', 'VI': '106', 'DP': '2014 Jun 25', 'TI': 'Absolute quantification of apolipoproteins and associated proteins on human plasma lipoproteins.', 'PG': '181-90', 'LID': '10.1016/j.jprot.2014.04.030 [doi] S1874-3919(14)00206-1 [pii]', 'AB': \"UNLABELLED: Lipoprotein-associated proteins form an intrinsic part of the major plasma lipoprotein classes. There is increasing evidence that the quantity of these proteins per lipoprotein particle determines lipoprotein function including redox, inflammatory and thrombotic properties and may impact on lipoprotein-related risks for developing heart disease. However, only limited information on the relative quantity of these proteins has been published and no comprehensive absolute quantitative data providing the stoichiometry of proteins associated with lipoproteins is available to date. To address this, we performed extensive absolute quantification by mass spectrometry of 17 lipoprotein-associated proteins on VLDL, LDL, Lp(a) and HDL from healthy subjects. For the first time we show the exact stoichiometry of apolipoproteins on different lipoprotein classes. The most distinct differences were seen in the abundance of all apoCs, apoE and apoF. We further revealed strong variations between individual samples, which indicates the complexity of the protein complement of lipoproteins and can provide additional insights into lipoprotein-related risk factors. This approach has the potential to determine alterations in the protein profiles of lipoproteins in disease states such as CVD or diabetes and, if performed on large cohorts, to translate into a tool for identifying new candidate biomarkers for risk of disease. BIOLOGICAL SIGNIFICANCE: A more comprehensive picture about the protein complement on individual lipoprotein classes is the goal of lipoprotein proteomics analyses. Despite many such studies, there is a lack of absolute quantitative data on lipoproteins isolated from individual subjects. The stoichiometry of lipoprotein-associated proteins rather than their presence or absence could provide insights into an individual's predisposition for disease such as heart disease or diabetes. Our study provides a comprehensive overview of the absolute quantity of proteins on the major apolipoprotein classes VLDL, LDL, Lp(a) and HDL.\", 'CI': ['Copyright (c) 2014 Elsevier B.V. All rights reserved.'], 'FAU': ['von Zychlinski, Anne', 'Williams, Michael', 'McCormick, Sally', 'Kleffmann, Torsten'], 'AU': ['von Zychlinski A', 'Williams M', 'McCormick S', 'Kleffmann T'], 'AD': ['Department of Biochemistry, University of Otago, Dunedin, New Zealand. Electronic address: anne.kleffmann@otago.ac.nz.', 'Department of Medicine, University of Otago, Dunedin, New Zealand.', 'Department of Biochemistry, University of Otago, Dunedin, New Zealand.', 'Department of Biochemistry, University of Otago, Dunedin, New Zealand; Centre for Protein Research, University of Otago, Dunedin, New Zealand.'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20140426', 'PL': 'Netherlands', 'TA': 'J Proteomics', 'JT': 'Journal of proteomics', 'JID': '101475056', 'RN': ['0 (Apolipoproteins)', '0 (Lipoprotein(a))', '0 (Lipoproteins, HDL)', '0 (Lipoproteins, LDL)', '0 (Lipoproteins, VLDL)', '0 (Proteome)', 'EC 3.4.21.4 (Trypsin)'], 'SB': 'IM', 'MH': ['Adult', 'Aged', 'Apolipoproteins/*blood/*chemistry', 'Cardiovascular Diseases/blood', 'Cluster Analysis', 'Diabetes Mellitus/blood', 'Humans', 'Lipoprotein(a)/blood', 'Lipoproteins, HDL/blood', 'Lipoproteins, LDL/blood', 'Lipoproteins, VLDL/blood', 'Mass Spectrometry/*methods', 'Middle Aged', '*Proteome', 'Proteomics', 'Trypsin/chemistry', 'Young Adult'], 'OTO': ['NOTNLM'], 'OT': ['Absolute protein quantification', 'Cardiovascular disease', 'Lipoproteins', 'Stoichiometry of apolipoproteins'], 'EDAT': '2014/05/02 06:00', 'MHDA': '2015/02/24 06:00', 'CRDT': ['2014/05/01 06:00'], 'PHST': ['2014/01/20 00:00 [received]', '2014/04/14 00:00 [revised]', '2014/04/18 00:00 [accepted]', '2014/05/01 06:00 [entrez]', '2014/05/02 06:00 [pubmed]', '2015/02/24 06:00 [medline]'], 'AID': ['S1874-3919(14)00206-1 [pii]', '10.1016/j.jprot.2014.04.030 [doi]'], 'PST': 'ppublish', 'SO': 'J Proteomics. 2014 Jun 25;106:181-90. doi: 10.1016/j.jprot.2014.04.030. Epub 2014 Apr 26.'}\n",
      "{'PMID': '24738046', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20150109', 'LR': '20181113', 'IS': '2314-6141 (Electronic)', 'VI': '2014', 'DP': '2014', 'TI': 'Comparison of the ventricle muscle proteome between patients with rheumatic heart disease and controls with mitral valve prolapse: HSP 60 may be a specific protein in RHD.', 'PG': '151726', 'LID': '10.1155/2014/151726 [doi]', 'AB': 'OBJECTIVE: Rheumatic heart disease (RHD) is a serious autoimmune heart disease. The present study was aimed at identifying the differentially expressed proteins between patients with RHD and controls with mitral valve prolapse. METHODS: Nine patients with RHD and nine controls with mitral valve prolapsed were enrolled for this study. Two-dimensional difference in-gel electrophoresis (2D-DIGE) and matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF-MS) were performed. RESULTS: A total of 39 protein spots with differential expressions were identified between the two groups (P < 0.05, Average Ratio > 1.2 or Average Ratio < -1.2) and four upregulated proteins (including heat shock protein 60 (HSP 60), desmin, PDZ and LIM domain protein 1, and proteasome subunit alpha type-1) and three downregulated proteins (including tropomyosin alpha-1 chain, malate dehydrogenase, and chaperone activity of bc1 complex homolog) were determined. CONCLUSION: These seven proteins, especially HSP 60, may serve as potential biomarkers for the diagnosis of RHD and provide evidence to explain the mechanisms of this complex disease in the future.', 'FAU': ['Zheng, Dawei', 'Xu, Limin', 'Sun, Lebo', 'Feng, Qiang', 'Wang, Zishan', 'Shao, Guofeng', 'Ni, Yiming'], 'AU': ['Zheng D', 'Xu L', 'Sun L', 'Feng Q', 'Wang Z', 'Shao G', 'Ni Y'], 'AD': ['Department of Cardiothoracic Surgery, The Affiliated Hospital, Ningbo Medical Centre Lihuili Hospital, Ningbo University, Ningbo, Zhejiang 315041, China ; Department of Cardiothoracic Surgery, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310006, China.', 'Department of Cardiothoracic Surgery, The Affiliated Hospital, Ningbo Medical Centre Lihuili Hospital, Ningbo University, Ningbo, Zhejiang 315041, China.', 'Department of Cardiothoracic Surgery, The Affiliated Hospital, Ningbo Medical Centre Lihuili Hospital, Ningbo University, Ningbo, Zhejiang 315041, China.', 'Department of Cardiothoracic Surgery, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310006, China.', 'Department of Cardiothoracic Surgery, The Affiliated Hospital, Ningbo Medical Centre Lihuili Hospital, Ningbo University, Ningbo, Zhejiang 315041, China.', 'Department of Cardiothoracic Surgery, The Affiliated Hospital, Ningbo Medical Centre Lihuili Hospital, Ningbo University, Ningbo, Zhejiang 315041, China.', 'Department of Cardiothoracic Surgery, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310006, China.'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20140312', 'PL': 'United States', 'TA': 'Biomed Res Int', 'JT': 'BioMed research international', 'JID': '101600173', 'RN': ['0 (Biomarkers)', '0 (Chaperonin 60)', '0 (Proteome)'], 'SB': 'IM', 'MH': ['Adolescent', 'Adult', 'Biomarkers/metabolism', 'Chaperonin 60/genetics/*metabolism', 'Down-Regulation/genetics', 'Female', 'Heart Ventricles/*metabolism', 'Humans', 'Male', 'Middle Aged', 'Mitral Valve Prolapse/genetics/*metabolism', 'Myocardium/*metabolism', 'Proteome/genetics/*metabolism', 'Proteomics/methods', 'Rheumatic Heart Disease/genetics/*metabolism', 'Up-Regulation/genetics', 'Young Adult'], 'PMC': 'PMC3971496', 'EDAT': '2014/04/17 06:00', 'MHDA': '2015/01/13 06:00', 'CRDT': ['2014/04/17 06:00'], 'PHST': ['2013/12/02 00:00 [received]', '2014/01/31 00:00 [revised]', '2014/02/03 00:00 [accepted]', '2014/04/17 06:00 [entrez]', '2014/04/17 06:00 [pubmed]', '2015/01/13 06:00 [medline]'], 'AID': ['10.1155/2014/151726 [doi]'], 'PST': 'ppublish', 'SO': 'Biomed Res Int. 2014;2014:151726. doi: 10.1155/2014/151726. Epub 2014 Mar 12.'}\n",
      "{'PMID': '24689886', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20150420', 'LR': '20140814', 'IS': '1535-3907 (Electronic) 1535-3893 (Linking)', 'VI': '13', 'IP': '5', 'DP': '2014 May 2', 'TI': 'NMR-based lipidomic analysis of blood lipoproteins differentiates the progression of coronary heart disease.', 'PG': '2585-98', 'LID': '10.1021/pr500061n [doi]', 'AB': 'Abnormal lipid composition and metabolism of plasma lipoproteins play a crucial role in the pathogenesis of coronary heart disease (CHD). A (1)H NMR-based lipidomic approach was used to investigate the correlation of coronary artery stenosis with the atherogenic (non-HDL) and atheroprotective (HDL) lipid profiles in 99 patients with CHD of various stages of disease and compared with 60 patients with normal coronary arteries (NCA), all documented in coronary angiography. The pattern recognition models created from lipid profiles predicted the presence of CHD with a sensitivity of 87% and a specificity of 88% in the HDL model and with 90% and 89% in the non-HDL model, respectively. Patients with mild, moderate, and severe coronary artery stenosis were progressively differentiated from those with NCA in the non-HDL model with a statistically significant separation of severe stage from both mild and moderate. In the HDL model, the progressive differentiation of the disease stages was statistically significant only between patients with mild and severe coronary artery stenosis. The lipid constituents of lipoproteins that mainly characterized the initial stages and then the progression of the disease were the high levels of saturated fatty acids in lipids in both HDL and non-HDL particles, the low levels of HDL-phosphatidylcholine, HDL-sphingomyelin, and omega-3 fatty acids and linoleic acid in lipids in non-HDL particles. The conventional lipid marker, total cholesterol, found in low levels in HDL and in high levels in non-HDL, also contributed to the onset of the disease but with a much lower coefficient of significance. (1)H NMR-based lipidomic analysis of atherogenic and atheroprotective lipoproteins could contribute to the early evaluation of the onset of coronary artery disease and possibly to the establishment of an appropriate therapeutic option.', 'FAU': ['Kostara, Christina E', 'Papathanasiou, Athanasios', 'Psychogios, Nikolaos', 'Cung, Manh Thong', 'Elisaf, Moses S', 'Goudevenos, John', 'Bairaktari, Eleni T'], 'AU': ['Kostara CE', 'Papathanasiou A', 'Psychogios N', 'Cung MT', 'Elisaf MS', 'Goudevenos J', 'Bairaktari ET'], 'AD': ['Laboratory of Clinical Chemistry and double daggerDepartment of Internal Medicine, Medical School, University of Ioannina , 451 10, Ioannina, Greece.'], 'LA': ['eng'], 'PT': ['Journal Article'], 'DEP': '20140414', 'PL': 'United States', 'TA': 'J Proteome Res', 'JT': 'Journal of proteome research', 'JID': '101128775', 'RN': ['0 (Lipoproteins)', '0 (Lipoproteins, HDL)'], 'SB': 'IM', 'MH': ['Aged', 'Atherosclerosis', 'Coronary Disease/*blood/pathology', 'Coronary Vessels/metabolism', 'Disease Progression', 'Female', 'Humans', '*Lipid Metabolism', 'Lipoproteins/*blood/*metabolism', 'Lipoproteins, HDL/blood/metabolism', 'Male', 'Middle Aged', 'Proton Magnetic Resonance Spectroscopy/*methods', 'Reproducibility of Results', 'Severity of Illness Index'], 'EDAT': '2014/04/03 06:00', 'MHDA': '2015/04/22 06:00', 'CRDT': ['2014/04/03 06:00'], 'PHST': ['2014/04/03 06:00 [entrez]', '2014/04/03 06:00 [pubmed]', '2015/04/22 06:00 [medline]'], 'AID': ['10.1021/pr500061n [doi]'], 'PST': 'ppublish', 'SO': 'J Proteome Res. 2014 May 2;13(5):2585-98. doi: 10.1021/pr500061n. Epub 2014 Apr 14.'}\n",
      "{'PMID': '24548642', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20141204', 'LR': '20181113', 'IS': '1873-2402 (Electronic) 0006-3223 (Linking)', 'VI': '75', 'IP': '9', 'DP': '2014 May 1', 'TI': \"Phosphorylated tau-Abeta42 ratio as a continuous trait for biomarker discovery for early-stage Alzheimer's disease in multiplex immunoassay panels of cerebrospinal fluid.\", 'PG': '723-31', 'LID': '10.1016/j.biopsych.2013.11.032 [doi] S0006-3223(14)00018-3 [pii]', 'AB': \"BACKGROUND: Identification of the physiologic changes that occur during the early stages of Alzheimer's disease (AD) may provide critical insights for the diagnosis, prognosis, and treatment of disease. Cerebrospinal fluid (CSF) biomarkers are a rich source of information that reflect the brain proteome. METHODS: A novel approach was applied to screen a panel of ~190 CSF analytes quantified by multiplex immunoassay, and common associations were detected in the Knight Alzheimer's Disease Research Center (N = 311) and the Alzheimer's Disease Neuroimaging Initiative (N = 293) cohorts. Rather than case-control status, the ratio of CSF levels of tau phosphorylated at threonine 181 (ptau181) and Abeta42 was used as a continuous trait in these analyses. RESULTS: The ptau181-Abeta42 ratio has more statistical power than traditional modeling approaches, and the levels of CSF heart-type fatty acid binding protein (FABP) and 12 other correlated analytes increase as AD progresses. These results were validated using the traditional case-control status model. Stratification of the dataset demonstrated that increases in these analytes occur very early in the disease course and were apparent even in nondemented individuals with AD pathology (low ptau181, low Abeta42) compared with elderly control subjects with no pathology (low ptau181, high Abeta42). The FABP-Abeta42 ratio demonstrates a similar hazard ratio for disease conversion to ptau181-Abeta42 even though the overlap in classification is incomplete suggesting that FABP contributes independent information as a predictor of AD. CONCLUSIONS: Our results indicate that the approach presented here can be used to identify novel biomarkers for AD correctly and that CSF heart FABP levels start to increase at very early stages of AD.\", 'CI': ['Copyright (c) 2014 Society of Biological Psychiatry. Published by Elsevier Inc.', 'All rights reserved.'], 'FAU': ['Harari, Oscar', 'Cruchaga, Carlos', 'Kauwe, John S K', 'Ainscough, Benjamin J', 'Bales, Kelly', 'Pickering, Eve H', 'Bertelsen, Sarah', 'Fagan, Anne M', 'Holtzman, David M', 'Morris, John C', 'Goate, Alison M'], 'AU': ['Harari O', 'Cruchaga C', 'Kauwe JS', 'Ainscough BJ', 'Bales K', 'Pickering EH', 'Bertelsen S', 'Fagan AM', 'Holtzman DM', 'Morris JC', 'Goate AM'], 'AD': ['Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri.', 'Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri; Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, Missouri.', 'Department of Biology, Brigham Young University, Provo, Utah.', 'Division of Biology & Biomedical Sciences, Washington University School of Medicine, St. Louis, Missouri.', 'Neuroscience Research Unit, Worldwide Research and Development, Pfizer, Inc., Groton, Connecticut.', 'Neuroscience Research Unit, Worldwide Research and Development, Pfizer, Inc., Groton, Connecticut.', 'Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri.', \"Department of Neurology, Washington University School of Medicine, St. Louis, Missouri; Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, Missouri; Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, Missouri.\", \"Department of Neurology, Washington University School of Medicine, St. Louis, Missouri; Developmental Biology, Washington University School of Medicine, St. Louis, Missouri; Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, Missouri; Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, Missouri.\", \"Department of Neurology, Washington University School of Medicine, St. Louis, Missouri; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri; Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, Missouri; Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, Missouri.\", \"Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri; Department of Neurology, Washington University School of Medicine, St. Louis, Missouri; Department of Genetics, Washington University School of Medicine, St. Louis, Missouri; Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, Missouri; Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, Missouri. Electronic address: goatea@psychiatry.wustl.edu.\"], 'CN': [\"Alzheimer's Disease Neuroimaging Initiative\"], 'LA': ['eng'], 'GR': ['K01 AG030514/AG/NIA NIH HHS/United States', 'P50 AG05681/AG/NIA NIH HHS/United States', 'F30 AG041681/AG/NIA NIH HHS/United States', 'R01 AG042611/AG/NIA NIH HHS/United States', 'U01 AG024904/AG/NIA NIH HHS/United States', 'U19 AG010483/AG/NIA NIH HHS/United States', 'P01 AG003991/AG/NIA NIH HHS/United States', 'P50 AG005681/AG/NIA NIH HHS/United States', 'P01 AG026276/AG/NIA NIH HHS/United States', 'P30 NS069329-01/NS/NINDS NIH HHS/United States', 'P01 AG03991/AG/NIA NIH HHS/United States', 'Canadian Institutes of Health Research/Canada', 'UL1 TR000448/TR/NCATS NIH HHS/United States', 'P30 AG010129/AG/NIA NIH HHS/United States', 'R25 DA027995/DA/NIDA NIH HHS/United States', 'P30 NS069329/NS/NINDS NIH HHS/United States', 'R01 AG16208/AG/NIA NIH HHS/United States', 'R01 AG016208/AG/NIA NIH HHS/United States', 'R01 AG035083/AG/NIA NIH HHS/United States'], 'PT': ['Journal Article', 'Research Support, N.I.H., Extramural', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20140119', 'PL': 'United States', 'TA': 'Biol Psychiatry', 'JT': 'Biological psychiatry', 'JID': '0213264', 'RN': ['0 (Amyloid beta-Peptides)', '0 (Biomarkers)', '0 (FABP3 protein, human)', '0 (Fatty Acid Binding Protein 3)', '0 (Fatty Acid-Binding Proteins)', '0 (MAPT protein, human)', '0 (Macrophage Migration-Inhibitory Factors)', '0 (Peptide Fragments)', '0 (VEGFA protein, human)', '0 (Vascular Endothelial Growth Factor A)', '0 (amyloid beta-protein (1-42))', '0 (tau Proteins)', 'EC 5.3.- (Intramolecular Oxidoreductases)', 'EC 5.3.2.1 (MIF protein, human)'], 'SB': 'IM', 'MH': ['Aged, 80 and over', 'Alzheimer Disease/*cerebrospinal fluid', 'Amyloid beta-Peptides/*cerebrospinal fluid', 'Biomarkers/cerebrospinal fluid', 'Case-Control Studies', 'Cohort Studies', 'Disease Progression', 'Fatty Acid Binding Protein 3', 'Fatty Acid-Binding Proteins/cerebrospinal fluid', 'Female', 'Humans', 'Immunoassay/methods', 'Intramolecular Oxidoreductases/cerebrospinal fluid', 'Kaplan-Meier Estimate', 'Macrophage Migration-Inhibitory Factors/cerebrospinal fluid', 'Male', 'Multivariate Analysis', 'Peptide Fragments/*cerebrospinal fluid', 'Phosphorylation', 'Time Factors', 'Vascular Endothelial Growth Factor A/cerebrospinal fluid', 'tau Proteins/*cerebrospinal fluid'], 'PMC': 'PMC4007142', 'MID': ['NIHMS569534'], 'OTO': ['NOTNLM'], 'OT': [\"Alzheimer's disease\", 'biomarkers', 'brain proteome-Rules Based Medicine Discovery Multi-Analyte Profile 1.0', 'cerebrospinal fluid (CSF)', 'heart-type fatty acid binding protein', 'ptau-Abeta(42) ratio'], 'EDAT': '2014/02/20 06:00', 'MHDA': '2014/12/15 06:00', 'CRDT': ['2014/02/20 06:00'], 'PHST': ['2013/06/19 00:00 [received]', '2013/10/07 00:00 [revised]', '2013/11/19 00:00 [accepted]', '2014/02/20 06:00 [entrez]', '2014/02/20 06:00 [pubmed]', '2014/12/15 06:00 [medline]'], 'AID': ['S0006-3223(14)00018-3 [pii]', '10.1016/j.biopsych.2013.11.032 [doi]'], 'PST': 'ppublish', 'SO': 'Biol Psychiatry. 2014 May 1;75(9):723-31. doi: 10.1016/j.biopsych.2013.11.032. Epub 2014 Jan 19.'}\n",
      "{'PMID': '24182678', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20140812', 'LR': '20131118', 'IS': '1874-1754 (Electronic) 0167-5273 (Linking)', 'VI': '170', 'IP': '1', 'DP': '2013 Dec 5', 'TI': 'Effect of age and sex differences on wild-type transthyretin amyloid formation in familial amyloidotic polyneuropathy: a proteomic approach.', 'PG': '69-74', 'LID': '10.1016/j.ijcard.2013.10.033 [doi] S0167-5273(13)01847-0 [pii]', 'AB': 'BACKGROUND: Age and sex differences are closely related to the onset of senile systemic amyloidosis (SSA) caused by wild-type (WT) transthyretin (TTR). However, the effects of these differences on the amyloid formation mechanism in familial amyloid polyneuropathy (FAP) caused by variant TTR, have remained unclear. To elucidate age and sex differences in FAP, we investigated biochemical characteristics of amyloid deposits in different tissue sites of FAP by proteomic analysis. METHODS: We used shotgun liquid chromatography/tandem mass spectrometry to analyze the proportions of variant and WT TTR in amyloid deposits in different tissues, such as cardiac, kidney, peripheral nerves, and gastrointestinal tissues, from 23 autopsied FAP cases. RESULTS AND CONCLUSIONS: The analysis revealed a highly significant correlation between the proportion of WT TTR and age at autopsy in cardiac tissues, whereas the analysis indicated no correlation in kidney, peripheral nerves, and gastrointestinal tissues. In addition, we demonstrated age-related significantly increased WT TTR deposits, but not variant TTR deposits, in cardiac tissues of male patients. Taken together, these data suggest that both age and sex differences affect cardiac amyloid formation, mainly derived from WT TTR, in FAP.', 'CI': ['(c) 2013.'], 'FAU': ['Tasaki, Masayoshi', 'Ueda, Mitsuharu', 'Obayashi, Konen', 'Koike, Haruki', 'Kitagawa, Keisuke', 'Ogi, Yasuhiro', 'Jono, Hirofumi', 'Su, Yu', 'Suenaga, Genki', 'Oshima, Toshinori', 'Misumi, Yohei', 'Yoshida, Mari', 'Yamashita, Taro', 'Sobue, Gen', 'Ando, Yukio'], 'AU': ['Tasaki M', 'Ueda M', 'Obayashi K', 'Koike H', 'Kitagawa K', 'Ogi Y', 'Jono H', 'Su Y', 'Suenaga G', 'Oshima T', 'Misumi Y', 'Yoshida M', 'Yamashita T', 'Sobue G', 'Ando Y'], 'AD': ['Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto 860-0811, Japan; Department of Immunology and Hematology, Division of Informative Clinical Science, Graduate School of Medical Sciences, Kumamoto University, 4-24-1 kuhonji, Kumamoto 862-0976, Japan.'], 'LA': ['eng'], 'PT': ['Journal Article'], 'DEP': '20131015', 'PL': 'Netherlands', 'TA': 'Int J Cardiol', 'JT': 'International journal of cardiology', 'JID': '8200291', 'RN': ['0 (Prealbumin)'], 'SB': 'IM', 'MH': ['Adult', 'Age Factors', 'Amyloid Neuropathies, Familial/diagnosis/*metabolism/*physiopathology', 'Female', 'Humans', 'Male', 'Middle Aged', 'Myocardium/pathology', 'Prealbumin/genetics/*metabolism', 'Proteomics/*methods', '*Sex Characteristics', 'Young Adult'], 'OTO': ['NOTNLM'], 'OT': ['Aging', 'Amyloidosis', 'Familial amyloidotic polyneuropathy', 'Proteome', 'Sex differences', 'Transthyretin'], 'EDAT': '2013/11/05 06:00', 'MHDA': '2014/08/13 06:00', 'CRDT': ['2013/11/05 06:00'], 'PHST': ['2013/05/17 00:00 [received]', '2013/09/12 00:00 [revised]', '2013/10/07 00:00 [accepted]', '2013/11/05 06:00 [entrez]', '2013/11/05 06:00 [pubmed]', '2014/08/13 06:00 [medline]'], 'AID': ['S0167-5273(13)01847-0 [pii]', '10.1016/j.ijcard.2013.10.033 [doi]'], 'PST': 'ppublish', 'SO': 'Int J Cardiol. 2013 Dec 5;170(1):69-74. doi: 10.1016/j.ijcard.2013.10.033. Epub 2013 Oct 15.'}\n",
      "{'PMID': '24140280', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20140722', 'LR': '20160518', 'IS': '1876-7737 (Electronic) 1874-3919 (Linking)', 'VI': '94', 'DP': '2013 Dec 6', 'TI': 'Proteomics discovery of biomarkers for mitral regurgitation caused by mitral valve prolapse.', 'PG': '337-45', 'LID': '10.1016/j.jprot.2013.10.009 [doi] S1874-3919(13)00518-6 [pii]', 'AB': 'UNLABELLED: Mitral regurgitation (MR) is a common valvular lesion frequently caused by mitral valve prolapse (MVP). Surgical intervention in MVP patients with significant MR is predicated on symptoms and measures of left ventricular dysfunction. Because these indicators may be subjective or imprecise, serological biomarkers of disease could be a valuable adjunct to standard evaluation. This study aimed to identify such biomarkers by a proteomics approach. Two pooled plasma samples from 24 MVP subjects with MR (MVP/MR) and 24 non-MVP individuals were treated with the combinatorial peptide ligand library (CPLL) beads prior to iTRAQ labeling and ESI-MS/MS. Lower levels of haptoglobin, platelet basic protein (PBP), and complement component C4b were observed in the MVP/MR as compared to the control sample. These findings were verified by ELISA testing of each of the 24 paired samples, and another 42 matched cases and controls. The AUC values, sensitivities and specificities for (i) haptoglobin, (ii) PBP, (iii) C4b, and (iv) all 3 proteins in combination were (i) 0.813, 76%, 74%; (ii) 0.721, 56%, 77%; (iii) 0.689, 83%, 49%; and (iv) 0.840, 89%, 67%, respectively. In conclusion, haptoglobin, PBP, and C4b are down-regulated in MVP/MR. Their value as serological biomarkers of valvular pathology should be further explored. BIOLOGICAL SIGNIFICANCE: We report the first study that performed comparative proteomics of clinical human plasma samples to identify novel diagnostic biomarkers for mitral valve prolapse (MVP) patients with moderate to severe mitral regurgitation (MR). MR is a common valvular lesion that can be complicated by heart failure, sudden death and atrial fibrillation, yet many patients with severe MR are asymptomatic. Our results revealed reduced levels of haptoglobin, platelet basic protein (PBP), and complement component C4b in the MVP/MR patients as compared to the matched control cases. The plasma proteomics findings were subsequently confirmed by ELISA. Each of these candidate biomarkers has a putative role in the pathophysiology of MVP/MR, further supporting their roles in detection and possibly surveillance and prognostication of this disease.', 'CI': ['(c) 2013.'], 'FAU': ['Tan, Hwee Tong', 'Ling, Lieng H', 'Dolor-Torres, Maria Consolacion', 'Yip, James Wei-Luen', 'Richards, Arthur Mark', 'Chung, Maxey C M'], 'AU': ['Tan HT', 'Ling LH', 'Dolor-Torres MC', 'Yip JW', 'Richards AM', 'Chung MC'], 'AD': ['Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, 8 Medical Drive, Singapore 117597, Singapore.'], 'LA': ['eng'], 'PT': ['Clinical Trial', 'Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20131016', 'PL': 'Netherlands', 'TA': 'J Proteomics', 'JT': 'Journal of proteomics', 'JID': '101475056', 'RN': ['0 (Biomarkers)', '0 (Proteome)'], 'SB': 'IM', 'MH': ['Adult', 'Aged', 'Biomarkers/blood', 'Female', 'Humans', 'Male', 'Middle Aged', 'Mitral Valve Insufficiency/*blood/etiology', 'Mitral Valve Prolapse/*blood/complications', 'Proteome/*metabolism', '*Proteomics'], 'OTO': ['NOTNLM'], 'OT': ['Biomarkers', 'Complement component C4b', 'Haptoglobin', 'Mitral regurgitation', 'Mitral valve prolapse', 'Platelet basic protein'], 'EDAT': '2013/10/22 06:00', 'MHDA': '2014/07/23 06:00', 'CRDT': ['2013/10/22 06:00'], 'PHST': ['2013/06/28 00:00 [received]', '2013/10/04 00:00 [revised]', '2013/10/07 00:00 [accepted]', '2013/10/22 06:00 [entrez]', '2013/10/22 06:00 [pubmed]', '2014/07/23 06:00 [medline]'], 'AID': ['S1874-3919(13)00518-6 [pii]', '10.1016/j.jprot.2013.10.009 [doi]'], 'PST': 'ppublish', 'SO': 'J Proteomics. 2013 Dec 6;94:337-45. doi: 10.1016/j.jprot.2013.10.009. Epub 2013 Oct 16.'}\n",
      "{'PMID': '24055733', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20140130', 'LR': '20131206', 'IS': '1524-4571 (Electronic) 0009-7330 (Linking)', 'VI': '113', 'IP': '12', 'DP': '2013 Dec 6', 'TI': 'Exercise training in patients with chronic heart failure promotes restoration of high-density lipoprotein functional properties.', 'PG': '1345-55', 'LID': '10.1161/CIRCRESAHA.113.301684 [doi]', 'AB': 'RATIONALE: High-density lipoprotein (HDL) exerts endothelial-protective effects via stimulation of endothelial cell (EC) nitric oxide (NO) production. This function is impaired in patients with cardiovascular disease. Protective effects of exercise training (ET) on endothelial function have been demonstrated. OBJECTIVE: This study was performed to evaluate the impact of ET on HDL-mediated protective effects and the respective molecular pathways in patients with chronic heart failure (CHF). METHODS AND RESULTS: HDL was isolated from 16 healthy controls (HDL(healthy)) and 16 patients with CHF-NYHA-III (HDL(NYHA-IIIb)) before and after ET, as well as from 8 patients with CHF-NYHA-II (HDL(NYHA-II)). ECs were incubated with HDL, and phosphorylation of eNOS-Ser(1177), eNOS-Thr(495), PKC-betaII-Ser(660), and p70S6K-Ser(411) was evaluated. HDL-bound malondialdehyde and HDL-induced NO production by EC were quantified. Endothelial function was assessed by flow-mediated dilatation. The proteome of HDL particles was profiled by shotgun LC-MS/MS. Incubation of EC with HDL(NYHA-IIIb) triggered a lower stimulation of phosphorylation at eNOS-Ser(1177) and a higher phosphorylation at eNOS-Thr(495) when compared with HDL(healthy). This was associated with lower NO production of EC. In addition, an elevated activation of p70S6K, PKC-betaII by HDL(NYHA-IIIb), and a higher amount of malondialdehyde bound to HDL(NYHA-IIIb) compared with HDL(healthy) was measured. In healthy individuals, ET had no effect on HDL function, whereas ET of CHF-NYHA-IIIb significantly improved HDL function. A correlation between changes in HDL-induced NO production and flow-mediated dilatation improvement by ET was evident. CONCLUSIONS: These results demonstrate that HDL function is impaired in CHF and that ET improved the HDL-mediated vascular effects. This may be one mechanism how ET exerts beneficial effects in CHF.', 'FAU': ['Adams, Volker', 'Besler, Christian', 'Fischer, Tina', 'Riwanto, Meliana', 'Noack, Friederike', 'Hollriegel, Robert', 'Oberbach, Andreas', 'Jehmlich, Nico', 'Volker, Uwe', 'Winzer, Ephraim B', 'Lenk, Karsten', 'Hambrecht, Rainer', 'Schuler, Gerhard', 'Linke, Axel', 'Landmesser, Ulf', 'Erbs, Sandra'], 'AU': ['Adams V', 'Besler C', 'Fischer T', 'Riwanto M', 'Noack F', 'Hollriegel R', 'Oberbach A', 'Jehmlich N', 'Volker U', 'Winzer EB', 'Lenk K', 'Hambrecht R', 'Schuler G', 'Linke A', 'Landmesser U', 'Erbs S'], 'AD': ['From the Departments of Cardiology (V.A., T.F., F.N., R.H., E.B.W., K.L., G.S., A.L., S.E.) and Cardiac Surgery (A.O.), Heart Center Leipzig, Leipzig University, Germany; Department of Cardiology, University Hospital Zurich, Switzerland (C.B., M.R., U.L.); Department of Functional Genomics, Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Germany (N.J., U.V.); DZHK (German Center for Cardiovascular Research), Greifswald, Germany (U.V.); and Klinikum Links der Weser, Heart Center Bremen, Germany (R.H.).'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20130920', 'PL': 'United States', 'TA': 'Circ Res', 'JT': 'Circulation research', 'JID': '0047103', 'RN': ['0 (Lipoproteins, HDL)'], 'SB': 'IM', 'CIN': ['Circ Res. 2013 Dec 6;113(12):1275-7. PMID: 24311613'], 'MH': ['Aged', 'Cells, Cultured', 'Chronic Disease', 'Cohort Studies', 'Exercise Test/*methods', 'Female', 'Follow-Up Studies', 'Heart Failure/blood/physiopathology/*therapy', 'Humans', 'Lipoproteins, HDL/blood/*physiology', 'Male', 'Middle Aged', 'Physical Conditioning, Human/*physiology'], 'OTO': ['NOTNLM'], 'OT': ['aerobic exercise', 'eNOS', 'lipoproteins, HDL'], 'EDAT': '2013/09/24 06:00', 'MHDA': '2014/01/31 06:00', 'CRDT': ['2013/09/24 06:00'], 'PHST': ['2013/09/24 06:00 [entrez]', '2013/09/24 06:00 [pubmed]', '2014/01/31 06:00 [medline]'], 'AID': ['CIRCRESAHA.113.301684 [pii]', '10.1161/CIRCRESAHA.113.301684 [doi]'], 'PST': 'ppublish', 'SO': 'Circ Res. 2013 Dec 6;113(12):1345-55. doi: 10.1161/CIRCRESAHA.113.301684. Epub 2013 Sep 20.'}\n",
      "{'PMID': '23974919', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20140117', 'LR': '20181113', 'IS': '1939-327X (Electronic) 0012-1797 (Linking)', 'VI': '62', 'IP': '12', 'DP': '2013 Dec', 'TI': 'Gestational diabetes mellitus impairs Nrf2-mediated adaptive antioxidant defenses and redox signaling in fetal endothelial cells in utero.', 'PG': '4088-97', 'LID': '10.2337/db13-0169 [doi]', 'AB': 'In utero exposure to gestational diabetes mellitus (GDM) is associated with an increased risk of type 2 diabetes and cardiovascular disease in later life, yet the underlying mechanisms remain to be elucidated. We examined the effects of GDM on the proteome, redox status, and nuclear factor erythroid 2-related factor 2 (Nrf2)-mediated antioxidant gene expression in human fetal endothelial cells. Proteomic analysis revealed that proteins involved in redox homeostasis were significantly altered in GDM and associated with increased mitochondrial superoxide generation, protein oxidation, DNA damage, and diminished glutathione (GSH) synthesis. In GDM cells, the lipid peroxidation product 4-hydroxynonenal (HNE) failed to induce nuclear Nrf2 accumulation and mRNA and/or protein expression of Nrf2 and its target genes NAD(P)H:quinone oxidoreductase 1 (NQO1), Bach1, cystine/glutamate transporter, and glutamate cysteine ligase. Although methylation of CpG islands in Nrf2 or NQO1 promoters was unaltered by GDM, decreased DJ-1 and increased phosphorylated glycogen synthase kinase 3beta levels may account for impaired Nrf2 signaling. HNE-induced increases in GSH and NQO1 levels were abrogated by Nrf2 small interfering RNA in normal cells, and overexpression of Nrf2 in GDM cells partially restored NQO1 induction. Dysregulation of Nrf2 in fetal endothelium may contribute to the increased risk of type 2 diabetes and cardiovascular disease in offspring.', 'FAU': ['Cheng, Xinghua', 'Chapple, Sarah J', 'Patel, Bijal', 'Puszyk, William', 'Sugden, David', 'Yin, Xiaoke', 'Mayr, Manuel', 'Siow, Richard C M', 'Mann, Giovanni E'], 'AU': ['Cheng X', 'Chapple SJ', 'Patel B', 'Puszyk W', 'Sugden D', 'Yin X', 'Mayr M', 'Siow RC', 'Mann GE'], 'AD': [\"Cardiovascular Division, British Heart Foundation Centre of Research Excellence, King's College London, London, U.K.\"], 'LA': ['eng'], 'GR': ['12/0004530/Diabetes UK/United Kingdom', 'FS/13/2/29892/British Heart Foundation/United Kingdom', 'PG/13/1/29801/British Heart Foundation/United Kingdom', 'FS/10/59/28533/British Heart Foundation/United Kingdom'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20130823', 'PL': 'United States', 'TA': 'Diabetes', 'JT': 'Diabetes', 'JID': '0372763', 'RN': ['0 (Antioxidants)', '0 (NF-E2-Related Factor 2)', '0 (NFE2L2 protein, human)', '0 (Reactive Oxygen Species)', 'GAN16C9B8O (Glutathione)'], 'SB': 'AIM IM', 'MH': ['Adult', 'Antioxidants/*metabolism', 'Diabetes, Gestational/*metabolism', 'Female', 'Glutathione/metabolism', 'Human Umbilical Vein Endothelial Cells/*metabolism', 'Humans', 'NF-E2-Related Factor 2/*metabolism', 'Oxidation-Reduction', 'Pregnancy', 'Reactive Oxygen Species/metabolism', 'Signal Transduction/*physiology', 'Up-Regulation'], 'PMC': 'PMC3837032', 'EDAT': '2013/08/27 06:00', 'MHDA': '2014/01/18 06:00', 'CRDT': ['2013/08/27 06:00'], 'PHST': ['2013/08/27 06:00 [entrez]', '2013/08/27 06:00 [pubmed]', '2014/01/18 06:00 [medline]'], 'AID': ['db13-0169 [pii]', '10.2337/db13-0169 [doi]'], 'PST': 'ppublish', 'SO': 'Diabetes. 2013 Dec;62(12):4088-97. doi: 10.2337/db13-0169. Epub 2013 Aug 23.'}\n",
      "{'PMID': '23916682', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20150402', 'LR': '20191008', 'IS': '1873-6513 (Electronic) 0885-3924 (Linking)', 'VI': '47', 'IP': '4', 'DP': '2014 Apr', 'TI': 'Proteomic serum profile of fatigued men receiving localized external beam radiation therapy for non-metastatic prostate cancer.', 'PG': '748-756.e4', 'LID': '10.1016/j.jpainsymman.2013.05.016 [doi] S0885-3924(13)00333-3 [pii]', 'AB': 'CONTEXT: Fatigue is the most distressing side effect of radiation therapy, and its progression etiology is unknown. OBJECTIVES: This study describes proteome changes from sera of fatigued men with non-metastatic prostate cancer receiving external beam radiation therapy (EBRT). METHODS: Fatigue scores, measured by the Functional Assessment of Chronic Illness Therapy-Fatigue, and serum were collected from 12 subjects at baseline (before EBRT) and at midpoint (Day 21) of EBRT. Depleted sera from both time points were analyzed using two-dimensional difference gel electrophoresis, and up/down regulated proteins were identified using liquid chromatography-tandem mass spectrometry. Western blot analyses confirmed the protein changes observed. RESULTS: Results showed that apolipoprotein (Apo)A1, ApoE, and transthyretin (TTR) consistently changed from baseline (Day 0) to midpoint (Day 21). The mean ApoE level of subjects with high change in fatigue (HF: n = 9) increased significantly from baseline to midpoint and were higher than in subjects with no change in fatigue. The mean ApoA1 level was higher in HF subjects at baseline and at midpoint than in no fatigue subjects at both time points. The mean TTR level of no fatigue subjects was higher at baseline and midpoint than in HF subjects. CONCLUSION: These ApoE, ApoA1, and TTR results may assist in understanding pathways that can explain fatigue progression etiology in this clinical population.', 'CI': ['Published by Elsevier Inc.'], 'FAU': ['Lukkahatai, Nada', 'Patel, Sajni', 'Gucek, Marjan', 'Hsiao, Chao-Pin', 'Saligan, Leorey N'], 'AU': ['Lukkahatai N', 'Patel S', 'Gucek M', 'Hsiao CP', 'Saligan LN'], 'AD': ['National Institute of Nursing Research, National Institutes of Health, Bethesda, Maryland, USA. Electronic address: nada.lukkahatai@nih.gov.', 'National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA.', 'National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA.', 'National Institute of Nursing Research, National Institutes of Health, Bethesda, Maryland, USA.', 'National Institute of Nursing Research, National Institutes of Health, Bethesda, Maryland, USA.'], 'LA': ['eng'], 'GR': ['Z99 NR999999/Intramural NIH HHS/United States'], 'PT': ['Journal Article', 'Research Support, N.I.H., Intramural'], 'DEP': '20130731', 'PL': 'United States', 'TA': 'J Pain Symptom Manage', 'JT': 'Journal of pain and symptom management', 'JID': '8605836', 'RN': ['0 (APOA1 protein, human)', '0 (Apolipoprotein A-I)', '0 (Apolipoproteins E)', '0 (Prealbumin)'], 'SB': 'IM', 'MH': ['Aged', 'Apolipoprotein A-I/blood', 'Apolipoproteins E/blood', 'Blotting, Western', 'Chromatography, Liquid', 'Disease Progression', 'Fatigue/*blood/*etiology', 'Humans', 'Male', 'Middle Aged', 'Prealbumin/metabolism', 'Prostatic Neoplasms/*blood/*radiotherapy', 'Proteomics/methods', 'Severity of Illness Index', 'Tandem Mass Spectrometry', 'Time Factors', 'Two-Dimensional Difference Gel Electrophoresis'], 'PMC': 'PMC3743082', 'MID': ['NIHMS497179'], 'OTO': ['NOTNLM'], 'OT': ['External beam radiation therapy', 'Western blot', 'fatigue', 'prostate cancer', 'quantitative proteomics'], 'EDAT': '2013/08/07 06:00', 'MHDA': '2015/04/04 06:00', 'CRDT': ['2013/08/07 06:00'], 'PHST': ['2013/03/26 00:00 [received]', '2013/05/07 00:00 [revised]', '2013/05/15 00:00 [accepted]', '2013/08/07 06:00 [entrez]', '2013/08/07 06:00 [pubmed]', '2015/04/04 06:00 [medline]'], 'AID': ['S0885-3924(13)00333-3 [pii]', '10.1016/j.jpainsymman.2013.05.016 [doi]'], 'PST': 'ppublish', 'SO': 'J Pain Symptom Manage. 2014 Apr;47(4):748-756.e4. doi: 10.1016/j.jpainsymman.2013.05.016. Epub 2013 Jul 31.'}\n",
      "{'PMID': '23836408', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20140512', 'LR': '20130718', 'IS': '1791-244X (Electronic) 1107-3756 (Linking)', 'VI': '32', 'IP': '3', 'DP': '2013 Sep', 'TI': 'Loss of caveolin-1 promotes endothelial-mesenchymal transition during sepsis: a membrane proteomic study.', 'PG': '585-92', 'LID': '10.3892/ijmm.2013.1432 [doi]', 'AB': 'Sepsis is a clinical syndrome that reflects an uncontrolled systemic inflammatory response to microbial infections. Endothelial cells, which are highly responsive to their extracellular environment, are the primary targets of sepsis-induced damage. Endothelial-mesenchymal transition (EndMT), characterized by loss of endothelial cell markers and gain of mesenchymal cell markers, contributes to embryonic cardiac formation as well as development of various diseases. We showed that incubation with septic serum induced a rapid loss of endothelial barrier integrity in a human umbilical vein endothelial cell (HUVEC) monolayer. Notably, exposure to septic serum triggered EndMT in HUVECs, companied by increased cell motility and invasion. Furthermore, membrane proteomic analysis was applied to analyze the key mediators in septic serum-induced EndMT. A total of 29 proteins with altered expression level were positively identified. Expression of four proteins with the most significant alteration, including caveolin-1, S100A4, alpha-enolase and galectin-1, were validated by western blotting. Finally, we showed that restoration of caveolin-1 expression markedly attenuated septic serum-induced EndMT in HUVEC cells. This is the first report showing that endothelial cells undergo EndMT during sepsis. The present study may lead to a better understanding of the biological role of endothelial cells and caveolin-1 during sepsis.', 'FAU': ['Huang, Xiaobo', 'Pan, Lingai', 'Pu, Hong', 'Wang, Yiping', 'Zhang, Xiaoqin', 'Li, Chunling', 'Yang, Zhenglin'], 'AU': ['Huang X', 'Pan L', 'Pu H', 'Wang Y', 'Zhang X', 'Li C', 'Yang Z'], 'AD': [\"Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, Chengdu, Sichuan 610072, P.R. China.\"], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20130705', 'PL': 'Greece', 'TA': 'Int J Mol Med', 'JT': 'International journal of molecular medicine', 'JID': '9810955', 'RN': ['0 (Caveolin 1)', '0 (Proteome)'], 'SB': 'IM', 'MH': ['Adult', 'Aged', 'Aged, 80 and over', 'Capillary Permeability', 'Caveolin 1/genetics/*metabolism', 'Cell Membrane/metabolism', 'Endothelial Cells/metabolism/pathology', '*Epithelial-Mesenchymal Transition/genetics', 'Human Umbilical Vein Endothelial Cells', 'Humans', 'Middle Aged', 'Proteome', 'Proteomics', 'Reproducibility of Results', 'Sepsis/blood/*metabolism/pathology'], 'EDAT': '2013/07/10 06:00', 'MHDA': '2014/05/13 06:00', 'CRDT': ['2013/07/10 06:00'], 'PHST': ['2012/10/22 00:00 [received]', '2012/12/21 00:00 [accepted]', '2013/07/10 06:00 [entrez]', '2013/07/10 06:00 [pubmed]', '2014/05/13 06:00 [medline]'], 'AID': ['10.3892/ijmm.2013.1432 [doi]'], 'PST': 'ppublish', 'SO': 'Int J Mol Med. 2013 Sep;32(3):585-92. doi: 10.3892/ijmm.2013.1432. Epub 2013 Jul 5.'}\n",
      "{'PMID': '23804534', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20140811', 'LR': '20131204', 'IS': '1930-739X (Electronic) 1930-7381 (Linking)', 'VI': '21', 'IP': '12', 'DP': '2013 Dec', 'TI': 'Impaired HDL function in obese adolescents: impact of lifestyle intervention and bariatric surgery.', 'PG': 'E687-95', 'LID': '10.1002/oby.20538 [doi]', 'AB': 'OBJECTIVE: HDL regulates endothelial function via stimulation of nitric oxide production. It is documented that endothelial function is impaired in obese adolescents, and improved by lifestyle interventions (LI). DESIGN AND METHODS: HDL function in obese adolescents and the impact of LI or Roux-en-Y gastric bypass surgery (RYGB) was assessed. HDL was isolated from 14 adolescents with normal body mass index (HDLcontrol ), 10 obese (HDLobese ) before and after 6 month LI, and five severe obese adolescents before and one year after RYGB. HDL-mediated phosphorylation of endothelial nitric oxide synthase (eNOS)-Ser(1177) , eNOS-Thr(495) , and PKC-ssII was evaluated. In addition the HDL proteome was analyzed. RESULTS: HDLobese -mediated eNOS-Ser(1177) phosphorylation was reduced, whereas eNOS-Thr(495) phosphorylation increased significantly when compared to HDLcontrol . No impact of obesity was observed on PKC-ssII phosphorylation. LI and RYGB had no impact on HDL-mediated phosphorylation of eNOS and PKC-ssII. A principle component plot analysis of the HDL particle separated controls and severe obese, whereas the interventions did not trigger sufficient differences to the HDL proteome to permit distinction. CONCLUSION: These results demonstrated that HDL-function is impaired in obese adolescents, and that LI or RYGB did not correct this dysfunction. This might be an argument for developing earlier prevention strategies in obese adolescents to avoid HDL dysfunction.', 'CI': ['Copyright (c) 2013 The Obesity Society.'], 'FAU': ['Matsuo, Yae', 'Oberbach, Andreas', 'Till, Holger', 'Inge, Thomas H', 'Wabitsch, Martin', 'Moss, Anja', 'Jehmlich, Nico', 'Volker, Uwe', 'Muller, Ulrike', 'Siegfried, Wolfgang', 'Kanesawa, Norio', 'Kurabayashi, Masahiko', 'Schuler, Gerhard', 'Linke, Axel', 'Adams, Volker'], 'AU': ['Matsuo Y', 'Oberbach A', 'Till H', 'Inge TH', 'Wabitsch M', 'Moss A', 'Jehmlich N', 'Volker U', 'Muller U', 'Siegfried W', 'Kanesawa N', 'Kurabayashi M', 'Schuler G', 'Linke A', 'Adams V'], 'AD': ['University Leipzig-Heart Center Leipzig, Department of Cardiology, Leipzig, Germany; Takasaki General Medical Center, Division of Cardiology, Takasaki, Japan; Gunma University School of Medicine, Department of Cardiology, Maebashi, Japan.'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20130813', 'PL': 'United States', 'TA': 'Obesity (Silver Spring)', 'JT': 'Obesity (Silver Spring, Md.)', 'JID': '101264860', 'RN': ['0 (Cholesterol, HDL)', '0 (Proteome)', '11002-13-4 (Angiotensinogen)', 'EC 1.14.13.39 (NOS3 protein, human)', 'EC 1.14.13.39 (Nitric Oxide Synthase Type III)', 'EC 2.7.11.13 (Protein Kinase C beta)'], 'SB': 'IM', 'MH': ['Adolescent', 'Angiotensinogen/metabolism', 'Case-Control Studies', 'Child', 'Cholesterol, HDL/*blood', 'Endothelial Cells/metabolism', 'Endothelium/metabolism', 'Female', 'Follow-Up Studies', '*Gastric Bypass', 'Healthy Volunteers', 'Humans', '*Life Style', 'Male', 'Nitric Oxide Synthase Type III/genetics/metabolism', 'Pediatric Obesity/blood/*surgery', 'Phosphorylation', 'Protein Kinase C beta/genetics/metabolism', 'Proteome/metabolism', 'Young Adult'], 'EDAT': '2013/06/28 06:00', 'MHDA': '2014/08/12 06:00', 'CRDT': ['2013/06/28 06:00'], 'PHST': ['2012/12/11 00:00 [received]', '2013/04/12 00:00 [revised]', '2013/06/03 00:00 [accepted]', '2013/06/28 06:00 [entrez]', '2013/06/28 06:00 [pubmed]', '2014/08/12 06:00 [medline]'], 'AID': ['10.1002/oby.20538 [doi]'], 'PST': 'ppublish', 'SO': 'Obesity (Silver Spring). 2013 Dec;21(12):E687-95. doi: 10.1002/oby.20538. Epub 2013 Aug 13.'}\n",
      "{'PMID': '23797974', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20140404', 'LR': '20130916', 'IS': '1615-9861 (Electronic) 1615-9853 (Linking)', 'VI': '13', 'IP': '17', 'DP': '2013 Sep', 'TI': 'Proteomics analysis of human pericardial fluid.', 'PG': '2692-5', 'LID': '10.1002/pmic.201200317 [doi]', 'AB': 'Pericardial fluid (PF) is considered as a biochemical window of heart. To date, there have been limited attempts to perform an in-depth analysis of the PF proteome. In this study, an SDS-PAGE-LC-MS/MS platform was utilized to explore depleted PF, which showed great coverage of low-abundant proteins. In total, 1007 nonredundant proteins were identified with at least two peptides. This is the first comprehensive analysis of human PF proteome and provides a foundation for further application of PF in cardiovascular research. The data have been deposited to the ProteomeXchange with identifier PXD000194.', 'CI': ['(c) 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.'], 'FAU': ['Xiang, Fei', 'Guo, Xuejiang', 'Chen, Wen', 'Wang, Jing', 'Zhou, Tao', 'Huang, Fuhua', 'Cao, Changchun', 'Chen, Xin'], 'AU': ['Xiang F', 'Guo X', 'Chen W', 'Wang J', 'Zhou T', 'Huang F', 'Cao C', 'Chen X'], 'AD': ['Department of Thoracic and Cardiovascular Surgery, Nanjing First Hospital Affiliated to Nanjing Medical University, Nanjing, P. R. China.'], 'LA': ['eng'], 'PT': ['Journal Article'], 'DEP': '20130805', 'PL': 'Germany', 'TA': 'Proteomics', 'JT': 'Proteomics', 'JID': '101092707', 'RN': ['0 (Proteins)', '0 (Proteome)'], 'SB': 'IM', 'MH': ['Adolescent', 'Adult', 'Chromatography, Liquid', 'Electrophoresis, Polyacrylamide Gel', 'Heart', 'Humans', 'Pericardial Effusion/*metabolism', 'Proteins/*analysis', 'Proteome/*analysis', 'Proteomics', 'Tandem Mass Spectrometry', 'Young Adult'], 'OTO': ['NOTNLM'], 'OT': ['Heart', 'Pericardial fluid', 'Systems biology'], 'EDAT': '2013/06/26 06:00', 'MHDA': '2014/04/05 06:00', 'CRDT': ['2013/06/26 06:00'], 'PHST': ['2012/07/24 00:00 [received]', '2013/05/18 00:00 [revised]', '2013/06/03 00:00 [accepted]', '2013/06/26 06:00 [entrez]', '2013/06/26 06:00 [pubmed]', '2014/04/05 06:00 [medline]'], 'AID': ['10.1002/pmic.201200317 [doi]'], 'PST': 'ppublish', 'SO': 'Proteomics. 2013 Sep;13(17):2692-5. doi: 10.1002/pmic.201200317. Epub 2013 Aug 5.'}\n",
      "{'PMID': '23704777', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20140402', 'LR': '20181202', 'IS': '1535-9484 (Electronic) 1535-9476 (Linking)', 'VI': '12', 'IP': '9', 'DP': '2013 Sep', 'TI': 'Modification of the secretion pattern of proteases, inflammatory mediators, and extracellular matrix proteins by human aortic valve is key in severe aortic stenosis.', 'PG': '2426-39', 'LID': '10.1074/mcp.M113.027425 [doi]', 'AB': 'One of the major challenges in cardiovascular medicine is to identify candidate biomarker proteins. Secretome analysis is particularly relevant in this search as it focuses on a subset of proteins released by a cell or tissue under certain conditions. The sample can be considered as a plasma subproteome and it provides a more direct approximation to the in vivo situation. Degenerative aortic stenosis is the most common worldwide cause of valve replacement. Using a proteomic analysis of the secretome from aortic stenosis valves we could identify candidate markers related to this pathology, which may facilitate early diagnosis and treatment. For this purpose, we have designed a method to validate the origin of secreted proteins, demonstrating their synthesis and release by the tissue and ruling out blood origin. The nLC-MS/MS analysis showed the labeling of 61 proteins, 82% of which incorporated the label in only one group. Western blot and selective reaction monitoring differential analysis, revealed a notable role of the extracellular matrix. Variation in particular proteins such as PEDF, cystatin and clusterin emphasizes the link between aortic stenosis and atherosclerosis. In particular, certain proteins variation in secretome levels correlates well, not only with label incorporation trend (only labeled in aortic stenosis group) but, more importantly, with alterations found in plasma from an independent cohort of samples, pointing to specific candidate markers to follow up in diagnosis, prognosis, and therapeutic intervention.', 'FAU': ['Alvarez-Llamas, Gloria', 'Martin-Rojas, Tatiana', 'de la Cuesta, Fernando', 'Calvo, Enrique', 'Gil-Dones, Felix', 'Darde, Veronica M', 'Lopez-Almodovar, Luis F', 'Padial, Luis R', 'Lopez, Juan-Antonio', 'Vivanco, Fernando', 'Barderas, Maria G'], 'AU': ['Alvarez-Llamas G', 'Martin-Rojas T', 'de la Cuesta F', 'Calvo E', 'Gil-Dones F', 'Darde VM', 'Lopez-Almodovar LF', 'Padial LR', 'Lopez JA', 'Vivanco F', 'Barderas MG'], 'AD': ['Department of Immunology, IIS-Fundacion Jimenez Diaz, Madrid, Spain. galvarez@fjd.es'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20130523', 'PL': 'United States', 'TA': 'Mol Cell Proteomics', 'JT': 'Molecular & cellular proteomics : MCP', 'JID': '101125647', 'RN': ['0 (Extracellular Matrix Proteins)', '0 (Inflammation Mediators)', '0 (Proteome)', 'EC 3.4.- (Peptide Hydrolases)'], 'SB': 'IM', 'MH': ['Aged', 'Aortic Valve/*metabolism/*pathology', 'Aortic Valve Stenosis/blood/*metabolism', 'Blotting, Western', 'Extracellular Matrix Proteins/*metabolism', 'Female', 'Humans', 'Inflammation Mediators/*metabolism', 'Isotope Labeling', 'Male', 'Mass Spectrometry', 'Peptide Hydrolases/*metabolism', 'Protein Interaction Maps', 'Proteome/classification/metabolism', 'Proteomics', 'Reproducibility of Results', 'Time Factors'], 'PMC': 'PMC3769321', 'EDAT': '2013/05/25 06:00', 'MHDA': '2014/04/03 06:00', 'CRDT': ['2013/05/25 06:00'], 'PHST': ['2013/05/25 06:00 [entrez]', '2013/05/25 06:00 [pubmed]', '2014/04/03 06:00 [medline]'], 'AID': ['M113.027425 [pii]', '10.1074/mcp.M113.027425 [doi]'], 'PST': 'ppublish', 'SO': 'Mol Cell Proteomics. 2013 Sep;12(9):2426-39. doi: 10.1074/mcp.M113.027425. Epub 2013 May 23.'}\n",
      "{'PMID': '23701180', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20131111', 'LR': '20151119', 'IS': '1365-2060 (Electronic) 0785-3890 (Linking)', 'VI': '45', 'IP': '4', 'DP': '2013 Jun', 'TI': 'Identification and confirmation of haptoglobin as a potential serum biomarker in hypertrophic cardiomyopathy using proteomic approaches.', 'PG': '341-7', 'LID': '10.3109/07853890.2013.792555 [doi]', 'AB': 'INTRODUCTION: Aiming at identifying biomarkers for hypertrophic cardiomyopathy (HCM), the serum proteome was explored through a two-dimensional gel-based proteomic approach (2D-DIGE) coupled with mass spectrometry and database interrogation. METHODS: Serum samples from 20 male HCM patients and their sex- and age-matched controls were cleaned from interfering components. Patients and controls were pooled in five matched groups with the same age, and proteins extracts from each pool were labelled with cyanine dyes. Then, gel images were analysed using a fluorescence scanner and proteins were identified. Tryptic peptides were analysed by capillary reversed-phase liquid chromatography coupled online with tandem mass spectrometry (MS/MS). RESULTS: Four different proteins were observed to be differentially expressed between HCM patients and their matched controls. Of them, decreases in haptoglobin levels were confirmed to be associated with HCM in an independent set of 181 consecutive HCM patients from our monographic clinic and 114 controls with similar age and sex using a nephelometer-based technique. Moreover, a significant negative correlation was observed between haptoglobin and subaortic gradient, thus highlighting the role of haptoglobin in HCM. CONCLUSION: All these observations point out the utility of the 2D-DIGE proteomic strategy for the identification of serum proteins indicative of the presence of cardiac injury.', 'FAU': ['Orenes-Pinero, Esteban', 'Hernandez-Romero, Diana', 'de Torre, Carlos', 'Vilchez, Juan Antonio', 'Martinez, Marina', 'Romero-Aniorte, Ana Isabel', 'Climent, Vicente', 'Garcia-Honrubia, Antonio', 'Valdes, Mariano', 'Marin, Francisco'], 'AU': ['Orenes-Pinero E', 'Hernandez-Romero D', 'de Torre C', 'Vilchez JA', 'Martinez M', 'Romero-Aniorte AI', 'Climent V', 'Garcia-Honrubia A', 'Valdes M', 'Marin F'], 'AD': ['Department of Cardiology, Hospital Universitario Virgen de la Arrixaca, Universidad de Murcia, Murcia, Spain. eorenes@um.es'], 'LA': ['eng'], 'PT': ['Comparative Study', 'Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20130523', 'PL': 'England', 'TA': 'Ann Med', 'JT': 'Annals of medicine', 'JID': '8906388', 'RN': ['0 (Biomarkers)', '0 (Haptoglobins)'], 'SB': 'IM', 'MH': ['Adult', 'Biomarkers/blood', 'Cardiomyopathy, Hypertrophic/*blood/*diagnosis', 'Electrophoresis, Gel, Two-Dimensional', 'Haptoglobins/*metabolism', 'Humans', 'Male', 'Middle Aged', 'Prognosis', 'Sensitivity and Specificity', 'Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization/*methods'], 'EDAT': '2013/05/25 06:00', 'MHDA': '2013/11/12 06:00', 'CRDT': ['2013/05/25 06:00'], 'PHST': ['2013/05/25 06:00 [entrez]', '2013/05/25 06:00 [pubmed]', '2013/11/12 06:00 [medline]'], 'AID': ['10.3109/07853890.2013.792555 [doi]'], 'PST': 'ppublish', 'SO': 'Ann Med. 2013 Jun;45(4):341-7. doi: 10.3109/07853890.2013.792555. Epub 2013 May 23.'}\n",
      "{'PMID': '23660474', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20140317', 'LR': '20200305', 'IS': '1535-9484 (Electronic) 1535-9476 (Linking)', 'VI': '12', 'IP': '8', 'DP': '2013 Aug', 'TI': 'Heterogeneity in neutrophil microparticles reveals distinct proteome and functional properties.', 'PG': '2205-19', 'LID': '10.1074/mcp.M113.028589 [doi]', 'AB': 'Altered plasma neutrophil microparticle levels have recently been implicated in a number of vascular and inflammatory diseases, yet our understanding of their actions is very limited. Herein, we investigate the proteome of neutrophil microparticles in order to shed light on their biological actions. Stimulation of human neutrophils, either in suspension or adherent to an endothelial monolayer, led to the production of microparticles containing >400 distinct proteins with only 223 being shared by the two subsets. For instance, postadherent microparticles were enriched in alpha-2 macroglobulin and ceruloplasmin, whereas microparticles produced by neutrophils in suspension were abundant in heat shock 70 kDa protein 1. Annexin A1 and lactotransferrin were expressed in both microparticle subsets. We next determined relative abundance of these proteins in three types of human microparticle samples: healthy volunteer plasma, plasma of septic patients and skin blister exudates finding that these proteins were differentially expressed on neutrophil microparticles from these samples reflecting in part the expression profiles we found in vitro. Functional assessment of the neutrophil microparticles subsets demonstrated that in response to direct stimulation neutrophil microparticles produced reactive oxygen species and leukotriene B4 as well as locomoted toward a chemotactic gradient. Finally, we investigated the actions of the two neutrophil microparticles subsets described herein on target cell responses. Microarray analysis with human primary endothelial cells incubated with either microparticle subset revealed a discrete modulation of endothelial cell gene expression profile. These findings demonstrate that neutrophil microparticles are heterogenous and can deliver packaged information propagating the activation status of the parent cell, potentially exerting novel and fundamental roles both under homeostatic and disease conditions.', 'FAU': ['Dalli, Jesmond', 'Montero-Melendez, Trinidad', 'Norling, Lucy V', 'Yin, Xiaoke', 'Hinds, Charles', 'Haskard, Dorian', 'Mayr, Manuel', 'Perretti, Mauro'], 'AU': ['Dalli J', 'Montero-Melendez T', 'Norling LV', 'Yin X', 'Hinds C', 'Haskard D', 'Mayr M', 'Perretti M'], 'AD': ['The William Harvey Research Institute, Barts and The London School of Medical, Charterhouse Square, London EC1M 6BQ, United Kingdom.'], 'LA': ['eng'], 'GR': ['19909/ARC_/Arthritis Research UK/United Kingdom', '19909/VAC_/Versus Arthritis/United Kingdom', 'FS/13/2/29892/BHF_/British Heart Foundation/United Kingdom', '086867/Z/08/WT_/Wellcome Trust/United Kingdom'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20130508', 'PL': 'United States', 'TA': 'Mol Cell Proteomics', 'JT': 'Molecular & cellular proteomics : MCP', 'JID': '101125647', 'RN': ['0 (Proteome)', '0 (Reactive Oxygen Species)', '1HGW4DR56D (Leukotriene B4)'], 'SB': 'IM', 'MH': ['Adult', 'Cell-Derived Microparticles/*metabolism', 'Cells, Cultured', 'Chemotaxis, Leukocyte', 'Female', 'Human Umbilical Vein Endothelial Cells/metabolism', 'Humans', 'Leukotriene B4/metabolism', 'Male', 'Middle Aged', 'Neutrophils/*physiology', 'Proteome', 'Reactive Oxygen Species/metabolism'], 'PMC': 'PMC3734580', 'EDAT': '2013/05/11 06:00', 'MHDA': '2014/03/19 06:00', 'CRDT': ['2013/05/11 06:00'], 'PHST': ['2013/05/11 06:00 [entrez]', '2013/05/11 06:00 [pubmed]', '2014/03/19 06:00 [medline]'], 'AID': ['M113.028589 [pii]', '10.1074/mcp.M113.028589 [doi]'], 'PST': 'ppublish', 'SO': 'Mol Cell Proteomics. 2013 Aug;12(8):2205-19. doi: 10.1074/mcp.M113.028589. Epub 2013 May 8.'}\n",
      "{'PMID': '23593175', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20131104', 'LR': '20181113', 'IS': '1932-6203 (Electronic) 1932-6203 (Linking)', 'VI': '8', 'IP': '4', 'DP': '2013', 'TI': 'Protein analysis of atrial fibrosis via label-free proteomics in chronic atrial fibrillation patients with mitral valve disease.', 'PG': 'e60210', 'LID': '10.1371/journal.pone.0060210 [doi]', 'AB': 'BACKGROUND: Atrial fibrosis, as a hallmark of atrial structure remodeling, plays an important role in maintenance of chronic atrial fibrillation, but interrelationship of atrial fibrosis and atrial fibrillation is uncertain. Label-free proteomics can implement high throughput screening for finding and analyzing pivotal proteins related to the disease.. Therefore, we used label-free proteomics to explore and analyze differentially proteins in chronic atrial fibrillation patients with mitral valve disease. METHODS: Left and right atrial appendages obtained from patients with mitral valve disease were both in chronic atrial fibrillation (CAF, AF>/=6 months, n = 6) and in sinus rhythm (SR, n = 6). One part of the sample was used for histological analysis and fibrosis quantification; other part were analyzed by label-free proteomic combining liquid chromatography with mass spectrometry (LC-MS), we utilized bioinformatics analysis to identify differential proteins. RESULTS: Degree of atrial fibrosis was higher in CAF patients than that of SR patients. 223 differential proteins were detected between two groups. These proteins mainly had vital functions such as cell proliferation, stress response, focal adhesion apoptosis. We evaluated that serine/threonine protein kinase N2 (PKN2), dermatopontin (DP), S100 calcium binding protein B (S100B), protein tyrosine kinase 2 (PTK2) and discoidin domain receptor tyrosine kinase 2 (DDR2) played important roles in fibrotic process related to atrial fibrillation. CONCLUSION: The study presented differential proteins responsible for atrial fibrosis in chronic atrial fibrillation patients through label-free proteomic analysis. We assessed some vital proteins including their characters and roles. These findings may open up new realm for mechanism research of atrial fibrillation.', 'FAU': ['Zhang, Peide', 'Wang, Wei', 'Wang, Xin', 'Wang, Xu', 'Song, Yunhu', 'Han, Yong', 'Zhang, Jing', 'Zhao, Hui'], 'AU': ['Zhang P', 'Wang W', 'Wang X', 'Wang X', 'Song Y', 'Han Y', 'Zhang J', 'Zhao H'], 'AD': [\"Cardiovascular Surgery Department, Fuwai Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, People's Republic of China.\"], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20130404', 'PL': 'United States', 'TA': 'PLoS One', 'JT': 'PloS one', 'JID': '101285081', 'RN': ['0 (Proteome)'], 'SB': 'IM', 'MH': ['Adult', 'Aged', 'Atrial Appendage/metabolism/pathology', 'Atrial Fibrillation/*complications/*metabolism', 'Chronic Disease', 'Female', 'Fibrosis', 'Heart Valve Diseases/*complications/*metabolism', 'Humans', 'Male', 'Middle Aged', 'Mitral Valve/*pathology', 'Protein Interaction Mapping', 'Protein Interaction Maps', '*Proteome', '*Proteomics', 'Signal Transduction'], 'PMC': 'PMC3617171', 'EDAT': '2013/04/18 06:00', 'MHDA': '2013/11/05 06:00', 'CRDT': ['2013/04/18 06:00'], 'PHST': ['2012/11/02 00:00 [received]', '2013/02/22 00:00 [accepted]', '2013/04/18 06:00 [entrez]', '2013/04/18 06:00 [pubmed]', '2013/11/05 06:00 [medline]'], 'AID': ['10.1371/journal.pone.0060210 [doi]', 'PONE-D-12-34443 [pii]'], 'PST': 'epublish', 'SO': 'PLoS One. 2013 Apr 4;8(4):e60210. doi: 10.1371/journal.pone.0060210. Print 2013.'}\n",
      "{'PMID': '23519648', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20140910', 'LR': '20181113', 'IS': '1436-2813 (Electronic) 0941-1291 (Linking)', 'VI': '44', 'IP': '1', 'DP': '2014 Jan', 'TI': 'Proteomic analysis of the abdominal aortic aneurysm wall.', 'PG': '142-51', 'LID': '10.1007/s00595-012-0480-6 [doi]', 'AB': 'PURPOSES: A ruptured AAA (rAAA) is a common cause of death in males over 60 years of age, and the global mortality from rAAA exceeds 80 %. The pathological processes occurring in the wall of the developing AAA are still unclear. The potential pathophysiological mechanisms underlying aortic aneurysms have been examined by many studies using immunohistochemistry and were, therefore, targeted at specific, preselected protein antigens. METHODS: We collected samples of tissue from anterior wall of an aneurysm sac from 15 patients indicated for AAA resection (group A) during the period from 2010 to 2011. These samples were subjected to a proteomic analysis. In addition, we collected control samples of identical aortic tissue from 10 heart-beating deceased organ donors (group B). RESULTS: A total of 417 differentially expressed protein fractions were identified, 18 of which were only detected in the healthy controls, while 85 were specific for aneurysm tissue and 314 were detectable in both groups. In 175 protein fractions, the gel-derived spot volumes differed significantly between aneurismal and healthy aortic tissue. CONCLUSIONS: We found a significant difference in the proteome of the AAA tissue and non-dilated aortic tissue. We demonstrated that the AAA proteome is considerably richer and more varied than the healthy and atherosclerotic aorta. We believe that our results clearly demonstrate a completely different etiopathogenesis of atherosclerosis and aneurismal disease.', 'FAU': ['Molacek, Jiri', 'Mares, Jan', 'Treska, Vladislav', 'Houdek, Karel', 'Baxa, Jan'], 'AU': ['Molacek J', 'Mares J', 'Treska V', 'Houdek K', 'Baxa J'], 'AD': ['School of Medicine in Pilsen, Charles University in Prague, Husova 3, 306 05, Pilsen, Czech Republic, molacek@fnplzen.cz.'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20130322', 'PL': 'Japan', 'TA': 'Surg Today', 'JT': 'Surgery today', 'JID': '9204360', 'RN': ['0 (Proteome)'], 'SB': 'IM', 'MH': ['Adolescent', 'Adult', 'Aged', 'Aortic Aneurysm, Abdominal/*genetics/metabolism', 'Atherosclerosis/genetics', 'Electrophoresis, Gel, Two-Dimensional', 'Female', 'Humans', 'Male', 'Middle Aged', 'Proteome/*genetics/metabolism', '*Proteomics/methods', 'Young Adult'], 'PMC': 'PMC3898145', 'EDAT': '2013/03/23 06:00', 'MHDA': '2014/09/11 06:00', 'CRDT': ['2013/03/23 06:00'], 'PHST': ['2012/05/21 00:00 [received]', '2012/10/26 00:00 [accepted]', '2013/03/23 06:00 [entrez]', '2013/03/23 06:00 [pubmed]', '2014/09/11 06:00 [medline]'], 'AID': ['10.1007/s00595-012-0480-6 [doi]'], 'PST': 'ppublish', 'SO': 'Surg Today. 2014 Jan;44(1):142-51. doi: 10.1007/s00595-012-0480-6. Epub 2013 Mar 22.'}\n",
      "{'PMID': '23431486', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20130905', 'LR': '20151119', 'IS': '1758-1001 (Electronic) 0004-5632 (Linking)', 'VI': '50', 'IP': 'Pt 2', 'DP': '2013 Mar', 'TI': 'Characterization of the perfusate proteome of human donor kidneys.', 'PG': '140-6', 'LID': '10.1258/acb.2012.011144 [doi]', 'AB': 'BACKGROUND: Preservation of deceased donor kidneys by hypothermic machine perfusion results in superior transplant outcomes as compared with static cold storage and provides the opportunity to measure biomarkers of cellular injury in perfusate samples. Identification of biomarkers predicting early graft dysfunction so far has met with limited success. METHODS: Two-dimensional difference gel electrophoresis and mass spectrometry were used to explore the proteome of perfusate samples from machine-perfused human donor kidneys (N = 18) and to discover novel biomarkers of ischaemic acute kidney injury. RESULTS: Thirty-two protein spots were successfully identified, representing 19 unique proteins that were derived from renal tissue and from residual plasma in the renal microcirculation. Two unidentified protein spots were significantly up-regulated, whereas one protein spot--identified as haptoglobin--was significantly down-regulated in the perfusate of ischaemically injured kidneys from donors after cardiac death as compared with kidneys from brain-dead donors who had not suffered warm ischaemic injury. Furthermore, two protein spots were up-regulated in kidneys that never functioned after transplantation, whereas one spot was up-regulated--identified as alpha1-antitrypsin--in kidneys with delayed graft function. CONCLUSIONS: We provide the first description of the renal perfusate proteome and present preliminary evidence of differentially expressed biomarkers in human donor kidneys with different levels of acute ischaemic injury. Their diagnostic value for the selection of marginal kidneys in clinical transplantation should be determined in future studies.', 'FAU': ['Snoeijs, Maarten G J', 'Pulinx, Bianca', 'van Dieijen-Visser, Marja P', 'Buurman, Wim A', 'van Heurn, L W Ernest', 'Wodzig, Will K W H'], 'AU': ['Snoeijs MG', 'Pulinx B', 'van Dieijen-Visser MP', 'Buurman WA', 'van Heurn LW', 'Wodzig WK'], 'AD': ['Department of Surgery, Maastricht University Medical Center, PO Box 5800, Maastricht 6202 AZ, The Netherlands. m.snoeijs@mumc.nl'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20130221', 'PL': 'England', 'TA': 'Ann Clin Biochem', 'JT': 'Annals of clinical biochemistry', 'JID': '0324055', 'RN': ['0 (Biomarkers)', '0 (Proteome)'], 'SB': 'IM', 'MH': ['Biomarkers/metabolism', 'Female', 'Humans', 'Kidney/*metabolism', '*Kidney Transplantation', 'Male', 'Middle Aged', '*Perfusion', 'Proteome/analysis/*metabolism', 'Proteomics', '*Tissue Donors', 'Tissue Preservation'], 'EDAT': '2013/02/23 06:00', 'MHDA': '2013/09/06 06:00', 'CRDT': ['2013/02/23 06:00'], 'PHST': ['2013/02/23 06:00 [entrez]', '2013/02/23 06:00 [pubmed]', '2013/09/06 06:00 [medline]'], 'AID': ['acb.2012.011144 [pii]', '10.1258/acb.2012.011144 [doi]'], 'PST': 'ppublish', 'SO': 'Ann Clin Biochem. 2013 Mar;50(Pt 2):140-6. doi: 10.1258/acb.2012.011144. Epub 2013 Feb 21.'}\n",
      "{'PMID': '23384050', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20130923', 'LR': '20181113', 'IS': '1532-4281 (Electronic) 1079-9893 (Linking)', 'VI': '33', 'IP': '2', 'DP': '2013 Apr', 'TI': 'Novel proteins associated with human dilated cardiomyopathy: selective reduction in alpha(1A)-adrenergic receptors and increased desensitization proteins.', 'PG': '96-106', 'LID': '10.3109/10799893.2013.764897 [doi]', 'AB': 'Abstract Therapeutics to treat human heart failure (HF) and the identification of proteins associated with HF are still limited. We analyzed alpha(1)-adrenergic receptor (AR) subtypes in human HF and performed proteomic analysis on more uniform samples to identify novel proteins associated with human HF. Six failing hearts with end-stage dilated cardiomyopathy (DCM) and four non-failing heart controls were subjected to proteomic analysis. Out of 48 identified proteins, 26 proteins were redundant between samples. Ten of these 26 proteins were previously reported to be associated with HF. Of the newly identified proteins, we found several muscle proteins and mitochondrial/electron transport proteins, while novel were functionally similar to previous reports. However, we also found novel proteins involved in functional classes such as beta-oxidation and G-protein coupled receptor signaling and desensitization not previously associated with HF. We also performed radioligand-binding studies on the heart samples and not only confirmed a large loss of beta(1)-ARs in end-stage DCM, but also found a selective decrease in the alpha(1A)-AR subtype not previously reported. We have identified new proteins and functional categories associated with end-stage DCM. We also report that similar to the previously characterized loss of beta(1)-AR in HF, there is also a concomitant loss of alpha(1A)-ARs, which are considered cardioprotective proteins.', 'FAU': ['Shi, Ting', 'Moravec, Christine S', 'Perez, Dianne M'], 'AU': ['Shi T', 'Moravec CS', 'Perez DM'], 'AD': ['Department of Molecular Cardiology, Lerner Research Institute, Cleveland, OH, USA.'], 'LA': ['eng'], 'GR': ['R01 HL098279/HL/NHLBI NIH HHS/United States', 'UL1 TR000439/TR/NCATS NIH HHS/United States', '1R01HL03593/HL/NHLBI NIH HHS/United States'], 'PT': ['Journal Article', 'Research Support, N.I.H., Extramural'], 'DEP': '20130206', 'PL': 'England', 'TA': 'J Recept Signal Transduct Res', 'JT': 'Journal of receptor and signal transduction research', 'JID': '9509432', 'RN': ['0 (Proteome)', '0 (Receptors, Adrenergic, alpha-1)', '0 (Receptors, G-Protein-Coupled)'], 'SB': 'IM', 'MH': ['Adult', 'Cardiomyopathy, Dilated/*metabolism/pathology/surgery', 'Heart Failure/*metabolism/pathology/surgery', 'Humans', 'Male', 'Middle Aged', 'Proteome/*analysis', 'Receptors, Adrenergic, alpha-1/*metabolism', 'Receptors, G-Protein-Coupled/metabolism', 'Signal Transduction'], 'PMC': 'PMC3624731', 'MID': ['NIHMS454409'], 'EDAT': '2013/02/07 06:00', 'MHDA': '2013/09/24 06:00', 'CRDT': ['2013/02/07 06:00'], 'PHST': ['2013/02/07 06:00 [entrez]', '2013/02/07 06:00 [pubmed]', '2013/09/24 06:00 [medline]'], 'AID': ['10.3109/10799893.2013.764897 [doi]'], 'PST': 'ppublish', 'SO': 'J Recept Signal Transduct Res. 2013 Apr;33(2):96-106. doi: 10.3109/10799893.2013.764897. Epub 2013 Feb 6.'}\n",
      "{'PMID': '23195030', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20130614', 'LR': '20151119', 'IS': '1873-3492 (Electronic) 0009-8981 (Linking)', 'VI': '416', 'DP': '2013 Feb 1', 'TI': 'Proteomic analysis of adverse outcomes in patients with acute coronary syndromes.', 'PG': '60-6', 'LID': '10.1016/j.cca.2012.11.019 [doi] S0009-8981(12)00559-1 [pii]', 'AB': 'BACKGROUND: Most biomarkers lack clinical sensitivity and specificity for predicting adverse outcomes in patients with acute coronary syndromes (ACS). We identified potential predictors through proteomic analysis. METHODS: Serum proteomic analysis was performed by surface-enhanced laser desorption/ionization protein chip technology in 409 patients with ACS. The primary endpoints were 30-day and 3-year occurrence of major adverse cardiovascular events (cardiac death, non-fatal myocardial infarction and target lesion revascularization). RESULTS: A m/z 4174.39 peak was associated with an increased incidence of 3-year events. In multivariate analysis, the m/z 4174.39 peak showed an independent correlation with 3-year (over 30-day) events (hazard ratio, 2.33; 95% confidence interval (CI), 1.23 to 4.39; P=0.009 for the fourth versus first quartile), while the creatine kinase MB fraction (CK-MB) and troponin T levels were associated with 30-day events ((ln CK-MB: hazard ratio, 1.36; 95% CI, 1.07 to 1.73; P=0.013); (ln troponin T: hazard ratio, 1.36; 95% CI, 1.12 to 1.64; P=0.002)). CONCLUSIONS: The m/z 4174.39 peak is a strong marker for predicting the long-term outcomes, and may correspond to a new biomarker, such as a member of the CXC chemokine family, and provide additional prognostic value in ACS.', 'CI': ['Copyright (c) 2012 Elsevier B.V. All rights reserved.'], 'FAU': ['Dong, Sheng-Yong', 'Sun, Xiao-Nan', 'Zeng, Qiang', 'Xu, Yang', 'Sun, Jing', 'Ma, Li-Hua'], 'AU': ['Dong SY', 'Sun XN', 'Zeng Q', 'Xu Y', 'Sun J', 'Ma LH'], 'AD': ['International Medical Center, Chinese PLA General Hospital, 28 Fuxing Road, Beijing, 100853, China.'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20121127', 'PL': 'Netherlands', 'TA': 'Clin Chim Acta', 'JT': 'Clinica chimica acta; international journal of clinical chemistry', 'JID': '1302422', 'RN': ['0 (Biomarkers)', '0 (Proteome)'], 'SB': 'IM', 'MH': ['Acute Coronary Syndrome/*genetics/metabolism/*pathology', 'Biomarkers/*blood', 'Female', 'Follow-Up Studies', 'Humans', 'Middle Aged', 'Multivariate Analysis', 'Prognosis', 'Proteome/*analysis', '*Proteomics', 'Sensitivity and Specificity'], 'EDAT': '2012/12/01 06:00', 'MHDA': '2013/06/15 06:00', 'CRDT': ['2012/12/01 06:00'], 'PHST': ['2012/09/28 00:00 [received]', '2012/11/08 00:00 [revised]', '2012/11/09 00:00 [accepted]', '2012/12/01 06:00 [entrez]', '2012/12/01 06:00 [pubmed]', '2013/06/15 06:00 [medline]'], 'AID': ['S0009-8981(12)00559-1 [pii]', '10.1016/j.cca.2012.11.019 [doi]'], 'PST': 'ppublish', 'SO': 'Clin Chim Acta. 2013 Feb 1;416:60-6. doi: 10.1016/j.cca.2012.11.019. Epub 2012 Nov 27.'}\n",
      "{'PMID': '23160667', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20130523', 'LR': '20151119', 'IS': '1791-7549 (Electronic) 0258-851X (Linking)', 'VI': '26', 'IP': '6', 'DP': '2012 Nov-Dec', 'TI': 'Proteomic profiling to identify prognostic biomarkers in heart failure.', 'PG': '875-82', 'AB': 'BACKGROUND: The ability to predict mode, as well as risk, of death in left ventricular systolic dysfunction (LVSD) is important, as the clinical and cost-effectiveness of implantable cardioverter defibrillators (ICD) therapy depends on its use in appropriately selected patient populations. The value of a proteomic approach in identifying prognostic biomarkers in LVSD is unknown. The aims of this pilot study were to use proteomic techniques to identify serum biomarkers associated with LVSD and to prospectively explore their association with prognosis. PATIENTS AND METHODS: Serum was analysed by surface-enhanced laser desorption ionisation time-of-flight mass spectrometry (SELDI-TOF MS) in patients with (n=78) and without (n=45) systolic heart failure (SHF). Spectra were compared to identify differentially expressed signal peaks as potential biomarker indicators. The ability of these peaks to predict all-cause mortality and survival with appropriate ICD therapy was then tested prospectively in patients with ICDs, on the background of LVSD (n=141). RESULTS: For the identification stage spectra (2-200 kDa) from SHF and control patients were randomly separated into two equally sized discovery and validation sets. Six protein peaks were identified that were differentially expressed in SHF in both sets. In the prospective phase, during a mean follow-up of 15+/-3 months, 11 patients died and 39 survived with appropriate ICD therapy. Five out of the six proteomic biomarkers predicted all-cause mortality but none predicted appropriate ICD therapy. CONCLUSION: These results provide proof-of-principle and are supportive of the SELDI proteomic approach as a high-throughput screening tool in identifying potentially prognostic protein peaks in patients with LVSD.', 'FAU': ['Scott, Paul A', 'Zeidan, Bashar', 'Ng, Leong L', 'Zeb, Mehmood', 'Rosengarten, James A', 'Garbis, Spiros', 'Curzen, Nick P', 'Morgan, John M', 'Townsend, Paul A'], 'AU': ['Scott PA', 'Zeidan B', 'Ng LL', 'Zeb M', 'Rosengarten JA', 'Garbis S', 'Curzen NP', 'Morgan JM', 'Townsend PA'], 'AD': ['Wessex Cardiothoracic Unit, Southampton University Hospitals NHS Trust, UK.'], 'LA': ['eng'], 'GR': ['British Heart Foundation/United Kingdom'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'PL': 'Greece', 'TA': 'In Vivo', 'JT': 'In vivo (Athens, Greece)', 'JID': '8806809', 'RN': ['0 (Biomarkers)', '0 (Proteome)'], 'SB': 'IM', 'MH': ['Biomarkers/*blood', 'Female', 'Gene Expression Profiling', 'Heart Failure/*blood', 'Humans', 'Male', 'Middle Aged', 'Pilot Projects', 'Prognosis', 'Protein Array Analysis', 'Proteome/*analysis', 'Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization', 'Ventricular Dysfunction, Left/*blood'], 'EDAT': '2012/11/20 06:00', 'MHDA': '2013/05/25 06:00', 'CRDT': ['2012/11/20 06:00'], 'PHST': ['2012/11/20 06:00 [entrez]', '2012/11/20 06:00 [pubmed]', '2013/05/25 06:00 [medline]'], 'AID': ['26/6/875 [pii]'], 'PST': 'ppublish', 'SO': 'In Vivo. 2012 Nov-Dec;26(6):875-82.'}\n",
      "{'PMID': '23002038', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20140113', 'LR': '20181113', 'IS': '1862-8354 (Electronic) 1862-8346 (Linking)', 'VI': '6', 'IP': '11-12', 'DP': '2012 Dec', 'TI': 'Autoimmunoreactive IgGs from patients with postural orthostatic tachycardia syndrome.', 'PG': '615-25', 'LID': '10.1002/prca.201200049 [doi]', 'AB': 'PURPOSE: Autoantibodies are implicated in the pathogenesis of cardiovascular diseases and cardiac arrhythmias. In this pilot study, we tested the hypothesis that autoantibodies are present in patients with postural orthostatic tachycardia syndrome (POTS). EXPERIMENTAL DESIGN: Seven control subjects (6 F:1 M, average age 36.1 years) and ten patients with the diagnosis of POTS (7 F: 3 M, average age 35.1 years) provided informed consent and 30 mL of venous blood. Human heart membrane proteins were resolved by 2DE and immunoblotted against purified IgGs from controls and patients. RESULTS: Eighteen protein spots immunoreactive specifically against patient IgGs were detected and they were excised from gels, trypsin-digested, and analyzed by nanoLC-electrospray MS/MS. Forty unique proteins were identified and these include proteins that are associated with cardiac hypertrophy (mimecan, myozenin), cardiac remodeling (periostin), cardiomyopathy (desmin, desmoplakin), cell survival (laminin), structural integrity (filamin), chaperone proteins (crystalline, HSP70), mitochondrial enzymes, and channel proteins. Ingenuity Pathway Analysis showed multiple pathways were involved including those that regulate energy metabolism, redox, fibrosis, cardiac hypertrophy, and degeneration. CONCLUSIONS AND CLINICAL RELEVANCE: Autoantibodies are present in patients with POTS. These autoantibodies cross-react with a wide range of cardiac proteins and may induce alterations in cardiac function. Autoimmune pathogenetic mechanisms should be further explored in these patients.', 'CI': ['(c) 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.'], 'FAU': ['Wang, Xiao-Li', 'Chai, Qiang', 'Charlesworth, M Cristine', 'Figueroa, Juan J', 'Low, Phillip', 'Shen, Win-Kuang', 'Lee, Hon-Chi'], 'AU': ['Wang XL', 'Chai Q', 'Charlesworth MC', 'Figueroa JJ', 'Low P', 'Shen WK', 'Lee HC'], 'AD': ['Department of Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA. wang.xiaoli@mayo.edu'], 'LA': ['eng'], 'GR': ['R56 HL074180/HL/NHLBI NIH HHS/United States', 'R01 HL080118/HL/NHLBI NIH HHS/United States', 'R01 HL074180/HL/NHLBI NIH HHS/United States', 'HL74180/HL/NHLBI NIH HHS/United States', 'HL080118/HL/NHLBI NIH HHS/United States'], 'PT': ['Journal Article', 'Research Support, N.I.H., Extramural', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20121108', 'PL': 'Germany', 'TA': 'Proteomics Clin Appl', 'JT': 'Proteomics. Clinical applications', 'JID': '101298608', 'RN': ['0 (Immunoglobulin G)', '0 (Proteome)'], 'SB': 'IM', 'MH': ['Adolescent', 'Adult', 'Case-Control Studies', 'Electrophoresis, Gel, Two-Dimensional', 'Female', 'Humans', 'Immunoblotting', 'Immunoglobulin G/*immunology', 'Male', 'Mass Spectrometry', 'Middle Aged', 'Postural Orthostatic Tachycardia Syndrome/*immunology', 'Protein Interaction Maps/immunology', 'Proteome/chemistry/metabolism', 'Young Adult'], 'PMC': 'PMC3786406', 'MID': ['NIHMS502292'], 'EDAT': '2012/09/25 06:00', 'MHDA': '2014/01/15 06:00', 'CRDT': ['2012/09/25 06:00'], 'PHST': ['2012/06/05 00:00 [received]', '2012/08/10 00:00 [revised]', '2012/08/14 00:00 [accepted]', '2012/09/25 06:00 [entrez]', '2012/09/25 06:00 [pubmed]', '2014/01/15 06:00 [medline]'], 'AID': ['10.1002/prca.201200049 [doi]'], 'PST': 'ppublish', 'SO': 'Proteomics Clin Appl. 2012 Dec;6(11-12):615-25. doi: 10.1002/prca.201200049. Epub 2012 Nov 8.'}\n",
      "{'PMID': '22959663', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20130408', 'LR': '20120926', 'IS': '1879-1484 (Electronic) 0021-9150 (Linking)', 'VI': '224', 'IP': '2', 'DP': '2012 Oct', 'TI': 'Changes in lipid transport-involved proteins of epicardial adipose tissue associated with coronary artery disease.', 'PG': '492-9', 'LID': '10.1016/j.atherosclerosis.2012.07.014 [doi] S0021-9150(12)00460-1 [pii]', 'AB': 'OBJECTIVE: Recent studies have focused on the potential role of epicardial adipose tissue (EAT) in the physiopathology of several metabolic and cardiovascular diseases, especially coronary artery disease (CAD). We aimed to study whether there are differences in the proteome and the secretome between epicardial and subcutaneous adipose tissue (SAT) from patients with and without CAD. METHODS: EAT and SAT samples were collected from 64 patients undergoing elective cardiac surgery either for coronary artery bypass grafting or valve surgery. One or two-dimensional electrophoresis were performed on tissue samples and media collected at 3, 6, 24 or 48 of tissue culture. Protein identification was performed with mass spectrometry, and the results were then validated with Western blot or enzyme immunoassay. mRNA expression levels were analysed by real time polymerase chain reaction. RESULTS: The release of several proteins was found to be higher in EAT that in SAT. Remarkably, there were higher levels of apolipoprotein A-I and glutation S-transferase P release, whereas mRNA expression of fatty acid binding protein 4 was lower in EAT. Although apolipoprotein A-I protein quantity in EAT was similar between CAD and non CAD patients, its released levels from this fat pad were lower in CAD. CONCLUSION: EAT and SAT show different profiles of protein release and a different pattern was also found in samples from patients with CAD. These findings might support the hypothesis that EAT plays an interesting role in the physiopathology of atherosclerosis and CAD.', 'CI': ['Copyright (c) 2012 Elsevier Ireland Ltd. All rights reserved.'], 'FAU': ['Salgado-Somoza, Antonio', 'Teijeira-Fernandez, Elvis', 'Fernandez, Angel Luis', 'Gonzalez-Juanatey, Jose Ramon', 'Eiras, Sonia'], 'AU': ['Salgado-Somoza A', 'Teijeira-Fernandez E', 'Fernandez AL', 'Gonzalez-Juanatey JR', 'Eiras S'], 'AD': ['Cardiovascular Division, Health Research Institute, University Clinical Hospital of Santiago de Compostela, Spain.'], 'LA': ['eng'], 'PT': ['Comparative Study', 'Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20120827', 'PL': 'Ireland', 'TA': 'Atherosclerosis', 'JT': 'Atherosclerosis', 'JID': '0242543', 'RN': ['0 (APOA1 protein, human)', '0 (Apolipoprotein A-I)', '0 (Culture Media, Conditioned)', '0 (FABP4 protein, human)', '0 (Fatty Acid-Binding Proteins)', '0 (RNA, Messenger)', 'EC 2.5.1.18 (GSTP1 protein, human)', 'EC 2.5.1.18 (Glutathione S-Transferase pi)'], 'SB': 'IM', 'MH': ['Adipose Tissue/*metabolism', 'Aged', 'Apolipoprotein A-I/genetics/metabolism', 'Biological Transport', 'Blotting, Western', 'Case-Control Studies', 'Coronary Artery Disease/genetics/*metabolism', 'Culture Media, Conditioned/metabolism', 'Electrophoresis, Gel, Two-Dimensional', 'Fatty Acid-Binding Proteins/genetics/metabolism', 'Female', 'Glutathione S-Transferase pi/genetics/metabolism', 'Humans', 'Immunoenzyme Techniques', '*Lipid Metabolism/genetics', 'Male', 'Mass Spectrometry', 'Middle Aged', 'Pericardium/*metabolism', 'Proteomics/methods', 'RNA, Messenger/metabolism', 'Real-Time Polymerase Chain Reaction', 'Reproducibility of Results', 'Reverse Transcriptase Polymerase Chain Reaction', 'Subcutaneous Fat/metabolism', 'Time Factors', 'Tissue Culture Techniques'], 'EDAT': '2012/09/11 06:00', 'MHDA': '2013/04/09 06:00', 'CRDT': ['2012/09/11 06:00'], 'PHST': ['2011/07/28 00:00 [received]', '2012/06/08 00:00 [revised]', '2012/07/01 00:00 [accepted]', '2012/09/11 06:00 [entrez]', '2012/09/11 06:00 [pubmed]', '2013/04/09 06:00 [medline]'], 'AID': ['S0021-9150(12)00460-1 [pii]', '10.1016/j.atherosclerosis.2012.07.014 [doi]'], 'PST': 'ppublish', 'SO': 'Atherosclerosis. 2012 Oct;224(2):492-9. doi: 10.1016/j.atherosclerosis.2012.07.014. Epub 2012 Aug 27.'}\n",
      "{'PMID': '22789915', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20130114', 'LR': '20181113', 'IS': '1522-9645 (Electronic) 0195-668X (Linking)', 'VI': '33', 'IP': '18', 'DP': '2012 Sep', 'TI': 'Urinary proteome analysis in hypertensive patients with left ventricular diastolic dysfunction.', 'PG': '2342-50', 'LID': '10.1093/eurheartj/ehs185 [doi]', 'AB': 'AIMS: Despite the significant heart failure (HF) burden on society, easily applicable screening techniques, particularly for the early detection of asymptomatic left ventricular (LV) dysfunction, are lacking. The present study aimed to identify and test a set of urinary polypeptides that may indicate early LV diastolic dysfunction as defined by echocardiography in hypertensive patients in a cross-sectional case-control study nested within the FLEMish study on ENvironment, Genes and Health Outcome (FLEMENGHO). METHODS AND RESULTS: To identify potentially discriminating urinary biomarkers for LV diastolic dysfunction, we applied capillary electrophoresis coupled to mass spectrometry. In the discovery set, we compared 19 hypertensive patients with asymptomatic LV diastolic dysfunction with 19 healthy controls. In the absence of adjustment for multiple testing, 85 urinary peptides were different between cases and controls at a P-value of <0.033. With adjustment for multiple testing, three potential biomarkers remained significantly different between cases and controls (P </= 0.02). We combined the 85 potential biomarkers in a high-dimensional model (classifier), which we applied in a blinded manner to an independent test set of 16 hypertensive patients with symptomatic HF and 16 healthy controls. Upon unblinding, the area under the receiver operating characteristic curve (AUC) of the HF classification was 0.84 (95% CI: 0.70-0.98; P= 0.001). CONCLUSION: In asymptomatic hypertensive patients with LV diastolic dysfunction, we identified a set of urinary polypeptides specific for essential hypertension with LV diastolic dysfunction that subsequently distinguished hypertensive patients with overt HF from healthy controls.', 'FAU': ['Kuznetsova, Tatiana', 'Mischak, Harald', 'Mullen, William', 'Staessen, Jan A'], 'AU': ['Kuznetsova T', 'Mischak H', 'Mullen W', 'Staessen JA'], 'AD': ['Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Sciences, University of Leuven, Campus Sint Rafael, Kapucijnenvoer 35, B 3000 Leuven, Belgium.'], 'LA': ['eng'], 'GR': ['294713/European Research Council/International'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20120711', 'PL': 'England', 'TA': 'Eur Heart J', 'JT': 'European heart journal', 'JID': '8006263', 'RN': ['0 (Biomarkers)', '0 (Peptides)'], 'SB': 'IM', 'MH': ['Biomarkers/urine', 'Case-Control Studies', 'Cross-Sectional Studies', 'Early Diagnosis', 'Female', 'Humans', 'Hypertension/*complications', 'Male', 'Middle Aged', 'Peptides/*urine', 'Proteomics/*methods', 'Risk Assessment', 'Ventricular Dysfunction, Left/*diagnosis/etiology'], 'PMC': 'PMC3705161', 'MID': ['EMS52458'], 'OID': ['NLM: EMS52458'], 'EDAT': '2012/07/14 06:00', 'MHDA': '2013/01/15 06:00', 'CRDT': ['2012/07/14 06:00'], 'PHST': ['2012/07/14 06:00 [entrez]', '2012/07/14 06:00 [pubmed]', '2013/01/15 06:00 [medline]'], 'AID': ['ehs185 [pii]', '10.1093/eurheartj/ehs185 [doi]'], 'PST': 'ppublish', 'SO': 'Eur Heart J. 2012 Sep;33(18):2342-50. doi: 10.1093/eurheartj/ehs185. Epub 2012 Jul 11.'}\n",
      "{'PMID': '22781565', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20130320', 'LR': '20120711', 'IS': '0376-2491 (Print) 0376-2491 (Linking)', 'VI': '92', 'IP': '14', 'DP': '2012 Apr 10', 'TI': '[Preliminary proteomic analysis of peripheral skeletal muscle atrophy in chronic obstructive pulmonary disease].', 'PG': '948-51', 'AB': 'OBJECTIVE: To conduct a preliminary proteomic study of chronic obstructive pulmonary disease (COPD) with peripheral skeletal muscle atrophy. METHODS: A total of 16 COPD patients and 8 aged-matched persons because of bone fractures were recruited in First Hospital Affiliated to Kunming Medical College from February to July in 2010. According to body mass index, fat free mass index, quadriceps femoris perimeter and quadriceps femoris active contraction, they were divided into those with muscle atrophy (group A, n = 8) and those without (group B, n = 8). There were 6 males and 2 females with an average age of (70 +/- 8) years in the group A and 5 males and 3 females with an average age of (74 +/- 8) years in the group B. And the control group had 6 males and 2 females with an average age of (72 +/- 6) years. All samples of total quadriceps protein were separated by two-dimensional gel electrophoresis. The abnormal protein points on electrophoresis were compared by PDQuest image software. And the differential protein expression was detected. Then the corresponding peptide quality fingerprint spectrum was analyzed by mass spectrometer. Finally the differential protein points were partially detected by a search of database. RESULTS: The two-dimensional gel electrophoresis yielded an excellent profile of resolution and repeatability. And 12 proteins likely to cause skeletal muscle atrophy in COPD were identified. Among them, 8 proteins belonged to structural proteins (actin alpha cardiac muscle isoform CRA_c, myosin regulatory light chain 2, ventricular/cardiac muscle isoform, myoglobin isoform myosin heavy polypeptide 7 cardiac muscle beta isoform CRA_c, actin, alpha skeletal muscle, actin alpha cardiac muscle isoform CRA_b, hemoglobin alpha 1 globin chain & myosin light chain 6B) and 4 proteins were of functional proteins (chain A, crystal structure of human enolase; troponin T, slow skeletal muscle isoform alpha, carbonate anhydrase, troponin T & slow skeletal muscle isoform b). CONCLUSIONS: COPD patients are often accompanied with obvious peripheral skeletal muscle atrophy. It may be caused by quantitative or qualitative changes of peripheral skeletal structural and functional proteins.', 'FAU': ['Guo, Wei', 'Fu, Wei-ping', 'Yang, Yu', 'Dai, Lu-ming'], 'AU': ['Guo W', 'Fu WP', 'Yang Y', 'Dai LM'], 'AD': ['Department of Respiratory Critical Care Medicine, First Affiliated Hospital, Kunming Medical College, Kunming 650032, China.'], 'LA': ['chi'], 'PT': ['English Abstract', 'Journal Article', \"Research Support, U.S. Gov't, Non-P.H.S.\"], 'PL': 'China', 'TA': 'Zhonghua Yi Xue Za Zhi', 'JT': 'Zhonghua yi xue za zhi', 'JID': '7511141', 'RN': ['0 (Muscle Proteins)', '0 (Proteome)'], 'SB': 'IM', 'MH': ['Aged', 'Female', 'Humans', 'Male', 'Muscle Proteins/*metabolism', 'Muscle, Skeletal/*metabolism', 'Muscular Atrophy/complications/*metabolism', 'Proteome/analysis', 'Proteomics', 'Pulmonary Disease, Chronic Obstructive/complications/*metabolism'], 'EDAT': '2012/07/12 06:00', 'MHDA': '2013/03/21 06:00', 'CRDT': ['2012/07/12 06:00'], 'PHST': ['2012/07/12 06:00 [entrez]', '2012/07/12 06:00 [pubmed]', '2013/03/21 06:00 [medline]'], 'PST': 'ppublish', 'SO': 'Zhonghua Yi Xue Za Zhi. 2012 Apr 10;92(14):948-51.'}\n",
      "{'PMID': '22665935', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20120926', 'LR': '20201214', 'IS': '1528-0020 (Electronic) 0006-4971 (Linking)', 'VI': '120', 'IP': '2', 'DP': '2012 Jul 12', 'TI': 'Calpain inhibition stabilizes the platelet proteome and reactivity in diabetes.', 'PG': '415-23', 'LID': '10.1182/blood-2011-12-399980 [doi]', 'AB': 'Platelets from patients with diabetes are hyperreactive and demonstrate increased adhesiveness, aggregation, degranulation, and thrombus formation, processes that contribute to the accelerated development of vascular disease. Part of the problem seems to be dysregulated platelet Ca(2+) signaling and the activation of calpains, which are Ca(2+)-activated proteases that result in the limited proteolysis of substrate proteins and subsequent alterations in signaling. In the present study, we report that the activation of mu- and m-calpain in patients with type 2 diabetes has profound effects on the platelet proteome and have identified septin-5 and the integrin-linked kinase (ILK) as novel calpain substrates. The calpain-dependent cleavage of septin-5 disturbed its association with syntaxin-4 and promoted the secretion of alpha-granule contents, including TGF-beta and CCL5. Calpain was also released by platelets and cleaved CCL5 to generate a variant with enhanced activity. Calpain activation also disrupted the ILK-PINCH-Parvin complex and altered platelet adhesion and spreading. In diabetic mice, calpain inhibition reversed the effects of diabetes on platelet protein cleavage, decreased circulating CCL5 levels, reduced platelet-leukocyte aggregate formation, and improved platelet function. The results of the present study indicate that diabetes-induced platelet dysfunction is mediated largely by calpain activation and suggest that calpain inhibition may be an effective way of preserving platelet function and eventually decelerating atherothrombosis development.', 'FAU': ['Randriamboavonjy, Voahanginirina', 'Isaak, Johann', 'Elgheznawy, Amro', 'Pistrosch, Frank', 'Fromel, Timo', 'Yin, Xiaoke', 'Badenhoop, Klaus', 'Heide, Heinrich', 'Mayr, Manuel', 'Fleming, Ingrid'], 'AU': ['Randriamboavonjy V', 'Isaak J', 'Elgheznawy A', 'Pistrosch F', 'Fromel T', 'Yin X', 'Badenhoop K', 'Heide H', 'Mayr M', 'Fleming I'], 'AD': ['Institute for Vascular Signalling, Centre for Molecular Medicine, Goethe University, Theodor-Stern-Kai 7, Frankfurt am Main, Germany.'], 'LA': ['eng'], 'GR': ['FS/08/002/24537/British Heart Foundation/United Kingdom', 'PG/10/61/28498/British Heart Foundation/United Kingdom'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20120604', 'PL': 'United States', 'TA': 'Blood', 'JT': 'Blood', 'JID': '7603509', 'RN': ['0 (Blood Proteins)', '0 (CCL5 protein, human)', '0 (Cell Cycle Proteins)', '0 (Chemokine CCL5)', '0 (Hypoglycemic Agents)', '0 (Thiazolidinediones)', 'EC 2.7.1.- (integrin-linked kinase)', 'EC 2.7.11.1 (Protein-Serine-Threonine Kinases)', 'EC 3.4.22.- (Calpain)', 'EC 3.4.22.- (m-calpain)', 'EC 3.4.22.- (mu-calpain)', 'EC 3.6.1.- (SEPTIN5 protein, human)', 'EC 3.6.1.- (Septins)', 'X4OV71U42S (Pioglitazone)'], 'SB': 'AIM IM', 'MH': ['Adult', 'Aged', 'Animals', 'Blood Platelets/drug effects/*metabolism', 'Blood Proteins/metabolism', 'Calcium Signaling', 'Calpain/*antagonists & inhibitors/*blood/deficiency/genetics', 'Case-Control Studies', 'Cell Cycle Proteins/blood', 'Chemokine CCL5/blood', 'Diabetes Mellitus, Type 2/*blood/drug therapy', 'Female', 'Humans', 'Hypoglycemic Agents/therapeutic use', 'Male', 'Mice', 'Mice, Inbred C57BL', 'Mice, Knockout', 'Middle Aged', 'Pioglitazone', 'Platelet Activation/drug effects/physiology', 'Protein-Serine-Threonine Kinases/blood', 'Proteomics', 'Septins/blood', 'Thiazolidinediones/therapeutic use'], 'EDAT': '2012/06/06 06:00', 'MHDA': '2012/09/27 06:00', 'CRDT': ['2012/06/06 06:00'], 'PHST': ['2012/06/06 06:00 [entrez]', '2012/06/06 06:00 [pubmed]', '2012/09/27 06:00 [medline]'], 'AID': ['blood-2011-12-399980 [pii]', '10.1182/blood-2011-12-399980 [doi]'], 'PST': 'ppublish', 'SO': 'Blood. 2012 Jul 12;120(2):415-23. doi: 10.1182/blood-2011-12-399980. Epub 2012 Jun 4.'}\n",
      "{'PMID': '22543060', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20121221', 'LR': '20181113', 'IS': '1535-9484 (Electronic) 1535-9476 (Linking)', 'VI': '11', 'IP': '8', 'DP': '2012 Aug', 'TI': 'Serum proteomic signature of human chagasic patients for the identification of novel potential protein biomarkers of disease.', 'PG': '435-52', 'LID': '10.1074/mcp.M112.017640 [doi]', 'AB': 'Chagas disease is initiated upon infection by Trypanosoma cruzi. Among the health consequences is a decline in heart function, and the pathophysiological mechanisms underlying this manifestation are not well understood. To explore the possible mechanisms, we employed IgY LC10 affinity chromatography in conjunction with ProteomeLab PF2D and two-dimensional gel electrophoresis to resolve the proteome signature of high and low abundance serum proteins in chagasic patients. MALDI-TOF MS/MS analysis yielded 80 and 14 differentially expressed proteins associated with cardiomyopathy of chagasic and other etiologies, respectively. The extent of oxidative stress-induced carbonyl modifications of the differentially expressed proteins (n = 26) was increased and coupled with a depression of antioxidant proteins. Functional annotation of the top networks developed by ingenuity pathway analysis of proteome database identified dysregulation of inflammation/acute phase response signaling and lipid metabolism relevant to production of prostaglandins and arachidonic acid in chagasic patients. Overlay of the major networks identified prothrombin and plasminogen at a nodal position with connectivity to proteome signature indicative of heart disease (i.e., thrombosis, angiogenesis, vasodilatation of blood vessels or the aorta, and increased permeability of blood vessel and endothelial tubes), and inflammatory responses (e.g., platelet aggregation, complement activation, and phagocyte activation and migration). The detection of cardiac proteins (myosin light chain 2 and myosin heavy chain 11) and increased levels of vinculin and plasminogen provided a comprehensive set of biomarkers of cardiac muscle injury and development of clinical Chagas disease in human patients. These results provide an impetus for biomarker validation in large cohorts of clinically characterized chagasic patients.', 'FAU': ['Wen, Jian-Jun', 'Zago, M Paola', 'Nunez, Sonia', 'Gupta, Shivali', 'Burgos, Federico Nunez', 'Garg, Nisha Jain'], 'AU': ['Wen JJ', 'Zago MP', 'Nunez S', 'Gupta S', 'Burgos FN', 'Garg NJ'], 'AD': ['Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas 77555-1070, USA.'], 'LA': ['eng'], 'GR': ['R01 HL094802/HL/NHLBI NIH HHS/United States', 'R21 HL088230/HL/NHLBI NIH HHS/United States', 'HL088230/HL/NHLBI NIH HHS/United States', 'HL094802/HL/NHLBI NIH HHS/United States'], 'PT': ['Journal Article', 'Research Support, N.I.H., Extramural'], 'DEP': '20120427', 'PL': 'United States', 'TA': 'Mol Cell Proteomics', 'JT': 'Molecular & cellular proteomics : MCP', 'JID': '101125647', 'RN': ['0 (Biomarkers)', '0 (Proteome)'], 'SB': 'IM', 'MH': ['Adolescent', 'Adult', 'Aged', 'Biomarkers/*blood/metabolism', 'Chagas Cardiomyopathy/blood/metabolism', 'Chagas Disease/*blood/metabolism', 'Electrophoresis, Gel, Two-Dimensional', 'Female', 'Humans', 'Male', 'Middle Aged', 'Protein Carbonylation', 'Proteome/*analysis/classification/metabolism', 'Proteomics/*methods', 'Signal Transduction', 'Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization', 'Young Adult'], 'PMC': 'PMC3412973', 'EDAT': '2012/05/01 06:00', 'MHDA': '2012/12/22 06:00', 'CRDT': ['2012/05/01 06:00'], 'PHST': ['2012/05/01 06:00 [entrez]', '2012/05/01 06:00 [pubmed]', '2012/12/22 06:00 [medline]'], 'AID': ['M112.017640 [pii]', '10.1074/mcp.M112.017640 [doi]'], 'PST': 'ppublish', 'SO': 'Mol Cell Proteomics. 2012 Aug;11(8):435-52. doi: 10.1074/mcp.M112.017640. Epub 2012 Apr 27.'}\n",
      "{'PMID': '22435364', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20130326', 'LR': '20181113', 'IS': '1582-4934 (Electronic) 1582-1838 (Linking)', 'VI': '16', 'IP': '10', 'DP': '2012 Oct', 'TI': 'Cardiac protein changes in ischaemic and dilated cardiomyopathy: a proteomic study of human left ventricular tissue.', 'PG': '2471-86', 'LID': '10.1111/j.1582-4934.2012.01565.x [doi]', 'AB': 'The development of heart failure (HF) is characterized by progressive alteration of left ventricle structure and function. Previous works on proteomic analysis in cardiac tissue from patients with HF remain scant. The purpose of our study was to use a proteomic approach to investigate variations in protein expression of left ventricle tissue from patients with ischaemic (ICM) and dilated cardiomyopathy (DCM). Twenty-four explanted human hearts, 12 from patients with ICM and 12 with DCM undergoing cardiac transplantation and six non-diseased donor hearts (CNT) were analysed by 2DE. Proteins of interest were identified by mass spectrometry and validated by Western blotting and immunofluorescence. We encountered 35 differentially regulated spots in the comparison CNT versus ICM, 33 in CNT versus DCM, and 34 in ICM versus DCM. We identified glyceraldehyde 3-phophate dehydrogenase up-regulation in both ICM and DCM, and alpha-crystallin B down-regulation in both ICM and DCM. Heat shock 70 protein 1 was up-regulated only in ICM. Ten of the eleven differentially regulated proteins common to both aetiologies are interconnected as a part of a same network. In summary, we have shown by proteomics analysis that HF is associated with changes in proteins involved in the cellular stress response, respiratory chain and cardiac metabolism. Although we found altered expression of eleven proteins common to both ischaemic and dilated aetiology, we also observed different proteins altered in both groups. Furthermore, we obtained that seven of these eleven proteins are involved in cell death and apoptosis processes, and therefore in HF progression.', 'CI': ['(c) 2012 The Authors Journal of Cellular and Molecular Medicine (c) 2012', 'Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd.'], 'FAU': ['Rosello-Lleti, Esther', 'Alonso, Jana', 'Cortes, Raquel', 'Almenar, Luis', 'Martinez-Dolz, Luis', 'Sanchez-Lazaro, Ignacio', 'Lago, Francisca', 'Azorin, Inmaculada', 'Juanatey, Jose R Gonzalez', 'Portoles, Manuel', 'Rivera, Miguel'], 'AU': ['Rosello-Lleti E', 'Alonso J', 'Cortes R', 'Almenar L', 'Martinez-Dolz L', 'Sanchez-Lazaro I', 'Lago F', 'Azorin I', 'Juanatey JR', 'Portoles M', 'Rivera M'], 'AD': ['Cardiocirculatory Unit, Research Center, Hospital Universitario La Fe, Valencia, Spain.'], 'LA': ['eng'], 'PT': ['Comparative Study', 'Journal Article', \"Research Support, Non-U.S. Gov't\"], 'PL': 'England', 'TA': 'J Cell Mol Med', 'JT': 'Journal of cellular and molecular medicine', 'JID': '101083777', 'RN': ['0 (HSP72 Heat-Shock Proteins)', '0 (Proteome)', '0 (alpha-Crystallin B Chain)', 'EC 1.2.1.9 (Glyceraldehyde 3-Phosphate Dehydrogenase (NADP+))'], 'SB': 'IM', 'MH': ['Adult', 'Blotting, Western', 'Cardiomyopathy, Dilated/*diagnosis/*physiopathology', 'Down-Regulation', 'Electrophoresis, Gel, Two-Dimensional', 'Female', 'Glyceraldehyde 3-Phosphate Dehydrogenase (NADP+)/genetics/metabolism', 'HSP72 Heat-Shock Proteins/genetics/metabolism', 'Heart Failure/physiopathology', 'Heart Ventricles/physiopathology', 'Humans', 'Male', 'Mass Spectrometry', 'Microscopy, Fluorescence', 'Middle Aged', 'Myocardial Ischemia/*diagnosis/*physiopathology', 'Proteome/*analysis', 'Proteomics', 'Up-Regulation', 'alpha-Crystallin B Chain/genetics/metabolism'], 'PMC': 'PMC3823441', 'EDAT': '2012/03/23 06:00', 'MHDA': '2013/03/27 06:00', 'CRDT': ['2012/03/23 06:00'], 'PHST': ['2012/03/23 06:00 [entrez]', '2012/03/23 06:00 [pubmed]', '2013/03/27 06:00 [medline]'], 'AID': ['10.1111/j.1582-4934.2012.01565.x [doi]'], 'PST': 'ppublish', 'SO': 'J Cell Mol Med. 2012 Oct;16(10):2471-86. doi: 10.1111/j.1582-4934.2012.01565.x.'}\n",
      "{'PMID': '22384053', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20120827', 'LR': '20181113', 'IS': '1932-6203 (Electronic) 1932-6203 (Linking)', 'VI': '7', 'IP': '2', 'DP': '2012', 'TI': 'DIGE proteome analysis reveals suitability of ischemic cardiac in vitro model for studying cellular response to acute ischemia and regeneration.', 'PG': 'e31669', 'LID': '10.1371/journal.pone.0031669 [doi]', 'AB': 'Proteomic analysis of myocardial tissue from patient population is suited to yield insights into cellular and molecular mechanisms taking place in cardiovascular diseases. However, it has been limited by small sized biopsies and complicated by high variances between patients. Therefore, there is a high demand for suitable model systems with the capability to simulate ischemic and cardiotoxic effects in vitro, under defined conditions. In this context, we established an in vitro ischemia/reperfusion cardiac disease model based on the contractile HL-1 cell line. To identify pathways involved in the cellular alterations induced by ischemia and thereby defining disease-specific biomarkers and potential target structures for new drug candidates we used fluorescence 2D-difference gel electrophoresis. By comparing spot density changes in ischemic and reperfusion samples we detected several protein spots that were differentially abundant. Using MALDI-TOF/TOF-MS and ESI-MS the proteins were identified and subsequently grouped by functionality. Most prominent were changes in apoptosis signalling, cell structure and energy-metabolism. Alterations were confirmed by analysis of human biopsies from patients with ischemic cardiomyopathy.With the establishment of our in vitro disease model for ischemia injury target identification via proteomic research becomes independent from rare human material and will create new possibilities in cardiac research.', 'FAU': ['Haas, Sina', 'Jahnke, Heinz-Georg', 'Moerbt, Nora', 'von Bergen, Martin', 'Aharinejad, Seyedhossein', 'Andrukhova, Olena', 'Robitzki, Andrea A'], 'AU': ['Haas S', 'Jahnke HG', 'Moerbt N', 'von Bergen M', 'Aharinejad S', 'Andrukhova O', 'Robitzki AA'], 'AD': ['Division of Molecular Biological-Biochemical Processing Technology, Center for Biotechnology and Biomedicine, Universitat Leipzig, Leipzig, Germany.'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20120222', 'PL': 'United States', 'TA': 'PLoS One', 'JT': 'PloS one', 'JID': '101285081', 'RN': ['0 (Biomarkers)', '0 (Proteome)'], 'SB': 'IM', 'MH': ['Adult', 'Apoptosis', 'Biomarkers/metabolism', 'Biopsy', 'Cardiomyopathies/pathology', 'Cytosol/metabolism', 'Electrophoresis, Gel, Two-Dimensional', 'Female', 'Gene Expression Profiling', 'Gene Expression Regulation', 'Heart/physiology', 'Humans', 'Male', 'Middle Aged', 'Myocardial Ischemia/*pathology', 'Myocytes, Cardiac/cytology', 'Proteome/*analysis', 'Proteomics/*methods', 'Regeneration', 'Spectrometry, Mass, Electrospray Ionization/methods', 'Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization/methods'], 'PMC': 'PMC3285183', 'EDAT': '2012/03/03 06:00', 'MHDA': '2012/08/28 06:00', 'CRDT': ['2012/03/03 06:00'], 'PHST': ['2011/07/18 00:00 [received]', '2012/01/11 00:00 [accepted]', '2012/03/03 06:00 [entrez]', '2012/03/03 06:00 [pubmed]', '2012/08/28 06:00 [medline]'], 'AID': ['10.1371/journal.pone.0031669 [doi]', 'PONE-D-11-14282 [pii]'], 'PST': 'ppublish', 'SO': 'PLoS One. 2012;7(2):e31669. doi: 10.1371/journal.pone.0031669. Epub 2012 Feb 22.'}\n",
      "{'PMID': '22276806', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20120709', 'LR': '20120302', 'IS': '1535-3907 (Electronic) 1535-3893 (Linking)', 'VI': '11', 'IP': '3', 'DP': '2012 Mar 2', 'TI': 'Proteomic profile of human aortic stenosis: insights into the degenerative process.', 'PG': '1537-50', 'LID': '10.1021/pr2005692 [doi]', 'AB': 'Degenerative aortic stenosis is the most common worldwide cause of valve replacement. While it shares certain risk factors with coronary artery disease, it is not delayed or reversed by reducing exposure to risk factors (e.g., therapies that lower lipids). Therefore, it is necessary to better understand its pathophysiology for preventive measures to be taken. In this work, aortic valve samples were collected from 20 patients that underwent aortic valve replacement (55% males, mean age of 74 years) and 20 normal control valves were obtained from necropsies (40% males, mean age of 69 years). The proteome of the samples was analyzed by quantitative differential electrophoresis (2D-DIGE) and mass spectrometry, and 35 protein species were clearly increased in aortic valves, including apolipoprotein AI, alpha-1-antitrypsin, serum albumin, lumican, alfa-1-glycoprotein, vimentin, superoxide dismutase Cu-Zn, serum amyloid P-component, glutathione S-transferase-P, fatty acid-binding protein, transthyretin, and fibrinogen gamma. By contrast, 8 protein species were decreased (transgelin, haptoglobin, glutathione peroxidase 3, HSP27, and calreticulin). All of the proteins identified play a significant role in cardiovascular processes, such as fibrosis, homeostasis, and coagulation. The significant changes observed in the abundance of key cardiovascular proteins strongly suggest that they can be involved in the pathogenesis of degenerative aortic stenosis. Further studies are warranted to better understand this process before we can attempt to modulate it.', 'FAU': ['Martin-Rojas, Tatiana', 'Gil-Dones, Felix', 'Lopez-Almodovar, Luis F', 'Padial, Luis R', 'Vivanco, Fernando', 'Barderas, Maria G'], 'AU': ['Martin-Rojas T', 'Gil-Dones F', 'Lopez-Almodovar LF', 'Padial LR', 'Vivanco F', 'Barderas MG'], 'AD': ['Department of Vascular Physiopathology, Hospital Nacional de Paraplejicos (HNP), SESCAM, Toledo, Spain.'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20120216', 'PL': 'United States', 'TA': 'J Proteome Res', 'JT': 'Journal of proteome research', 'JID': '101128775', 'RN': ['0 (Cytoskeletal Proteins)', '0 (Inflammation Mediators)', '0 (Proteome)'], 'SB': 'IM', 'MH': ['Adult', 'Aged', 'Aged, 80 and over', 'Aortic Valve Stenosis/enzymology/*metabolism/pathology', 'Blotting, Western', 'Case-Control Studies', 'Cytoskeletal Proteins/metabolism', 'Female', 'Heart Valves/enzymology/*metabolism/pathology', 'Humans', 'Inflammation Mediators/metabolism', 'Male', 'Middle Aged', 'Multivariate Analysis', 'Principal Component Analysis', 'Proteome/*metabolism', 'Proteomics', 'Two-Dimensional Difference Gel Electrophoresis'], 'EDAT': '2012/01/27 06:00', 'MHDA': '2012/07/10 06:00', 'CRDT': ['2012/01/27 06:00'], 'PHST': ['2012/01/27 06:00 [entrez]', '2012/01/27 06:00 [pubmed]', '2012/07/10 06:00 [medline]'], 'AID': ['10.1021/pr2005692 [doi]'], 'PST': 'ppublish', 'SO': 'J Proteome Res. 2012 Mar 2;11(3):1537-50. doi: 10.1021/pr2005692. Epub 2012 Feb 16.'}\n",
      "{'PMID': '22221959', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20120518', 'LR': '20181113', 'IS': '1479-5876 (Electronic) 1479-5876 (Linking)', 'VI': '10', 'DP': '2012 Jan 5', 'TI': 'Identification and proteomic profiling of exosomes in human cerebrospinal fluid.', 'PG': '5', 'LID': '10.1186/1479-5876-10-5 [doi]', 'AB': \"BACKGROUND: Exosomes are released from multiple cell types, contain protein and RNA species, and have been exploited as a novel reservoir for disease biomarker discovery. They can transfer information between cells and may cause pathology, for example, a role for exosomes has been proposed in the pathophysiology of Alzheimer's disease. Although studied in several biofluids, exosomes have not been extensively studied in the cerebrospinal fluid (CSF) from humans. The objective of this study was to determine: 1) whether human CSF contains exosomes and 2) the variability in exosomal protein content across individuals. METHODS: CSF was collected from 5 study participants undergoing thoraco-abdominal aortic aneurysm repair (around 200 - 500 ml per participant) and low-density membrane vesicles were concentrated by ultracentrifugation. The presence of exosomes was determined by western blot for marker proteins, isopycnic centrifugation on a sucrose step gradient and transmission electron microscopy with immuno-labelling. Whole protein profiling was performed using Fourier transform ion cyclotron resonance mass spectrometry (FT-ICR). RESULTS: Flotillin 1 and tumor susceptibility gene 101 (TSG101), two exosomal marker proteins, were identified in the ultracentrifugation pellet using western blot. These markers localized to a density consistent with exosomes following isopycnic centrifugation. Transmission electron microscopy visualized structures consistent with exosomes in size and appearance that labelled positive for flotillin 1. Therefore, the pellet that resulted from ultracentrifugation of human CSF contained exosomes. FT-ICR profiling of this pellet was performed and 84-161 ions were detected per study participant. Around one third of these ions were only present in a single study participant and one third were detected in all five. With regard to ion quantity, the median coefficient of variation was 81% for ions detected in two or more samples. CONCLUSIONS: Exosomes were identified in human CSF and their proteome is a potential new reservoir for biomarker discovery in neurological disorders such as Alzheimer's disease. However, techniques used to concentrate exosomes from CSF need refinement to reduce variability. In this study we used relatively large starting volumes of human CSF, future studies will focus on exosome isolation from smaller 'real life' clinical samples; a key challenge in the development of exosomes as translational tools.\", 'FAU': ['Street, Jonathan M', 'Barran, Perdita E', 'Mackay, C Logan', 'Weidt, Stefan', 'Balmforth, Craig', 'Walsh, Tim S', 'Chalmers, Rod T A', 'Webb, David J', 'Dear, James W'], 'AU': ['Street JM', 'Barran PE', 'Mackay CL', 'Weidt S', 'Balmforth C', 'Walsh TS', 'Chalmers RT', 'Webb DJ', 'Dear JW'], 'AD': [\"University/British Heart Foundation Centre for Cardiovascular Science, Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, UK.\"], 'LA': ['eng'], 'GR': ['British Heart Foundation/United Kingdom', 'Biotechnology and Biological Sciences Research Council/United Kingdom'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20120105', 'PL': 'England', 'TA': 'J Transl Med', 'JT': 'Journal of translational medicine', 'JID': '101190741', 'RN': ['0 (Ions)'], 'SB': 'IM', 'MH': ['Aged', 'Cerebrospinal Fluid/*metabolism', 'Cyclotrons', 'Demography', 'Exosomes/*metabolism/ultrastructure', 'Fourier Analysis', 'Humans', 'Ions', 'Male', 'Mass Spectrometry', 'Proteomics/*methods', 'Ultracentrifugation'], 'PMC': 'PMC3275480', 'EDAT': '2012/01/10 06:00', 'MHDA': '2012/05/19 06:00', 'CRDT': ['2012/01/07 06:00'], 'PHST': ['2011/09/09 00:00 [received]', '2012/01/05 00:00 [accepted]', '2012/01/07 06:00 [entrez]', '2012/01/10 06:00 [pubmed]', '2012/05/19 06:00 [medline]'], 'AID': ['1479-5876-10-5 [pii]', '10.1186/1479-5876-10-5 [doi]'], 'PST': 'epublish', 'SO': 'J Transl Med. 2012 Jan 5;10:5. doi: 10.1186/1479-5876-10-5.'}\n",
      "{'PMID': '21767674', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20120322', 'LR': '20160518', 'IS': '1876-7737 (Electronic) 1874-3919 (Linking)', 'VI': '75', 'IP': '1', 'DP': '2011 Dec 10', 'TI': 'Proteomic analysis of plasma samples from patients with acute myocardial infarction identifies haptoglobin as a potential prognostic biomarker.', 'PG': '229-36', 'LID': '10.1016/j.jprot.2011.06.028 [doi]', 'AB': 'Prognosis of clinical outcome following myocardial infarction is variable and difficult to predict. We have analyzed the plasma proteome of thirty patients with acute myocardial infarction to search for new prognostic biomarkers. Proteomic analyses of blood samples were performed by 2-D-DiGE after plasma depletion of albumin and immunoglobulins G. New York Heart Association (NYHA) class determined at 1-year follow-up was used to identify patients with heart failure. Principal component analysis and hierarchical clustering of proteomic data revealed that patients could be separated into 3 groups. The 22 differentially expressed proteins involved in this grouping were identified as haptoglobin (Hp) and respective isoforms. The 3 groups of patients had distinct Hp isoforms: patients from group 1 had the alpha1-alpha1, patients from group 2 the alpha2-alpha1, and patients from group 3 the alpha2-alpha2 genotype. This classification was also associated with different total plasma levels of Hp. The presence of the alpha2 genotype and low plasma levels of Hp was associated with a higher NYHA class and therefore with a detrimental functional outcome after myocardial infarction. A plasma level of Hp below 1.4g/L predicted the occurrence of heart failure (NYHA 2, 3, 4) at 1-year with 100% sensitivity.', 'CI': ['Copyright (c) 2011 Elsevier B.V. All rights reserved.'], 'FAU': ['Haas, Benjamin', 'Serchi, Tommaso', 'Wagner, Daniel R', 'Gilson, Georges', 'Planchon, Sebastien', 'Renaut, Jenny', 'Hoffmann, Lucien', 'Bohn, Torsten', 'Devaux, Yvan'], 'AU': ['Haas B', 'Serchi T', 'Wagner DR', 'Gilson G', 'Planchon S', 'Renaut J', 'Hoffmann L', 'Bohn T', 'Devaux Y'], 'AD': ['Laboratory of Cardiovascular Research, Centre de Recherche Public-Sante, Luxembourg, Luxembourg.'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20110713', 'PL': 'Netherlands', 'TA': 'J Proteomics', 'JT': 'Journal of proteomics', 'JID': '101475056', 'RN': ['0 (Biomarkers)', '0 (Haptoglobins)', '0 (Protein Isoforms)'], 'SB': 'IM', 'MH': ['Acute Disease', 'Biomarkers/*analysis/blood', 'Haptoglobins/*analysis/genetics/metabolism', 'Heart Failure/metabolism/pathology', 'Humans', 'Male', 'Middle Aged', 'Myocardial Infarction/metabolism/*pathology', 'Prognosis', 'Protein Isoforms/analysis/genetics/metabolism', 'Proteomics/*methods'], 'EDAT': '2011/07/20 06:00', 'MHDA': '2012/03/23 06:00', 'CRDT': ['2011/07/20 06:00'], 'PHST': ['2011/03/24 00:00 [received]', '2011/06/09 00:00 [revised]', '2011/06/27 00:00 [accepted]', '2011/07/20 06:00 [entrez]', '2011/07/20 06:00 [pubmed]', '2012/03/23 06:00 [medline]'], 'AID': ['S1874-3919(11)00285-5 [pii]', '10.1016/j.jprot.2011.06.028 [doi]'], 'PST': 'ppublish', 'SO': 'J Proteomics. 2011 Dec 10;75(1):229-36. doi: 10.1016/j.jprot.2011.06.028. Epub 2011 Jul 13.'}\n",
      "{'PMID': '21751358', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20111121', 'LR': '20151119', 'IS': '1615-9861 (Electronic) 1615-9853 (Linking)', 'VI': '11', 'IP': '16', 'DP': '2011 Aug', 'TI': 'Proteomic changes related to \"bewildered\" circulating platelets in the acute coronary syndrome.', 'PG': '3335-48', 'LID': '10.1002/pmic.201000708 [doi]', 'AB': 'Acute coronary syndromes (ACS) are associated with platelet activation. The aim of the present study was to study the protein expression level associated with glycolysis, oxidative stress, cytoskeleton and cell survival in platelets obtained during an ACS. Platelets from 42 coronary ischemic patients, divided into patients admitted within 24 h after the onset of chest pain (ACS group; n=16) and patients with stable coronary ischemic disease (CAD, n=26), were analyzed using proteomics. The expression levels of proteins involved in cellular cytoskeleton (F-actin capping, beta-tubulin, alpha-tubulin isotypes 1 and 2, vinculin, vimentin and two Ras-related protein Rab-7b isotypes), glycolysis pathway (glyceraldehyde-3-phosphate dehydrogenase, lactate dehydrogenase and two pyruvate kinase isotypes) and cellular-related antioxidant system (manganese superoxide dismutase) and even the expression and activity of glutathione-S-transferase were significantly reduced in platelets from ACS patients compared to CAD patients. Moreover, reduction in the expression of proteins associated with cell survival such as proteasome subunit beta type 1 was also observed in ACS platelets compared with CAD platelets. Principal component and logistic regression analysis suggested the existence of factors (proteins) expressed in the platelets inversely associated with acute coronary ischemia. In summary, these results suggest the existence of circulating antioxidant, cytoskeleton and glycolytic-\"bewildered\" platelets during the acute phase of a coronary event.', 'CI': ['Copyright (c) 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.'], 'FAU': ['Lopez-Farre, Antonio J', 'Zamorano-Leon, Jose J', 'Azcona, Luis', 'Modrego, Javier', 'Mateos-Caceres, Petra J', 'Gonzalez-Armengol, Juan', 'Villarroel, Pedro', 'Moreno-Herrero, Rosario', 'Rodriguez-Sierra, Pablo', 'Segura, Antonio', 'Tamargo, Juan', 'Macaya, Carlos'], 'AU': ['Lopez-Farre AJ', 'Zamorano-Leon JJ', 'Azcona L', 'Modrego J', 'Mateos-Caceres PJ', 'Gonzalez-Armengol J', 'Villarroel P', 'Moreno-Herrero R', 'Rodriguez-Sierra P', 'Segura A', 'Tamargo J', 'Macaya C'], 'AD': ['Cardiovascular Research Unit, Cardiology Department, Hospital Clinico San Carlos, Madrid, Spain.'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20110714', 'PL': 'Germany', 'TA': 'Proteomics', 'JT': 'Proteomics', 'JID': '101092707', 'RN': ['0 (Biomarkers)', '0 (Blood Proteins)', '0 (Cytoskeletal Proteins)', '0 (Proteome)'], 'SB': 'IM', 'MH': ['Acute Coronary Syndrome/blood/*metabolism', 'Aged', 'Amino Acid Sequence', 'Biomarkers/blood/metabolism', 'Blood Platelets/chemistry/*metabolism', 'Blood Proteins/*metabolism', 'Cell Survival/physiology', 'Cytoskeletal Proteins/metabolism', 'Electrophoresis, Gel, Two-Dimensional', 'Female', 'Flow Cytometry', 'Glycolysis', 'Humans', 'Male', 'Middle Aged', 'Molecular Sequence Data', 'Myocardium/metabolism', 'Oxidative Stress', 'Platelet Activation', 'Principal Component Analysis', 'Proteome/*metabolism', 'Proteomics/*methods', 'Statistics, Nonparametric', 'Tandem Mass Spectrometry'], 'EDAT': '2011/07/14 06:00', 'MHDA': '2011/12/13 00:00', 'CRDT': ['2011/07/14 06:00'], 'PHST': ['2010/11/03 00:00 [received]', '2011/05/09 00:00 [revised]', '2011/05/12 00:00 [accepted]', '2011/07/14 06:00 [entrez]', '2011/07/14 06:00 [pubmed]', '2011/12/13 00:00 [medline]'], 'AID': ['10.1002/pmic.201000708 [doi]'], 'PST': 'ppublish', 'SO': 'Proteomics. 2011 Aug;11(16):3335-48. doi: 10.1002/pmic.201000708. Epub 2011 Jul 14.'}\n",
      "{'PMID': '21736391', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20120103', 'LR': '20181113', 'IS': '1535-3907 (Electronic) 1535-3893 (Linking)', 'VI': '10', 'IP': '8', 'DP': '2011 Aug 5', 'TI': 'Development of a novel proteomic approach for mitochondrial proteomics from cardiac tissue from patients with atrial fibrillation.', 'PG': '3484-92', 'LID': '10.1021/pr200108m [doi]', 'AB': 'Atrial fibrillation (AF) is the most common cardiac arrhythmia affecting approximately 2.2 million Americans. Because several studies have suggested that changes in mitochondrial function and morphology may contribute to AF, we developed a novel proteomic workflow focused on the identification of differentially expressed mitochondrial proteins in AF patients. Right human atrial tissue was collected from 20 patients, 10 with and 10 without AF, and the tissue was subjected to hydrostatic pressure cycling-based lysis followed by label-free mass spectrometric (MS) analysis of mitochondrial enriched isolates. Approximately 5% of the 700 proteins identified by MS analysis were differentially expressed between the AF and non-AF samples. We chose four differentially abundant proteins for further verification using reverse phase protein microarray analysis based on their known importance in energy production and regulatory association with atrial ion channels: four and a half LIM, destrin, heat shock protein 2, and chaperonin-containing TCP1. These initial study results provide evidence that a workflow to identify AF-related proteins that combines a powerful upfront tissue cell lysis with high resolution MS for discovery and protein array technology for verification may be an effective strategy for discovering candidate markers in highly fibrous tissue samples.', 'FAU': ['Goudarzi, Maryam', 'Ross, Mark M', 'Zhou, Weidong', 'Van Meter, Amy', 'Deng, Jianghong', 'Martin, Lisa M', 'Martin, Chidima', 'Liotta, Lance', 'Petricoin, Emanuel', 'Ad, Niv'], 'AU': ['Goudarzi M', 'Ross MM', 'Zhou W', 'Van Meter A', 'Deng J', 'Martin LM', 'Martin C', 'Liotta L', 'Petricoin E', 'Ad N'], 'AD': ['Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, Virginia, USA.'], 'LA': ['eng'], 'GR': ['R21 CA125698/CA/NCI NIH HHS/United States', 'R21 CA137706/CA/NCI NIH HHS/United States', 'R21 EY018942/EY/NEI NIH HHS/United States', 'R33 CA157403/CA/NCI NIH HHS/United States'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20110708', 'PL': 'United States', 'TA': 'J Proteome Res', 'JT': 'Journal of proteome research', 'JID': '101128775', 'RN': ['0 (Muscle Proteins)'], 'SB': 'IM', 'MH': ['Aged', 'Atrial Fibrillation/*metabolism', 'Female', 'Humans', 'Male', 'Mass Spectrometry', 'Middle Aged', 'Mitochondria, Heart/*metabolism', 'Muscle Proteins/*metabolism', '*Proteomics'], 'PMC': 'PMC5564307', 'MID': ['NIHMS891829'], 'EDAT': '2011/07/09 06:00', 'MHDA': '2012/01/04 06:00', 'CRDT': ['2011/07/09 06:00'], 'PHST': ['2011/07/09 06:00 [entrez]', '2011/07/09 06:00 [pubmed]', '2012/01/04 06:00 [medline]'], 'AID': ['10.1021/pr200108m [doi]'], 'PST': 'ppublish', 'SO': 'J Proteome Res. 2011 Aug 5;10(8):3484-92. doi: 10.1021/pr200108m. Epub 2011 Jul 8.'}\n",
      "{'PMID': '21712045', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20120515', 'LR': '20120123', 'IS': '1095-8584 (Electronic) 0022-2828 (Linking)', 'VI': '52', 'IP': '2', 'DP': '2012 Feb', 'TI': 'Reorganized PKA-AKAP associations in the failing human heart.', 'PG': '511-8', 'LID': '10.1016/j.yjmcc.2011.06.003 [doi]', 'AB': 'Here we reveal that the characterization of large-scale re-arrangements of signaling scaffolds induced by heart failure can serve as a novel concept to identify more specific therapeutic targets. In the mammalian heart, the cAMP pathway, with the cAMP-dependent protein kinase (PKA) in a central role, acts directly downstream of adrenergic receptors to mediate cardiac contractility and rhythm. Heart failure, characterized by severe alterations in adrenergic stimulation is, amongst other interventions, often treated with beta-blockers. Contrasting results, however, have shown both beneficial and detrimental effects of decreased cAMP levels in failing hearts. We hypothesize that the origin of this behavior lies in the complex spatiotemporal organization of the regulatory subunit of PKA (PKA-R), which associates tightly with various A-kinase anchoring proteins (AKAPs) to specifically localize PKA\\'s activity. Using chemical proteomics directly applied to human patient and control heart tissue we demonstrate that the association profile of PKA-R with several AKAPs is severely altered in the failing heart, for instance effecting the interaction between PKA and the novel AKAP SPHKAP was 6-fold upregulated upon failing heart conditions. Also a significant increase in captured cGMP-dependent protein kinase (PKG) and phosphodiesterase 2 (PDE2) was observed. The observed altered profiles can already explain many aspects of the aberrant cAMP-response in the failing human heart, validating that this dataset may provide a resource for several novel, more specific, treatment options. This article is part of a Special Issue entitled \"Local Signaling in Myocytes\".', 'CI': ['Copyright (c) 2011 Elsevier Ltd. All rights reserved.'], 'FAU': ['Aye, Thin-Thin', 'Soni, Siddarth', 'van Veen, Toon A B', 'van der Heyden, Marcel A G', 'Cappadona, Salvatore', 'Varro, Andras', 'de Weger, Roel A', 'de Jonge, Nicolaas', 'Vos, Marc A', 'Heck, Albert J R', 'Scholten, Arjen'], 'AU': ['Aye TT', 'Soni S', 'van Veen TA', 'van der Heyden MA', 'Cappadona S', 'Varro A', 'de Weger RA', 'de Jonge N', 'Vos MA', 'Heck AJ', 'Scholten A'], 'AD': ['Biomolecular Mass Spectrometry and Proteomics Group, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Padualaan 8, 3584 CH, Utrecht, The Netherlands.'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20110612', 'PL': 'England', 'TA': 'J Mol Cell Cardiol', 'JT': 'Journal of molecular and cellular cardiology', 'JID': '0262322', 'RN': ['0 (A Kinase Anchor Proteins)', '0 (Proteome)', 'EC 2.7.11.11 (Cyclic AMP-Dependent Protein Kinases)'], 'SB': 'IM', 'MH': ['A Kinase Anchor Proteins/*metabolism', 'Adult', 'Aged', 'Cyclic AMP-Dependent Protein Kinases/*metabolism', 'Female', 'Heart Failure/*metabolism', 'Humans', 'Male', 'Middle Aged', 'Myocardium/metabolism', 'Myofibrils/metabolism', 'Protein Binding', 'Protein Interaction Mapping', 'Proteome/metabolism', 'Signal Transduction', 'Young Adult'], 'EDAT': '2011/06/30 06:00', 'MHDA': '2012/05/16 06:00', 'CRDT': ['2011/06/30 06:00'], 'PHST': ['2011/03/28 00:00 [received]', '2011/05/20 00:00 [revised]', '2011/06/02 00:00 [accepted]', '2011/06/30 06:00 [entrez]', '2011/06/30 06:00 [pubmed]', '2012/05/16 06:00 [medline]'], 'AID': ['S0022-2828(11)00223-9 [pii]', '10.1016/j.yjmcc.2011.06.003 [doi]'], 'PST': 'ppublish', 'SO': 'J Mol Cell Cardiol. 2012 Feb;52(2):511-8. doi: 10.1016/j.yjmcc.2011.06.003. Epub 2011 Jun 12.'}\n",
      "{'PMID': '21681990', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20111025', 'LR': '20181113', 'IS': '1615-9861 (Electronic) 1615-9853 (Linking)', 'VI': '11', 'IP': '14', 'DP': '2011 Jul', 'TI': 'Discovery of biomarker candidates for coronary artery disease from an APOE-knock out mouse model using iTRAQ-based multiplex quantitative proteomics.', 'PG': '2763-76', 'LID': '10.1002/pmic.201000202 [doi]', 'AB': \"Due to the lack of precise markers indicative of its occurrence and progression, coronary artery disease (CAD), the most common type of heart diseases, is currently associated with high mortality in the United States. To systemically identify novel protein biomarkers associated with CAD progression for early diagnosis and possible therapeutic intervention, we employed an iTRAQ-based quantitative proteomic approach to analyze the proteome changes in the plasma collected from a pair of wild-type versus apolipoprotein E knockout (APOE(-/-) ) mice which were fed with a high fat diet. In a multiplex manner, iTRAQ serves as the quantitative 'in-spectra' marker for 'cross-sample' comparisons to determine the differentially expressed/secreted proteins caused by APOE knock-out. To obtain the most comprehensive proteomic data sets from this CAD-associated mouse model, we applied both MALDI and ESI-based mass spectrometric (MS) platforms coupled with two different schemes of multidimensional liquid chromatography (2-D LC) separation. We then comparatively analyzed a series of the plasma samples collected at 6 and 12 wk of age after the mice were fed with fat diets, where the 6- or 12-wk time point represents the early or intermediate phase of the fat-induced CAD, respectively. We then categorized those proteins showing abundance changes in accordance with APOE depletion. Several proteins such as the gamma and beta chains of fibrinogen, apolipoprotein B, apolipoprotein C-I, and thrombospondin-4 were among the previously known CAD markers identified by other methods. Our results suggested that these unbiased proteomic methods are both feasible and a practical means of discovering potential biomarkers associated with CAD progression.\", 'CI': ['Copyright (c) 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.'], 'FAU': ['Jing, Linhong', 'Parker, Carol E', 'Seo, David', 'Hines, Maria Warren', 'Dicheva, Nedyalka', 'Yu, Yanbao', 'Schwinn, Debra', 'Ginsburg, Geoffrey S', 'Chen, Xian'], 'AU': ['Jing L', 'Parker CE', 'Seo D', 'Hines MW', 'Dicheva N', 'Yu Y', 'Schwinn D', 'Ginsburg GS', 'Chen X'], 'AD': ['Program of Molecular Biology and Biotechnology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.'], 'LA': ['eng'], 'GR': ['R01 AI064806/AI/NIAID NIH HHS/United States', '1R01AI064806/AI/NIAID NIH HHS/United States'], 'PT': ['Journal Article', 'Research Support, N.I.H., Extramural', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20110617', 'PL': 'Germany', 'TA': 'Proteomics', 'JT': 'Proteomics', 'JID': '101092707', 'RN': ['0 (Apolipoproteins E)', '0 (Biomarkers)'], 'SB': 'IM', 'MH': ['Adult', 'Animals', 'Apolipoproteins E/*genetics', 'Biomarkers/*blood/chemistry', 'Chromatography, Liquid/methods', 'Coronary Artery Disease/*blood/diagnosis', 'Disease Progression', 'Female', 'Humans', 'Male', 'Mice', 'Mice, Inbred C57BL', '*Mice, Knockout', 'Proteomics/*methods', 'Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization/methods'], 'PMC': 'PMC4360897', 'MID': ['NIHMS401185'], 'EDAT': '2011/06/18 06:00', 'MHDA': '2011/10/26 06:00', 'CRDT': ['2011/06/18 06:00'], 'PHST': ['2010/03/29 00:00 [received]', '2011/01/20 00:00 [revised]', '2011/02/21 00:00 [accepted]', '2011/06/18 06:00 [entrez]', '2011/06/18 06:00 [pubmed]', '2011/10/26 06:00 [medline]'], 'AID': ['10.1002/pmic.201000202 [doi]'], 'PST': 'ppublish', 'SO': 'Proteomics. 2011 Jul;11(14):2763-76. doi: 10.1002/pmic.201000202. Epub 2011 Jun 17.'}\n",
      "{'PMID': '21593211', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20120529', 'LR': '20191008', 'IS': '1535-9484 (Electronic) 1535-9476 (Linking)', 'VI': '10', 'IP': '8', 'DP': '2011 Aug', 'TI': 'Extracellular matrix composition and remodeling in human abdominal aortic aneurysms: a proteomics approach.', 'PG': 'M111.008128', 'LID': '10.1074/mcp.M111.008128 [doi]', 'AB': 'Abdominal aortic aneurysms (AAA) are characterized by pathological remodeling of the aortic extracellular matrix (ECM). However, besides the well-characterized elastolysis and collagenolysis little is known about changes in other ECM proteins. Previous proteomics studies on AAA focused on cellular changes without emphasis on the ECM. In the present study, ECM proteins and their degradation products were selectively extracted from aneurysmal and control aortas using a solubility-based subfractionation methodology and analyzed by gel-liquid chromatography-tandem MS and label-free quantitation. The proteomics analysis revealed novel changes in the ECM of AAA, including increased expression as well as degradation of collagen XII, thrombospondin 2, aortic carboxypeptidase-like protein, periostin, fibronectin and tenascin. Proteomics also confirmed the accumulation of macrophage metalloelastase (MMP-12). Incubation of control aortic tissue with recombinant MMP-12 resulted in the extensive fragmentation of these glycoproteins, most of which are novel substrates of MMP-12. In conclusion, our proteomics methodology allowed the first detailed analysis of the ECM in AAA and identified markers of pathological ECM remodeling related to MMP-12 activity.', 'FAU': ['Didangelos, Athanasios', 'Yin, Xiaoke', 'Mandal, Kaushik', 'Saje, Angelika', 'Smith, Alberto', 'Xu, Qingbo', 'Jahangiri, Marjan', 'Mayr, Manuel'], 'AU': ['Didangelos A', 'Yin X', 'Mandal K', 'Saje A', 'Smith A', 'Xu Q', 'Jahangiri M', 'Mayr M'], 'AD': [\"King's British Heart Foundation Centre, King's College London, London, UK.\"], 'LA': ['eng'], 'GR': ['FS/08/002/24537/British Heart Foundation/United Kingdom'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20110518', 'PL': 'United States', 'TA': 'Mol Cell Proteomics', 'JT': 'Molecular & cellular proteomics : MCP', 'JID': '101125647', 'RN': ['0 (AEBP1 protein, human)', '0 (Extracellular Matrix Proteins)', '0 (Glycoproteins)', '0 (Inflammation Mediators)', '0 (Proteome)', '0 (Repressor Proteins)', 'EC 3.4.- (Carboxypeptidases)', 'EC 3.4.24.65 (MMP12 protein, human)', 'EC 3.4.24.65 (Matrix Metalloproteinase 12)', 'JU58VJ6Y3B (Guanidine)'], 'SB': 'IM', 'MH': ['Adult', 'Aged', 'Aorta, Abdominal/pathology/*physiopathology', 'Aortic Aneurysm, Abdominal/*metabolism', 'Carboxypeptidases/metabolism', 'Case-Control Studies', 'Chemical Fractionation', 'Cluster Analysis', 'Extracellular Matrix Proteins/chemistry/isolation & purification/*metabolism', 'Female', 'Glycoproteins/chemistry/isolation & purification/metabolism', 'Guanidine/chemistry', 'Humans', 'Inflammation Mediators/chemistry/isolation & purification/metabolism', 'Male', 'Matrix Metalloproteinase 12/metabolism', 'Middle Aged', 'Proteome/chemistry/isolation & purification/*metabolism', 'Proteomics', 'Repressor Proteins/metabolism', 'Solubility', 'Young Adult'], 'PMC': 'PMC3149094', 'EDAT': '2011/05/20 06:00', 'MHDA': '2012/05/30 06:00', 'CRDT': ['2011/05/20 06:00'], 'PHST': ['2011/05/20 06:00 [entrez]', '2011/05/20 06:00 [pubmed]', '2012/05/30 06:00 [medline]'], 'AID': ['M111.008128 [pii]', '10.1074/mcp.M111.008128 [doi]'], 'PST': 'ppublish', 'SO': 'Mol Cell Proteomics. 2011 Aug;10(8):M111.008128. doi: 10.1074/mcp.M111.008128. Epub 2011 May 18.'}\n",
      "{'PMID': '21545686', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20120608', 'LR': '20181113', 'IS': '1582-4934 (Electronic) 1582-1838 (Linking)', 'VI': '16', 'IP': '1', 'DP': '2012 Jan', 'TI': 'Proteomic analysis of metabolic, cytoskeletal and stress response proteins in human heart failure.', 'PG': '59-71', 'LID': '10.1111/j.1582-4934.2011.01336.x [doi]', 'AB': 'Human heart failure is a complex syndrome and a primary cause of morbidity and mortality in the world. However, the molecular pathways involved in the remodelling process are poorly understood. In this study, we performed exhaustive global proteomic surveys of cardiac ventricle isolated from failing and non-failing human hearts, and determined the regulatory pathway to uncover the mechanism underlying heart failure. Two-dimensional gel electrophoresis (2-DE) coupled with tandem mass spectrometry was used to identify differentially expressed proteins in specimens from failing (n = 9) and non-failing (n = 6) human hearts. A total of 25 proteins with at least 1.5-fold change in the failing heart were identified; 15 proteins were up-regulated and 10 proteins were down-regulated. The altered proteins belong to three broad functional categories: (i) metabolic [e.g. NADH dehydrogenase (ubiquinone), dihydrolipoamide dehydrogenase, and the cytochrome c oxidase subunit]; (ii) cytoskeletal (e.g. myosin light chain proteins, troponin I type 3 and transthyretin) and (iii) stress response (e.g. alphaB-crystallin, HSP27 and HSP20). The marked differences in the expression of selected proteins, including HSP27 and HSP20, were further confirmed by Western blot. Thus, we carried out full-scale screening of the protein changes in human heart failure and profiled proteins that may be critical in cardiac dysfunction for future mapping.', 'CI': ['(c) 2011 The Authors Journal of Cellular and Molecular Medicine (c) 2011', 'Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd.'], 'FAU': ['Li, Weiming', 'Rong, Rong', 'Zhao, Sheng', 'Zhu, Xiaoming', 'Zhang, Ke', 'Xiong, Xin', 'Yu, Xueqing', 'Cui, Qinghua', 'Li, Shuqiang', 'Chen, Li', 'Cai, Jun', 'Du, Jie'], 'AU': ['Li W', 'Rong R', 'Zhao S', 'Zhu X', 'Zhang K', 'Xiong X', 'Yu X', 'Cui Q', 'Li S', 'Chen L', 'Cai J', 'Du J'], 'AD': ['Department of Cardiology, Chaoyang Hospital, The Key Laboratory of Remodelling-related Cardiovascular Diseases, Capital Medical University, Ministry of Education, Beijing, China.'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'PL': 'England', 'TA': 'J Cell Mol Med', 'JT': 'Journal of cellular and molecular medicine', 'JID': '101083777', 'RN': ['0 (Heat-Shock Proteins)', '0 (Proteome)'], 'SB': 'IM', 'MH': ['Adult', 'Cytoskeleton/*metabolism', 'Female', 'Gene Expression Profiling', 'Gene Expression Regulation', 'Heart Failure/*metabolism/physiopathology', 'Heart Ventricles/metabolism/physiopathology', 'Heat-Shock Proteins/*metabolism', 'Humans', 'Male', 'Metabolic Networks and Pathways/physiology', 'Microarray Analysis', 'Middle Aged', 'Proteome/*analysis', 'Proteomics/methods'], 'PMC': 'PMC3823093', 'EDAT': '2011/05/07 06:00', 'MHDA': '2012/06/09 06:00', 'CRDT': ['2011/05/07 06:00'], 'PHST': ['2011/05/07 06:00 [entrez]', '2011/05/07 06:00 [pubmed]', '2012/06/09 06:00 [medline]'], 'AID': ['10.1111/j.1582-4934.2011.01336.x [doi]'], 'PST': 'ppublish', 'SO': 'J Cell Mol Med. 2012 Jan;16(1):59-71. doi: 10.1111/j.1582-4934.2011.01336.x.'}\n",
      "{'PMID': '21468545', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20110930', 'LR': '20130222', 'IS': '1791-3004 (Electronic) 1791-2997 (Linking)', 'VI': '4', 'IP': '4', 'DP': '2011 Jul-Aug', 'TI': 'Comparative proteomic analysis of atrial appendages from rheumatic heart disease patients with sinus rhythm and atrial fibrillation.', 'PG': '655-61', 'LID': '10.3892/mmr.2011.468 [doi]', 'AB': 'Atrial fibrillation (AF) is the most common form of arrhythmia encountered in clinical practice, and contributes to cardiovascular morbidity and mortality. Despite significant advances in the understanding of the mechanisms associated with AF, the number of effective biomarkers and viable therapeutic targets remains relatively limited. In this study, 2-DE and MS/MS analysis was used to identify differentially expressed proteins in human atrial appendage tissues from patients with AF (n=4) compared to controls with sinus rhythm (SR; n=5). All subjects had rheumatic heart disease. Following 2-DE analysis, Coomassie Brilliant Blue staining and MS/MS identification, a total of 19 protein spots were found to be differentially expressed between the AF and SR groups. By cluster and metabolic/signaling pathway analysis, these proteins were divided into three major groups: proteins involved in the cytoskeleton and myofilament, energy metabolism associated proteins, and proteins associated with oxidative stress. The proteins identified in this study may enable a better understanding of the molecular mechanisms of AF, and may provide useful biomarkers and novel targets for drug development.', 'FAU': ['Huang, Wen-Jun', 'Zhou, Rui', 'Zeng, Xiao-Rong', 'Tan, Xiao-Qiu', 'Cheng, Zhi-Hui', 'Tang, Ming-Hai', 'Gou, Lan-Tu', 'Chen, Li-Juan', 'Tong, Ai-Ping', 'He, Yong', 'Yang, Jin-Liang'], 'AU': ['Huang WJ', 'Zhou R', 'Zeng XR', 'Tan XQ', 'Cheng ZH', 'Tang MH', 'Gou LT', 'Chen LJ', 'Tong AP', 'He Y', 'Yang JL'], 'AD': [\"State Key Laboratory of Biotherapy and Cancer Center, West China Medical School, Sichuan University, Chengdu, People's Republic of China.\"], 'LA': ['eng'], 'PT': ['Comparative Study', 'Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20110331', 'PL': 'Greece', 'TA': 'Mol Med Rep', 'JT': 'Molecular medicine reports', 'JID': '101475259', 'RN': ['0 (Proteome)'], 'SB': 'IM', 'MH': ['Adult', 'Amino Acid Sequence', 'Arrhythmia, Sinus/complications/*metabolism', 'Atrial Appendage/*metabolism', 'Atrial Fibrillation/complications/*metabolism', 'Electrophoresis, Gel, Two-Dimensional', 'Energy Metabolism', 'Female', 'Humans', 'Male', 'Middle Aged', 'Molecular Sequence Data', 'Proteome/*analysis', 'Rheumatic Heart Disease/complications/diagnosis/*metabolism', 'Spectrometry, Mass, Electrospray Ionization'], 'EDAT': '2011/04/07 06:00', 'MHDA': '2011/10/01 06:00', 'CRDT': ['2011/04/07 06:00'], 'PHST': ['2010/12/02 00:00 [received]', '2011/03/22 00:00 [accepted]', '2011/04/07 06:00 [entrez]', '2011/04/07 06:00 [pubmed]', '2011/10/01 06:00 [medline]'], 'AID': ['10.3892/mmr.2011.468 [doi]'], 'PST': 'ppublish', 'SO': 'Mol Med Rep. 2011 Jul-Aug;4(4):655-61. doi: 10.3892/mmr.2011.468. Epub 2011 Mar 31.'}\n",
      "{'PMID': '21211997', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20110929', 'LR': '20110412', 'IS': '1557-3117 (Electronic) 1053-2498 (Linking)', 'VI': '30', 'IP': '5', 'DP': '2011 May', 'TI': 'Proteomic profiling of the human failing heart after left ventricular assist device support.', 'PG': '497-506', 'LID': '10.1016/j.healun.2010.11.011 [doi]', 'AB': 'BACKGROUND: Left ventricular assist device (LVAD) support is commonly used in patients with heart failure as a bridge to heart transplantation. Whereas myocardial gene expression profile changes have been well established after LVAD support, the consequences on the protein level largely remain unclear. METHODS: Pre-LVAD and post-LVAD myocardial tissue specimens from dilated cardiomyopathy (DCM) and ischemic heart disease (IHD) patients were analyzed by fluorescent 2-dimensional difference gel electrophoresis, and differentially expressed proteins were identified by mass spectrometry. RESULTS: In the DCM group, 16 proteins were detected that showed statistically significant downregulation from pre-LVAD to post-LVAD tissue. In IHD patients, 50 alterations were found, including upregulated (n = 12) and downregulated (n = 38) proteins. The identified proteins in both groups partially overlapped and included proteins from cytoskeleton and mitochondrial energy metabolism. The latter changes were paralleled by severe abnormalities in mitochondrial morphology, as shown by electron microscopy. Post-LVAD proteomes of both DCM and IHD patients largely mimicked the protein profiles of non-failing hearts. Downregulation of the serine protease inhibitor alpha-1-antichymotrypsin in both DCM and IHD patients after LVAD support was confirmed by immunosorbent assay. CONCLUSIONS: LVAD-induced cardiac remodeling in DCM and IHD patients is associated with downregulation of alpha-1-antichymotrypsin and specific atrophic changes in protein expression profiles predominantly involved in cytoskeleton integrity and mitochondrial energy metabolism.', 'CI': ['Copyright (c) 2011 International Society for Heart and Lung Transplantation.', 'Published by Elsevier Inc. All rights reserved.'], 'FAU': ['de Weger, Roel A', 'Schipper, Marguerite E I', 'Siera-de Koning, Erica', 'van der Weide, Petra', 'van Oosterhout, Matthijs F M', 'Quadir, Razi', 'Steenbergen-Nakken, Helga', 'Lahpor, Jaap R', 'de Jonge, Nicolaas', 'Bovenschen, Niels'], 'AU': ['de Weger RA', 'Schipper ME', 'Siera-de Koning E', 'van der Weide P', 'van Oosterhout MF', 'Quadir R', 'Steenbergen-Nakken H', 'Lahpor JR', 'de Jonge N', 'Bovenschen N'], 'AD': ['Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20110106', 'PL': 'United States', 'TA': 'J Heart Lung Transplant', 'JT': 'The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation', 'JID': '9102703', 'RN': ['0 (Cytoskeletal Proteins)', '0 (Mitochondrial Proteins)', '0 (Proteome)', '0 (alpha 1-Antichymotrypsin)'], 'SB': 'IM', 'CIN': ['J Heart Lung Transplant. 2011 May;30(5):494-6. PMID: 21388831'], 'MH': ['Adult', 'Cardiomyopathy, Dilated/metabolism/therapy', 'Cytoskeletal Proteins/metabolism', 'Energy Metabolism/physiology', 'Female', '*Gene Expression Profiling', 'Heart Failure/*metabolism/*therapy', '*Heart-Assist Devices', 'Humans', 'Male', 'Middle Aged', 'Mitochondrial Proteins/metabolism', 'Myocardial Ischemia/metabolism/therapy', 'Proteome/*metabolism', 'Retrospective Studies', 'alpha 1-Antichymotrypsin/metabolism'], 'EDAT': '2011/01/08 06:00', 'MHDA': '2011/10/01 06:00', 'CRDT': ['2011/01/08 06:00'], 'PHST': ['2010/09/17 00:00 [received]', '2010/11/04 00:00 [revised]', '2010/11/29 00:00 [accepted]', '2011/01/08 06:00 [entrez]', '2011/01/08 06:00 [pubmed]', '2011/10/01 06:00 [medline]'], 'AID': ['S1053-2498(10)00763-1 [pii]', '10.1016/j.healun.2010.11.011 [doi]'], 'PST': 'ppublish', 'SO': 'J Heart Lung Transplant. 2011 May;30(5):497-506. doi: 10.1016/j.healun.2010.11.011. Epub 2011 Jan 6.'}\n",
      "{'PMID': '21166718', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20110822', 'LR': '20151119', 'IS': '1600-0714 (Electronic) 0904-2512 (Linking)', 'VI': '40', 'IP': '5', 'DP': '2011 May', 'TI': 'Analysis of differentially expressed proteins in oral squamous cell carcinoma by MALDI-TOF MS.', 'PG': '369-79', 'LID': '10.1111/j.1600-0714.2010.00982.x [doi]', 'AB': 'PURPOSE: To explore the presence of differentially expressed proteins in OSCC for discrimination of tumour and normal mucosa to establish potential biomarkers and therapeutic targets. EXPERIMENTAL DESIGN: Paired protein samples of 12 individuals (tongue cancer and non-cancerous mucosa) were separated by two-dimensional polyacrylamid gel electrophoresis. The protein patterns were compared pairwise and protein spots were quantified. We identified about 70 regulated proteins which we subsequently identified by MALDI-TOF mass spectrometry. RESULTS: Cancerous and non-cancerous tissues could be most precisely distinguished by a panel of proteins. They include the heat shock proteins (hsp)70 and 90, keratins (ck) 5, 6, 13, 14, 16, 17 and 19, beta globin, alpha-2-actin, stratifin, tropomyosin, calreticulin precursor, beta-2-tubulin, galectin7, thioredoxin, involucrin, adenylyl-cyclase-associated protein, disulfide isomerase-associated protein, thyrosine 3-monooxygenase, MYL2 and the s100 calcium binding protein. MYL3, cardiac muscle alpha actin 1 proprotein and transferrin were under-represented in OSCC. Six biomarkers, ck6 und ck13, beta globin, alpha-2-actin, hsp70 and hsp90 discriminated best between cancerous and non-cancerous oral tissues. All over-expressed proteins were analysed by STRING-analysis to highlight experimentally determined and computationally predicted interactions between the proteins. Especially involucrin, hsp70, calreticulin precursor, stratifin, (ck) 5, 6, 14, 19, tyrosine 3-monooxygenase, beta-2-tubulin and disulfide isomerase associated protein showed multiple relations. CONCLUSION: We identified six proteins which are differentially expressed in most OSCC compared to healthy tissues. Of those, by string analysis, multiple interaction partners are assumed for hsp70. This protein is supposed to be the most promising candidate as marker molecule and target for OSCC therapy.', 'CI': ['(c) 2010 John Wiley & Sons A/S.'], 'FAU': ['Thiel, Uta J E', 'Feltens, Ralph', 'Adryan, Boris', 'Gieringer, Rita', 'Brochhausen, Christoph', 'Schuon, Robert', 'Fillies, Thomas', 'Grus, Franz', 'Mann, Wolf J', 'Brieger, Juergen'], 'AU': ['Thiel UJ', 'Feltens R', 'Adryan B', 'Gieringer R', 'Brochhausen C', 'Schuon R', 'Fillies T', 'Grus F', 'Mann WJ', 'Brieger J'], 'AD': ['Department of Otorhinolaryngology, Head and Neck Surgery, University Medical Centre of the Johannes Gutenberg University Mainz, Germany. uta.thiel@unimedizin-mainz.de'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20101217', 'PL': 'Denmark', 'TA': 'J Oral Pathol Med', 'JT': 'Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology', 'JID': '8911934', 'RN': ['0 (Actins)', '0 (Biomarkers, Tumor)', '0 (HSP70 Heat-Shock Proteins)', '0 (HSP90 Heat-Shock Proteins)', '0 (Keratin-13)', '0 (Keratin-6)', '0 (Neoplasm Proteins)', '0 (Proteome)', '0 (beta-Globins)'], 'SB': 'D IM', 'MH': ['Actins/analysis/biosynthesis', 'Aged', '*Biomarkers, Tumor/analysis', 'Blotting, Western', 'Carcinoma, Squamous Cell/*metabolism', 'Case-Control Studies', 'Computational Biology', 'Female', 'Gene Expression Regulation, Neoplastic', 'HSP70 Heat-Shock Proteins/analysis/biosynthesis', 'HSP90 Heat-Shock Proteins/analysis/biosynthesis', 'Humans', 'Isoelectric Focusing', 'Keratin-13/analysis/biosynthesis', 'Keratin-6/analysis/biosynthesis', 'Male', 'Middle Aged', 'Mouth Mucosa/chemistry/*metabolism', 'Neoplasm Proteins/analysis/*biosynthesis', 'Proteome', 'Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization', 'Tongue Neoplasms/*metabolism', 'beta-Globins/analysis/biosynthesis'], 'EDAT': '2010/12/21 06:00', 'MHDA': '2011/08/23 06:00', 'CRDT': ['2010/12/21 06:00'], 'PHST': ['2010/12/21 06:00 [entrez]', '2010/12/21 06:00 [pubmed]', '2011/08/23 06:00 [medline]'], 'AID': ['10.1111/j.1600-0714.2010.00982.x [doi]'], 'PST': 'ppublish', 'SO': 'J Oral Pathol Med. 2011 May;40(5):369-79. doi: 10.1111/j.1600-0714.2010.00982.x. Epub 2010 Dec 17.'}\n",
      "{'PMID': '21043527', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20110516', 'LR': '20151119', 'IS': '1535-3907 (Electronic) 1535-3893 (Linking)', 'VI': '10', 'IP': '1', 'DP': '2011 Jan 7', 'TI': 'Proteomic signature of Apolipoprotein J in the early phase of new-onset myocardial infarction.', 'PG': '211-20', 'LID': '10.1021/pr100805h [doi]', 'AB': 'Acute myocardial infarction (AMI) is one of the major causes of mortality and morbidity worldwide. Despite all the efforts, there is a lack of early markers for prevention, diagnosis, and treatment of ischemic syndromes. By applying a proteomic expression profiling approach to identify biomarkers of early stages of AMI, we have detected significant changes in Apolipoprotein J/clusterin (ApoJ) in patients with an acute new-onset myocardial infarction. ApoJ characterization by bidimensional electrophoresis (2-DE), followed by mass spectrometry (MALDI-TOF) depicted a cluster of 13 spots (pI, 4.5-5.0; M(w), 37.1-47.3 kDa) with a significantly different distribution between AMI-patients and controls. Specifically, spots 2, 3, 7, 10, and 13 showed a 2-fold increase in their intensity in AMI-patients (P = 0.001). Western-blot analysis (WB) for total serum ApoJ depicted two bands of 40-45 and 65-70 kDa. When only glycosylated forms were analyzed, the band of 65-70 kDa was the most predominant one. A 25% decrease (P = 0.05) of ApoJ glycosylated forms in AMI-patients was detected by 2-DE. Serum ApoJ levels, determined by a commercial ELISA, were significantly lower (P < 0.001) in AMI-patients (n = 39) immediately after the event than in controls (n = 60). In 60% of patients, the lowest ApoJ level was detected within 6 h after the onset of AMI. Between 72 and 96 h after admission, ApoJ values in AMI-patients had reached control levels. Our results demonstrate alterations in ApoJ proteomic profile, due to a differential glycosylation pattern, in AMI-patients within the first 6 h after the onset of the event. Therefore, the analysis of this isoform glycosylation shift in patients with AMI may be of better use to understand ApoJ function than the total serum levels of ApoJ and this isoform shift may become an early marker of AMI.', 'FAU': ['Cubedo, Judit', 'Padro, Teresa', 'Garcia-Moll, Xavier', 'Pinto, Xavier', 'Cinca, Juan', 'Badimon, Lina'], 'AU': ['Cubedo J', 'Padro T', 'Garcia-Moll X', 'Pinto X', 'Cinca J', 'Badimon L'], 'AD': ['Cardiovascular Research Center (CSIC-ICCC), CIBERobn, Cardiology Service, Hospital Santa Creu i Sant Pau, University Hospital Bellvitge, Autonomous University of Barcelona, Barcelona, Spain.'], 'LA': ['eng'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20101117', 'PL': 'United States', 'TA': 'J Proteome Res', 'JT': 'Journal of proteome research', 'JID': '101128775', 'RN': ['0 (Biomarkers)', '0 (Blood Proteins)', '0 (CLU protein, human)', '0 (Clusterin)'], 'SB': 'IM', 'MH': ['Acute Disease', 'Age Factors', 'Aged', 'Biomarkers/*blood', 'Blood Proteins/analysis', 'Blotting, Western', 'Case-Control Studies', 'Clusterin/*blood', 'Electrophoresis, Gel, Two-Dimensional', 'Enzyme-Linked Immunosorbent Assay', 'Exosomes', 'Female', 'Humans', 'Immunohistochemistry', 'Magnetic Resonance Imaging', 'Male', 'Middle Aged', 'Myocardial Infarction/*blood/epidemiology/metabolism', 'Myocardium/chemistry', 'Proteomics/*methods', 'Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization'], 'EDAT': '2010/11/04 06:00', 'MHDA': '2011/05/17 06:00', 'CRDT': ['2010/11/04 06:00'], 'PHST': ['2010/11/04 06:00 [entrez]', '2010/11/04 06:00 [pubmed]', '2011/05/17 06:00 [medline]'], 'AID': ['10.1021/pr100805h [doi]'], 'PST': 'ppublish', 'SO': 'J Proteome Res. 2011 Jan 7;10(1):211-20. doi: 10.1021/pr100805h. Epub 2010 Nov 17.'}\n",
      "{'PMID': '21041689', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20120110', 'LR': '20170215', 'IS': '1524-4539 (Electronic) 0009-7322 (Linking)', 'VI': '122', 'IP': '20', 'DP': '2010 Nov 16', 'TI': 'Proteomic analysis of lung tissues from patients with pulmonary arterial hypertension.', 'PG': '2058-67', 'LID': '10.1161/CIRCULATIONAHA.110.972745 [doi]', 'AB': 'BACKGROUND: Pulmonary arterial hypertension is a disorder of vascular remodeling causing increased resistance to pulmonary blood flow. The expression of proteins in lungs from pulmonary arterial hypertension patients was investigated in an unbiased approach to further understand the pathobiology of this disease. METHODS AND RESULTS: Label-free liquid chromatography tandem mass spectrometry was used to compare protein profiles in surgical samples of lungs from 8 patients with pulmonary arterial hypertension and 8 control subjects. More than 300 proteins were detected. On the basis of robust criteria, the levels of 25 proteins varied between the 2 groups. The majority of upregulated proteins were associated with cell growth, proliferation, and cell metabolism. Novel findings included an increased expression of chloride intracellular channel 4, receptor for advanced glycation end products, and periostin. Increased expression of chloride intracellular channel 4, a multifunctional protein involved in angiogenesis, and several signaling pathways implicated in pulmonary arterial hypertension--transforming growth factor-beta, vascular endothelial growth factor, and bone morphogenetic protein--was confirmed by Western blotting and localized predominantly to endothelial cells in occlusive and plexiform vascular lesions. CONCLUSIONS: Label-free proteomics identified differences in the expression of several proteins in the pulmonary arterial hypertension lung, many of which are relevant to the disease process. Increased expression of chloride intracellular channel 4 may be pertinent to the disorganized angiogenesis of plexiform lesions.', 'FAU': ['Abdul-Salam, Vahitha B', 'Wharton, John', 'Cupitt, John', 'Berryman, Mark', 'Edwards, Robert J', 'Wilkins, Martin R'], 'AU': ['Abdul-Salam VB', 'Wharton J', 'Cupitt J', 'Berryman M', 'Edwards RJ', 'Wilkins MR'], 'AD': ['Centre for Pharmacology and Therapeutics, Department of Medicine, Imperial College London, London, UK.'], 'LA': ['eng'], 'GR': ['R15 GM084414/GM/NIGMS NIH HHS/United States', 'British Heart Foundation/United Kingdom'], 'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20101101', 'PL': 'United States', 'TA': 'Circulation', 'JT': 'Circulation', 'JID': '0147763', 'RN': ['0 (Proteome)'], 'SB': 'AIM IM', 'MH': ['Adult', 'Aged', '*Cell Proliferation', 'Chromatography, Liquid', 'Familial Primary Pulmonary Hypertension', 'Female', 'Humans', 'Hypertension, Pulmonary/*metabolism/pathology', 'Lung/*metabolism/pathology', 'Male', 'Middle Aged', 'Proteome/*metabolism', '*Proteomics', 'Tandem Mass Spectrometry', '*Up-Regulation'], 'EDAT': '2010/11/03 06:00', 'MHDA': '2012/01/11 06:00', 'CRDT': ['2010/11/03 06:00'], 'PHST': ['2010/11/03 06:00 [entrez]', '2010/11/03 06:00 [pubmed]', '2012/01/11 06:00 [medline]'], 'AID': ['CIRCULATIONAHA.110.972745 [pii]', '10.1161/CIRCULATIONAHA.110.972745 [doi]'], 'PST': 'ppublish', 'SO': 'Circulation. 2010 Nov 16;122(20):2058-67. doi: 10.1161/CIRCULATIONAHA.110.972745. Epub 2010 Nov 1.'}\n",
      "{'PMID': '20936781', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20110516', 'LR': '20151119', 'IS': '1535-3907 (Electronic) 1535-3893 (Linking)', 'VI': '10', 'IP': '1', 'DP': '2011 Jan 7', 'TI': 'Semi-targeted plasma proteomics discovery workflow utilizing two-stage protein depletion and off-line LC-MALDI MS/MS.', 'PG': '34-45', 'LID': '10.1021/pr100659e [doi]', 'AB': 'A quantitative proteomics workflow was implemented that provides extended plasma protein coverage by extensive protein depletion in combination with the sensitivity and breadth of analysis of two-dimensional LC-MS/MS shotgun analysis. Abundant proteins were depleted by a two-stage process using IgY and Supermix depletion columns in series. Samples are then extensively fractionated by two-dimensional chromatography with fractions directly deposited onto MALDI plates. Decoupling sample fractionation from mass spectrometry facilitates a targeted MS/MS precursor selection strategy that maximizes measurement of a consistent set of peptides across experiments. Multiplexed stable isotope labeling provides quantification relative to a common reference sample and ensures an identical set of peptides measured in the set of samples (set of eight) combined in a single experiment. The more extensive protein depletion provided by the addition of the Supermix column did not compromise overall reproducibility of the measurements or the ability to reliably detect changes in protein levels between samples. The implementation of this workflow is presented for a case study aimed at generating molecular signatures for prediction of first heart attack.', 'FAU': ['Juhasz, Peter', 'Lynch, Moira', 'Sethuraman, Mahadevan', 'Campbell, Jennifer', 'Hines, Wade', 'Paniagua, Manuel', 'Song, Leijun', 'Kulkarni, Mahesh', 'Adourian, Aram', 'Guo, Yu', 'Li, Xiaohong', 'Martin, Stephen', 'Gordon, Neal'], 'AU': ['Juhasz P', 'Lynch M', 'Sethuraman M', 'Campbell J', 'Hines W', 'Paniagua M', 'Song L', 'Kulkarni M', 'Adourian A', 'Guo Y', 'Li X', 'Martin S', 'Gordon N'], 'AD': ['BG Medicine, Waltham, Massachusetts 02451, USA. pjuhasz@bg-medicine.com'], 'LA': ['eng'], 'PT': ['Journal Article'], 'DEP': '20101102', 'PL': 'United States', 'TA': 'J Proteome Res', 'JT': 'Journal of proteome research', 'JID': '101128775', 'RN': ['0 (Biomarkers)', '0 (Blood Proteins)', '0 (IgY)', '0 (Immunoglobulins)'], 'SB': 'IM', 'MH': ['Aged', 'Aged, 80 and over', 'Biomarkers', '*Blood Proteins/analysis/chemistry/isolation & purification', 'Chromatography, Affinity/*methods', 'Female', 'Humans', 'Immunoassay', 'Immunoglobulins/metabolism', 'Isotope Labeling', 'Male', 'Middle Aged', 'Myocardial Infarction/metabolism', 'Proteomics/*methods', 'Reproducibility of Results', 'Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization/*methods', 'Tandem Mass Spectrometry/*methods'], 'EDAT': '2010/10/13 06:00', 'MHDA': '2011/05/17 06:00', 'CRDT': ['2010/10/13 06:00'], 'PHST': ['2010/10/13 06:00 [entrez]', '2010/10/13 06:00 [pubmed]', '2011/05/17 06:00 [medline]'], 'AID': ['10.1021/pr100659e [doi]'], 'PST': 'ppublish', 'SO': 'J Proteome Res. 2011 Jan 7;10(1):34-45. doi: 10.1021/pr100659e. Epub 2010 Nov 2.'}\n",
      "{'PMID': '20936720', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20110503', 'LR': '20101011', 'IS': '1008-9292 (Print) 1008-9292 (Linking)', 'VI': '39', 'IP': '5', 'DP': '2010 Sep', 'TI': '[A proteomic study of peripheral blood mononuclear cells in patients undergoing cardiopulmonary bypass].', 'PG': '470-6', 'AB': 'OBJECTIVE: To explore the effect of cardiopulmonary bypass (CPB) on the profile of protein expression in peripheral blood mononuclear cells (PBMCs). METHODS: Eleven patients undergoing cardiac surgery under cardiopulmonary bypass were enrolled in the study. Peripheral blood samples were collected before CPB (T0), 1 h after CPB (T1) and at the end of operation (T2), and PBMCs were obtained by gradient centrifugation. The profile of protein expression was analyzed using 2-D gel electrophoresis (2-DE) and mass spectrometry. The candidate proteins were further identified by Western blotting. RESULT: Compared to protein profile at T0, 12 protein spots were identified to be up-regulated in PBMCs at T1 (P <0.05), among which S100A9 reached the peak level at T1 and decreased after operation,but not returned to its initial level. CONCLUSION: Results indicate that 12 proteins are likely to be involved in CPB, however, their roles need to be elucidated.', 'FAU': ['Yang, Yan-Qin', 'Tang, Jin', 'Gu, Miao-Ning', 'Guo, Yuan-Bo', 'Zhao, Zhen-Long', 'Chen, Ye-Ming', 'Chen, Wen-Ting'], 'AU': ['Yang YQ', 'Tang J', 'Gu MN', 'Guo YB', 'Zhao ZL', 'Chen YM', 'Chen WT'], 'AD': ['Department of Anesthesiology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.'], 'LA': ['chi'], 'PT': ['English Abstract', 'Journal Article', \"Research Support, Non-U.S. Gov't\"], 'PL': 'China', 'TA': 'Zhejiang Da Xue Xue Bao Yi Xue Ban', 'JT': 'Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences', 'JID': '100927946', 'RN': ['0 (Proteome)'], 'SB': 'IM', 'MH': ['Adult', '*Cardiopulmonary Bypass', 'Electrophoresis, Gel, Two-Dimensional', 'Female', 'Humans', 'Leukocytes, Mononuclear/*metabolism', 'Male', 'Mass Spectrometry', 'Middle Aged', 'Proteome/*metabolism', 'Proteomics', 'Young Adult'], 'EDAT': '2010/10/12 06:00', 'MHDA': '2011/05/04 06:00', 'CRDT': ['2010/10/12 06:00'], 'PHST': ['2010/10/12 06:00 [entrez]', '2010/10/12 06:00 [pubmed]', '2011/05/04 06:00 [medline]'], 'PST': 'ppublish', 'SO': 'Zhejiang Da Xue Xue Bao Yi Xue Ban. 2010 Sep;39(5):470-6.'}\n",
      "{'PMID': '20853909', 'OWN': 'NLM', 'STAT': 'MEDLINE', 'DCOM': '20110524', 'LR': '20181113', 'IS': '1535-3907 (Electronic) 1535-3893 (Linking)', 'VI': '9', 'IP': '12', 'DP': '2010 Dec 3', 'TI': 'Metabolome-wide association study identifies multiple biomarkers that discriminate north and south Chinese populations at differing risks of cardiovascular disease: INTERMAP study.', 'PG': '6647-54', 'LID': '10.1021/pr100798r [doi]', 'AB': 'Rates of heart disease and stroke vary markedly between north and south China. A (1)H NMR spectroscopy-based metabolome-wide association approach was used to identify urinary metabolites that discriminate between southern and northern Chinese population samples, to investigate population biomarkers that might relate to the difference in cardiovascular disease risk. NMR spectra were acquired from two 24-h urine specimens per person for 523 northern and 244 southern Chinese participants in the INTERMAP Study of macro/micronutrients and blood pressure. Discriminating metabolites were identified using orthogonal partial least squares discriminant analysis and assessed for statistical significance with conservative family wise error rate < 0.01 to minimize false positive findings. Urinary metabolites significantly (P < 1.2 x 10(-16) to 2.9 x 10(-69)) higher in northern than southern Chinese populations included dimethylglycine, alanine, lactate, branched-chain amino acids (isoleucine, leucine, valine), N-acetyls of glycoprotein fragments (including uromodulin), N-acetyl neuraminic acid, pentanoic/heptanoic acid, and methylguanidine; metabolites significantly (P < 1.1 x 10(-12) to 2 x 10(-127)) higher in the south were gut microbial cometabolites (hippurate, 4-cresyl sulfate, phenylacetylglutamine, 2-hydroxyisobutyrate), succinate, creatine, scyllo-inositol, prolinebetaine, and trans-aconitate. These findings indicate the importance of environmental influences (e.g., diet), endogenous metabolism, and mammalian-gut microbial cometabolism, which may help explain north-south China differences in cardiovascular disease risk.', 'FAU': ['Yap, Ivan K S', 'Brown, Ian J', 'Chan, Queenie', 'Wijeyesekera, Anisha', 'Garcia-Perez, Isabel', 'Bictash, Magda', 'Loo, Ruey Leng', 'Chadeau-Hyam, Marc', 'Ebbels, Timothy', 'De Iorio, Maria', 'Maibaum, Elaine', 'Zhao, Liancheng', 'Kesteloot, Hugo', 'Daviglus, Martha L', 'Stamler, Jeremiah', 'Nicholson, Jeremy K', 'Elliott, Paul', 'Holmes, Elaine'], 'AU': ['Yap IK', 'Brown IJ', 'Chan Q', 'Wijeyesekera A', 'Garcia-Perez I', 'Bictash M', 'Loo RL', 'Chadeau-Hyam M', 'Ebbels T', 'De Iorio M', 'Maibaum E', 'Zhao L', 'Kesteloot H', 'Daviglus ML', 'Stamler J', 'Nicholson JK', 'Elliott P', 'Holmes E'], 'AD': ['Department of Surgery and Cancer, Faculty of Medicine, School of Public Health, Imperial College London, United Kingdom.'], 'LA': ['eng'], 'GR': ['G0801056/Medical Research Council/United Kingdom', 'R01 HL084228-04/HL/NHLBI NIH HHS/United States', 'R01-HL050490/HL/NHLBI NIH HHS/United States', 'R01-HL084228/HL/NHLBI NIH HHS/United States', 'R01 HL050490-17/HL/NHLBI NIH HHS/United States', 'R01 HL050490/HL/NHLBI NIH HHS/United States', 'R01 HL084228/HL/NHLBI NIH HHS/United States'], 'PT': ['Journal Article', 'Research Support, N.I.H., Extramural', \"Research Support, Non-U.S. Gov't\"], 'DEP': '20101102', 'PL': 'United States', 'TA': 'J Proteome Res', 'JT': 'Journal of proteome research', 'JID': '101128775', 'RN': ['0 (Amino Acids, Branched-Chain)', '0 (Biomarkers)', '0 (Uromodulin)', 'AB6MNQ6J6L (Succinic Acid)', 'GZP2782OP0 (N-Acetylneuraminic Acid)', 'MU72812GK0 (Creatine)'], 'SB': 'IM', 'MH': ['Adult', 'Amino Acids, Branched-Chain/urine', 'Asian Continental Ancestry Group/statistics & numerical data', 'Biomarkers/*urine', 'Cardiovascular Diseases/ethnology/*urine', 'China', 'Creatine/urine', 'Discriminant Analysis', 'Female', 'Geography', 'Humans', 'Least-Squares Analysis', 'Magnetic Resonance Spectroscopy', 'Male', 'Metabolomics/*methods', 'Middle Aged', 'N-Acetylneuraminic Acid/urine', 'Risk Assessment/statistics & numerical data', 'Risk Factors', 'Succinic Acid/urine', 'Uromodulin/urine'], 'PMC': 'PMC3117148', 'MID': ['NIHMS293774'], 'EDAT': '2010/09/22 06:00', 'MHDA': '2011/05/25 06:00', 'CRDT': ['2010/09/22 06:00'], 'PHST': ['2010/09/22 06:00 [entrez]', '2010/09/22 06:00 [pubmed]', '2011/05/25 06:00 [medline]'], 'AID': ['10.1021/pr100798r [doi]'], 'PST': 'ppublish', 'SO': 'J Proteome Res. 2010 Dec 3;9(12):6647-54. doi: 10.1021/pr100798r. Epub 2010 Nov 2.'}\n"
     ]
    }
   ],
   "source": [
    "#using the API's EFetch function to retrieve records for each of the PubMed IDs\n",
    "#entries are obtained in the MEDLINE format\n",
    "from Bio import Medline\n",
    "handle = Entrez.efetch(db=\"pubmed\", id=idlist, rettype=\"medline\", retmode = \"text\")\n",
    "pm_recs = Medline.parse(handle)\n",
    "pm_recs_list = list(pm_recs)\n",
    "for rec in pm_recs_list:\n",
    "  print(rec)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [],
   "source": [
    "#saving the title and abstract for each to a file\n",
    "with open(absts_filename, \"w\") as outfile:\n",
    "  for rec in pm_recs_list:\n",
    "    title = rec.get('TI')\n",
    "    abst = rec.get('AB', \"No Abstract\")\n",
    "    outfile.write(title + \"\\n\" + abst + \"\\n\\n\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "107 out of 200 entries have PMC IDs.\n",
      "['PMC7489050', 'PMC7378184', 'PMC7266817', 'PMC7237418', 'PMC7211010', 'PMC7146314', 'PMC7031431', 'PMC6953276', 'PMC6925199', 'PMC6914779', 'PMC6901481', 'PMC7062043', 'PMC6627068', 'PMC6560130', 'PMC6542631', 'PMC6437869', 'PMC6558644', 'PMC6420620', 'PMC6430080', 'PMC6484326', 'PMC6399814', 'PMC6398744', 'PMC6369230', 'PMC6403451', 'PMC6264811', 'PMC6475111', 'PMC6242904', 'PMC6263790', 'PMC6192629', 'PMC6265639', 'PMC6152976', 'PMC6284793', 'PMC6156053', 'PMC6196832', 'PMC6011234', 'PMC5949160', 'PMC6023756', 'PMC5962559', 'PMC5931620', 'PMC6104105', 'PMC5905170', 'PMC6162093', 'PMC5837105', 'PMC5978942', 'PMC5869115', 'PMC5849518', 'PMC5813793', 'PMC5719427', 'PMC5695135', 'PMC5880582', 'PMC5553757', 'PMC5550488', 'PMC5586413', 'PMC5515959', 'PMC5573768', 'PMC5564650', 'PMC5342174', 'PMC5335613', 'PMC5314136', 'PMC5834230', 'PMC5053516', 'PMC7101709', 'PMC4911082', 'PMC4882859', 'PMC4833206', 'PMC4719542', 'PMC4707500', 'PMC4664895', 'PMC4644493', 'PMC4715256', 'PMC4762624', 'PMC4572899', 'PMC4452854', 'PMC4444479', 'PMC4513993', 'PMC4408082', 'PMC4375938', 'PMC4317744', 'PMC4232587', 'PMC4407605', 'PMC4242444', 'PMC4166610', 'PMC4130503', 'PMC4137824', 'PMC4222349', 'PMC4155932', 'PMC4032332', 'PMC3971496', 'PMC4007142', 'PMC3837032', 'PMC3743082', 'PMC3769321', 'PMC3734580', 'PMC3617171', 'PMC3898145', 'PMC3624731', 'PMC3786406', 'PMC3705161', 'PMC3412973', 'PMC3823441', 'PMC3285183', 'PMC3275480', 'PMC5564307', 'PMC4360897', 'PMC3149094', 'PMC3823093', 'PMC3117148']\n"
     ]
    }
   ],
   "source": [
    "#retrieving full-text documents from PubMed Central\n",
    "pmc_ids = []\n",
    "for rec in pm_recs_list:\n",
    "  pmc_ids.append(rec.get('PMC'))\n",
    "  pmc_ids_filtered = list(filter(None, pmc_ids)) \n",
    "print(\"%s out of %s entries have PMC IDs.\" % (len(pmc_ids_filtered), len(pm_recs_list)))\n",
    "print(pmc_ids_filtered)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [],
   "source": [
    "#removing \"PMC\" from the PMC IDs before fetching records\n",
    "pmc_ids_trim = [id[3:] for id in pmc_ids_filtered]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [],
   "source": [
    "import xml.dom.minidom"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {
    "scrolled": true
   },
   "outputs": [],
   "source": [
    "handle = Entrez.efetch(db=\"pmc\", id=pmc_ids_trim, rettype='full', retmode='xml')\n",
    "hxml = xml.dom.minidom.parseString(handle.read())\n",
    "hxml_pretty = hxml.toprettyxml()\n",
    "\n",
    "with open(reports_filename, \"w\") as outfile:\n",
    "  for line in hxml_pretty:\n",
    "    outfile.write(line)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [],
   "source": [
    "#using Python's request package to obtain annotations of named entities from PubTator Central in BioC XML format\n",
    "import requests, xml.dom.minidom"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [],
   "source": [
    "#obtaining annotations for the PubMed Central full texts\n",
    "\n",
    "#pmc_ids_joined = \",\".join(pmc_ids_filtered)\n",
    "pmc_ids_joined = \",\".join(pmc_ids_filtered[:50])\n",
    "r = requests.get(\"https://www.ncbi.nlm.nih.gov/research/pubtator-api/publications/export/biocxml?&concepts=gene&pmcids=\" + pmc_ids_joined)\n",
    "rxml_reports = xml.dom.minidom.parseString(r.text)\n",
    "rxml_pretty_reports = rxml_reports.toprettyxml()\n",
    "\n",
    "with open(reports_annotations_filename, \"w\") as outfile:\n",
    "  for line in rxml_pretty_reports:\n",
    "    outfile.write(line)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [],
   "source": [
    "#And some quick file cleaning.\n",
    "with open(reports_annotations_filename, \"r\") as readfile:\n",
    "  lines = readfile.readlines()\n",
    "with open(reports_annotations_filename, \"w\") as outfile:\n",
    "  for line in lines:\n",
    "    if line.strip(\"\\n\") not in [\"<?xml version=\\\"1.0\\\" ?>\", \n",
    "                                \"<!DOCTYPE collection\",\n",
    "                                \"  SYSTEM 'BioC.dtd'>\"]:\n",
    "      outfile.write(line)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [],
   "source": [
    "#retrieving annotations for all PubMed entries now\n",
    "\n",
    "#First, a small function to help with preparing batches.\n",
    "def batch_this(mylist, n=1):\n",
    "  length = len(mylist)\n",
    "  for ndx in range(0, length, n):\n",
    "    yield mylist[ndx:min(ndx + n, length)]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [],
   "source": [
    "for batch in batch_this(idlist,100): \n",
    "  pmids_joined = \",\".join(batch)\n",
    "  r = requests.get(\"https://www.ncbi.nlm.nih.gov/research/pubtator-api/publications/export/biocxml?&concepts=gene&pmids=\" + pmids_joined)\n",
    "  rxml_absts = xml.dom.minidom.parseString(r.text)\n",
    "  rxml_pretty_absts = rxml_absts.toprettyxml()\n",
    "\n",
    "  with open(absts_annotations_filename, \"a\") as outfile:\n",
    "    for line in rxml_pretty_absts:\n",
    "      outfile.write(line)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [],
   "source": [
    "#Need to clean up the XML output a bit to join.\n",
    "with open(absts_annotations_filename, \"r\") as readfile:\n",
    "  lines = readfile.readlines()\n",
    "with open(absts_annotations_filename, \"w\") as outfile:\n",
    "  seenheaders = []\n",
    "  for line in lines:\n",
    "    line_ok = True\n",
    "    if line.strip(\"\\n\") in [\"<collection>\",\n",
    "                            \"\t<source>PubTator</source>\",\n",
    "                            \"\t<date/>\",\n",
    "                            \"\t<key>BioC.key</key>\"]:\n",
    "      if line in seenheaders:\n",
    "        line_ok = False\n",
    "      else:\n",
    "        seenheaders.append(line)\n",
    "    if line.strip(\"\\n\") == \"</collection>\":\n",
    "        line_ok = False\n",
    "    if line.strip(\"\\n\") in [\"<?xml version=\\\"1.0\\\" ?>\", \n",
    "                            \"<!DOCTYPE collection\",\n",
    "                            \"  SYSTEM 'BioC.dtd'>\"]:\n",
    "        line_ok = False\n",
    "    if line_ok:\n",
    "      outfile.write(line)\n",
    "  outfile.write(\"</collection>\\n\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [],
   "source": [
    "#currently have two sets of annotations: one for abstracts and one for full texts in BioC XML format\n",
    "\n",
    "import xml.etree.ElementTree as ET\n",
    "from collections import Counter, OrderedDict\n",
    "corpus_filenames = [reports_annotations_filename, absts_annotations_filename]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "* Reading from cardiac_fulltexts_pubtator_annotations.xml\n",
      "\n",
      "** Gene frequency across the entire corpus:\n",
      "5034: 327\n",
      "335: 157\n",
      "18129: 134\n",
      "4353: 125\n",
      "3620: 116\n",
      "1756: 111\n",
      "1401: 105\n",
      "722: 98\n",
      "9242: 96\n",
      "5284: 84\n",
      "7273: 81\n",
      "6908: 79\n",
      "2244: 74\n",
      "51206: 74\n",
      "30968: 70\n",
      "348: 68\n",
      "3630: 65\n",
      "38: 65\n",
      "3075: 63\n",
      "7040: 62\n",
      "338: 61\n",
      "31293: 58\n",
      "4879: 56\n",
      "151648: 53\n",
      "345: 51\n",
      "11102: 47\n",
      "56267: 46\n",
      "2934: 44\n",
      "3700: 43\n",
      "152330: 41\n",
      "133522: 40\n",
      "183: 39\n",
      "6288: 37\n",
      "17880: 37\n",
      "59284: 37\n",
      "3934: 36\n",
      "3827: 35\n",
      "4312: 35\n",
      "718: 35\n",
      "4311: 34\n",
      "699: 33\n",
      "213: 33\n",
      "116519: 32\n",
      "5496: 31\n",
      "56925: 31\n",
      "1: 31\n",
      "50848: 31\n",
      "55937: 31\n",
      "3250: 31\n",
      "337: 30\n",
      "3303: 30\n",
      "1003: 30\n",
      "7547: 29\n",
      "2828: 29\n",
      "170589: 29\n",
      "4316: 29\n",
      "820: 28\n",
      "7058: 28\n",
      "3053: 28\n",
      "6714: 27\n",
      "351: 27\n",
      "2670: 27\n",
      "3816: 26\n",
      "966: 26\n",
      "7124: 26\n",
      "7412: 26\n",
      "6876: 26\n",
      "1012: 26\n",
      "100130342: 25\n",
      "7276: 25\n",
      "1628: 24\n",
      "133: 23\n",
      "1509: 22\n",
      "5345: 22\n",
      "207: 21\n",
      "9575: 21\n",
      "3952: 21\n",
      "2: 21\n",
      "3918: 20\n",
      "3482: 20\n",
      "3494: 19\n",
      "341: 19\n",
      "7057: 19\n",
      "1803: 19\n",
      "8550: 19\n",
      "4846: 18\n",
      "336: 18\n",
      "7448: 18\n",
      "2335: 18\n",
      "6696: 18\n",
      "3933: 18\n",
      "3080: 18\n",
      "728: 18\n",
      "5265: 17\n",
      "18131: 17\n",
      "5624: 17\n",
      "1351: 16\n",
      "5465: 16\n",
      "5444: 16\n",
      "19: 16\n",
      "3554: 16\n",
      "7422: 16\n",
      "2192: 16\n",
      "2147: 16\n",
      "948: 16\n",
      "3815: 16\n",
      "27241: 15\n",
      "5340: 15\n",
      "344: 15\n",
      "3217: 15\n",
      "4591: 15\n",
      "2878: 15\n",
      "727698: 15\n",
      "5327: 15\n",
      "10891: 14\n",
      "2597: 14\n",
      "10631: 14\n",
      "2243: 14\n",
      "462: 14\n",
      "114770: 14\n",
      "712: 14\n",
      "5832: 14\n",
      "8991: 13\n",
      "5468: 13\n",
      "4397: 13\n",
      "4790: 13\n",
      "1272: 13\n",
      "716: 13\n",
      "3485: 13\n",
      "4345: 13\n",
      "875: 13\n",
      "197: 13\n",
      "1361: 13\n",
      "10563: 13\n",
      "629: 12\n",
      "9518: 12\n",
      "5481: 12\n",
      "2195: 12\n",
      "4318: 12\n",
      "5885: 12\n",
      "10320: 12\n",
      "4582: 12\n",
      "5336: 12\n",
      "12: 12\n",
      "3818: 12\n",
      "5566: 12\n",
      "3569: 11\n",
      "7077: 11\n",
      "5972: 11\n",
      "4036: 11\n",
      "4900: 11\n",
      "3263: 11\n",
      "4060: 11\n",
      "350: 11\n",
      "6236: 10\n",
      "1738: 10\n",
      "9049: 10\n",
      "23334: 10\n",
      "958: 10\n",
      "5175: 10\n",
      "3643: 10\n",
      "22915: 10\n",
      "23411: 10\n",
      "118471: 10\n",
      "2202: 10\n",
      "6402: 10\n",
      "1423: 10\n",
      "5594: 10\n",
      "5595;5594: 10\n",
      "3273: 10\n",
      "597: 10\n",
      "255738: 10\n",
      "3958: 9\n",
      "7035: 9\n",
      "6761: 9\n",
      "3929: 9\n",
      "2475: 9\n",
      "5660: 9\n",
      "2039: 9\n",
      "1636: 9\n",
      "1508: 9\n",
      "649: 9\n",
      "8542: 9\n",
      "3426: 9\n",
      "5858: 9\n",
      "5267: 9\n",
      "947: 9\n",
      "6407: 9\n",
      "2923: 9\n",
      "8829: 9\n",
      "50802: 9\n",
      "6576: 9\n",
      "31: 9\n",
      "973: 9\n",
      "342184: 9\n",
      "1191: 8\n",
      "6462: 8\n",
      "717: 8\n",
      "177: 8\n",
      "5118: 8\n",
      "2268: 8\n",
      "1431: 8\n",
      "9377: 8\n",
      "7414: 8\n",
      "2170: 8\n",
      "1956: 8\n",
      "9370: 8\n",
      "6372: 8\n",
      "4853: 8\n",
      "18810: 8\n",
      "871: 8\n",
      "2266: 8\n",
      "6262: 8\n",
      "79784: 8\n",
      "1356: 8\n",
      "4162: 8\n",
      "221476: 8\n",
      "713: 8\n",
      "2022: 8\n",
      "151246: 8\n",
      "5347: 8\n",
      "4088: 8\n",
      "6222: 8\n",
      "325: 8\n",
      "6647: 8\n",
      "6472: 8\n",
      "377677: 8\n",
      "4018: 7\n",
      "2152: 7\n",
      "1520: 7\n",
      "11816: 7\n",
      "6360: 7\n",
      "1983: 7\n",
      "6239: 7\n",
      "6256: 7\n",
      "6469: 7\n",
      "2026: 7\n",
      "6280: 7\n",
      "17345: 7\n",
      "16976: 7\n",
      "5763: 7\n",
      "2638: 7\n",
      "6599: 7\n",
      "5788: 7\n",
      "6352: 7\n",
      "6281: 7\n",
      "3572: 7\n",
      "2160: 7\n",
      "2165: 7\n",
      "8547: 7\n",
      "5196: 7\n",
      "9669: 7\n",
      "2876: 7\n",
      "1845: 7\n",
      "4239: 7\n",
      "6347: 6\n",
      "4094: 6\n",
      "4282: 6\n",
      "3959: 6\n",
      "7139: 6\n",
      "2745: 6\n",
      "5004: 6\n",
      "55915: 6\n",
      "866: 6\n",
      "3500: 6\n",
      "4137: 6\n",
      "5653: 6\n",
      "3698: 6\n",
      "2004: 6\n",
      "102637287: 6\n",
      "16449: 6\n",
      "2033: 6\n",
      "87: 6\n",
      "488: 6\n",
      "3493: 6\n",
      "280838: 6\n",
      "725: 6\n",
      "3627: 6\n",
      "5950: 6\n",
      "2316: 6\n",
      "3751: 6\n",
      "3759: 6\n",
      "9126: 6\n",
      "83872: 6\n",
      "3383: 6\n",
      "3992: 6\n",
      "25824: 6\n",
      "203068: 6\n",
      "3512: 6\n",
      "259: 6\n",
      "4257: 6\n",
      "10618: 6\n",
      "25902: 6\n",
      "54927: 6\n",
      "137970: 6\n",
      "1471: 6\n",
      "4224: 6\n",
      "347902: 6\n",
      "60498: 6\n",
      "81: 6\n",
      "4513: 5\n",
      "319: 5\n",
      "7316: 5\n",
      "54205: 5\n",
      "929: 5\n",
      "7155: 5\n",
      "282996: 5\n",
      "382056: 5\n",
      "6624: 5\n",
      "11315: 5\n",
      "2149: 5\n",
      "8862: 5\n",
      "922: 5\n",
      "18128: 5\n",
      "14910: 5\n",
      "2079: 5\n",
      "12091: 5\n",
      "761: 5\n",
      "1158: 5\n",
      "1906: 5\n",
      "1071: 5\n",
      "293: 5\n",
      "715: 5\n",
      "6279: 5\n",
      "83442: 5\n",
      "1072: 5\n",
      "5446: 5\n",
      "6830: 5\n",
      "841: 5\n",
      "3082: 5\n",
      "4283: 5\n",
      "6363: 5\n",
      "3553: 5\n",
      "1499: 5\n",
      "157570: 5\n",
      "1844: 5\n",
      "332: 5\n",
      "3764: 5\n",
      "21345: 5\n",
      "1291: 5\n",
      "2006: 5\n",
      "10544: 5\n",
      "6403: 5\n",
      "29126: 5\n",
      "7037: 5\n",
      "3339: 5\n",
      "441931: 5\n",
      "7295: 5\n",
      "7018: 5\n",
      "15930: 5\n",
      "2796: 5\n",
      "5005: 5\n",
      "5549: 5\n",
      "3026: 5\n",
      "30878: 5\n",
      "8106: 5\n",
      "23211: 5\n",
      "7431: 5\n",
      "6218: 5\n",
      "173: 5\n",
      "3848: 5\n",
      "4314: 5\n",
      "4969: 5\n",
      "10516: 5\n",
      "6278: 4\n",
      "12753: 4\n",
      "346: 4\n",
      "776: 4\n",
      "55540: 4\n",
      "5159: 4\n",
      "2098: 4\n",
      "627: 4\n",
      "5697: 4\n",
      "4478: 4\n",
      "4843: 4\n",
      "4210: 4\n",
      "14725: 4\n",
      "9588: 4\n",
      "7001: 4\n",
      "51115: 4\n",
      "4744: 4\n",
      "7167: 4\n",
      "9622: 4\n",
      "185: 4\n",
      "6772: 4\n",
      "2919: 4\n",
      "8517: 4\n",
      "4629: 4\n",
      "12306: 4\n",
      "182: 4\n",
      "11171: 4\n",
      "654: 4\n",
      "56963: 4\n",
      "84735: 4\n",
      "650: 4\n",
      "22138: 4\n",
      "26998: 4\n",
      "4878: 4\n",
      "283: 4\n",
      "5599;5601;5602: 4\n",
      "5595;5594;5595: 4\n",
      "5599: 4\n",
      "10664: 4\n",
      "5104: 4\n",
      "23616: 4\n",
      "55079: 4\n",
      "10376: 4\n",
      "928: 4\n",
      "3481: 4\n",
      "3678: 4\n",
      "7450: 4\n",
      "9601: 4\n",
      "10130: 4\n",
      "94175: 4\n",
      "346288: 4\n",
      "84680: 4\n",
      "28885: 4\n",
      "55766: 4\n",
      "2209: 4\n",
      "1968: 4\n",
      "3309: 4\n",
      "1632: 4\n",
      "823: 4\n",
      "5831: 4\n",
      "5562: 4\n",
      "139322: 4\n",
      "51142: 4\n",
      "4321: 4\n",
      "1991: 4\n",
      "1950: 4\n",
      "710: 4\n",
      "7045: 4\n",
      "2822: 4\n",
      "5305: 4\n",
      "727897: 4\n",
      "397315: 4\n",
      "643834: 4\n",
      "84898: 4\n",
      "5743: 3\n",
      "11303: 3\n",
      "1893: 3\n",
      "54757: 3\n",
      "57819: 3\n",
      "10327: 3\n",
      "6369: 3\n",
      "4153: 3\n",
      "4055: 3\n",
      "3240: 3\n",
      "4053: 3\n",
      "8029: 3\n",
      "5155: 3\n",
      "2947: 3\n",
      "9805: 3\n",
      "4329: 3\n",
      "23545: 3\n",
      "1400: 3\n",
      "8506: 3\n",
      "4130: 3\n",
      "120: 3\n",
      "4135: 3\n",
      "5315: 3\n",
      "730249: 3\n",
      "3697: 3\n",
      "301: 3\n",
      "12367: 3\n",
      "93692: 3\n",
      "13033: 3\n",
      "20779: 3\n",
      "5216: 3\n",
      "824: 3\n",
      "22061: 3\n",
      "2658: 3\n",
      "226: 3\n",
      "5320: 3\n",
      "6300: 3\n",
      "4604: 3\n",
      "441549: 3\n",
      "1800: 3\n",
      "7994: 3\n",
      "2056: 3\n",
      "25823: 3\n",
      "91107: 3\n",
      "3931: 3\n",
      "5460: 3\n",
      "57306: 3\n",
      "3270: 3\n",
      "6546: 3\n",
      "51279: 3\n",
      "55118: 3\n",
      "801: 3\n",
      "720: 3\n",
      "949: 3\n",
      "714: 3\n",
      "1464: 3\n",
      "5228: 3\n",
      "959: 3\n",
      "682: 3\n",
      "1675: 3\n",
      "3635: 3\n",
      "659: 3\n",
      "1663: 3\n",
      "25836: 3\n",
      "100187907: 3\n",
      "2187: 3\n",
      "2626: 3\n",
      "3791: 3\n",
      "153090: 3\n",
      "1889: 3\n",
      "23136: 3\n",
      "1969: 3\n",
      "290: 3\n",
      "54751: 3\n",
      "1947: 3\n",
      "7852: 3\n",
      "1934: 3\n",
      "1511: 3\n",
      "7502: 3\n",
      "2690: 3\n",
      "10774: 3\n",
      "6264: 3\n",
      "169355: 3\n",
      "3495: 3\n",
      "28410: 3\n",
      "8359: 3\n",
      "28903: 3\n",
      "3699: 3\n",
      "3483: 3\n",
      "2205: 3\n",
      "2688: 3\n",
      "6283: 3\n",
      "6927: 3\n",
      "3172: 3\n",
      "595: 3\n",
      "2034: 3\n",
      "6122: 3\n",
      "808: 3\n",
      "6268: 3\n",
      "4830: 3\n",
      "10312: 3\n",
      "39: 3\n",
      "4713: 3\n",
      "7153: 3\n",
      "7158: 3\n",
      "6208: 3\n",
      "18127: 3\n",
      "6772;20846;6774;20848: 3\n",
      "6774: 3\n",
      "58986: 3\n",
      "90865: 3\n",
      "3606: 3\n",
      "7039: 3\n",
      "5908: 3\n",
      "302: 3\n",
      "829: 3\n",
      "358: 3\n",
      "3507: 3\n",
      "3543: 3\n",
      "26503: 3\n",
      "106480993: 3\n",
      "721: 3\n",
      "15439: 3\n",
      "8630: 3\n",
      "1292: 3\n",
      "10575: 2\n",
      "728378: 2\n",
      "5054: 2\n",
      "2875: 2\n",
      "110446: 2\n",
      "347: 2\n",
      "51449: 2\n",
      "3586: 2\n",
      "3552: 2\n",
      "27086: 2\n",
      "339221: 2\n",
      "4481: 2\n",
      "6285: 2\n",
      "26577: 2\n",
      "5781: 2\n",
      "5828: 2\n",
      "373156: 2\n",
      "7352: 2\n",
      "3162: 2\n",
      "20423: 2\n",
      "368262: 2\n",
      "6853: 2\n",
      "7905: 2\n",
      "3939: 2\n",
      "23576: 2\n",
      "1428: 2\n",
      "10935: 2\n",
      "23114: 2\n",
      "3181: 2\n",
      "51727: 2\n",
      "217: 2\n",
      "914: 2\n",
      "23013: 2\n",
      "59272: 2\n",
      "2309: 2\n",
      "3936: 2\n",
      "3371: 2\n",
      "58516: 2\n",
      "7157: 2\n",
      "4609: 2\n",
      "29146: 2\n",
      "25496: 2\n",
      "19264: 2\n",
      "12514: 2\n",
      "18453: 2\n",
      "22352: 2\n",
      "12406: 2\n",
      "22370: 2\n",
      "17395: 2\n",
      "20201: 2\n",
      "54567: 2\n",
      "4851: 2\n",
      "22402: 2\n",
      "12165: 2\n",
      "18821: 2\n",
      "22339: 2\n",
      "17390: 2\n",
      "12797: 2\n",
      "57320: 2\n",
      "56426: 2\n",
      "312981: 2\n",
      "13726: 2\n",
      "4634: 2\n",
      "7137: 2\n",
      "815: 2\n",
      "817: 2\n",
      "7136: 2\n",
      "4192: 2\n",
      "10135: 2\n",
      "6636: 2\n",
      "29104: 2\n",
      "10961: 2\n",
      "1271: 2\n",
      "9817: 2\n",
      "1360: 2\n",
      "4780: 2\n",
      "3479: 2\n",
      "16000: 2\n",
      "5977: 2\n",
      "9425: 2\n",
      "27291: 2\n",
      "7468: 2\n",
      "114548: 2\n",
      "57088: 2\n",
      "5350: 2\n",
      "818: 2\n",
      "57159: 2\n",
      "223920: 2\n",
      "7068: 2\n",
      "6414: 2\n",
      "1370: 2\n",
      "8876: 2\n",
      "5176: 2\n",
      "7114: 2\n",
      "8407: 2\n",
      "622: 2\n",
      "8781: 2\n",
      "90075: 2\n",
      "5199: 2\n",
      "22918: 2\n",
      "22835: 2\n",
      "22996: 2\n",
      "5329: 2\n",
      "1116: 2\n",
      "7046: 2\n",
      "112950: 2\n",
      "130399: 2\n",
      "136259: 2\n",
      "228357: 2\n",
      "2837: 2\n",
      "5293: 2\n",
      "1820: 2\n",
      "6367: 2\n",
      "5428: 2\n",
      "72415: 2\n",
      "27125: 2\n",
      "7169: 2\n",
      "7171: 2\n",
      "800: 2\n",
      "84260: 2\n",
      "8243: 2\n",
      "55869: 2\n",
      "25789: 2\n",
      "10146: 2\n",
      "94025: 2\n",
      "9046: 2\n",
      "5156: 2\n",
      "3170: 2\n",
      "10643: 2\n",
      "123: 2\n",
      "64866: 2\n",
      "8795: 2\n",
      "288: 2\n",
      "81671: 2\n",
      "9414: 2\n",
      "8541: 2\n",
      "133418: 2\n",
      "54795: 2\n",
      "110454: 2\n",
      "12151: 2\n",
      "8842: 2\n",
      "17470: 2\n",
      "2324: 2\n",
      "774: 2\n",
      "567: 2\n",
      "3689: 2\n",
      "6401: 2\n",
      "598: 2\n",
      "596: 2\n",
      "5710: 2\n",
      "5711: 2\n",
      "128: 2\n",
      "3039: 2\n",
      "260431: 2\n",
      "53369: 2\n",
      "231004: 2\n",
      "3674: 2\n",
      "716;715: 2\n",
      "9971: 2\n",
      "3492: 2\n",
      "633: 2\n",
      "2358: 2\n",
      "55576: 2\n",
      "1410: 2\n",
      "5648: 2\n",
      "10747: 2\n",
      "8365: 2\n",
      "2494: 2\n",
      "5698: 2\n",
      "6275: 2\n",
      "71: 2\n",
      "708: 2\n",
      "7490: 2\n",
      "2767: 2\n",
      "64083: 2\n",
      "51067: 2\n",
      "7841: 2\n",
      "3422: 2\n",
      "55054: 2\n",
      "3710: 2\n",
      "4628: 2\n",
      "143: 2\n",
      "384: 2\n",
      "51070: 2\n",
      "7520: 2\n",
      "440275: 2\n",
      "20846: 2\n",
      "12928: 2\n",
      "4312;4316;4318: 2\n",
      "1000: 2\n",
      "4322: 2\n",
      "3557: 2\n",
      "8809: 2\n",
      "727: 2\n",
      "6302: 2\n",
      "1510: 2\n",
      "57463: 2\n",
      "309: 2\n",
      "4666: 2\n",
      "10627: 2\n",
      "10093: 2\n",
      "2771: 2\n",
      "3690: 2\n",
      "3920: 2\n",
      "2815: 2\n",
      "1465: 2\n",
      "10398: 2\n",
      "5657: 2\n",
      "566: 2\n",
      "2488: 2\n",
      "354: 2\n",
      "50964: 2\n",
      "23647: 2\n",
      "91851: 2\n",
      "28452: 2\n",
      "3849: 2\n",
      "375337: 2\n",
      "571: 2\n",
      "51076: 2\n",
      "15458: 2\n",
      "81570: 2\n",
      "4323: 2\n",
      "57479: 2\n",
      "5604: 2\n",
      "1462: 2\n",
      "306: 2\n",
      "24609: 2\n",
      "911: 1\n",
      "7248: 1\n",
      "2185: 1\n",
      "11865: 1\n",
      "406: 1\n",
      "4862: 1\n",
      "406947: 1\n",
      "5742: 1\n",
      "133522;5468: 1\n",
      "4512: 1\n",
      "23082: 1\n",
      "22796: 1\n",
      "291567: 1\n",
      "56606: 1\n",
      "6287: 1\n",
      "3558: 1\n",
      "95;27122: 1\n",
      "196: 1\n",
      "10894: 1\n",
      "2530: 1\n",
      "4792: 1\n",
      "13040: 1\n",
      "10614: 1\n",
      "16177: 1\n",
      "56975: 1\n",
      "5581: 1\n",
      "3727: 1\n",
      "2736: 1\n",
      "7941: 1\n",
      "76477: 1\n",
      "9332: 1\n",
      "57783: 1\n",
      "51311: 1\n",
      "6359: 1\n",
      "6368: 1\n",
      "29569: 1\n",
      "7132: 1\n",
      "1118: 1\n",
      "8463: 1\n",
      "2950: 1\n",
      "3308: 1\n",
      "83805: 1\n",
      "8431: 1\n",
      "306;2243: 1\n",
      "2987: 1\n",
      "100271694: 1\n",
      "171483: 1\n",
      "206412: 1\n",
      "5408: 1\n",
      "64848: 1\n",
      "56155: 1\n",
      "3949: 1\n",
      "21974: 1\n",
      "9423: 1\n",
      "3567: 1\n",
      "253559: 1\n",
      "6855: 1\n",
      "5037: 1\n",
      "3040: 1\n",
      "760: 1\n",
      "93185: 1\n",
      "961: 1\n",
      "998: 1\n",
      "7447: 1\n",
      "2782: 1\n",
      "23545;4709: 1\n",
      "9446: 1\n",
      "1743: 1\n",
      "9201: 1\n",
      "3501: 1\n",
      "7453: 1\n",
      "7432: 1\n",
      "28815: 1\n",
      "14268: 1\n",
      "56729: 1\n",
      "5970: 1\n",
      "257629: 1\n",
      "4092: 1\n",
      "285: 1\n",
      "22: 1\n",
      "5690: 1\n",
      "6634: 1\n",
      "7879: 1\n",
      "3123: 1\n",
      "6035: 1\n",
      "4522: 1\n",
      "813: 1\n",
      "4837: 1\n",
      "11151: 1\n",
      "5654: 1\n",
      "1200: 1\n",
      "4048: 1\n",
      "22871: 1\n",
      "51129: 1\n",
      "16198: 1\n",
      "19664: 1\n",
      "20201;20202: 1\n",
      "20202: 1\n",
      "54485: 1\n",
      "4854: 1\n",
      "15213: 1\n",
      "12576: 1\n",
      "20344: 1\n",
      "17392: 1\n",
      "22417: 1\n",
      "12387: 1\n",
      "22413: 1\n",
      "13805: 1\n",
      "15251: 1\n",
      "16952: 1\n",
      "22060: 1\n",
      "18226: 1\n",
      "14828: 1\n",
      "14775: 1\n",
      "12505: 1\n",
      "17313: 1\n",
      "4256: 1\n",
      "12043: 1\n",
      "12215: 1\n",
      "68588: 1\n",
      "23789: 1\n",
      "93689: 1\n",
      "118449: 1\n",
      "67399: 1\n",
      "233335: 1\n",
      "13430: 1\n",
      "19223: 1\n",
      "19015: 1\n",
      "56717: 1\n",
      "14056: 1\n",
      "16418: 1\n",
      "20692: 1\n",
      "14173: 1\n",
      "19016: 1\n",
      "13846: 1\n",
      "15205: 1\n",
      "11651: 1\n",
      "18132: 1\n",
      "13448: 1\n",
      "7205: 1\n",
      "68365: 1\n",
      "13649: 1\n",
      "14183: 1\n",
      "14086: 1\n",
      "15129: 1\n",
      "393775: 1\n",
      "65973: 1\n",
      "541344: 1\n",
      "40506: 1\n",
      "109905: 1\n",
      "217737: 1\n",
      "18033: 1\n",
      "18035: 1\n",
      "56458: 1\n",
      "1027: 1\n",
      "84648: 1\n",
      "4067: 1\n",
      "608: 1\n",
      "2208: 1\n",
      "4915: 1\n",
      "5623: 1\n",
      "10541: 1\n",
      "100131268: 1\n",
      "56677: 1\n",
      "4190: 1\n",
      "4916: 1\n",
      "9021: 1\n",
      "482: 1\n",
      "816: 1\n",
      "127294: 1\n",
      "13405: 1\n",
      "22288: 1\n",
      "2489: 1\n",
      "16002: 1\n",
      "477: 1\n",
      "3779: 1\n",
      "22933: 1\n",
      "23410: 1\n",
      "57108: 1\n",
      "4087;4088: 1\n",
      "3066;9759;10014: 1\n",
      "4300: 1\n",
      "1387: 1\n",
      "9759: 1\n",
      "19017: 1\n",
      "11806: 1\n",
      "6657: 1\n",
      "9314: 1\n",
      "27074: 1\n",
      "11938: 1\n",
      "51422: 1\n",
      "9997: 1\n",
      "84676: 1\n",
      "84675: 1\n",
      "5360: 1\n",
      "6291: 1\n",
      "5967: 1\n",
      "2159: 1\n",
      "2158: 1\n",
      "105259599: 1\n",
      "55600: 1\n",
      "7993: 1\n",
      "9619: 1\n",
      "7421: 1\n",
      "100009253: 1\n",
      "18979: 1\n",
      "55247: 1\n",
      "51592: 1\n",
      "6906: 1\n",
      "64805: 1\n",
      "3486: 1\n",
      "8772: 1\n",
      "836: 1\n",
      "8815: 1\n",
      "22693: 1\n",
      "14825: 1\n",
      "4907: 1\n",
      "7070: 1\n",
      "7079: 1\n",
      "1116;1675: 1\n",
      "1435: 1\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "6019: 1\n",
      "284;285: 1\n",
      "8038: 1\n",
      "2735: 1\n",
      "2833: 1\n",
      "6373: 1\n",
      "1236: 1\n",
      "6366: 1\n",
      "7042: 1\n",
      "55532: 1\n",
      "1306: 1\n",
      "51535: 1\n",
      "64167: 1\n",
      "23768: 1\n",
      "92: 1\n",
      "5457: 1\n",
      "9033: 1\n",
      "6558: 1\n",
      "775: 1\n",
      "785: 1\n",
      "766: 1\n",
      "64116: 1\n",
      "2250: 1\n",
      "2254: 1\n",
      "81575: 1\n",
      "10266: 1\n",
      "11318: 1\n",
      "115557: 1\n",
      "4140: 1\n",
      "56034: 1\n",
      "7201: 1\n",
      "134: 1\n",
      "2555: 1\n",
      "5139: 1\n",
      "6523: 1\n",
      "1453: 1\n",
      "2077: 1\n",
      "11535: 1\n",
      "12310: 1\n",
      "54598: 1\n",
      "72: 1\n",
      "1890: 1\n",
      "322275: 1\n",
      "4682: 1\n",
      "23352: 1\n",
      "407: 1\n",
      "5177: 1\n",
      "3552;3562;3567;3576: 1\n",
      "7040;21803: 1\n",
      "81693: 1\n",
      "326: 1\n",
      "4585: 1\n",
      "545370: 1\n",
      "21803: 1\n",
      "6406: 1\n",
      "367: 1\n",
      "668478: 1\n",
      "16017: 1\n",
      "10678: 1\n",
      "4069: 1\n",
      "51266: 1\n",
      "100302740: 1\n",
      "5308: 1\n",
      "21825: 1\n",
      "6310: 1\n",
      "9429: 1\n",
      "16590: 1\n",
      "5015: 1\n",
      "6615: 1\n",
      "3651: 1\n",
      "64321: 1\n",
      "176: 1\n",
      "4074: 1\n",
      "4924: 1\n",
      "5351: 1\n",
      "57554: 1\n",
      "23037: 1\n",
      "25977: 1\n",
      "6709: 1\n",
      "3675: 1\n",
      "58513: 1\n",
      "23516: 1\n",
      "133957: 1\n",
      "20: 1\n",
      "2043: 1\n",
      "57582: 1\n",
      "64398: 1\n",
      "7436: 1\n",
      "80727: 1\n",
      "6541: 1\n",
      "8793: 1\n",
      "57003: 1\n",
      "84059: 1\n",
      "3673: 1\n",
      "7433: 1\n",
      "8325: 1\n",
      "59284;50848: 1\n",
      "1002: 1\n",
      "3384: 1\n",
      "8482: 1\n",
      "12562: 1\n",
      "16456: 1\n",
      "6531: 1\n",
      "26269: 1\n",
      "2990: 1\n",
      "3028: 1\n",
      "5420: 1\n",
      "1297: 1\n",
      "3480: 1\n",
      "131450: 1\n",
      "648: 1\n",
      "10411: 1\n",
      "54386: 1\n",
      "7296: 1\n",
      "7057;2153: 1\n",
      "5269: 1\n",
      "653509: 1\n",
      "100328595: 1\n",
      "14827: 1\n",
      "4626: 1\n",
      "4085: 1\n",
      "3683: 1\n",
      "3687: 1\n",
      "5055: 1\n",
      "637: 1\n",
      "581: 1\n",
      "330: 1\n",
      "2662: 1\n",
      "10549: 1\n",
      "2882;493869: 1\n",
      "308: 1\n",
      "2811: 1\n",
      "27035: 1\n",
      "5588: 1\n",
      "1909: 1\n",
      "116844: 1\n",
      "5879: 1\n",
      "4644: 1\n",
      "8228: 1\n",
      "8993: 1\n",
      "89858: 1\n",
      "5364: 1\n",
      "51497: 1\n",
      "29993: 1\n",
      "2;201780: 1\n",
      "4023: 1\n",
      "1879: 1\n",
      "28898;28884: 1\n",
      "16153: 1\n",
      "6999: 1\n",
      "883: 1\n",
      "3156: 1\n",
      "56720: 1\n",
      "3458: 1\n",
      "4524: 1\n",
      "5212: 1\n",
      "28452;3512: 1\n",
      "10462: 1\n",
      "1588: 1\n",
      "2920: 1\n",
      "5664: 1\n",
      "83931: 1\n",
      "81494: 1\n",
      "3588: 1\n",
      "6776: 1\n",
      "383: 1\n",
      "9611: 1\n",
      "7376: 1\n",
      "3570: 1\n",
      "4050: 1\n",
      "4973: 1\n",
      "5579: 1\n",
      "5582: 1\n",
      "1019: 1\n",
      "4043: 1\n",
      "5721: 1\n",
      "8743: 1\n",
      "715;716: 1\n",
      "9510: 1\n",
      "1369: 1\n",
      "2162: 1\n",
      "9245: 1\n",
      "139760: 1\n",
      "79577: 1\n",
      "407008: 1\n",
      "83939: 1\n",
      "8663: 1\n",
      "1975: 1\n",
      "8672: 1\n",
      "387: 1\n",
      "2099: 1\n",
      "2100: 1\n",
      "28957: 1\n",
      "10240: 1\n",
      "51081: 1\n",
      "10682: 1\n",
      "3725: 1\n",
      "6224: 1\n",
      "84864: 1\n",
      "5447: 1\n",
      "2879: 1\n",
      "39866: 1\n",
      "3091: 1\n",
      "494336: 1\n",
      "574506: 1\n",
      "10413: 1\n",
      "6901: 1\n",
      "4205: 1\n",
      "472: 1\n",
      "78294: 1\n",
      "20848: 1\n",
      "19353: 1\n",
      "22324: 1\n",
      "101082699: 1\n",
      "101083283: 1\n",
      "1515: 1\n",
      "2308: 1\n",
      "28809: 1\n",
      "1396: 1\n",
      "4313: 1\n",
      "4326: 1\n",
      "7078: 1\n",
      "100861467: 1\n",
      "4586: 1\n",
      "2251: 1\n",
      "80781: 1\n",
      "2641: 1\n",
      "56931: 1\n",
      "84639: 1\n",
      "1875: 1\n",
      "57644: 1\n",
      "85480: 1\n",
      "21826: 1\n",
      "1829: 1\n",
      "8718: 1\n",
      "57142: 1\n",
      "5592: 1\n",
      "3852: 1\n",
      "9948: 1\n",
      "2812: 1\n",
      "5880: 1\n",
      "7277: 1\n",
      "1278: 1\n",
      "4052: 1\n",
      "1213: 1\n",
      "11153: 1\n",
      "3113: 1\n",
      "5906: 1\n",
      "9567: 1\n",
      "23886: 1\n",
      "16337: 1\n",
      "11201: 1\n",
      "8144: 1\n",
      "10220: 1\n",
      "14561: 1\n",
      "7402: 1\n",
      "57338: 1\n",
      "57107: 1\n",
      "16835: 1\n",
      "653820: 1\n",
      "4150: 1\n",
      "759: 1\n",
      "2877: 1\n",
      "727;729: 1\n",
      "18024: 1\n",
      "12013: 1\n",
      "80739: 1\n",
      "64386: 1\n",
      "281401: 1\n",
      "83953: 1\n",
      "805: 1\n",
      "9086: 1\n",
      "8907: 1\n",
      "3188: 1\n",
      "55763: 1\n",
      "11532: 1\n",
      "1050: 1\n",
      "25291: 1\n",
      "24185: 1\n",
      "29116: 1\n",
      "25149: 1\n",
      "\n",
      "** Gene frequency in each document (identified by PubMed Central ID):\n",
      "5695135: [('3816', 25), ('3494', 19), ('820', 16), ('1738', 10), ('6236', 5), ('4879', 4), ('6278', 4), ('3958', 2), ('27241', 2), ('10575', 2), ('728378', 1), ('911', 1), ('7248', 1), ('5054', 1), ('1401', 1), ('207', 1), ('2185', 1), ('4846', 1)]\n",
      "5719427: [('9575', 21), ('8991', 7), ('966', 7), ('1628', 6), ('12753', 4), ('3952', 1), ('3630', 1), ('11865', 1), ('406', 1), ('4862', 1), ('406947', 1)]\n",
      "5813793: [('152330', 41), ('133522', 40), ('1351', 13), ('10891', 9), ('4513', 5), ('5465', 5), ('5743', 3), ('5468', 3), ('5742', 1), ('133522;5468', 1), ('4512', 1), ('23082', 1), ('22796', 1), ('4018', 1), ('291567', 1), ('56606', 1), ('6347', 1)]\n",
      "5837105: [('4353', 71), ('335', 11), ('338', 7), ('3569', 4), ('7124', 4), ('6347', 3), ('4397', 3), ('27241', 2), ('1401', 2), ('348', 2), ('336', 2), ('337', 2), ('341', 2), ('345', 2), ('346', 2), ('347', 2), ('319', 2), ('1191', 2), ('51449', 2), ('5444', 2), ('7448', 2), ('19', 2), ('2875', 1), ('966', 1), ('3630', 1), ('110446', 1), ('11303', 1), ('6287', 1), ('6288', 1), ('6462', 1), ('4846', 1), ('3558', 1), ('3586', 1), ('4018', 1)]\n",
      "5849518: [('5496', 31), ('348', 28), ('4790', 7), ('4094', 6), ('7316', 5), ('3554', 5), ('3959', 5), ('4282', 4), ('776', 4), ('55540', 4), ('2597', 3), ('177', 3), ('54757', 3), ('57819', 3), ('2934', 3), ('1520', 3), ('10327', 3), ('2152', 2), ('3552', 2), ('5265', 2), ('27086', 2), ('1272', 2), ('7077', 2), ('3630', 2), ('339221', 2), ('4481', 2), ('95;27122', 1), ('7058', 1), ('1893', 1), ('717', 1), ('196', 1), ('10894', 1), ('629', 1), ('2530', 1), ('4792', 1), ('13040', 1), ('10614', 1), ('16177', 1), ('11816', 1), ('56975', 1), ('5581', 1), ('3727', 1), ('2736', 1), ('5159', 1)]\n",
      "5869115: [('1401', 10), ('5118', 8), ('6360', 7), ('7035', 5), ('2152', 5), ('6369', 3), ('4153', 3), ('4055', 3), ('4879', 2), ('9518', 2), ('6285', 2), ('26577', 2), ('6761', 1), ('3958', 1), ('7139', 1), ('7941', 1), ('5972', 1), ('76477', 1), ('3569', 1), ('9332', 1), ('3630', 1), ('57783', 1), ('51311', 1), ('6359', 1), ('6368', 1), ('29569', 1), ('7132', 1), ('1118', 1)]\n",
      "5880582: [('3303', 30), ('9049', 10), ('5481', 10), ('3630', 9), ('2268', 8), ('1431', 8), ('9377', 8), ('1983', 7), ('6714', 5), ('2098', 4), ('627', 4), ('5697', 4), ('54205', 3), ('5781', 2), ('5828', 2), ('373156', 2), ('7352', 2), ('7414', 1), ('8463', 1), ('2950', 1), ('3308', 1), ('83805', 1), ('8431', 1), ('2745', 1), ('3162', 1)]\n",
      "5905170: [('338', 11), ('2', 10), ('4036', 10), ('23334', 9), ('6239', 7), ('6469', 7), ('55915', 6), ('7155', 5), ('282996', 5), ('382056', 5), ('3929', 4), ('4843', 4), ('4210', 4), ('14725', 4), ('183', 4), ('335', 4), ('4053', 3), ('8029', 3), ('5004', 2), ('929', 2), ('2335', 2), ('27241', 2), ('3053', 2), ('3569', 2), ('5972', 2), ('368262', 2), ('306;2243', 1), ('2987', 1), ('3240', 1), ('7057', 1), ('4397', 1), ('4478', 1), ('100271694', 1), ('7040', 1), ('171483', 1), ('206412', 1), ('5408', 1), ('64848', 1), ('56155', 1), ('6256', 1), ('3949', 1), ('20423', 1), ('11816', 1), ('21974', 1), ('5155', 1), ('7273', 1), ('9423', 1), ('2475', 1), ('866', 1)]\n",
      "5931620: [('351', 27), ('2670', 27), ('3918', 20), ('1509', 14), ('4900', 11), ('5660', 9), ('2026', 7), ('2170', 6), ('4137', 6), ('6624', 5), ('9588', 4), ('11315', 4), ('7001', 4), ('51115', 4), ('4744', 4), ('7167', 4), ('2947', 3), ('9805', 3), ('4329', 3), ('23545', 3), ('1400', 3), ('2039', 3), ('4130', 3), ('120', 3), ('4135', 3), ('5315', 3), ('6853', 2), ('3939', 2), ('3500', 2), ('23576', 2), ('1428', 2), ('10935', 2), ('8506', 2), ('23114', 2), ('3181', 2), ('51727', 2), ('217', 2), ('914', 2), ('3567', 1), ('253559', 1), ('6855', 1), ('7905', 1), ('1272', 1), ('5037', 1), ('3040', 1), ('760', 1), ('93185', 1), ('961', 1), ('998', 1), ('7447', 1), ('2782', 1), ('23545;4709', 1), ('9446', 1), ('1743', 1), ('9201', 1), ('3501', 1), ('7453', 1), ('7432', 1), ('6236', 1), ('7422', 1)]\n",
      "5949160: [('4311', 34), ('7412', 26), ('6696', 17), ('183', 11), ('2335', 8), ('3827', 8), ('2', 5), ('1636', 4), ('9622', 4), ('185', 4), ('4478', 3), ('27241', 3), ('1956', 3), ('23013', 2), ('59272', 2), ('28815', 1), ('3816', 1), ('14268', 1), ('3240', 1), ('9370', 1), ('56729', 1), ('5970', 1), ('257629', 1), ('4092', 1), ('285', 1), ('6772', 1)]\n",
      "5962559: [('4879', 16), ('3952', 9), ('177', 4), ('6372', 4), ('2919', 4), ('958', 4), ('8517', 4), ('7422', 4), ('5653', 4), ('5175', 4), ('2149', 4), ('4312', 4), ('7124', 2), ('1401', 1), ('22', 1), ('2309', 1), ('8862', 1)]\n",
      "6011234: [('7124', 9), ('5465', 9), ('5468', 9), ('3643', 8), ('22915', 7), ('2004', 6), ('7448', 5), ('4629', 3), ('730249', 3), ('3936', 2), ('1508', 2), ('7057', 2), ('3371', 2), ('922', 2), ('58516', 2), ('5690', 1), ('6634', 1), ('7905', 1), ('7879', 1), ('3123', 1), ('6035', 1), ('4522', 1), ('813', 1), ('4837', 1), ('6280', 1), ('3698', 1), ('10631', 1), ('11151', 1), ('5654', 1), ('338', 1), ('1200', 1), ('3697', 1), ('4048', 1), ('3630', 1), ('2335', 1), ('11816', 1), ('301', 1), ('22871', 1), ('51129', 1), ('7040', 1), ('7157', 1), ('4609', 1)]\n",
      "6023756: [('18129', 134), ('31293', 58), ('17880', 37), ('18131', 17), ('4853', 8), ('18810', 8), ('17345', 7), ('102637287', 6), ('16449', 6), ('18128', 5), ('14910', 5), ('2079', 5), ('12091', 5), ('12306', 4), ('182', 4), ('871', 4), ('7448', 4), ('12367', 3), ('93692', 3), ('22061', 3), ('29146', 2), ('25496', 2), ('5155', 2), ('19264', 2), ('12514', 2), ('18453', 2), ('22352', 2), ('12406', 2), ('22370', 2), ('17395', 2), ('13033', 2), ('20201', 2), ('54567', 2), ('4851', 2), ('22402', 2), ('12165', 2), ('22339', 2), ('17390', 2), ('12797', 2), ('57320', 2), ('56426', 2), ('312981', 2), ('2170', 2), ('13726', 2), ('16198', 1), ('5034', 1), ('19664', 1), ('20201;20202', 1), ('20202', 1), ('54485', 1), ('4854', 1), ('15213', 1), ('12576', 1), ('20344', 1), ('17392', 1), ('22417', 1), ('12387', 1), ('22413', 1), ('13805', 1), ('15251', 1), ('16952', 1), ('22060', 1), ('18226', 1), ('14828', 1), ('20779', 1), ('14775', 1), ('12505', 1), ('17313', 1), ('4256', 1), ('649', 1), ('12043', 1), ('12215', 1), ('68588', 1), ('5216', 1), ('23789', 1), ('93689', 1), ('118449', 1), ('67399', 1), ('18821', 1), ('233335', 1), ('13430', 1), ('19223', 1), ('19015', 1), ('2192', 1), ('56717', 1), ('824', 1), ('14056', 1), ('16418', 1), ('20692', 1), ('14173', 1), ('19016', 1), ('13846', 1), ('15205', 1), ('11651', 1), ('18132', 1), ('13448', 1), ('7205', 1), ('68365', 1), ('13649', 1), ('14183', 1), ('14086', 1), ('15129', 1), ('393775', 1), ('65973', 1), ('541344', 1), ('40506', 1), ('109905', 1), ('217737', 1), ('11171', 1), ('18033', 1), ('18035', 1), ('56458', 1), ('2658', 1), ('1027', 1), ('7057', 1)]\n",
      "6104105: [('1756', 110), ('3952', 7), ('2195', 7), ('3053', 6), ('7077', 5), ('761', 5), ('1158', 5), ('649', 5), ('654', 4), ('7040', 4), ('56963', 4), ('11171', 3), ('226', 3), ('5320', 3), ('6300', 3), ('4604', 3), ('3482', 3), ('441549', 3), ('4634', 2), ('718', 2), ('2243', 2), ('2244', 2), ('2266', 2), ('3630', 2), ('2658', 2), ('815', 2), ('817', 2), ('7136', 2), ('4192', 2), ('10135', 2), ('6636', 2), ('29104', 2), ('10961', 2), ('1271', 2), ('9817', 2), ('1360', 2), ('4318', 2), ('84648', 1), ('348', 1), ('4067', 1), ('5340', 1), ('608', 1), ('2208', 1), ('4915', 1), ('5623', 1), ('10541', 1), ('7137', 1), ('100131268', 1), ('56677', 1), ('4190', 1), ('4916', 1), ('1800', 1), ('84735', 1), ('4780', 1), ('183', 1), ('9021', 1), ('3479', 1), ('207', 1), ('482', 1), ('816', 1), ('127294', 1), ('2335', 1), ('13405', 1), ('22288', 1), ('2489', 1), ('16002', 1), ('650', 1), ('16000', 1), ('477', 1)]\n",
      "6152976: [('7547', 29), ('3075', 22), ('16976', 7), ('5972', 6), ('2475', 4), ('2244', 4), ('3779', 1)]\n",
      "6156053: [('2033', 6), ('7994', 3), ('25823', 3), ('27241', 3), ('91107', 3), ('7040', 3), ('10891', 3), ('5977', 2), ('9425', 2), ('2056', 2), ('27291', 2), ('6772', 2), ('23411', 1), ('22933', 1), ('23410', 1), ('57108', 1), ('4087;4088', 1), ('3066;9759;10014', 1), ('4300', 1), ('1387', 1), ('9759', 1), ('19017', 1)]\n",
      "6162093: [('335', 93), ('338', 14), ('5763', 7), ('19', 4), ('4397', 2), ('7468', 2), ('110446', 1), ('114548', 1), ('11806', 1), ('3931', 1), ('1508', 1), ('8991', 1)]\n",
      "6192629: [('7273', 80), ('183', 20), ('6262', 8), ('56925', 5), ('79784', 5), ('488', 5), ('87', 4), ('22138', 4), ('7139', 4), ('5460', 3), ('57306', 3), ('3270', 3), ('6546', 3), ('57088', 2), ('5350', 2), ('818', 2), ('57159', 2), ('6657', 1), ('9314', 1), ('4609', 1), ('27074', 1), ('11938', 1), ('18821', 1), ('51422', 1), ('1756', 1), ('9997', 1), ('1906', 1), ('84676', 1), ('84675', 1)]\n",
      "6196832: [('4353', 54), ('3933', 18), ('338', 7), ('5444', 6), ('3630', 4), ('335', 3), ('4397', 3), ('348', 3), ('1071', 3), ('223920', 2), ('11303', 2), ('336', 2), ('344', 2), ('8542', 2), ('19', 2), ('1', 1), ('337', 1), ('341', 1), ('3493', 1), ('3697', 1), ('5360', 1), ('6291', 1), ('346', 1), ('5967', 1), ('4318', 1), ('6347', 1), ('1401', 1)]\n",
      "6242904: [('100130342', 25), ('1401', 20), ('3217', 15), ('3630', 14), ('344', 10), ('118471', 9), ('5858', 7), ('6462', 7), ('280838', 6), ('3426', 5), ('866', 5), ('722', 5), ('6280', 5), ('6279', 5), ('26998', 4), ('725', 4), ('3827', 3), ('51279', 3), ('3263', 3), ('715', 3), ('1356', 3), ('55118', 3), ('7077', 3), ('2202', 3), ('3075', 3), ('629', 3), ('1509', 3), ('293', 2), ('7068', 2), ('6414', 2), ('1370', 2), ('1', 2), ('4060', 2), ('8876', 2), ('5176', 2), ('801', 2), ('7114', 2), ('1072', 2), ('5216', 2), ('8407', 2), ('716', 2), ('622', 2), ('462', 1), ('2159', 1), ('2147', 1), ('2158', 1), ('105259599', 1), ('114770', 1), ('3959', 1), ('83442', 1), ('3697', 1), ('3698', 1), ('7124', 1), ('9370', 1), ('55600', 1), ('7993', 1)]\n",
      "6263790: [('820', 12), ('337', 12), ('6288', 12), ('335', 11), ('5444', 8), ('2934', 7), ('2638', 6), ('717', 5), ('19', 4), ('341', 4), ('3827', 3), ('2', 3), ('344', 3), ('319', 3), ('293', 3), ('3493', 3), ('629', 3), ('716', 3), ('3500', 3), ('720', 3), ('348', 3), ('8781', 2), ('3931', 2), ('336', 2), ('345', 2), ('462', 1), ('718', 1), ('114548', 1), ('9619', 1), ('949', 1), ('7421', 1), ('346', 1), ('1191', 1), ('100009253', 1), ('4018', 1), ('18979', 1), ('338', 1), ('5446', 1)]\n",
      "6264811: [('6402', 9), ('221476', 8), ('6599', 7), ('3075', 7), ('712', 6), ('6830', 5), ('841', 5), ('713', 4), ('4878', 4), ('714', 3), ('90075', 2), ('5199', 2), ('715', 2), ('716', 2), ('2147', 2), ('22835', 2), ('22996', 2), ('4162', 1), ('6236', 1), ('1956', 1), ('335', 1), ('6280', 1), ('55247', 1), ('51592', 1), ('5267', 1), ('6906', 1), ('5340', 1), ('22918', 1), ('64805', 1), ('3479', 1), ('3486', 1), ('8772', 1), ('836', 1), ('8815', 1), ('22693', 1), ('14825', 1)]\n",
      "6265639: [('38', 65), ('948', 16), ('947', 8), ('4162', 7), ('6352', 7), ('3627', 6), ('3082', 5), ('4283', 5), ('6363', 5), ('5788', 4), ('5175', 4), ('2022', 4), ('958', 4), ('3485', 4), ('5159', 3), ('1464', 3), ('283', 3), ('5228', 3), ('3952', 3), ('9370', 3), ('959', 3), ('682', 3), ('9518', 3), ('3554', 3), ('1803', 2), ('7058', 2), ('4282', 2), ('5950', 2), ('7124', 2), ('5329', 2), ('7422', 2), ('3630', 2), ('1116', 2), ('4907', 1), ('7070', 1), ('1003', 1), ('7079', 1), ('118471', 1), ('929', 1), ('1116;1675', 1), ('1435', 1), ('6019', 1), ('6761', 1), ('284;285', 1), ('1675', 1), ('20423', 1), ('8038', 1), ('2735', 1), ('3553', 1), ('2833', 1), ('6373', 1), ('1236', 1), ('6366', 1)]\n",
      "6284793: [('1628', 16), ('1423', 10), ('7040', 10), ('1499', 5), ('7422', 5), ('348', 4), ('11816', 3), ('133', 3), ('112950', 2), ('130399', 2), ('650', 2), ('136259', 2), ('228357', 2), ('2837', 2), ('5293', 2), ('1820', 2), ('54205', 2), ('6367', 2), ('7042', 1), ('55532', 1), ('7046', 1), ('1306', 1), ('23334', 1), ('51535', 1), ('64167', 1), ('23768', 1), ('92', 1), ('5457', 1), ('9033', 1), ('6558', 1), ('775', 1), ('785', 1), ('766', 1), ('64116', 1), ('2250', 1), ('2254', 1), ('81575', 1), ('10266', 1), ('11318', 1), ('115557', 1), ('183', 1), ('4140', 1), ('56034', 1), ('7201', 1), ('134', 1), ('2555', 1), ('5139', 1), ('6523', 1), ('1453', 1), ('2077', 1), ('3635', 1), ('659', 1), ('11535', 1), ('12310', 1), ('54598', 1)]\n",
      "6369230: [('151648', 53), ('11102', 47), ('7040', 40), ('699', 33), ('6876', 25), ('5885', 12), ('10320', 12), ('151246', 8), ('5347', 8), ('4088', 8), ('3751', 6), ('3759', 6), ('9126', 6), ('157570', 5), ('1844', 5), ('3764', 5), ('6281', 5), ('5594', 5), ('21345', 5), ('332', 4), ('5595;5594', 4), ('5599;5601;5602', 4), ('5595;5594;5595', 4), ('10664', 4), ('4591', 4), ('1663', 3), ('25836', 3), ('2597', 3), ('2316', 2), ('5428', 2), ('72415', 2), ('27125', 2), ('22915', 2), ('7169', 2), ('800', 2), ('84260', 2), ('5599', 2), ('8243', 2), ('55869', 2), ('25789', 2), ('72', 1), ('1890', 1), ('7171', 1), ('7046', 1), ('322275', 1), ('6236', 1), ('4682', 1), ('338', 1), ('23352', 1)]\n",
      "6398744: [('407', 1), ('5177', 1)]\n",
      "6399814: [('1012', 26), ('7276', 16), ('4582', 12), ('6407', 9), ('83872', 6), ('1291', 5), ('2006', 4), ('83442', 4), ('5104', 4), ('23616', 4), ('9370', 3), ('10544', 3), ('7040', 2), ('10146', 2), ('3552;3562;3567;3576', 1), ('2244', 1), ('27241', 1), ('7422', 1), ('7040;21803', 1), ('2745', 1), ('7124', 1), ('6696', 1), ('81693', 1), ('326', 1), ('4585', 1), ('94025', 1), ('545370', 1), ('21803', 1), ('6406', 1), ('367', 1)]\n",
      "6403451: [('51206', 72), ('2244', 26), ('1401', 22), ('6714', 22), ('5336', 11), ('722', 8), ('7057', 7), ('2147', 5), ('2597', 5), ('55079', 4), ('6403', 4), ('3630', 3), ('2187', 3), ('56925', 2), ('100187907', 2), ('87', 2), ('668478', 1), ('16017', 1), ('10678', 1), ('4069', 1), ('51266', 1), ('7414', 1), ('100302740', 1), ('9046', 1), ('5308', 1), ('21825', 1)]\n",
      "6420620: [('9242', 96), ('59284', 37), ('50848', 31), ('2828', 29), ('1003', 28), ('3482', 17), ('1803', 17), ('3815', 16), ('4345', 13), ('966', 10), ('3485', 9), ('3572', 7), ('29126', 5), ('7037', 5), ('441931', 5), ('6372', 4), ('10376', 4), ('928', 4), ('3481', 4), ('3678', 4), ('3383', 4), ('2022', 4), ('2626', 3), ('3791', 3), ('4312', 3), ('153090', 3), ('1889', 3), ('23136', 3), ('1969', 3), ('290', 3), ('54751', 3), ('1947', 3), ('2597', 3), ('5156', 2), ('10643', 2), ('3553', 2), ('123', 2), ('64866', 2), ('8795', 2), ('288', 2), ('81671', 2), ('3339', 2), ('9414', 2), ('8541', 2), ('133418', 2), ('3992', 2), ('54795', 2), ('110454', 2), ('12151', 2), ('958', 2), ('8842', 2), ('17470', 2), ('2324', 2), ('774', 2), ('6310', 1), ('9429', 1), ('16590', 1), ('5015', 1), ('6615', 1), ('3170', 1), ('3651', 1), ('64321', 1), ('176', 1), ('4074', 1), ('4924', 1), ('5351', 1), ('57554', 1), ('8506', 1), ('23037', 1), ('25977', 1), ('6709', 1), ('3675', 1), ('58513', 1), ('23516', 1), ('133957', 1), ('20', 1), ('2043', 1), ('57582', 1), ('64398', 1), ('7436', 1), ('80727', 1), ('6541', 1), ('8793', 1), ('57003', 1), ('1956', 1), ('84059', 1), ('3673', 1), ('7852', 1), ('7433', 1), ('8325', 1), ('22918', 1), ('59284;50848', 1), ('1002', 1), ('488', 1), ('947', 1), ('3384', 1), ('8482', 1), ('12562', 1), ('16456', 1), ('6531', 1), ('27241', 1), ('213', 1), ('26269', 1), ('2990', 1), ('3028', 1), ('5420', 1), ('1297', 1), ('3643', 1), ('3480', 1), ('131450', 1), ('648', 1), ('5788', 1), ('10411', 1), ('54386', 1)]\n",
      "6430080: [('5034', 326), ('56925', 21), ('2923', 9), ('722', 7), ('2335', 6), ('3273', 6), ('7295', 5), ('9601', 4), ('2745', 4), ('6222', 4), ('94175', 4), ('7450', 3), ('1934', 3), ('7448', 3), ('1401', 3), ('10130', 3), ('2244', 3), ('567', 2), ('3827', 2), ('929', 2), ('3689', 2), ('3383', 2), ('6401', 2), ('2243', 2), ('598', 2), ('596', 2), ('5710', 2), ('5711', 2), ('25824', 2), ('2147', 2), ('7296', 1), ('7057;2153', 1), ('5269', 1), ('653509', 1), ('100328595', 1), ('14827', 1), ('1003', 1), ('4626', 1), ('4085', 1), ('3683', 1), ('3687', 1), ('6402', 1), ('5054', 1), ('5055', 1), ('597', 1), ('637', 1), ('581', 1), ('330', 1), ('2662', 1), ('7018', 1), ('728378', 1), ('10549', 1), ('2882;493869', 1), ('308', 1), ('7057', 1), ('1511', 1), ('2811', 1), ('2878', 1), ('128', 1), ('27035', 1), ('2160', 1), ('5588', 1), ('1909', 1), ('116844', 1), ('5879', 1)]\n",
      "6437869: [('3700', 36), ('213', 31), ('1', 23), ('3080', 18), ('3075', 18), ('3630', 9), ('337', 8), ('114770', 8), ('718', 5), ('5446', 4), ('338', 4), ('335', 3), ('7502', 3), ('19', 2), ('348', 2), ('4644', 1), ('8228', 1), ('3039', 1), ('4018', 1), ('8993', 1), ('5265', 1), ('4318', 1), ('11315', 1), ('89858', 1), ('966', 1), ('3827', 1)]\n",
      "6475111: [('6908', 79), ('170589', 29), ('335', 19), ('5345', 10), ('1401', 9), ('8829', 9), ('597', 9), ('336', 7), ('2160', 6), ('348', 5), ('84735', 3), ('2690', 3), ('260431', 2), ('1800', 2), ('3827', 2), ('19', 2), ('1071', 2), ('1636', 1), ('5364', 1), ('650', 1), ('5468', 1), ('53369', 1)]\n",
      "6484326: [('2244', 25), ('346288', 4), ('203068', 4), ('2', 3), ('231004', 2), ('51206', 2), ('3674', 2), ('51497', 1), ('27241', 1), ('29993', 1), ('2;201780', 1), ('84680', 1), ('2147', 1)]\n",
      "6558644: [('345', 36), ('116519', 32), ('4591', 11), ('348', 4), ('3992', 4), ('3630', 4), ('338', 3), ('10774', 3), ('84680', 2), ('1401', 1), ('335', 1), ('6264', 1), ('4023', 1), ('1879', 1), ('3039', 1), ('28898;28884', 1)]\n",
      "6560130: [('3620', 116), ('56267', 46), ('15930', 5), ('2796', 5), ('169355', 3), ('3630', 2), ('16153', 1), ('6999', 1), ('883', 1), ('255738', 1), ('3156', 1), ('56720', 1), ('11816', 1), ('3586', 1), ('94025', 1), ('3458', 1), ('7124', 1)]\n",
      "6627068: [('1401', 15), ('6288', 14), ('875', 13), ('3827', 12), ('341', 12), ('2244', 12), ('5265', 11), ('345', 11), ('2192', 10), ('2243', 10), ('50802', 9), ('462', 9), ('5345', 9), ('3053', 9), ('5340', 9), ('197', 8), ('722', 8), ('2878', 8), ('7276', 8), ('350', 7), ('2165', 7), ('335', 7), ('55937', 7), ('3700', 7), ('12', 7), ('8542', 7), ('8547', 7), ('2934', 7), ('712', 7), ('3818', 7), ('4790', 6), ('3512', 6), ('259', 6), ('1361', 6), ('5005', 5), ('114770', 5), ('3929', 5), ('337', 5), ('28885', 4), ('871', 4), ('713', 4), ('5004', 4), ('325', 4), ('5196', 4), ('55766', 4), ('5950', 4), ('716', 4), ('1191', 4), ('3426', 4), ('207', 4), ('5595;5594', 4), ('2209', 4), ('3495', 3), ('28410', 3), ('8359', 3), ('56925', 3), ('28903', 3), ('348', 3), ('3698', 3), ('3699', 3), ('4060', 3), ('3483', 3), ('2205', 3), ('2688', 3), ('6283', 3), ('6927', 3), ('3172', 3), ('595', 3), ('716;715', 2), ('5858', 2), ('6256', 2), ('3492', 2), ('633', 2), ('2358', 2), ('5599', 2), ('949', 2), ('55576', 2), ('1410', 2), ('1508', 2), ('3075', 2), ('5648', 2), ('10747', 2), ('2266', 2), ('8365', 2), ('2494', 2), ('5549', 2), ('3553', 2), ('3635', 2), ('5465', 2), ('5698', 2), ('7124', 2), ('9971', 1), ('4524', 1), ('2875', 1), ('1356', 1), ('3263', 1), ('2638', 1), ('5212', 1), ('5267', 1), ('28452;3512', 1), ('10462', 1), ('1588', 1), ('6347', 1), ('2920', 1), ('3273', 1), ('3554', 1), ('3643', 1), ('5664', 1), ('83931', 1), ('81494', 1), ('3588', 1), ('6776', 1), ('383', 1), ('3569', 1), ('3958', 1), ('9611', 1), ('7376', 1), ('3026', 1), ('3570', 1), ('4050', 1), ('4973', 1), ('5579', 1), ('5582', 1), ('177', 1), ('1019', 1), ('4043', 1), ('5336', 1), ('5721', 1), ('8743', 1), ('7157', 1), ('715;716', 1), ('9510', 1), ('332', 1), ('1369', 1), ('2162', 1), ('9245', 1), ('139760', 1), ('3500', 1)]\n",
      "6901481: [('30968', 70), ('4846', 16), ('207', 14), ('5832', 14), ('6576', 9), ('23411', 9), ('31', 9), ('6647', 8), ('6472', 8), ('9669', 7), ('4257', 6), ('10618', 6), ('25902', 6), ('54927', 6), ('30878', 5), ('8106', 5), ('23211', 5), ('6218', 5), ('1968', 4), ('8862', 4), ('5594', 4), ('1632', 4), ('7431', 4), ('6222', 4), ('5831', 4), ('5562', 4), ('139322', 4), ('51142', 4), ('2034', 3), ('3309', 3), ('6122', 3), ('808', 3), ('5566', 3), ('6268', 3), ('4830', 3), ('10312', 3), ('39', 3), ('4713', 3), ('2475', 3), ('7153', 3), ('7158', 3), ('6208', 3), ('6275', 2), ('71', 2), ('203068', 2), ('708', 2), ('1956', 2), ('7490', 2), ('2767', 2), ('6264', 2), ('7852', 2), ('64083', 2), ('51067', 2), ('7841', 2), ('3422', 2), ('301', 2), ('55054', 2), ('3710', 2), ('4628', 2), ('143', 2), ('823', 2), ('384', 2), ('51070', 2), ('10891', 2), ('5481', 2), ('7520', 2), ('659', 2), ('440275', 2), ('6876', 1), ('79577', 1), ('407008', 1), ('83939', 1), ('8663', 1), ('1975', 1), ('8672', 1), ('387', 1), ('2099', 1), ('2100', 1), ('28957', 1), ('10240', 1), ('51081', 1), ('10682', 1), ('3725', 1), ('6224', 1), ('84864', 1), ('5447', 1), ('2876', 1), ('2879', 1), ('5175', 1), ('39866', 1), ('3091', 1), ('494336', 1), ('574506', 1), ('1906', 1), ('10413', 1), ('6901', 1), ('18127', 1), ('4205', 1), ('472', 1), ('3630', 1)]\n",
      "6914779: [('4312', 27), ('718', 19), ('8550', 19), ('4879', 17), ('4316', 16), ('727698', 15), ('1520', 4), ('1906', 3), ('1636', 3), ('6772;20846;6774;20848', 3), ('6774', 3), ('20846', 2), ('20779', 2), ('12928', 2), ('3569', 2), ('4312;4316;4318', 2), ('4318', 2), ('1000', 2), ('78294', 1), ('20848', 1), ('19353', 1), ('22324', 1), ('6772', 1), ('101082699', 1), ('101083283', 1), ('1515', 1), ('2308', 1), ('2309', 1), ('2149', 1), ('1508', 1)]\n",
      "6925199: [('7058', 25), ('728', 18), ('1401', 17), ('5624', 17), ('2934', 16), ('5327', 15), ('10563', 13), ('1272', 10), ('5566', 9), ('377677', 8), ('3554', 7), ('1845', 7), ('137970', 6), ('718', 5), ('7124', 4), ('3958', 4), ('7035', 4), ('3075', 4), ('6761', 3), ('5340', 3), ('462', 3), ('58986', 3), ('90865', 3), ('3606', 3), ('183', 2), ('8991', 2), ('1628', 2), ('4316', 2), ('4321', 2), ('10631', 2), ('5788', 2), ('3557', 2), ('8809', 2), ('727', 2), ('10544', 2), ('6281', 2), ('213', 1), ('28809', 1), ('1396', 1), ('4313', 1), ('4322', 1), ('4326', 1), ('7077', 1), ('4312', 1), ('7078', 1), ('100861467', 1), ('2147', 1), ('4586', 1), ('7450', 1), ('5972', 1), ('6403', 1), ('7171', 1), ('2251', 1), ('7422', 1), ('283', 1), ('80781', 1), ('2641', 1), ('2056', 1), ('207', 1), ('2475', 1), ('56931', 1), ('7139', 1), ('7137', 1), ('5175', 1), ('4629', 1), ('7431', 1), ('4879', 1), ('84639', 1), ('1875', 1), ('57644', 1), ('85480', 1), ('21826', 1), ('716', 1), ('1829', 1), ('8718', 1), ('57142', 1)]\n",
      "6953276: [('3934', 36), ('133', 20), ('4879', 16), ('1471', 6), ('6761', 4), ('966', 4), ('1351', 3), ('6302', 2), ('5653', 2), ('3075', 2), ('1956', 1), ('1510', 1), ('4316', 1), ('1508', 1), ('4224', 1), ('1991', 1), ('3569', 1), ('3958', 1), ('9518', 1), ('4036', 1), ('5972', 1), ('5592', 1)]\n",
      "7031431: [('722', 70), ('7057', 7), ('347902', 6), ('7414', 6), ('2039', 6), ('1950', 4), ('2266', 4), ('2316', 4), ('25824', 4), ('3053', 4), ('7448', 4), ('3026', 4), ('7039', 3), ('5908', 3), ('2192', 3), ('302', 3), ('829', 3), ('3827', 3), ('358', 3), ('1072', 3), ('5345', 3), ('4060', 3), ('3507', 3), ('3273', 3), ('5196', 3), ('1991', 3), ('4018', 3), ('7422', 2), ('6236', 2), ('57463', 2), ('710', 2), ('309', 2), ('4666', 2), ('10627', 2), ('725', 2), ('10093', 2), ('1361', 2), ('1675', 2), ('2771', 2), ('3690', 2), ('3920', 2), ('2815', 2), ('1465', 2), ('10398', 2), ('5657', 2), ('2876', 2), ('348', 2), ('338', 2), ('3075', 2), ('566', 2), ('2147', 2), ('79784', 2), ('1191', 1), ('3852', 1), ('9948', 1), ('3309', 1), ('2812', 1), ('5880', 1), ('7277', 1), ('10130', 1), ('1278', 1), ('801', 1), ('4052', 1), ('1213', 1), ('84680', 1), ('100187907', 1), ('9046', 1), ('11153', 1), ('3113', 1), ('5906', 1), ('9567', 1)]\n",
      "7062043: [('9518', 6), ('649', 3), ('2488', 2), ('354', 2), ('50964', 2), ('23647', 2), ('91851', 2), ('4321', 2), ('23886', 1), ('16000', 1), ('16337', 1), ('11201', 1), ('8144', 1), ('10220', 1), ('14561', 1), ('7402', 1), ('3952', 1)]\n",
      "7146314: [('55937', 24), ('348', 11), ('2934', 11), ('338', 10), ('255738', 9), ('3630', 9), ('2195', 5), ('173', 5), ('197', 5), ('3053', 5), ('629', 5), ('3818', 5), ('1', 5), ('336', 5), ('3848', 5), ('335', 4), ('7045', 4), ('2822', 4), ('5267', 4), ('350', 4), ('325', 4), ('8991', 3), ('5265', 3), ('3543', 3), ('12', 3), ('26503', 3), ('106480993', 3), ('1401', 2), ('717', 2), ('2147', 2), ('3263', 2), ('3493', 2), ('28452', 2), ('7018', 2), ('3849', 2), ('57338', 1), ('53369', 1), ('57107', 1), ('3170', 1), ('22915', 1), ('16835', 1), ('653820', 1), ('4150', 1), ('7040', 1)]\n",
      "7211010: [('3250', 31), ('2878', 6), ('1361', 5), ('3263', 5), ('6256', 4), ('5305', 4), ('2876', 4), ('1356', 4), ('727897', 4), ('718', 3), ('922', 3), ('721', 3), ('3075', 3), ('15439', 3), ('966', 3), ('375337', 2), ('571', 2), ('51076', 2), ('12', 2), ('710', 2), ('5595;5594', 2), ('15458', 2), ('81570', 2), ('759', 1), ('9971', 1), ('4780', 1), ('2877', 1), ('712', 1), ('716', 1), ('727;729', 1), ('3698', 1), ('5340', 1), ('3240', 1), ('18024', 1), ('12013', 1)]\n",
      "7237418: [('5284', 84), ('4316', 10), ('973', 9), ('4318', 6), ('60498', 6), ('81', 6), ('1509', 5), ('4314', 5), ('4224', 5), ('397315', 4), ('643834', 4), ('823', 2), ('824', 2), ('1508', 2), ('1511', 2), ('4323', 2), ('80739', 1), ('64386', 1), ('1510', 1), ('4322', 1), ('281401', 1), ('83953', 1), ('13033', 1)]\n",
      "7266817: [('10631', 11), ('6288', 10), ('342184', 9), ('2202', 7), ('4239', 7), ('4969', 5), ('10516', 5), ('84898', 4), ('4397', 4), ('8630', 3), ('1292', 3), ('5267', 3), ('3339', 3), ('5549', 3), ('4060', 3), ('57479', 2), ('3053', 2), ('7018', 2), ('2192', 2), ('5604', 2), ('1462', 2), ('1893', 2), ('306', 2), ('337', 2), ('24609', 2), ('18127', 2), ('1636', 1), ('2006', 1), ('3827', 1), ('5594', 1), ('805', 1), ('7276', 1), ('9086', 1), ('8907', 1), ('3188', 1), ('55763', 1), ('11532', 1), ('79784', 1), ('1050', 1), ('25291', 1), ('24185', 1), ('1401', 1), ('2244', 1), ('3162', 1), ('29116', 1), ('128', 1), ('25149', 1)]\n",
      "\n",
      "* Reading from cardiac_absts_pubtator_annotations.xml\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "** Gene frequency across the entire corpus:\n",
      "335: 279\n",
      "7276: 225\n",
      "3075: 216\n",
      "348: 189\n",
      "4353: 162\n",
      "5034: 135\n",
      "6287: 126\n",
      "5265: 124\n",
      "1674: 117\n",
      "2244: 117\n",
      "3240: 117\n",
      "8216: 108\n",
      "1191: 108\n",
      "4780: 90\n",
      "6279: 81\n",
      "18129: 72\n",
      "5444: 72\n",
      "5216: 72\n",
      "2023: 63\n",
      "345: 63\n",
      "3620: 63\n",
      "3308: 63\n",
      "947: 63\n",
      "494326: 63\n",
      "1401: 55\n",
      "10631: 54\n",
      "5950: 54\n",
      "6439: 54\n",
      "133522: 54\n",
      "152330: 54\n",
      "7547: 54\n",
      "7273: 54\n",
      "5500: 54\n",
      "51206: 54\n",
      "3315: 54\n",
      "5473: 54\n",
      "723814: 54\n",
      "7052: 54\n",
      "350: 50\n",
      "3934: 45\n",
      "7422: 45\n",
      "2335: 45\n",
      "5315: 45\n",
      "336: 45\n",
      "857: 45\n",
      "6280: 45\n",
      "11816: 45\n",
      "100329167: 45\n",
      "1728: 45\n",
      "6120: 45\n",
      "5284: 45\n",
      "26762: 36\n",
      "811: 36\n",
      "338: 36\n",
      "12: 36\n",
      "4879: 36\n",
      "2: 36\n",
      "4311: 36\n",
      "5894: 36\n",
      "3630: 36\n",
      "6908: 36\n",
      "151648: 36\n",
      "50848: 36\n",
      "7431: 36\n",
      "4321: 36\n",
      "721: 36\n",
      "3329: 36\n",
      "53369: 36\n",
      "10935: 36\n",
      "462: 29\n",
      "9370: 28\n",
      "3320: 27\n",
      "344: 27\n",
      "3569: 27\n",
      "3371: 27\n",
      "11346: 27\n",
      "3303: 27\n",
      "4633: 27\n",
      "7018: 27\n",
      "1756: 27\n",
      "7412: 27\n",
      "183: 27\n",
      "7124: 27\n",
      "4345: 27\n",
      "2828: 27\n",
      "3080: 27\n",
      "5321: 27\n",
      "4069: 27\n",
      "718: 27\n",
      "3250: 27\n",
      "25932: 27\n",
      "773: 27\n",
      "6238: 27\n",
      "6289: 27\n",
      "1471: 20\n",
      "2638: 20\n",
      "5972: 20\n",
      "2273: 18\n",
      "1805: 18\n",
      "729359: 18\n",
      "3827: 18\n",
      "4629: 18\n",
      "3309: 18\n",
      "4723: 18\n",
      "3685: 18\n",
      "1983: 18\n",
      "4634: 18\n",
      "6876: 18\n",
      "4036: 18\n",
      "23334: 18\n",
      "11315: 18\n",
      "4312: 18\n",
      "22808: 18\n",
      "699: 18\n",
      "6256: 18\n",
      "2006: 18\n",
      "1003: 18\n",
      "59284: 18\n",
      "3700: 18\n",
      "4010: 18\n",
      "336;55937: 18\n",
      "2697: 18\n",
      "146: 18\n",
      "5829: 18\n",
      "182: 18\n",
      "7058: 18\n",
      "347902: 18\n",
      "3043: 18\n",
      "2810: 18\n",
      "3713: 18\n",
      "126393: 18\n",
      "8165: 18\n",
      "7414: 18\n",
      "10211: 18\n",
      "7251: 18\n",
      "5413: 18\n",
      "6352: 18\n",
      "5586: 18\n",
      "6285: 18\n",
      "7297: 18\n",
      "6198: 18\n",
      "4137: 18\n",
      "4680: 18\n",
      "341: 18\n",
      "2081: 18\n",
      "1915: 18\n",
      "2717: 18\n",
      "108101: 18\n",
      "116844: 18\n",
      "723857: 18\n",
      "26998: 18\n",
      "59083: 18\n",
      "1509: 18\n",
      "1808: 18\n",
      "1200: 18\n",
      "8935: 18\n",
      "50802: 18\n",
      "875: 16\n",
      "2192: 12\n",
      "197: 12\n",
      "710: 11\n",
      "9518: 10\n",
      "302: 10\n",
      "59272: 9\n",
      "1490: 9\n",
      "55752: 9\n",
      "100507027: 9\n",
      "2869: 9\n",
      "3502: 9\n",
      "309: 9\n",
      "509: 9\n",
      "2949: 9\n",
      "10063: 9\n",
      "306: 9\n",
      "2805: 9\n",
      "8659: 9\n",
      "5162: 9\n",
      "622: 9\n",
      "66035: 9\n",
      "3326: 9\n",
      "94239: 9\n",
      "55937: 9\n",
      "5465: 9\n",
      "5595;5594: 9\n",
      "1462: 9\n",
      "6271: 9\n",
      "1938: 9\n",
      "627: 9\n",
      "92737: 9\n",
      "6364: 9\n",
      "4314: 9\n",
      "690: 9\n",
      "26291: 9\n",
      "3593: 9\n",
      "5617: 9\n",
      "7984: 9\n",
      "5806: 9\n",
      "6401: 9\n",
      "128876: 9\n",
      "7448: 9\n",
      "2268: 9\n",
      "2316: 9\n",
      "6369: 9\n",
      "4153: 9\n",
      "4055: 9\n",
      "5118: 9\n",
      "4635: 9\n",
      "58498: 9\n",
      "2217: 9\n",
      "7001: 9\n",
      "664: 9\n",
      "596: 9\n",
      "5160: 9\n",
      "8802: 9\n",
      "34: 9\n",
      "654: 9\n",
      "7077: 9\n",
      "6624: 9\n",
      "2947: 9\n",
      "9588: 9\n",
      "4900: 9\n",
      "101669765: 9\n",
      "6372: 9\n",
      "2919: 9\n",
      "958: 9\n",
      "8517: 9\n",
      "5653: 9\n",
      "5175: 9\n",
      "145624: 9\n",
      "4853: 9\n",
      "18810: 9\n",
      "12306: 9\n",
      "4853;18129: 9\n",
      "5468: 9\n",
      "351: 9\n",
      "3816: 9\n",
      "7453: 9\n",
      "170589: 9\n",
      "5345: 9\n",
      "761: 9\n",
      "51266;5159: 9\n",
      "51266: 9\n",
      "5159: 9\n",
      "6714: 9\n",
      "5336: 9\n",
      "3458: 9\n",
      "347: 9\n",
      "7031: 9\n",
      "1012: 9\n",
      "4582: 9\n",
      "1291: 9\n",
      "6407: 9\n",
      "346288: 9\n",
      "203068: 9\n",
      "1: 9\n",
      "213: 9\n",
      "5320: 9\n",
      "567: 9\n",
      "229: 9\n",
      "4790: 9\n",
      "3558: 9\n",
      "3576: 9\n",
      "3586: 9\n",
      "9806: 9\n",
      "4237: 9\n",
      "4851: 9\n",
      "4316: 9\n",
      "2934: 9\n",
      "1351: 9\n",
      "6288: 9\n",
      "7296: 9\n",
      "none: 9\n",
      "7369: 9\n",
      "3308;3320;3860;3861;3868;3872;3880: 9\n",
      "3963: 9\n",
      "7295: 9\n",
      "3860: 9\n",
      "7054: 9\n",
      "165: 9\n",
      "238055: 9\n",
      "11812: 9\n",
      "21828: 9\n",
      "5592: 9\n",
      "10611: 9\n",
      "11034: 9\n",
      "338382: 9\n",
      "2597: 9\n",
      "6647: 9\n",
      "2878: 9\n",
      "6810: 9\n",
      "20304: 9\n",
      "4633;103910: 9\n",
      "3039: 9\n",
      "140465: 9\n",
      "2167: 9\n",
      "153: 9\n",
      "5747: 9\n",
      "4921: 9\n",
      "1356: 9\n",
      "301: 9\n",
      "4057: 9\n",
      "5176: 9\n",
      "4846: 9\n",
      "6275: 9\n",
      "3956: 9\n",
      "84909: 9\n",
      "571: 9\n",
      "9124: 9\n",
      "5682: 9\n",
      "7168: 9\n",
      "4199: 9\n",
      "319: 9\n",
      "6252: 9\n",
      "7494: 9\n",
      "22926: 9\n",
      "3895: 9\n",
      "57142: 9\n",
      "1738: 9\n",
      "1431: 9\n",
      "53947: 9\n",
      "5730: 9\n",
      "4920: 9\n",
      "1969: 9\n",
      "5362: 9\n",
      "14000: 9\n",
      "387160: 9\n",
      "387161: 9\n",
      "387173: 9\n",
      "20208: 9\n",
      "20209: 9\n",
      "3875: 9\n",
      "4735: 9\n",
      "106478911: 9\n",
      "3856: 9\n",
      "813: 9\n",
      "171221: 9\n",
      "307: 9\n",
      "114548: 9\n",
      "6291: 9\n",
      "3659: 9\n",
      "633: 9\n",
      "5549: 9\n",
      "642658: 9\n",
      "3673: 9\n",
      "320: 9\n",
      "6696: 9\n",
      "7057: 9\n",
      "3263: 9\n",
      "488: 7\n",
      "488;1769: 7\n",
      "27344: 7\n",
      "1491: 7\n",
      "5654: 5\n",
      "292: 5\n",
      "1956: 5\n",
      "1272: 5\n",
      "80739: 5\n",
      "25402: 4\n",
      "364052: 4\n",
      "113893: 4\n",
      "10131: 4\n",
      "8988: 4\n",
      "10598: 4\n",
      "84061: 2\n",
      "978: 2\n",
      "5641: 2\n",
      "8942: 2\n",
      "10923: 2\n",
      "929: 2\n",
      "\n",
      "** Gene frequency in each document (identified by PubMed ID):\n",
      "27230659: [('3934', 4), ('26762', 4)]\n",
      "27308822: [('5265', 1)]\n",
      "27363418: [('7422', 3)]\n",
      "27412778: [('59272', 1), ('10631', 1), ('1490', 1), ('2335', 1)]\n",
      "27429122: []\n",
      "27450324: [('55752', 1), ('2273', 1), ('1805', 1)]\n",
      "27616206: [('6279', 3), ('729359', 2), ('3827', 2)]\n",
      "27624754: [('2023', 6), ('5315', 5), ('811', 1), ('4629', 1), ('100507027', 1)]\n",
      "27711126: [('3320', 2), ('2869', 1), ('336', 1), ('3502', 1), ('309', 1), ('509', 1), ('2949', 1), ('10063', 1), ('857', 1), ('306', 1), ('2805', 1), ('8659', 1), ('5162', 1), ('622', 1), ('66035', 1), ('3326', 1), ('94239', 1), ('3309', 1), ('4723', 1)]\n",
      "27908912: []\n",
      "28196416: [('7276', 4), ('5950', 3)]\n",
      "28209220: [('348', 9), ('345', 6), ('344', 3), ('335', 2), ('338', 2), ('336', 1), ('55937', 1)]\n",
      "28223106: [('338', 1)]\n",
      "28256566: [('5465', 1), ('5595;5594', 1)]\n",
      "28273075: []\n",
      "28329269: [('12', 2), ('10631', 1), ('1462', 1)]\n",
      "28341603: [('1674', 11)]\n",
      "28427148: [('6271', 1), ('1938', 1)]\n",
      "28437237: [('627', 1), ('92737', 1), ('6364', 1), ('4314', 1), ('690', 1), ('26291', 1), ('3593', 1), ('5617', 1), ('7984', 1), ('3569', 1), ('5806', 1), ('6401', 1)]\n",
      "28501389: [('335', 1), ('128876', 1)]\n",
      "28624389: []\n",
      "28679606: []\n",
      "28720870: [('3685', 2), ('2335', 2), ('3371', 2), ('7448', 1)]\n",
      "28784649: []\n",
      "28794502: []\n",
      "28800743: [('11346', 3)]\n",
      "28922609: [('7276', 7)]\n",
      "29151592: [('3303', 2), ('1983', 2), ('2268', 1)]\n",
      "29158831: []\n",
      "29215023: []\n",
      "29235871: []\n",
      "29251807: [('2316', 1), ('6439', 1)]\n",
      "29258006: [('133522', 6), ('152330', 6)]\n",
      "29258991: [('348', 4)]\n",
      "29320704: []\n",
      "29369166: [('6369', 1), ('4879', 1), ('4153', 1), ('4055', 1), ('5118', 1)]\n",
      "29484645: [('4635', 1), ('58498', 1), ('4634', 1), ('4633', 1), ('6876', 1)]\n",
      "29505607: [('4353', 11)]\n",
      "29540862: [('2217', 1), ('7018', 1), ('5265', 1)]\n",
      "29649363: [('335', 9)]\n",
      "29665821: [('4036', 2), ('23334', 2), ('338', 1), ('2', 1)]\n",
      "29676857: [('7001', 1), ('11315', 1), ('664', 1), ('596', 1), ('5160', 1), ('8802', 1), ('34', 1), ('4723', 1)]\n",
      "29682908: [('1756', 3), ('654', 1), ('7077', 1)]\n",
      "29717219: [('6624', 1), ('2947', 1), ('9588', 1), ('4900', 1)]\n",
      "29784904: [('4879', 2), ('101669765', 1), ('6372', 1), ('2919', 1), ('958', 1), ('8517', 1), ('7422', 1), ('5653', 1), ('5175', 1), ('145624', 1), ('4312', 1)]\n",
      "29853569: [('18129', 8), ('4853', 1), ('18810', 1), ('12306', 1), ('4853;18129', 1)]\n",
      "29854824: [('4311', 4), ('7412', 3)]\n",
      "29915101: [('5468', 1)]\n",
      "29956481: []\n",
      "30002058: []\n",
      "30192561: [('351', 1), ('3816', 1)]\n",
      "30201848: [('4353', 7)]\n",
      "30212933: []\n",
      "30224653: []\n",
      "30248148: [('3075', 8), ('7547', 6)]\n",
      "30255987: []\n",
      "30261322: [('335', 3), ('7453', 1), ('2', 1)]\n",
      "30332462: [('7273', 6), ('183', 1)]\n",
      "30347343: []\n",
      "30368668: [('8216', 12), ('5500', 6), ('5894', 4), ('22808', 2)]\n",
      "30451909: [('3630', 1)]\n",
      "30478197: [('6908', 4), ('336', 2), ('1401', 1), ('170589', 1), ('5345', 1)]\n",
      "30496173: []\n",
      "30562113: [('761', 1), ('1674', 1), ('2273', 1)]\n",
      "30571344: [('348', 1), ('51266;5159', 1), ('51266', 1), ('5159', 1)]\n",
      "30658193: [('51206', 6), ('1401', 3), ('2244', 1), ('6714', 1), ('5336', 1)]\n",
      "30739867: [('151648', 4), ('699', 2)]\n",
      "30742448: [('3458', 1), ('7124', 1)]\n",
      "30782942: []\n",
      "30805593: []\n",
      "30806752: [('6256', 1), ('348', 1), ('347', 1), ('7031', 1)]\n",
      "30836973: [('2006', 2), ('1012', 1), ('4582', 1), ('1291', 1), ('6407', 1)]\n",
      "30838756: [('2244', 3), ('2', 1), ('346288', 1), ('203068', 1)]\n",
      "30870787: [('5034', 15), ('2335', 1)]\n",
      "30874584: [('50848', 4), ('4345', 3), ('2828', 3), ('1003', 2), ('59284', 2)]\n",
      "30887811: []\n",
      "30907085: []\n",
      "30922315: [('3080', 3), ('3700', 2), ('1', 1), ('213', 1)]\n",
      "30928653: []\n",
      "31056672: []\n",
      "31092728: [('5321', 3), ('5320', 1)]\n",
      "31104495: [('7124', 2)]\n",
      "31186442: [('3620', 7)]\n",
      "31204432: [('567', 1), ('229', 1), ('710', 1)]\n",
      "31242583: [('875', 1), ('4790', 1)]\n",
      "31286493: [('4010', 2)]\n",
      "31434864: []\n",
      "31476444: [('5444', 8), ('1471', 2), ('4069', 2), ('336;55937', 2)]\n",
      "31494943: [('2697', 2), ('146', 1)]\n",
      "31562990: [('2244', 1), ('3558', 1), ('3576', 1), ('3586', 1), ('3569', 1)]\n",
      "31585756: [('5829', 2), ('7431', 2), ('182', 2), ('9806', 1), ('4237', 1), ('4851', 1)]\n",
      "31734660: []\n",
      "31806903: []\n",
      "31844116: [('718', 1), ('4312', 1), ('4316', 1)]\n",
      "31862877: [('7058', 1), ('2934', 1)]\n",
      "31918764: [('4879', 1), ('3934', 1), ('1351', 1)]\n",
      "32117548: [('347902', 2)]\n",
      "32385381: [('3250', 3), ('6256', 1)]\n",
      "32487995: [('6288', 1), ('7296', 1)]\n",
      "32806897: [('None', 1), ('335', 1)]\n",
      "19960371: [('25402', 1), ('364052', 1), ('113893', 1)]\n",
      "20020777: []\n",
      "20398479: []\n",
      "20451270: [('2192', 3), ('10131', 1), ('8988', 1), ('10598', 1)]\n",
      "20515752: [('2638', 5)]\n",
      "20603051: [('488', 1), ('488;1769', 1)]\n",
      "20811296: [('5265', 1), ('27344', 1)]\n",
      "20817827: [('875', 1), ('1491', 1)]\n",
      "20853909: [('7369', 1)]\n",
      "20936720: [('6280', 1)]\n",
      "20936781: []\n",
      "21041689: [('25932', 3), ('10631', 1), ('7422', 1)]\n",
      "21043527: [('1191', 12)]\n",
      "21166718: [('3308', 3), ('3043', 2), ('2810', 2), ('811', 2), ('3713', 2), ('3308;3320;3860;3861;3868;3872;3880', 1), ('3963', 1), ('7295', 1), ('4633', 1), ('4634', 1), ('7018', 1), ('3860', 1), ('3320', 1), ('7054', 1)]\n",
      "21211997: [('12', 2)]\n",
      "21468545: []\n",
      "21545686: [('3315', 2), ('126393', 2), ('7276', 1)]\n",
      "21593211: [('4321', 4), ('7058', 1), ('165', 1), ('10631', 1), ('2335', 1), ('3371', 1)]\n",
      "21681990: [('11816', 5), ('238055', 1), ('11812', 1), ('21828', 1)]\n",
      "21712045: [('8165', 2), ('5592', 1)]\n",
      "21736391: [('10611', 1), ('11034', 1)]\n",
      "21751358: [('7414', 1), ('7431', 1), ('338382', 1), ('2597', 1)]\n",
      "21767674: [('3240', 2)]\n",
      "22221959: [('10211', 2), ('7251', 2)]\n",
      "22276806: [('335', 1), ('5265', 1), ('7431', 1), ('6647', 1), ('6876', 1), ('3240', 1), ('2878', 1), ('3315', 1), ('811', 1)]\n",
      "22384053: []\n",
      "22435364: []\n",
      "22543060: [('4633', 1), ('4629', 1), ('7414', 1)]\n",
      "22665935: [('5413', 2), ('6352', 2), ('6810', 1), ('20304', 1)]\n",
      "22781565: [('4633;103910', 1), ('3039', 1), ('140465', 1)]\n",
      "22789915: []\n",
      "22959663: [('335', 2), ('2167', 1)]\n",
      "23002038: [('10631', 1), ('3308', 1)]\n",
      "23160667: []\n",
      "23195030: []\n",
      "23384050: [('773', 3), ('153', 1)]\n",
      "23431486: [('3240', 1), ('5265', 1)]\n",
      "23519648: [('100329167', 5)]\n",
      "23593175: [('5586', 2), ('6285', 2), ('7297', 2), ('1805', 1), ('5747', 1), ('4921', 1)]\n",
      "23660474: [('2', 1), ('1356', 1), ('3303', 1), ('301', 1), ('4057', 1)]\n",
      "23701180: [('3240', 4)]\n",
      "23704777: [('5176', 1)]\n",
      "23797974: []\n",
      "23804534: [('4846', 1)]\n",
      "23836408: [('857', 4), ('6275', 1), ('2023', 1), ('3956', 1)]\n",
      "23916682: [('348', 4), ('7276', 4), ('335', 2), ('84909', 1)]\n",
      "23974919: [('4780', 10), ('1728', 5), ('571', 1), ('11315', 1)]\n",
      "24055733: [('6198', 2)]\n",
      "24140280: [('5473', 6), ('3240', 4), ('721', 4)]\n",
      "24182678: [('7276', 9)]\n",
      "24548642: [('4137', 2)]\n",
      "24689886: [('4680', 2)]\n",
      "24738046: [('3329', 4), ('1674', 1), ('9124', 1), ('5682', 1), ('7168', 1), ('4199', 1)]\n",
      "24780726: [('348', 2), ('319', 1)]\n",
      "24859250: [('6287', 3), ('341', 2)]\n",
      "25065337: [('3075', 8)]\n",
      "25072840: []\n",
      "25083839: []\n",
      "25099258: []\n",
      "25117565: [('6280', 4)]\n",
      "25217443: [('5216', 8)]\n",
      "25226522: [('6238', 3), ('2081', 2), ('6252', 1), ('3309', 1), ('7494', 1), ('22926', 1), ('3895', 1), ('57142', 1)]\n",
      "25318410: [('5950', 3), ('718', 2), ('9370', 2), ('183', 2)]\n",
      "25341944: [('335', 7), ('345', 1), ('53369', 1), ('336', 1)]\n",
      "25382018: [('1915', 1), ('10935', 1)]\n",
      "25397948: [('10935', 3), ('1738', 1), ('1915', 1)]\n",
      "25424990: [('6439', 5), ('6287', 4)]\n",
      "25548805: [('1431', 1)]\n",
      "25666440: [('2717', 2), ('53947', 1), ('5730', 1)]\n",
      "25684225: [('4920', 1), ('1969', 1), ('5362', 1)]\n",
      "25786980: []\n",
      "25857276: []\n",
      "25905469: []\n",
      "25944670: [('723814', 6), ('108101', 2), ('14000', 1), ('387160', 1), ('387161', 1), ('387173', 1)]\n",
      "25945665: []\n",
      "25995210: [('6287', 3), ('335', 1), ('6289', 1), ('20208', 1), ('20209', 1)]\n",
      "26028931: [('3315', 3), ('3308', 3), ('2244', 3), ('3875', 1), ('4735', 1), ('106478911', 1), ('3856', 1), ('813', 1), ('171221', 1), ('307', 1)]\n",
      "26037829: [('6287', 4), ('53369', 3), ('1401', 1), ('3569', 1), ('335', 1)]\n",
      "26063667: [('3075', 8)]\n",
      "26078484: [('462', 3)]\n",
      "26160894: [('116844', 2), ('4069', 1)]\n",
      "26285659: []\n",
      "26437904: []\n",
      "26476107: []\n",
      "26483418: [('5265', 8), ('146', 1)]\n",
      "26535788: [('6289', 2), ('335', 1), ('114548', 1), ('6291', 1)]\n",
      "26561523: [('2244', 5), ('3659', 1)]\n",
      "26564600: [('947', 7), ('494326', 7), ('723857', 2)]\n",
      "26603189: [('3630', 3), ('26998', 2), ('59083', 2)]\n",
      "26620461: [('633', 1), ('10631', 1), ('5549', 1)]\n",
      "26653129: []\n",
      "26688386: [('642658', 1), ('3673', 1), ('320', 1)]\n",
      "26750556: []\n",
      "26792056: [('6279', 6)]\n",
      "26834087: [('6120', 5)]\n",
      "26898369: [('6696', 1)]\n",
      "27084846: [('7052', 6), ('1509', 2), ('1808', 2), ('1200', 2), ('5265', 1)]\n",
      "27095521: [('8935', 2), ('7057', 1)]\n",
      "27122311: [('50802', 2), ('3263', 1), ('7018', 1), ('3240', 1)]\n",
      "27220540: []\n",
      "27230659: [('3934', 4), ('26762', 4)]\n",
      "27308822: [('5265', 1)]\n",
      "27363418: [('7422', 3)]\n",
      "27412778: [('59272', 1), ('10631', 1), ('1490', 1), ('2335', 1)]\n",
      "27429122: []\n",
      "27450324: [('55752', 1), ('2273', 1), ('1805', 1)]\n",
      "27616206: [('6279', 3), ('729359', 2), ('3827', 2)]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "27624754: [('2023', 6), ('5315', 5), ('811', 1), ('4629', 1), ('100507027', 1)]\n",
      "27711126: [('3320', 2), ('2869', 1), ('336', 1), ('3502', 1), ('309', 1), ('509', 1), ('2949', 1), ('10063', 1), ('857', 1), ('306', 1), ('2805', 1), ('8659', 1), ('5162', 1), ('622', 1), ('66035', 1), ('3326', 1), ('94239', 1), ('3309', 1), ('4723', 1)]\n",
      "27908912: []\n",
      "28196416: [('7276', 4), ('5950', 3)]\n",
      "28209220: [('348', 9), ('345', 6), ('344', 3), ('335', 2), ('338', 2), ('336', 1), ('55937', 1)]\n",
      "28223106: [('338', 1)]\n",
      "28256566: [('5465', 1), ('5595;5594', 1)]\n",
      "28273075: []\n",
      "28329269: [('12', 2), ('10631', 1), ('1462', 1)]\n",
      "28341603: [('1674', 11)]\n",
      "28427148: [('6271', 1), ('1938', 1)]\n",
      "28437237: [('627', 1), ('92737', 1), ('6364', 1), ('4314', 1), ('690', 1), ('26291', 1), ('3593', 1), ('5617', 1), ('7984', 1), ('3569', 1), ('5806', 1), ('6401', 1)]\n",
      "28501389: [('335', 1), ('128876', 1)]\n",
      "28624389: []\n",
      "28679606: []\n",
      "28720870: [('3685', 2), ('2335', 2), ('3371', 2), ('7448', 1)]\n",
      "28784649: []\n",
      "28794502: []\n",
      "28800743: [('11346', 3)]\n",
      "28922609: [('7276', 7)]\n",
      "29151592: [('3303', 2), ('1983', 2), ('2268', 1)]\n",
      "29158831: []\n",
      "29215023: []\n",
      "29235871: []\n",
      "29251807: [('2316', 1), ('6439', 1)]\n",
      "29258006: [('133522', 6), ('152330', 6)]\n",
      "29258991: [('348', 4)]\n",
      "29320704: []\n",
      "29369166: [('6369', 1), ('4879', 1), ('4153', 1), ('4055', 1), ('5118', 1)]\n",
      "29484645: [('4635', 1), ('58498', 1), ('4634', 1), ('4633', 1), ('6876', 1)]\n",
      "29505607: [('4353', 11)]\n",
      "29540862: [('2217', 1), ('7018', 1), ('5265', 1)]\n",
      "29649363: [('335', 9)]\n",
      "29665821: [('4036', 2), ('23334', 2), ('338', 1), ('2', 1)]\n",
      "29676857: [('7001', 1), ('11315', 1), ('664', 1), ('596', 1), ('5160', 1), ('8802', 1), ('34', 1), ('4723', 1)]\n",
      "29682908: [('1756', 3), ('654', 1), ('7077', 1)]\n",
      "29717219: [('6624', 1), ('2947', 1), ('9588', 1), ('4900', 1)]\n",
      "29784904: [('4879', 2), ('101669765', 1), ('6372', 1), ('2919', 1), ('958', 1), ('8517', 1), ('7422', 1), ('5653', 1), ('5175', 1), ('145624', 1), ('4312', 1)]\n",
      "29853569: [('18129', 8), ('4853', 1), ('18810', 1), ('12306', 1), ('4853;18129', 1)]\n",
      "29854824: [('4311', 4), ('7412', 3)]\n",
      "29915101: [('5468', 1)]\n",
      "29956481: []\n",
      "30002058: []\n",
      "30192561: [('351', 1), ('3816', 1)]\n",
      "30201848: [('4353', 7)]\n",
      "30212933: []\n",
      "30224653: []\n",
      "30248148: [('3075', 8), ('7547', 6)]\n",
      "30255987: []\n",
      "30261322: [('335', 3), ('7453', 1), ('2', 1)]\n",
      "30332462: [('7273', 6), ('183', 1)]\n",
      "30347343: []\n",
      "30368668: [('8216', 12), ('5500', 6), ('5894', 4), ('22808', 2)]\n",
      "30451909: [('3630', 1)]\n",
      "30478197: [('6908', 4), ('336', 2), ('1401', 1), ('170589', 1), ('5345', 1)]\n",
      "30496173: []\n",
      "30562113: [('761', 1), ('1674', 1), ('2273', 1)]\n",
      "30571344: [('348', 1), ('51266;5159', 1), ('51266', 1), ('5159', 1)]\n",
      "30658193: [('51206', 6), ('1401', 3), ('2244', 1), ('6714', 1), ('5336', 1)]\n",
      "30739867: [('151648', 4), ('699', 2)]\n",
      "30742448: [('3458', 1), ('7124', 1)]\n",
      "30782942: []\n",
      "30805593: []\n",
      "30806752: [('6256', 1), ('348', 1), ('347', 1), ('7031', 1)]\n",
      "30836973: [('2006', 2), ('1012', 1), ('4582', 1), ('1291', 1), ('6407', 1)]\n",
      "30838756: [('2244', 3), ('2', 1), ('346288', 1), ('203068', 1)]\n",
      "30870787: [('5034', 15), ('2335', 1)]\n",
      "30874584: [('50848', 4), ('4345', 3), ('2828', 3), ('1003', 2), ('59284', 2)]\n",
      "30887811: []\n",
      "30907085: []\n",
      "30922315: [('3080', 3), ('3700', 2), ('1', 1), ('213', 1)]\n",
      "30928653: []\n",
      "31056672: []\n",
      "31092728: [('5321', 3), ('5320', 1)]\n",
      "31104495: [('7124', 2)]\n",
      "31186442: [('3620', 7)]\n",
      "31204432: [('567', 1), ('229', 1), ('710', 1)]\n",
      "31242583: [('875', 1), ('4790', 1)]\n",
      "31286493: [('4010', 2)]\n",
      "31434864: []\n",
      "31476444: [('5444', 8), ('1471', 2), ('4069', 2), ('336;55937', 2)]\n",
      "31494943: [('2697', 2), ('146', 1)]\n",
      "31562990: [('2244', 1), ('3558', 1), ('3576', 1), ('3586', 1), ('3569', 1)]\n",
      "31585756: [('5829', 2), ('7431', 2), ('182', 2), ('9806', 1), ('4237', 1), ('4851', 1)]\n",
      "31734660: []\n",
      "31806903: []\n",
      "31844116: [('718', 1), ('4312', 1), ('4316', 1)]\n",
      "31862877: [('7058', 1), ('2934', 1)]\n",
      "31918764: [('4879', 1), ('3934', 1), ('1351', 1)]\n",
      "32117548: [('347902', 2)]\n",
      "32385381: [('3250', 3), ('6256', 1)]\n",
      "32487995: [('6288', 1), ('7296', 1)]\n",
      "32806897: [('None', 1), ('335', 1)]\n",
      "19960371: [('25402', 1), ('364052', 1), ('113893', 1)]\n",
      "20020777: []\n",
      "20398479: []\n",
      "20451270: [('2192', 3), ('10131', 1), ('8988', 1), ('10598', 1)]\n",
      "20515752: [('2638', 5)]\n",
      "20603051: [('488', 1), ('488;1769', 1)]\n",
      "20811296: [('5265', 1), ('27344', 1)]\n",
      "20817827: [('875', 1), ('1491', 1)]\n",
      "20853909: [('7369', 1)]\n",
      "20936720: [('6280', 1)]\n",
      "20936781: []\n",
      "21041689: [('25932', 3), ('10631', 1), ('7422', 1)]\n",
      "21043527: [('1191', 12)]\n",
      "21166718: [('3308', 3), ('3043', 2), ('2810', 2), ('811', 2), ('3713', 2), ('3308;3320;3860;3861;3868;3872;3880', 1), ('3963', 1), ('7295', 1), ('4633', 1), ('4634', 1), ('7018', 1), ('3860', 1), ('3320', 1), ('7054', 1)]\n",
      "21211997: [('12', 2)]\n",
      "21468545: []\n",
      "21545686: [('3315', 2), ('126393', 2), ('7276', 1)]\n",
      "21593211: [('4321', 4), ('7058', 1), ('165', 1), ('10631', 1), ('2335', 1), ('3371', 1)]\n",
      "21681990: [('11816', 5), ('238055', 1), ('11812', 1), ('21828', 1)]\n",
      "21712045: [('8165', 2), ('5592', 1)]\n",
      "21736391: [('10611', 1), ('11034', 1)]\n",
      "21751358: [('7414', 1), ('7431', 1), ('338382', 1), ('2597', 1)]\n",
      "21767674: [('3240', 2)]\n",
      "22221959: [('10211', 2), ('7251', 2)]\n",
      "22276806: [('335', 1), ('5265', 1), ('7431', 1), ('6647', 1), ('6876', 1), ('3240', 1), ('2878', 1), ('3315', 1), ('811', 1)]\n",
      "22384053: []\n",
      "22435364: []\n",
      "22543060: [('4633', 1), ('4629', 1), ('7414', 1)]\n",
      "22665935: [('5413', 2), ('6352', 2), ('6810', 1), ('20304', 1)]\n",
      "22781565: [('4633;103910', 1), ('3039', 1), ('140465', 1)]\n",
      "22789915: []\n",
      "22959663: [('335', 2), ('2167', 1)]\n",
      "23002038: [('10631', 1), ('3308', 1)]\n",
      "23160667: []\n",
      "23195030: []\n",
      "23384050: [('773', 3), ('153', 1)]\n",
      "23431486: [('3240', 1), ('5265', 1)]\n",
      "23519648: [('100329167', 5)]\n",
      "23593175: [('5586', 2), ('6285', 2), ('7297', 2), ('1805', 1), ('5747', 1), ('4921', 1)]\n",
      "23660474: [('2', 1), ('1356', 1), ('3303', 1), ('301', 1), ('4057', 1)]\n",
      "23701180: [('3240', 4)]\n",
      "23704777: [('5176', 1)]\n",
      "23797974: []\n",
      "23804534: [('4846', 1)]\n",
      "23836408: [('857', 4), ('6275', 1), ('2023', 1), ('3956', 1)]\n",
      "23916682: [('348', 4), ('7276', 4), ('335', 2), ('84909', 1)]\n",
      "23974919: [('4780', 10), ('1728', 5), ('571', 1), ('11315', 1)]\n",
      "24055733: [('6198', 2)]\n",
      "24140280: [('5473', 6), ('3240', 4), ('721', 4)]\n",
      "24182678: [('7276', 9)]\n",
      "24548642: [('4137', 2)]\n",
      "24689886: [('4680', 2)]\n",
      "24738046: [('3329', 4), ('1674', 1), ('9124', 1), ('5682', 1), ('7168', 1), ('4199', 1)]\n",
      "24780726: [('348', 2), ('319', 1)]\n",
      "24859250: [('6287', 3), ('341', 2)]\n",
      "25065337: [('3075', 8)]\n",
      "25072840: []\n",
      "25083839: []\n",
      "25099258: []\n",
      "25117565: [('6280', 4)]\n",
      "25217443: [('5216', 8)]\n",
      "25226522: [('6238', 3), ('2081', 2), ('6252', 1), ('3309', 1), ('7494', 1), ('22926', 1), ('3895', 1), ('57142', 1)]\n",
      "25318410: [('5950', 3), ('718', 2), ('9370', 2), ('183', 2)]\n",
      "25341944: [('335', 7), ('345', 1), ('53369', 1), ('336', 1)]\n",
      "25382018: [('1915', 1), ('10935', 1)]\n",
      "25397948: [('10935', 3), ('1738', 1), ('1915', 1)]\n",
      "25424990: [('6439', 5), ('6287', 4)]\n",
      "25548805: [('1431', 1)]\n",
      "25666440: [('2717', 2), ('53947', 1), ('5730', 1)]\n",
      "25684225: [('4920', 1), ('1969', 1), ('5362', 1)]\n",
      "25786980: []\n",
      "25857276: []\n",
      "25905469: []\n",
      "25944670: [('723814', 6), ('108101', 2), ('14000', 1), ('387160', 1), ('387161', 1), ('387173', 1)]\n",
      "25945665: []\n",
      "25995210: [('6287', 3), ('335', 1), ('6289', 1), ('20208', 1), ('20209', 1)]\n",
      "26028931: [('3315', 3), ('3308', 3), ('2244', 3), ('3875', 1), ('4735', 1), ('106478911', 1), ('3856', 1), ('813', 1), ('171221', 1), ('307', 1)]\n",
      "26037829: [('6287', 4), ('53369', 3), ('1401', 1), ('3569', 1), ('335', 1)]\n",
      "26063667: [('3075', 8)]\n",
      "26078484: [('462', 3)]\n",
      "26160894: [('116844', 2), ('4069', 1)]\n",
      "26285659: []\n",
      "26437904: []\n",
      "26476107: []\n",
      "26483418: [('5265', 8), ('146', 1)]\n",
      "26535788: [('6289', 2), ('335', 1), ('114548', 1), ('6291', 1)]\n",
      "26561523: [('2244', 5), ('3659', 1)]\n",
      "26564600: [('947', 7), ('494326', 7), ('723857', 2)]\n",
      "26603189: [('3630', 3), ('26998', 2), ('59083', 2)]\n",
      "26620461: [('633', 1), ('10631', 1), ('5549', 1)]\n",
      "26653129: []\n",
      "26688386: [('642658', 1), ('3673', 1), ('320', 1)]\n",
      "26750556: []\n",
      "26792056: [('6279', 6)]\n",
      "26834087: [('6120', 5)]\n",
      "26898369: [('6696', 1)]\n",
      "27084846: [('7052', 6), ('1509', 2), ('1808', 2), ('1200', 2), ('5265', 1)]\n",
      "27095521: [('8935', 2), ('7057', 1)]\n",
      "27122311: [('50802', 2), ('3263', 1), ('7018', 1), ('3240', 1)]\n",
      "27220540: []\n",
      "27230659: [('3934', 4), ('26762', 4)]\n",
      "27308822: [('5265', 1)]\n",
      "27363418: [('7422', 3)]\n",
      "27412778: [('59272', 1), ('10631', 1), ('1490', 1), ('2335', 1)]\n",
      "27429122: []\n",
      "27450324: [('55752', 1), ('2273', 1), ('1805', 1)]\n",
      "27616206: [('6279', 3), ('729359', 2), ('3827', 2)]\n",
      "27624754: [('2023', 6), ('5315', 5), ('811', 1), ('4629', 1), ('100507027', 1)]\n",
      "27711126: [('3320', 2), ('2869', 1), ('336', 1), ('3502', 1), ('309', 1), ('509', 1), ('2949', 1), ('10063', 1), ('857', 1), ('306', 1), ('2805', 1), ('8659', 1), ('5162', 1), ('622', 1), ('66035', 1), ('3326', 1), ('94239', 1), ('3309', 1), ('4723', 1)]\n",
      "27908912: []\n",
      "28196416: [('7276', 4), ('5950', 3)]\n",
      "28209220: [('348', 9), ('345', 6), ('344', 3), ('335', 2), ('338', 2), ('336', 1), ('55937', 1)]\n",
      "28223106: [('338', 1)]\n",
      "28256566: [('5465', 1), ('5595;5594', 1)]\n",
      "28273075: []\n",
      "28329269: [('12', 2), ('10631', 1), ('1462', 1)]\n",
      "28341603: [('1674', 11)]\n",
      "28427148: [('6271', 1), ('1938', 1)]\n",
      "28437237: [('627', 1), ('92737', 1), ('6364', 1), ('4314', 1), ('690', 1), ('26291', 1), ('3593', 1), ('5617', 1), ('7984', 1), ('3569', 1), ('5806', 1), ('6401', 1)]\n",
      "28501389: [('335', 1), ('128876', 1)]\n",
      "28624389: []\n",
      "28679606: []\n",
      "28720870: [('3685', 2), ('2335', 2), ('3371', 2), ('7448', 1)]\n",
      "28784649: []\n",
      "28794502: []\n",
      "28800743: [('11346', 3)]\n",
      "28922609: [('7276', 7)]\n",
      "29151592: [('3303', 2), ('1983', 2), ('2268', 1)]\n",
      "29158831: []\n",
      "29215023: []\n",
      "29235871: []\n",
      "29251807: [('2316', 1), ('6439', 1)]\n",
      "29258006: [('133522', 6), ('152330', 6)]\n",
      "29258991: [('348', 4)]\n",
      "29320704: []\n",
      "29369166: [('6369', 1), ('4879', 1), ('4153', 1), ('4055', 1), ('5118', 1)]\n",
      "29484645: [('4635', 1), ('58498', 1), ('4634', 1), ('4633', 1), ('6876', 1)]\n",
      "29505607: [('4353', 11)]\n",
      "29540862: [('2217', 1), ('7018', 1), ('5265', 1)]\n",
      "29649363: [('335', 9)]\n",
      "29665821: [('4036', 2), ('23334', 2), ('338', 1), ('2', 1)]\n",
      "29676857: [('7001', 1), ('11315', 1), ('664', 1), ('596', 1), ('5160', 1), ('8802', 1), ('34', 1), ('4723', 1)]\n",
      "29682908: [('1756', 3), ('654', 1), ('7077', 1)]\n",
      "29717219: [('6624', 1), ('2947', 1), ('9588', 1), ('4900', 1)]\n",
      "29784904: [('4879', 2), ('101669765', 1), ('6372', 1), ('2919', 1), ('958', 1), ('8517', 1), ('7422', 1), ('5653', 1), ('5175', 1), ('145624', 1), ('4312', 1)]\n",
      "29853569: [('18129', 8), ('4853', 1), ('18810', 1), ('12306', 1), ('4853;18129', 1)]\n",
      "29854824: [('4311', 4), ('7412', 3)]\n",
      "29915101: [('5468', 1)]\n",
      "29956481: []\n",
      "30002058: []\n",
      "30192561: [('351', 1), ('3816', 1)]\n",
      "30201848: [('4353', 7)]\n",
      "30212933: []\n",
      "30224653: []\n",
      "30248148: [('3075', 8), ('7547', 6)]\n",
      "30255987: []\n",
      "30261322: [('335', 3), ('7453', 1), ('2', 1)]\n",
      "30332462: [('7273', 6), ('183', 1)]\n",
      "30347343: []\n",
      "30368668: [('8216', 12), ('5500', 6), ('5894', 4), ('22808', 2)]\n",
      "30451909: [('3630', 1)]\n",
      "30478197: [('6908', 4), ('336', 2), ('1401', 1), ('170589', 1), ('5345', 1)]\n",
      "30496173: []\n",
      "30562113: [('761', 1), ('1674', 1), ('2273', 1)]\n",
      "30571344: [('348', 1), ('51266;5159', 1), ('51266', 1), ('5159', 1)]\n",
      "30658193: [('51206', 6), ('1401', 3), ('2244', 1), ('6714', 1), ('5336', 1)]\n",
      "30739867: [('151648', 4), ('699', 2)]\n",
      "30742448: [('3458', 1), ('7124', 1)]\n",
      "30782942: []\n",
      "30805593: []\n",
      "30806752: [('6256', 1), ('348', 1), ('347', 1), ('7031', 1)]\n",
      "30836973: [('2006', 2), ('1012', 1), ('4582', 1), ('1291', 1), ('6407', 1)]\n",
      "30838756: [('2244', 3), ('2', 1), ('346288', 1), ('203068', 1)]\n",
      "30870787: [('5034', 15), ('2335', 1)]\n",
      "30874584: [('50848', 4), ('4345', 3), ('2828', 3), ('1003', 2), ('59284', 2)]\n",
      "30887811: []\n",
      "30907085: []\n",
      "30922315: [('3080', 3), ('3700', 2), ('1', 1), ('213', 1)]\n",
      "30928653: []\n",
      "31056672: []\n",
      "31092728: [('5321', 3), ('5320', 1)]\n",
      "31104495: [('7124', 2)]\n",
      "31186442: [('3620', 7)]\n",
      "31204432: [('567', 1), ('229', 1), ('710', 1)]\n",
      "31242583: [('875', 1), ('4790', 1)]\n",
      "31286493: [('4010', 2)]\n",
      "31434864: []\n",
      "31476444: [('5444', 8), ('1471', 2), ('4069', 2), ('336;55937', 2)]\n",
      "31494943: [('2697', 2), ('146', 1)]\n",
      "31562990: [('2244', 1), ('3558', 1), ('3576', 1), ('3586', 1), ('3569', 1)]\n",
      "31585756: [('5829', 2), ('7431', 2), ('182', 2), ('9806', 1), ('4237', 1), ('4851', 1)]\n",
      "31734660: []\n",
      "31806903: []\n",
      "31844116: [('718', 1), ('4312', 1), ('4316', 1)]\n",
      "31862877: [('7058', 1), ('2934', 1)]\n",
      "31918764: [('4879', 1), ('3934', 1), ('1351', 1)]\n",
      "32117548: [('347902', 2)]\n",
      "32385381: [('3250', 3), ('6256', 1)]\n",
      "32487995: [('6288', 1), ('7296', 1)]\n",
      "32806897: [('None', 1), ('335', 1)]\n",
      "19960371: [('25402', 1), ('364052', 1), ('113893', 1)]\n",
      "20020777: []\n",
      "20398479: []\n",
      "20451270: [('2192', 3), ('10131', 1), ('8988', 1), ('10598', 1)]\n",
      "20515752: [('2638', 5)]\n",
      "20603051: [('488', 1), ('488;1769', 1)]\n",
      "20811296: [('5265', 1), ('27344', 1)]\n",
      "20817827: [('875', 1), ('1491', 1)]\n",
      "20853909: [('7369', 1)]\n",
      "20936720: [('6280', 1)]\n",
      "20936781: []\n",
      "21041689: [('25932', 3), ('10631', 1), ('7422', 1)]\n",
      "21043527: [('1191', 12)]\n",
      "21166718: [('3308', 3), ('3043', 2), ('2810', 2), ('811', 2), ('3713', 2), ('3308;3320;3860;3861;3868;3872;3880', 1), ('3963', 1), ('7295', 1), ('4633', 1), ('4634', 1), ('7018', 1), ('3860', 1), ('3320', 1), ('7054', 1)]\n",
      "21211997: [('12', 2)]\n",
      "21468545: []\n",
      "21545686: [('3315', 2), ('126393', 2), ('7276', 1)]\n",
      "21593211: [('4321', 4), ('7058', 1), ('165', 1), ('10631', 1), ('2335', 1), ('3371', 1)]\n",
      "21681990: [('11816', 5), ('238055', 1), ('11812', 1), ('21828', 1)]\n",
      "21712045: [('8165', 2), ('5592', 1)]\n",
      "21736391: [('10611', 1), ('11034', 1)]\n",
      "21751358: [('7414', 1), ('7431', 1), ('338382', 1), ('2597', 1)]\n",
      "21767674: [('3240', 2)]\n",
      "22221959: [('10211', 2), ('7251', 2)]\n",
      "22276806: [('335', 1), ('5265', 1), ('7431', 1), ('6647', 1), ('6876', 1), ('3240', 1), ('2878', 1), ('3315', 1), ('811', 1)]\n",
      "22384053: []\n",
      "22435364: []\n",
      "22543060: [('4633', 1), ('4629', 1), ('7414', 1)]\n",
      "22665935: [('5413', 2), ('6352', 2), ('6810', 1), ('20304', 1)]\n",
      "22781565: [('4633;103910', 1), ('3039', 1), ('140465', 1)]\n",
      "22789915: []\n",
      "22959663: [('335', 2), ('2167', 1)]\n",
      "23002038: [('10631', 1), ('3308', 1)]\n",
      "23160667: []\n",
      "23195030: []\n",
      "23384050: [('773', 3), ('153', 1)]\n",
      "23431486: [('3240', 1), ('5265', 1)]\n",
      "23519648: [('100329167', 5)]\n",
      "23593175: [('5586', 2), ('6285', 2), ('7297', 2), ('1805', 1), ('5747', 1), ('4921', 1)]\n",
      "23660474: [('2', 1), ('1356', 1), ('3303', 1), ('301', 1), ('4057', 1)]\n",
      "23701180: [('3240', 4)]\n",
      "23704777: [('5176', 1)]\n",
      "23797974: []\n",
      "23804534: [('4846', 1)]\n",
      "23836408: [('857', 4), ('6275', 1), ('2023', 1), ('3956', 1)]\n",
      "23916682: [('348', 4), ('7276', 4), ('335', 2), ('84909', 1)]\n",
      "23974919: [('4780', 10), ('1728', 5), ('571', 1), ('11315', 1)]\n",
      "24055733: [('6198', 2)]\n",
      "24140280: [('5473', 6), ('3240', 4), ('721', 4)]\n",
      "24182678: [('7276', 9)]\n",
      "24548642: [('4137', 2)]\n",
      "24689886: [('4680', 2)]\n",
      "24738046: [('3329', 4), ('1674', 1), ('9124', 1), ('5682', 1), ('7168', 1), ('4199', 1)]\n",
      "24780726: [('348', 2), ('319', 1)]\n",
      "24859250: [('6287', 3), ('341', 2)]\n",
      "25065337: [('3075', 8)]\n",
      "25072840: []\n",
      "25083839: []\n",
      "25099258: []\n",
      "25117565: [('6280', 4)]\n",
      "25217443: [('5216', 8)]\n",
      "25226522: [('6238', 3), ('2081', 2), ('6252', 1), ('3309', 1), ('7494', 1), ('22926', 1), ('3895', 1), ('57142', 1)]\n",
      "25318410: [('5950', 3), ('718', 2), ('9370', 2), ('183', 2)]\n",
      "25341944: [('335', 7), ('345', 1), ('53369', 1), ('336', 1)]\n",
      "25382018: [('1915', 1), ('10935', 1)]\n",
      "25397948: [('10935', 3), ('1738', 1), ('1915', 1)]\n",
      "25424990: [('6439', 5), ('6287', 4)]\n",
      "25548805: [('1431', 1)]\n",
      "25666440: [('2717', 2), ('53947', 1), ('5730', 1)]\n",
      "25684225: [('4920', 1), ('1969', 1), ('5362', 1)]\n",
      "25786980: []\n",
      "25857276: []\n",
      "25905469: []\n",
      "25944670: [('723814', 6), ('108101', 2), ('14000', 1), ('387160', 1), ('387161', 1), ('387173', 1)]\n",
      "25945665: []\n",
      "25995210: [('6287', 3), ('335', 1), ('6289', 1), ('20208', 1), ('20209', 1)]\n",
      "26028931: [('3315', 3), ('3308', 3), ('2244', 3), ('3875', 1), ('4735', 1), ('106478911', 1), ('3856', 1), ('813', 1), ('171221', 1), ('307', 1)]\n",
      "26037829: [('6287', 4), ('53369', 3), ('1401', 1), ('3569', 1), ('335', 1)]\n",
      "26063667: [('3075', 8)]\n",
      "26078484: [('462', 3)]\n",
      "26160894: [('116844', 2), ('4069', 1)]\n",
      "26285659: []\n",
      "26437904: []\n",
      "26476107: []\n",
      "26483418: [('5265', 8), ('146', 1)]\n",
      "26535788: [('6289', 2), ('335', 1), ('114548', 1), ('6291', 1)]\n",
      "26561523: [('2244', 5), ('3659', 1)]\n",
      "26564600: [('947', 7), ('494326', 7), ('723857', 2)]\n",
      "26603189: [('3630', 3), ('26998', 2), ('59083', 2)]\n",
      "26620461: [('633', 1), ('10631', 1), ('5549', 1)]\n",
      "26653129: []\n",
      "26688386: [('642658', 1), ('3673', 1), ('320', 1)]\n",
      "26750556: []\n",
      "26792056: [('6279', 6)]\n",
      "26834087: [('6120', 5)]\n",
      "26898369: [('6696', 1)]\n",
      "27084846: [('7052', 6), ('1509', 2), ('1808', 2), ('1200', 2), ('5265', 1)]\n",
      "27095521: [('8935', 2), ('7057', 1)]\n",
      "27122311: [('50802', 2), ('3263', 1), ('7018', 1), ('3240', 1)]\n",
      "27220540: []\n",
      "27230659: [('3934', 4), ('26762', 4)]\n",
      "27308822: [('5265', 1)]\n",
      "27363418: [('7422', 3)]\n",
      "27412778: [('59272', 1), ('10631', 1), ('1490', 1), ('2335', 1)]\n",
      "27429122: []\n",
      "27450324: [('55752', 1), ('2273', 1), ('1805', 1)]\n",
      "27616206: [('6279', 3), ('729359', 2), ('3827', 2)]\n",
      "27624754: [('2023', 6), ('5315', 5), ('811', 1), ('4629', 1), ('100507027', 1)]\n",
      "27711126: [('3320', 2), ('2869', 1), ('336', 1), ('3502', 1), ('309', 1), ('509', 1), ('2949', 1), ('10063', 1), ('857', 1), ('306', 1), ('2805', 1), ('8659', 1), ('5162', 1), ('622', 1), ('66035', 1), ('3326', 1), ('94239', 1), ('3309', 1), ('4723', 1)]\n",
      "27908912: []\n",
      "28196416: [('7276', 4), ('5950', 3)]\n",
      "28209220: [('348', 9), ('345', 6), ('344', 3), ('335', 2), ('338', 2), ('336', 1), ('55937', 1)]\n",
      "28223106: [('338', 1)]\n",
      "28256566: [('5465', 1), ('5595;5594', 1)]\n",
      "28273075: []\n",
      "28329269: [('12', 2), ('10631', 1), ('1462', 1)]\n",
      "28341603: [('1674', 11)]\n",
      "28427148: [('6271', 1), ('1938', 1)]\n",
      "28437237: [('627', 1), ('92737', 1), ('6364', 1), ('4314', 1), ('690', 1), ('26291', 1), ('3593', 1), ('5617', 1), ('7984', 1), ('3569', 1), ('5806', 1), ('6401', 1)]\n",
      "28501389: [('335', 1), ('128876', 1)]\n",
      "28624389: []\n",
      "28679606: []\n",
      "28720870: [('3685', 2), ('2335', 2), ('3371', 2), ('7448', 1)]\n",
      "28784649: []\n",
      "28794502: []\n",
      "28800743: [('11346', 3)]\n",
      "28922609: [('7276', 7)]\n",
      "29151592: [('3303', 2), ('1983', 2), ('2268', 1)]\n",
      "29158831: []\n",
      "29215023: []\n",
      "29235871: []\n",
      "29251807: [('2316', 1), ('6439', 1)]\n",
      "29258006: [('133522', 6), ('152330', 6)]\n",
      "29258991: [('348', 4)]\n",
      "29320704: []\n",
      "29369166: [('6369', 1), ('4879', 1), ('4153', 1), ('4055', 1), ('5118', 1)]\n",
      "29484645: [('4635', 1), ('58498', 1), ('4634', 1), ('4633', 1), ('6876', 1)]\n",
      "29505607: [('4353', 11)]\n",
      "29540862: [('2217', 1), ('7018', 1), ('5265', 1)]\n",
      "29649363: [('335', 9)]\n",
      "29665821: [('4036', 2), ('23334', 2), ('338', 1), ('2', 1)]\n",
      "29676857: [('7001', 1), ('11315', 1), ('664', 1), ('596', 1), ('5160', 1), ('8802', 1), ('34', 1), ('4723', 1)]\n",
      "29682908: [('1756', 3), ('654', 1), ('7077', 1)]\n",
      "29717219: [('6624', 1), ('2947', 1), ('9588', 1), ('4900', 1)]\n",
      "29784904: [('4879', 2), ('101669765', 1), ('6372', 1), ('2919', 1), ('958', 1), ('8517', 1), ('7422', 1), ('5653', 1), ('5175', 1), ('145624', 1), ('4312', 1)]\n",
      "29853569: [('18129', 8), ('4853', 1), ('18810', 1), ('12306', 1), ('4853;18129', 1)]\n",
      "29854824: [('4311', 4), ('7412', 3)]\n",
      "29915101: [('5468', 1)]\n",
      "29956481: []\n",
      "30002058: []\n",
      "30192561: [('351', 1), ('3816', 1)]\n",
      "30201848: [('4353', 7)]\n",
      "30212933: []\n",
      "30224653: []\n",
      "30248148: [('3075', 8), ('7547', 6)]\n",
      "30255987: []\n",
      "30261322: [('335', 3), ('7453', 1), ('2', 1)]\n",
      "30332462: [('7273', 6), ('183', 1)]\n",
      "30347343: []\n",
      "30368668: [('8216', 12), ('5500', 6), ('5894', 4), ('22808', 2)]\n",
      "30451909: [('3630', 1)]\n",
      "30478197: [('6908', 4), ('336', 2), ('1401', 1), ('170589', 1), ('5345', 1)]\n",
      "30496173: []\n",
      "30562113: [('761', 1), ('1674', 1), ('2273', 1)]\n",
      "30571344: [('348', 1), ('51266;5159', 1), ('51266', 1), ('5159', 1)]\n",
      "30658193: [('51206', 6), ('1401', 3), ('2244', 1), ('6714', 1), ('5336', 1)]\n",
      "30739867: [('151648', 4), ('699', 2)]\n",
      "30742448: [('3458', 1), ('7124', 1)]\n",
      "30782942: []\n",
      "30805593: []\n",
      "30806752: [('6256', 1), ('348', 1), ('347', 1), ('7031', 1)]\n",
      "30836973: [('2006', 2), ('1012', 1), ('4582', 1), ('1291', 1), ('6407', 1)]\n",
      "30838756: [('2244', 3), ('2', 1), ('346288', 1), ('203068', 1)]\n",
      "30870787: [('5034', 15), ('2335', 1)]\n",
      "30874584: [('50848', 4), ('4345', 3), ('2828', 3), ('1003', 2), ('59284', 2)]\n",
      "30887811: []\n",
      "30907085: []\n",
      "30922315: [('3080', 3), ('3700', 2), ('1', 1), ('213', 1)]\n",
      "30928653: []\n",
      "31056672: []\n",
      "31092728: [('5321', 3), ('5320', 1)]\n",
      "31104495: [('7124', 2)]\n",
      "31186442: [('3620', 7)]\n",
      "31204432: [('567', 1), ('229', 1), ('710', 1)]\n",
      "31242583: [('875', 1), ('4790', 1)]\n",
      "31286493: [('4010', 2)]\n",
      "31434864: []\n",
      "31476444: [('5444', 8), ('1471', 2), ('4069', 2), ('336;55937', 2)]\n",
      "31494943: [('2697', 2), ('146', 1)]\n",
      "31562990: [('2244', 1), ('3558', 1), ('3576', 1), ('3586', 1), ('3569', 1)]\n",
      "31585756: [('5829', 2), ('7431', 2), ('182', 2), ('9806', 1), ('4237', 1), ('4851', 1)]\n",
      "31734660: []\n",
      "31806903: []\n",
      "31844116: [('718', 1), ('4312', 1), ('4316', 1)]\n",
      "31862877: [('7058', 1), ('2934', 1)]\n",
      "31918764: [('4879', 1), ('3934', 1), ('1351', 1)]\n",
      "32117548: [('347902', 2)]\n",
      "32385381: [('3250', 3), ('6256', 1)]\n",
      "32487995: [('6288', 1), ('7296', 1)]\n",
      "32806897: [('None', 1), ('335', 1)]\n",
      "19960371: [('25402', 1), ('364052', 1), ('113893', 1)]\n",
      "20020777: []\n",
      "20398479: []\n",
      "20451270: [('2192', 3), ('10131', 1), ('8988', 1), ('10598', 1)]\n",
      "20515752: [('2638', 5)]\n",
      "20603051: [('488', 1), ('488;1769', 1)]\n",
      "20811296: [('5265', 1), ('27344', 1)]\n",
      "20817827: [('875', 1), ('1491', 1)]\n",
      "20853909: [('7369', 1)]\n",
      "20936720: [('6280', 1)]\n",
      "20936781: []\n",
      "21041689: [('25932', 3), ('10631', 1), ('7422', 1)]\n",
      "21043527: [('1191', 12)]\n",
      "21166718: [('3308', 3), ('3043', 2), ('2810', 2), ('811', 2), ('3713', 2), ('3308;3320;3860;3861;3868;3872;3880', 1), ('3963', 1), ('7295', 1), ('4633', 1), ('4634', 1), ('7018', 1), ('3860', 1), ('3320', 1), ('7054', 1)]\n",
      "21211997: [('12', 2)]\n",
      "21468545: []\n",
      "21545686: [('3315', 2), ('126393', 2), ('7276', 1)]\n",
      "21593211: [('4321', 4), ('7058', 1), ('165', 1), ('10631', 1), ('2335', 1), ('3371', 1)]\n",
      "21681990: [('11816', 5), ('238055', 1), ('11812', 1), ('21828', 1)]\n",
      "21712045: [('8165', 2), ('5592', 1)]\n",
      "21736391: [('10611', 1), ('11034', 1)]\n",
      "21751358: [('7414', 1), ('7431', 1), ('338382', 1), ('2597', 1)]\n",
      "21767674: [('3240', 2)]\n",
      "22221959: [('10211', 2), ('7251', 2)]\n",
      "22276806: [('335', 1), ('5265', 1), ('7431', 1), ('6647', 1), ('6876', 1), ('3240', 1), ('2878', 1), ('3315', 1), ('811', 1)]\n",
      "22384053: []\n",
      "22435364: []\n",
      "22543060: [('4633', 1), ('4629', 1), ('7414', 1)]\n",
      "22665935: [('5413', 2), ('6352', 2), ('6810', 1), ('20304', 1)]\n",
      "22781565: [('4633;103910', 1), ('3039', 1), ('140465', 1)]\n",
      "22789915: []\n",
      "22959663: [('335', 2), ('2167', 1)]\n",
      "23002038: [('10631', 1), ('3308', 1)]\n",
      "23160667: []\n",
      "23195030: []\n",
      "23384050: [('773', 3), ('153', 1)]\n",
      "23431486: [('3240', 1), ('5265', 1)]\n",
      "23519648: [('100329167', 5)]\n",
      "23593175: [('5586', 2), ('6285', 2), ('7297', 2), ('1805', 1), ('5747', 1), ('4921', 1)]\n",
      "23660474: [('2', 1), ('1356', 1), ('3303', 1), ('301', 1), ('4057', 1)]\n",
      "23701180: [('3240', 4)]\n",
      "23704777: [('5176', 1)]\n",
      "23797974: []\n",
      "23804534: [('4846', 1)]\n",
      "23836408: [('857', 4), ('6275', 1), ('2023', 1), ('3956', 1)]\n",
      "23916682: [('348', 4), ('7276', 4), ('335', 2), ('84909', 1)]\n",
      "23974919: [('4780', 10), ('1728', 5), ('571', 1), ('11315', 1)]\n",
      "24055733: [('6198', 2)]\n",
      "24140280: [('5473', 6), ('3240', 4), ('721', 4)]\n",
      "24182678: [('7276', 9)]\n",
      "24548642: [('4137', 2)]\n",
      "24689886: [('4680', 2)]\n",
      "24738046: [('3329', 4), ('1674', 1), ('9124', 1), ('5682', 1), ('7168', 1), ('4199', 1)]\n",
      "24780726: [('348', 2), ('319', 1)]\n",
      "24859250: [('6287', 3), ('341', 2)]\n",
      "25065337: [('3075', 8)]\n",
      "25072840: []\n",
      "25083839: []\n",
      "25099258: []\n",
      "25117565: [('6280', 4)]\n",
      "25217443: [('5216', 8)]\n",
      "25226522: [('6238', 3), ('2081', 2), ('6252', 1), ('3309', 1), ('7494', 1), ('22926', 1), ('3895', 1), ('57142', 1)]\n",
      "25318410: [('5950', 3), ('718', 2), ('9370', 2), ('183', 2)]\n",
      "25341944: [('335', 7), ('345', 1), ('53369', 1), ('336', 1)]\n",
      "25382018: [('1915', 1), ('10935', 1)]\n",
      "25397948: [('10935', 3), ('1738', 1), ('1915', 1)]\n",
      "25424990: [('6439', 5), ('6287', 4)]\n",
      "25548805: [('1431', 1)]\n",
      "25666440: [('2717', 2), ('53947', 1), ('5730', 1)]\n",
      "25684225: [('4920', 1), ('1969', 1), ('5362', 1)]\n",
      "25786980: []\n",
      "25857276: []\n",
      "25905469: []\n",
      "25944670: [('723814', 6), ('108101', 2), ('14000', 1), ('387160', 1), ('387161', 1), ('387173', 1)]\n",
      "25945665: []\n",
      "25995210: [('6287', 3), ('335', 1), ('6289', 1), ('20208', 1), ('20209', 1)]\n",
      "26028931: [('3315', 3), ('3308', 3), ('2244', 3), ('3875', 1), ('4735', 1), ('106478911', 1), ('3856', 1), ('813', 1), ('171221', 1), ('307', 1)]\n",
      "26037829: [('6287', 4), ('53369', 3), ('1401', 1), ('3569', 1), ('335', 1)]\n",
      "26063667: [('3075', 8)]\n",
      "26078484: [('462', 3)]\n",
      "26160894: [('116844', 2), ('4069', 1)]\n",
      "26285659: []\n",
      "26437904: []\n",
      "26476107: []\n",
      "26483418: [('5265', 8), ('146', 1)]\n",
      "26535788: [('6289', 2), ('335', 1), ('114548', 1), ('6291', 1)]\n",
      "26561523: [('2244', 5), ('3659', 1)]\n",
      "26564600: [('947', 7), ('494326', 7), ('723857', 2)]\n",
      "26603189: [('3630', 3), ('26998', 2), ('59083', 2)]\n",
      "26620461: [('633', 1), ('10631', 1), ('5549', 1)]\n",
      "26653129: []\n",
      "26688386: [('642658', 1), ('3673', 1), ('320', 1)]\n",
      "26750556: []\n",
      "26792056: [('6279', 6)]\n",
      "26834087: [('6120', 5)]\n",
      "26898369: [('6696', 1)]\n",
      "27084846: [('7052', 6), ('1509', 2), ('1808', 2), ('1200', 2), ('5265', 1)]\n",
      "27095521: [('8935', 2), ('7057', 1)]\n",
      "27122311: [('50802', 2), ('3263', 1), ('7018', 1), ('3240', 1)]\n",
      "27220540: []\n",
      "27450324: [('55752', 1), ('2273', 1), ('1805', 1)]\n",
      "27616206: [('6279', 3), ('729359', 2), ('3827', 2)]\n",
      "27624754: [('2023', 6), ('5315', 5), ('811', 1), ('4629', 1), ('100507027', 1)]\n",
      "27711126: [('3320', 2), ('2869', 1), ('336', 1), ('3502', 1), ('309', 1), ('509', 1), ('2949', 1), ('10063', 1), ('857', 1), ('306', 1), ('2805', 1), ('8659', 1), ('5162', 1), ('622', 1), ('66035', 1), ('3326', 1), ('94239', 1), ('3309', 1), ('4723', 1)]\n",
      "27908912: []\n",
      "28196416: [('7276', 4), ('5950', 3)]\n",
      "28209220: [('348', 9), ('345', 6), ('344', 3), ('335', 2), ('338', 2), ('336', 1), ('55937', 1)]\n",
      "28223106: [('338', 1)]\n",
      "28256566: [('5465', 1), ('5595;5594', 1)]\n",
      "28273075: []\n",
      "28329269: [('12', 2), ('10631', 1), ('1462', 1)]\n",
      "28341603: [('1674', 11)]\n",
      "28427148: [('6271', 1), ('1938', 1)]\n",
      "28437237: [('627', 1), ('92737', 1), ('6364', 1), ('4314', 1), ('690', 1), ('26291', 1), ('3593', 1), ('5617', 1), ('7984', 1), ('3569', 1), ('5806', 1), ('6401', 1)]\n",
      "28501389: [('335', 1), ('128876', 1)]\n",
      "28624389: []\n",
      "28679606: []\n",
      "28720870: [('3685', 2), ('2335', 2), ('3371', 2), ('7448', 1)]\n",
      "28784649: []\n",
      "28794502: []\n",
      "28800743: [('11346', 3)]\n",
      "28922609: [('7276', 7)]\n",
      "29151592: [('3303', 2), ('1983', 2), ('2268', 1)]\n",
      "29158831: []\n",
      "29215023: []\n",
      "29235871: []\n",
      "29251807: [('2316', 1), ('6439', 1)]\n",
      "29258006: [('133522', 6), ('152330', 6)]\n",
      "29258991: [('348', 4)]\n",
      "29320704: []\n",
      "29369166: [('6369', 1), ('4879', 1), ('4153', 1), ('4055', 1), ('5118', 1)]\n",
      "29484645: [('4635', 1), ('58498', 1), ('4634', 1), ('4633', 1), ('6876', 1)]\n",
      "29505607: [('4353', 11)]\n",
      "29540862: [('2217', 1), ('7018', 1), ('5265', 1)]\n",
      "29649363: [('335', 9)]\n",
      "29665821: [('4036', 2), ('23334', 2), ('338', 1), ('2', 1)]\n",
      "29676857: [('7001', 1), ('11315', 1), ('664', 1), ('596', 1), ('5160', 1), ('8802', 1), ('34', 1), ('4723', 1)]\n",
      "29682908: [('1756', 3), ('654', 1), ('7077', 1)]\n",
      "29717219: [('6624', 1), ('2947', 1), ('9588', 1), ('4900', 1)]\n",
      "29784904: [('4879', 2), ('101669765', 1), ('6372', 1), ('2919', 1), ('958', 1), ('8517', 1), ('7422', 1), ('5653', 1), ('5175', 1), ('145624', 1), ('4312', 1)]\n",
      "29853569: [('18129', 8), ('4853', 1), ('18810', 1), ('12306', 1), ('4853;18129', 1)]\n",
      "29854824: [('4311', 4), ('7412', 3)]\n",
      "29915101: [('5468', 1)]\n",
      "29956481: []\n",
      "30002058: []\n",
      "30192561: [('351', 1), ('3816', 1)]\n",
      "30201848: [('4353', 7)]\n",
      "30212933: []\n",
      "30224653: []\n",
      "30248148: [('3075', 8), ('7547', 6)]\n",
      "30255987: []\n",
      "30261322: [('335', 3), ('7453', 1), ('2', 1)]\n",
      "30332462: [('7273', 6), ('183', 1)]\n",
      "30347343: []\n",
      "30368668: [('8216', 12), ('5500', 6), ('5894', 4), ('22808', 2)]\n",
      "30451909: [('3630', 1)]\n",
      "30478197: [('6908', 4), ('336', 2), ('1401', 1), ('170589', 1), ('5345', 1)]\n",
      "30496173: []\n",
      "30562113: [('761', 1), ('1674', 1), ('2273', 1)]\n",
      "30571344: [('348', 1), ('51266;5159', 1), ('51266', 1), ('5159', 1)]\n",
      "30658193: [('51206', 6), ('1401', 3), ('2244', 1), ('6714', 1), ('5336', 1)]\n",
      "30739867: [('151648', 4), ('699', 2)]\n",
      "30742448: [('3458', 1), ('7124', 1)]\n",
      "30782942: []\n",
      "30805593: []\n",
      "30806752: [('6256', 1), ('348', 1), ('347', 1), ('7031', 1)]\n",
      "30836973: [('2006', 2), ('1012', 1), ('4582', 1), ('1291', 1), ('6407', 1)]\n",
      "30838756: [('2244', 3), ('2', 1), ('346288', 1), ('203068', 1)]\n",
      "30870787: [('5034', 15), ('2335', 1)]\n",
      "30874584: [('50848', 4), ('4345', 3), ('2828', 3), ('1003', 2), ('59284', 2)]\n",
      "30887811: []\n",
      "30907085: []\n",
      "30922315: [('3080', 3), ('3700', 2), ('1', 1), ('213', 1)]\n",
      "30928653: []\n",
      "31056672: []\n",
      "31092728: [('5321', 3), ('5320', 1)]\n",
      "31104495: [('7124', 2)]\n",
      "31186442: [('3620', 7)]\n",
      "31204432: [('567', 1), ('229', 1), ('710', 1)]\n",
      "31242583: [('875', 1), ('4790', 1)]\n",
      "31286493: [('4010', 2)]\n",
      "31434864: []\n",
      "31476444: [('5444', 8), ('1471', 2), ('4069', 2), ('336;55937', 2)]\n",
      "31494943: [('2697', 2), ('146', 1)]\n",
      "31562990: [('2244', 1), ('3558', 1), ('3576', 1), ('3586', 1), ('3569', 1)]\n",
      "31585756: [('5829', 2), ('7431', 2), ('182', 2), ('9806', 1), ('4237', 1), ('4851', 1)]\n",
      "31734660: []\n",
      "31806903: []\n",
      "31819116: []\n",
      "31844116: [('718', 1), ('4312', 1), ('4316', 1)]\n",
      "31862877: [('7058', 1), ('2934', 1)]\n",
      "31918764: [('4879', 1), ('3934', 1), ('1351', 1)]\n",
      "31988066: [('5972', 4), ('9518', 2), ('9370', 2), ('5654', 1), ('292', 1), ('1956', 1), ('1272', 1)]\n",
      "32117548: [('347902', 2)]\n",
      "32178279: []\n",
      "32385381: [('3250', 3), ('6256', 1)]\n",
      "32427855: [('5284', 9), ('80739', 1)]\n",
      "32487995: [('6288', 1), ('7296', 1)]\n",
      "32806897: [('None', 1), ('335', 1)]\n",
      "32938215: [('350', 10), ('1401', 2)]\n",
      "20603051: [('488', 1), ('488;1769', 1)]\n",
      "20811296: [('5265', 1), ('27344', 1)]\n",
      "20817827: [('875', 1), ('1491', 1)]\n",
      "20853909: [('7369', 1)]\n",
      "20936720: [('6280', 1)]\n",
      "20936781: []\n",
      "21041689: [('25932', 3), ('10631', 1), ('7422', 1)]\n",
      "21043527: [('1191', 12)]\n",
      "21166718: [('3308', 3), ('3043', 2), ('2810', 2), ('811', 2), ('3713', 2), ('3308;3320;3860;3861;3868;3872;3880', 1), ('3963', 1), ('7295', 1), ('4633', 1), ('4634', 1), ('7018', 1), ('3860', 1), ('3320', 1), ('7054', 1)]\n",
      "21211997: [('12', 2)]\n",
      "21468545: []\n",
      "21545686: [('3315', 2), ('126393', 2), ('7276', 1)]\n",
      "21593211: [('4321', 4), ('7058', 1), ('165', 1), ('10631', 1), ('2335', 1), ('3371', 1)]\n",
      "21681990: [('11816', 5), ('238055', 1), ('11812', 1), ('21828', 1)]\n",
      "21712045: [('8165', 2), ('5592', 1)]\n",
      "21736391: [('10611', 1), ('11034', 1)]\n",
      "21751358: [('7414', 1), ('7431', 1), ('338382', 1), ('2597', 1)]\n",
      "21767674: [('3240', 2)]\n",
      "22221959: [('10211', 2), ('7251', 2)]\n",
      "22276806: [('335', 1), ('5265', 1), ('7431', 1), ('6647', 1), ('6876', 1), ('3240', 1), ('2878', 1), ('3315', 1), ('811', 1)]\n",
      "22384053: []\n",
      "22435364: []\n",
      "22543060: [('4633', 1), ('4629', 1), ('7414', 1)]\n",
      "22665935: [('5413', 2), ('6352', 2), ('6810', 1), ('20304', 1)]\n",
      "22781565: [('4633;103910', 1), ('3039', 1), ('140465', 1)]\n",
      "22789915: []\n",
      "22959663: [('335', 2), ('2167', 1)]\n",
      "23002038: [('10631', 1), ('3308', 1)]\n",
      "23160667: []\n",
      "23195030: []\n",
      "23384050: [('773', 3), ('153', 1)]\n",
      "23431486: [('3240', 1), ('5265', 1)]\n",
      "23519648: [('100329167', 5)]\n",
      "23593175: [('5586', 2), ('6285', 2), ('7297', 2), ('1805', 1), ('5747', 1), ('4921', 1)]\n",
      "23660474: [('2', 1), ('1356', 1), ('3303', 1), ('301', 1), ('4057', 1)]\n",
      "23701180: [('3240', 4)]\n",
      "23704777: [('5176', 1)]\n",
      "23797974: []\n",
      "23804534: [('4846', 1)]\n",
      "23836408: [('857', 4), ('6275', 1), ('2023', 1), ('3956', 1)]\n",
      "23916682: [('348', 4), ('7276', 4), ('335', 2), ('84909', 1)]\n",
      "23974919: [('4780', 10), ('1728', 5), ('571', 1), ('11315', 1)]\n",
      "24055733: [('6198', 2)]\n",
      "24140280: [('5473', 6), ('3240', 4), ('721', 4)]\n",
      "24182678: [('7276', 9)]\n",
      "24548642: [('4137', 2)]\n",
      "24689886: [('4680', 2)]\n",
      "24738046: [('3329', 4), ('1674', 1), ('9124', 1), ('5682', 1), ('7168', 1), ('4199', 1)]\n",
      "24780726: [('348', 2), ('319', 1)]\n",
      "24859250: [('6287', 3), ('341', 2)]\n",
      "25065337: [('3075', 8)]\n",
      "25072840: []\n",
      "25083839: []\n",
      "25099258: []\n",
      "25117565: [('6280', 4)]\n",
      "25217443: [('5216', 8)]\n",
      "25226522: [('6238', 3), ('2081', 2), ('6252', 1), ('3309', 1), ('7494', 1), ('22926', 1), ('3895', 1), ('57142', 1)]\n",
      "25318410: [('5950', 3), ('718', 2), ('9370', 2), ('183', 2)]\n",
      "25341944: [('335', 7), ('345', 1), ('53369', 1), ('336', 1)]\n",
      "25382018: [('1915', 1), ('10935', 1)]\n",
      "25397948: [('10935', 3), ('1738', 1), ('1915', 1)]\n",
      "25424990: [('6439', 5), ('6287', 4)]\n",
      "25548805: [('1431', 1)]\n",
      "25666440: [('2717', 2), ('53947', 1), ('5730', 1)]\n",
      "25684225: [('4920', 1), ('1969', 1), ('5362', 1)]\n",
      "25786980: []\n",
      "25857276: []\n",
      "25905469: []\n",
      "25944670: [('723814', 6), ('108101', 2), ('14000', 1), ('387160', 1), ('387161', 1), ('387173', 1)]\n",
      "25945665: []\n",
      "25995210: [('6287', 3), ('335', 1), ('6289', 1), ('20208', 1), ('20209', 1)]\n",
      "26028931: [('3315', 3), ('3308', 3), ('2244', 3), ('3875', 1), ('4735', 1), ('106478911', 1), ('3856', 1), ('813', 1), ('171221', 1), ('307', 1)]\n",
      "26037829: [('6287', 4), ('53369', 3), ('1401', 1), ('3569', 1), ('335', 1)]\n",
      "26063667: [('3075', 8)]\n",
      "26078484: [('462', 3)]\n",
      "26160894: [('116844', 2), ('4069', 1)]\n",
      "26285659: []\n",
      "26437904: []\n",
      "26476107: []\n",
      "26483418: [('5265', 8), ('146', 1)]\n",
      "26535788: [('6289', 2), ('335', 1), ('114548', 1), ('6291', 1)]\n",
      "26561523: [('2244', 5), ('3659', 1)]\n",
      "26564600: [('947', 7), ('494326', 7), ('723857', 2)]\n",
      "26603189: [('3630', 3), ('26998', 2), ('59083', 2)]\n",
      "26620461: [('633', 1), ('10631', 1), ('5549', 1)]\n",
      "26653129: []\n",
      "26688386: [('642658', 1), ('3673', 1), ('320', 1)]\n",
      "26750556: []\n",
      "26792056: [('6279', 6)]\n",
      "26834087: [('6120', 5)]\n",
      "26898369: [('6696', 1)]\n",
      "27084846: [('7052', 6), ('1509', 2), ('1808', 2), ('1200', 2), ('5265', 1)]\n",
      "27095521: [('8935', 2), ('7057', 1)]\n",
      "27122311: [('50802', 2), ('3263', 1), ('7018', 1), ('3240', 1)]\n",
      "27220540: []\n",
      "27230659: [('3934', 4), ('26762', 4)]\n",
      "27308822: [('5265', 1)]\n",
      "27363418: [('7422', 3)]\n",
      "27412778: [('59272', 1), ('10631', 1), ('1490', 1), ('2335', 1)]\n",
      "27429122: []\n",
      "27450324: [('55752', 1), ('2273', 1), ('1805', 1)]\n",
      "27616206: [('6279', 3), ('729359', 2), ('3827', 2)]\n",
      "27624754: [('2023', 6), ('5315', 5), ('811', 1), ('4629', 1), ('100507027', 1)]\n",
      "27711126: [('3320', 2), ('2869', 1), ('336', 1), ('3502', 1), ('309', 1), ('509', 1), ('2949', 1), ('10063', 1), ('857', 1), ('306', 1), ('2805', 1), ('8659', 1), ('5162', 1), ('622', 1), ('66035', 1), ('3326', 1), ('94239', 1), ('3309', 1), ('4723', 1)]\n",
      "27908912: []\n",
      "28196416: [('7276', 4), ('5950', 3)]\n",
      "28209220: [('348', 9), ('345', 6), ('344', 3), ('335', 2), ('338', 2), ('336', 1), ('55937', 1)]\n",
      "28223106: [('338', 1)]\n",
      "28256566: [('5465', 1), ('5595;5594', 1)]\n",
      "28273075: []\n",
      "28329269: [('12', 2), ('10631', 1), ('1462', 1)]\n",
      "28341603: [('1674', 11)]\n",
      "28427148: [('6271', 1), ('1938', 1)]\n",
      "28437237: [('627', 1), ('92737', 1), ('6364', 1), ('4314', 1), ('690', 1), ('26291', 1), ('3593', 1), ('5617', 1), ('7984', 1), ('3569', 1), ('5806', 1), ('6401', 1)]\n",
      "28501389: [('335', 1), ('128876', 1)]\n",
      "28624389: []\n",
      "28679606: []\n",
      "28720870: [('3685', 2), ('2335', 2), ('3371', 2), ('7448', 1)]\n",
      "28784649: []\n",
      "28794502: []\n",
      "28800743: [('11346', 3)]\n",
      "28922609: [('7276', 7)]\n",
      "29151592: [('3303', 2), ('1983', 2), ('2268', 1)]\n",
      "29158831: []\n",
      "29215023: []\n",
      "29235871: []\n",
      "29251807: [('2316', 1), ('6439', 1)]\n",
      "29258006: [('133522', 6), ('152330', 6)]\n",
      "29258991: [('348', 4)]\n",
      "29320704: []\n",
      "29369166: [('6369', 1), ('4879', 1), ('4153', 1), ('4055', 1), ('5118', 1)]\n",
      "29484645: [('4635', 1), ('58498', 1), ('4634', 1), ('4633', 1), ('6876', 1)]\n",
      "29505607: [('4353', 11)]\n",
      "29540862: [('2217', 1), ('7018', 1), ('5265', 1)]\n",
      "29649363: [('335', 9)]\n",
      "29665821: [('4036', 2), ('23334', 2), ('338', 1), ('2', 1)]\n",
      "29676857: [('7001', 1), ('11315', 1), ('664', 1), ('596', 1), ('5160', 1), ('8802', 1), ('34', 1), ('4723', 1)]\n",
      "29682908: [('1756', 3), ('654', 1), ('7077', 1)]\n",
      "29717219: [('6624', 1), ('2947', 1), ('9588', 1), ('4900', 1)]\n",
      "29784904: [('4879', 2), ('101669765', 1), ('6372', 1), ('2919', 1), ('958', 1), ('8517', 1), ('7422', 1), ('5653', 1), ('5175', 1), ('145624', 1), ('4312', 1)]\n",
      "29853569: [('18129', 8), ('4853', 1), ('18810', 1), ('12306', 1), ('4853;18129', 1)]\n",
      "29854824: [('4311', 4), ('7412', 3)]\n",
      "29915101: [('5468', 1)]\n",
      "29956481: []\n",
      "30002058: []\n",
      "30192561: [('351', 1), ('3816', 1)]\n",
      "30201848: [('4353', 7)]\n",
      "30212933: []\n",
      "30224653: []\n",
      "30248148: [('3075', 8), ('7547', 6)]\n",
      "30255987: []\n",
      "30261322: [('335', 3), ('7453', 1), ('2', 1)]\n",
      "30332462: [('7273', 6), ('183', 1)]\n",
      "30347343: []\n",
      "30368668: [('8216', 12), ('5500', 6), ('5894', 4), ('22808', 2)]\n",
      "30451909: [('3630', 1)]\n",
      "30478197: [('6908', 4), ('336', 2), ('1401', 1), ('170589', 1), ('5345', 1)]\n",
      "30496173: []\n",
      "30562113: [('761', 1), ('1674', 1), ('2273', 1)]\n",
      "30571344: [('348', 1), ('51266;5159', 1), ('51266', 1), ('5159', 1)]\n",
      "30658193: [('51206', 6), ('1401', 3), ('2244', 1), ('6714', 1), ('5336', 1)]\n",
      "30739867: [('151648', 4), ('699', 2)]\n",
      "30742448: [('3458', 1), ('7124', 1)]\n",
      "30782942: []\n",
      "30805593: []\n",
      "30806752: [('6256', 1), ('348', 1), ('347', 1), ('7031', 1)]\n",
      "30836973: [('2006', 2), ('1012', 1), ('4582', 1), ('1291', 1), ('6407', 1)]\n",
      "30838756: [('2244', 3), ('2', 1), ('346288', 1), ('203068', 1)]\n",
      "30870787: [('5034', 15), ('2335', 1)]\n",
      "30874584: [('50848', 4), ('4345', 3), ('2828', 3), ('1003', 2), ('59284', 2)]\n",
      "30887811: []\n",
      "30907085: []\n",
      "30922315: [('3080', 3), ('3700', 2), ('1', 1), ('213', 1)]\n",
      "30928653: []\n",
      "31056672: []\n",
      "31092728: [('5321', 3), ('5320', 1)]\n",
      "31104495: [('7124', 2)]\n",
      "31186442: [('3620', 7)]\n",
      "31204432: [('567', 1), ('229', 1), ('710', 1)]\n",
      "31242583: [('875', 1), ('4790', 1)]\n",
      "31286493: [('4010', 2)]\n",
      "31434864: []\n",
      "31476444: [('5444', 8), ('1471', 2), ('4069', 2), ('336;55937', 2)]\n",
      "31494943: [('2697', 2), ('146', 1)]\n",
      "31562990: [('2244', 1), ('3558', 1), ('3576', 1), ('3586', 1), ('3569', 1)]\n",
      "31585756: [('5829', 2), ('7431', 2), ('182', 2), ('9806', 1), ('4237', 1), ('4851', 1)]\n",
      "31734660: []\n",
      "31806903: []\n",
      "31819116: []\n",
      "31844116: [('718', 1), ('4312', 1), ('4316', 1)]\n",
      "31862877: [('7058', 1), ('2934', 1)]\n",
      "31918764: [('4879', 1), ('3934', 1), ('1351', 1)]\n",
      "31988066: [('5972', 4), ('9518', 2), ('9370', 2), ('5654', 1), ('292', 1), ('1956', 1), ('1272', 1)]\n",
      "32117548: [('347902', 2)]\n",
      "32178279: []\n",
      "32385381: [('3250', 3), ('6256', 1)]\n",
      "32427855: [('5284', 9), ('80739', 1)]\n",
      "32487995: [('6288', 1), ('7296', 1)]\n",
      "32806897: [('None', 1), ('335', 1)]\n",
      "32938215: [('350', 10), ('1401', 2)]\n",
      "20603051: [('488', 1), ('488;1769', 1)]\n",
      "20811296: [('5265', 1), ('27344', 1)]\n",
      "20817827: [('875', 1), ('1491', 1)]\n",
      "20853909: [('7369', 1)]\n",
      "20936720: [('6280', 1)]\n",
      "20936781: []\n",
      "21041689: [('25932', 3), ('10631', 1), ('7422', 1)]\n",
      "21043527: [('1191', 12)]\n",
      "21166718: [('3308', 3), ('3043', 2), ('2810', 2), ('811', 2), ('3713', 2), ('3308;3320;3860;3861;3868;3872;3880', 1), ('3963', 1), ('7295', 1), ('4633', 1), ('4634', 1), ('7018', 1), ('3860', 1), ('3320', 1), ('7054', 1)]\n",
      "21211997: [('12', 2)]\n",
      "21468545: []\n",
      "21545686: [('3315', 2), ('126393', 2), ('7276', 1)]\n",
      "21593211: [('4321', 4), ('7058', 1), ('165', 1), ('10631', 1), ('2335', 1), ('3371', 1)]\n",
      "21681990: [('11816', 5), ('238055', 1), ('11812', 1), ('21828', 1)]\n",
      "21712045: [('8165', 2), ('5592', 1)]\n",
      "21736391: [('10611', 1), ('11034', 1)]\n",
      "21751358: [('7414', 1), ('7431', 1), ('338382', 1), ('2597', 1)]\n",
      "21767674: [('3240', 2)]\n",
      "22221959: [('10211', 2), ('7251', 2)]\n",
      "22276806: [('335', 1), ('5265', 1), ('7431', 1), ('6647', 1), ('6876', 1), ('3240', 1), ('2878', 1), ('3315', 1), ('811', 1)]\n",
      "22384053: []\n",
      "22435364: []\n",
      "22543060: [('4633', 1), ('4629', 1), ('7414', 1)]\n",
      "22665935: [('5413', 2), ('6352', 2), ('6810', 1), ('20304', 1)]\n",
      "22781565: [('4633;103910', 1), ('3039', 1), ('140465', 1)]\n",
      "22789915: []\n",
      "22959663: [('335', 2), ('2167', 1)]\n",
      "23002038: [('10631', 1), ('3308', 1)]\n",
      "23160667: []\n",
      "23195030: []\n",
      "23384050: [('773', 3), ('153', 1)]\n",
      "23431486: [('3240', 1), ('5265', 1)]\n",
      "23519648: [('100329167', 5)]\n",
      "23593175: [('5586', 2), ('6285', 2), ('7297', 2), ('1805', 1), ('5747', 1), ('4921', 1)]\n",
      "23660474: [('2', 1), ('1356', 1), ('3303', 1), ('301', 1), ('4057', 1)]\n",
      "23701180: [('3240', 4)]\n",
      "23704777: [('5176', 1)]\n",
      "23797974: []\n",
      "23804534: [('4846', 1)]\n",
      "23836408: [('857', 4), ('6275', 1), ('2023', 1), ('3956', 1)]\n",
      "23916682: [('348', 4), ('7276', 4), ('335', 2), ('84909', 1)]\n",
      "23974919: [('4780', 10), ('1728', 5), ('571', 1), ('11315', 1)]\n",
      "24055733: [('6198', 2)]\n",
      "24140280: [('5473', 6), ('3240', 4), ('721', 4)]\n",
      "24182678: [('7276', 9)]\n",
      "24548642: [('4137', 2)]\n",
      "24689886: [('4680', 2)]\n",
      "24738046: [('3329', 4), ('1674', 1), ('9124', 1), ('5682', 1), ('7168', 1), ('4199', 1)]\n",
      "24780726: [('348', 2), ('319', 1)]\n",
      "24859250: [('6287', 3), ('341', 2)]\n",
      "25065337: [('3075', 8)]\n",
      "25072840: []\n",
      "25083839: []\n",
      "25099258: []\n",
      "25117565: [('6280', 4)]\n",
      "25217443: [('5216', 8)]\n",
      "25226522: [('6238', 3), ('2081', 2), ('6252', 1), ('3309', 1), ('7494', 1), ('22926', 1), ('3895', 1), ('57142', 1)]\n",
      "25318410: [('5950', 3), ('718', 2), ('9370', 2), ('183', 2)]\n",
      "25341944: [('335', 7), ('345', 1), ('53369', 1), ('336', 1)]\n",
      "25382018: [('1915', 1), ('10935', 1)]\n",
      "25397948: [('10935', 3), ('1738', 1), ('1915', 1)]\n",
      "25424990: [('6439', 5), ('6287', 4)]\n",
      "25548805: [('1431', 1)]\n",
      "25666440: [('2717', 2), ('53947', 1), ('5730', 1)]\n",
      "25684225: [('4920', 1), ('1969', 1), ('5362', 1)]\n",
      "25786980: []\n",
      "25857276: []\n",
      "25905469: []\n",
      "25944670: [('723814', 6), ('108101', 2), ('14000', 1), ('387160', 1), ('387161', 1), ('387173', 1)]\n",
      "25945665: []\n",
      "25995210: [('6287', 3), ('335', 1), ('6289', 1), ('20208', 1), ('20209', 1)]\n",
      "26028931: [('3315', 3), ('3308', 3), ('2244', 3), ('3875', 1), ('4735', 1), ('106478911', 1), ('3856', 1), ('813', 1), ('171221', 1), ('307', 1)]\n",
      "26037829: [('6287', 4), ('53369', 3), ('1401', 1), ('3569', 1), ('335', 1)]\n",
      "26063667: [('3075', 8)]\n",
      "26078484: [('462', 3)]\n",
      "26160894: [('116844', 2), ('4069', 1)]\n",
      "26285659: []\n",
      "26437904: []\n",
      "26476107: []\n",
      "26483418: [('5265', 8), ('146', 1)]\n",
      "26535788: [('6289', 2), ('335', 1), ('114548', 1), ('6291', 1)]\n",
      "26561523: [('2244', 5), ('3659', 1)]\n",
      "26564600: [('947', 7), ('494326', 7), ('723857', 2)]\n",
      "26603189: [('3630', 3), ('26998', 2), ('59083', 2)]\n",
      "26620461: [('633', 1), ('10631', 1), ('5549', 1)]\n",
      "26653129: []\n",
      "26688386: [('642658', 1), ('3673', 1), ('320', 1)]\n",
      "26750556: []\n",
      "26792056: [('6279', 6)]\n",
      "26834087: [('6120', 5)]\n",
      "26898369: [('6696', 1)]\n",
      "27084846: [('7052', 6), ('1509', 2), ('1808', 2), ('1200', 2), ('5265', 1)]\n",
      "27095521: [('8935', 2), ('7057', 1)]\n",
      "27122311: [('50802', 2), ('3263', 1), ('7018', 1), ('3240', 1)]\n",
      "27220540: []\n",
      "27230659: [('3934', 4), ('26762', 4)]\n",
      "27308822: [('5265', 1)]\n",
      "27363418: [('7422', 3)]\n",
      "27412778: [('59272', 1), ('10631', 1), ('1490', 1), ('2335', 1)]\n",
      "27429122: []\n",
      "27450324: [('55752', 1), ('2273', 1), ('1805', 1)]\n",
      "27616206: [('6279', 3), ('729359', 2), ('3827', 2)]\n",
      "27624754: [('2023', 6), ('5315', 5), ('811', 1), ('4629', 1), ('100507027', 1)]\n",
      "27711126: [('3320', 2), ('2869', 1), ('336', 1), ('3502', 1), ('309', 1), ('509', 1), ('2949', 1), ('10063', 1), ('857', 1), ('306', 1), ('2805', 1), ('8659', 1), ('5162', 1), ('622', 1), ('66035', 1), ('3326', 1), ('94239', 1), ('3309', 1), ('4723', 1)]\n",
      "27908912: []\n",
      "28196416: [('7276', 4), ('5950', 3)]\n",
      "28209220: [('348', 9), ('345', 6), ('344', 3), ('335', 2), ('338', 2), ('336', 1), ('55937', 1)]\n",
      "28223106: [('338', 1)]\n",
      "28256566: [('5465', 1), ('5595;5594', 1)]\n",
      "28273075: []\n",
      "28329269: [('12', 2), ('10631', 1), ('1462', 1)]\n",
      "28341603: [('1674', 11)]\n",
      "28427148: [('6271', 1), ('1938', 1)]\n",
      "28437237: [('627', 1), ('92737', 1), ('6364', 1), ('4314', 1), ('690', 1), ('26291', 1), ('3593', 1), ('5617', 1), ('7984', 1), ('3569', 1), ('5806', 1), ('6401', 1)]\n",
      "28501389: [('335', 1), ('128876', 1)]\n",
      "28624389: []\n",
      "28679606: []\n",
      "28720870: [('3685', 2), ('2335', 2), ('3371', 2), ('7448', 1)]\n",
      "28784649: []\n",
      "28794502: []\n",
      "28800743: [('11346', 3)]\n",
      "28922609: [('7276', 7)]\n",
      "29151592: [('3303', 2), ('1983', 2), ('2268', 1)]\n",
      "29158831: []\n",
      "29215023: []\n",
      "29235871: []\n",
      "29251807: [('2316', 1), ('6439', 1)]\n",
      "29258006: [('133522', 6), ('152330', 6)]\n",
      "29258991: [('348', 4)]\n",
      "29320704: []\n",
      "29369166: [('6369', 1), ('4879', 1), ('4153', 1), ('4055', 1), ('5118', 1)]\n",
      "29484645: [('4635', 1), ('58498', 1), ('4634', 1), ('4633', 1), ('6876', 1)]\n",
      "29505607: [('4353', 11)]\n",
      "29540862: [('2217', 1), ('7018', 1), ('5265', 1)]\n",
      "29649363: [('335', 9)]\n",
      "29665821: [('4036', 2), ('23334', 2), ('338', 1), ('2', 1)]\n",
      "29676857: [('7001', 1), ('11315', 1), ('664', 1), ('596', 1), ('5160', 1), ('8802', 1), ('34', 1), ('4723', 1)]\n",
      "29682908: [('1756', 3), ('654', 1), ('7077', 1)]\n",
      "29717219: [('6624', 1), ('2947', 1), ('9588', 1), ('4900', 1)]\n",
      "29784904: [('4879', 2), ('101669765', 1), ('6372', 1), ('2919', 1), ('958', 1), ('8517', 1), ('7422', 1), ('5653', 1), ('5175', 1), ('145624', 1), ('4312', 1)]\n",
      "29853569: [('18129', 8), ('4853', 1), ('18810', 1), ('12306', 1), ('4853;18129', 1)]\n",
      "29854824: [('4311', 4), ('7412', 3)]\n",
      "29915101: [('5468', 1)]\n",
      "29956481: []\n",
      "30002058: []\n",
      "30192561: [('351', 1), ('3816', 1)]\n",
      "30201848: [('4353', 7)]\n",
      "30212933: []\n",
      "30224653: []\n",
      "30248148: [('3075', 8), ('7547', 6)]\n",
      "30255987: []\n",
      "30261322: [('335', 3), ('7453', 1), ('2', 1)]\n",
      "30332462: [('7273', 6), ('183', 1)]\n",
      "30347343: []\n",
      "30368668: [('8216', 12), ('5500', 6), ('5894', 4), ('22808', 2)]\n",
      "30451909: [('3630', 1)]\n",
      "30478197: [('6908', 4), ('336', 2), ('1401', 1), ('170589', 1), ('5345', 1)]\n",
      "30496173: []\n",
      "30562113: [('761', 1), ('1674', 1), ('2273', 1)]\n",
      "30571344: [('348', 1), ('51266;5159', 1), ('51266', 1), ('5159', 1)]\n",
      "30658193: [('51206', 6), ('1401', 3), ('2244', 1), ('6714', 1), ('5336', 1)]\n",
      "30739867: [('151648', 4), ('699', 2)]\n",
      "30742448: [('3458', 1), ('7124', 1)]\n",
      "30782942: []\n",
      "30805593: []\n",
      "30806752: [('6256', 1), ('348', 1), ('347', 1), ('7031', 1)]\n",
      "30836973: [('2006', 2), ('1012', 1), ('4582', 1), ('1291', 1), ('6407', 1)]\n",
      "30838756: [('2244', 3), ('2', 1), ('346288', 1), ('203068', 1)]\n",
      "30870787: [('5034', 15), ('2335', 1)]\n",
      "30874584: [('50848', 4), ('4345', 3), ('2828', 3), ('1003', 2), ('59284', 2)]\n",
      "30887811: []\n",
      "30907085: []\n",
      "30922315: [('3080', 3), ('3700', 2), ('1', 1), ('213', 1)]\n",
      "30928653: []\n",
      "31056672: []\n",
      "31092728: [('5321', 3), ('5320', 1)]\n",
      "31104495: [('7124', 2)]\n",
      "31186442: [('3620', 7)]\n",
      "31204432: [('567', 1), ('229', 1), ('710', 1)]\n",
      "31242583: [('875', 1), ('4790', 1)]\n",
      "31286493: [('4010', 2)]\n",
      "31434864: []\n",
      "31476444: [('5444', 8), ('1471', 2), ('4069', 2), ('336;55937', 2)]\n",
      "31494943: [('2697', 2), ('146', 1)]\n",
      "31562990: [('2244', 1), ('3558', 1), ('3576', 1), ('3586', 1), ('3569', 1)]\n",
      "31585756: [('5829', 2), ('7431', 2), ('182', 2), ('9806', 1), ('4237', 1), ('4851', 1)]\n",
      "31734660: []\n",
      "31806903: []\n",
      "31819116: []\n",
      "31844116: [('718', 1), ('4312', 1), ('4316', 1)]\n",
      "31862877: [('7058', 1), ('2934', 1)]\n",
      "31918764: [('4879', 1), ('3934', 1), ('1351', 1)]\n",
      "31988066: [('5972', 4), ('9518', 2), ('9370', 2), ('5654', 1), ('292', 1), ('1956', 1), ('1272', 1)]\n",
      "32117548: [('347902', 2)]\n",
      "32178279: []\n",
      "32385381: [('3250', 3), ('6256', 1)]\n",
      "32427855: [('5284', 9), ('80739', 1)]\n",
      "32487995: [('6288', 1), ('7296', 1)]\n",
      "32806897: [('None', 1), ('335', 1)]\n",
      "32938215: [('350', 10), ('1401', 2)]\n",
      "20603051: [('488', 1), ('488;1769', 1)]\n",
      "20811296: [('5265', 1), ('27344', 1)]\n",
      "20817827: [('875', 1), ('1491', 1)]\n",
      "20853909: [('7369', 1)]\n",
      "20936720: [('6280', 1)]\n",
      "20936781: []\n",
      "21041689: [('25932', 3), ('10631', 1), ('7422', 1)]\n",
      "21043527: [('1191', 12)]\n",
      "21166718: [('3308', 3), ('3043', 2), ('2810', 2), ('811', 2), ('3713', 2), ('3308;3320;3860;3861;3868;3872;3880', 1), ('3963', 1), ('7295', 1), ('4633', 1), ('4634', 1), ('7018', 1), ('3860', 1), ('3320', 1), ('7054', 1)]\n",
      "21211997: [('12', 2)]\n",
      "21468545: []\n",
      "21545686: [('3315', 2), ('126393', 2), ('7276', 1)]\n",
      "21593211: [('4321', 4), ('7058', 1), ('165', 1), ('10631', 1), ('2335', 1), ('3371', 1)]\n",
      "21681990: [('11816', 5), ('238055', 1), ('11812', 1), ('21828', 1)]\n",
      "21712045: [('8165', 2), ('5592', 1)]\n",
      "21736391: [('10611', 1), ('11034', 1)]\n",
      "21751358: [('7414', 1), ('7431', 1), ('338382', 1), ('2597', 1)]\n",
      "21767674: [('3240', 2)]\n",
      "22221959: [('10211', 2), ('7251', 2)]\n",
      "22276806: [('335', 1), ('5265', 1), ('7431', 1), ('6647', 1), ('6876', 1), ('3240', 1), ('2878', 1), ('3315', 1), ('811', 1)]\n",
      "22384053: []\n",
      "22435364: []\n",
      "22543060: [('4633', 1), ('4629', 1), ('7414', 1)]\n",
      "22665935: [('5413', 2), ('6352', 2), ('6810', 1), ('20304', 1)]\n",
      "22781565: [('4633;103910', 1), ('3039', 1), ('140465', 1)]\n",
      "22789915: []\n",
      "22959663: [('335', 2), ('2167', 1)]\n",
      "23002038: [('10631', 1), ('3308', 1)]\n",
      "23160667: []\n",
      "23195030: []\n",
      "23384050: [('773', 3), ('153', 1)]\n",
      "23431486: [('3240', 1), ('5265', 1)]\n",
      "23519648: [('100329167', 5)]\n",
      "23593175: [('5586', 2), ('6285', 2), ('7297', 2), ('1805', 1), ('5747', 1), ('4921', 1)]\n",
      "23660474: [('2', 1), ('1356', 1), ('3303', 1), ('301', 1), ('4057', 1)]\n",
      "23701180: [('3240', 4)]\n",
      "23704777: [('5176', 1)]\n",
      "23797974: []\n",
      "23804534: [('4846', 1)]\n",
      "23836408: [('857', 4), ('6275', 1), ('2023', 1), ('3956', 1)]\n",
      "23916682: [('348', 4), ('7276', 4), ('335', 2), ('84909', 1)]\n",
      "23974919: [('4780', 10), ('1728', 5), ('571', 1), ('11315', 1)]\n",
      "24055733: [('6198', 2)]\n",
      "24140280: [('5473', 6), ('3240', 4), ('721', 4)]\n",
      "24182678: [('7276', 9)]\n",
      "24548642: [('4137', 2)]\n",
      "24689886: [('4680', 2)]\n",
      "24738046: [('3329', 4), ('1674', 1), ('9124', 1), ('5682', 1), ('7168', 1), ('4199', 1)]\n",
      "24780726: [('348', 2), ('319', 1)]\n",
      "24859250: [('6287', 3), ('341', 2)]\n",
      "25065337: [('3075', 8)]\n",
      "25072840: []\n",
      "25083839: []\n",
      "25099258: []\n",
      "25117565: [('6280', 4)]\n",
      "25217443: [('5216', 8)]\n",
      "25226522: [('6238', 3), ('2081', 2), ('6252', 1), ('3309', 1), ('7494', 1), ('22926', 1), ('3895', 1), ('57142', 1)]\n",
      "25318410: [('5950', 3), ('718', 2), ('9370', 2), ('183', 2)]\n",
      "25341944: [('335', 7), ('345', 1), ('53369', 1), ('336', 1)]\n",
      "25382018: [('1915', 1), ('10935', 1)]\n",
      "25397948: [('10935', 3), ('1738', 1), ('1915', 1)]\n",
      "25424990: [('6439', 5), ('6287', 4)]\n",
      "25548805: [('1431', 1)]\n",
      "25666440: [('2717', 2), ('53947', 1), ('5730', 1)]\n",
      "25684225: [('4920', 1), ('1969', 1), ('5362', 1)]\n",
      "25786980: []\n",
      "25857276: []\n",
      "25905469: []\n",
      "25944670: [('723814', 6), ('108101', 2), ('14000', 1), ('387160', 1), ('387161', 1), ('387173', 1)]\n",
      "25945665: []\n",
      "25995210: [('6287', 3), ('335', 1), ('6289', 1), ('20208', 1), ('20209', 1)]\n",
      "26028931: [('3315', 3), ('3308', 3), ('2244', 3), ('3875', 1), ('4735', 1), ('106478911', 1), ('3856', 1), ('813', 1), ('171221', 1), ('307', 1)]\n",
      "26037829: [('6287', 4), ('53369', 3), ('1401', 1), ('3569', 1), ('335', 1)]\n",
      "26063667: [('3075', 8)]\n",
      "26078484: [('462', 3)]\n",
      "26160894: [('116844', 2), ('4069', 1)]\n",
      "26285659: []\n",
      "26437904: []\n",
      "26476107: []\n",
      "26483418: [('5265', 8), ('146', 1)]\n",
      "26535788: [('6289', 2), ('335', 1), ('114548', 1), ('6291', 1)]\n",
      "26561523: [('2244', 5), ('3659', 1)]\n",
      "26564600: [('947', 7), ('494326', 7), ('723857', 2)]\n",
      "26603189: [('3630', 3), ('26998', 2), ('59083', 2)]\n",
      "26620461: [('633', 1), ('10631', 1), ('5549', 1)]\n",
      "26653129: []\n",
      "26688386: [('642658', 1), ('3673', 1), ('320', 1)]\n",
      "26750556: []\n",
      "26792056: [('6279', 6)]\n",
      "26834087: [('6120', 5)]\n",
      "26898369: [('6696', 1)]\n",
      "27084846: [('7052', 6), ('1509', 2), ('1808', 2), ('1200', 2), ('5265', 1)]\n",
      "27095521: [('8935', 2), ('7057', 1)]\n",
      "27122311: [('50802', 2), ('3263', 1), ('7018', 1), ('3240', 1)]\n",
      "27220540: []\n",
      "27230659: [('3934', 4), ('26762', 4)]\n",
      "27308822: [('5265', 1)]\n",
      "27363418: [('7422', 3)]\n",
      "27412778: [('59272', 1), ('10631', 1), ('1490', 1), ('2335', 1)]\n",
      "27429122: []\n",
      "27616206: [('6279', 3), ('729359', 2), ('3827', 2)]\n",
      "27908912: []\n",
      "28196416: [('7276', 4), ('5950', 3)]\n",
      "28209220: [('348', 9), ('345', 6), ('344', 3), ('335', 2), ('338', 2), ('336', 1), ('55937', 1)]\n",
      "28223106: [('338', 1)]\n",
      "28256566: [('5465', 1), ('5595;5594', 1)]\n",
      "28273075: []\n",
      "28329269: [('12', 2), ('10631', 1), ('1462', 1)]\n",
      "28341603: [('1674', 11)]\n",
      "28427148: [('6271', 1), ('1938', 1)]\n",
      "28437237: [('627', 1), ('92737', 1), ('6364', 1), ('4314', 1), ('690', 1), ('26291', 1), ('3593', 1), ('5617', 1), ('7984', 1), ('3569', 1), ('5806', 1), ('6401', 1)]\n",
      "28501389: [('335', 1), ('128876', 1)]\n",
      "28624389: []\n",
      "28679606: []\n",
      "28720870: [('3685', 2), ('2335', 2), ('3371', 2), ('7448', 1)]\n",
      "28784649: []\n",
      "28794502: []\n",
      "28800743: [('11346', 3)]\n",
      "28922609: [('7276', 7)]\n",
      "29151592: [('3303', 2), ('1983', 2), ('2268', 1)]\n",
      "29158831: []\n",
      "29215023: []\n",
      "29235871: []\n",
      "29251807: [('2316', 1), ('6439', 1)]\n",
      "29258006: [('133522', 6), ('152330', 6)]\n",
      "29258991: [('348', 4)]\n",
      "29320704: []\n",
      "29369166: [('6369', 1), ('4879', 1), ('4153', 1), ('4055', 1), ('5118', 1)]\n",
      "29484645: [('4635', 1), ('58498', 1), ('4634', 1), ('4633', 1), ('6876', 1)]\n",
      "29505607: [('4353', 11)]\n",
      "29540862: [('2217', 1), ('7018', 1), ('5265', 1)]\n",
      "29649363: [('335', 9)]\n",
      "29665821: [('4036', 2), ('23334', 2), ('338', 1), ('2', 1)]\n",
      "29676857: [('7001', 1), ('11315', 1), ('664', 1), ('596', 1), ('5160', 1), ('8802', 1), ('34', 1), ('4723', 1)]\n",
      "29682908: [('1756', 3), ('654', 1), ('7077', 1)]\n",
      "29717219: [('6624', 1), ('2947', 1), ('9588', 1), ('4900', 1)]\n",
      "29784904: [('4879', 2), ('101669765', 1), ('6372', 1), ('2919', 1), ('958', 1), ('8517', 1), ('7422', 1), ('5653', 1), ('5175', 1), ('145624', 1), ('4312', 1)]\n",
      "29853569: [('18129', 8), ('4853', 1), ('18810', 1), ('12306', 1), ('4853;18129', 1)]\n",
      "29854824: [('4311', 4), ('7412', 3)]\n",
      "29915101: [('5468', 1)]\n",
      "29956481: []\n",
      "30002058: []\n",
      "30192561: [('351', 1), ('3816', 1)]\n",
      "30201848: [('4353', 7)]\n",
      "30212933: []\n",
      "30224653: []\n",
      "30248148: [('3075', 8), ('7547', 6)]\n",
      "30255987: []\n",
      "30261322: [('335', 3), ('7453', 1), ('2', 1)]\n",
      "30332462: [('7273', 6), ('183', 1)]\n",
      "30347343: []\n",
      "30368668: [('8216', 12), ('5500', 6), ('5894', 4), ('22808', 2)]\n",
      "30451909: [('3630', 1)]\n",
      "30478197: [('6908', 4), ('336', 2), ('1401', 1), ('170589', 1), ('5345', 1)]\n",
      "30496173: []\n",
      "30562113: [('761', 1), ('1674', 1), ('2273', 1)]\n",
      "30571344: [('348', 1), ('51266;5159', 1), ('51266', 1), ('5159', 1)]\n",
      "30658193: [('51206', 6), ('1401', 3), ('2244', 1), ('6714', 1), ('5336', 1)]\n",
      "30739867: [('151648', 4), ('699', 2)]\n",
      "30742448: [('3458', 1), ('7124', 1)]\n",
      "30782942: []\n",
      "30805593: []\n",
      "30806752: [('6256', 1), ('348', 1), ('347', 1), ('7031', 1)]\n",
      "30836973: [('2006', 2), ('1012', 1), ('4582', 1), ('1291', 1), ('6407', 1)]\n",
      "30838756: [('2244', 3), ('2', 1), ('346288', 1), ('203068', 1)]\n",
      "30870787: [('5034', 15), ('2335', 1)]\n",
      "30874584: [('50848', 4), ('4345', 3), ('2828', 3), ('1003', 2), ('59284', 2)]\n",
      "30887811: []\n",
      "30907085: []\n",
      "30922315: [('3080', 3), ('3700', 2), ('1', 1), ('213', 1)]\n",
      "30928653: []\n",
      "31056672: []\n",
      "31092728: [('5321', 3), ('5320', 1)]\n",
      "31104495: [('7124', 2)]\n",
      "31186442: [('3620', 7)]\n",
      "31204432: [('567', 1), ('229', 1), ('710', 1)]\n",
      "31242583: [('875', 1), ('4790', 1)]\n",
      "31286493: [('4010', 2)]\n",
      "31434864: []\n",
      "31476444: [('5444', 8), ('1471', 2), ('4069', 2), ('336;55937', 2)]\n",
      "31494943: [('2697', 2), ('146', 1)]\n",
      "31562990: [('2244', 1), ('3558', 1), ('3576', 1), ('3586', 1), ('3569', 1)]\n",
      "31585756: [('5829', 2), ('7431', 2), ('182', 2), ('9806', 1), ('4237', 1), ('4851', 1)]\n",
      "31734660: []\n",
      "31783201: [('197', 6), ('302', 5)]\n",
      "31806903: []\n",
      "31819116: []\n",
      "31825151: [('84061', 1), ('978', 1), ('5641', 1), ('8942', 1), ('10923', 1)]\n",
      "31844116: [('718', 1), ('4312', 1), ('4316', 1)]\n",
      "31862877: [('7058', 1), ('2934', 1)]\n",
      "31918764: [('4879', 1), ('3934', 1), ('1351', 1)]\n",
      "31988066: [('5972', 4), ('9518', 2), ('9370', 2), ('5654', 1), ('292', 1), ('1956', 1), ('1272', 1)]\n",
      "32117548: [('347902', 2)]\n",
      "32178279: []\n",
      "32385381: [('3250', 3), ('6256', 1)]\n",
      "32427855: [('5284', 9), ('80739', 1)]\n",
      "32487995: [('6288', 1), ('7296', 1)]\n",
      "32704130: [('929', 1), ('1471', 1), ('462', 1), ('710', 1)]\n",
      "32806897: [('None', 1), ('335', 1)]\n",
      "32938215: [('350', 10), ('1401', 2)]\n",
      "20853909: [('7369', 1)]\n",
      "20936720: [('6280', 1)]\n",
      "20936781: []\n",
      "21041689: [('25932', 3), ('10631', 1), ('7422', 1)]\n",
      "21043527: [('1191', 12)]\n",
      "21166718: [('3308', 3), ('3043', 2), ('2810', 2), ('811', 2), ('3713', 2), ('3308;3320;3860;3861;3868;3872;3880', 1), ('3963', 1), ('7295', 1), ('4633', 1), ('4634', 1), ('7018', 1), ('3860', 1), ('3320', 1), ('7054', 1)]\n",
      "21211997: [('12', 2)]\n",
      "21468545: []\n",
      "21545686: [('3315', 2), ('126393', 2), ('7276', 1)]\n",
      "21593211: [('4321', 4), ('7058', 1), ('165', 1), ('10631', 1), ('2335', 1), ('3371', 1)]\n",
      "21681990: [('11816', 5), ('238055', 1), ('11812', 1), ('21828', 1)]\n",
      "21712045: [('8165', 2), ('5592', 1)]\n",
      "21736391: [('10611', 1), ('11034', 1)]\n",
      "21751358: [('7414', 1), ('7431', 1), ('338382', 1), ('2597', 1)]\n",
      "21767674: [('3240', 2)]\n",
      "22221959: [('10211', 2), ('7251', 2)]\n",
      "22276806: [('335', 1), ('5265', 1), ('7431', 1), ('6647', 1), ('6876', 1), ('3240', 1), ('2878', 1), ('3315', 1), ('811', 1)]\n",
      "22384053: []\n",
      "22435364: []\n",
      "22543060: [('4633', 1), ('4629', 1), ('7414', 1)]\n",
      "22665935: [('5413', 2), ('6352', 2), ('6810', 1), ('20304', 1)]\n",
      "22781565: [('4633;103910', 1), ('3039', 1), ('140465', 1)]\n",
      "22789915: []\n",
      "22959663: [('335', 2), ('2167', 1)]\n",
      "23002038: [('10631', 1), ('3308', 1)]\n",
      "23160667: []\n",
      "23195030: []\n",
      "23384050: [('773', 3), ('153', 1)]\n",
      "23431486: [('3240', 1), ('5265', 1)]\n",
      "23519648: [('100329167', 5)]\n",
      "23593175: [('5586', 2), ('6285', 2), ('7297', 2), ('1805', 1), ('5747', 1), ('4921', 1)]\n",
      "23660474: [('2', 1), ('1356', 1), ('3303', 1), ('301', 1), ('4057', 1)]\n",
      "23701180: [('3240', 4)]\n",
      "23704777: [('5176', 1)]\n",
      "23797974: []\n",
      "23804534: [('4846', 1)]\n",
      "23836408: [('857', 4), ('6275', 1), ('2023', 1), ('3956', 1)]\n",
      "23916682: [('348', 4), ('7276', 4), ('335', 2), ('84909', 1)]\n",
      "23974919: [('4780', 10), ('1728', 5), ('571', 1), ('11315', 1)]\n",
      "24055733: [('6198', 2)]\n",
      "24140280: [('5473', 6), ('3240', 4), ('721', 4)]\n",
      "24182678: [('7276', 9)]\n",
      "24548642: [('4137', 2)]\n",
      "24689886: [('4680', 2)]\n",
      "24738046: [('3329', 4), ('1674', 1), ('9124', 1), ('5682', 1), ('7168', 1), ('4199', 1)]\n",
      "24780726: [('348', 2), ('319', 1)]\n",
      "24859250: [('6287', 3), ('341', 2)]\n",
      "25065337: [('3075', 8)]\n",
      "25072840: []\n",
      "25083839: []\n",
      "25099258: []\n",
      "25117565: [('6280', 4)]\n",
      "25217443: [('5216', 8)]\n",
      "25226522: [('6238', 3), ('2081', 2), ('6252', 1), ('3309', 1), ('7494', 1), ('22926', 1), ('3895', 1), ('57142', 1)]\n",
      "25318410: [('5950', 3), ('718', 2), ('9370', 2), ('183', 2)]\n",
      "25341944: [('335', 7), ('345', 1), ('53369', 1), ('336', 1)]\n",
      "25382018: [('1915', 1), ('10935', 1)]\n",
      "25397948: [('10935', 3), ('1738', 1), ('1915', 1)]\n",
      "25424990: [('6439', 5), ('6287', 4)]\n",
      "25548805: [('1431', 1)]\n",
      "25666440: [('2717', 2), ('53947', 1), ('5730', 1)]\n",
      "25684225: [('4920', 1), ('1969', 1), ('5362', 1)]\n",
      "25786980: []\n",
      "25857276: []\n",
      "25905469: []\n",
      "25944670: [('723814', 6), ('108101', 2), ('14000', 1), ('387160', 1), ('387161', 1), ('387173', 1)]\n",
      "25945665: []\n",
      "25995210: [('6287', 3), ('335', 1), ('6289', 1), ('20208', 1), ('20209', 1)]\n",
      "26028931: [('3315', 3), ('3308', 3), ('2244', 3), ('3875', 1), ('4735', 1), ('106478911', 1), ('3856', 1), ('813', 1), ('171221', 1), ('307', 1)]\n",
      "26037829: [('6287', 4), ('53369', 3), ('1401', 1), ('3569', 1), ('335', 1)]\n",
      "26063667: [('3075', 8)]\n",
      "26078484: [('462', 3)]\n",
      "26160894: [('116844', 2), ('4069', 1)]\n",
      "26285659: []\n",
      "26437904: []\n",
      "26476107: []\n",
      "26483418: [('5265', 8), ('146', 1)]\n",
      "26535788: [('6289', 2), ('335', 1), ('114548', 1), ('6291', 1)]\n",
      "26561523: [('2244', 5), ('3659', 1)]\n",
      "26564600: [('947', 7), ('494326', 7), ('723857', 2)]\n",
      "26603189: [('3630', 3), ('26998', 2), ('59083', 2)]\n",
      "26620461: [('633', 1), ('10631', 1), ('5549', 1)]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "26653129: []\n",
      "26688386: [('642658', 1), ('3673', 1), ('320', 1)]\n",
      "26750556: []\n",
      "26792056: [('6279', 6)]\n",
      "26834087: [('6120', 5)]\n",
      "26898369: [('6696', 1)]\n",
      "27084846: [('7052', 6), ('1509', 2), ('1808', 2), ('1200', 2), ('5265', 1)]\n",
      "27095521: [('8935', 2), ('7057', 1)]\n",
      "27122311: [('50802', 2), ('3263', 1), ('7018', 1), ('3240', 1)]\n",
      "27220540: []\n",
      "27230659: [('3934', 4), ('26762', 4)]\n",
      "27308822: [('5265', 1)]\n",
      "27363418: [('7422', 3)]\n",
      "27412778: [('59272', 1), ('10631', 1), ('1490', 1), ('2335', 1)]\n",
      "27429122: []\n",
      "27450324: [('55752', 1), ('2273', 1), ('1805', 1)]\n",
      "27624754: [('2023', 6), ('5315', 5), ('811', 1), ('4629', 1), ('100507027', 1)]\n",
      "27711126: [('3320', 2), ('2869', 1), ('336', 1), ('3502', 1), ('309', 1), ('509', 1), ('2949', 1), ('10063', 1), ('857', 1), ('306', 1), ('2805', 1), ('8659', 1), ('5162', 1), ('622', 1), ('66035', 1), ('3326', 1), ('94239', 1), ('3309', 1), ('4723', 1)]\n",
      "27616206: [('6279', 3), ('729359', 2), ('3827', 2)]\n",
      "27908912: []\n",
      "28196416: [('7276', 4), ('5950', 3)]\n",
      "28209220: [('348', 9), ('345', 6), ('344', 3), ('335', 2), ('338', 2), ('336', 1), ('55937', 1)]\n",
      "28223106: [('338', 1)]\n",
      "28256566: [('5465', 1), ('5595;5594', 1)]\n",
      "28273075: []\n",
      "28329269: [('12', 2), ('10631', 1), ('1462', 1)]\n",
      "28341603: [('1674', 11)]\n",
      "28427148: [('6271', 1), ('1938', 1)]\n",
      "28437237: [('627', 1), ('92737', 1), ('6364', 1), ('4314', 1), ('690', 1), ('26291', 1), ('3593', 1), ('5617', 1), ('7984', 1), ('3569', 1), ('5806', 1), ('6401', 1)]\n",
      "28501389: [('335', 1), ('128876', 1)]\n",
      "28624389: []\n",
      "28679606: []\n",
      "28720870: [('3685', 2), ('2335', 2), ('3371', 2), ('7448', 1)]\n",
      "28784649: []\n",
      "28794502: []\n",
      "28800743: [('11346', 3)]\n",
      "28922609: [('7276', 7)]\n",
      "29151592: [('3303', 2), ('1983', 2), ('2268', 1)]\n",
      "29158831: []\n",
      "29215023: []\n",
      "29235871: []\n",
      "29251807: [('2316', 1), ('6439', 1)]\n",
      "29258006: [('133522', 6), ('152330', 6)]\n",
      "29258991: [('348', 4)]\n",
      "29320704: []\n",
      "29369166: [('6369', 1), ('4879', 1), ('4153', 1), ('4055', 1), ('5118', 1)]\n",
      "29484645: [('4635', 1), ('58498', 1), ('4634', 1), ('4633', 1), ('6876', 1)]\n",
      "29505607: [('4353', 11)]\n",
      "29540862: [('2217', 1), ('7018', 1), ('5265', 1)]\n",
      "29649363: [('335', 9)]\n",
      "29665821: [('4036', 2), ('23334', 2), ('338', 1), ('2', 1)]\n",
      "29676857: [('7001', 1), ('11315', 1), ('664', 1), ('596', 1), ('5160', 1), ('8802', 1), ('34', 1), ('4723', 1)]\n",
      "29682908: [('1756', 3), ('654', 1), ('7077', 1)]\n",
      "29717219: [('6624', 1), ('2947', 1), ('9588', 1), ('4900', 1)]\n",
      "29784904: [('4879', 2), ('101669765', 1), ('6372', 1), ('2919', 1), ('958', 1), ('8517', 1), ('7422', 1), ('5653', 1), ('5175', 1), ('145624', 1), ('4312', 1)]\n",
      "29853569: [('18129', 8), ('4853', 1), ('18810', 1), ('12306', 1), ('4853;18129', 1)]\n",
      "29854824: [('4311', 4), ('7412', 3)]\n",
      "29915101: [('5468', 1)]\n",
      "29956481: []\n",
      "30002058: []\n",
      "30192561: [('351', 1), ('3816', 1)]\n",
      "30201848: [('4353', 7)]\n",
      "30212933: []\n",
      "30224653: []\n",
      "30248148: [('3075', 8), ('7547', 6)]\n",
      "30255987: []\n",
      "30261322: [('335', 3), ('7453', 1), ('2', 1)]\n",
      "30332462: [('7273', 6), ('183', 1)]\n",
      "30347343: []\n",
      "30368668: [('8216', 12), ('5500', 6), ('5894', 4), ('22808', 2)]\n",
      "30451909: [('3630', 1)]\n",
      "30478197: [('6908', 4), ('336', 2), ('1401', 1), ('170589', 1), ('5345', 1)]\n",
      "30496173: []\n",
      "30562113: [('761', 1), ('1674', 1), ('2273', 1)]\n",
      "30571344: [('348', 1), ('51266;5159', 1), ('51266', 1), ('5159', 1)]\n",
      "30658193: [('51206', 6), ('1401', 3), ('2244', 1), ('6714', 1), ('5336', 1)]\n",
      "30739867: [('151648', 4), ('699', 2)]\n",
      "30742448: [('3458', 1), ('7124', 1)]\n",
      "30782942: []\n",
      "30805593: []\n",
      "30806752: [('6256', 1), ('348', 1), ('347', 1), ('7031', 1)]\n",
      "30836973: [('2006', 2), ('1012', 1), ('4582', 1), ('1291', 1), ('6407', 1)]\n",
      "30838756: [('2244', 3), ('2', 1), ('346288', 1), ('203068', 1)]\n",
      "30870787: [('5034', 15), ('2335', 1)]\n",
      "30874584: [('50848', 4), ('4345', 3), ('2828', 3), ('1003', 2), ('59284', 2)]\n",
      "30887811: []\n",
      "30907085: []\n",
      "30922315: [('3080', 3), ('3700', 2), ('1', 1), ('213', 1)]\n",
      "30928653: []\n",
      "31056672: []\n",
      "31092728: [('5321', 3), ('5320', 1)]\n",
      "31104495: [('7124', 2)]\n",
      "31186442: [('3620', 7)]\n",
      "31204432: [('567', 1), ('229', 1), ('710', 1)]\n",
      "31242583: [('875', 1), ('4790', 1)]\n",
      "31286493: [('4010', 2)]\n",
      "31434864: []\n",
      "31476444: [('5444', 8), ('1471', 2), ('4069', 2), ('336;55937', 2)]\n",
      "31494943: [('2697', 2), ('146', 1)]\n",
      "31562990: [('2244', 1), ('3558', 1), ('3576', 1), ('3586', 1), ('3569', 1)]\n",
      "31585756: [('5829', 2), ('7431', 2), ('182', 2), ('9806', 1), ('4237', 1), ('4851', 1)]\n",
      "31734660: []\n",
      "31783201: [('197', 6), ('302', 5)]\n",
      "31806903: []\n",
      "31819116: []\n",
      "31825151: [('84061', 1), ('978', 1), ('5641', 1), ('8942', 1), ('10923', 1)]\n",
      "31844116: [('718', 1), ('4312', 1), ('4316', 1)]\n",
      "31862877: [('7058', 1), ('2934', 1)]\n",
      "31918764: [('4879', 1), ('3934', 1), ('1351', 1)]\n",
      "31988066: [('5972', 4), ('9518', 2), ('9370', 2), ('5654', 1), ('292', 1), ('1956', 1), ('1272', 1)]\n",
      "32117548: [('347902', 2)]\n",
      "32178279: []\n",
      "32385381: [('3250', 3), ('6256', 1)]\n",
      "32427855: [('5284', 9), ('80739', 1)]\n",
      "32487995: [('6288', 1), ('7296', 1)]\n",
      "32704130: [('929', 1), ('1471', 1), ('462', 1), ('710', 1)]\n",
      "32806897: [('None', 1), ('335', 1)]\n",
      "32938215: [('350', 10), ('1401', 2)]\n",
      "20853909: [('7369', 1)]\n",
      "20936720: [('6280', 1)]\n",
      "20936781: []\n",
      "21041689: [('25932', 3), ('10631', 1), ('7422', 1)]\n",
      "21043527: [('1191', 12)]\n",
      "21166718: [('3308', 3), ('3043', 2), ('2810', 2), ('811', 2), ('3713', 2), ('3308;3320;3860;3861;3868;3872;3880', 1), ('3963', 1), ('7295', 1), ('4633', 1), ('4634', 1), ('7018', 1), ('3860', 1), ('3320', 1), ('7054', 1)]\n",
      "21211997: [('12', 2)]\n",
      "21468545: []\n",
      "21545686: [('3315', 2), ('126393', 2), ('7276', 1)]\n",
      "21593211: [('4321', 4), ('7058', 1), ('165', 1), ('10631', 1), ('2335', 1), ('3371', 1)]\n",
      "21681990: [('11816', 5), ('238055', 1), ('11812', 1), ('21828', 1)]\n",
      "21712045: [('8165', 2), ('5592', 1)]\n",
      "21736391: [('10611', 1), ('11034', 1)]\n",
      "21751358: [('7414', 1), ('7431', 1), ('338382', 1), ('2597', 1)]\n",
      "21767674: [('3240', 2)]\n",
      "22221959: [('10211', 2), ('7251', 2)]\n",
      "22276806: [('335', 1), ('5265', 1), ('7431', 1), ('6647', 1), ('6876', 1), ('3240', 1), ('2878', 1), ('3315', 1), ('811', 1)]\n",
      "22384053: []\n",
      "22435364: []\n",
      "22543060: [('4633', 1), ('4629', 1), ('7414', 1)]\n",
      "22665935: [('5413', 2), ('6352', 2), ('6810', 1), ('20304', 1)]\n",
      "22781565: [('4633;103910', 1), ('3039', 1), ('140465', 1)]\n",
      "22789915: []\n",
      "22959663: [('335', 2), ('2167', 1)]\n",
      "23002038: [('10631', 1), ('3308', 1)]\n",
      "23160667: []\n",
      "23195030: []\n",
      "23384050: [('773', 3), ('153', 1)]\n",
      "23431486: [('3240', 1), ('5265', 1)]\n",
      "23519648: [('100329167', 5)]\n",
      "23593175: [('5586', 2), ('6285', 2), ('7297', 2), ('1805', 1), ('5747', 1), ('4921', 1)]\n",
      "23660474: [('2', 1), ('1356', 1), ('3303', 1), ('301', 1), ('4057', 1)]\n",
      "23701180: [('3240', 4)]\n",
      "23704777: [('5176', 1)]\n",
      "23797974: []\n",
      "23804534: [('4846', 1)]\n",
      "23836408: [('857', 4), ('6275', 1), ('2023', 1), ('3956', 1)]\n",
      "23916682: [('348', 4), ('7276', 4), ('335', 2), ('84909', 1)]\n",
      "23974919: [('4780', 10), ('1728', 5), ('571', 1), ('11315', 1)]\n",
      "24055733: [('6198', 2)]\n",
      "24140280: [('5473', 6), ('3240', 4), ('721', 4)]\n",
      "24182678: [('7276', 9)]\n",
      "24548642: [('4137', 2)]\n",
      "24689886: [('4680', 2)]\n",
      "24738046: [('3329', 4), ('1674', 1), ('9124', 1), ('5682', 1), ('7168', 1), ('4199', 1)]\n",
      "24780726: [('348', 2), ('319', 1)]\n",
      "24859250: [('6287', 3), ('341', 2)]\n",
      "25065337: [('3075', 8)]\n",
      "25072840: []\n",
      "25083839: []\n",
      "25099258: []\n",
      "25117565: [('6280', 4)]\n",
      "25217443: [('5216', 8)]\n",
      "25226522: [('6238', 3), ('2081', 2), ('6252', 1), ('3309', 1), ('7494', 1), ('22926', 1), ('3895', 1), ('57142', 1)]\n",
      "25318410: [('5950', 3), ('718', 2), ('9370', 2), ('183', 2)]\n",
      "25341944: [('335', 7), ('345', 1), ('53369', 1), ('336', 1)]\n",
      "25382018: [('1915', 1), ('10935', 1)]\n",
      "25397948: [('10935', 3), ('1738', 1), ('1915', 1)]\n",
      "25424990: [('6439', 5), ('6287', 4)]\n",
      "25548805: [('1431', 1)]\n",
      "25666440: [('2717', 2), ('53947', 1), ('5730', 1)]\n",
      "25684225: [('4920', 1), ('1969', 1), ('5362', 1)]\n",
      "25786980: []\n",
      "25857276: []\n",
      "25905469: []\n",
      "25944670: [('723814', 6), ('108101', 2), ('14000', 1), ('387160', 1), ('387161', 1), ('387173', 1)]\n",
      "25945665: []\n",
      "25995210: [('6287', 3), ('335', 1), ('6289', 1), ('20208', 1), ('20209', 1)]\n",
      "26028931: [('3315', 3), ('3308', 3), ('2244', 3), ('3875', 1), ('4735', 1), ('106478911', 1), ('3856', 1), ('813', 1), ('171221', 1), ('307', 1)]\n",
      "26037829: [('6287', 4), ('53369', 3), ('1401', 1), ('3569', 1), ('335', 1)]\n",
      "26063667: [('3075', 8)]\n",
      "26078484: [('462', 3)]\n",
      "26160894: [('116844', 2), ('4069', 1)]\n",
      "26285659: []\n",
      "26437904: []\n",
      "26476107: []\n",
      "26483418: [('5265', 8), ('146', 1)]\n",
      "26535788: [('6289', 2), ('335', 1), ('114548', 1), ('6291', 1)]\n",
      "26561523: [('2244', 5), ('3659', 1)]\n",
      "26564600: [('947', 7), ('494326', 7), ('723857', 2)]\n",
      "26603189: [('3630', 3), ('26998', 2), ('59083', 2)]\n",
      "26620461: [('633', 1), ('10631', 1), ('5549', 1)]\n",
      "26653129: []\n",
      "26688386: [('642658', 1), ('3673', 1), ('320', 1)]\n",
      "26750556: []\n",
      "26792056: [('6279', 6)]\n",
      "26834087: [('6120', 5)]\n",
      "26898369: [('6696', 1)]\n",
      "27084846: [('7052', 6), ('1509', 2), ('1808', 2), ('1200', 2), ('5265', 1)]\n",
      "27095521: [('8935', 2), ('7057', 1)]\n",
      "27122311: [('50802', 2), ('3263', 1), ('7018', 1), ('3240', 1)]\n",
      "27220540: []\n",
      "27230659: [('3934', 4), ('26762', 4)]\n",
      "27308822: [('5265', 1)]\n",
      "27363418: [('7422', 3)]\n",
      "27412778: [('59272', 1), ('10631', 1), ('1490', 1), ('2335', 1)]\n",
      "27429122: []\n",
      "27450324: [('55752', 1), ('2273', 1), ('1805', 1)]\n",
      "27624754: [('2023', 6), ('5315', 5), ('811', 1), ('4629', 1), ('100507027', 1)]\n",
      "27711126: [('3320', 2), ('2869', 1), ('336', 1), ('3502', 1), ('309', 1), ('509', 1), ('2949', 1), ('10063', 1), ('857', 1), ('306', 1), ('2805', 1), ('8659', 1), ('5162', 1), ('622', 1), ('66035', 1), ('3326', 1), ('94239', 1), ('3309', 1), ('4723', 1)]\n"
     ]
    }
   ],
   "source": [
    "#now counting total number of unique annotations for each set, per set and per document\n",
    "\n",
    "fulltext_gene_ids = [] #will hold all the gene ids found across all fulltexts\n",
    "abstract_gene_ids = [] #will hold all the gene ids found across all abstracts\n",
    "\n",
    "for corpus in corpus_filenames:\n",
    "  print(\"\\n* Reading from \" + corpus)\n",
    "  tree = ET.parse(corpus)\n",
    "  root = tree.getroot()\n",
    "  \n",
    "  print(\"\\n** Gene frequency across the entire corpus:\")\n",
    "  corpus_annotations = []\n",
    " \n",
    "  for text in root.findall(\"./document/passage/annotation/infon[1]\"):\n",
    "    #We ignore capitalization to merge counts where it varies\n",
    "    corpus_annotations.append((text.text).lower())\n",
    "  #Have to get counts of each term's occurrence\n",
    "  corpus_annotations_counts = dict(Counter(corpus_annotations))\n",
    "  sorted_corpus_annotations_counts = sorted(corpus_annotations_counts.items(), \n",
    "                                            key=lambda kv: kv[1],\n",
    "                                            reverse = True)\n",
    "  for count in sorted_corpus_annotations_counts:\n",
    "    if corpus == \"cardiac_fulltexts_pubtator_annotations.xml\":    \n",
    "        fulltext_gene_ids.append(count[0])\n",
    "    if corpus == \"cardiac_absts_pubtator_annotations.xml\":\n",
    "        abstract_gene_ids.append(count[0])\n",
    "    print(count[0] +\": \" + str(count[1]))\n",
    "    \n",
    "    \n",
    "  if corpus == \"cardiac_fulltexts_pubtator_annotations.xml\":\n",
    "    print(\"\\n** Gene frequency in each document (identified by PubMed Central ID):\")\n",
    "    \n",
    "  if corpus == \"cardiac_absts_pubtator_annotations.xml\":\n",
    "    print(\"\\n** Gene frequency in each document (identified by PubMed ID):\")\n",
    "    \n",
    "  for document in root.findall(\"document\"):\n",
    "    pmid = document.find('id').text\n",
    "    document_annotations = []\n",
    "    for annotation in document.iter('annotation'):\n",
    "        document_annotations.append(annotation[0].text)\n",
    "    #Now to get counts\n",
    "    doc_annotations_counts = dict(Counter(document_annotations))\n",
    "    sorted_doc_annotations_counts = sorted(doc_annotations_counts.items(), \n",
    "                                            key=lambda kv: kv[1],\n",
    "                                            reverse = True)\n",
    "    print(pmid + \": \" + str(sorted_doc_annotations_counts))\n",
    "    \n",
    "    "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {
    "scrolled": true
   },
   "outputs": [],
   "source": [
    "#converted the uniprot IDs of the heart tissue proteins from The Human Protein Atlas into gene IDs and stored in a csv\n",
    "\n",
    "#this code is reading this csv and putting the gene IDs into an array for the next comparison\n",
    "import csv\n",
    "with open('heart_tissue_gene_ids - Sheet1.csv') as csvfile:\n",
    "    readCSV = csv.reader(csvfile)\n",
    "    \n",
    "    heart_tissue_gene_ids = []\n",
    "    \n",
    "    for row in readCSV:\n",
    "        heart_tissue_gene_ids.append(row[0])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      " **Genes that are in both fulltexts list and heart tissue list from The Human Protein Atlas:\n",
      "['7273', '4879', '9377', '2170', '6262', '5196', '7139', '488', '54205', '282996', '3764', '4878', '3270', '6546', '2626', '26577', '1428', '4634', '7137', '5350', '1410', '1000', '10627', '4512', '4190', '816', '127294', '51422', '84675', '55600', '775', '5139', '4023', '57644', '9086']\n",
      "*The number of gene ids in this list is:\n",
      "35\n",
      "\n",
      " **Genes that are in both abstract list and heart tissue list from The Human Protein Atlas:\n",
      "['1674', '7273', '4879', '11346', '4633', '4634', '22808', '2805', '6271', '4635', '58498', '10611', '153', '7168', '5730', '488', '8988']\n",
      "*The number of gene ids in this list is:\n",
      "17\n"
     ]
    }
   ],
   "source": [
    "#way the intersection between two lists will be found\n",
    "def intersection(lst1, lst2):\n",
    "    temp = set(lst2)\n",
    "    lst3 = [value for value in lst1 if value in temp]\n",
    "    return lst3\n",
    "\n",
    "#these will hold the gene ids that are in the intersections\n",
    "fulltext_intersection = []\n",
    "abstract_intersection = []\n",
    "\n",
    "#finding the intersection between the two lists\n",
    "fulltext_intersection = intersection(fulltext_gene_ids, heart_tissue_gene_ids)\n",
    "abstract_intersection = intersection(abstract_gene_ids, heart_tissue_gene_ids)\n",
    "\n",
    "#printing intersection of fulltext list and heart tissue list\n",
    "print(\"\\n **Genes that are in both fulltexts list and heart tissue list from The Human Protein Atlas:\")\n",
    "\n",
    "print(fulltext_intersection)\n",
    "print(\"*The number of gene ids in this list is:\")\n",
    "print(len(fulltext_intersection))\n",
    "\n",
    "#printing intersection of abstract list and heart tissue list\n",
    "print(\"\\n **Genes that are in both abstract list and heart tissue list from The Human Protein Atlas:\")\n",
    "\n",
    "print(abstract_intersection)\n",
    "print(\"*The number of gene ids in this list is:\" )\n",
    "print(len(abstract_intersection))"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.8.5"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
